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0001
PRORESOLVINGANTIINFLAMMATORY
MECHANISMSARENOVEL POTENTIAL TARGETS
AGAINST EPILEPTOGENESIS
F. Frigerio*, R. Colas†, S. Marchini‡, E. van Vliet§, P. Foerch¶,
E. Aronica§,**,††, M. Perretti†, J. Dalli†, R. Kaminski¶,
A. Vezzani*
*IRCCS-Mario Negri Institute for Pharmacological Research,
Department of Neuroscience, Milan, Italy, †William Harvey
Research Institute, Barts and The London School of Medicine
and Dentistry, Queen Mary University of London, London,
United Kingdom, ‡IRCCS-Mario Negri Institute for
Pharmacological Research, Department of Oncology, Milan,
Italy, §Academic Medical Center, University of Amsterdam,
Amsterdam, Netherlands, ¶UCB Biopharma SPRL, Braine
l’Alleud, Belgium, **Stichting Epilepsie Instellingen Nederland,
Heemstede, Netherlands, **Stichting Epilepsie Instellingen
Nederland, Heemstede, Netherlands, ††Swammerram Institute for
Life Sciences, University of Amsterdam, Amsterdam, Netherlands
Purpose: Resolution of inflammation is an active homeostatic process
controlled by proresolving lipids and peptides. We characterized this pro-
cess during epileptogenesis to test whether boosting resolution mecha-
nisms prevents epileptogenesis or mediates disease modifications.
Method: Our analyses were done in the hippocampus of mice exposed to
status epilepticus (SE) and their sham controls, and patients who died ≤5
or ≥7 days from SE and autopsy controls. Mice were studied 2 h, 24 h
and 72 h after SE (epileptogenesis) evoked by intraamygdala injection of
kainic acid. We measured by RTqPCR and/or immunohistochemistry:
proinflammatory cytokines (IL-1b; TNF-a), proresolving lipid´s biosyn-
thetic enzymes (LOX5; LOX15), key proresolving receptors (ALXR;
ChemR23) and peptides (AnnexinA1; IL-1Ra). Proresolving lipids and
related molecules were measured in mouse hippocampus by LC-MS/MS
lipidomic analysis. The AnnexinA1 fragment Ac2-50, BML111 or PD1n-
3DPA-Me, stable analogues of LipoxinA4 and neuroprotectin PD1n-3DPA,
or their respective vehicles, were injected individually icv in mice twice/
day for 4 days starting 1 h post SE, then mice were killed for neuroin-
flammation analysis.
Results: IL-1b and TNF-a mRNA levels increased by 2 h and remained
elevated for 72 h post SE. LOX5 and LOX15mRNA levels were induced
72 h post SE. ALXR and ChemR23 expression was limited to pyramidal
cells and hilar interneurons in sham mice and autopsy controls while it
was induced in activated astrocytes 72 h post SE in mice and in patients;
AnnexinA1 and PD1n-3DPA were upregulated by 2- and 20-fold,
respectively. PD1n-3DPA-Me injection abolished IL-1b increase during
epileptogenesis while BML111 and Ac2-50 were ineffective.
Conclusion: The activation of proresolving mechanisms occurs with a
delay after the onset of neuroinflammation during epileptogenesis. The
anticipation and potentiation of the resolution response with PD1n-3DPA-
Me inhibited neuroinflammation. PD1n-3DPA-Me is an ideal candidate for
testing potential neuroprotective and anti-epileptogenic actions by boost-
ing resolution mechanisms of neuroinflammation.
0002
NOVELDRUG-SCREENING IN “EPILEPTIC”
ZEBRAFISHUNCOVERSHISTONEDEACETYLASE
(HDAC) 1 AND 3 ASANOVELANTICONVULSANT
TARGET
K. Ibhazehiebo*, C. de la Hoz*, C. Gavrilovici†, J.M. Rho†,
D.M. Kurrasch*
*University of Calgary, Medical Genetics, Calgary, AB,
Canada, †University of Calgary, Department of Pediatrics,
Calgary, AB, Canada
Rationale: Epilepsy is a common neurological condition that affects
approximately 1–2% of the general population. 30–40% of patients are
unresponsive to drugs and continue to suffer from unremitting recurrent
seizures, suggesting a need for drugs with newmechanisms of action. We
created a drug-screening platform that harnesses the power of zebrafish
(ZF) genetics and the measurement of whole animal bioenergetics to
unbiasedly uncover novel agents with unexpected mechanisms of action.
Previously, we identified vorinostat (a broad HDAC-inhibitor) as a
potent and efficacious anticonvulsant agent. In the present study, we fur-
ther investigated class I, IIa, IIb, and IV HDAC inhibitors to identify the
specific class of HDACs that might be responsible for the anticonvulsant
properties observed with vorinostat.
Methods: We introduced mutations into the zebrafish ortholog (kcna1)
of KV1.1 epilepsy-associated gene, and analyzed their bioenergetics pro-
file using the XF24 Extracellular Flux analyzer. Systematic analysis of
bioenergetics activities of 26 HDAC inhibitors in kcna1-null zebrafish
was conducted. All HDAC inhibitors that restored mitochondrially-
mediated bioenergetics to baseline levels were further validated using
video electroencephalogram (EEG) recording in Kv1.1 mutant rodent
models.
Results: HDAC 1 and 3 inhibitors (class I HDAC) effectively restored
elevated mitochondrially-mediated metabolism (p < 0.01), and reversed
the abnormal metabolic bioenergetics profile observed in kcna1-null zeb-
rafish. Also, treatment of the spontaneously seizing Kv1.1 mutant mice
with HDAC 1 and 3 inhibitor led to >50% (p < 0.01) in the frequency of
seizures observed in these mice. This further suggests that inhibition of
HDAC 1 and 3 activity can serve as a potential anticonvulsant target.
Conclusions: Our metabolic approach to drug screening represents a
new direction that could be used to identify therapeutics with novel
mechanisms of action, which might be effective for the treatment of
monogenic intractable epilepsy.
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ANTI-EPILEPTOGENIC ANDEPILEPSY
COMORBIDITYMODIFYING EFFECTSOFA
SELECTIVE T-TYPE CA†+ CHANNELANTAGONIST,
Z944, IN THE POST-STATUS EPILEPTICUSMODELOF
TEMPORAL LOBEEPILEPSY
P.M. Casillas-Espinosa*, E. Braine*, S. Shultz*, N. Jones*,
T. Snutch†, T. O’Brien*, K. Powell*
*The University of Melbourne, Department of Medicine,
Parkville, VIC, Australia, †Michael Smith Laboratories,
University of British Columbia, Vancouver, BC, Canada
Purpose: Current pharmacotherapy for TLE has no disease-modifying
effect on epileptogenesis. T-type Ca†+ channels have been strongly
implicated in the pathogenesis of TLE. Therefore, in this study we set out
to evaluate the effects of Z944, a potent and selective T-type Ca†+ antago-
nist, on epileptogenesis in the post-status epilepticus (post-SE) model of
TLE.
Method: Wistar rats underwent implantation of EEG recording elec-
trodes and kainic acid induced SE for 4 hours. Sham animals
received saline injections only. SE was terminated with diazepam and
animals were assigned to one of five treatment groups: post-SE+Z944
(60 mg/kg/day, n = 8); post-SE+levetiracetam (200 mg/kg/day,
n = 9); post-SE+vehicle (n = 8); sham+vehicle (n = 6) or sham+Z944
(60 mg/kg/day, n = 6). Treatments were delivered by continuous sub-
cutaneous infusion for four weeks. Four weeks after completion of
treatment, the animals had two weeks of continuous video-EEG moni-
toring to evaluate the effects of the different treatments on epilepto-
genesis. Behavioural tests were performed to evaluate anxiety,
depression, learning and memory.
Results: Following drug washout, post-SE + vehicle animals had the
highest average number of seizures per day (0.77  0.09), followed by
post-SE + levetiracetam (0.536  0.076). Treatment with Z944 greatly
reduced the number of seizures per day (0.017  0.012) which was sig-
nificantly different when compared to vehicle and levetiracetam treated
animals (p < 0.0001). Only 2 post-SE+Z944 animals had seizures
recorded (one seizure each during the two weeks of recordings), whereas
all of the animals in the other post-SE groups had several seizures.
Depressive-like behaviour was assessed using the sucrose preference and
forced swim test. Post-SE+Z944 treatment significantly improved
depressive like behaviour (p < 0.05 in comparison to post-SE+vehicle)
in both tests.
Conclusion: This indicates that pharmacologically targeting T-type
Ca†+ channel with Z944may be an effective disease-modifying treatment
for TLE. Z944 has been found to have a favourable safety profile facili-
tating the translation of the results of this preclinical study into a clinical
anti-epileptogenesis trial.
0004/p0137
INHIBITIONOFGLUTAMATEDECARBOXYLASE
(GAD) BY ETHYLKETOPENTENOATE (EKP) INDUCES
TREATMENT-RESISTANT EPILEPTIC SEIZURES IN
ZEBRAFISH
Y. Zhang*, M. Vanmeert†, A. Siekierska*, A. Ny*, J. John‡,
G. Callewaert§, E. Lescrinier†, W. Dehaen‡, P.A.M. de Witte*,
R.M. Kaminski¶
*Laboratory for Molecular Biodiscovery, KU Leuven,
Department of Pharmaceutical and Pharmacological Sciences,
Leuven, Belgium, †REGA institute for Medicinal Chemistry, KU
Leuven, Department of Pharmaceutical and Pharmacological
Sciences, Leuven, Belgium, ‡Molecular Design and Synthesis,
KU Leuven, Department of Chemistry, KU Leuven, Leuven,
Belgium, §KU Leuven, Department of Cellular and Molecular
Medicine, Leuven, Belgium, ¶Neuroscience TA, UCB
Biopharma, Braine-l’Alleud, Belgium
Purpose: Epilepsy is a chronic brain disorder characterized by recurrent
seizures due to abnormal, excessive and synchronous neuronal activities
in the brain. It affects approximately 65 million people worldwide, one
third of which are still estimated to suffer from refractory seizures. Glu-
tamic acid decarboxylase (GAD) that converts glutamate into GABA is a
key enzyme in the dynamic regulation of neural network excitability.
Importantly, clinical evidence shows that lowered GAD activity is asso-
ciated with several forms of epilepsy which are often treatment resistant.
We have previously shown that (D, L)-allylglycine (AG) reduced GABA
content and as a consequence induced epileptiform activity in zebrafish
larvae and mice. The oxidative metabolite of AG, 2-keto-4-pentenoic
acid (KPA), was proven to be a far more potent GAD inhibitor.
Method: We explored the possibility to use ethyl ketopentenoate (EKP),
a lipid-permeable form of KPA to induce refractory seizures in zebrafish
larvae. We performed locomotor tracking, local field potential (LFP)
recording and neuroluminescence monitoring to phenotypically and
pharmacologically characterize this model.
Results: Our results demonstrate that EKP evoked robust convulsive
locomotor activities, excessive epileptiform discharges and upregulated
c-fos expression in zebrafish. Moreover, transgenic animals in which
neuronal cells express apoaequorin, a Ca†+-sensitive bioluminescent pho-
toprotein, displayed large luminescence signals indicating strong EKP-
induced neuronal activation. Molecular docking data indicated that this
proconvulsant activity resulted from the direct inhibition of both gad67
and gad65. Limited protective efficacy of tested anti-seizure drugs
(ASDs) demonstrated a high level of treatment resistance of EKP-
induced seizures.
Conclusion: We conclude that EKP is more effective than AG in induc-
ing refractory seizures and can serve as a high-throughput model to dis-
cover novel ASDs. Furthermore, it is anticipated that the
neuroluminescence technique as a tool to monitor whole brain neuronal
activity in freely moving animals, might be particularly interest for future
anti-epileptic or anti-epileptogenic drug discovery strategies.
0005
THENINDS/NIH EPILEPSY THERAPY SCREENING
PROGRAM (ETSP)
J.H. Kehne*, S. Raeissi*, S. Sharma*, B.D. Klein*
*National Institute of Neurological Disorders and Stroke NINDS,
National Institutes of Health NIH, Bethesda, MD, United States
Building on the success of the longstanding NINDS/NIH Anticonvulsant
Screening Program (ASP), the recently-renamed Epilepsy Therapy
Screening Program (ETSP) has a refocused mission to facilitate the
discovery and characterization of novel agents for addressing the signifi-
cant remaining unmet medical needs in epilepsy, most notably treatment-
resistance, and disease prevention and modification. With ongoing feed-
back provided by an External Consultant Board (ECB), the ETSP has
implemented significant changes in its testing strategies. The ETSP has
developed a refined two-stage flow chart to evaluate the potential of com-
pounds for clinically-differentiated treatments for drug refractory epi-
lepsy. An initial “Identification” phase utilizes two acute seizure models
in neurologically-intact rodents, the maximal electroshock (MES) sei-
zure test, and the mouse 6 Hz 44 mA model of pharmacoresistant sei-
zures. To help identify mechanistically-novel agents that interact with
aberrant processes in the epileptic brain and therefore may not be
detected by acute seizure tests, the Identification phase has two additional
assays with ”disease-like” characteristics, corneal kindled seizures, and
an in vitro spontaneous electrical bursting slice model. A subsequent
“Differentiation” phase utilizes three advanced disease models: the lam-
otrigine-resistant amygdala-kindled rat model; mouse mesial Temporal
Lobe Epilepsy (mTLE) model, and chronically-epileptic rat model with
video/EEG recording. The ETSP has also incorporated models of special
epilepsy populations: a mouse model of viral-induced encephalitis [Thei-
ler’s murine encephalitis virus (TMEV) model], and a rat model of ben-
zodiazepine pharmacoresistant status epilepticus. The mTLE mouse and
chronic epileptic rat models are also adapted for evaluating potential
antiepileptogenic activity. Finally, to encourage further discovery efforts
from external investigators, the ETSP established the publicly-accessible
PANAChE database that provides methodological information and a
searchable repository for non-confidential data generated on compounds
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tested by the ETSP. Together, these efforts are aimed at identifying
promising agents that will comprise the next-generation of pharmacolog-
ical treatments for significantly reducing the burden of epilepsy.
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0006
SPINDLEOSCILLATIONS TRIGGERROLANDIC
DISCHARGES IN BENIGNCHILDHOODEPILEPSY
S. Kohsaka*, M. Kohsaka†, H. Shiraishi*
*Hokkaido University School of Medicine, Department of
Pediatrics, Sapporo, Japan, †Ishikane Hospital, Saporo, Japan
Purpose: Rolandic discharges (RDs) are the hallmarks of interictal
epileptic discharges in benign childhood epilepsy with centro-temporal
foci (BECT). The RD rate increases during non-REM sleep. Our preced-
ing study on the cross-correlation between the RD rate and background
EEG power showed that the development of RD rate precedes that of
delta-band power, but synchronize with sigma-band power. While the
results showed a close link between RDs and spindle oscillations, the
one-to-one temporal relationship between RDs and spindle oscillations
still remains to be solved.
Method: Seven children diagnosed with BECT, with predominant uni-
lateral RDs, were enrolled in the study (4 boys and 3 girls, aged from 6 to
11 years). 8-channel EEGs were recorded throughout a night, and sam-
pled (1.25-kHz sampling frequency). The RDs were detected semi-auto-
matically, and the EEG data with growing periods of delta-band power
during the first sleep cycle were subjected to the analysis. We applied
wavelet analysis on the contralateral lead of RDs (Fp1-C3 or Fp2-C4,
8192 points / frame) with the fixed point of RDs (6144-point in a frame),
then averaged (spike-triggered wavelet average, STWA). The results of
STWAwere accumulated within the spindle range (spindle power; 10.2 -
13.5 Hz), and divided into 32 blocks (8192 / 256 points; 0.205 s for a
block). They were tested for the significance of time series by one-way
repeated measure ANOVA.
Results: The results showed the significant time-series changes around
the RDs (F = 2.74, p < 0.001). The spindle power increased around 0.6 s
before the onset of RDs.
Conclusion: Spindle oscillations trigger RDs in BECT.
0007
LOCALIZINGNON-EPILEPTIC ABNORMALBRAIN
FUNCTION IN CHILDRENUSINGHIGHDENSITY EEG
(HDEEG): LECTRIC SOURCE IMAGINGOF FOCAL
SLOWING
S. Baldini*, A. Coito†, C. Korff‡, K. Schaller§, M. Seeck¶,
F. Pittau**, S. Vulliemoz¶
*University of Geneva, Clinical Neuroscience, Geneva,
Switzerland, †University of Geneva - Faculty of Medicine,
Functional Brain Mapping Lab, Geneva, Switzerland, ‡Geneva
University Hospitals, Pediatric Neurology Department, Geneva,
Switzerland, §Geneva University Hospitals, Department of
Neurosurgery, Geneva, Switzerland, ¶Geneva University
Hospitals and Faculty of Medicine, Neurology Department,
Geneva, Switzerland, **Geneva University Hospitals,
Neurology Department, Geneva, Switzerland
Purpose: A proportion of pediatric patients who are candidate for epi-
lepsy surgery show the absence of interictal epileptiform discharges or
multifocal spikes on interictal EEG. The “Non-spiking” pathological
brain activity such as abnormal low-frequency activity could provide
important localisation information. This study aims to map the brain
source of pathological focal slowing in children with drug resistant
epilepsy in order to validate a new electrical imaging source (ESI) index
able to identify the epileptic focus.
Method: We selected 17 children (7F/10M), who underwent high den-
sity EEG (hdEEG), presurgical assessments and surgical treatment. Mean
age at the evaluation was 12  4 yrs, mean duration and onset of disease
were, respectively 7  5 yrs and 4  5 yrs. For each patient, we
exported about 15 epochs of pathological focal slowing lasting 2sec. We
applied for each channel the S-transform to obtain the frequency content
of the signal across time, taking in account only the dominant FS
frequency: 1–4 Hz or 4–8 Hz. Then, for each frequency and time point,
we applied the inverse solution obtaining the spectral power at each solu-
tion point, which was averaged in order to identify the frequency and time
that correspond to the maximal spectral power providing the FS source
localization. Finally, we computed the Euclidian distance between this
solution point and the nearest solution point included in the resection.
Results: In patients with seizure free outcome (16/17), the median dis-
tance was 2.7 mm, and the distance between ESI focal slowing and resec-
tion was smaller than 5 mm in the 65% (41% into resection). One patient
had Class III outcome and a distance superior to 10 mm from resection.
Conclusion: These findings suggest that the analysis of focal slowing
activity could be useful for the estimation of the epileptogenic zone.
0008
ASSOCIATIONOFDEFAULTMODENETWORK (DMN)
REGIONS ATABSENCE SEIZUREONSET
UNCONSTRAINED BYTHEIR FREQUENCY
CONFINEMENT
S. Sinha*, V. Jayabal†, N. Mariyappa†, V. Gadad†,
P. Satishchandra†, S.S. Nagarajan‡
*NIMHANS, Neurology, Bangalore, India, †NIMHANS,
Bangalore, India, ‡UCSF, San Francisco, CA, United States
Purpose: We investigated the leading generators of electrographic
absence seizures, at different frequency bandwidths (1–200 Hz), during
MEG.
Methods: Nineteen patients (M: F = 10:9; age:10.25  3.39 years),
with childhood (n = 11) and juvenile (n = 8) absence epilepsies under-
went MEG. Generalized spike-wave discharges (GSWD) for >5 seconds
(s), was regarded ‘electrographic absence seizures’. Data was analyzed at
3 frequency bandwidths: 1–30 Hz (C), 30–80 Hz (G) and 80–200 Hz
(R). At each frequency band, for every subject, leading 300 ms of ictal
GSWD of seizures were concatenated and subjected to source localiza-
tion over a cortical grid using adaptive spatial filtering. At each frequency
band, group statistics was computed with t-test, corrected for multiple
comparisons using cluster permutation approach (n = 500;p < 0.05).
Cortical regions with significant cluster thresholds were segregated and
termed as generators of absence seizures.
Results: There were 5135 (232.37  49.82) independent ictal GSWD in
19 patients, among which 119 were electrographic seizures
(5.95  1.2s). The frequently localized cortical regions, at 3 frequency
bands (C, G and R) were superior, middle and inferior frontal gyri, frontal
operculum, supplementary motor area, somatosensory cortex, angular
gyrus, inferior parietal lobule, precuneus, middle temporal gyrus, cuneus,
calcarine and middle occipital gyri, and anterior cingulate gyrus. Brain
regions responsible for generating all seizures (n = 49) were expressed
in proportions and grouped pertaining to the lobes: frontal (C = 49.28%;
G = 47.39%; R = 43.44%), temporal (C = 9.44%;G = 11.33%;
R = 9.37%), parietal (C = 20%;G = 30.9%;R = 24.17%), occipital
(C = 14.33%; G = 7.06%;R = 19.18%) cortices and anterior cingulate
(C = 6.94%;G = 10.38%; R = 3.85%) regions. There were no differ-
ences in the source localization regions acquired at 3 frequency bands
(p > 0.05).
Conclusion: Multiple focal cortical regions were involved at 3 fre-
quency bands in absence epilepsy. The excited regions for generating the
absence seizure were positioned in the DMN, regardless of their excita-
tion frequency (1–200 Hz), indicating under-modulation of intrinsic neu-
ronal firing. These might suggest that unconsciousness in absence
seizures could probably be related to the (multi)focal disruption of these
specific networks.
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NEWHYBRIDMICRO-MACROELECTRODES TO
RECORD FAST-RIPPLES IN PATIENTSWITHDRUG-
REFRACTORYEPILEPSY
E. Despouy*,†, J. Curot*,‡, M. Deudon*, M. Denuelle‡, J.-
C. Sol‡, J.-A. Lotterie‡, L. Valton*,‡, E. Barbeau*
*Centre de Recherche Cerveau & Cognition, UMR 5549,
Toulouse, France, †DIXI Medical, Toulouse, France, ‡CHU
Purpan, Toulouse, France
Purpose: Patients with drug-refractory epilepsy are explored using stere-
oelectroencephalography (SEEG) to identify the brain areas where
epileptic seizures originate. When the seizure onset zone (SOZ) can be
identified, surgical resection may be possible with usually good outcome.
During SEEG, fast activities (gamma) but also high frequency oscilla-
tions like Ripples (> 80 Hz) and Fast Ripples (FR, > 200 Hz) can be
recorded. FR are candidates to be new biomarkers of the SOZ. They are
usually recorded with macroelectrodes (800–1300 μm) but microelec-
trodes (20-–50 μm) - not currently used in clinical practice - appear to
facilitate their recordings. The aim of our study is to assess whether
newly designed hybrid micro-macro electrodes work correctly and if they
present an interest.
Method: The EpiFaR study was accepted in 2014 and has been proposed
to all epileptic patients undergoing a SEEG in the CHU of Toulouse since
March 2015. When electrodes locations (based exclusively on clinical
criteria) has been determined, the implantation of 4 micro-macroelec-
trodes instead of the classical macroelectrodes is scheduled. One is
located in the presumed SOZ and the other anteriorly, posteriorly and
contralateraly. The micro-macroelectrodes are provided by DIXI Medi-
cal. Each consists of several macrocontacts and 2 or 3 tetrodes (each with
4 microwires with a diameter of 20 μm). Each patient is recorded 24/24
using the clinical video-SEEG system from Micromed. In addition, 1 h
of signal is recorded from the microwires everyday using a Blackrock
amplifier sampling the signal at 30 kHz.
Results: Our results show that FR are preferentially recorded with
microelectrodes as predicted. Other events are also recorded by micro-
electrodes like seizures, interictal spikes and single and multi-unit activi-
ties. The tetrode configuration allows a better identification of the
neuronal activity. Cognitive task also generate specific potentials in the
micro-spatial domain.
Conclusion: These data suggest that these new microelectrodes are
highly promising.
0010
ELECTROENCEPHALOGRAPHIC ABNORMALITIES
IN ANTI NMDARENCEPHALITIS
S. Jeannin-Mayer*, C. Boutet†, S. Rosenberg‡, N. Andre-
Obadia§, J.-C. Antoine¶, L. Mazzola¶
*Ho^pital Neurologique - Pierre Wertheimer, Neurologie
Fonctionnelle et Epileptologie, Bron, France, †CHU Saint
Etienne, Service de Radiologie, Saint Priest en Jarez, France,
‡CHU Clermont Ferrand, Service de Neurologie, Clermont
Ferrand, France, §Ho^pital Neurologique - Pierre Wertheimer,
Neurologie Fonctionnelle et Epileptologie, Lyon, France,
¶CHU Saint Etienne, Service de Neurologie, Saint Priest en
Jarez, France
Purpose: Anti-NMDA (N-methyl D-aspartate) receptor encephalitis
(anti-NMDARE) is an autoimmune encephalitis. Early treatment initia-
tion improves its prognosis. The electroencephalogram (EEG) is an
accessible tool, easy to achieve. The aim of our study was to describe the
different EEG patterns in patients suffering from anti-NMDARE. We
further looked for EEG abnormalities timeline in the course of the dis-
ease, their correlation with clinical data, and whether any EEG pattern
could be a reliable predictor of outcome.
Methods: We retrospectively analyzed 300 EEG recordings, including
60 days of EEG-monitoring, from 24 patients suffering of anti-
NMDARE. Patients were hospitalized in the University Hospital of Cler-
mont-Ferrand, Lyon and Saint-Etienne, between November 2007 and
June 2016.
Results: Our study describes three typical EEG patterns in patients with
anti-NMDARE: Excessive Beta Activity range 14–20 Hz (EBA) in
70.8% of our patients, Extreme Delta Brush (EDB) in 62.5% and Gener-
alized Delta Activity (GDA) in 50%. A temporal organization and time-
line in these EEG patterns could be evidenced in the course of disease:
EBA appears first, followed by EDB and then GDA, as the median time
of appearance for EBA, EDB and GDA was respectively 10, 15 and
22 days. GDA were correlated with the occurrence of abnormal move-
ments; their presence at the time of EEG recordings increased the risk to
observe abnormal movements at the same time by 4.7 (CI 95% 2.3–9.3,
p < 0.001). The absence of GDA was significantly associated with a
good outcome (modified Rankin Scale score< 4) at 6 months
(p = 0.011), and 18 months of follow-up (p = 0.05).
Conclusion: These results provide new diagnostic and prognostic sup-
ports in the anti-NMDARE. The rhythmic aspect of GDA should not be
misinterpreted as status epilepticus, to avoid antiepileptic treatments
intensification and their adverse effects, we discussed potential electro-
physiological generators of these EEG patterns, and their correlations
with physiopathological hypothesis.
Epilepsy Surgery 1
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RELATIONSHIP BETWEENCORTICALRESECTION
ANDVISUAL FUNCTIONAFTEROCCIPITAL LOBE
EPILEPSY SURGERY
C.K. Chung*, W. Heo†
*Seoul National University Hospital, Neurosurgery, Seoul,
Korea, †Seoul National University Hospital, Seoul, Korea
Purpose: To describe the long-term clinical and visual outcomes of
occipital lobe epilepsy (OLE) surgery and to analyze the relationship
between visual cortical resection and visual function in OLE surgery.
Method: A total of 42 consecutive patients who were diagnosed with
OLE and underwent occipital lobe resection from June 1995 to Novem-
ber 2013 were included. Clinical, radiological, and histopathological data
were retrospectively reviewed. Seizure outcomes were classified accord-
ing to the Engel classification. Visual function after surgery was assessed
by the National Eye Institute Visual Functioning Questionnaire 25 (NEI-
VFQ-25). The relationship between the resected area of the visual cortex
and visual function was demonstrated by multivariate linear regression
models.
Results: After a mean follow-up period of 102.2 months, 27 patients
(64.3%) were seizure free, and six patients (14.3%) had Engel class II
outcome. Nineteen of 33 patients (57.6%) were in the normal or quadran-
tanopia group after surgery. The normal or quadrantanopia group had bet-
ter vision-related quality of life than the hemanopsia group. The
resection of lateral occipital areas 1 and 2 (LO1, LO2) of the occipital
lobe was significantly associated with difficulties in general vision,
peripheral vision, and vision-specific roles. Additionally, the resection of
intraparietal sulcus 3 or 4 (IPS3 or IPS4) was significantly associated
with decreased social functioning.
Conclusion: We found a favorable seizure control rate of 78.6% (Engel
class I or II), with 57.6% of the subjects having good visual function after
OLE surgery (normal or quadrantanopia). Lateral occipital cortical resec-
tion had also a significant impact on visual function despite the preserva-
tion of the visual field.
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FOCALEPILEPTIFORMDISCHARGESDETECTED BY
MAGNETOENCEPHALOGRAPHYAND
SIMULTANEOUS ELECTROENCEPHALOGRAPHY
L. Duez*, H. Tankisi*, P. Sidenius†, A. Sabers‡, L. Pinborg‡,
M. Fabricius§, G. Rubboli¶, B. Pedersen¶, A.-M. Leffers**,
P. Uldall††, J. Brennum‡‡, A. Fuglsang-Frederiksena*,
S. Beniczkya*,§§
*Aarhus University Hospital, Department of Clinical
Neurophysiology, Aarhus, Denmark, †Aarhus University
Hospital, Department of Neurology, Aarhus, Denmark,
‡Rigshospitalet, Department of Neurology, Copenhagen,
Denmark, §Rigshospitalet, Department of Clinical
Neurophysiology, Copenhagen, Denmark, ¶The Epilepsy
Hospital, Department of Neurology, Dianalund, Denmark,
**Hvidovre Hospital, Department of Diagnostic Radiology,
Hvidovre, Denmark, ††Rigshospitalet, Department of
Paediatrics, Child Neurology, Copenhagen, Denmark,
‡‡Rigshospitalet, Department of Neurosurgery, Copenhagen,
Denmark, §§The Epilepsy Hospital, Department of Clinical
Neurophysiology, Dianalund, Denmark
Purpose: To compare the diagnostic yield of magnetoencephalography
(MEG) and electroencephalography (EEG) for detecting interictal
epileptiform discharges (IEDs) in patients referred for epilepsy surgery
evaluation.
Method: One-hundred-and-forty-one patients undergoing epilepsy sur-
gery evaluation were prospectively analyzed. A MEG whole-head 306-
channel Elekta Neuromag system, and simultaneous high density EEG
(70 electrodes, range 58 to 80) using a non-magnetic cap (EASYCAP)
were recorded in 115 consecutive patients. Eight patients were investi-
gated with an array of 19 EEG electrodes, according to the 10–20 system.
Due to large head circumference or inability to cooperate, 18 patients
were investigated without EEG. Spontaneous electric and magnetic brain
activity was recorded for 15 h. The data were offline band-pass filtered
05 to 70 Hz. MEG-EEG was visually inspected by trained physicians
(LD, SB) for well-defined IEDs using CURRY 7 Neuroimaging Suite
and BESA-MEG.
Results: Ninety-six different clusters of IEDs were identified in 85
patients. In 73% (70/96) of the foci the IEDs were visible both in MEG
and EEG. In 15% (14/96) of the foci the IEDs were visible only in EEG.
In 13% (12/96) the foci were visible only in MEG. There was no statisti-
cal difference in the number of IEDs detected only by EEG compared to
IEDs detected only byMEG (p-value 06731).
Conclusion: Although the majority of IEDs are detected in raw data by
both modalities, in about one third of the cases the discharges were
detectable in only one modality. Simultaneous recording of MEG and
EEG signals supplements each other and optimizes diagnostic yield.
aThese authors contributed equally
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MEANINGFUL IMPROVEMENT INQUALITYOFLIFE
AFTERTEMPORAL LOBEEPILEPSY SURGERY: A
PROSPECTIVE STUDYWITHBRAZILIAN PATIENTS
C. Pauli*, M.L. Schwarzbold*, A.P. Diaz*, M.E.R.O. Thais*,
C. Kondageski*, M.N. Linhares*, R. Guarnieri*,
B.D.L. Zingano*, J. Ben*, J.C. Nunes*, H.J. Markowitsch†,
P. Wolf*,‡, S. Wiebe§, K. Lin*, R. Walz*
*Federal University of Santa Catarina, Florianopolis, Brazil,
†University of Bielefeld, Bielefeld, Germany, ‡Danish Epilepsy
Center, Dianalund, Denmark, §University of Calgary, Calgary,
AB, Canada
Purpose: To investigate prospectively the independent predictors of a
minimum clinically important change (MCIC) in quality of life (QOL)
after anterior temporal lobectomy (ATL) for drug resistant mesial-tem-
poral lobe epilepsy related to hippocampus sclerosis (MTLE-HS) in
Brazilian patients.
Method: Multiple binary logistic regression analysis was performed to
identify the clinical, demographic, radiological, and electrophysiological
variables independently associated with MCIC in the QOLIE-31 overall
score one year after anterior temporal lobectomy (ATL) in 77 consecu-
tive patients with unilateral MTLE-HS.
Results: The overall QOLIE-31 score and all its subscale scores
increased significantly (p < 0.0001) 1 year after ATL. In the final logis-
tic regression model, absence of pre-surgical diagnosis of depression (ad-
justed OR 4.4, CI 95% 1.1 - 16.1; p = 0.02) and complete postoperative
seizure control (adjusted OR 4.1, CI 95% 1.2 - 14.5; p = 0.03) were inde-
pendently associated with improvement equal to or greater than the
MCIC in QOL after ATL. The overall model accuracy for MCIC
improvement in the QOL was 85.6%, with a 95.2% of sensitivity and
46.7% of specificity.
Conclusion: These results in Brazilian patients reinforce the external
validation of previous findings in Canadian patients showing that pre-sur-
gical depression and complete seizure control after surgery are indepen-
dent predictors for meaningful improvement in QOL after ATL, and have
implications for the surgical management of MTLE patients.
0014
FEASIBILITY AND SAFETYOFREPEAT
STEREOTACTIC RADIOFREQUENCY
THERMOCOAGULATION FORRECURRENT
GELASTIC SEIZUREDUE TOHYPOTHALAMIC
HAMARTOMA
H. Shirozu*,†, H. Masuda*,†, Y. Ito*,†, Y. Nakayama*,†,
T. Higashijima*,†, M. Fukuda*,†, S. Kameyama*,†
*Nishi-Niigata Chuo National Hospital, Department of
Functional Neurosurgery, Niigata, Japan, †Nishi-Niigata Chuo
National Hospital, Hypothalamic Hamartoma Center, Niigata,
Japan
Purpose: This study aimed to validate the feasibility and safety of repeat
stereotactic radiofrequency thermocoagulation (SRT) for recurrent gelas-
tic seizure (GS) due to hypothalamic hamartoma (HH).
Method: We retrospectively evaluated seizure outcomes, postoperative
complications, and clinical factors associated with seizure recurrence in
140 patients (86 males and 54 females; median age at surgery: 9 year,
range 1–50) with gelastic seizure due to HH (median maximum size:
15 mm, range 4.5–80), who were followed up for at least one year after
initial SRT.
Results: Ninety (64.3%) of 140 patients achieved freedom from GS after
initial SRT, and 42 patients (30.0%) underwent repeat SRTs (2 SRTs in
34, 3 SRTs in 6, and 4 SRTs in 3). Finally, GS-freedoms were achieved in
118 (86.1%). In contrast, 86 (74.1%) of 115 patients with other types of
seizures (non-GS) became free from non-GS only after initial SRT.
Repeat SRTs were not effective for recurrent non-GS. The overall seizure
freedoms were achieved in 85 (64.4%) by a total of 196 SRTs. The rates
of transient complications did not increase between the initial (74.2%)
and repeat (64.2%) SRTs. Prolonged severe complications were seen in 9
(6.4%) patients. GS recurrences after initial SRT were not influenced by
size or shape of HH, previous treatments or SRT procedures, but were
significantly affected by younger age at surgery and shorter duration of
epilepsy (p < 0.01). Non-GS recurrence was significantly associated
with older age and longer duration of epilepsy (p < 0.01), and was
strongly affected by multiple previous treatments (p < 0.001).
Conclusion: Repeat SRTs are effective and feasible for recurrent GS
without increasing risks, and finally achieved excellent seizure outcomes.
SRT can be a single procedure to treat HH regardless of size or shape of
HH and previous treatment. Early SRT is recommended to reduce the
incidence of intractable non-GS.
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STIMULATION INDUCED SEIZURESDURING
EXTRAOPERATIVE DIRECT ELECTRICAL
CORTICAL STIMULATIONORCORTICALMAPPING
M. Spilioti*, M. Centeno†,‡, C.A. Scott‡, T. Wehner†,‡, B. Diehl†,‡
*Aristotle University of Thessaloniki, AHEPA Hospital,
1st Department of Neurology, Thessaloniki, Greece, †Institute of
Neurology, National Hospital for Neurology and Neurosurgery,
London, United Kingdom, ‡National Hospital for Neurology and
Neurosurgery, Department of Clinical Neurophysiology,
London, United Kingdom
Purpose: Direct electrical cortical stimulation (CS) is used routinely for
mapping of eloquent cortex in patients undergoing intracranial EEG as
part of their presurgical evaluation. CS can, as a by-product, elicit after-
discharges, subclinical EEG seizures, stimulus induced seizures (SIS)
and stimulus induced auras (SIA). SIS and SIA may have habitual or non
habitual symptomatology compared to spontaneous seizures and auras.
The purpose of this study is to: (1) determine the frequency of SIS with
habitual or non habitual symptomatology and (2) estimate their potential
diagnostic role in defining the seizure onset zone.
Method: We performed a retrospective review of 134 focal epilepsy
patients who underwent intracranial electrode implantation and CS at the
National Hospital for Neurology and Neurosurgery, Queen Square from
2008 until 2016.
Results: 46 (34%) of those had SIS, SIA or a subclinical EEG seizure
during CS. Of those 46 pts, 29 experienced SIS (63%) in 14pts (30.4%)
SIS were of habitual semiology, and 9 of those had concordance with the
ictal onset zone of spontaneous seizures. In 15pts(32.6%)SIS were non
habitual.SIA were elicited in 16 pts (35%), 12 of those were of habitual
semiology. Subclinical EEG seizures were elicited in 4 pts (8.7%)
Conclusion: In conclusion, our retrospective review of CS mapping
revealed that about a third of all patients will experience unintended stim-
ulation induced seizures. Those seizures are habitual or non habitual in
equal proportion. In two thirds of cases the location of eliciting habitual
SIS will be from the same location of the spontaneous seizure onset zone.
This calls for caution to routinely use SIS to localize the seizure onset
zone, although in some cases SIS mimicking the effect of spontaneous
epileptic discharges on cortexduring CS could be a potential additional
diagnostic tool to localize the seizure onset zone.
Living with Seizures/Epilepsy 1
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BEHAVIOURALANDEMOTIONALCOMORBIDITYOF
ACUTE SEIZURES IN YOUNGKENYANCHILDREN: A
POPULATION-BASED STUDY
S. Kariuki*, A. Abubakar*, M. Kombe*, M. Kazungu*,
R. Odhiambo*, A. Stein†, C. Newton*,†
*KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya,
†University of Oxford, Department of Psychiatry, Oxford, United
Kingdom
Purpose: Acute seizures in young children in Africa may be associated
with poor behavioural and emotional problems. It is unclear if beha-
vioural and emotional comorbidities of acute seizures are related to the
seizures, or shared genetic susceptibility and neurological damage.
Method: We conducted a population-based study on 3,273 young chil-
dren aged 1–6 years on the Kenyan coast to examine the relationship
between acute seizures and behavioural and emotional problems, and to
determine the factors associated with the comorbidity. Prevalence of
behavioural and emotional problems was derived from the inverse link of
a logit model. Generalised linear models were used to measure the inde-
pendent association between acute seizures and behavioural and
emotional problems, and to determine associated risk factors. Sobel-
Goodmanmediation tests were used to performmediation analysis.
Results: The crude prevalence of total behavioural and emotional prob-
lems was 30% (95%CI, 20%-43%) for children with acute symptomatic
seizures and 25% (95%CI, 15%-38%) for those with febrile seizures;
being greater than for those without seizures (11% (95%CI, 11%-12%);
Chi-squared p ≤ 0.001). Behavioural and emotional scores were higher
in acute seizures than in those without seizures (Cohens d = 0.44 (95%
CI, 0.30–0.59)). Acute seizures were associated with total behavioural
and emotional problems
(risk ratio (RR)=1.92 (95%CI, 1.34–2.77)) after accounting for
sociodemographic and medical confounders. The proportion of total
effects of acute seizures on behavioural and emotional problems medi-
ated by epilepsy was small (15.3% (95%CI, 4.5–34.9%)). Among chil-
dren with acute seizures, important risk factors for mental health
comorbidity included family history of febrile seizures (RR=3.36 (95%
CI, 1.34–8.41)) for total problems, repetitive acute seizures (b=0.36
(95%CI, 0.15–0.57)) for externalizing problems and focal acute seizures
(RR=1.80 (95%CI, 1.05–3.08)) for internalising problems.
Conclusion: Acute seizures are associated with substantial behavioural
and emotional problems, which should be assessed and addressed in chil-
dren with these seizures in this rural area of Kenya.
0017
PARENTING STRESS AND PERCEIVED STIGMA IN
MOTHERSOFCHILDRENWITHEARLYONSET
EPILEPSY: A POPULATION-BASED STUDY
C. Reilly*, P. Atkinson†, A. Memon†, C. Gillberg‡, K. Das§,
B. Neville§, L. Dabydeen*, C. Jones*, R. Scott§,¶
*Young Epilepsy, Lingfield, United Kingdom, †Crawley Child
Development Centre, Crawley, United Kingdom, ‡University of
Gothenburg, Gothenburg, Sweden, §University College London,
Institute of Child Health, London, United Kingdom, ¶University
of Vermont, Department of Neurological Sciences, Burlington,
VT, United States
Purpose: To provide population-based data on parenting stress and per-
ceived stigma in mothers of young children with epilepsy, and to com-
pare findings with those of mothers of developmental, age and gender
matched children with non-epilepsy related neurodisability (i.e. neuro-
logical and/or neurodevelopmental difficulty).
Method: The mothers of young children (1–7 years) with epilepsy
(n = 47) in a defined geographical area of the UK completed the Parent-
ing Stress Index-4th Edition and a measure of perceived stigma (Austin
et al. 2004). The responses of mothers of children with epilepsy are com-
pared with parents of developmental, age and gender matched children
with non-epilepsy related neurodisability (n = 48). Alpha level is
p < 0.05.
Results: Significantly more mothers of children with epilepsy scored in
the abnormal range (>85th percentile) on the Parent-Child Dysfunctional
Interaction subscale (Epilepsy 45% vs.. Controls 21%; p = 0.013), but
not on the Parental Distress subscale (Epilepsy 32% vs.. Controls 23%;
p = 0.325), Difficult Child Subscale (Epilepsy 57% vs.. Control 46%;
p = 0.257) or Total Stress Score (epilepsy 38% vs.. Controls 21%;
p = 0.062). There was not a significant difference on the perceived
stigma measure between mothers of children with epilepsy and mothers
of children with non-epilepsy related neurodisability (p = 0.508).
Conclusion: Mothers of young children with epilepsy report high levels
of parenting stress. They also showed higher levels of parenting stress on
the Parent-Child Dysfunctional Interaction subscale compared with
mothers of children with non-epilepsy related neurodisability. Levels of
perceived stigma did not differ between the groups. Further analysis will
attempt to identify factors associated with parenting stress and stigma in
mothers of young children with epilepsy. Additionally we will also seek
to identify why parent-child interaction may be more compromised in
mothers of children with epilepsy.
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“SEIZUREMONITORINGONMYAPP”ANURSING
APPROACH IN THE IMPLEMENTATIONOFA
SEIZUREAPP. PERSPECTIVES FROMCLINICAL
PRACTICE
L. Olsen*, P. Rasmussen†, V. Stubbings‡
*Danish Epilepsy Center, Out-Patient Clinic for Adults with
Epilepsy, Dianalund, Denmark, †Danish Epilepsy Center,
IT - Department, Dianalund, Denmark, ‡Danish Epilepsy
Center, Research Department, Dianalund, Denmark
Purpose: Various App`s have been introduced to the market which also
includes Apps within the Health Sector. At the Danish Epilepsy Center,
we therefore introduced a Seizure App for patients treated at our hospital
in order to offer patients and their relatives a tool that could monitor their
seizures in a safe and correct form. As the intention was also to ensure a
fast track to the medical file, the App is designed in a way that enables
the patient to register not only their seizures, but also acute medication
and possible triggers and every 24-h have it sent directly to their own
medical file at the Epilepsy Center. The overall purpose is to obtain a
clinical precise overview over the seizure situation based on the particu-
lar seizures that the clinician has classified. As the seizures gets automati-
cally registered in the patients´medical file it ensures that there is always
an updated clinical status in order for the MD to adjust and monitor treat-
ment.
Method: In order to be able to distinguish amongst the vast numbers of
different seizures, the patient/relatives are, before getting the password,
introduced to only their own specific seizure semiology. The process
thereby includes and ensures a valuable introduction to an individual sei-
zure semiology which is entirely based on the introduction and education
from the nurses. It is also possible to film a seizure and after acceptance
from the MD it can be sent directly to the hospital.
Results: So far we have 600 users, which is a gradually growing number.
Conclusion: The App has proven very useful in the clinical context.
There is always a precise and updated seizure registration available and
more important it is based on the patients clinically diagnosed seizures in
an accurate manner.
0019
AN ECONOMIC EVALUATIONOFAMULTI-
COMPONENT SELF-MANAGEMENT INTERVENTION
FORADULTSWITHEPILEPSY (ZMILE STUDY)
B. Wijnen*, L. Leenen†, R. de Kinderen‡, C. van Heugten§,¶,
M. Majoie**,††, S. Evers‡,‡‡
*Maastricht University, Health Services Research, Maastricht,
Netherlands, †Epilepsy Centre Kempenhaeghe, Research &
Development, Heeze, Netherlands, ‡Trimbos Institute,
Netherlands Institute of Mental Health and Addiction, Utrecht,
Netherlands, §MHENS, School for Mental Health and
Neuroscience, Department of Psychiatry and Neuropsychology,
Maastricht, Netherlands, ¶Maastricht University, Department of
Neuropsychology and Psychopharmacology, Maastricht,
Netherlands, **Academic Centre for Epileptology
Kempenhaeghe, Department of Neurology, Maastricht,
Netherlands, ††School of Health Professions Education,
Maastricht University, Faculty of Health, Medicine and Life
Sciences, Maastricht, Netherlands, ‡‡Maastricht University,
Department of Health Services Research, Maastricht,
Netherlands
Purpose: The objective of this (trial-based) economic evaluation was,
from a societal perspective, to compare the cost-effectiveness of a multi
component self-management intervention (MCI) with care as usual
(CAU) in adult patients with epilepsy over a 12 month period.
Method: In a randomized-controlled trial participants were randomized
into intervention or CAU group. Adherence, self-efficacy (ESES), qual-
ity adjusted life years (QALYs), health care costs, production losses, and
patient & family costs were assessed at baseline and during the 12-month
study period. Incremental cost-effectiveness ratios (ICERs) (i.e. cost per
increased adherence, self-efficacy or QALY), and cost-effectiveness
acceptability curves were calculated.
Results: In total, 102 patients were included in the study, of whom 52
were in the intervention group. Adherence rates over 6 months were
63.7% for the CAU group and 75.9% for the intervention group. Adher-
ence, ESES and quality of life did not differ significantly between groups.
An ICER of €54 per point increase in ESES-score at 6 months and €1105
per point increase at 12 months follow-up was found. The intervention
resulted in an ICER of €88 per percentage of adherence increase at
6 months. ICERs of €8,272 and €15,144 per QALY gained were found at
6 and 12 months follow-up, respectively.
Conclusion: Although no statistically significant difference was found
after baseline adjustments, cost-effectiveness estimates for MCI appear
to be promising. As rules of inference are arbitrary, it has been argued
that decisions should be based only on the net benefits, irrespective of
whether differences are statistically significant. Hence, the MCI may be a
cost-effective addition to the current standard care for adults with epi-
lepsy.
0020
KNOWLEDGEANDATTITUDES TOWARDS EPILEPSY
OF PARENTS INMALI
Y. Maiga*, S. Diallo†, S.H. Diallo*, M. Camara†, A. Cissoko*,
K. Nimaga‡, T. Coulibaly*, G. Landoure*, M. Sangare*,
G. Cheick Oumar*
*Faculty of Medicine and Odontostomatology FMOS, USTTB,
Bamako, Mali, †CHUGabriel Toure, Department of Neurology,
Bamako, Mali, ‡Clinique Medicale ‘Dinandougou’,
Markacoungo, Mali
Background: In Mali, epilepsy affects 15 persons per thousand yet its
psychosocial impact remains to be explored.
Objectives: The objective of this study was to evaluate the knowledge
and attitudes towards epilepsy of parents with children affected by epi-
lepsy inMali compared to unaffected parents.
Methods: We interviewed 720 adults in Bamako (Capital of Mali), half
of which were parents of children living with epilepsy. The groups were
matched for age, sex, education and socio-economic status.
Results: In our population 78% of parents had seen at least one epileptic
seizure. Of these, only 33% recognised the need to intervene while 22%
believed their first action should be to pour fresh water on the head of the
patient. 57% reported that their first action would be to take the patient to
a traditional healer. Knowledge about the clinical characteristics of sei-
zures was more accurate in the parents with affected children. But, the
misconceptions about epilepsy were high in both groups and sometimes
even more prevalent in the parents with affected children.
Conclusion: Our study demonstrates the widespread misconceptions
towards epilepsy in parents whether affected or not. Our findings argue
for the need of a focused effort on education towards the population of
Mali, including traditional healers, to improve the quality of life of chil-
dren living with epilepsy and their family by improving knowledge and
reducing stigma.
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AETIOLOGYAND SUBCORTICAL STRUCTURE
VOLUMEAREASSOCIATEDWITH SUBSEQUENT
COGNITIVEDEFICITS IN CHILDREN FOLLOWING
CONVULSIVE STATUS EPILEPTICUS (CSE)
K.H. Bennett*,†, S.S. Pujar‡, M.M. Martinos§, M.M. Yoong*,†,¶,
R.F.M. Chin*,†,¶
*University of Edinburgh, College of Medicine and Veterinary
Medicine, Edinburgh, United Kingdom, †University of
Edinburgh, Muir Maxwell Epilepsy Centre, Edinburgh, United
Kingdom, ‡University College London, Institute of Child Health,
London, United Kingdom, §University College London,
Developmental Cognitive Neurosciences Unit, Institute of Child
Health, London, United Kingdom, ¶Royal Hospital for Sick
Children, Department of Paediatric Neurosciences, Edinburgh,
United Kingdom
Purpose: Childhood CSE is associated with poorer neuropsychological
outcomes with aetiology as a significant risk factor. We recently showed
a wide spectrum of decreased subcortical structure volumes are associ-
ated with lower IQ in childhood epilepsy. We hypothesise that in child-
hood CSE, aetiology and decreased subcortical structural volumes are
associated with cognitive measures.
Method: Structural MRI scans (Siemens Avanto, 1.5T) and cognitive
measures (FSIQ, PIQ, VIQ (Wechsler Abbreviated Scale of Intelligence)
and GMS (Children’s Memory Scale)) were collected from age and gen-
der matched controls and patients at a mean 8.5 years post-CSE (Pro-
longed Febrile Seizures (PFS), n = 30; Symptomatic, n = 30; and Other,
n = 12). Scans underwent quantitative volumetric analysis using FSL
(Analysis Group, FMRIB, Oxford) to provide subcortical structure
volume, grey/white matter volume, and intracranial volume (ICV).
Multivariable linear regression was performed for each subcortical
structure of patients to identify significant predictors of cognition, whilst
correcting for aetiology, age, gender and ICV; Bonferroni correction was
applied. Due to significant collinearity between structures, an additional
multivariable analysis was used with total subcortical structure volume
instead of individual subcortical structures, whilst additionally correcting
for white/grey matter volume.
Results: 72 controls (12  2.9SD years; 43 male) and 72 patients
(11.7  3.4SD years; 36 male) underwent analysis. Aetiology is a signif-
icant predictor of long-term cognitive outcome post-CSE. Volumes of
the left putamen and globus pallidus both significantly correlated with
FSIQ (p < 0.05) and PIQ (p < 0.05). In the final model, total subcortical
volume was independently associated with FSIQ (p < 0.05), PIQ
(p < 0.05) and GMS (p < 0.05).
Conclusion: Our findings suggest that in addition to aetiology,
decreased volumes of the left putamen and globus pallidus are associated
with cognitive deficits following CSE. This, along with our findings with
total subcortical volume, indicates that a subcortical network rather than
individual structures may be associated with cognition.
0022
CANNABIDIOL (CBD) REDUCES CONVULSIVE
SEIZURE FREQUENCY INDRAVET SYNDROME:
RESULTSOFAMULTI-CENTRE, RANDOMISED,
DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
(GWPCARE1)
J.H. Cross*, O. Devinsky†, L. Laux‡, E. Marsh§, I. Miller¶,
R. Nabbout**, I.E. Scheffer††, E.A. Thiele‡‡, S. Wright§§
*UCL Great Ormond Street Institute of Child Health, London,
United Kingdom, †NYU Langone Medical Center, New York, NY,
United States, ‡Ann and Robert H Lurie Children’s Hospital of
Chicago, Lurie Children’s Epilepsy Center, Chicago, IL, United
States, §The Children’s Hospital of Philadelphia, Philadelphia,
PA, United States, ¶Miami Children’s Hospital, Miami, FL,
United States, **Ho^pital Necker - Enfants Malades, Paris,
France, ††University of Melbourne, Florey Institute, Austin
Health and Royal Children’s Hospital, Melbourne, VIC,
Australia, ‡‡Massachusetts General Hospital, Boston, MA,
United States, §§GWResearch, Ltd, Cambridge, United
Kingdom
Purpose: Assess the effect of CBD added to antiepileptic drug (AED)
therapy for the treatment of drug-resistant seizures in Dravet syndrome.
Method: This double-blind, placebo-controlled trial randomised 120
children aged 2–18 years with Dravet syndrome and drug-resistant sei-
zures to receive CBD oral solution 20 mg/kg/day (n = 61) or placebo
(n = 59) for 14 weeks (2 week titration; 12 week maintenance). The pri-
mary endpoint was the percentage change from baseline in convulsive
seizures (tonic-clonic, tonic, clonic, and atonic) frequency over the
14-week treatment period.
Results: The groups were well-balanced at baseline for demographics.
Mean age was 10 years, with 29% of patients <6 years. Patients had pre-
viously tried a median 4 AEDs, and were currently taking a median 3
AEDs. Convulsive seizure frequency per month decreased from a median
of 12.4 to 5.9 (median reduction of 39%) with CBD vs.. 14.9 to 14.1 (me-
dian reduction of 13%) with placebo (difference between groups of 23%;
p = 0.012). The proportion of patients with ≥50% reduction in convul-
sive seizure frequency was 42.6% with CBD vs.. 27.1% with placebo
(OR=2.0; p = 0.078). Adverse events (AEs) occurred in 93.4% of CBD
and 74.6% of placebo patients, and were mostly mild or moderate; the
most common were somnolence, diarrhea, and decreased appetite. Seri-
ous AEs were reported in 16.4% of CBD and 5.1% of placebo patients,
and were considered treatment-related in 8.2% of CBD patients, all of
whom discontinued CBD. Some elevations in transaminases were noted
without elevations of bilirubin; all were on concomitant valproate and all
resolved. There were no deaths in the study.
Conclusion: Results from this study suggest that CBD add-on therapy
for drug-resistant seizures in Dravet syndrome may be efficacious, with
more AEs than placebo but generally well tolerated. (Funded by GW
Research, Ltd; NCT02091375)
0023
GENETIC AND PHENOTYPICHETEROGENEITY
SUGGEST THERAPEUTIC IMPLICATIONS IN SCN2A-
RELATEDDISORDERS
M.Wolff*, K.M. Johannesen†, U.B.S. Hedrich‡, G. Kluger§,
H. Lerche‡, R.S. Møller†, SCN2A Study Group
*University Children’s Hospital, Department of Pediatric
Neurology and Developmental Medecine, T€ubingen, Germany,
†Danish Epilepsy Centre, Dianalund, Denmark, ‡University of
T€ubingen, Department of Neurology and Epileptology, Hertie
Institute for Clinical Brain Research, T€ubingen, Germany,
§Epilepsy Center for Children and Adolescents, Schoen Klinik,
Vogtareuth, Germany
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Purpose: SCN2Amutations are associated with a spectrum of epilepsies
and neurodevelopmental disorders. In single functional investigations
both gain- and loss-of-function effects on the sodium channel were
found. Here, we report the phenotypic spectrum in a large cohort of novel
patients, describe the effect of sodium channel blockers (SCB) on epilep-
tic seizures, and correlate the findings with genetic and functional proper-
ties.
Method: 71 unpublished children with SCN2Amutations were collected
across multiple centers in Europe and the US. Cases were analyzed
regarding genotype, phenotype and response to SCB. Functional studies
were performed in selected missense mutations using whole cell patch-
clamping.
Results: 28 had encephalopathy with early-infantile-onset epilepsy
(< 3 months), including Ohtahara syndrome (8) and epilepsy of infancy
with migrating focal seizures (5). 29 had encephalopathy with infantile/
childhood-onset epilepsy (≥3 months), including West syndrome (9),
Lennox-Gastaut syndrome (6), and focal epilepsies with an ESES-like
EEG pattern (6). Five children had intellectual disability/autism without
seizures. Nine children had benign neonatal/infantile seizures. The use of
SCB was associated with significant seizure reduction/freedom in chil-
dren with early infantile epilepsies, whereas SCB were rarely effective in
epilepsies with later onset and sometimes induced seizure worsening.
Truncating mutations were exclusively seen in patients with late onset
epilepsies and lack of response to SCB. Missense mutations associated
with early infantile epilepsy and a good response to SCB resulted in
increased sodium channel activity with gain-of-function (GOF). In con-
trast, mutations in patients with late-onset forms and an insufficient
response to SCBwere associated with loss-of-function effects (LOF).
Conclusion: Our study reflects the large spectrum of SCN2A-related
disorders. We establish two distinct main groups with seizure onset either
before or after three months of age, which show phenotypic differences,
GOF vs.. LOF effects and a related differential response to treatment with
SCB. Our findings enable specific treatment decisions.
0024
NEURODEVELOPMENTALOUTCOMES IN
NEWBORNSWITHNEONATAL SEIZURES CAUSED BY
ROTAVIRUS-ASSOCIATED
LEUKOENCEPHALOPATHY
K.Y. Lee*, Y.C. Weon†, S.H. Choi†, O. KW*, H. Park‡
*Ulsan University Hospital, University of Ulsan College of
Medicine, Pediatrics, Ulsan, Korea, †Ulsan University Hospital,
University of Ulsan College of Medicine, Radiology, Ulsan,
Korea, ‡University of Ulsan, Child and Family Welfare, Ulsan,
Korea
Purpose: Rotavirus infection has recently been reported to be associated
with or to cause leukoencephalopathy in newborns presenting with
neonatal seizures and distinctive symmetric cerebral white matter lesions
on magnetic resonance imaging (MRI). We investigated long-term out-
comes and prognostic factors in newborns with rotavirus-associated
leukoencephalopathy.
Method: We retrospectively reviewed the records and brain magnetic
resonance (MR) images of 32 patients who fulfilled the following crite-
ria: (1) neonatal seizures, (2) distinctive symmetric cerebral white matter
lesions on diffusion-weighted MR images (DWI), (3) rotavirus infection,
(4) absence of a specific etiology of seizures, except for the aforemen-
tioned DWI lesions, and (5) Korean Bayley Scales of Infant Development
II (K-BSID-II) assessment after 12 months of age.
Results: The mean age at seizure onset was 4.7  0.8 days. The age of
the patients at the time of K-BSID-II assessment was 24.2  8.1 months.
Fourteen patients (43.8%) showed normal or accelerated performance in
the mental and motor scales, while 18 patients (56.2%) had delayed per-
formance in the mental and/or motor scales. Three patients (8.6%) were
significantly delayed in both the mental and motor scales. The percentage
of volume of diffusion-restricted lesions based on total brain volume was
significantly negatively correlated with the mental developmental index
(MDI) score (r = -0.507, p = 0.003), but not with the psychomotor
developmental index (PDI) score (r = -0.324, p = 0.071). Follow-up
MR images indicated that patients with more severe atrophy of white
matter showed a non-significant trend for decreased MDI and PDI
scores.
Conclusion: Rotavirus-associated leukoencephalopathy in newborns
around 5 days of age can cause adverse neurodevelopmental outcomes
with a wide range of severity. The extent of white matter lesion on initial
DWI can predict neurocognitive outcome.
0025
ELECTRICAL STATUS EPILEPTICUS IN SLEEP
AFTERTHALAMIC INJURY: CLINICALAND
NEUROIMAGING PREDICTORS IN 26 CHILDREN
B. van den Munckhof*, A.F. Zwart*, L.C. Weeke†, A. Leemans‡,
M.J.N.L. Benders†, K.P.J. Braun*, L.S. de Vries†, F.E. Jansen*
*University Medical Centre Utrecht, Brain Center Rudolf
Magnus, Pediatric Neurology, Utrecht, Netherlands, †University
Medical Center Utrecht, Wilhelmina Children’s Hospital,
Neonatology, Utrecht, Netherlands, ‡University Medical Center
Utrecht, Image Sciences Institute, Utrecht, Netherlands
Purpose: Epileptic encephalopathy with electrical status epilepticus in
sleep (ESES) is characterized by near-continuous epileptiform activity
during sleep accompanied by acquired neurodevelopmental deficits.
Perinatal thalamic injury has previously been reported to predispose to
ESES. The aim of this study was to identify possible predictors for the
occurrence of ESES after perinatal thalamic injury.
Method: We included patients with perinatal thalamic injury, diagnosed
in our center in the neonatal period (incidence cohort), or referred later
during childhood. Thalamic injury was classified as anterior, medial,
ventral, lateral or pulvinar based on the conventional MRI sequences.
Thalamic and caudate nucleus volumes were calculated after automatic
segmentation of the DTI MRI-scans. Sleep EEGs distinguished
patients into ESES (spike wave index [SWI] >85%), ESES-spectrum
(SWI 50–85%) or no ESES (SWI< 50%).
Results: 26 patients were included. Conventional MRI sequences were
available in 22 neonates, at around three months in 18 and during child-
hood in 21 patients, with DTI images of sufficient quality in 4, 8 and 8
patients respectively. In the incidence cohort (n = 20), 8 had ESES, 7
ESES-spectrum and 5 had not developed ESES after a median sleep EEG
follow-up of 7 years. In the total cohort (n = 26), 13 had ESES, and 8
ESES-spectrum. At three months of age, thalamic volume and volume
ratio thalamus / caudate nucleus were lower in children who later devel-
oped ESES(-spectrum) (volume left 7650 vs.. 4574 mm‡ [p = 0.004];
ratio 4.1 vs.. 3.2 [p < 0.001], volume right 8254 vs.. 4930 mm‡
[p = 0.004]; ratio 4.4 vs. 3.5 [p = 0.002]). Bilateral injury (p = 0.005)
and involvement of the anterior thalamic nuclei (p = 0.006) were associ-
ated with lower IQ/DQ after ESES onset.
Conclusion: ESES(-spectrum) is seen in a majority of patients after tha-
lamic injury. Smaller remaining thalamic volume is associated with
development of ESES and bilateral injury and involvement of the anterior
nuclei predict neurodevelopmental deficits.
0026
CANNABIDIOL (CBD) SIGNIFICANTLYREDUCES
DROPANDTOTAL SEIZURE FREQUENCY IN
LENNOX-GASTAUT SYNDROME (LGS): RESULTSOF
ADOSE-RANGING,MULTI-CENTRE, RANDOMISED,
DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
(GWPCARE3)
S. Zuberi*, O. Devinsky†, A. Patel‡, J.H. Cross§, V. Villanueva¶,
E.C. Wirrell**, C. Roberts††, D. Checketts††, K. van
Landingham‡‡
*Royal Hospital for Sick Children in Glasgow, Glasgow, United
Kingdom, †NYU Langone Medical Center, New York, NY, United
States, ‡Nationwide Children’s Hospital, Columbus, OH, United
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States, §UCL Great Ormond Street Institute of Child Health,
London, United Kingdom, ¶University Hospital and Polytechnic,
Valencia, Spain, **Mayo Clinic, Rochester, MN, United States,
††GWResearch, Ltd, Cambridge, United Kingdom, ‡‡Greenwich
Biosciences, Inc, Carlsbad, CA, United States
Purpose: Evaluate efficacy of add-on CBD for the treatment of seizures
associated with LGS.
Method: Eligible patients were 2–55 years old with a clinical diagnosis
of LGS, ≥8 drop seizures during 4-week baseline, and documented failure
of ≥1 antiepileptic drug (AED). Patients were randomised (1:1:1) to
20 mg/kg/day CBD, 10 mg/kg/day CBD, or placebo for 14 weeks
(2-week titration; 12-week maintenance). The primary efficacy endpoint
was percentage change from baseline in drop seizures/month over the
14-week treatment period for CBD vs. placebo; ≥50% responder rate and
percentage change in total seizures were assessed.
Results: 225 patients were randomised (76 CBD 20 mg/kg, 73 CBD
10 mg/kg, 76 placebo); 9 CBD 20 mg/kg, 2 CBD 10 mg/kg, and 2 pla-
cebo patients withdrew. Groups were similar at baseline; mean age was
16 years (30% of patients ≥18 years) and median drop seizures/month
was 85 (IQR: 44, 168). Patients had failed a median of 6 and were taking
a median of 3 AEDs. Reduction in drop seizures was significantly greater
for CBD 20 mg/kg (42%) and CBD 10 mg/kg (37%) than placebo (17%;
p = 0.0047 and p = 0.0016), as were ≥50% responder rates (40% and
36% vs.. 15%; p = 0.0006 and p = 0.0030) and reductions in total
seizures (38% and 36% vs.. 18%; p = 0.0091 and p = 0.0015). Adverse
events (AEs) occurred in 94% of CBD 20 mg/kg, 84% of CBD
10 mg/kg, and 72% of placebo patients, and were mostly mild or moder-
ate; the most common were somnolence and decreased appetite. Treat-
ment-related serious AEs occurred in 5 CBD 20 mg/kg, 2 CBD 10 mg/
kg, and 0 placebo patients. Some elevations in transaminases were seen.
There were no deaths. Of 212 completers, 99% entered the open-label
extension study.
Conclusion: Results suggest that add-on CBD for treatment of seizures
associated with LGS may be efficacious, with more adverse events than
placebo, but generally well-tolerated. (Funded by GW Research, Ltd;
NCT02224560).
0027
CONSIDERINGANTI-EPILEPTIC DRUG
WITHDRAWAL? ATOOL FOR INDIVIDUAL
PREDICTIONOF SEIZUREOUTCOMES
H.J. Lamberink*, W.M. Otte†,‡, A.T. Geerts§, M. Pavlovic¶,
J. Ramos-Lizana**, A.G. Marson††, J. Overweg‡‡, L. Sauma§§,
L.M. Specchio¶¶, M. Tennison***, T.M. Cardoso§§,
S. Shinnar†††, D. Schmidt‡‡‡, K. Geleijns*, K.P. Braun*
*University Medical Center Utrecht, Brain Center Rudolf
Magnus, Pediatric Neurology, Utrecht, Netherlands, †University
Medical Center Utrecht, Brain Center Rudolf Magnus, Pediatric
Neurology/ Biomedical MR Imaging and Spectroscopy Group,
Utrecht, Netherlands, ‡Stichting Epilepsie Instellingen
Nederland SEIN, Heemstede, Netherlands, §Erasmus MC, Sophia
Children’s Hospital, Rotterdam, Netherlands, ¶Al Sabah
Hospital, Pediatric Neurology, Kuwait City, Kuwait,
**Torrecardenas Hospital, Pediatric Neurology, Almeria,
Spain, ††University of Liverpool, Department of Molecular and
Clinical Pharmacology, Liverpool, United Kingdom, ‡‡Meer en
Bosch - Cruquiushoeve, Heemstede, Netherlands, §§University
of Campinas, Neurology, Campinas, Brazil, ¶¶University of
Foggia, Ospedali Riuniti, Neurology, Foggia, Italy,
***University of North Carolina, Neurology, Chapel Hill, NC,
United States, †††Albert Einstein College of Medicine,
Neurology, Pediatrics and Epidemiology and Population
Health, Montefiore Medical Center, New York City, NY,
United States, ‡‡‡Epilepsy Research Group, Berlin, Germany
Purpose: Seizure-free persons with epilepsy may ask whether
antiepileptic drug (AED) treatment is still necessary. Stopping AEDs car-
ries the risk of seizure recurrence, and although many publications stud-
ied predictors of seizure outcome it is difficult to apply this knowledge to
the individual patient. The aim was to create an individualised prediction
model for seizure recurrence and long-term seizure outcome, through an
Individual Participant Data meta-analysis.
Method: Systematic review of literature identified all candidate predic-
tors and eligible publications, of which authors were contacted to provide
individual participant data. Through regression analysis the strongest
predictors were selected. Internal-external cross-validation was per-
formed to ensure generalizability. Ultimately, nomograms were created
to visually represent computed prediction models.
Results: Ten cohorts with 1769 patients were gathered, with both chil-
dren and adults, of which 812 (46%) experienced seizure recurrence and
9% had seizures in the last year of follow-up (median 5.3 years,
interquartile range 3–10 years). Prediction models for seizure recurrence
(c-statistic: 0.65; 95%CI 0.65–0.66) and chance of long-term seizure
freedom (c-statistic: 0.71; 95%CI 0.70–0.71) were created with good cal-
ibration and stable validation across all ten populations.
Conclusion: It is now possible to compute combined risks of seizure
recurrence and the chance of long-term seizure freedom after AED with-
drawal. The nomograms are based on a large cohort, validated in both
children and adults, and will aid consultation of seizure free people with
epilepsy. The nomograms may therefore guide the physician as well as
the patient in person-tailored choices.
0028
ADJUNCTIVE EVEROLIMUS IN PATIENTSWITH
TREATMENT-REFRACTORY SEIZURESASSOCIATED
WITHTUBEROUS SCLEROSIS COMPLEX (TSC):
ANALYSIS OF EXPOSURE-EFFICACYAND
EXPOSURE-SAFETYRELATIONSHIPS IN THE
RANDOMIZED, PHASE 3, EXIST-3 TRIAL
J.A. French*, P. Curatolo†, J.A. Lawson‡, Z. Yapici§, H. Ikeda¶,
T. Polster**, R. Nabbout††, P.J. de Vries‡‡, D.J. Dlugos§§,
J. Fan¶¶, N. Coello***, D. Pelov¶¶, M. Voi¶¶, D.N. Franz†††
*NYU Comprehensive Epilepsy Center, New York City, NY,
United States, †Tor Vergata University Hospital, Rome, Italy,
‡Tuberous Sclerosis Multidisciplinary Management Clinic,
Sydney Children’s Hospital, Randwick, NSW, Australia,
§Division of Child Neurology, Department of Neurology,
Istanbul Faculty of Medicine, Istanbul University, Istanbul,
Turkey, ¶NHO Epilepsy Center, Shizuoka Institute of Epilepsy
and Neurological Disorders, Shizuoka, Japan, **Paediatric
Epileptology, Mara Hospital, Bethel Epilepsy Center, Bielefeld,
Germany, ††Hospital Necker-Enfants Malades, Paris Descartes
University, Paris, France, ‡‡Division of Child and Adolescent
Psychiatry, University of Cape Town, Cape Town, South Africa,
§§Children’s Hospital of Philadelphia, Perelman School of
Medicine at the University of Pennsylvania, Departments of
Neurology and Pediatrics, Philadelphia, PA, United States,
¶¶Novartis Pharmaceuticals Corporation, East Hanover, NJ,
United States, ***Novartis AG, Basel, Switzerland,
†††Cincinnati Children’s Hospital Medical Center, Department
of Neurology, Cincinnati, OH, United States
Purpose: This exploratory analysis of EXIST-3 (NCT01713946) evalu-
ated the impact of time and serum concentration on the efficacy and
safety of everolimus.
Method: Patients with TSC-associated treatment-refractory seizures were
randomized (1:1:1) to receive placebo, low-exposure (LE, 3–7 ng/mL) or
high-exposure everolimus (HE, 9–15 ng/mL) during the core phase
(18-weeks). In the extension phase (≥48-weeks), target exposure for all
patients was 3–15 ng/mL. Post-baseline average weekly seizure frequency
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(SF) and time-to-first adverse events (AEs) occurrence were correlated to
median time-normalized trough concentration (TN-Cmin) and duration of
therapy to determine if one or both contributed to the outcome.
Results: 361/366 randomized patients received everolimus in core or
extension phases. Median Cmin of everolimus after 1 year was 5.4, 7.9,
and 6.2 ng/mL for patients initially randomized to LE, HE and placebo,
respectively. Median percentage reductions in SF from baseline at week
18 and at 1 year were 42.4% (95%CI:26.2–47.8;N = 107) and 43.9%
(95%CI:30.2–66.7;N = 91) in LE, and 47.4% (95%CI:35.8–58.3;
N = 123) and 71.1% (95%CI:57.0–84.1;N = 102) in HE, respectively.
Pharmacokinetic-efficacy analysis showed a 2-fold increase in TN-Cmin
was associated with a statistically significant average reductions of 8.9%
(95%CI:6.9–11.0) in post-baseline SF over a two weeks intervals. Each
additional 12-week treatment resulted in 6.4% (95%CI:4.5–8.3) reduc-
tion in SF, regardless of exposure.
A two-fold increase in TN-Cmin was not associated with higher risk of
the most common AEs (stomatitis, HR:1.00; 95%CI:0.80–1.26; pyrexia,
HR:0.89; 95%CI:0.65–1.23; diarrhea, HR:1.26; 95%CI:0.88–1.80;
nasopharyngitis, HR:0.98; 95%CI:0.67–1.43; upper respiratory tract
infections, HR:1.20; 95%CI:0.81–1.79).
Conclusion: Reduction in SF with everolimus was both time- and expo-
sure-dependent. LE everolimus over a longer period of time achieved
similar gradual reductions in SF as HE over a short period of time. How-
ever, HE achieved higher reduction in SF with time. These findings sug-
gest a potential disease-modifying effect of everolimus for TSC-
associated treatment-refractory seizures. No unexpected toxicities/safety
concerns were observed with higher exposure.
0029
SYMPTOMATIC TREATMENTOFANTI-GABABRAND
ANTI-LGI1 AUTOIMMUNEEPILEPSY
M.A.A.M. de Bruijn*, A. van Sonderen†, M.H. van Coevorden-
Hameete*, M.W.J. Schreurs‡, F.S.S. Leijten§, R.P.W. Rouhl¶,
C.A. van Donselaar**, R.D. Thijs††, H.J.M. Majoie‡‡,
P.A.E. Sillevis Smitt*, M.J. Titulaer*
*Erasmus MC, Neurology, Rotterdam, Netherlands, †Haga
Teaching Hospital, Neurology, The Hague, Netherlands,
‡Erasmus MC, Immunology, Rotterdam, Netherlands, §UMC
Utrecht, Neurology, Utrecht, Netherlands, ¶Maastricht
University Medical Center, Neurology, Maastricht, Netherlands,
**Maasstad Hospital, Neurology, Rotterdam, Netherlands,
††Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands, ‡‡Kempenhaeghe, Heeze, Netherlands
Purpose: In this nationwide study we report anti-GABAbR and anti-
LGI1 autoimmune epilepsy (AIE), with specific emphasis on response to
anti-epileptic drug (AED).treatment.
Method: We collected patients with anti-GABAbR and anti-LGI1
encephalitis, confirmed with both cell-based assay and immunohisto-
chemistry, from January 2007 till August 2016. Information on seizure
type, seizure frequency, AED treatment, immunotherapy, response to
treatment and adverse events was obtained in interviews and from medi-
cal records.
Results: Of 70 patients with autoimmune encephalitis (23 with anti-
GABAbR and 47 with anti-LGI1 encephalitis), 87% suffered from sei-
zures (21/23 and 41/47, respectively). Seizures were the presenting
symptom in 51% of patients. Anti-LGI1 encephalitis patients initially
presented with focal seizures (44%), faciobrachial dystonic seizures
(FBDS; 29%) or tonic-clonic seizures (TCS; 27%), while most anti-
GABAbR patients presented with TCS (86%). Status epilepticus occurred
in 10/21 anti-GABAbR patients (48%) and in 6/41 anti-LGI1 encephalitis
patients (15%; p = 0.012), twelve of them super-refractory. Patients
were mainly treated with levetiracetam (n = 42), valproic acid (n = 33)
and carbamazepine (n = 21), with a median use of 2 AED (0–6). Of AED
used, TCS seemed to respond to levetiracetam in a minority of anti-
GABAbR patients (31%). In anti-LGI1 encephalitis carbamazepine
reduced focal seizures (32%) and valproic acid reduced TCS (32%).
Overall, only 6/51 patients (12%) achieved seizure freedom with AED
(2 anti-GABAbR and 4 anti-LGI1 patients). Contrarily, immunotherapy
resulted in seizure freedom in 35/52 patients (67%, p < 0.0001), in 16
within 7 days (31%; 3 anti-GABAbR and 13 anti-LGI1 encephalitis).
Seizure frequency was reduced in 41/52 patients (79%). Reported
adverse events of AEDwere additional cognitive decline by valproic acid
(12%), mood- and behavior disorders by levetiracetam (21%) and rash by
carbamazepine (29%).
Conclusion: It is important to consider AIE in refractory epilepsy or in
stereotypic focal seizures, as symptomatic treatment with AED is often
insufficient and early, additional immunotherapy is essential.
0030
COMPARINGTHEEFFICACYOF SODIUM
VALPROATEANDLEVETIRACETAMFOLLOWING
INITIAL LORAZEPAM INGENERALIZED
CONVULSIVE STATUS EPILEPTICUS (GCSE) IN
ELDERLY: A PROSPECTIVE RANDOMIZED
CONTROLLED STUDY
D. Nene*, R.C. Mundlamuri*, P. Satishchandra*, M. Nagappa*,
P.S. Bindu*, P.S. Mathuranath*, J. Saini†, R.D. Bharath†,
K. Thennarasu‡, P.V. Prathyusha‡, A.B. Taly*, S. Sinha*
*NIMHANS, Neurology, Bengaluru, India, †NIMHANS,
Radiology, Bengaluru, India, ‡NIMHANS, Biostatistics,
Bengaluru, India
Purpose: This prospective randomized controlled study was conducted
to compare the efficacy of sodium valproate (SVA) and levetiracetam
(LVM) following initial lorazepam in elderly patients with GCSE and
analyse the predictors for poor seizure control.
Method: One hundred and eighteen patients >60 years (mean:
67.5  7.5 years, M:F = 1.6:1) with GCSE were recruited after obtain-
ing consent and randomized into either SVA and LVM treatment arms.
All patients received initial lorazepam (0.1 mg/kg) followed by par-
enteral SVA (20–25 mg/kg) or LVM (20–25 mg/kg). Those uncon-
trolled with 1st AED, crossed over to receive the 2nd AED. One hundred
patients (SVA-50; LVM-50) completed the study. Analysis for seizure
outcome and prognostic markers was performed in all 118 patients
(SVA: 60, LVM: 58).
Results: SE could be controlled with lorazepam and one of AEDs (SVA/
LVM) in 71.18% (84/118). ITT analysis showed that the 2 groups didn’t
differ significantly [SVA: 41/60(68.3%); LVM: 43/58(74.1%), p-0.486].
Among the 100 patients who completed the study, SE control was
achieved in SVA-38/50(76%) and LVM-43/50(86%) (p-0.202). After
crossing over to 2nd AED, SE could be controlled in: SVA (+LVM) group
-6/12 (50%); LVM (+SVA) group -1/7 (14.3%). Overall, after the 2nd
AED, it was controlled in 77.1% (91/118). Two patients were given
anaesthetic medications for seizure control. Longer duration of SE (p-
0.038), lower systolic BP (p-0.04), higher STESS (p-0.038), lower GCS
at admission (p-0.016) and discharge (p-0.007), higher mean mRS (p-
0.018) and lower mean GOS at discharge (p-0.004) were significantly
associated with poor therapeutic response. The 30-day mortality was
20.3% (23/113).
Conclusion: Efficacy of SVA and LVM following initial lorazepam in
controlling SE in elderly population was statistically not different; hence
the choice of AED could be individualised. Overall seizure control of
77.1% was achieved by adding 2nd AED, especially without the anaes-
thetic medication, which is encouraging in a resource limited setting.
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FAMILIALMESIAL TEMPORAL LOBEEPILEPSYAND
THEBORDERLANDOFDEJAVU
P. Perucca*, D.E. Crompton†, S.T. Bellows†, M. Intosh*,†,
T. Kalincik*, MR Newton†, F.J.E. Vajda*, I.E. Scheffer†,‡,
P. Kwan*, T.J. O’Brien*, K.M. Tan*, S.F. Berkovic†
*Royal Melbourne Hospital, University of Melbourne,
Departments of Neurology and Medicine, Melbourne, VIC,
Australia, †Austin Health, University of Melbourne, Epilepsy
Research Centre and Department of Medicine, Melbourne, VIC,
Australia, ‡The Florey Institute of Neuroscience and Mental
Health, Melbourne, VIC, Australia
Purpose: The cause of temporal lobe epilepsy is often unknown. We
ascertained the frequency of familial mesial temporal lobe epilepsy
(FMTLE) among patients presenting to a First Seizure Clinic with non-
lesional mesial temporal lobe epilepsy (MTLE).
Method: We assessed all available first-degree relatives (cases) of
patients presenting to the Austin Health First Seizure Clinic with MTLE
with normal MRI (MTLE-NL) or hippocampal sclerosis (MTLE-HS)
over a 10-year period. Cases and pairwise age- and sex-matched controls
underwent a comprehensive epilepsy questionnaire. Interview transcripts
were reviewed independently by two epileptologists blinded to partici-
pants’ group allocation, who classified each subject as follows: epilepsy,
specifying if MTLE; manifestations suspicious of epilepsy; or unaf-
fected. The presence of physiological deja vu was noted.
Results: Forty-four patients with MTLE-NL or MTLE-HS were
included. In only 2 of them, MTLE had been previously recognized to be
familial. Among 242 participants interviewed, MTLE was diagnosed in
9/121 cases vs. 0/121 controls (p = 0.008). All affected cases had focal
aware seizures with intense deja vu and accompanying features; 6 had
not been previously diagnosed. Deja vu experiences which were suspi-
cious, but not diagnostic, of MTLE occurred in an additional 6 cases vs.
none of the controls (p = 0.04). Physiological deja vu was frequent, and
did not differ between cases and controls. After completing the inter-
views, FMTLEwas diagnosed in 8 of 44 patients (18.2%).
Conclusion: FMTLE accounts for almost one-fifth of new diagnoses of
non-lesional MTLE, and is largely unrecognized. Relatives of patients
with MTLE may experience deja vu phenomena which lie in the ‘border-
land’ between epileptic seizures and physiological deja vu.
0032
SEIZURES ANDHIGH-GRADEGLIOMAS: A UK
SINGLECENTRERETROSPECTIVEANALYSIS
O. Riley*, N. Allcroft*, M. Maguire*, L. Saukila*
*Leeds Teaching Hospitals NHS Trust, Leeds Centre for
Neurosciences, Leeds, United Kingdom
Purpose: High-grade gliomas (HGG) originate de novo (primary) or fol-
lowing transformation of a low-grade glioma (secondary), and can be
considered as two different pathologies, influencing clinical behaviour.
Despite this, both tumour types are currently managed similarly. Limited
evidence exists investigating the two as separate entities in relation to sei-
zure activity and biochemical markers, therefore forming the focus of our
study.
Method: Retrospective analysis of 132 confirmed HGG cases in a single
neurosciences centre. Variables recorded: patient demographics, tumour
features (cytogenetics, location, primary or transformational, grade), sei-
zure characteristics (type/onset), anti-epileptic drugs (AED) prescribed
(prophylaxis/post-seizure) and operative intervention.
Results: 132 patients analysed: mean age at diagnosis 56 (range 21–82),
1.75:1 male:female, 48% males: 40% females experienced seizures.
105:27 primary:transformational HGG. Most common tumour location:
frontal (38%) and temporal (23%). 30% HGG patients initially presented
with seizures, 14% developed seizures post-diagnosis. 62/132 were pre-
scribed AEDs; 84% post-seizure, 16% prophylactically. Compared to
temporal lobe, frontal lobe HGG was a significant predictor of seizures
(p < 0.05). Transformational HGG was significantly more likely to pre-
sent with seizures (p < 0.05) compared to primary HGG (88%:58%).
HGG with IDH1-IDH2 mutation was significantly more likely to present
with seizures (p < 0.05), with a 2:1 prevalence of IDH1-IDH2 mutation
in transformational:primary. Right-sided HGG was significantly more
likely to cause seizures (p < 0.01). No significant difference was found
between seizures andMGMT hypermethylation/1p-19q co-deletion.
Conclusion: The differing HGG pathologies appear to influence the
likelihood of developing seizures. Transformational HGG and the pres-
ence of IDH1-IDH2 mutation are associated with increased likelihood of
seizure at presentation. Right-sided and frontal lobe HGG are associated
with both increased seizures at presentation and overall occurrence. With
further analysis of AED impact, this could potentially lead to a change in
management of patients with HGG. However, conclusions drawn remain
complicated by the limitations of a retrospective analysis.
0033
IMPACTOF SEIZURESAFTERTHROMBOLYSIS FOR
ACUTE ISCHEMIC STROKE: THEENCHANTED
TRIAL
Y. Xu*, M. Hackett*, J. Chalmers*, R. Lindley*, X. Wang*,
L. Q*, T. Robinson†, H. Arima*,‡, P. Lavados§, C. Anderson*,¶,**
*The George Institute for Global Health, The University of
Sydney, Sydney, NSW, Australia, †University of Leicester,
Department of Cardiovascular Sciences and NIHR Biomedical
Research Unit for Cardiovascular Diseases, Leicester, United
Kingdom, ‡Fukuoka University, Department of Public Health,
Fukuoka, Japan, §Clinica Alemana de Santiago, Facultad de
Medicina, Clinica Alemana Universidad del Desarrollo,
Santiago, Chile, ¶Royal Prince Alfred Hospital, Neurology
Department, Sydney, NSW, Australia, **The George Institute
China at Peking University Health Science Center, Beijing,
China
Purpose: To determine the frequency, determinants and significance of
seizures after thrombolysis for acute ischemic stroke.
Method: Data are from the Enhanced Control of Hypertension and
Thrombolysis Stroke Study (ENCHANTED), an international, multicen-
ter, randomized controlled trial where patients with acute ischemic stroke
were randomized to low-dose (0.6 mg/kg) or standard-dose (0.9 mg/kg)
intravenous alteplase. The protocol pre-specified prospective data collec-
tion on in-hospital seizures over 7-days post-randomization. Logistic
regression models were used to determine variables associated with sei-
zures and their significance on poor outcomes of death or disability (mod-
ified Rankin scale [mRS] scores 3–6), symptomatic intracerebral
hemorrhage (sICH), and health-related quality of life (European Quality
of life 5-Dimensions questionnaire [EQ-5D]) over 90 days.
Results: Data were available for 3139 acute ischemic stroke participants,
of whom 42 (1.3%) had seizures at a median 22.7 hours after the onset of
symptoms. Baseline variables associated with seizures were male (odds
ratio [OR] 2.19, 95% confidence interval [CI] 1.07–4.50), severe neuro-
logical impairment (National Institutes of Health Stroke Scale [NIHSS]
score ≥10; OR 2.16, 95% CI 1.06–4.40) and fever (OR 4.55, 95% CI
2.37–8.71). Seizures independently predicted poor recovery: death or
major disability (OR 2.88, 95% CI 1.28–6.47), unfavorable ordinal shift
of mRS scores (OR 1.94, 95% CI 1.10–3.39) and lower than median
EQ-5D health utility index score (OR 3.50, 95% CI 1.37–8.91). There
was no association of seizures with sICH in adjusted analyses.
Conclusion: In thrombolysis-treated patients with acute ischemic stroke,
seizures are uncommon, occur early, relate to neurological severity, and
predict poor recovery.
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0034
CIRCUMSTANCESOF SUDEPS: A SWEDISH
NATIONWIDE POPULATION-BASED STUDYOF 329
CASES
O. Sveinsson*, T. Andersson†, S. Carlsson†, T. Tomson*
*Karolinska Institutet, Department of Clinical Neuroscience,
Stockholm, Sweden, †Karolinska Institutet, Institute of
Environmental Medicine, Stockholm, Sweden
Purpose: Given the importance of identifying high risk situations of sud-
den unexpected death in epilepsy (SUDEP) and for development of effec-
tive preventions, we analyzed SUDEP circumstances in a Swedish
nationwide population-based case series including 329 SUDEPs.
Method: We identified all persons that at some point during 1998–2005
were registered in the National Patient Registry with an ICD code for epi-
lepsy and were alive July 1st, 2006 (n = 78 524). All deaths in this study
population from 1 July 2006 to 31 December 2011 with epilepsy men-
tioned on the death certificate, and all deaths during 2008, were identified
by linkage to the National Cause-of-Death Registry. In all, 3166 deaths
were included. Death certificates, medical charts, autopsy and police
reports were reviewed to identify SUDEP cases and related circum-
stances.
Results: We found 329 cases of SUDEP (63% men) (167 definite, 89
probable and 73 possible) according to the Annegers’ classification. The
average age at death was 50.8 (median 52) years. More than half, 58%
(n = 191) died at night (between 00.00 and 08.00). A vast majority, 91%
(n = 299) died at home. Among these, 65% (n = 195) were found dead
in bed. Of all cases, 71% (n = 233) were living alone. Only 14%
(n = 47) shared a bedroom. In 66% (n = 217) there was a witnessed
(n = 46) or a suspected (n = 171) seizure. When documented, 70%
(n = 100) were found prone.
Conclusion: This largest SUDEP study to date, illustrates that epilepsy
patients who die of SUDEP, largely die at home, live alone, die at night
in bed, in the prone position with indication of a previous seizure. This
supports that lack of supervision may play a crucial role in SUDEP risk
and illustrates challenges that need to be considered in the development
of preventive strategies.
0035
INTER-ICTALCARDIACREPOLARIZATION
ABNORMALITIES IN PEOPLEWITHEPILEPSY
N. Kishk*, Y. Sharaf†, A. Ibrahim*, N. Alieldin‡, Y. Baghdady†,
A. Afify†, A. Damaty†
*Cairo University School of Medicine, Neurology, Cairo, Egypt,
†Cairo University School of Medicine, Cardiology, Cairo,
Egypt, ‡Cairo University School of Medicine, Cancer
Epidemiology, Cairo, Egypt
Background and purpose: It is well established that acute ventricular
arrhythmia following repolarization disorders is a leading cause for sud-
den cardiac arrest. The occurrence of cardiac electrical disturbances in
epilepsy patients was previously documented and may, in part, clarify the
mechanism of sudden unexpected death in those patients. The aim of this
study was to investigate the frequency of cardiac repolarization disorders
among epilepsy patients and whether specific demographic or disease-
related features are associated with their occurrence.
Methods: This cross sectional study was carried out on 1000 subjects
with epilepsy who were compared to age and sex matched 2500 subjects
without epilepsy. Clinical assessment, which included careful history
taking and examination, was carried out for all subjects. A resting 12-lead
electrocardiogram (ECG) was recorded in all participants. ECGs were
reviewed by experienced cardiologists. ECG intervals were measured
and morphological abnormalities were identified using standard guide-
lines.
Results: Repolarization abnormalities were found in 140 (14%) epilepsy
patients. A statistically significant elevation in percentage of QTc prolon-
gation among epilepsy patients compared to controls was documented
(8.2% vs. 2%, p = 0.001). Affected patients were significantly older and
the abnormality was significantly more prevalent among males and those
with poor seizure control. On the other hand, early repolarization and
Brugada-type ECG patterns were significantly more prevalent in subjects
without epilepsy.
Conclusions: Our results demonstrated that epilepsy patients, especially
if uncontrolled, are at higher risk for development of QTc interval prolon-
gation. To prove the relationship between this type of arrhythmia and the
occurrence of sudden unexpected death in epilepsy further studies are
warranted.
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0036
PRECISION THERAPY FOREPILEPSYDUETOKCNT1
MUTATIONS: ANORDER-RANDOMISED, DOUBLE-
BLIND, PLACEBO-CONTROLLEDCROSS-OVER
TRIALOFORALQUINIDINE
S. Mullen*, P. Carney*,†, A. Roten‡, M. Ching§, P. Lightfoot‡,
L. Churilov*, U. Nair*, M. Li*, S. Berkovic‡, S. Petrou*,
I. Scheffer†,¶
*The Florey Institute of Neuroscience and Mental Health,
Melbourne, VIC, Australia, †Monash University, Department of
Medicine, Eastern Health, Melbourne, VIC, Australia, ‡The
University of Melbourne, Epilepsy Research Centre, Department
of Medicine, Austin Health, Melbourne, VIC, Australia, §Austin
Health, Department of Pharmacy, Melbourne, VIC, Australia,
¶The University of Melbourne, Department of Paediatrics,
Melbourne, VIC, Australia
Purpose: Gain-of-function mutations of the potassium channel encoded
by KCNT1 cause severe epilepsy. Quinidine is a proposed precision ther-
apy due to in vitro blockade of KCNT1 function; open label use has been
successful in case reports or small series. We aimed to systematically
evaluate quinidine for KCNT1 severe autosomal dominant nocturnal
frontal lobe epilepsy (ADNFLE),
Method: A single-center, inpatient, order-randomized, blinded, pla-
cebo-controlled, cross-over trial of oral quinidine included 6 patients
with severe ADNFLE due to KCNT1mutation. Order was block random-
ized and blinded. Four day treatment blocks were used with a two day
wash-out between. Dose started at 900 mg over three divided doses then,
in subsequent participants, reduced to 600 mg, then 300 mg. Primary
outcome was seizure frequency measured on continuous video-EEG in
those completing the trial.
Results: Prolonged QT-interval occurred in the first two patients at doses
of 900 mg and 600 mg quinidine per day respectively, despite serum
quinidine levels well below the therapeutic range (0.61 μg/ml and
0.51 μg/ml, reference range 1.3–5.0 μg/ml). Four patients completed
treatment with 300 mg per day without adverse events. Patients complet-
ing the trial had very frequent seizures (mean 14 per day, SD 7, median
13, IQR 10–18). Seizures per day were non-significantly increased by
quinidine (median 2, IQR -0.25 - 4.25, p = 0.15) and no patient had a
50% seizure reduction.
Conclusion: Quinidine did not show efficacy in adults and teenagers
with ADNFLE. Dose-limiting cardiac side effects were observed even in
the presence of low measured serum quinidine levels. Although small,
this trial suggests use of quinidine in ADNFLE is likely to be ineffective
coupled with considerable cardiac risks. It also demonstrates that small
trials in severe epilepsy are practical and achievable without overwhelm-
ing expense and can provide definitive results that guide the implementa-
tion of precision medicine.
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THE PHENOTYPIC SPECTRUMOF SCN8A
MUTATIONS ANDTREATMENTRESPONSE
M.K. Johannesen*,†, E. Gardella*,†, M.F. Hammer‡,§,
G. Rubboli*,¶, R.S. Møller*,†, SCN8A Study Group
*The Danish Epilepsy Centre, Dianalund, Denmark, †University
of Southern Denmark, Institute for Regional Health Research,
Odense, Denmark, ‡University of Arizona, ARL Division of
Biotechnology, Tuscon, AZ, United States, §University of
Arizona, Department of Neurology, Tuscon, AZ, United States,
¶University of Copenhagen, Copenhagen, Denmark
Purpose: Since 2012, SCN8A has been known to cause severe epileptic
encephalopathy with seizures that are difficult to treat, and a high inci-
dence of sudden unexpected death in epilepsy. Only recently it was
discovered that SCN8A can cause more benign forms of epilepsy, where
cognition is normal and seizures are treatable. The purpose of this study
was to confirm and complete the phenotypic spectrum, andevaluate the
treatment response in patients with SCN8Amutations.
Method: We collected a cohort of 131 published and unpublished
patients with pathogenic mutations in SCN8A.
Results: The mutational landscape included one de novo 5’-UTR muta-
tion, one partial deletion of SCN8A, one in-frame deletion, four stop or
frameshift mutations, whereas the remaining mutations were missense.
The majority of the mutations occurred de novo, however we also
observed nine familial cases. The phenotypic spectrum ranged from
benign epilepsy with normal cognition, treatable epilepsy in patients with
autism and/or slightly affected cognition, and patients with ID or autism
without epilepsy to severe epileptic encephalopathies with severely
affected cognition and ongoing seizures. Movement disorders such as
paroxysmal dyskinesia, ataxia and choreoathetosis were seen in all
patient groups. Treatment response was evaluated in each subgroup. All
subgroups showed a good response in form of better seizure control to
sodium channel blockers. In seems that the milder forms respond well,
and often got seizure free, with the aid of carbamazepine, whereas the
more severely affected seemed to benefit more from high dosages of
oxcarbazepine or phenytoin.
Conclusion: This study takes the first steps toward personalized treat-
ment in SCN8A patients, however, further studies are needed to con-
firm the position of sodium channel blockers in the treatment
protocol.
0039
KCNT1 PATHOGENIC VARIANTS CAUSE
NOCTURNAL FRONTALLOBEEPILEPSY AND
MALFORMATIONOFCORTICALDEVELOPMENT
G. Rubboli*,†, G. Plazzi‡,§, L. Nobili¶, E. Gardella*,**,
R.S. Møller*,**, F. Picard††, S. Baulac‡‡
*Danish Epilepsy Center, Dianalund, Denmark, †University of
Copenhagen, Copenhagen, Denmark, ‡IRCCS Institute of
Neurological Sciences, Bologna, Italy, §University of Bologna,
Department of Biomedical and Neuromotor Sciences, Bologna,
Italy, ¶Niguarda Hospital, Epilepsy Surgery Center, Milan, Italy,
**University of Southern Denmark, Odense, Denmark,
††University Hospital, Geneva, Switzerland, ‡‡Sorbonne
Universites, Institut du Cerveau et la Moelle, Ho^pital Pitie-
Salpe^triere, Paris, France
Purpose: Pathogenic variants of KCNT1 sodium-dependent potassium
channel gene have been recently demonstrated to cause nonlesional noc-
turnal frontal lobe epilepsy (NFLE). The aim of this study is to report the
novel association of KCNT1-related NFLE with malformation of cortical
development (MCD) in four subjects.
Method: Four patients (2 M, 2 F; two of them brother and sister) with
drug-resistant focal epilepsies were submitted to wakefulness/sleep EEG,
including long-term video-EEG monitoring for presurgical evaluation in
three of them. MRI was performed in all, PET scanning in two. Next gen-
eration sequencing of KCNT1was performed in all subjects.
Results: Nocturnal seizures occurred in all patients; ictal semiology
(bizarre movements, screaming, choking, tonic/dystonic stiffening, noc-
turnal wandering) was consistent with frontal lobe seizures, leading to
the diagnosis of NFLE. Two patients (brother and sister) presented with
mental retardation and psychotic features and one had behavioral distur-
bances and neuropsychological deficits (impulsivity, attention deficit,
poor executive functions) consistent with a frontal lobe dysfunction.
Neuroimaging investigations showed blurring plus PET hypometabolism
of the left frontal operculum in one patient and transmantle heterotopia in
another one. The two MRI-negative patients underwent surgical treat-
ment after intracranial EEG recordings. Seizure outcome was Engel
Class III in both (follow-up is 13 and 9 years respectively). Histopathol-
ogy showed type I focal cortical dysplasia (FCD I) in both cases. Genetic
testing revealed pathogenic missense variants of KCNT1 gene in all four
patients.
Conclusions: We show for the first time that KCNT1 pathogenic vari-
ants causing drug-resistant NFLE can be associated with MCD. We can
hypothesize that: a) KCNT1 and MCDmay exert reciprocal influences in
determining the mechanisms that underlye seizure generation; b) ulti-
mately, a role for ion channel disorders in the pathogenesis of migration
brain abnormalities cannot be excluded.
0040
AETIOLOGIES ANDCOST-EFFECTIVENESS OF
GENOMIC TESTING IN SEVEREEPILEPSIES OF
INFANCY: A POPULATION-BASED STUDY
K.B. Howell*,†,‡, S. Eggers§, K. Dalziel¶, J. Riseley§,
S. Mandelstam†,**,††, G.L. Carvill‡‡, H.C. Mefford‡‡,
I.E. Scheffer*,†,§§,¶¶, A.S. Harvey*,†,‡, V.S.Eo.I.S. Group
*Royal Children’s Hospital, Melbourne, Neurology, Melbourne,
VIC, Australia, †University of Melbourne, Paediatrics,
Melbourne, VIC, Australia, ‡Murdoch Childrens Research
Institute, Clinical Sciences, Melbourne, VIC, Australia,
§Murdoch Childrens Research Institute, Translational Genomics
Unit, Melbourne, VIC, Australia, ¶University of Melbourne,
Melbourne School of Population and Global Health, Melbourne,
VIC, Australia, **Royal Children’s Hospital, Melbourne,
Radiology, Melbourne, VIC, Australia, ††Murdoch Childrens
Research Institute, Melbourne, VIC, Australia, ‡‡University of
Washington, Paediatrics, Seattle, WA, United States,
§§University of Melbourne, Medicine, Epilepsy Research Centre,
Melbourne, VIC, Australia, ¶¶Florey Institute, University of
Melbourne, Melbourne, VIC, Australia
Purpose: Many infants with severe epilepsies of infancy (SEI) have a
genetic or presumed genetic aetiology, but access to genomic testing in
clinical practice remains limited. The health economics of genomic test-
ing has not been studied.
Method: Population-based study of the aetiologies and cost-effective-
ness of genomic testing in infants with SEI born 2011–2013. SEI was
defined as epilepsy onset before age 18 months, frequent seizures,
epileptiform EEG and failed ≥ 2 antiepileptic drugs; epileptic spasms
were automatically included. Aetiology was determined from review of
medical records, EEG recordings and clinical investigations. Whole
exome sequencing (WES) was performed if aetiology was unknown. The
current diagnostic pathway for infants with no diagnosis at epilepsy onset
includes brain MRI, chromosomal microarray and metabolic testing, per-
formed in tiers; genomic testing is not routine. Modelling of diagnostic
pathways was performed using actual patient diagnoses and standardised
costs to the hospital of tiers of investigation. The yield and cost of the cur-
rent diagnostic pathway was compared with a revised pathway withWES
performed early and metabolic testing limited.
Results: 114 infants with SEI were identified. Aetiology was determined
in 76 infants, being acquired brain injury (14), focal cortical dysplasia
(14), other brain malformation (17), metabolic (6), chromosomal (9),
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other ´genetic´ disorders (16) and unknown (presumed genetic) (38). 86
infants had no aetiologic diagnosis at epilepsy onset. Simulation of diag-
nostic pathways showed higher yield with the revised pathway than the
current pathway (47/86 (55%) vs. 39/86 (45%). Cost per diagnosis was
lower with the revised pathway ($12,967AUD vs. $22,754AUD).
Conclusion: Implementation of WES into clinical practice early in the
diagnostic pathway, and limiting metabolic testing, will increase diag-
nostic yield for less cost than current standard diagnostic testing in SEI.
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0041
THE IMPACTOF PHYSICALATTRACTIVENESS
JUDGMENTSON STIGMAOF EPILEPSY
A. Ristic*, O. Jovanovic†, D. Popadic†, A.M. Naduvil‡,
A. Ilankovic§, V. Bascarevic¶, N. Vojvodic*, D. Sokic*
*Center for Epilepsy and Sleep Disorders, Neurology Clinic,
Medical School, University of Belgrade, Belgrade, Serbia,
†University of Belgrade, Department of Psychology, Faculty of
Philosophy, Belgrade, Serbia, ‡Epilepsy Center, Cleveland
Clinic, Cleveland, OH, United States, §Clinic for Psychiatry,
Medical School, University of Belgrade, Belgrade, Serbia,
¶Neurosurgery Clinic, Medical School, University of Belgrade,
Belgrade, Serbia
Purpose: We aimed to investigate whether the physical attractiveness
judgment affects perception of epilepsy among healthy individuals and
patients with multiple sclerosis (pMS). We tested hypothesis that sub-
jects, in the absence of relevant clues, would catch upon the facial attrac-
tiveness when asked to speculate which person suffers epilepsy and
select less attractive choices.
Method: Two photo-arrays (7 photos for each gender) selected from the
Chicago Face Database (180 neutral faces of Caucasian volunteers with
unknown medical status) were shown to subjects. Photos were evenly
distributed along the continuum of attractiveness that was estimated by
independent raters in pre-study stage. In each photo-array three photos
had ratings 1–3 (unattractive), one photo had rating 4 (neutral), and three
photos had rating 5–7 (attractive). High-quality printed photo-arrays
were presented to subjects and they were asked to select a one person
from each photo-array “who has been diagnosed as epilepsy”. Finally, all
subjects were asked to complete questionnaire of self-esteem and 19-item
Scale of stereotypes toward people with epilepsy.
Results: In total 71 students of psychology/anthropology/andragogy
(mean age 21.6  1.7; female 85.9%) and 70 pMS (mean age 37.9  8;
female 71.4%) were tested. Majority of students or pMS had no previous
personal experience with individuals with epilepsy (63.4%; 47.1%,
p = 0.052). Male photo was selected as epileptic in following propor-
tions: students - 84.5% unattractive, 8.5% neutral, and 7% attractive;
pMS - 62.9% unattractive, 8.6% neutral, and 28.6% attractive
(p = 0.003). Female photo was selected as epileptic in following propor-
tions: students - 38% unattractive, 52.1% neutral, and 9.9% attractive;
pMS - 32.9% unattractive, 34.3% neutral, and 32.9% attractive (0.037).
Both groups showed very low potential for stigmatization: significantly
lower in pMS in 5 items. pMS showed significantly higher self-esteem
then students (p = 0.007).
Conclusion: Both students and pMS seemed less willing to attribute epi-
lepsy to attractive person of both gender.
0042
SELF-MANAGEMENT EDUCATION FORADULTS
WITH POORLYCONTROLLED EPILEPSY (SMILE-UK)
L. Ridsdale*, G. Wojewodka*, E. Robinson*, S. Landau*,
A.J. Noble†, M. Morgan*, S.J. Taylor‡, M. Richardson*,
G. Baker†, L.H. Goldstein*
*King’s College London, London, United Kingdom, †University
of Liverpool, Liverpool, United Kingdom, ‡Bart’s and the
London School of Medicine and Dentistry, London, United
Kingdom
Introduction: Seizures are controlled with medication for 60–70% of
people with epilepsy (PWE). For those with recurring seizures, self-
management is important to prevent risks including injury, psychological
co-morbidity and premature death. PWE want to know more about self-
management but little training has been tested or provided, and none in
the UK. In this context, we tested a two-day course delivered in groups
for UK PWEwith recurring seizures.
Objective: To evaluate by a randomized-control trial Self-Management
education for adults with poorly controlled epILEpsy (SMILE-UK).
Methods: Patients with ≥ 2 seizures in the previous year were ran-
domised into the treatment or wait-listed control group and followed-up
for 1 year. The primary outcome was quality of life measured by
QOLIE-31-P. Secondary outcomes included: seizure frequency, anxiety
and depression, stigma, self-mastery. Participants were purposefully
selected for interview < 6 months after the course.
Results: 404 PWE participated, with a median 18 years since diagnosis,
54% were female, and 69% experienced ≥10 seizures in the prior year.
Mean QOLIE-31-P score was 66 at enrolment. There was no difference
between the two groups at baseline or 1 year later. In-depth interviews
showed facilitated group learning helped participants overcome their
sense of isolation, open up, discuss feelings, and improve confidence
whilst comparing attitudes and practice.
Conclusion: People with drug-resistant epilepsy need to find ways to
self-manage. Group education courses offer them the opportunity to learn
from experts, and by talking together, to overcome their sense of isolation
and build confidence. However, they are insufficient to change quality of
life after 1 year. Trial registration: ISRCTN57937389. Funding: NIHR-
HTA 09/165/01. The views and opinions expressed in this evaluation are
those of the authors and not necessarily those of the NHS, the NIHR or
the Department of Health.
0043
NEWEPILEPSYGUIDELINE INNORWAY -
AVAILABLEONNETANDAS A FREEAPP
K.O. Nakken*, E.S. Kjendbakke†, M.L. Hem†, K.M. Aaberg†,
H. Peersen‡
*Oslo University Hospital, National Centre for Epilepsy, Oslo,
Norway, †Oslo University Hospital, National Centre for
Epilepsy, Sandvika, Norway, ‡Norwegian Epilepsy Association,
Oslo, Norway
Purpose: For many years, the Norwegian Epilepsy Association has
received feedback from their members about a very variable quality of
the epilepsy care in Norway. Hence, in 2014 the Norwegian health
authorities appointed a committee to prepare an evidence-based guide-
line on diagnostics, treatment, follow-up and education for people with
epilepsy. The aim was to equalize the differences between the parts of the
country and increase the quality of the care.
Method: Amultidisciplinary committee was soon established, including
child- and adult epileptologists, epilepsy nurses, a neuropsychologist, a
physiotherapist, a social worker, an educationist, a dietician, representa-
tives from the Epilepsy Association, and a librarian. A thorough search in
different databases was undertaken, and in evaluating the quality of the
documentation and the strength of our recommendations we employed
the GRADE system - with some modifications.
Results: The guideline comprises a short introduction on epilepsy, fol-
lowed by recommendations on diagnostic work-up in patients suspected
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of epilepsy, different treatment options (drugs, surgery, neurostimula-
tions, diets), handling of special patient groups (children, intellectual dis-
abled, pregnant women, elderly, status epilepticus), practical handling of
ongoing seizures, follow-up, and rehabilitation. After finalizing the
guideline, we have made an e-learning aiming at informing the patients
and their relatives about some of the highlights in the guideline, and how
to make use of it.
Discussion: So far, the guideline has been warmly welcomed. The col-
leagues find it user friendly, it has a good search function, and it is easy to
get access via mobile phone and as a free available app. The net address
is: www.epilepsibehandling.no.
Conclusion: We have made a new electronically available evidence
based guideline on epilepsy in Norway.We believe it meet a need for up-
dated information, not only for doctors treating patients with epilepsy,
but also for other health personnel, patients themselves, and their rela-
tives.
0044
ATTITUDES ANDEXPERIENCESOFMEDICINAL
CANNABIS USE IN EPILEPSY
L. Todd*, J. Burford†, A. Vithanage*, C. Ireland*, A. Suraev‡,
N. Lintzeris‡
*Epilepsy Action Australia, Sydney, NSW, Australia, †Epilepsy
Action Australia, Adelaide, SA, Australia, ‡The Lambert
Initiative, The University of Sydney, Sydney, NSW, Australia
Purpose: To measure the Australian experience and attitudes of canna-
bis use in epilepsy of adults and parents/guardians of children living with
epilepsy.
Method: Online distribution of a forty-one item survey measuring
demographic and clinical factors plus attitudes and opinions of cannabis
use in epilepsy. IP address capture was deactivated. Inclusion criteria
required a response to question seventeen “Have you or the person with
epilepsy tried any form of medicinal cannabis for seizures?”
Results: 1,277 responses received over a ten day period. 983 responses
met analysis criteria with a distribution of 45% adults and 55% parents of
children with epilepsy. 62% of children and 50% of adults identified as
having medical conditions in addition to epilepsy. Overall, 14% of survey
respondents have previously used, or currently use medicinal cannabis
for epilepsy. Of these people, 86% reported a positive response to canna-
bis use in managing seizures. 66% of survey respondents would be will-
ing to participate in a medicinal cannabis research trial with 68% of the
parents/guardians made comments themed as “willing to try anything”.
Conclusion: This survey provides an insight into the attitudes, experi-
ences and opinions of adults and parents of children living with epilepsy
in Australia seeking cannabis as a viable treatment option for epilepsy.
Findings support the need for information and education about the canna-
bis plant, the endocannabinoid system, medicinal uses of cannabinoids
and current state of legislation and clinical trials.
0045
EFFECTSOFA SPECIALIZED INPATIENT
TREATMENT PROGRAMONEPILEPSYRELATED
IMPAIRMENTSOF PATIENTSWITHEPILEPSYAND
INTELLECTUALDISABILITYAS RATEDBY
RELATIVES ANDCARERS
C. Brandt*, B. M€uffelmann*, T. May†, R. Thorbecke†, L. Hopf*,
H. Ottenottebrock*, C. Wolfertz*, C. Bien*
*Epilepsy Center Bethel, Klinik Mara 1, Bielefeld, Germany,
†Epilepsy Center Bethel, Society for Epilepsy Research,
Bielefeld, Germany
Purpose: We tested the hypothesis that patients participating ≥ 14 days
in a specialized inpatient treatment program (SITP) will experience a sig-
nificant improvement of epilepsy related impairments and Quality of Life
(QoL).
Method: The epilepsy center Bethel offers a SITP for adult patients with
epilepsy and intellectual disability (PwE&ID). In a controlled prospec-
tive study with a pre/post design, parents and carers of PwE&ID were
interviewed twice, the time between first and second interview being
4–6 months: A) treatment group (TG): before intake and 4–6 months
after discharge B) control group (CG): consecutive patients from the
waiting list at registration, and 4–6 months later before admission.
Results: We analyzed the data of 199 patients (TG/CG 108/91; response
rate 90%). At baseline most patients had a high (>= 1 per week) seizure
frequency, were treated with a polytherapy with frequent side effects.
Median duration of stay: 31 days. The TG showed in comparison to the
CG a highly significant improvement in the GEOS-43D (total score) and
in the subscales “Concerns About Seizures“, „Seizure Related Risks“,
“Side Effects/Medical Treatment”. There were no effects in the subscales
„Social Impact of Epilepsy“ and „Concerns of Family Members”. There
were also significant improvements in the secondary outcome measures:
Global QoL, Global Health, efficacy and tolerability of AEDs, and sei-
zure frequency.
Conclusion: The results confirm our hypothesis that a specialized treat-
ment program improves epilepsy related impairments in patients with
epilepsy and intellectual disability.
0046
FUNCTIONALCONNECTIVITYOFMPFC
COMPENSATES EPISODICMEMORYENCODING
NETWORKFOLLOWINGMEDIAL TEMPORALLOBE
RESECTION
W. Jeong*,†, H. Lee‡, C.K. Chung*,†,§, J.S. Kim§
*Seoul National University Hospital, Neurosurgery, Seoul,
Korea, †Seoul National University College of Natural Science,
Interdisciplinary Program in Neuroscience, Seoul, Korea,
‡National Center for Mental Health, Department of Mental
Health Research, Seoul, Korea, §Seoul National University
College of Natural Sciences, Department of Brain and Cognitive
Sciences, Seoul, Korea
Purpose: Although it is generally known that widespread functional
reorganization occurs after brain damage, these functional recovery pat-
terns in patients with medial temporal lobe resection (MTLR) in relation
with memory are still poorly understood. In this study, we investigated
whole brain memory encoding network in patients who showed normal
range of memory function following unilateral MTLR.
Method: We studied 37 adult temporal lobe epilepsy patients who
underwent unilateral MTLR (left=17, follow-up = 6.45  2.75 years,
seizure free=31/37) and 24 healthy controls. All subjects underwent stan-
dardized neuropsychological examination and functional MRI scanning
with memory encoding paradigm of words and abstract figures. An
event-related analysis and task-based functional connectivity (FC) analy-
sis were adopted to explore brain activation patterns for subsequently
remembered stimuli.
Results: Both patient groups exhibited normal range of intelligence and
memory function after surgery. Functional activations for both word and
figure encoding were similar across the subject groups. However, group
comparisons revealed that well-known task-negative areas including
medial prefrontal cortex (mPFC) were less deactivated in MTLR
patients. During successful encoding, both patient groups showed
increased FC between mPFC and widespread memory-related brain areas
including contralateral hippocampus when compared with healthy con-
trols. Furthermore, FC of the right mPFC - left middle frontal gyrus was
positively correlated with verbal recall scores in left MTLR patients; FC
of the right mPFC - left hippocampus was positively correlated with
visual recall scores in RMTLR patients.
Conclusion: Thanks to the relatively long follow-up period, we could
investigate stable memory encoding network after functional reorganiza-
tion process in postoperative patients with unilateral MTLR. Our data
suggest that hyper-connectivity between the mPFC and contra-resected
hippocampus together with remote neocortical areas may play a compen-
satory role in episodic memory function for the loss of functional connec-
tions in surgically removedMTLs.
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0047
SEIZURECONTROLANDHIPPOCAMPAL SCLEROSIS
ARERELATED TOMETABOLIC ALTERATIONS IN
MESIAL TEMPORAL LOBEEPILEPSY
L. Pimentel-Silva*, R. Fernandes Casseb*, M. Koutsodontis
Machado Alvim*, R. Barbosa*, C. Lin Yassuda*, F. Cendes*
*University of Campinas/UNICAMP - School of Medical
Sciences, Campinas, Brazil
Purpose: We aimed to better characterize conflicting data on N-acetyl
aspartate (NAA) and glutamate in mesial temporal lobe epilepsy (MTLE)
with or without MRI signs of hippocampal sclerosis (HS) using proton
magnetic resonance spectroscopy.
Methods: We included 94 unilateral MTLE patients and 50 healthy con-
trols. Patients were divided per seizure control into poor (PSz, frequent
seizures) and good (GSz, seizure-free or rare seizures), and per presence/
side of HS into left-HS, right-HS andMRI-negative. Single-voxel spectra
were acquired in a Philips 3T-scanner using PRESS sequence (Point
Resolved Spectroscopy, TR/TE= 2000/35 msec) and quantified using
LCModel. We usedMANCOVA co-varying for age with Bonferroni cor-
rections to compare total NAA (NAAt) and total glutamate (Glx) ratios to
creatine between groups, using SPSS software.
Results: There were significant differences in NAAt and Glx regarding
seizure control (F(8, 240)=4.55, p < 0.0001). We found an ipsilateral
reduction of NAAt in PSz compared to GSz (p < 0.0001) and controls
(p = 0.001). NAAt was also reduced contralaterally in PSz group com-
pared to controls (p = 0.001). Glx was reduced only ipsilateral to HS in
PSz compared to GSz (p = 0.04) and controls (p = 0.002). Regarding
HS side, there was a significant difference between groups (F(12, 363)
=2.44, p = 0.004) only for NAAt. It was decreased ipsi- and contralater-
ally in left-HS compared to controls (p < 0.0001 and p = 0.003). Right-
HS showed only ipsilateral reduction compared to controls (p = 0.003).
Further analysis combining groups showed differences in NAAt and Glx
(F(24, 472)=2.17, p = 0.001), however only NAAt survived Bonferroni
correction. NAAt was decreased ipisilaterally in PSz-left-HS compared
to GSz-right-HS, GSz-MRI-negative and controls (p = 0.039, p = 0.04
and p < 0.0001) and reduced contralaterally in PSz-left-HS compared to
controls (p = 0.009).
Conclusion: Our results suggest more pronounced NAA alterations in
left-HS with poor seizure control than right-HS and MRI-negative TLE
patients, whilst Glx alterations are more related with seizure control than
with the presence of HS.
0048
EEG SOURCECONNECTIVITY TOLOCALIZE THE
SEIZUREONSET ZONE FROMCLINICAL ICTAL EEG
INREFRACTORYEPILEPSY PATIENTS
W. Staljanssens*, G. Strobbe†, R. Van Holen*, V. Keereman*,‡,
S. Gadeyne‡, E. Carrette‡, A. Meurs‡, M. Seeck§, P. Boon‡,
S. Vandenberghe*, S. Vulliemoz§,¶, K. Vonck‡, P. van Mierlo*,**
*Ghent University - IMEC, Medical Image and Signal
Processing Group, Department of Electronics and Information
Systems, Ghent, Belgium, †Epilog nv, Zwijnaarde, Belgium,
‡Ghent University Hospital, Laboratory for Clinical and
Experimental Neurophysiology, Neurobiology and
Neuropsychology, Department of Neurology, Ghent, Belgium,
§EEG and Epilepsy Unit, Neurology Department, University
Hospitals and Faculty of Medicine of Geneva, Geneva,
Switzerland, ¶Functional Brain Mapping Lab, Department of
Fundamental Neurosciences, University of Geneva, Geneva,
Switzerland, **University of Geneva, Laboratory for Clinical
and Experimental Neurophysiology, Neurobiology and
Neuropsychology, Department of Neurology, Geneva,
Switzerland
Purpose: Accurate delineation of the seizure onset zone (SOZ) is impor-
tant during the presurgical evaluation to assess whether the patient quali-
fies for epilepsy surgery. Currently, ictal EEG analysis happens visually,
which is time-consuming, challenging and subjective. In this study, we
validate a methodology to objectively localize the SOZ from ictal EEG.
Methods: We retrospectively analyzed 95 seizures recorded with 27 and
32 EEG electrodes in 26 patients from Ghent and Geneva University
Hospital. All patients had Engel class I outcome with at least 1 year fol-
low-up. For every seizure, an artifact-free epoch close to the electro-
graphic seizure onset was selected. We applied EEG source localization
(LORETA) followed by functional connectivity analysis using the spec-
trum-weighted Adaptive Directed Transfer Function to depict the brain
region with most outgoing connections during the ictal epoch. For valida-
tion, the distance between the depicted SOZ and the border of the
resected zone (RZ) segmented from the post-operative MRI was calcu-
lated. Moreover, we compared this error to the distance between the
source with maximal power after ESI and the RZ to assess the added
value of functional connectivity analysis over ESI.
Results: ESI with subsequent connectivity analysis was able to localize
the SOZ within 20 mm of the RZ in 88% of the seizures, within 10 mm
in 59% and inside the RZ in 44%. When using only ESI these numbers
dropped to 60%, 37% and 30%, respectively. ESI followed by connectiv-
ity analysis significantly outperformed SOZ localization based on maxi-
mal power after ESI. Furthermore, the intra-patient robustness was
significantly higher.
Conclusion: ESI combined with subsequent functional connectivity
analysis is able to localize the SOZ in a non-invasive and objective way.
Therefore it could be a valuable tool in the presurgical evaluation of epi-
lepsy.
0049
INTRANAT ELECTRODES: A FREE SOFTWARETO
VISUALIZE SEEGDATA IN PATIENTREFERENTIAL
AND INITIATEGROUP STUDIES
P. Deman*, M. Bhattacharjee*, L. Trebaul*, D. Riviere†,‡,
Y. Cointepas†,‡, P. Kahane*,§, O. David*
*INSERM, U 1216, Grenoble Institut des Neurosciences, La
Tronche, France, †Neurospin - CEA Saclay, UNATI Lab, Gif sur
Yvette, France, ‡Multicenter Neuroimaging Platform, CATI,
Paris, France, §CHUGrenoble, Neurology Department,
Grenoble, France
Purpose: Patients with drug-resistant focal epilepsy can be implanted
with intracranial electrodes to find the seizure onset zone to be resected.
In stereo-electroencephalography (SEEG), patient have around 120 elec-
trode contacts, recording signal in a 3.5 mm sphere approximately. The
spatial coverage is around 1% of the brain activity per patient and differ
between patients. Group studies over different types of epilepsy thus need
a large number of patients with a multicentric perspective in the long run.
To facilitate them, we developed a software for visualizing electrode
implantation and related epileptogenicity, functional and cognitive maps,
on the basis of a patient database allowing various search criteria for
highlighting various group features.
Methods: For each patient, imaging modalities (PET, anatomical MRI,
fMRI, DTI, CT, Destrieux parcellation) are coregistered (using ANTs or
SPM12) and MarsAtlas parcellation is performed (using Brainvisa).
Using post implantation images the user can insert the 3D modelized
electrodes. Each contact is labeled according to its position in MarsAtlas
or Destrieux parcellation, Brodmann or AAL atlases, and resection mask
(as assessed by subtracting the T1 brain segmentation after resection
minus before implantation). Users can manually add more contact labels,
such as clinical response after electrical stimulation cortico-cortical
evoked potentials, gamma band activity during cognitive task or epilepto-
genicity during seizures.
Results: IntrAnat Electrodes provides a means to visualize SEEG
implantations, resection over anatomical or functional imaging and to
summarize epileptogenic and functional information provided by SEEG
signals. The contact labeling allows to search for patient in the database
according to criteria (contact position, resection localization, response to
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stimulation, etc. . .). IntrAnat Electrodes will be available in the forth-
coming release of BrainVisa (http://brainvisa.info/web/index.html).
*This work was funded by European Research Council under the Euro-
pean Union´s Seventh Framework Programme (FP/2007–2013)/ERC
Grant Agreement n. 616268 F-TRACT, and by a french ANR grant
(Force project, ANR-13-TECS-0013-01).
0050
IN-VIVO IMAGINGOFACTIVATEDNMDA
RECEPTOR IONCHANNELSWITHTHE
RADIOLIGAND 18F-GE179
A. Vibholm*,†, J. Christensen‡, S. Beniczky§, A. Landau†,
M. Dietz†, A. Møller†, J. Christian Hedemann Sørensen†,¶,
D. Brooks†
*Aarhus University Hospital, Neurology, Aarhus, Denmark,
†Aarhus University, Aarhus, Denmark, ‡Aalborg University
Hospital, Neurology, Aarhus, Denmark, §Aalborg University
Hospital, Aarhus, Denmark, ¶Aalborg University Hospital,
Neurosurgery, Aarhus, Denmark
Purpose: To validate the radioligand 18F-GE179 as a use dependent
marker of NMDA receptor activity in the living brain by non-invasive
detection of overactive NMDARs in the pre-surgical evaluation of
patients with refractory focal epilepsy using Positron Emission Tomogra-
phy (PET) and 18F-GE179, which selectively binds to open NMDAR ion
channel (IC). This may lead to better detection and understanding of
altered NMDARs.
Method: 18F-GE179 PET and MRI were performed during stimulation
from electrodes unilaterally implanted into the amygdala/hippocampus
of 21 rats and 6 pigs. EEG evident spiking and afterdischarge was electri-
cally induced in rats and seizures were induced during DBS in pigs.
Humans underwent anatomical MRI and functional 18F-GE179 PET with
simultaneous interictal EEG.
Results: In rats, the implanted and stimulated animals (n = 5) showed
significantly increased 18F-GE179 uptake adjacent to the electrode tip.
Administration ketamine (NMDAR-IC antagonist) effectively blocked
18F-GE179 uptake during induced seizures (n = 3). No focal 18F-GE179
uptake was seen in the control rats (n = 13). In pigs, 18F-GE179 uptake
was globally increased in a current dependent manner during DBS in all
pigs. In humans, 18FGE-179 PET detected clusters of significantly
increased interictal uptake in 8 of 10 patients, twice the detection rate of
focal abnormalities by the simultaneously recorded EEG. Patients who
had extensive clusters of raised 18FGE-179 uptake also showed the most
clear-cut abnormalities on their simultaneous EEG. No control showed
focally increased 18FGE-179 uptake or EEG abnormalities.
Conclusion: 18F-GE-179 PETmay have capacity to map the distribution
of abnormal NMDAR-IC activation and reveal subjects with increased
susceptibility to seizures and identify subjects with a higher risk of epi-
lepsy after brain insults such as stroke or traumatic brain injury. Addi-
tionally, it may advance our understanding of the role of glutamate ion
channels in paroxysmal neurological disease and psychiatric disorders.
Basic Sciences 2
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0051
ANAUTOMATEDTOOLFORRELIABLEDETECTION
OF SEIZURES IN RODENTMODELSOFEPILEPSY
A. Sargsyan*, D. Melkonian*, P.M. Casillas-Espinosa†,
T.J. O’Brien†
*Kaoskey Pty. Ltd., Sydney, NSW, Australia, †The Royal
Melbourne Hospital, The Unviersity of Melbourne, Deaprtment
of Medicine, Melbourne, VIC, Australia
Purpose: Prolonged video-EEG monitoring in chronic epilepsy rodent
models has become an important tool in pre-clinical drug development of
new therapies, in particular for anti-epileptogenesis, disease modification
and drug resistant epilepsy. We have developed an easy to use, reliable,
computational tool for detection of electrographic seizures from pro-
longed EEG recordings in rodent models of epilepsy.
Method: We applied a novel method based on advanced time-frequency
analysis which detects the episodes of EEGwith excessive activity in cer-
tain frequency bands. The method uses an advanced technique of short
term spectral analysis - the Similar Basis Function algorithm. The
method was applied for off-line seizure detection from chronic EEG
recordings from two spontaneously seizing, chronic epilepsy rat models,
post-status epilepticus model of temporal lobe epilepsy and the fluid per-
cussion injury model of post-traumatic epilepsy (n = 34 and 5 rats,
n = 88 and 49 seizures respectively).
Results: High values of power spectrum in frequency band 20–23 Hz
were found to specifically indicate seizures in both animal models. This
peculiarity comes from the frequency composition of single discharges
within the seizures in these animals. Focusing on this band, our computer
program detected 100% of seizures in all 39 rats. Electrode artefacts,
which are usually present in long-term EEG recordings, may also signifi-
cantly contribute to this frequency band, so they were also selected by the
program. This selection, however, generated a very low rate of false posi-
tives. For their elimination, a quick user inspection was needed. The
overall processing time for 12 day-long recordings varied from few min-
utes (5–10) to an hour, depending on the number of artefacts.
Conclusion: Our seizure detection tool provides high sensitivity, with
acceptable specificity, for chronic EEG recordings from chronic rat epi-
lepsy models. This has the potential to improve the efficiency and rigor
of pre-clinical research and therapy development using these models.
0052
MMP-9 ACTIVITYAFTERTRAUMATIC BRAIN
INJURYAS ARISK FOREPILEPSYDEVELOPMENT
B. Pijet*, M. Stefaniuk*, E. Rejmak-Kozicka*, L. Kaczmarek*
*Nencki Institute of Experimental Biology, Warsaw, Poland
Purpose: Epilepsy in 20% of cases, develops as an effect of traumatic
brain injury (TBI). Recent evidence indicate important role of extracellu-
lar matrix metalloproteinase-9 (MMP-9) in neuronal circuitry remodel-
ing and synaptic plasticity. The aim of the present study was to evaluate
the MMP-9 activity changes, dendritic spines density after brain injury
and the influence of MMP-9 expression level on spontaneous seizures
appearance after TBI.
Method: We used Controlled Cortical Impact (CCI) as a model of TBI
in animals with altered MMP-9 levels (lacking: MMP-9 KO; overex-
pressing:MMP-9OE) and theirWT siblings. 12 weeks after CCI animals
were subjected to continuous video-EEG monitoring. To verify MMP-9
changes after TBI: gel zymography and in situ hybridization were used.
For dendritic spine alterations staining using liophilic dye DiI were per-
formed.
Results: TBI resulted in progressive cortex (Cx) degeneration during
30 days after TBI. This effect was MMP-9 dependent. In MMP-9 KO
animals degeneration volume degree was significantly smaller compared
to wildtype siblings and MMP-9 OE mice. Gel zymography analysis
showed time-associated elevation of MMP-9 activity in ipsilateral Cx
and Hp, also in the thalamus samples during 3 days after CCI. Moreover,
in situ hybridization showed increase of MMP-9 mRNA expression
which reached the peak 6 h post-CCI. Density of the dendritic spines
measured 7 and 14 d after CCI was significantly decreased in ipsilateral
Cx and CA1. EEG recordings with threshold test showed decreased sei-
zure latency in MMP-9 OEmice while increased in MMP-9 KO. Interest-
ingly total seizure number was the highest inMMP-9 OE animals.
Conclusion: We described the correlation between TBI and MMP-9
activity and action post trauma. We indicated that MMP-9 might be an
important factor for major dendritic spine reshaping, observed after brain
injury, which in consequence may lead to altered sensibility of neuronal
circuits to trigger seizures.
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NEONATAL ELECTROGRAPHIC SEIZURES AND
BEHAVIORAL IMPAIRMENT INMICEWITHANAV
GENETIC1.2 CHANNELOPATHY
W. Fazeli*,†,‡, S. Schoeb†,‡, B. Engeland†,‡, S. Marguet†,‡,
I. Jakovcevski†,‡, M. Sahmeni†,‡, F. Morellini§, D. Isbrandt†,‡
*University Hospital Cologne, Pediatric Neurology, Cologne,
Germany, †German Center for Neurodegenerative Diseases,
Bonn, Germany, ‡University of Cologne, Institute for Molecular
and Behavioral Neuroscience, Cologne, Germany, §Centre for
Molecular Neurobiology Hamburg, Behavioural Biology Unit,
Hamburg, Germany
Background: Voltage-gated sodium channels are essential for action
potential initiation in neurons. Mutations in the SCN2A gene encoding
NaV1.2 are associated with a broad spectrum of epilepsies, ranging from
benign phenotypes to severe epileptic encephalopathy. Recently, a mis-
sense mutation in SCN2A (A263V) was identified in a patient with
neonatal onset, therapy-resistant seizures and variable episodes of ataxia,
myoclonus, headache and back pain, starting at the age of 18 months.
Electrophysiological characterization of NaV1.2(A263V) channels in a
heterologous expression system revealed an increase in the persistent
sodium current, i.e. a pronounced gain-of-function effect.
Method: To investigate the underlying mechanisms of epileptogenesis,
we generated Scn2a(A263V) knock-in mice by homologous recombina-
tion in embryonic stem cells and characterized the effect of the mutation
on neuronal network activity and behavior.
Results: Homozygous and heterozygous A263V knock-in mice were
born at the expected Mendelian ratio, but had a reduced body weight.
Homozygous mice frequently showed spontaneous behavioral seizures
in adulthood, while their mortality was increased from the third week of
life onward. In vivo depth recordings in neonatal mutants revealed that
epileptic network activity within the hippocampal CA1 region was pre-
sent before the onset of motor seizures, i.e. as early as postnatal day 2.
Spontaneous electrographic seizures were also recorded in about 20% of
heterozygous mice, although less frequently. Behavioral characterization
of adult mice revealed hyperactivity and cognitive impairment, being
particularly pronounced in homozygous animals. Chronic treatment with
the non-specific sodium channel blocker phenytoin during the first post-
natal week was able to prevent the occurrence of electrographic hip-
pocampal seizures when animals were recorded at the age of seven or
fifteen days.
Conclusion: In summary, the Scn2a(A263V) knock-in mouse line repre-
sents a new channelopathy model giving us the opportunity to study
epileptogenesis and behavioral comorbidities, and to develop and test
new therapeutic strategies.
0054
THEMASHL+/- KNOCK-INMOUSEASAMODEL FOR
HUMAN SUDEP SUITABLE TO SCREEN FOR
POTENTIALANTI-SUDEPAGENTS
M. Sachdev*, A. Hunanyan*, E. Abdelnour*, M. Mikati*
*Duke University Medical Center, Division of Pediatric
Neurology, Durham, NC, United States
Purpose: To demonstrate occurrence of sudden unexpected death in epi-
lepsy (SUDEP) in Mashl+/- knock-in mice (carrying Atp1a3 D801N
mutation); to determine at what age SUDEP is highest; and to investigate
whether dextromethorphan (DXM), a medication that reduces spreading
depolarization the mechanism, can ameliorate Mashl+/- predisposition to
SUDEP as an illustration of the usefulness of this model to screen for
anti-SUDEP agents.
Method: The natural time course of SUDEP in theMashl+/- mice, known
to manifest spontaneous recurrent seizures and vestibular stimulation
induced seizures, was examined. Next, 4 groups were studied: 2 WT and
2 D801N Mashl+/- mice, one of each receiving vehicle and one of each
receiving DXM (20 mg/kg). Animals underwent vestibular stimulation
20 min after receiving vehicle/DXM once/day for 10 days. Then animals
were subjected to flurothyl-induced seizures.
Results: Mortality was significantly higher in the second quarter of life
in Mashl+/- mice: n = 39, P < 0.05, x2 test (7/39 in the 1st quarter; 16/39
in the 2nd; 11/39 in the 3rd; and 5/39 in the 4th). Spontaneous recurrent
seizures were observed in 3/22 (14%) Mashl+/- mice as compared to 0/40
(0%) WT mice. After undergoing vestibular stimulation, all Mashl+/-
mice had seizures irrespective of whether they received DXM or vehicle.
Preliminary results show trends that DXM treatment decreases seizure
latency in both WT and Mashl+/- mice (WT, n = 2, P = 0.058; Mashl+/-,
n = 2, P = 0.052), and increases mortality in Mashl+/-mice (WT-Vehicle
0/2, WT-DXM0/2, Mashl+/--Vehicle 1/4, Mashl+/--DXM 2/4).
Conclusion: SUDEP occurred most commonly during the second quar-
ter of life. By virtue of the occurrence of stimulus-induced seizures, this
model can be used to screen for potential anti-SUDEP medications. Pre-
liminary data gathered regarding DXM in this model do not appear favor-
able for a positive effect.
0055
MOLECULARVARIABILITYOFCHILDHOODAND
ADULTEPILEPTOGENESIS: DIFFERENCES INMIRNA
PROFILEOFADULTAND INFANTILE RATS
P. Bencurova*,†,‡, J. Baloun§, S. Pospisilova‡,§, H. Kubova¶,
M. Brazdil*,†,‡
*Masaryk University, CEITEC, Brain andMind Research, Brno,
Czech Republic, †St. Anne’s University Hospital, Brno, Czech
Republic, ‡Masaryk University, Faculty of Medicine, Brno,
Czech Republic, §Masaryk University, CEITEC, Molecular
Medicine, Brno, Czech Republic, ¶Academy of Sciences of the
Czech Republic, Instute of Physiology, Department of
Developmental Epileptology, Prague, Czech Republic
Purpose: The onset of epilepsy frequently occurs in early childhood
when the brain is more susceptible to seizures. The early onset epilepsies
are different from those acquired in adulthood. The primary aim of this
study was to identify the alterations in microRNA (miRNA/miR) expres-
sion in hippocampal tissues of rats undergoing epileptogenesis triggered
with LiCl/pilocarpine-induced status epilepticus (SE) in adulthood (P60)
or infancy (P12).
Method: Rats were exposed to LiCl/pilocarpine induced SE at P60
(n = 11) or P12 (n = 13). Age matched animals were used as controls
(n = 11 per each age group). Hippocampal tissue was collected 24 h after
SE and quickly frozen. Total RNA was isolated from frozen specimens.
To address the clinically relevant miRNAs we performed the expression
analysis using miQPCR on 30 miRNAs identified with altered expression
in mTLE+HS patients.
Results: The majority of tested miRNAs had similar expression in both
adult and P12 hippocampi. miR-144-5p was downregulated in rats with
SE induced in P12 compared with controls. On the other hand, expression
levels of let-7i-5p and miR-4443 were decreased only in adult rat brains
after SE.
Conclusion: Epileptogenesis in adult and developing brain has common
features; however, there are differences at both clinical and molecular
level. Altered levels of miR-144-5p, -4443, and let-7i-5p are the possible
cause of this variability.
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SEIZURECONTROLAFTER SURGERY FOR
INTRACRANIALMENINGIOMA: A SINGLECENTER
COHORT STUDY
H. Xue*, O. Sveinsson†, T. Tomson†, T. Mathiesen‡,
L. Kihlstr€om‡, J. Bartek‡, P. F€orander‡, S. Skyrman‡, R. Shafiei†
*Beijing Tiantan Hospital, Capital Medical University,
Department of Neurosurgery, Beijing, China, †Karolinska
Institute Hospital, Department of Neurology, Stockholm,
Sweden, ‡Karolinska Institute Hospital, Department of
Neurosurgery, Stockholm, Sweden
Purpose: Meningiomas account for approximately 30% of primary CNS
neoplasms in adults. Seizures occur frequently both pre- and postopera-
tively. The purpose of this study was to investigate the long-term seizure
outcomes and antiepileptic drug (AED) prescription, and identify possi-
ble predictors of seizures before and after surgery in patients operated for
cranial meningioma.
Method: Adult patients with newly diagnosed meningioma and operated
at the Karolinska University Hospital between 2006 and 2008 were
included and followed until end of 2015. Preoperative data and details on
surgical procedures were obtained through chart review. Data on seizure
outcome and AED prescriptions were obtained through chart review and
telephone interview. Logistic regression and survival analysis was
applied to identify risk factors for pre- and postoperative seizures.
Results: Of the 113 patients analyzed, seizures occurred in 21 (18.6%)
patients before surgery of which 38.1% achieved completely seizure free-
dom after surgery. Thirteen (14%) patients had new-onset seizures after
surgery. Tumor diameter≥3.5 cm was a risk factors for preoperative sei-
zures (OR: 3.83, 95% CI 1.14–12.87) while having no headache (OR:
0.19, 95% CI 0.05–0.76), and non-skull base location (0.14, 95% CI
0.04–0.44) were protective for preoperative seizures. Predictors for post-
operative unprovoked seizures were tumor diameter≥3.5 cm (OR: 2.65,
95% CI 1.06–6.62) and history of preoperative seizures (OR: 3.50, 95%
CI 1.55–7.90).
Conclusion: Seizures are relatively common before and after intracra-
nial meningioma surgery. Just over a third of patients with preoperative
seizures become seizure free after operation while 14% acquire new sei-
zures after operation. Size of the tumor and preoperative seizures are risk
factors for postoperative seizures.
0057
HIGHEXPRESSIONOFCYSTINE-GLUTAMATE
ANTIPORTERXCT (SLC7A11) IS AN INDEPENDENT
BIOMARKER FOREPILEPTIC SEIZURESAT
DIAGNOSIS INGLIOMA
C.P. Beier*, S.B. Heimisdottir†, M.F. Soerensen†,
H. Wohlleben‡, B.W. Kristensen‡
*Odense University Hospital/Institute of Clinical Research and
University of Southern Denmark, Neurology, Odense, Denmark,
†Odense University Hospital/Institute of Clinical Research and
University of Southern Denmark, Neurology and Pathology,
Odense, Denmark, ‡Odense University Hospital/Institute of
Clinical Research and University of Southern Denmark,
Pathology, Odense, Denmark
Purpose: Epileptic seizures are an important cause of morbidity of
glioma patients. Several lines of evidence support the concept of excita-
tory neurotransmitter glutamate being the crucial mediator of gliomas
associated seizures. The main mechanism of glutamate secretion in
glioma is secretion mainly via the cystine-glutamate exchanger xCT.
Method: In this retrospective cohort study, the journal records of 229
patients were analyzed with respect to the presence, time course and
severity of anti-epileptic seizures. The expression of xCTwas determined
in three independent samples from the same biopsy using tissue microar-
rays. The maximal expression of the protein was determined and used for
further analysis.
Results: 221 patients were included in the study (7.1% grade II, 6.7%
grade III, 86.2% grade IV). In a multivariate analysis, high xCT expres-
sion but not tumor grade, vGlut1 expression, or IDH1 R132H mutations
were significantly associated with epileptic seizures at diagnosis (Odds
ratio 4.9, p = 0.02). In further exploratory analyses, low-grade gliomas
with IDH1 R132H mutations were more likely to develop seizures irre-
spective of xCT expression (p = 0.07) and had significant lower xCT
expression (p = 0.039). Both associations completely disappeared in
glioblastoma (GBM). Although xCT expression was significantly
increased in GBM, the extent of xCT expression was not associated with
survival (log-rank p = 0.27) in our cohort.
Conclusion: xCT is an independent marker for glioma-associated sei-
zures, more abundant in GBM and shows an inverse correlation with
IDH1 R132H mutations in low-grade glioma. Our data clearly support
the idea that glutamate release via xCT is crucial for glioma-associated
seizures and a promising therapeutic target.
0058
AUTOIMMUNEEPILEPSY: KEY FINDINGS TO
IDENTIFYA POTENTIALLY TREATABLEDISEASE
S. Matricardi*, I. Pappalardo†, E. Freri*, F. Ragona*,
G. Didato†, F. Andreetta‡, S. Franceschetti§, N. Nardocci*,
C. Pastori†, F. Villani†, T. Granata*
*Foundation IRCCS Neurological Institute ‘Carlo Besta’,
Department of Pediatric Neuroscience, Milan, Italy, †Clinical
Epileptology and Experimental Neurophysiology Unit,
Fondazione IRCCS Neurological Institute ‘Carlo Besta’, Milan,
Italy, ‡Neuromuscular Diseases and Neuroimmunology Unit,
Foundation IRCCS Neurological Institute ‘Carlo Besta’, Milan,
Italy, §Clinical Neurophysiology and Epilepsy Center,
Foundation I.R.C.C.S. Neurological Institute ‘Carlo Besta’,
Milan, Italy
Purpose: To analyse clinical and laboratory features, and response to
immunotherapy in patients with autoimmune epilepsy.
Method: The series comprises 45 patients (18 children, 27 adults) with
epileptic seizures as predominant or only symptom, in whom an autoim-
mune etiology was defined by the detection of pathogenic antibodies or
suspected on clinical basis. The latter group include patients in whom
paraclinical biomarkers supported CNS inflammation, or patients suc-
cessfully treated with immunotherapy, or with a history of systemic
autoimmunity or recent infective disease.
Results: Patients were followed-up at for least 24 months. Focal sei-
zures were the most common seizure type, drug refractory in 80% of
cases. High seizure frequency was recorded in 75%, mainly at disease
onset, and 48% of patients experienced epileptic status. In 35% of the
patients, neural antibodies search was positive in serum and/or CSF. In
the majority of patients, cognitive compromise, behavioural distur-
bances, and movement disorders were also associated. All the patients
were treated with immunomodulatory therapy with first- and/or second-
line drug trials. A favourable response, with significant (≥ 50%) reduc-
tion in seizure frequency, was detected in 68% during follow-up. We
compared the clinical and paraclinical features of patients with definite
and possible autoimmune epilepsy.
Conclusion: The role of neuroinflammation is increasingly recognized
in triggering or sustaining epileptic activity. The comparison between
definite and suspected autoimmune epilepsy may improve the operative
definition of autoimmune epilepsy. This might prompt early diagnosis
and appropriate treatment, thus improving the outcome.
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ICTALVOCALIZATION IN FOCALEPILEPSY
E. Hartl*, T. Knoche*, J. Remi*, H. Choupina†,‡, J. Cunha§,
S. Noachtar*
*University of Munich, Epilepsy Center, Department of
Neurology, Munich, Germany, †University of Aveiro,
Department of Electronics, Telecommunications and
Informatics, Aveiro, Portugal, ‡Institute of Electronics and
Informatics Engineering of Aveiro IEETA, Aveiro, Portugal,
§University of Porto, Institute for Systems Engineering and
Computers - Technology and Science INESCTEC, and Faculty of
Engineering FEUP, Porto, Portugal
Background: Systematic analysis of video recorded seizures established
several localizing and lateralizing semiological signs. However, the sign-
ficance of ictal vocalization is not yet well determined. This study inves-
tigates frequency and audio signal characteristics of ictal vocalization
with regard to different focal epilepsy syndromes.
Methods: Up to four consecutive partial seizures were evaluated in 277
lesional focal epilepsy patients, excluding isolated auras and subclinical
seizure patterns. Vocalization was considered to be present if observed in
at least one of the analyzed seizures and not being of speech quality. Spe-
cial audio-analysis software (Praat©, www.praat.org) was used to quan-
tify the vocalization intensity of the first seizure in 14 patients with
frontal (FE) and 17 with temporal (TE) epilepsy.
Results: Vocalization was observed in 37% of the patients (102/277). It
was similarly frequent amongst different epilepsy syndromes (27/62 FE;
5/11 paracentral, 64/185 TE; 6/19 parieto-occipital epilepsy). Automotor
seizures with ictal vocalization were significantly more common in TE
than in extratemporal epilepsy (ETE, p < 0.0001) and identified TE
patients with a sensitivity of 92% and specificity of 70%. Audio signal
comparison of ictal vocalization in FE and TE did reveal a significant
lower minimum (p = 0.0034) and a significant higher maximum inten-
sity (p = 0.033), as well as a bigger intensity range (p = 0.0003) for FE
than TE. Further, the intensity variation during the vocalization as well as
the velocity of intensity increase at the beginning of the vocalization were
significantly greater in FE than TE (p = 0.0001 and p = 0.0006). No sig-
nificant difference was found for vocalization duration and mean inten-
sity.
Conclusion: Ictal vocalization is similarly common in different focal
epilepsies. It’s analysis permits differentiation of automotor seizures of
temporal or extratemporal origin. Further, observer independent audio
analysis is helpful to objectively distinguish between ictal vocalizations
in FE and TE and adds another promising diagnostic entity to presurgical
semiology analysis.
0060
UTILITYOFHOMEVIDEOS FORDIAGNOSIS OF PNES
B. Ramanujam*, M. Verma*, D. Masliwal*, S. Sharma*,
M. Tripathi*
*All India Institute of Medical Sciences, Neurology, New Delhi,
India
Purpose/background: Psychogenic non-epileptic seizures (PNES)
resemble epileptic seizures, and 10 to 50% of patients referred to epilepsy
centers maybe subsequently diagnosed with PNES.
The objective was to assess the utility of home-videos in the diagnosis
of PNES.
Methods: Consecutive patients with suspected PNES were asked to
make home video recordings of the events on their mobile phones, with
instructions on how to record so as to get maximum information from the
videos. Those subjects who, on a subsequent visit, had a video with at
least one habitual episode were enrolled, and underwent short-term
video-EEG monitoring. Both were assessed by different epileptologists
blinded to each other’s findings. Diagnoses of PNES, epileptic seizures,
both or other episodic events were arrived at using a checklist of clinical
features in the case of home videos, and concordance with the video-
EEG diagnoses noted, and statistics applied. Neuropsychiatric and
quality of health (QOL) rating scales were also administered to these sub-
jects.
Results: Sixty-nine of the seventy-three patients had habitual seizures
during the video-EEGmonitoring; six subjects’ home videos were incon-
clusive due to quality issues. Sixty-six home videos had been labelled
correctly as PNES; with sensitivity of 98.51% and specificity of 83.33%.
Of these patients, 34 were noted to have a major depressive episode, and
13 had anxiety.
Conclusion: Home videos made on care-givers’ mobile phones may be
effectively used to diagnose PNES obviating the need for video-EEG
monitoring, important in resource-poor settings.
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LENTIVECTOR-MEDIATED POTASSIUMCHANNEL
OVEREXPRESSIONDECREASES FOCALCORTICAL
SEIZURE FREQUENCY
R.C. Wykes*, K. Hashemi†, M.C. Walker‡, D. Kullmann‡,
S. Schorge‡
*UCL Institute of Neurology, Clinical & Experimental Epilepsy,
London, United Kingdom, †Open Source Instruments,
Watertown, MA, United States, ‡UCL Institute of Neurology,
London, United Kingdom
Purpose: Gene therapy is a promising alternative to epilepsy surgery in
the treatment of refractory focal epilepsy. Overexpression of the human
potassium channel Kv1.1, encoded by KCNA1, attenuates pathological
cortical activity in a rat model of epilepsia partialis continua. We asked if
Kv1.1 overexpression is effective in a model of occipital lobe epilepsy
characterized by discrete seizures highly similar to human focal neocorti-
cal epilepsy.
Method: Tetanus toxin injection into the rat visual cortex was followed
by the development of spontaneous seizures lasting approximately one
minute, which increased in frequency over several weeks before remit-
ting 6–10 weeks later. Greater than 16,000 h of ECoG was recorded
from 16 animals and analysed with an automated seizure detection pro-
gram based on pattern recognition. More than 5,500 seizures were
detected and visually confirmed by an experimenter. A lentivector
expressing the human KCNA1 gene together with a fluorescent reporter
gene, or expressing the reporter alone, was injected into the same region
two weeks after tetanus toxin, and the frequency and duration of seizures
was compared between the two groups.
Results: Overexpression of Kv1.1 led to a rapid decrease in seizure fre-
quency, which persisted throughout the monitoring period. The treatment
was well tolerated. Transduction of only a small region of the cortex (less
than 1 mm‡) was sufficient to achieve an anti-epileptic effect.
Conclusion: Kv1.1 overexpression holds promise for clinical translation
in treatment-refractory epilepsy.
0062
CHANGES IN SYNAPTIC EXPRESSIONOF
GLUTAMATERGICAMPARECEPTORS IN CORTICAL
INHIBITORY INTERNEURONS INAMOUSEMODEL
OFABSENCE EPILEPSY
N.K. Adotevi*, B. Leitch*
*University of Otago, Department of Anatomy, Brain Health
Research Centre, School of Biomedical Sciences, Dunedin, New
Zealand
Purpose: Absence seizures are characterized by spike-wave discharges
(SWDs), which arise from aberrant hypersynchronous activity within the
corticothalamocortical (CTC) network. However, the distinct mecha-
nisms underlying seizure activity in genetically different patients and
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variability in response to drug treatment are not fully understood. While
the loss of feed-forward inhibition in the CTC circuitry has been impli-
cated in several animal models of absence epilepsy, it is still unclear if
this aberration is a direct consequence of loss of excitatory input to local
inhibitory interneurons. The stargazer mouse model of absence epilepsy
presents with a genetic deficit in stargazin, an AMPA receptor (AMPAR)
trafficking protein, which is predominantly expressed in fast-spiking par-
valbumin-positive (PV+) inhibitory interneurons. Hence, we investigated
the impact of loss of stargazin on the synaptic expression of AMPAR
GluA1-4 in cortical PV+ neurons, which could potentially alter their exci-
tation and thus disrupt feed-forward inhibition to pyramidal cells.
Method: Samples were dissected from the cortex of adult epileptic
stargazers and non-epileptic littermates (n ≥ 5 pairs). Cortical synaptic
fractions were obtained using biochemical fractionation, and then pro-
cessed by western blotting to analyze GluA1-4 expression. Double post-
embedding immunogold-cytochemistry was also used to analyze the rela-
tive density of GluA1-4 at excitatory synapses onto cortical PV+
interneurons.
Results: In synaptic fractions, AMPAR expression was significantly
reduced in stargazers (23% GluA1, 39% GluA2, 48% GluA4; p < 0.005)
compared to non-epileptic littermates. Ultrastructural analyses revealed
loss of AMPARs at excitatory synapses onto PV+ neurons in stargazers
(21% GluA1, 17% GluA2/3, 30% GluA4; p < 0.005, n = 200 synapses/
subunit) compared to non-epileptic controls.
Conclusion: Our results show a significant loss of synaptic AMPARs,
specifically at excitatory synapses on PV+ inhibitory interneurons, in the
stargazer cortex. This could compromise AMPAR-mediated excitation
onto cortical PV+ neurons and impair subsequent feed-forward inhibition
within the cortical network, leading to pathological hypersynchronous
SWDs.
0063
COMPARISONOFMIRNAEXPRESSION PROFILES IN
RATMODELOFEPILEPSYWITHHUMANMTLE+HS
PATIENTS
J. Baloun*, P. Bencurova*,†,‡, K. Musilova*,†,§, M. Pail†,‡,
E. Brichtova†, M. Hermanova†,‡, H. Kubova¶, M. Mraz*,†,§,
M. Brazdil*,†,‡, S. Pospisilova*,†
*CElTEC-MU, Brno, Czech Republic, †Medical Faculty,
Masaryk University, Brno, Czech Republic, ‡St. Anne’s
University Hospital, Brno, Czech Republic, §University Hospital
Brno, Brno, Czech Republic, ¶Institute of Physiology, Academy
of Sciences of Czech Republic, Praha, Czech Republic
Purpose: The primary aim of this study was to identify microRNAs
(miRNA/miR) which were aberrantly expressed in both mesial temporal
lobe epilepsy (mTLE) patients with hippocampal sclerosis (HS) and rats
with pilocarpine-induced epileptogenesis.
Method: miRNA expression in samples from mTLE+HS patient was
analysed using sequencing approach and validated by qPCR.We selected
28 miRNAs aberrantly expressed in patients for comparison with the ani-
mal model. Rats were exposed to LiCl/pilocarpine induced Status Epilep-
ticus (SE) at P60. The miRNA was isolated from hippocampal tissues
from 18 treated rats and 12 age matched controls. Expression of selected
miRNAs was quantified using a technique specific for miRNA quantifi-
cation, miQPCR.
Results: Our quantification analyses revealed that four of 28 selected
miRNAs had significantly aberrant expression in treated rats (miR-19b-
3p, miR-142-3p, miR-142-5p, and miR-374b-5p) in comparison with
controls. miR-142-3p and miR-142-5p were upregulated in treated rats as
well as in mTLE+HS patients. On the contrary, miR-374b-5p revealed
opposite regulation in expression in comparison with patients. Other
miRNAs were not differently expressed in rat model.
Conclusion: Our results revealed several miRNAs, which were aber-
rantly expressed in human patients as well as the animal model. This
comparative analysis significantly increases the confidence that these
miRNAs are directly involved in the biology of epilepsy and provide pos-
sible miR-therapeutic targets (miRNA mimics/inhibitors) that could be
tested in rat model of epilepsy.
0065
THEDYNAMICSOF THEEXCITATORYAND
INHIBITORYNEURALNETWORKDURING
DEVELOPMENTAND INITIATIONOF
CHEMOCONVULSANT-INDUCED CORTICAL
SEIZURES
Y. Schiller*,†, F. Aeed†
*RambamMedical Center, Neurology, Haifa, Israel, †Technion
Medical School, Neurobiology, Haifa, Israel
Under normal conditions, the cortical network is characterized by a bal-
anced state between excitation and inhibition. The transition between the
inter-ictal and ictal states during seizure initiation is probably caused by
disruption of the excitation-inhibition (E-I) balance, favoring excitation
over inhibition in the cortical network. In this study we used two photon
calcium imaging of GCaMP6 expressing neurons in the S1 barrel cortex
of adult mice to investigate the network dynamics during development
and initiation of partial neocortical epileptic seizures in-vivo. We moni-
tored the activity several sub types of excitatory and inhibitory neurons
including layer 2–3 (WT mice) and layer 5 (SIM1 transgenic mice) pyra-
midal neurons; all inhibitory inter-neurons (GAD-Cre transgenic mice),
and two sub-classes of inhibitory inter-neurons, somatostatin-expressing
inter-neurons (SOM-Cre transgenic mice), and paravalbumin-expressing
inter-neurons (PV-Cre transgenic mice). In our experiments we moni-
tored calcium imaging from both the somata and dendrites of the differ-
ent neurons. Seizures where induced by local application of the chemo-
convulsant 4-aminopyridine onto the neocortical surface, and seizure
activity was monitored electrophysiologically, by a glass recording pip-
ette. We found that dynamics markedly differed between different neu-
ronal sub populations during development and initiation of seizures.
While layer 2–3 neurons and PV-inter-neurons tended to fire in syn-
chronously bursts with increasing intensity during development of sei-
zures, layer-5 pyramidal neurons and SST inter-neurons were recruited
gradually and asynchronously during the pre-ictal state. Moreover, sei-
zure initiation was associated with a synchronized burst of layer 2–3,
layer 5 and PV-inter-neurons followed by intense firing in these neurons.
In contrast, SST-inter-neurons were only gradually recruited during the
seizure. Our findings show that during the pre-ictal state different neu-
ronalpopulations are recruited with different dynamics into the epileptic
network. Our findings further suggest that the state transition associated
with seizure initiation may be caused by delayed recruitment of SST-
inter-neurons.
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IMPACTOFCOMORBIDITIES ONRISK FOR INJURIES
ANDACCIDENTS IN EPILEPSY: A PROSPECTIVE,
POPULATION-BASEDCOHORT STUDY
B. Mahler*,†, T. Torbj€orn*,‡, S. Carlsson†, T. Andersson†,§
*Karolinska University Hospital, Stockholm, Sweden,
†Karolinska Institutet, Institute of Environmental Medicine,
Epidemiology Unit, Stockholm, Sweden, ‡Karolinska Institutet,
Department of Clinical Neuroscience, Stockholm, Sweden,
§Stockholm County Council, Center for Occupational and
Environmental Medicine, Stockholm, Sweden
Purpose: To study the impact of comorbidities on the future risk of inju-
ries or accidents for people with newly diagnosed epilepsy (PWE).
Method: Between September 1st. 2001 and August 31st. 2008, all
patients in northern Stockholm with incident unprovoked seizures
(n = 2130) were included in the Stockholm Incidence Register on Epi-
lepsy (SIRE). For every exposed (patient with incident seizure), eight
unexposed controls were matched for sex, inclusion year and catchment
area (n = 16992). To identify injuries/accidents patients and controls
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were followed until December 31st, 2014 in the Swedish Outpatient
Register, the Swedish Hospital Discharge Register and the Cause of
Death Register. The two former registers were also used to identify the
existence of comorbidities in cases and controls up to the end of follow-
up.
Results: There were 1033 registrations for injuries/accidents among epi-
lepsy and 6202 among controls, (Hazard Ratio, HR=1.71, 95%CI= 1.60-
–1.83). Compared to controls without comorbidities HR was 1.17 (1.07–
1.28) in epilepsy without comorbidities, 7.15 (6.49–7.87) in epilepsy
with comorbidities, and 4.52 (4.18–4.88) in controls with comorbidities.
Comparing risks with or without psychiatric comorbidities, the HR in
epilepsy without such comorbidity was 1.55 (1.44–1.66), 6.35 (5.49–
7.35) in epilepsy with, and 4.52 (4.08–5.02) among controls with psychi-
atric morbidity. The pattern was the same for subgroups of psychiatric
disorders. A similar pattern with a modest but significant increase in HR
for injuries/accidents associated with epilepsy without specific comor-
bidities, and much higher HR associated with epilepsy with comorbidi-
ties such as malignant and benign brain tumours, diabetes, and dementia.
Conclusion: As in the general population the HR for injuries and acci-
dents among PWE is increased several fold in cases with comorbidities,
but epilepsy adds significantly to the HR of injuries/accidents regardless
of the existence of comorbidities.
0067
INTERVENTION STRATEGY FORTHE
MANAGEMENTOFEPILEPSY IN SOUTH-EAST ASIA
F. Boumediene*,†, P. Chivorakul‡, C. Chhour§, V. Souvong‡,
P. Odermatt¶,**, S. Ros§, S. Chan§, D. Gerard††, P.-M. Preux*,†
*UMR-S 1094 Tropical Neuroepidemiology Institute, Limoges,
France, †University of Limoges, Limoges, France, ‡Institute of
the Francophonie for Tropical Medicine (IFMT, Vientiane, Lao
People’s Democratic Republic, §Cambodian Society of
Neurology, Phnom Penh, Cambodia, ¶Swiss Tropical and Public
Health Institute, Basel, Switzerland, **University of Basel,
Basel, Switzerland, ††Sanofi’s Access to Medicines Department,
Paris, France
Purpose: The prevalence of epilepsy is 7.7& in Laos and 5.8& in Cam-
bodia, the treatment gap exceeds 95% in both countries. Our research
program aims to measure the effectiveness of two new community-based
health care approaches using two different types of Domestic Health
Visitors (DHV) trained to screen and follow patients with epilepsy
(PWE): (1) in Laos DHV chosen from health center staff (2) an identical
strategy in Cambodia where DHV duty was carried out by health volun-
teers residing in the villages.
Method: Between 2015 and 2017, these two quasi-experimental studies
were conducted in rural districts over a 12-months period comparing an
intervention area and a control area. Our intervention included an Infor-
mation, Education and Communication campaign, training of the DHV
staff, a number of surveys on general population about Knowledge, atti-
tudes and practices (KAP) and regular monitoring.
Results: In Laos after a 12-month intervention period, the treatment gap
was reduced by 5.5% (20 to 43 cases under treatment of the 418
expected) in the intervention vs. 0.5% (21 to 25 cases under treatment of
the 788 expected) in the control area (p < 0.0001). In Cambodia, after a
6-month period in area with a treatment gap of 100%, he was reduced by
31.1% (55 cases out of the 177 expected) in the intervention compared to
a 7.0% decrease (23 cases out of the 327 expected) in the control area
(p < 0.0001).
Conclusion: The strategy is more successful when the DHV lives in the
village where he/she is going to perform his/her duty. Observations on
KAP in the general population and among health staff, in addition to the
therapeutic pathway of PWE will enlighten our results. The results of the
intervention in Laos have resulted in an Advocacy Policy Plan which has
been favorably received by the LaoMinistry of Health.
0068
THE INCIDENCEANDPREDICTORSOF
RECURRENCEAFTER FIRST SEIZURE IN
EMERGENCYDEPARTMENTANDOUTCOMES: A
RETROSPECTIVE STUDY INANUNIVERSITY
HOSPITAL
A. Praipanapong*, P. Sathirapanya†, C. Kongkamol‡
*Prince of Songkhla University, Internal Medicine, Songkhla,
Thailand, †Prince of Songkla University, Faculty of Medicine,
Division of Neurology Department of Internal Medicine, Hat
Yai, Thailand, ‡Prince of Songkla University, Faculty of
Medicine, Hat Yai, Thailand
Purpose: The risk factors of seizure recurrence after first seizure have
been generally studied. However, the risks and outcomes among adult
and elderly attending emergency services have been scarcely reported.
The authors aimed to demonstrate the risk factors of seizure recurrence
after the first seizure presenting to emergency department (ED) among
adult and elderly patients, as well as their final outcomes.
Method: The patients presented with first seizure at ED between January
2003 and December 2016 were recruited for this retrospective cohort
study. Final seizure outcomes were evaluated by Glasgow outcome scale
(1–3 unfavorable; 4–5 favorable). Risk factors associated with seizure
recurrence and final outcomes were assessed using Cox’s proportional
hazard analysis and multiple logistic regression.
Results: A total of 414 patients were recruited. They comprised of 267
adults (aged 16–64 years) and 147 elderly (aged ≥ 65 years) presented to
ED with first seizure. The Incidence of recurrent seizure at 6 months,
1 year and 2 years were 0.63 (95%CI 0.54–0.71), 0.76 (95%CI 0.67–
0.83) and 0.94 (95% CI 0.88–0.97) respectively. Independent predictors
of seizure recurrence were remote symptomatic etiology (adjusted HR =
2.21, 95%CI 1.38–3.55) and nocturnal seizure onset (Adjusted HR =
1.53, 95%CI 1.03–2.26 ). The factors predicted unfavorable final out-
come were remote symptomatic etiology (adjusted OR 2.34, 95%CI
1.25–4.37), and age ≥65 years (adjusted OR 4.35, 95% CI 2.42–7.83).
The anti-epileptic drug (AED) treatment was associated with unfavorable
outcome.
Conclusion: Remote symptomatic etiology had significant association
with seizure recurrence and poor outcome. However, advanced age asso-
ciated merely with poor outcomes. The unfavorable outcomes of AED
use might be related to presenting clinical severity.
0069
ACCIDENTALDEATHS IN PEOPLEWITHEPILEPSY:
A NATIONWIDECOHORT STUDY
S.R. Møller*, T.M. Laursen†, J. Christensen*
*Aarhus University Hospital, Department of Neurology, Aarhus
C, Denmark, †Aarhus University, Department of Economics and
Business Economics, Aarhus V, Denmark
Purpose: Epilepsy is associated with increased premature mortality. We
investigated the risk of premature mortality from accidents in people with
epilepsy (PWE) compared to the general population.
Methods: We created cohort of 3,431,393 people born in Denmark
between 1960 and 2011 who were alive in 1980 and residing in Denmark.
The follow-up period was from 1980 to 2011, and people were followed
until death, emigration or end of follow-up (31. December 2011). Poisson
regression was used to calculate mortality rate ratios (MRRs).
Results: After 75,227,547 years of follow-up, 347 PWE had died from
accidents. In PWE the mortality rate from accidents was more than three
times higher compared to people without epilepsy (MRR: 3.12 (95% CI:
2.80–3.47)). Psychiatric comorbidity was associated with the risk of acci-
dents. In people with both epilepsy and a psychiatric disease the MRR
was 9.42 (95% CI: 8.28–10.73) compared to people with neither epilepsy
nor psychiatric disease. After dividing cause of death from accidents into
transport accidents and other accidents, the MRR was 1.35 (95% CI:
1.09–1.66) for transport accidents and 5.81 (95%CI: 5.12–6.60) for other
accidents.
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Conclusion: The mortality from accidents is significantly increased in
PWE, especially in people with comorbid psychiatric diseases. Increas-
ing the information and the attention to these high risk groups may help
reduce the mortality associated with epilepsy.
0070
STATUS EPILEPTICUS IN AUCKLAND, NEW
ZEALAND; A PROSPECTIVE, HOSPITAL-BASED
INCIDENCE STUDY
P. Bergin*, A. Brockington*, J. Jayabal*, R. Litchfield*,
L. Roberts*, J. Timog*, B. Te Ao†, P. Parmar†, V. Feigin†,
EpiNet Study Group
*Auckland City Hospital, Auckland, New Zealand, †Auckland
University of Technology, Auckland, New Zealand
Purpose: To determine the incidence, causes and outcomes of Status
Epilepticus (SE) in Auckland, New Zealand, using the EpiNet database.
Method: All patients aged more than 4 weeks who presented to the 5
public hospitals within Auckland city (population 1.6 million) with SE
(seizure exceeding 10 min duration) between 6th April 2015 and 5th
April 2016 were identified using multiple overlapping sources of infor-
mation. Post anoxic SE was excluded. Baseline health economics, clini-
cal details, treatments, and outcomes for each episode of SE were entered
into the EpiNet Database. Patients will be followed for 2 years.
Results: Hospital records for > 6000 presentations with possible seizures
were reviewed. 638 episodes of possible SE were identified by study
nurses. 623 of these presentations (97%) have been reviewed by a neurol-
ogist. 460 presentations in 360 patients were considered definite or prob-
able SE; 56 patients had > 1 episode of SE during the year; 3 patients had
5 or more episodes. The incidence of primary and recurrent SE in Auck-
land is 27 episodes (21 persons) per 100 000 per year. 60% of episodes
lasted > 30 min. 56% of episodes ceased before arrival at ED. 50% of
patients received benzodiazepines before presentation to hospital. 48%
received iv AEDs in ED, with a median time to treatment of 27 min 51%
of patients were aged < 15. 44% of episodes in children were associated
with fever. 52% of patients had known epilepsy before the SE. 81% were
back to normal by discharge, but 35 (10%) died during the study period.
Conclusion: This study has determined the incidence, aetiology, treat-
ment and outcomes of SE in New Zealand. A form to collect comprehen-
sive data on SE in the EpiNet database has been developed; it can be used
for multicentre cohort studies and randomised controlled trials.
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FASTRIPPLES BESTDEFINEREGIONALNETWORKS
OFEPILEPTOGENESIS ON PEDIATRIC INTRA-
OPERATIVE ELECTROCORTICOGRAPHIES
S.A. Hussain*, G.W. Mathern†, R. Sankar*, J.Y. Wu*
*University of Calfiornia, Pediatrics, Los Angeles, CA, United
States, †University of Calfiornia, Neurosurgery, Los Angeles,
CA, United States
Purpose: High frequency oscillations are increasingly shown to be a spa-
tial biomarker of the epileptogenic zone. We investigated the predictive
value of unresected interictal fast ripples (FR, 250–500 Hz) for postoper-
ative seizure recurrence, and how well FR localized to the epileptogenic
zone compared with other conventional electrocorticographic abnormali-
ties.
Method: In 60 consecutive UCLA pediatric patients with medically
refractory epilepsy who underwent surgical resection, interictal FR were
visually identified on intra-operative electrocorticography (iECoG) with
standard anesthetic protocol. Initially these iECoGs were assessed retro-
spectively, subsequently prospectively and “live” in the operating room.
Resections were based on ictal scalp video-EEG, interictal FDG-PET,
brainMRI, and conventional iECoG.
Results: FR were identified in 80% (48/60) of iECoG´s, retrospectively
(n = 30), prospectively (n = 19), or “live” (n = 11). Median post-opera-
tive follow-up was 4.1 years. Six of the 48 children (12.5%) had unre-
sected interictal FR, and all 6 had postoperative seizure recurrence.
Time-to-first-postoperative-seizure was strongly associated with unre-
sected FR (hazard ratio = 25.4; p < 0.001). Furthermore, all seizures
returned quickly within 6 months postoperatively. Compared to other
iECoG findings of focal slowing, focal attenuation, spikes, continuous
epileptiform discharges, gamma, and ictal events, unresected interictal
FR was the best predictor of post-operative seizure recurrence, with
100% positive predictive value, 76% negative predictive value, 38% sen-
sitivity, and 100% specificity.
Conclusion: Interictal FRs on pediatric iECoG suggest: 1) the epilepto-
genic network may be more extensive than that determined by ictal scalp
EEG and neuroimaging; 2) interictal FR appears to be the best spatial
indicator of the epileptogenic network amongst all conventional iECoG
abnormalities, including ictal onset zone; 3) seizure recurs quickly within
6 months in all children with unresected FR; 4) a small remnant of the
epileptogenic network is sufficient for seizure recurrence. These findings
together suggest interictal FR may be the best localizing biomarker of the
epileptogenic network in children.
0072
SEEGEVALUATIONAND SURGICALOUTCOME IN
REFRACTORY POLYMICROGYRIA-RELATED
EPILEPSY: AMULTICENTRIC STUDY
L. Maillard*, L. Tassi†, F. Bartolomei‡, H. Catenoix§,
F. Dubeau¶, W. Szurhaj**, P. Kahane††, A. Nica‡‡, P. Marusic§§,
I. Mindruta¶¶, F. Chassoux***, G. Ramantani†††,‡‡‡
*University of Lorraine, Department of Neurology, Nancy,
France, †Niguarda Hospital, Center for Epilepsy Surgery,
Milano, Italy, ‡Aix Marseille Universite, Ho^pital de la Timone,
Service de Neurophysiologie Clinique, Marsaille, France,
§Pierre Wertheimer Neurological Hospital, Functional
Neurology and Epileptology Department, Lyon, France, ¶McGill
University, Montreal Neurological Institute and Hospital,
Montreal, QC, Canada, **CHU Lille, Epilepsy Unit, Lille,
France, ††Centre Hospitalier Universitaire Grenoble-Alpes,
Clinique de Neurologie, Grenoble, France, ‡‡Centre Hospitalier
Universitaire Rennes, Neurology Department, Rennes, France,
§§Charles University, 2nd Faculty of Medicine, Motol University
Hospital, Department of Neurology, Prague, Czech Republic,
¶¶University Emergency Hospital Bucharest, Department of
Neurology, Bucharest, Romania, ***Sainte-Anne Hospital,
Department of Neurosurgery, Paris, France, †††University
Childrens Hospital Zurich, Neuropediatrics, Epileptology,
Zurich, Switzerland, ‡‡‡Swiss Epilepsy Centre, Zurich,
Switzerland
Purpose: Polymicrogyria (PMG) is a common cortical malformation.
Although most patients present with epilepsy, two-thirds with a refrac-
tory course, epilepsy surgery is rarely considered. This multicentric study
aimed to assess the concordance between PMG and the epileptogenic
zone, and to determine the postsurgical seizure outcome in PMG-related
refractory epilepsy.
Method: We retrospectively analyzed 58 patients with PMG-related
refractory epilepsy: 49 had stereo-encephalography (SEEG) and 39
underwent resective surgery.
Results: Mean age at seizure onset was 11 years (range 0.1–36) and
mean age at SEEG or surgery was 28.3 years (range 2–50). PMG was
bilateral in 8 patients and unilateral in 50: 19(33%) unilobar, 19(33%)
perisylvian, 15(26%) multilobar and 5(9%) hemispheric. Twenty-two
(38%) patients additionally had schizencephaly, heterotopia or focal cor-
tical dysplasia. The SEEG-delineated epileptogenic zone was fully
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concordant with the PMG in only 8/49(16%) cases of unilobar and peri-
sylvian, and in none of multilobar PMG. The epileptogenic zone included
remote cortical areas in 21(43%) and localized predominantly in those in
5(10%) cases, all related to the mesial temporal structures. Only patients
with unilateral PMG had resective surgery: 21 unilobar resections, 13
multilobar resections, and 5 hemispherotomies. At last follow-up (mean
4.6 years, range 1–16), 28(72%) patients remained seizure free; 9 were
off antiepileptic drugs. Shorter epilepsy duration to surgery was the only
independent predictor of seizure freedom.
Conclusion: Our study demonstrates that SEEG is essential for guiding
tailored resections in PMG-related refractory epilepsy, since the epilepto-
genic zone may only partly overlap with the PMG and often include
remote cortical areas. In well-selected cases, epilepsy surgery is highly
effective in terms of seizure control and antiepileptic drug cessation, even
in patients with extensive unilateral but not in those with bilateral PMG.
Our data also shows that in patients with PMG-related refractory epi-
lepsy, early vs. delayed epilepsy surgery may be more beneficial.
0074
FOCALCORTICALDYSPLASIA TYPE II ISMEG,
MULTIMODALNEURONAVIGATIONAND
INTRAOPERATIVEMR IMAGINGHELPFUL FOR
SURGERY?
K. Roessler*, B. Kasper†, E. Heynold*, R. Coras‡, S. Rampp*,
B. Sommer*, H. Hamer†, I. Blumcke‡, M. Buchfelder*
*Erlangen University Clinic, Neurosurgery, Erlangen,
Germany, †Erlangen University Clinic, Neurology, Erlangen,
Germany, ‡Erlangen University Clinic, Neuropathology,
Erlangen, Germany
Purpose: Focal cortical dysplasia (FCD) is one important cause of drug-
resistant epilepsy potentially curable by epilepsy surgery. As complete
resection is one of the crucial factors for long term seizure control espe-
cially in FCDII, we integrated multimodal neuronavigation including
magneto- encephalography (MEG) and intraoperative magnetic reso-
nance tomography imaging (iopMRI) into surgery to maximize the resec-
tion and spare eloquent areas.
Methods: Between 2/2003 and 10/2016, altogether 62 FCD patients (29
female, 33 male, mean age 36  12 yrs) suffering from drug-resistant
epilepsy who had surgical resection were identified (39 FCDI/II, 23
FCDIII). Mean duration of epilepsy was 20.7  12.9 years. Surgery was
performed using multimodal neuronavigation (integration of functional
MRI/DTI imaging and MEG) and intraoperative 1.5T-iopMR imaging.
Additionally, three-dimensional visualization of phase-2 electrodes had
been integrated in 15 patients.
Results: Considering patients suffering from electro-clinical and radio-
logical focal epilepsy, 24 patients were identified correlating with the
postoperative histological report of FCD IIa (8 Patients) and FCD IIb (16
patients). Altogether, 71% (17/24) of that subgroup had an excellent
Engel Grade I seizure outcome (13 Grade IA), 1 patient after a second
surgery. A positive significant correlation of the resection amount and
the seizure outcome was found, patients with Engel Grad I outcome were
quoted as complete resections intraoperatively, patients with worse out-
come had suspected residual lesions in eloquent position during intraop-
erative scanning. Compared to 71% Engel Grade I outcome in FCDII
patients, the total series including associated FCDs showed 64% Engel
Grade I outcome. The surgical complication rate was 8% transient and
0% permanent severe deficits.
Conclusion: In FCD Grade II patients, functional neuronavigation
including MEG data and intraoperative MR imaging contributed to
enable a tailored resection of the epileptic zone, leading to an excellent
seizure outcome and a remarkable low complication rate.
0075
CANVOLUMESOFMESIAL TEMPORAL
STRUCTURES PREDICT PREAND POST-LASER
ABLATION PSYCHIATRIC COMORBIDITIES IN
PATIENTSWITHTEMPORAL LOBEEPILEPSY?
A. Kanner*, C. Millan*, C. Bermudez*, M. Lowe*,
M.E. Palomeque*, G. Rey*, R. Ribot*, E. Serrano*, N. Velez-
Ruiz*, J. Jagid*
*University of Miami, Miller School of Medicine, Miami, FL,
United States
Purpose: To determine whether volumes of mesial temporal structures
are associated with pre and /or post-surgical psychiatric comorbidities in
patients with mesial temporal lobe epilepsy (MTLE) who undergo an
MRI-guided laser ablation (MRI-GLA) of mesial temporal structures .
Method: 30 consecutive patients who underwent a MRI-GLA had a psy-
chiatric evaluation before surgery and were followed for post-surgical
psychiatric symptomatology at 1, 4, 12, 24 and 52 weeks. Manual quanti-
tative volumetric measurements of hippocampus and amygdala were per-
formed in 3 Tesla high-resolution brain MRI studies. Patients had to have
a minimal follow-up period of six months to be included in this study. T-
tests were used to identify significant differences in volumes between
patients with and without psychiatric comorbidities before and after laser
ablation.
Results: Among the 30 patients, 14 were women. Their mean age was
45 years old (range:24 to 71) and the mean post-surgical follow-up per-
iod was 19.9 months (range 6 to 37 months). In 16 patients, the ablation
was in the left side. Pre-surgical psychiatric comorbidities were identified
in 18 patients (60%); 11 had a left ablation. Post-surgical exacerbation in
the initial 4 weeks occurred in 14 patients (77% of symptomatic patients
pre-surgically). No patient had de-novo psychopathology. Persistent psy-
chiatric symptomatology at last contact was present in 11 patients (36%),
while 7 patients (39% of symptomatic patients pre-surgically) had a com-
plete remission of psychiatric symptoms. Volumetric measurements
revealed a significant association between pre-surgical mood/anxiety dis-
orders and a larger amygdala volume in the left side (p = 0.04). No sig-
nificant associations were identified between volumetric measurements
and post-surgical psychiatric outcome.
Conclusions: A larger left amygdala is associated with pre-surgical
mood and/or anxiety disorders. Ablation of mesial structures can yield an
immediate exacerbation of pre-surgical psychiatric comorbidities and a
complete psychiatric remission in 39% of patients in the long-term.
Genetics 2
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0076
ACOMPREHENSIVE ANALYSIS OFMISSENSE
MUTATIONS IN SCN1A IN PATIENTSWITHDRAVET
SYNDROME IMPROVES INTERPRETATIONOF
CLINICALLYRELEVANTVARIANTS
M. Coelho Gonsales*, M.A. Montenegro*, M.M. Guerreiro*,
A.C. Coan*, M. Paiva Quast*, S.B. Carvalho*, I. Lopes-Cendes*
*University of Campinas, Campinas, Brazil
Purpose: Interpreting the clinical significance of genetic variants found
in molecular tests can be challenging, particularly for variants of
unknown significance such as missense mutations. In order to access the
rate of success in the classification of missense variants, we assessed
algorithms to predict functional effects of SCN1A missense mutations in
patients with Dravet syndrome (DS) reported in the literature and in our
ownmolecular study.
Method: We assessed the use of ten different computer algorithms indi-
vidually to predict putative deleterious effects of amino acid changes
resulting from SCN1A missense mutations in patients with DS. In addi-
tion, we developed a classifier to obtain more reliable prediction
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combining the scores of five prediction algorithms. Furthermore, we
evaluated whether amino acid changes are predominant in specific
protein regions by performing a permutation test.
Results: In silico analysis of the deleterious effect of 353 SCN1A mis-
sense variants found in patients with DS showed that the majority
(57.5%) are predicted as deleterious by all ten algorithms individually. In
addition, almost all amino acid changes (92.6%) are considered deleteri-
ous by more than half of the algorithms tested. Our classifier combining
multiple prediction scores presented high accuracy (0.8873), sensitivity
(0.8379) and specificity (0.9191). Moreover, we found a predominance
of amino acid changes in the voltage sensor segment (S4), the pore form-
ing region (S5–S6) and adjacent subunit S6 (p < 0.05).
Conclusion: We were able to correctly ascertain putative pathogenic
effect in the vast majority of missense mutations in SCN1A found in
patients with DS, thus minimizing the inconvenience of inconclusive
reports in the molecular diagnosis of patients with this severe form of epi-
lepsy. The combined score created for testing functional changes in
SCN1A was highly sensitive and specific to discriminate pathogenic
changes and can be used in the clinical setting.
0077
SOMATICMUTATIONS AREABUNDANT IN FOCAL
CORTICALDYSPLASIA
V. Almeida*,†, S.H. Avansini*,†, M. Borges†,‡, F.R. Torres*,†,
F. Rogerio†,§, B.S. Carvalho†,‡, F. Cendes†,¶, I. Lopes-Cendes*,†
*UNICAMP, Department of Medical Genetics, Campinas,
Brazil, †Brazilian Institute of Neuroscience and
Neurotechnology BRAINN, Campinas, Brazil, ‡UNICAMP,
Department of Statistics, Campinas, Brazil, §UNICAMP,
Department of Anatomical Pathology, Campinas, Brazil,
¶UNICAMP, Department of Neurology, Campinas, Brazil
Malformations of cortical development (MCD), including focal cortical
dysplasia (FCD), can cause epilepsy and are associated with refractory
seizures. FCD is characterized by alterations in the cortical cytoarchitec-
ture also observed in other MCDs, such as in Tuberous Sclerosis (TS)
and Hemimegaencephaly (HME). Recently, mosaic mutations were
detected in TS, HME and in rare cases of FCD; however, it is still unclear
if only a single mutation event may lead to FCD or whether somatic
mosaicisms is a more widespread genetic mechanism. Exome sequencing
was performed on gDNA extracted from brain tissue resected by surgery
(BTRS) and blood samples of 12 FCD patients. We performed capturing
with Nextera Expanded Kit (Illumina). Samples were sequenced fol-
lowing a 200 bp paired-end protocol in a Hiseq2500 (Illumina) to
achieve at least 200x of average coverage. We aligned sequences and
variant calling using BWA-MEM and GATK. We evaluated mosaicism
using Mutect2. Effect of variants was evaluated using Variant Effect Pre-
dictor (VEP). In addition, we also focused in variants not described previ-
ously in the normal population (reference individuals) or variants whose
minor allele frequency (MAF) is ≤ 0.01. We identified potentially delete-
rious mosaic mutations in BTRS in all 12 patients analyzed. Mosaic
mutations were identified in 28 genes belonging to the mTOR pathway
and in 40 genes belonging to the TAU pathway. More interestingly, all
12 patients have somatic mutations in BTRS in at least two genes.
Somatic mutations were identified in genes with functional roles and
expression in the central nervous system. Somatic mutations were abun-
dant in FCD tissue, affecting several genes from the mTOR and Tau path-
ways, and were detected in all samples examined. Therefore, somatic
mosaicism seems to be a much more abundant and widespread genetic
phenomenon than previously described in FCD. Support: CEPID-
FAPESP.
0078
ANALYSIS OF FACIALASYMMETRYAND
DYSMORPHISM IN EPILEPSY
S. Balestrini*, K. Chinthapalli*, M. Suttie†,‡, P. Hammond†,‡,
S. Sisodiya*
*Institute of Neurology, UCL, Clinical and Experimental
Epilepsy, London, United Kingdom, †University of Oxford,
Nuffield Department of Obstetrics & Gynaecology, Oxford,
United Kingdom, ‡University of Oxford, Institute of Biomedical
Engineering, Oxford, United Kingdom
Purpose: There is variable clinical expressivity in each specific form of
epilepsy. Genotype-phenotype correlations are very helpful to under-
stand the origin and the mechanisms underlying the spectrum of clinical
variability in epilepsy. In the current study, we use novel phenotyping 3D
stereophotogrammetry and dense surface models, to evaluate facial
asymmetry and dysmorphism in people with focal epilepsies aiming to
generate new tools to explore the genetic contribution to these epilepsies.
Method: We consecutively recruited 859 people with epilepsy attending
the epilepsy clinics at the National Hospital for Neurology and Neuro-
surgery, London (UK). We used dense surface modeling of the full face
and signature analyses of 3-dimensional facial photographs to discrimi-
nate between cases and 205 healthy controls and to determine agreement
with epilepsy categorization.
Results: Cases with focal cryptogenic and idiopathic generalised epi-
lepsy showed more asymmetry compared to controls (p = 0.018 and
p = 0.014, two-sample t-test, respectively). There was no significant dif-
ference between focal symptomatic cases and controls. The opposite pat-
tern was observed when considering the signature analysis: no difference
emerged when comparing focal cryptogenic or idiopathic generalised
epilepsy cases with controls, whilst cases with focal symptomatic epi-
lepsy associated with unilateral lesions showed higher signature weights
than controls (p < 0.001, two-sample t-test).
Conclusion: Facial structure development is driven by complex molecu-
lar interactions between surface ectoderm and underlying forebrain and
neural crest cells. The increased level of facial asymmetry in cases with
focal cryptogenic and idiopathic generalised epilepsy might be explained
by a potential genetic cause, with underlying genetic pathways shared
between face and brain development. 3D stereophotogrammetry and
dense surface models could represent a powerful novel phenotyping pro-
cess that will permit greater understanding of genetic data, improved dis-
crimination between pathogenic and non-pathogenic variation, and
further insight into genetics of facial and neural development.
0079
MOSAICISMOFDE SCNNOVO1AMUTATIONS IN
EPILEPSY: AN EXPLANATION FORVARIABLE
PHENOTYPES?
I. de Lange*, M. Koudijs*, R. van’t Slot*, F. Mulder*,
E.C. Carbo*,†, M. van Kempen*, B. Gunning‡, L. van Gemert§,
A. Sonsma*, S. Savelberg*, N. Knoers*, E. Brilstra*,
B. Koeleman*
*University Medical Center Utrecht, Department of Genetics,
Center for Molecular Medicine, Utrecht, Netherlands,
†University of Groningen, University Medical Center
Groningen, Department of Genetics, Groningen, Netherlands,
‡Stichting Epilepsie Instellingen Nederland SEIN, Zwolle,
Netherlands, §Epilepsy Center Kempenhaeghe, Heeze,
Netherlands
Purpose: Phenotypes associated with de novo SCN1A mutations are
very variable, ranging from Dravet syndrome on the severe end of the
spectrum, to GEFS+ on the other end. We investigate whether mosaicism
is a major modifier of de novo SCN1Amutations.
Method: We tested 105 patients with de novo, pathogenic SCN1Amuta-
tions for mosaicism. Clinical data were collected from medical records
and semi-structured telephone interviews. Next Generation Sequencing
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with high coverage was performed on DNA from blood, after capture of
SCN1A by single molecule molecular inversion probes (smMIPs). Only
unique reads from single molecules were counted, using the single-mole-
cule tag to remove duplicate reads and provide unbiased estimates of
gene copies. The percentages mutated reads of pathogenic mutations
were used to determine whether mosaicism was likely, based on an
expected binomial distribution and comparison with heterozygous neu-
tral SNPs. Confirmation by droplet digital PCR and sequencing of buccal
DNA is pending. Developmental outcome was classified, based on avail-
able data on IQ and school functioning/education, rated by a child neurol-
ogist, neuropsychologist, and clinical geneticist.
Results: In 12 out of 105 patients, mosaicism is suspected (p-values
ranging from 3,08x10-11-2,6x10-305). Three patients were classified as
“very mild or unaffected”, four as “mild”, and five as “moderate or sev-
ere”, (10–34%, 33–41%, and 26–42% alternate allele respectively). Clas-
sification of the remaining part of the cohort and comparative statistical
analyses are in progress.
Conclusion: Mosaicism is suspected in 11% of patients in our cohort,
and could explain several mild cases. Confirmational tests and statistical
analyses will be presented to make definite conclusions about the predic-
tive value of mosaicism in blood.
0080
KCNB1MUTATIONS ARECAUSINGA
NEURODEVELOPMENTALDISORDER INCLUDING
EPILEPSYANDAUTISM
R.S. Møller*,†, C.G.F. de Kovel‡,§, S. Syrbe¶, B. Sch€onewolf-
Greulich**, M. Rokkjær††, D. Svaneby‡‡, L.H.G. Larsen§§,
E.H. Brilstra‡, N. Verbeek‡, B. Kerr¶¶,***, H. Dubbs†††,
A. Bayat‡‡‡, S. Desai§§§, S. Naidu¶¶¶, S. Srivastava****,
H. Caglayan††††, U. Yis‡‡‡‡, C. Saunders§§§§, M. Rook¶¶¶¶,
S. Plugge‡,*****, V. Jayaraman†††††, R. Rajagopalan†††††,
E. Goldberg‡‡‡‡‡, E. Marsh‡‡‡‡‡, S. Kessler‡‡‡‡‡,
C. Bergqvist‡‡‡‡‡, L. Conlin†††††, B. Krock†††††, I. Thiffault‡‡‡‡‡,
M. Pendziwiat‡‡‡‡‡, I. Helbig‡‡,¶¶¶¶¶, T. Polster*******,
I. Borggraefe†††††††, J.R. Lemke‡‡‡‡‡‡‡, M.-J. van den
Boogaardt‡, E. Gardella*,†, B.P.C. Koeleman‡
*Danish Epilepsy Centre, Dianalund, Denmark, †Institute for
Regional Health Services, University of Southern Denmark,
Odense, Denmark, ‡University Medical Center Utrecht,
Department of Genetics, Utrecht, Netherlands, §Max Planck
Institute for Psycholinguistics, Department of Language and
Genetics, Nijmegen, Netherlands, ¶University Hospital
Heidelberg, Department of General Pediatrics, Centre for
Pediatrics and Adolescent Medicine, Heidelberg, Germany,
**Center for Rett Syndrome, Kennedy Center, Department of
Clinical Genetics, Copenhagen University Hospital,
Rigshospitalet, Copenhagen, Denmark, ††Kolding Hospital,
Department of Paediatrics, Kolding, Denmark, ‡‡Vejle Hospital,
Department of Clinical Genetics, Vejle, Denmark, §§Amplexa
Genetics, Odense, Denmark, ¶¶Institute of Evolution, Systems
and Genomics, Faculty of Medical and Human Sciences,
University of Manchester, Manchester, United Kingdom,
***Central Manchester University Hospitals NHS Foundation
Trust, Manchester Academic Health Science, Manchester Centre
for Genomic Medicine, Manchester, United Kingdom, †††The
Children’s Hospital of Philadelphia, Division of Neurology,
Philadelphia, PA, United States, ‡‡‡University Hospital of
Hvidovre, Department of Pediatrics, Hvidovre, Denmark,
§§§Kennedy Krieger Institute, Department of Neurogenetics,
Baltimore, MD, United States, ¶¶¶Johns Hopkins School of
Medicine, Hugo Moser Research Institute, Kennedy Krieger
Institute, Department of Neurology and Pediatrics, Baltimore,
MD, United States, ****Boston Children’s Hospital,
Department of Neurology, Boston, MA, United States,
††††Bogazici University, Department of Molecular Biology and
Genetics, Istanbul, Turkey, ‡‡‡‡Dokuz Eyl€ul University, Division
of Child Neurology, Department 30 of Pediatrics, School of
Medicine, Izmir, Turkey, §§§§Center for Pediatric Genomic
Medicine, Children’s Mercy Hospital, University of Missouri-
Kansas City School of Medicine, Department of Pathology and
Laboratory Medicine and Department of Pediatrics, Kansas
City, MO, United States, ¶¶¶¶University Medical Center Utrecht,
Department of Medical Physiology, Utrecht, Netherlands,
*****University Medical Center Utrecht, Honours Student
Biomedical Sciences, Utrecht, Netherlands, †Division of
Genomic Diagnostics, Children’s Hospital of Philadel-
phia, Philadelphia, PA, United States, ‡Division of Neu-
rology, The Children’s Hospital of Philadelphia,
Philadelphia, PA, United States, §§§§§Center for Pediatric
Genomic Medicine, Department of Pathology and Laboratory
Medicine, and Department of Pediatrics, Children’s Mercy
Hospital, Kansas City, MO, United States, ¶¶¶¶¶University
Medical Center Schleswig-Holstein, Christian Albrechts
University, Department of Neuropediatrics, Kiel, Ger-
many, ******Epilepsiezentrum Bethel, Krankenhaus Mara,
Kinderepileptologie, Bielefeld, Germany, †University of
Munich, Dr. von Hauner`s Children`s Hospital, Depart-
ment of Pediatric Neurology, Developmental Medicine
and Social Pediatrics, Munich, Germany, ‡University of
Leipzig Hospitals and Clinics, Institute of Human Genet-
ics, Leipzig, Germany
Purpose: De novo mutations in KCNB1, encoding the Kv2.1 voltage-
gated potassium channel, have recently been associated with epileptic
encephalopathies (EEs). Our study aimed to describe the phenotypic
spectrum associated with KCNB1.
Method: We used high-throughput sequencing of KCNB1 in 292
patients with a range of EEs and childhood epilepsies. In addition, we
ascertained cases from other centers. A detailed clinical history including
EEG data was obtained.
Results: In our screening cohort we identified 5 patients (1.7%) with
KCNB1 mutations and ascertained 15 additional patients through collab-
orators, yielding a total of 20 novel patients. Fourteen patients carried
missense mutations and 6 carried either nonsense or frameshift muta-
tions. Detailed genotype-phenotype correlations were performed. All
patients presented with developmental delay in the first year of life, pre-
ceding onset of epilepsy, and all had intellectual disability, which was
mostly moderate to severe. The majority (80%) suffered from intractable
epilepsy with seizure onset in early childhood (median onset:
12 months). Epileptic spasms were observed in 4 patients with a median
onset at 11.5 months. Most patients developed multiple seizure types,
including tonic, focal-clonic, myoclonic, GTCS and atypical absences.
EEG was deeply abnormal in most patients, including hypsarrhythmia
and general slowing of background activity together with multifocal or
generalized spikes/polyspikes. Interestingly, several patients had an
extreme accentuation of the epileptiform abnormalities during sleep,
resembling an atypical ESES pattern. Psychiatric comorbidities includ-
ing autistic features, stereotypies, hand-wringing and ADHD were com-
mon. The most severely affected patients consistently harboured
missense variants within vital channel domains of KCNB1. The effect of
the nonsense or frameshift mutations was less clear-cut, though a ten-
dency existed towards less severe phenotypes.
Conclusion: De novo KCNB1 mutations are relatively frequent causes
of intractable epilepsy and encephalopathy. Our data suggest a correla-
tion between the type and position of the mutation with the severity of the
disorder.
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0081
ABNORMALELECTROPHYSIOLOGICAL
PROPERTIESOF A1783TMUTATION IN SCN1AMAY
CAUSES SMEI
Y. Zeng*, F. Wei*, W. Liao*
*Guangzhou Medical University/Nuroscience, Guangzhou,
China
Purpose: Mutations in the sodium channel gene, SCN1A (NaV1.1),
have been linked to a spectrum of epilepsy syndromes, and many of these
mutations obstruct the channel function. We identified a novel mutation,
A1783T, in the SCN1A pore region of a child with SMEI (Severe Myo-
clonic Epilepsy in Infancy), try to investigate if mutation A1783T has
impacts on channel function and expected to disclose the relationship
between genotype and phenotype of sodium channelopathies.
Method: Amutant plasmid was constructed with a SCN1A plasmid con-
taining a gene mRNA sequence and a pair of primers with point muta-
tions. RT-PCR and Western-blot were used to detect the expression of
target genes and proteins and the differences were compared between
mutant and wild-type. The plasmids were expressed in HEK293 and
whole-cell patch-clamp recording was used to define electrophysiologi-
cal properties between mutant and wild-type.
Results: Expression analysis in HEK293 cell from the gene and protein
level had no significant difference between mutant and wild-type. Func-
tional analysis demonstrated that SCN1A- A1783T had no measurable
sodium current, indicating a complete loss of function, while wild-type
of SCN1A had total channel activity.
Conclusion: This observation indicates that A1783T mutation in
SCN1A cause loss of function. These abnormal electrophysiological
properties may cause SMEI. This study may be helpful in understanding
the function of sodium channel as well as the pathogenesis of epilepsy.
0082
LONG-TERM SURGICALOUTCOME IN PEDIATRIC
PATIENTSWITHFOCALCORTICALDYSPLASIA
E. Martinez Lizana*, S. Fauser†, A. Brandt*, J. Jacobs*,
A. Schulze-Bonhage*
*Epilepsy Center, University Hospital, Freiburg, Germany,
†Epilepsy Center, Bielefeld, Germany
Purpose: Focal cortical dysplasia (FCD) is the mayor cause of focal
intractable epilepsy in childhood. Factors influencing the success of the
surgical treatment remain controversial. We investigated seizure freedom
following epilepsy surgery in one of the largest cohorts of children with
histologically confirmed FCD.
Method: Retrospective study of patients younger than 18 years under-
going epilepsy surgery with histologically ascertained FCD. Data about
age at epilepsy onset, seizure types, seizure frequency, disease duration,
FCD visibility in the MRI and location, histological subtype, age at sur-
gery, surgical strategy, postsurgical follow-up and pharmacological treat-
ment were collected. Statistical analysis was made with IBM SPSS
Statistics, MS Office Excel and R.
Results: 115 patients were analyzed (46 lesionectomies, 41 lobectomies,
20 multilobectomies and 8 hemispherotomies). At last follow-up, 51% of
the patients achieved complete seizure-freedom after a mean period of
5.6 years (62% classified as Engel 1); 23.5% of the patients discontinued
successfully the medication, and 36.1% succeeded to reduce the medica-
tion to monotherapy. The surgical approach was wider in the younger
patients (42% of the surgeries affecting more than one lobe in patients ≤9
vs. 23% in patients >9 years old, p = 0.038). Despite more regional
resections, the long-term outcome tended to be superior in older children
(42% of seizure freedom in patients ≤9 vs. 57% in patients >9 years old).
Conclusion: Our data confirmed the efficacy of surgery in epileptic chil-
dren with FCD also at long-term follow-up. In our study, earlier resec-
tions were frequently more extended than later resections, whereas there
is a tendency for better outcome with later, more tailored resections. It
puts forward the question as to when surgery in childhood should be per-
formed. Our data suggest that in patient with unclear extent of the dys-
plastic area, later resections may offer advantages in terms of precision of
the surgical resection planning.
0083
LONG-TERM SAFETYANDEFFICACYOF
INTRACEREBROVENTRICULAR ENZYME
REPLACEMENTTHERAPYWITHCERLIPONASE
ALFA INCHILDRENCLNWITH 2 DISEASE: INTERIM
RESULTS FROMANONGOINGMULTICENTER,
MULTINATIONAL EXTENSION STUDY
N. Specchio*, A. Schulz†, P. Gissen‡, E. de los Reyes§,
H. Cahan¶, P. Slasor¶, T. Ajayi¶, D. Jacoby¶
*Division of Neurology, Bambino Gesu Children’s Hospital,
IRCCS, Rome, Italy, †University Medical Center Hamburg-
Eppendorf, Hamburg, Germany, ‡Great Ormond Street Hospital
for Children, London, United Kingdom, §Nationwide Children’s
Hospital, Ohio State University, Columbus, OH, United States,
¶BioMarin Pharmaceutical Inc., Novato, CA, United States
Purpose: CLN2 disease, a rare, inherited, pediatric, neurodegenerative
lysosomal storage disorder caused by TPP1 deficiency, is characterized
by seizures, ataxia, language and motor function loss, blindness and early
death. A phase 1/2 study (NCT01907087) demonstrated that intracere-
broventricular (ICV) infusion of 300 mg cerliponase alfa, a recombinant
human TPP1 enzyme, every other week for 48 weeks was associated
with attenuation of CLN2 disease progression. This extension study
(NCT02485899) assesses long-term safety and efficacy of ICV-adminis-
tered cerliponase alfa in children with CLN2 disease for up to
240 weeks.
Method: Subjects who completed the phase 1/2 study enrolled in this
open-label extension study, and continued receiving 300 mg cerliponase
alfa qow. Cumulative data from both studies were used to evaluate long-
term safety (assessed by analysis of adverse events (AEs)) and efficacy
(assessed by changes in motor and language (ML) functions using the
CLN2 clinical rating scale).
Results: 24 subjects were initially treated with cerliponase alfa in the
phase 1/2 study (9 male, 15 female, mean (SD) age 4.3 years (1.24)); 23
subjects enrolled in the extension study (74–124 weeks total exposure).
All had AEs; most were Grade 1–2. Common AEs included pyrexia,
hypersensitivity and convulsion. Nineteen (79%) subjects had at least
one serious AE, which were mostly consistent with neurodegenerative
disease in a pediatric population. Significant attenuation of the rate of
decline in ML score (mean (95% CI): 0.32 (0.13, 0.52) points/48 weeks,
p < 0.0001) was observed compared with a rate of decline of 2.0 points/
48 weeks in untreated patients. The responder (< 2 point loss) rate at
81 weeks (87%, p = 0.0002) was unchanged compared to that observed
at 48 weeks, suggesting a persistent treatment effect.
Conclusion: These data suggest that enzyme replacement therapy with
ICV-administered cerliponase alfa has an acceptable safety profile and a
sustained effect over time.
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HIGHAGREEMENT IN THEEVALUATIONOF
STRUCTURALMRI CHARACTERISTICS IN
TUBEROUS SCLEROSIS COMPLEX
H.M. Hulshof*, B. Benova†, M. Kyncl‡, M.H. Lequin§,
A. Belohlavkova†, P. Jezdik¶, K.P.J. Braun*, P. Krsek**,
F.E. Jansen*
*University Medical Center Utrecht, Pediatric Neurology,
Utrecht, Netherlands, †2nd Faculty of Medicine, Charles
University and Motol Hospital, Prague, Czech Republic,
‡Motol University Hospital, Radiology, Prague, Czech Republic,
§UMC Utrecht, Radiology, Utrecht, Netherlands,
¶Motol University Hospital, Prague, Czech Republic,
**Motol University Hospital, Pediatric Neurology, Prague,
Czech Republic
Purpose: The majority of patients with tuberous sclerosis complex
(TSC) have severe and refractory epilepsy. Localization of the epilepto-
genic zone is often challenging. A reproducible evaluation of structural
MRI lesions would aid in the identification of epileptogenic zone and
subsequently candidates for epilepsy surgery, in patients in whom clini-
cal and electrographical data are not clearly focal. In these preliminary
data we assessed the interobserver variability in evaluating individual
MRI characteristics of TSC.
Method: Presurgical MRIs of 31 patients (aged > 1 year) with TSC who
underwent epilepsy surgery in Prague or Utrecht were retrospectively
and independently evaluated by two neuroradiologists experienced in
epilepsy. MRI characteristics typical of TSC (tubers, cysts, calcifica-
tions) and focal-cortical dysplasia (FCD) features (gray-white matter
blurring, transmantle sign, increased cortical thickness), as well as the
largest FCD-like affected area, were identified. Brain localisations were
categorized as frontal (mesial, lateral, basal, polar, central), temporal
(mesial or lateral), parietal (mesial or lateral) or occipital (mesial or lat-
eral). Interobserver variability was calculated using kappa statistic for the
TSC and FCD related features and the 22 brain localisations, and judged
as poor (0–0.20), fair (0.21–0.40), moderate (0.41–0.60), substantial
(0.61–0.80), or almost perfect (0.81–0.99).
Results: We found the overall consistency to be almost perfect for all
localisations, and for all individual imaging features (total score kappa
0.91; 0.91–0.92], p < 0.001), and also for the largest FCD-like affected
area (0.98; 0.96–0.99, p < 0.001).
Conclusion: A scoring system of MRI characteristics in TSC patients
evaluated for epilepsy surgery showed almost perfect reliability
between two experienced neuroradiologists. We feel that this scoring
system could be used for the standardized evaluation of brain pathology
related to TSC. We aim to employ it for detailed characterization of
epileptogenic brain regions, especially when evaluating patients for epi-
lepsy surgery.
0085
NEUROPSYCHOLOGICAL ANDBEHAVIORAL
DISORDERS SCREENING PROGRAM INNEW-ONSET
CHILDHOODEPILEPSIES. PRELIMINARYRESULTS
USINGCHILD BEHAVIORCHECKLIST EVALUATION
F. Ilski Lecoanet*, M. Gavanon*, R. Abadie*, A. Laurent*,
V. Herbillon*, E. Panagiotakaki*, J. De Bellescize*, P. Keo-
Kosal*, K. Ostrowsky-Coste*, A. Montavont*,
A. Arzimanoglou*
*University Hospitals of Lyon, Department of Clinical
Epileptology, Sleep Disorders and Functional Neurology in
Children, Lyon, France
Purpose: Cognitive impairments and emotional dysregulations are fre-
quently encountered in children with all types of epilepsy. Retrospective
studies highlight these difficulties but fail to determine their chronology
of appearance which might be influenced by many factors (syndrome,
seizure frequency, treatment. . .). Early detection of pre-existing or pro-
gressively developing deficits represent real challenges for global epi-
lepsy-care programs.
Method: We developed a comprehensive approach for an early detection
of behavioral and cognitive deficits in newly diagnosed epilepsies. Dur-
ing the first visit, children were received in a day hospital for a global
evaluation including a sleep and awake EEG, somatic and neurological
examination, an epilepsy nurse interview and a preliminary evaluation of
behavior and social competences using the Child Behavior Checklist
(CBCL, Achenbach, 1991). A first neuropsychological screening was
conducted to assess attention abilities and executive functions using Epi-
Track Junior (Helmstaedter, 2013). Depending on the results, a full neu-
ropsychological evaluation can be scheduled. At the follow-up outpatient
clinics, an epilepsy nurse interviewed the patient and his family using
questionnaires on AEDs side effects and on “living with epilepsy”. A
re-test with EpiTrack Junior is performed.
Results: Preliminary results of the CBCL evaluation for idiopathic
epilepsies (IE) - 36 children without epilepsy (NE); 37 children with IE
(11 under AED treatment) - showed that at maximum 6 months from epi-
lepsy onset, even benign forms of epilepsy score lower than NE in the
Competences scale, assessing scholar, extrascholar and social skills (t
(71)=2,01, p < 0.05), especially when under AEDs (t(45)= 2,53,
p < 0.02). Externalization scale showed that IE have more aggressive
and delinquent behaviors as compared to NE (t(71)=2,16, p < 0.03) espe-
cially when under treatment (t(45)= 2,55, p < 0.01).
Conclusion: Our results underscore the need for an early multidisci-
plinary approach and detection of neuropsychological or behavioral defi-
cits to engage appropriate reeducations.
Clinical Neurophysiology 2
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MODULATIONOFAUTONOMIC SYMPATHETIC
ACTIVITYREDUCES EPILEPTIC SEIZURES: ROLEOF
FRONTALCORTEX - AMYGDALA FUNCTIONAL
CONNECTIVITY
Y. Nagai*, J. Aram†, M. Koepp‡, L. Lemieux‡, M. Mula§,
H. Critchley*, S. Sisodiya‡, M. Cercignani*
*Brighton and Sussex Medical School, University of Sussex,
Brighton, United Kingdom, †Brighton and Sussex University
Hospital, Brighton, United Kingdom, ‡Institute of Neurology,
London, United Kingdom, §St Georges Hospital, London, United
Kingdom
Purpose: In 2004, Nagai and her colleagues introduced galvanic skin
response (GSR) biofeedback therapy in patients with drug resistant epi-
lepsy, demonstrating positive effects of a randomized controlled trial:
60% response rate. Accompanying neuroimaging investigations in
healthy individuals showed that ventromedial prefrontal cortex/or-
bitofrontal neural activity is inversely correlated to biofeedback-driven
changes in the tonic level of GSR. The present study aimed to replicate
and extend evidence for the efficacy of autonomic biofeedback therapy
and investigate the underlying neural mechanisms.
Method: Forty patients with drug-resistant temporal lobe epilepsy (TLE)
were allocated to either one of two groups; one group received therapy
with GSR biofeedback (n = 20), and the other received treatment as usual
for control (n = 20). Resting-state functional and structural MRI data were
acquired before and after one month of therapy in the therapy group, and
before and after a one-month interval in the control group. The percentage
change of seizure frequency was the primary outcome measure. The sec-
ond outcome was the change in default mode network (DMN) and limbic
network functional connectivity tested for effects of therapy.
Results: There was a significant difference in reduction of seizure fre-
quency between the therapy and control groups (p < 0.001). The seizure
frequency in the therapy group was significantly reduced (p < 0.001) fol-
lowing GSR biofeedback, with a mean seizure reduction of 43% (SD =
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32.12, median = -37.26. 45% of patients in the therapy group showed
greater than 50% seizure reduction. Neuroimaging analysis revealed that
post-therapy seizure reduction was linearly correlated with enhanced
functional connectivity between amygdala and the orbitofrontal cortex
(OFC).
Conclusion: Autonomic biofeedback therapy is an effective and potent
behavioral intervention for patients with drug-resistant epilepsy, medi-
ated through fronto-limbic change.
0087
PROSPECTIVE IDENTIFICATIONOF FASTRIPPLES
(FRS) HELPS DEFINE THE SPATIAL EXTENTOF THE
EPILEPTOGENIC NETWORK
H. Nariai*, D. Bernardo*, S. Hussain*, A. Fallah†, R. Sankar*,
J. Wu*
*University of California, Pediatrics, Division of Pediatric
Neurology, Los Angeles, CA, United States, †University of
California, Neurosurgery, Los Angeles, CA, United States
Purpose: Observations from humans and animal models of epilepsy sug-
gest that pathological high frequency oscillations (HFOs) may serve as a
biomarker of epileptogenic zone. Prior retrospective studies analyzing
extra-operative ECoG (electrocorticography) recording in neocortical
epilepsy in children demonstrated wide distribution of interictal and ictal
HFOs (Nariai et al. Epilepsia 2011 and Akiyama et al. Epilepsia 2011),
suggesting the high prevalence of extensive epileptic network in this pop-
ulation. The purpose of this study is to evaluate HFOs prospectively to
investigate the spatial extent of the epileptic network before the resec-
tion.
Method: Here we prospectively analyzed interictal fast ripples (FRs:
250–500 Hz) in seven patients with intractable focal epilepsy (the etiol-
ogy includes cortical dysplasia and tumor) who underwent extra-opera-
tive ECoG recording before determining the resection margin. Interictal
FRs were sampled at 2000 Hz, and were visually identified in 10 min of
slowwave sleep from the early phase of the recording.
Results: Interictal FRs were observed in at least one of the seizure onset
electrode(s) in all seven patients. The spatial distribution of FRs was
more extensive than that of the seizure onset electrode(s), but less exten-
sive than that of the spikes. Five out of seven patients showed widely dis-
tributed FRs; 2 had similar diffuse or multi-lobar neuroimaging
abnormalities (MRI and/or PET) preoperatively; 3 had focal or normal
neuroimaging findings preoperatively, yet there were widely distributed
FRs discernible in multiple electrodes. Those 5 patients also showed
other neurophysiological abnormalities including widely distributed
areas with spikes, slowing, and seizures, resulting in extended resection
margin.
Conclusion: The topological extent of network abnormalities in neocor-
tical epilepsy may exceed what is discernible by multimodal neuroimag-
ing and traditional electrocorticographic methods, and may be defined
more completely by an investigation of FRs.
0088
EVIDENCEOF FOCALITY IN INFANTILE SPASMSAS
INDICATED BY INTERHEMISPHERICONSET
LATENCYDIFFERENCES IN ICTALGAMMAAND
BETAACTIVITYONEEG
J.C. Beal*, R.S. Jehle*, H. Nariai*, A.S. Galanopoulou*,†,
W.B. Mowrey‡, S. Bickel*, Y. Sogawa§, S. Shinnar*,‡,
S.L. Moshe*,†
*Montefiore Medical Center, Neurology, Bronx, NY, United
States, †Albert Einstein College of Medicine, Neuroscience,
Bronx, NY, United States, ‡Albert Einstein College of Medicine,
Epidemiology and Population Health, Bronx, NY, United States,
§University of Pittsburgh Medical Center Health System,
Neurology, Pittsburgh, PA, United States
Purpose: The typical EEG correlate to infantile spasms in West syn-
drome (WS) is the electrodecremental response, which usually has a gen-
eralized electrographic appearance. However, focal lesions can produce
infantile spasms in both humans and animal models, and it has been sug-
gested that spasms may have a focal onset. We investigated ictal gamma
and beta activity on scalp EEG during infantile spasms in patients with
WS to evaluate for evidence of focal onset.
Method: A total of 1033 spasms from 34 patients withWS of various eti-
ologies were analyzed using time-frequency analysis. Ictal gamma (35–
90 Hz) and beta (15–30 Hz) activities were correlated with visual semi-
ology of spasms (symmetric vs. asymmetric), objective EMG (elec-
tromyography) analysis, and etiology of WS. Interhemispheric latency
differences were measured for the onset of ictal gamma and beta activity.
Results: Ictal gamma and/or beta EEG activities were present, tempo-
rally associated with spasms, and preceded the ictal motor manifestations
in all cases. Focal onset of ictal gamma activity was present in 24/34
(71%), including 8/10 patients with asymmetric semiology of spasms and
16/24 patients with symmetric semiology of spasms. Focal onset of ictal
beta activity was present in 23/34 (68%), including 6/10 patients with
asymmetric spasms and 17/24 patients with symmetric spasms. All
patients with asymmetric spasms and 21/24 patients with symmetric
spasms had interhemispheric onset latency differences ≥10 ms in either
gamma or beta activity.
Conclusion: Interhemispheric latency differences in the onset of ictal
gamma and beta activity were present in the majority of spasms, regard-
less of observed symmetric vs. asymmetric semiology. This supports the
theory that infantile spasms may have a focal electrographic onset, even
in cases with apparent generalized semiology. When present, asymmetry
of ictal gamma or beta activity may provide additional evidence of focal-
ity, assisting in the identification and lateralization of possible underlying
lesions.
0089
EEG (ICTALAND INTER-ICTAL) CONNECTIVITY
PATTERNSAND 3-D SPIKE SOURCEANALYSIS IN
FOCALEPILEPSYAND ITS RELATIONTONUCLEAR
MEDICINE IMAGING
A. Pinzon*,†,‡,§, M. Cabrerizo*, G. Lizarraga*, B. Wolf‡,§,
C. Vallin§,¶, S. Garcia§, M. Adjouadi*
*Florida International University, Electrical and Computer
Engineering, Miami, FL, United States, †Florida International
University, School of Medicine, Miami, FL, United States,
‡Baptist Health Epilepsy Center, Miami, FL, United States, §The
Neurology Group, Miami, FL, United States, ¶Nova
Southeastern University, Ft Lauderdale, FL, United States
Purpose: In this study we suggest a methodology for the connectivity
investigation of EEG networks of inter-ictal and ictal epileptiform dis-
charge activities and its correlation to nuclear medicine studies.
Method: Focal epileptiform discharges (FEDs) have specific patterns
that can be determined using EEG connectivity analysis. Metabolic
changes in nuclear medicine imaging are seen in epileptogenic regions at
different states (ictal or inter-ictal). In this study we present a time and
frequency domain analysis of FEDs based on the number of connections
(significance threshold p < 0.05) identified in the regions of interest that
belong to potentially activated networks. Cross-correlation coefficients
for Delta, Theta, Alpha and Beta bands were calculated for each electrode
pair using a time lag of  500 ms, where the maximum value was
selected. Furthermore, time domain analysis was performed using phase
synchronization among scalp electrodes, by adopting a nonlinear data-
driven method. Inverse solution was also applied to FEDs to help localize
the activation regions. These results are then correlated to metabolic
changes in nuclear medicine imaging during ictal and inter-ictal states.
Results: There are significantly less connections (symmetry and density)
in the surrounding non-epileptic regions than in the epileptic region in
the inter-ictal phase that correlate to hypo-metabolism in imaging. Hence
in FEDs, the focal pattern of abnormal activity is reflected in the connec-
tivity maps by higher number of within region connections and lower
number of between region connections. As expected, during ictal phase
S34
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
activity, connections become more apparent and widespread, also corre-
lating positively with hyper-metabolic activity shown on the PET/SPECT
brain imaging. These changes were calculated using the SUVR (stan-
dardized uptake value ratio).
Conclusion: Propagation characteristics are likely related to connectiv-
ity network activation in focal ictal events. The strength of the connec-
tions and their spreading behavior are directly related to metabolic
changes found on nuclear medicine imaging.
0090
USEFULNESSOFAUTOMATEDEEGANALYSIS TO
DETECT INTERICTALEPILEPTIC ACTIVITY IN
DIAGNOSTIC EEGRECORDINGSL: A STUDY IN 38
PATIENTS
P. van Mierlo*,†, V. Keereman†, S. Vulliemoz*, M. Seeck*
*University Hospital of Geneva, Geneva, Switzerland, †Ghent
University, Ghent, Belgium
Purpose: In clinical practice, the detection of interictal epileptiform dis-
charges in diagnostic overnight EEG is a labor-intensive and time con-
suming task. In this study, we investigate the usefulness of automatically
generated EEG reports that show detected epileptic spikes to aid in the
visual clinical interpretation of diagnostic EEG.
Method: Thirty-eight patients had a diagnostic EEG recording of
approximately 17 h (3 pm-8am) at the University Hospital of Geneva,
Switzerland. Visual “clinical” interpretation, performed by an expert
electrophysiologist (MS), was compared to automatically generated EEG
reports (Epilog, Belgium) that visualized the detected spikes in the EEG.
The average waveform of the epileptic spike clusters, their topography,
the detections over time and 10 examples of single spikes were depicted
in the report. A blinded expert electrophysiologist (SV) reviewed the
patients solely based on the reports by indicating whether the report
showed genuine epileptic spikes in each patient or not. We assessed the
correspondence between the labor-intensive visual analysis and the anal-
ysis based on the automatically generated reports.
Results: Visual interpretation revealed that 12 of the 38 admitted
patients had epileptic spikes present in the overnight EEG. The diagnosis
based on the report corresponded with the visual analysis in 33 of the 38
patients. The sensitivity of epileptic diagnosis was 75%, the specificity
92%, positive predictive value 82% and negative predictive value 89%,
which corresponds to a diagnostic odds ratio of 36.
Conclusion: We showed that automatically generated, objective and
standardized EEG reports can aid in the visual interpretation of overnight
EEG. This can help the neurologists decrease their time spend for visual
interpretation. The visual clinical interpretation of the EEGwas informed
by clinical details, whereas the reviewer of the automated reports was
blinded. In future studies we will adjust this to allow a more clinically
relevant comparison between both approaches.
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ASSOCIATION BETWEENENVIRONMENTALOZONE
LEVELS AND INCREASED EPILEPTIC SEIZURES IN
PATIENTSWITHEPILEPSY IN AHOSPITAL IN
MEXICOCITY
V. Gomez-Arias*, M. Rojas-Nu~nez*, L. Nu~nez-Orozco*
*National Medical Center ‘20 de Noviembre’, Neurology,
Mexico DF, Mexico
Purpose: In 2016, an environmental contingency was registered in Mex-
ico City due to alarming levels of pollution in the metropilitan area. This
study attempts to determine if there was a relationship between levels of
airborne pollutants, specifically ozone, and increased seizure frequency
of patients with epilepsy treated at the National Medical Center “20 de
Noviembre” in Mexico City.
Method: We studied 65 adult patients with different types of epilepsy
treated at the neurology service of the National Medical Center “20 de
Noviembre”. These patients recorded daily epileptic seizures during
March, April, and May 2016. During this time, we recorded daily reports
of environmental ozone concentrations, published by the state Environ-
ment Ministry. We recorded the levels according to the corresponding
score of the air quality index. We compared the total epileptic seizures of
all patients each day with ozone levels using the Spearman correlation
coefficient for random variables.
Results: We found a significant correlation (p < 0.05) between ozone
levels and the frequency of epileptic seizures, mainly on days with levels
classified as dangerous according to the air quality index.
Conclusion: Our results suggest that environmental contamination,
specifically ozone levels, may be a factor in increasing seizures in
patients with epilepsy. Further studies are required to determine the exact
nature and implications of this association.
p0094
PREDICTORSOFOUTCOME IN PATIENTSWITH
ACUTE SYMPTOMATIC SEIZURE
G.K. Dash*, J. Prajapati†, A. Patanvadia†
*Narayana Health City, Neurology, Bangalore, India,
†Narayana Healthcity, Bangalore, India
Purpose: Very few studies from developing nation have looked into the
predictors of outcome in patients with acute symptomatic seizures (AS).
We analyzed the predictors of outcome in patients with AS.
Methods: Between December 2014–August 2016, we retrospectively
analyzed the clinical records of patients with AS and abstracted their clin-
ical, laboratory, EEG and radiological data. Patients were dichotomized
to have good and poor outcome at discharge based upon modified rankin
scale (poor outcome= mRS 4 and above, good outcome mRS 3 or less).
Appropriate statistical methods were applied.
Results: Out of 200 patients, 137 (68.5%) were males. One hundred and
forty-three (72.6%) patients had good outcome and 54 (27.4%) patients
had poor outcome. The etiology of AS were vascular (infarct- 71, cortical
venous sinus thrombosis- 20, parenchymal bleed-10, posterior reversible
leukoencephalopathy-7, subarchnoid hemorrhage-5, arterio-venous mal-
formation-4, dural arterio-venous fistula-2), infection (42), metabolic
(17), traumatic brain injury (5), autoimmune encephalitis (4), alcohol
related (3), tumor (3) focal cortical dysplasia (1) and sturge weber syn-
drome (1). One hundred and fifty patients presented with generalized sei-
zures. Complex partial seizures and simple partial seizures were seen in
39 and 11 patients respectively. EEG data was available for 126 patients.
Fifty-six patients (45%) had mild diffuse slowing of background activity
(BGA) in theta range, 28 (23%) patients had moderate slowing of BGA
and 4 (3%) patients had severe bihemispheric dysfunction. Epileptiform
abnormalities were seen in 36 (29%) patients. Factors predicting poor
outcome were old age (p = 0.01), glassgow coma scale (GCS) at entry
(p = 0.001), vascular etiology (p = 0.003) and severe electrophysiologi-
cal dysfunction in EEG (p = 0.005).
Conclusion: The most common etiology of AS was vascular due to
ischemic stroke and cortical venous sinus thrombosis. Old age, poor GCS
at entry, vascular etiology and severe electrophysiological dysfunction in
EEG predicted the poor outcome in patients with AS at discharge.
p0096
TEMPORAL LOBEEPILEPSYWITHAMYGDALA
ENLARGEMENT: A CLINICAL STUDY
M. Takeda*, H. Ando†, T. Katsuura†, S. Ukon*, S. Watanabe*,
S. Kasama*, T. Kimura*, H. Yoshikawa*
*Hyogo College of Medicine, Neurology, Nishinomiya, Japan,
†Hyogo College of Medicine, Radiology, Nishinomiya, Japan
Purpose: Hippocampal sclerosis is the most common pathological find-
ing in mesial temporal lobe epilepsy (TLE). Several recent studies
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suggest the presence of amygdala enlargement in some patients with
TLE. This study sought to investigate clinical characteristics and treat-
ment outcomes in TLE patients with amygdala enlargement detected by
magnetic resonance imaging (MRI).
Method: This study enrolled 7 TLE patients with amygdala enlargement
(2 men, 5 women) and 20 TLE patients without abnormal MRI findings
(11 men, 9 women). Clinical features, seizure semiology, EEG findings,
and treatment outcomes were evaluated. Visual assessments of MRI find-
ings were performed by an experienced neurologist and a radiologist,
respectively.
Results: Average seizure onset age among TLE patients with amygdala
enlargement and patients without abnormal MRI findings was 46.6 (SD
17.7) years and 38.9 (SD 23.3) years. All patients with amygdala enlarge-
ment had complex partial seizures and 3 patients had occasional general-
ized tonic-clonic seizures. Two patients had memory decline. Four
patients suffered from depression or anxiety. Epileptiform discharges
appeared predominantly in the anterior or inferior temporal area ipsilat-
eral to amygdala enlargement. Six patients became seizure free or
showed remarkable improvement on antiepileptic medication. Volume
of the enlarged amygdala was reduced after treatment in 3 patients.
Among TLE patients without abnormal MRI findings, 2 patients had
depression and no patients had memory decline. Ten patients became sei-
zure free or showed remarkable improvement on antiepileptic medica-
tion.
Conclusion: TLE patients with amygdala enlargement generally are
older at epilepsy onset, have a tendency to non-convulsive seizure, and
show a good response to antiepileptic drugs. These results suggest a dif-
ference in pathophysiology between TLE patients with amygdala
enlargement and TLE patients without abnormal MRI.
p0099
MUSICOGENIC EPILEPSY - ANAUTOIMMUNE-
MEDIATEDCONDITION?
A.M. Staack*, A.-S. Wendling*, T. Intravooth*, C.G. Bien†,‡,
B.J. Steinhoff*
*Kork Epilepsy Center, Kehl-Kork, Germany, †Epilepsy Center
Bethel, Bielefeld, Germany, ‡Laboratory Krone, Bad Salzuflen,
Germany
Purpose: Musicogenic epilepsy is a rare form of complex reflex epi-
lepsy. The precipitation of seizures by music is a useful tool to investigate
seizure initiation, propagation and human’s brain processing. Little is
known about the pathophysiological origin of this exceptional phe-
nomenon. We present a series of patients with music induced seizures
with high titers of antibodies against glutamic acid decarboxylase 65 kD
(GAD65).
Patients and methods: We determined neural antibodies using a broad
panel of surface and intracellular antigens in serum only or in serum-cer-
ebrospinal fluid (CSF) of patients who fulfilled the clinical criteria of
potential (sub)acute limbic encephalitis or chronic autoimmune-
mediated temporal lobe epilepsy. We identified the positive cases and
characterized them clinically in order to uncover typical syndromatic
profiles.
Results: Out of 167 patients, eight patients had GAD65-antibodies.
Among those, four patients had musicogenic epilepsy (GAD65-antibody
serum titers between 1:2500 and 1:40 000). Common characteristics of
these four patients were female gender, late epilepsy onset, mood distur-
bances, slight memory decline, normal MRI and seizures induced by
individually preferred music, recorded by video-EEG. Spontaneous sei-
zures were rare and well controlled by antiepileptic drugs whereas occur-
rence of music induced seizures was not influenced by AED-treatment
and could only be prevented by avoidance of the specific musical stimu-
lus. Endocrinological comorbidities were seen in three of the four
patients. Immunomodulatory treatment has not been initiated yet because
of the missing proof of efficacy in intracellular antibodies.
Conclusion: To our best knowledge, this is the first report on musico-
genic epilepsy in patients with high titer GAD65-antibodies. These intra-
cellular antibodies have recently been considered as markers of an
immunopathological process of limbic structures in some chronic tempo-
ral lobe epilepsies. Since music processing strongly implicates the limbic
system, there might be a predisposition in patients with autoimmune-
mediated temporal lobe epilepsy to develop music-induced seizures.
p0100
FACTORSAFFECTINGTHENUMBEROF
OLIGODENDROCYTES INHUMANTEMPORAL LOBE
EPILEPSY: A CLINICOPATHOLOGICAL STUDY
H. Miyata*, A. Sugie†, J. Kawamura‡, T. Hori§
*Research Institute for Brain and Blood Vessels - AKITA,
Department of Neuropathology, Akita, Japan, †Akita University
School of Medicine, Akita, Japan, ‡Research Institute for Brain
and Blood Vessels - AKITA, Akita, Japan, §Tokyo Neurological
Center Hospital, Department of Neurosurgery, Tokyo, Japan
Purpose: Increased density and/or focal perivascular/perineuronal clus-
tering of oligodendrocytes in white matter are frequently encountered in
resected specimen from patients with temporal lobe epilepsy (TLE);
however, its pathological significance is yet to be determined.
Method: Immunohistochemical studies for olig2 and NeuN were per-
formed on formalin-fixed paraffin-embedded temporal lobe resection
specimen from 20 patients with TLE with and without pathologically
confirmed hippocampal sclerosis (HS (n = 9) and no-HS (n = 11)),
along with frontal lobe specimen from 5 patients with frontal lobe epi-
lepsy (FLE). Mean values of number of olig2-positive cells (Olig2/mm2)
and total glial cells (Total G/mm2) in deep white matter (DWM) as well
as proportion of olig2-positive cells among total glial cells (%Olig2)
were evaluated and compared among HS, no-HS and FLE groups
(ANOVA followed by post-hoc Scheffe´s test). Mean Olig2/mm2 in hip-
pocampal CA4 was also evaluated and compared between HS and no-HS
groups (t-test).
Results: While there was no significant difference in mean Olig2/mm2
in DWM among three groups and Olig2/mm2 didn´t correlate with num-
ber of NeuN-positive heterotopic neurons in all groups, Olig2/mm2 in
DWM positively correlated with both clinical duration (R2=0.527) and
age at operation (R2=0.606) only in no-HS group, and mean %Olig2 was
higher in no-HS than other groups (p < 0.05). There was a trend toward
lower mean Olig2/mm2 in CA4 in HS than No-HS group without statisti-
cal significance; however, Olig2/mm2 in CA4 inversely (R2=0.506) and
positively (R2=0.268) correlated with age at operation in HS and no-HS
groups, respectively.
Conclusion: These results indicate distinct effects of clinical duration
and age at operation but not heterotopic neurons on the number of oligo-
dendrocytes (Olig2/mm2) in temporal DWM and hippocampal CA4
between HS and No-HS groups, raising the possibility of pathogenesis
other than maldevelopmental mechanisms underlying the increased
number of oligodendrocytes in TLE patients.
p0102
INTERNAL-EXTERNAL LOCUSOFCONTROLAND
SELF-PERCEPTIONOFAURAS
J.L.W. Moritz*, R. Mameniskiene†, J. Rimsiene†, G.A. Calado*,
I.B. Rigon*, P.L.M. Cantu*, C. Meneguzzi*, K. Lin‡, P. Wolf§,¶
*Federal University of Santa Catarina, Florianopolis, Brazil,
†Vilnius University, Vilnius, Lithuania, ‡Federal University of
Santa Catarina, Department of Internal Medicine,
Florianopolis, Brazil, §Danish Epilepsy Centre, Dianalund,
Denmark, ¶Federal University of Santa Catarina, Medical
Sciences Post-Graduation Program, Florianopolis, Brazil
Purpose: A person’s Locus of Control (LoC) is where that person places
the primary causation of events in his or her life. One can interpret events
as being either a result of one’s own actions or external factors. LoC has
been used to predict from psychological well-being to health behaviors
and religiosity, from academic and economic success to reaction to hard-
ships. The aim of this study was to investigate how LoC is associated with
anxiety, depression, religiosity and quality of life in epilepsy.
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Method: A transcultural cross-sectional study was carried out with 189
consecutive patients with a definite diagnosis of epilepsy according to
current ILAE´s criteria in Brazil and Lithuania. Clinical and demographic
data were obtained and all patients answered to previously internationally
validated scales: Rotter´s General LoC, Hospital Anxiety and Depression
Scale (HADS), Index of Core Spiritual Experiences (INSPIRIT), and
Quality of Life in Epilepsy (QOLIE-31).
Results: Patients´ mean age was 35.8  13.87, 116 were female, mean
age of onset of epilepsy was 17.1  13.52 and monthly frequency of sei-
zures was 8.0  19.86. Eighty-five patients claimed that they could react
to the presence of auras, while 104 did not. Both groups scored statisti-
cally different on HAD-Depression (p = 0.002) and HAD-Anxiety
(p = 0.004). Brazilian and Lithuanian patients with epilepsy were signif-
icantly different according to HAD-Anxiety (p = 0.03), QOLIE-31
(p = 0.01) and INSPIRIT (p < 0.001), and were marginally different
according to LoC (p = 0.07).
Conclusion: Those who could react to an aura were more depressed and
more anxious than those who could not. We hypothesize that patients
who perceive their auras are more conscious of the presence of seizures,
and more constantly reminded of their condition, leading to higher rates
of depression and anxiety. In addition, cultural aspects may influence
patient´s quality of life and their way of coping with epilepsy.
p0103
UP-REGULATIONOFAUTOPHAGYANDMITOPHAGY
INREFRACTORYTEMPORAL LOBEEPILEPSY
PATIENTSWITHHIPPOCAMPAL SCLEROSIS
J.-M. Li*, M.Q. Wu*, D. Zhou*
*West China Hospital of Sichuan University, Department of
Neurology, Chengdu, China
Purpose: To determine the association between mitophagy and refrac-
tory temporal lobe epilepsy (rTLE).
Method: We continuously collected the hippocampi and temporal lobe
cortexes of rTLE patients who underwent the epilepsy surgery whose
pathological finding showed hippocampal sclerosis. The colocalization
of mitochondria and autophagosome markers in cells was performed
using fluorescence immunostaining and confocal microscopy analysis.
Transmission electron microscopy (TEM) was performed to investigate
whether there were autophagic vacuoles or abnormal mitochondria.
Results: Ten rTLE patients with the hippocampus and temporal lobe
cortex were collected. Immunofluorescence staining showed colocaliza-
tion of LC3B with mitochondria in hippocampi and temporal lobe cor-
texes of rTLE patients. Significant staining forcolocalization of LC3B
with mitochondria in hippocampi was lower than temporal lobe cortexes
(P < 0.001). TEM results showed damaged mitochondria with frag-
mented vesiculated cristae in three cases and early autophagosome in one
case.
Conclusion: The study revealed mitophagy expression in refractory
rTLE due to hippocamal sclerosis. It indicates damaged mitochondria
removing is inhibited in rTLE especially in hippocampus. It may
contribute to epileptogenesis of hippocampus sclerosis.
p0105
RELATIONBETWEENGENDER, PSYCHIATRIC AND
COGNITIVEDISORDERS ANDEXPERIENTIALAURAS
IN PATIENTSWITHTEMPORAL LOBE EPILEPSY
V. Benjumea-Cuartas*,†, B. Giagante†,‡, S. Oddo*,†,‡, N. Pereira
de Silva*,†, L. D’Alessio*,‡, M. Fernandez Lima†, P. Solıs†,
J.P. Princich†, P. Seoane*,†, E. Seoane*, S. Kochen*,†,‡
*JM Ramos Mejıa Hospital, Epilepsy Center, Neurology
Division, Buenos Aires, Argentina, †El Cruce Hospital,
Neurosciences Center, Epilepsy Unit, Florencio Varela,
Argentina, ‡Neurosciences and Complex Systems Unit ENYS,
CONICET National Council of Scientific and Technology
Research - UNAJ Arturo Jauretche National University - El
Cruce Hospital, Buenos Aires, Argentina
Purpose: To determine whether the experiential auras in patients with
temporal lobe epilepsy (TLE) are related to gender, educational level,
psychiatric comorbidity, visual or verbal material-specific memory
impairment, lateralization by video-EEG and epileptogenic lesions on
brainMRI.
Method: Retrospective review (1998–2015) of clinical charts and video-
EEG of patients with experiential auras and TLE followed at the JM
RamosMejıa and El Cruce Hospitals.
Results: We included 35 patients, 51.4% were male, mean age 35 years,
mean epilepsy duration 20.3 years. Laterality of the epileptogenic zone
was right (57.1%) and left (37.1%) temporal. An epileptogenic lesion
was detected in most of cases and hippocampal sclerosis was the most
common finding. Seventy-four percent of patients underwent epilepsy
surgery (Engel I-II: 65.4%). Educational level was mainly primary and
secondary. Most of patients presented visual or both memories deficits
associated with executive dysfunction. Almost half patients had a psychi-
atric comorbidity. Deja vu was the most frequent experiential aura
(60%), followed by jamais vu (20%), strangeness (20%) and depersonal-
ization (14.3%). Most patients had a single experiential aura (deja vu
54.5%, jamais vu 18.2%, strangeness 13.6%, depersonalization 9.1%,
prescience 4.5%) associated with non-experiential auras in the majority
of cases.
Conclusion: Most of patients presented a single experiential aura, most
frequently deja vu, associated with non-experiential auras, mainly fear. A
right temporal lobe seizure focus was the most frequent. In terms of gen-
der, deja vu was more common in male patients. A high prevalence of
psychiatric comorbidity was observed and despite of the reduced number
of cases, the 3 patients with psychosis presented deja vu. Most of patients
presented visual or both memories deficits associated with executive
dysfunction.We did not find any relation between the experiential auras
and educational level.
p0106
SEIZUREOUTCOMES IN PATIENTSWITHANTI-
NMDARENCEPHALITISL: A 6-YEAR FOLLOW-UP
STUDY
X. Liu*, X. Lai*, R. Wang*, D. Zhou*, Z. Hong*
*West China Hospital of Sichuan University, Chengdu, China
Purpose: To evaluate the long-term seizure outcome and potential fac-
tors associated with seizure outcome in patients with anti-N-methyl-D-
aspartate receptor encephalitis.
Method: In the setting of a prospective, single center, longitudinal
cohort study, 109 patients with anti-NMDAR encephalitis were recruited
consecutively. Patients underwent clinical evaluation every 3 months.
Seizure outcomes and the potential risk factors were assessed with med-
ian follow-up of 18 months (3–66 months).
Results: Of 109 patients (47 men; 62 women) with anti-NMDAR
encephalitis, 88 (80.7%) patients reported seizures at acute phase, includ-
ing single seizure (14/88, 15.9%), repetitive seizures (30/88, 34.1%),
NRSE (22/88, 25%), RSE (13/88, 14.8%), and SRSE (9/88, 10.2%).
After the acute phase, seizure recurrence rates were 21.1%, 11.4%,9.1%,
and 0% at 6, 12, 18, and 24 months of follow-up, respectively. Seizure
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recurrence was more likely to recur in patients with a tumor, SE develop-
ment, coma or ICU admission in the acute phase (P < 0.05). All patients
with acute seizure who received follow-up for more than 2 years after the
acute stage were seizure free.
Conclusion: Seizures are a common feature in the acute stage of anti-
NMDAR encephalitis but not thereafter. The presence of tumor, SE,
coma and/or ICU admission in the acute phase predict early seizure
recurrence. Seizure freedomwas typically achieved in our follow-up, and
long-term use of AEDs may not be necessary.
p0107
NON-DIPPINGNOCTURNAL BLOODPRESSURE IN
PATIENTSWITHEPILEPSY
S. Park, H. Lee, S.H. Kim, S.-C. Lim, W. Kim
College of Medicine, Catholic University of Korea, Department
of Neurology, Seoul, Korea
Purpose: The loss of nocturnal fall and rise in blood pressure (BP) has
been associated with an alteration in modulation of the sympathetic ner-
vous system. In patients with epilepsy, autonomic dysregulation may
account for increased mortality compared with general population. How-
ever, less is understood about autonomic function in epilepsy patients,
especially during nighttime. The aim of this study is to assess the patterns
of circadian BP variation in epilepsy patients and determine whether any
relationship exists between these patterns and clinical characteristics.
Method: We retrospectively analyzed the data from patients with epi-
lepsy who were underwent 24-h ambulatory BP monitoring and Holter
recording. Patients were classified according to the percentage fall in
mean systolic BP (SBP) at night compared to during the day as: dippers
(fall ≥ 10%) and non-dippers (< 10%).
Results: One hundred and thirty-two patients with epilepsy were
included in this study (62 men, 70 women; mean age 35.1 years). 38
patients (28.8%) were dippers and 94 (71.2%) were non-dippers. Among
94 non-dippers, fourteen patients were reverse dippers (< 0%, that is, a
rise in mean nocturnal SBP compared to mean daytime SBP). Compared
to dippers, non-dippers had more frequent seizures (12.3  2.52 vs.
1.9  4.01, p = 0.031) and received more antiepileptic drugs
(1.88  0.16 vs. 1.15  0.25, p = 0.020). Also, structural epileptogenic
lesions were more frequently identified from the non-dippers. (54.3 % vs.
31.6%, p = 0.021).
Conclusion: Non-dipping was relatively common pattern of circadian
BP variation seen in patients with epilepsy. This pattern was associated
with seizure frequency, the number of antiepileptic drugs prescribed and
epileptogenic lesions.
p0108
LONGITUDINAL BILATERALHIPPOCAMPALN-
ACETYL-ASPARTATE VALUESOBTAINEDUSING
MAGNETIC RESONANCE SPECTROSCOPYOVER
MORETHANTHREEYEARS IN PATIENTSWITH
EPILEPSY
T. Hoshida*, Y. Sawai*, T. Shimokahara*, H. Hirabayashi*
*National Hospital Organization, Nara Medical Center,
Epilepsy Center, Nara, Japan
Purpose: Our aim was to evaluate the variation patterns in the hip-
pocampal N-acetyl-aspartate (NAA) value in patients with epilepsy by
using single-voxel proton magnetic resonance spectroscopy (MRS) in a
longitudinal study over a period of more than 3 years.
Method: A total of 1,661 consecutive MRS studies performed on 787
patients with epilepsy. Quantitative MRS was conducted at 1.5 T using
LC-Model. Longitudinal changes were studied in 64 patients who had
been seizure-free including 28 cases of idiopathic generalized epilepsy
(IGE) and 36 cases of partial epilepsy (PE). We studied the coefficient of
variation (CV) of hippocampal NAA values over a period of more than
3 years, and the various factors in patients who demonstrated a CV value
of more than 10%.
Results: The mean CV of NAA value was 7.2% on the right side and
5.7% on the left side in the IGE group, and 7.2% and 6.1% in the PE
group. In the IGE group, patients showed less than 10% CVwere 78% on
the right side and 96% on the left side. In the PE group, patients showed
less than 10% CV were 78% on the right side and 89% on the left side.
Seven out of 9 patients demonstrating more than 10% of CV showed a
larger CV on the epileptic focus side than the unaffected side.
Conclusion: An increase or decrease in NAA values within 10% CV
might include the normal variance of NAA measurements. The seizure
focus side in the PE group demonstrated fluctuating patterns with more
than 10% CV. The emotional or social environmental change, such as
divorce, effected on the right hippocampus in the IGE group. Longitudi-
nal NAA measurements are needed to estimate the seizure focus side and
to exclude the normal variance for evaluation of ideal hippocampal func-
tion.
p0109
OCCURRENCEANDPREDICTORSOF POSTSTROKE
EPILEPSY. A PROSPECTIVE STUDYANDMETA-
ANALYSES
F. Rakhimov*, R. Gulnora†, M. Yulduz†
*Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan,
†Tashkent Medical Academy, Tashkent, Uzbekistan
Purpose: The aims of the study were to assess the occurrence of post-
stroke epilepsy (PSE) in patients with ischemic strokes, to identify pre-
dictors, and to investigate whether treatment in a stroke unit (SU)
influenced the long-term outcomes of epilepsy.
Method: Patients with PSE, defined as those having two ore more unpro-
voked epileptic seizures > or = 1 week after an ischemic stroke, were
identified from a cohort of 484 patients with ischemic strokes. The
patients were prospectively assessed 7–8 years after stroke or until death.
Different variables were studied to look for possible predictors.
Results: From 448 patients with ischemic strokes, PSE developed in 11
(2.5%) and 14 (3.1%) patients during the first year and 7–8 years after
stroke, respectively. Eight (53%) of these patients were treated in a stroke
unit (SU), and seven (47%) were treated in a general medical ward
(GMW). The mean age of those who developed PSE and those who did
not was 74.3 years and 76.3 years, respectively. In a multivariate analy-
sis, a Medical scale (MS) score < 30 on admission was a significant pre-
dictor for developing PSE [odds ratio (OR), 4.9; p = 0.004).
Conclusion: The prevalence of PSE, 7 to 8 years after an ischemic
stroke, was 3.1%.MS scores < 30 on admission were a significant predic-
tor for PSE. Neither treatment in SU vs. GMW, cortical location, nor age
at onset of stroke seemed to influence the risk of developing PSE.
p0111
SLEEPLESS IN SINGAPORE - CHARACTERIZATION
OF SLEEP-RELATED SEIZURES IN ATERTIARY
INSTITUTION
Y.-L. Tan*, M. Sim*, N.C.K. Tan*
*National Neuroscience Institute, Neurology, Singapore,
Singapore
Purpose: About 10–20% of patients with epilepsy suffer primarily
sleep-related seizures. Differentiating between generalized and focal
epilepsies may be challenging as nocturnal seizures are sometimes unwit-
nessed, and routine electroencephalograms (EEGs) are often normal. We
aimed to determine (i)proportion of generalized, focal, and unclassified
epilepsies in this population, (ii)response to anti-epileptic drug (AED)
therapy, and (iii)diagnostic yield of routine vs. sleep-deprived / pro-
longed video-EEG recording.
Method: We retrospectively identified 80 patients with sleep-related sei-
zures from 1996–2016 using an EEG database at our institution. Patients
aged ≥16 years were included if (i)>90% of seizures were sleep-related,
(ii)EEG and CT/MRI brain were performed, and (iii)≥ 6 months of clini-
cal follow-up was available.
S38
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Results: Mean age at seizure-onset was 34.5 years (SD=20.1); 31
(38.8%) were male. Eleven (13.8%) had a family history of epilepsy.
Fifty-nine (73.8%) were classified as having focal epilepsy (21 FLE, 13
TLE, 11 other foci and 14 non-localized), 5 (6.3%) as generalized epi-
lepsy, and 16 (20%) remained unclassified. Thirty-eight (47.5%) had < 2
seizures / year, 34 (42.5%) 2–12 seizures / year, and 8 (10%) had >12 sei-
zures / year. Most patients responded favorably to AEDs, with 62
(77.5%) showing ≥50% reduction in seizure frequency with 1 AED; 63
(78.8%) were seizure-free in the 3 months preceding follow-up. Twelve
(15%) had lesion-positive scans (3 malformations of cortical develop-
ment, 2 hippocampal sclerosis, 5 focal gliosis, and 2 benign neoplasms).
Epileptiform discharges were recorded in 28/98 (28.6%) and 3/11
(27.3%) of routine and sleep-deprived EEGs respectively. All 3 patients
with normal routine EEGs had epileptiform activity on subsequent full-
day video-EEG.
Conclusion: A significant proportion (20%) of patients with sleep-
related seizures in our series have unclassified epilepsy. Extending the
duration of EEG recording may increase diagnostic yield in this popula-
tion.
p0112
FOCALANDGENERALIZEDEPILEPSY:WHICH
SEIZURE-MODULATORY FACTORSAREMOST
FREQUENT?
J.S. Dalbem*,†, H.H. Siqueira*,†, A.F. Fonseca Junior†,
J.M. Alves†, B.S. Marques†, B. Baykan‡, E.U. €Ozcelik‡,
L.E.V. Zeissig§, R. Samaitien _e¶, L.P. Queiroz†, R. Walz†, K. Lin†,
P. Wolf**
*Federal University of Mato Grosso, Cuiaba, Brazil, †Federal
University of Santa Catarina, Florianopolis, Brazil, ‡Istanbul
University, Istanbul, Turkey, §Centro de Epilepsia Humana y
Neurocirurgia Funcional, Ciudad de Guatemala, Guatemala,
¶Vilnius University, Vilnius, Lithuania, **Danish Epilepsy
Center, Dianalund, Denmark
Purpose: Seizure-precipitating or inhibitory factors (modulatory factors
- MF) are often neglected and underestimated as part of epilepsy treat-
ment. Therefore we aimed to identify self-perceived MFs in patients with
focal vs. generalized epilepsy syndromes.
Method: This was a transcultural multicenter cross-sectional study. Epi-
lepsy syndromes were classified by board-certified epileptologists
according to ILAE´s criteria. Patients were interviewed using a
semistructured questionnaire on clinical and epidemiological data and
were asked to identify all experiencedMFs from a list.
Results: A total of 185 individuals were surveyed, 136 (73.5%) had a
diagnosis of focal and 49 (26.5%) generalized epilepsy at the four univer-
sity reference centers for the treatment of neurological diseases involved
in this study (Brazil, Guatemala, Lithuania and Turkey). Their mean age
was 34.98  11.70 vs. 24.88  10.12 (p ≤ 0.001), and 97 (52.4%) vs.
88 (47.6%) were female (p = 1.0), respectively. More than 80% of
patients reported experiencing provocative factors sometimes or fre-
quently, while more than 60% of patients never experienced an inhibitory
factor, regardless of epilepsy syndrome. The main precipitant factors
reported by focal epilepsy patients were (in order of appearance): nega-
tive feelings (66.2%; p = 0.040), emotional stress (61.8%; p = 0.029),
lack of sleep (55.9%; p = 0.127), certain memories (37.5%; p ≤ 0.001)
and certain thoughts (36.8%; p ≤ 0.001), while among generalized epi-
lepsy patients: lack of sleep (60.4%; p = 0.127), negative feelings
(49.0%; p = 0.040), emotional stress (42.9%; p = 0.029), seizures at
awakening (26.5%; p = 0.081) and working on computer, thinking/ con-
centration and visual stimuli (all 18.4%; ns).
Conclusion: The top three seizure-modulatory factors were similar in
focal and generalized epilepsy, only in different order of frequency,
certain thoughts and memories appear specific to focal epilepsy.
p0114
INTERLEUKINS INTERICTALDATAANDTAU-
PROTEIN IN PATIENTSWITHLONG-STANDING
PHARMACO-RESISTANT EPILEPSY
Y. Lekomtseva*, G. Gubina-Vakulik†, T. Gorbach‡, L. Bylik§
*State Institute of Neurology, Psychiatry and Narcology of the
NAMSU, Neurology Department, Kharkiv, Ukraine, †Kharkiv
National Medical University, Pathomorphology and
Pathological Anatomy Department, Kharkiv, Ukraine, ‡Kharkiv
National Medical University, Biochemistry Department,
Kharkiv, Ukraine, §State Institute of Neurology, Psychiatry and
Narcology of the NAMSU, Outpatient Neurology Clinic,
Kharkiv, Ukraine
Purpose: We investigated tau-mediated neurodegeneration by determi-
nation of tau protein level in correlation with proinflammatory inter-
leukins (ILs) involved into microglial-neuronal interactions and latent
neuroinflammation in patients with long-standing pharmaco-resistant
epilepsy (PhRE).
Method: Tau was measured by immunofluorescent method using mono-
clonal anti-mouse antitau-2 antibodies also specific for phosho-Tau in
PhRE (n = 59; 34–62 years, mean disease duration 16.24  8.51 years)
and healthy controls (HC=30; 25–35); results were expressed as optical
density (OD=log10F0/F1) units of FITC-labelled binding sites; IL-6, IL-8
measured by standard immunoenzyme assays using Vector-Best
reagents.
Results: In PhRE tau concentration was 0.37  0.04 compare to HC
0.08  0.002; PhRE showed average tau serum level: psychiatric com-
plications found in 52.54% patients; tau-mediated toxicity positively cor-
related with behavioral and neuropsychiatric changes. PhRE anamnesis:
brain injury (8 patients), febrile seizures (6), post-asphyxia encephalopa-
thy (6), meningo/encephalitis virus (4), chicken-pox infection (2). PhRE
medicated with one AED (35.59%), 38 patients (64.41%) were on poly-
therapy. Seizure frequency: 1–2 per 6 months (18.64%), 1–2 per/month
(72.88%), 1–2 per/week (8.48%). RhRE revealed high serum proinflam-
matory IL-6 level suggesting that increased IL-6 (Mean
26.34  6.51 pg/ml, range: 19–38.69 vs. HC 5.23  1.5) might be gen-
erated from activation of microglia-astrocyte network (p < 0.01;
t = 2.8), high IL-6 data were associated in 76.27% patients with high sei-
zure frequency; influenced by long-course of antiepileptic treatment
(69.49%). PhRE showed no differences in IL-8: 8.32  3.88 vs.
5.6  2.47 pg/ml. PhRE patients had focal neurological deficit (12),
severe headaches (14), cognitive decline (25). Proinflammatory cytoki-
nes may lead to neuronal excitability or neuron destruction associated
with cognitive impairment.
Conclusion: PhRE revealed elevated baseline proinflammatory IL-6
level associated with high seizure frequency and long antiepileptic ther-
apy. IL-6-dependent neuroinflammatory processes are important of
PhRE understanding there maybe potential role for anti-inflammatory
therapy targeting cytokines. PhRE found heightened hyperphosphory-
lated tau level where it might contribute to chronic progression and asso-
ciated with psychiatric complications or cognitive decline.
p0115
A PILOT STUDYONRELATIONSHIP BETWEEN
PLASMAHAPTOGLOBINAND POSTTRAUMATIC
EPILEPSY
H. Park*, K.I. Yang*, D.S. Jeong*, H.G. Oh*
*Soonchunhyang University Cheonan Hospital, Neurology,
Cheonan, Korea
Purpose: Delay hemoglobin clearance following cerebral injury might
exacerbate iron-dependent tissue damage and predispose to the develop-
ment of seizure disorders. Reduced plasma haptoglobin might interfere
with the normal clearance of hemoglobin from the site of an injury. We
evaluated the correlation between plasma haptoglobin level and posttrau-
matic epilepsy.
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Method: Using an immunonephelometric technique, we measured
plasma haptoglobin level in 30 patients with posttraumatic epilepsy, 35
non-epileptic patients with head trauma, and 35 normal controls.
Results: The plasma haptoglobin level was 77.57  45.65 mg% in
patients with posttraumatic epilepsy, 119.68  59.33 mg% in non-epi-
leptic patients with head trauma, and 117.20  55.39 mg% in normal
controls. The plasma haptoglobin level of patients with posttraumatic
epilepsy was significantly lower than that of normal controls and non-
epileptic patients with head trauma (p < 0.01).
Conclusion: Our study suggests that low level of plasma haptoglobin
may be associated with development of posttraumatic epilepsy.
p0116
AUDITOF EPILEPSYHEALTHCARE PROVISION IN A
LARGEUKCATEGORYB PRISON
R. Thomasson*, H. Coyle*, L. Reynolds*, A. Lees†,
L. Partington†, P. Cooper*
*Greater Manchester Neurosciences Centre, Greater
Manchester, United Kingdom, †Sodexo Justice Services, Greater
Manchester, United Kingdom
Purpose: This audit was undertaken to review standards of care for UK
prisoners diagnosed with epilepsy. Previous reports have highlighted
poor compliance with national guidelines for epilepsy care in prison set-
tings, although available data is sparse.
Methods: Standards were identified using the National Institute for
Health and Care Excellence (NICE) guidance and UK Medicines infor-
mation. Standards included access to annual specialist review, use of an
optimized anticonvulsant regimen, information provision regarding res-
cue medications, restrictions on duties or cell arrangements. The audit
was conducted in one of the largest category B prisons in the UK (A
closed prison for individuals who although not requiring maximum secu-
rity, are considered to be a risk to the public). Fifty five prisoners with a
diagnosis of epilepsy were identified during the audit period. Anon-
ymised audit data was collected using face to face interviews using a
standardized data collection proforma.
Results: Our findings highlight some unique demographics of prisoners
within the epilepsy patient population. There was an increased frequency
of adult seizure onset. 81.8% had a history of recent illicit drug misuse;
this has important implications for both seizure control and prescribing,
as Benzodiazepines and Pregabalin have high rates of diversion in prison
settings. Further optimization of anticonvulsant regimen was required in
67.3% of the study sample and only 14.5% of participants had been sei-
zure free for the last 12 months. This emphasized the need for regular
specialist review; just 37% of participants had been reviewed in the last
12 months. Regular, timely delivery of anticonvulsant medication had
been difficult in 43.6% of cases; reasons for this were multifactorial.
Rates of provision of safety information relevant to epilepsy ranged from
12.7% (cell arrangements) to 67.3% (Driving).
Conclusion: We are currently looking at ways to implement a compre-
hensive overhaul of epilepsy care in UK prison settings.
p0118
NEURONALAUTOANTIBODIES ARE INFREQUENTLY
ASSOCIATEDWITHMESIAL TEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS
A.W. Nobrega-Jr*, C.P. Gregory*, R. Schlindwein-Zanini*,
P. Wolf*,†, M. Steindel*, K. Lin*
*Federal University of Santa Catarina, Florianopolis, Brazil,
†Danish Epilepsy Centre, Dianalund, Denmark
Purpose: The occurrence of epileptic seizures is often the result of multi-
factorial mechanisms. In many epilepsy syndromes the etiology is little
known. However, in recent years, autoantibodies against neuronal sur-
face proteins and synaptic proteins have been detected in patients with
epilepsy without signs of previous encephalitis, including epilepsies pre-
viously said of unknown cause. Mesial temporal lobe epilepsy with hip-
pocampal sclerosis (MTLE-HS) is characterized by its well-defined
clinical profile, and its refractoriness. Limbic encephalitis (LE) is
increasingly recognized as a precipitating factor of adult onset MTLE-
HS. Some series have reported up to half theMTLE-HS patients with evi-
dence consistent with an autoimmune process. The aim of this study is to
analyze the prevalence of specific autoantibodies in a group of patients
with definite diagnosis of MTLE-HS.
Method: A cross-sectional study was carried out with 66 consecutive
patients and 16 healthy controls. All patients fulfilled Wieser´s criteria
for MTLE-HS. Clinical and demographic data were obtained. Blood was
collected from patients and controls and serum was stored at -80o Celsius
for subsequent analysis. Indirect immunofluorescence was performed for
detection of the following autoantibodies: anti-NMDA receptor, anti-
CASPR2, anti-LGI1, anti-GABA-B receptor, anti-AMPA-1 receptor and
anti-AMPA-2 receptor.
Results: Patients´mean age was 41.1 (11.6) years and of controls, 40.2
(13.6) years. As to gender, 57.6% of patients and 62.5% of controls
were female. Mean duration of epilepsy was 28.1 (13.4) years. Neu-
ronal autoantibodies were not found in both groups.
Conclusion: This study indicates that MTLE-HS may be infrequently
associated with the presence of the mentioned neuronal autoantibodies,
despite the fact that one recent study had shown the opposite. This is an
ongoing project and the presented results are preliminary.
p0120
COULDADULTTEMPORAL LOBEEPILEPSY
PREDICT COGNITIVEDECLINE?
V. Adell Ortega*, S. Jaraba*, J. Miro*, M. Juncadella†,
J. Campdelacreu‡, J. Gascon‡, R. Re~ne‡, C. Gamez§,
A. Mauleon¶, M. Falip*
*Bellvitge University Hospital, Epilepsy Unit, Hospitalet de
Llobregat, Spain, †Bellvitge University Hospital,
Neuropsychology Department, Hospitalet de Llobregat, Spain,
‡Bellvitge University Hospital, Dementia Care Unit, Hospitalet
de Llobregat, Spain, §IDI Image Diagnosis Institute, PET
Department, Hospitalet Llobregat, Spain, ¶ACE Foundation
Barcelona Alzheimer Treatment and Research Center,
Neurology, Barcelona, Spain
Purpose: Prevalence of dementia in the Spanish population is age
dependent, been approximately 10% at ≥ 70 years. Little is known about
how many dementia patients can suffer seizures at onset. In addition, the
prevalence of dementia in epileptic patient is uncertain. Our puporse is to
evaluate cognitive decline in adult onset temporal lobe epilepsy (A-TLE)
and related risk factors.
Method: Retrospectively selected A- TLE patients visited in our outpa-
tient department between May 2014–May 2015, older than 30 years, epi-
lepsy onset ≥ 30 years, and follow up of ≥ 5 years. We excluded rapidly
progressive dementia. We recoded clinical information, neuropsycholog-
ical tests, paraclinical tests (autoimmunity tests, cerebral IRM, FDG-
PET, and cerebral SPECT) and clinical and/ or neuropsychological evi-
dence of dementia and mild cognitive impairment (MCI). We defined
dementia as a multidomain dysfunction includingmemory severe enough
to interfere with daily life and MCI as a memory dysfunction (1SD bel-
low general population) not related to epilepsy focus. The aetiologies
were grouped: (1) vascular/ brain trauma, (2) low grade tumour/cortical
malformation, (3) CNS infection, (4) autoimmune epilepsy, (5)
unknown.
Results: We included 87 A- TLE. 47 were women (54%), median age
was 68 years (SD 10) and median time of epilepsy duration was 20 years
(SD 11). Developed dementia 15/87 (17%) patients and 16% had MCI.
A- TLE patients with dementia were older than patients without dementia
(75 vs. 66). The age at epilepsy onset and the disease duration were not
different. Were seizure- free 9/15 (60%) A-TLE patients with dementia .
The unknown group had the greater frequency of dementia 11/51
(21.6%) and the tumour group the lowest (0/7 patients) but without sig-
nificant statistical differences.
Conclusion: 1. High proportion of patients with A-TLE will develop
dementia. 2. Cryptogenic A-TLE should be screened or follow up care-
fully for cognitive decline.
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EFFECTOFLACOSAMIDEONEPILEPTIFORM
ACTIVITY INDUCED INHUMANNEOCORTICAL AND
HIPPOCAMPAL SLICES
S.Z. Reyes Garcia*,†, N.N. Ortiz Villatoro*, N. Araujo*,
L. Freitas Oliveira*, L. Damasceno Rodriguez*, J. Faber*,
C. Scorza*, R. Centeno*, E.M. Yacubian Targas*,
E. Cavalheiro*
*Universidade Federal de S~ao Paulo, Neurologia/
Neurocirurgia, S~ao Paulo, Brazil, †Universidad Nacional
Autonoma de Honduras, Ciencias Morfologicas, Tegucigalpa,
Honduras
Purpose: To assess the anticonvulsant effects of the antiepileptic drug
lacosamide on epileptiform activity induced in human neocortical and
hippocampal slices.
Method: This study was performed on surgically resected hippocampal
and neocortical tissue of 11 patients with drug-resistant temporal lobe
epilepsy (TLE). Using in vitro electrophysiology technique, the extracel-
lular field potentials were recorded in the granular cell layer of the den-
tate gyrus. A total of 78 slices were studied. The epileptiform activity
was induced in the hippocampus with 10–12 mM [K+] + electrical stim-
uli, in neocortex with 8 mM [K+] + 50 μM of bicuculline methiodide.
The activity was evaluated in 3 epochs, induction, drug application and
washout, each one with a duration of 20–25 min. Control value was
determined in other set of experiments as the mean of induction and
washout epoch recording on slices which lacosamide was not applied.
Results: Lacosamide therapeutic concentration (40 μM) shown
decrease effect on selizure-like events (SLE) induced with high potas-
sium protocol. Prolongation application of lacosamide (40 min) and
increase of dose concentration (80 μM) improved the antiepileptic effect,
however, the epileptiform activity under lacosamide application only
was reduced but never suppressed, the effect was observed affecting the
amplitude, duration and number of epileptiform events. Lacosamide also
was assessed in combination with other antiepileptic drugs such as carba-
mazepine and levetiracetam, nevertheless, the effect on SLE was not
enhanced and a marked reduction on the epileptiform activity only was
observed when lacosamide was applied.
Conclusion: The results indicate the potential of lacosamide in decrease
epileptiform activity induced in human neocortical and hippocampal tis-
sue. These results support the therapeutic possibility of use lacosamide in
refractory temporal lobe epilepsy in cases where the surgery not be possi-
ble.
p0131
NAV1.2 IS EXPRESSED INREELIN-POSITIVE
INTERNEURONS
K. Yamakawa*, T. Yamagata*
*RIKEN Brain Science Institute, Neurogenetics, Wako-shi,
Japan
Purpose: Mutations of SCN2A gene encoding voltage-gated sodium
channel alpha-2 subunit Nav1.2 have been found in patients with a wide
spectrum of epilepsies, intellectual disability and autism. To understand
the basic physiological role of Nav1.2, here we investigated the detailed
expression of Nav1.2 in mouse brain.
Method: Immunohistochemical investigation of Nav1.2 were performed
in mouse brain tissues with multiple developmental stages.
Results: In addition to unmyelinated fibers such as mossy fibers of hip-
pocampal granule cells, axons of striatal medial spiny neurons, cerebellar
parallel fibers, in early developmental stages major Nav1.2 immunosig-
nals were observed in myelinated axonic features of excitatory neurons
including cortical and hippocampal pyramidal cells. Of interest, neocorti-
cal and hippocampal reelin-positive somatostatin-negative interneurons
were also positive for Nav1.2 at those stages.
Conclusion: We for the first time showed that Nav1.2 is expressed in
neocortical and hippocampal reelin-positive somatostatin-negative
interneurons. This would contribute to understanding of the pathology of
patients with SCN2Amutations.
p0133
ANALYSIS OF IONCHANNEL PROPERTIES AND
RHYTHMICOSCILLATORYACTIVITY IN THE
THALAMOCORTICAL SYSTEMFOLLOWING
DEMYELINATION
R. Chaudhary*, T. Budde*
*Westf€alische Wilhelms-Universit€at, Physiology 1, M€unster,
Germany
Purpose: To understand the interaction between demyelination, inflam-
mation and the prevalence of seizure we used a mouse model of thalamo-
cortical epilepsy in combination with demyelination and application of
pro-inflammatory cytokines INF-a and IL-1b. We performed recordings
in C57BL/6J wild type, C3H/HeJ (absence epilepsy model) and cupri-
zone treated C3H/HeJ mice having acute demyelination.
Method: Network Oscillatory activity: 400 μm thick horizontal brain
slices were prepared and rhythmic burst activity was induced by stimulat-
ing the internal capsule using tungsten electrode and measuring the net-
work activity in the ventrobasal complex (VB) of thalamus using glass
electrode.Whole cell patch clamp: a. Voltage clamp recordings were per-
formed to study Ih current carried by hyperpolarization activated cyclic
nucleotide gated (HCN) channels. 300 μm thick coronal brain slices
were prepared. Thalamic relay neurons of VB were held at a holding
potential of -40 mV and voltage steps were applied with an increment of
-10 mV until -130 mV. b. To study firing pattern current clamp record-
ings were performed. It consisted of hyperpolarizing and depolarizing
current steps with fixed increments which led membrane potential rang-
ing from -100 mV to a potential saturated by action potentials.
Results: INF-a decreased Ih current density, hyperpolarized half maxi-
mal activation (H.M.A) of HCN channels, decreased rhythmic burst
activity in C57BL/6J, C3H control and Cuprizone treated C3H mice.
INF-a hyperpolarized resting membrane potential (R.M.P)
(-3.83  1.03 mV) and decreased tonic firing in C57BL/6J. IL-1b
decreased Ih current density (3.2  1.2 pA), hyperpolarized H.M.A
(-2.5  0.8 mV), depolarized R.M.P (-1.69  0.61 mV) and increased
low threshold calcium spikes (LTS) in C57BL/6J. IL-1b increased rhyth-
mic burst activity in C57BL/6J and C3H control mice. Demyelination
decreased rhythmic bursts and hyperpolarized R.M.P.
Conclusion: Our findings suggest that pro-inflammatory cytokines may
cause improper functioning of HCN channels and can have modulatory
effects on excitatory activities of thalamic relay neurons thus affecting
thalamocortical activity.
p0134
IMPAIRED BAROREFLEX SENSITIVITYAFTER
BILATERALCONVULSIVE SEIZURES IN PATIENTS
WITH FOCALEPILEPSY
K. Hampel*, C. Elger†, R. Surges†
*University Hospital La Fe, Multidisciplinary Epilepsy Unit
Neurology Service, Valencia, Spain, †University Hospital,
Department of Epileptology, Bonn, Germany
Purpose: In the majority of cases, SUDEP is probably due to an auto-
nomic failure in the early phase after bilateral convulsive seizures (BCS).
The baroreflex sensitivity (BRS) is one of the most robust biomarker for
autonomic function and sudden cardiac death. Here we investigate
whether postictal BRS depends on seizure type.
Method: Systemic blood pressure and heart rate were continuously and
non-invasively recorded with the ccNexfin device in patients with focal
epilepsy undergoing video-EEG telemetry. BRS was calculated using
two methods (sequence and spectral method). A random mixed-effect
linear model was applied to analyze the influence of seizure type on BRS
during three different time periods of 15-min length each (interictal, pre-
ictal and postictal). In addition, possible influencing factors such as
hypertension, hemispheric lateralization of ictal activity, body position
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and vigilance state were included into the model. Data are given as med-
ian with the interquartile range.
Results: A total of 26 seizures of 26 patients were analyzed. In BCS
(n = 7), BRS significantly dropped from a preictal value of 15.0 ms/mm
Hg (13.0 to 19.4) and an interictal value of 15.6 ms/mmHg (12.0 to 20.4)
to 3.1 ms/mm Hg (2.7 to 10.5) during the postictal period (p < 0.0001)
according to the sequence method. This finding was also replicated with
the spectral method. In contrast, focal seizures (n = 19) did not lead to
significant alterations of BRS during the postictal phase.
Conclusion: Postictal BRS depends on seizure type and is substantially
impaired after BCS. Our study provides further evidence for disturbed
autonomic function following BCS. These findings might be related to
cardiovascular failure facilitating SUDEP.
p0138
NR4A1 KNOCKDOWNSUPPRESSES SEIZURE
ACTIVITY BYREGULATING SURFACE EXPRESSION
OFNR2B
Y. Zhang*, W. Xuefeng†
*Chongqing Medical University, Chongqing, China, †First
Affiliated Hospital, Chongqing Medical University, Department
of Neurology, Chongqing, China
Nuclear receptor subfamily 4 group A member 1 (NR4A1), a down-
stream target of CREB that is a key regulator of epileptogenesis, has been
implicated in a variety of biological processes and was previously identi-
fied as a seizure-associated molecule. However, the relationship between
NR4A1 and epileptogenesis remains unclear. Here, we showed that
NR4A1 protein was predominantly expressed in neurons and up-regu-
lated in patients with epilepsy as well as pilocarpine-induced mouse
epileptic models. NR4A1 knockdown by lentivirus transfection (lenti-
shNR4A1) alleviated seizure severity and prolonged onset latency in
mouse models. Moreover, reciprocal coimmunoprecipitation of NR4A1
and NR2B demonstrated their interaction. Furthermore, the expression of
p-NR2B (Tyr1472) in epileptic mice and the expression of NR2B in the
postsynaptic density (PSD) were significantly reduced in the lenti-
shNR4A1 group, indicating that NR4A1 knockdown partly decreased
surface NR2B by promoting NR2B internalization. These results are the
first to indicate that the expression of NR4A1 in epileptic brain tissues
may provide new insights into the molecular mechanisms underlying
epilepsy.
p0139
PHYSICAL EXERCISE DURING PREGNANCY
ATTENUATES THENEGATIVE EFFECTSOF PTZ-
INDUCED SEIZURES INOFFSPRING FROMMOTHERS
SUBMITTED TOPRENATAL STRESS
G.M. Lopim*, E. Alves da Silva*, D. Vannucci Campos*,
R.M. Arida*
*Universidade Federal de S~ao Paulo/Escola Paulista de
Medicina UNIFESP/EPM, Neurologia/Neurocie^ncias, S~ao Paulo,
Brazil
Purpose: Prenatal stress is one important factor that can interferes on
brain development and affects the susceptibility of the developing brain
to epilepsy. Studies have shown that exercise during pregnancy has a pos-
itive influence on brain function in the offspring. Thus, physical exercise
contributes to reduce seizure susceptibility before brain insult and seizure
frequency in the chronic epilepsy condition. Although there are studies
which highlight the deleterious influence of stress during pregnancy on
offspring behavioral and seizure susceptibility, very little is known about
how to minimize these negative effects. This work aimed to verify
whether physical exercise during pregnancy in mothers submitted to pre-
natal stress minimizes offspring seizure susceptibility in the beginning of
postnatal development.
Method: Pregnant rats were divided into the following groups: control
(n = 6); exercise (treadmill) (n = 5); stress (restraint) (n = 5); exercise/
stress (n = 5). Male pups were used and divided into the following
groups: control (n = 34); exercise (n = 31); stress (n = 31) and exercise/
stress (n = 35). The threshold for first motor manifestation and seizures
severity after a unique dose of pentylenetetrazole (PTZ) (45 mg/kg) were
analyzed at two distinct ages (P15 and P25).
Results: A reduction in the threshold for first motor manifestation was
observed in the stress group compared to control group for both ages
(P15 and P25, p < 0.001) and physical exercise increased this threshold
compared to exercise/stress group (P15 p < 0.001 and P25 p < 0.05). A
reduction of seizures severity was noted in exercise/stress group com-
pared to stress group at P15 (p < 0.05). No significant difference in sei-
zures severity was observed among stress and exercise/stress groups at
P25.
Conclusion: Our findings demonstrate that physical exercise during
pregnancy attenuates the negative effects of PTZ-induced seizures in off-
spring frommothers submitted to prenatal stress.
p0144
IN VITROANTINEOPLASTIC EFFECTSONHUMAN
GLIOBLASTOMACELLSOF LACOSAMIDEAND
BRIVARACETAM
M.Maschio*, A. Rizzo†, S. Donzelli‡, V. Girgenti†, A. Sacconi‡,
C. Vasco†, A. Salmaggi§, G. Blandino‡, E. Ciusani†
*Regina Elena National Cancer Institute, Center for Tumor-
Related Epilepsy - UOSD Neurology, Rome, Italy, †Besta
Neurologic Institute, Clinical Pathology and Medical Genetic
Laboratory, Milano, Italy, ‡Regina Elena National Cancer
Institute, Oncogenomic and Epigenetic Unit, Rome, Italy,
§Hospital Manzoni, Stroke Unit - Dipartment of Neurology,
Lecco, Italy
Purpose: Epilepsy is a frequent symptom in patients with glioma.
Although treatment with antiepileptic drugs is generally effective in con-
trolling seizures, drug resistant patients are not uncommon. Multidrug
resistance proteins (MRPs) and P-gp are over-represented in brain tissue
of patients with drug-resistant epilepsy, suggesting their involvement in
the clearance of antiepileptic medications. In addition to their anticonvul-
sant action, some drugs have been documented for cytotoxic effects. Aim
of this study was to evaluate possible in vitro cytotoxic effects of two
new-generation antiepileptic drugs on a human glioma cell line U87MG.
Method: Cytotoxicity of brivaracetam and lacosamide was tested on
U87MG, SW1783 and T98G by MTS assay. Expression of chemoresis-
tance molecules was evaluated using flow cytometry in U87MG and
human umbilical vein endothelial cells (HUVECs). To investigate the
putative anti-proliferative effect, apoptosis assay, microRNA expression
profile and study of cell cycle were performed.
Results: Brivaracetam and lacosamide showed a dose-dependent cyto-
toxic and antimigratory effects. Cytotoxicity was not related to apoptosis.
The exposure of glioma cells to brivaracetam and lacosamide resulted in
the modulation of several microRNAs; particularly, the effect of miR-
195-5p modulation seemed to affect cell cycle, while miR-107 seemed to
be implicated in the inhibition of cells migration. Moreover, brivarac-
etam and lacosamide treatment did not modulate the expression of
chemoresistance-related molecules MRPs1-3-5, GSTp, P-gp on U87MG
and HUVECs.
Conclusion: Based on antineoplastic effect of brivaracetam and lacosa-
mide on glioma cells, we assume that patients with glioma could benefit
by the treatment with these two molecules, in addition to standard thera-
peutic options.
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ABLATIONOFNEWBORNGRANULECELLS AFTER
EPILEPSYONSETHALTS DISEASE PROGRESSION
B. Hosford, J. Liska, S. Danzer
Cincinnati Children’s Hospital, Cincinnati, OH, United States
Purpose: Aberrant integration of newborn hippocampal granule cells is
hypothesized to contribute to the development of temporal lobe epilepsy.
To test this hypothesis, we used a transgenic mouse model system to
selectively ablate these cells from the epileptic mouse brain. If these cells
promote epileptogenesis, then ablation should be therapeutic.
Method: Epileptogenesis was initiated using the pilocarpine status
epilepticus model. Diphtheria toxin receptor production was driven in
Nestin-expressing granule cell progenitors using a tamoxifen-inducible
mouse model system. Granule cells born shortly before and after the
insult were targeted; the population known to underlie dentate dysmor-
phogenesis. Continuous EEG monitoring was begun 2–3 months after
pilocarpine treatment. Four weeks into the EEG recording period, at a
time when spontaneous seizures were frequent, mice were treated with
diphtheria toxin to ablate newborn cells. Monitoring continued for
another month following ablation.
Results: Ablation halted epilepsy progression relative to untreated
epileptic mice; the latter showing a significant and dramatic 300%
increase in seizure frequency in the post-treatment period. This increase
was prevented in treated mice. Ablation did not, however, cause an
immediate reduction in seizures, suggesting that newborn cells mediate
epileptogenesis, but that seizures per se are initiated elsewhere in the cir-
cuit.
Conclusion: These findings demonstrate that targeted ablation of new-
born granule cells can produce a striking improvement in disease course,
and that the treatment can be effective when applied months after disease
onset. This latter observation suggests that the treatment window for dis-
ease modifying therapy may extend for months beyond the initial insult.
p0149
ROLEOF INTER-ICTALDISCHARGESL: INITIATING
ORDELAYING SEIZURES?
J. Hlinka*,†, M. Hadrava*,†,‡, P. Jiruska§
*Institute of Computer Science, Czech Academy of Sciences,
Prague, Czech Republic, †National Institute of Mental Health,
Klecany, Czech Republic, ‡Czech Technical University in
Prague / Faculty of Electrical Engineering, Prague, Czech
Republic, §Institute of Physiology, Czech Academy of Sciences,
Prague, Czech Republic
Purpose: Experimental observations provide contradictory evidence
concerning the role of inter-ictal discharges with respect to the seizure
dynamics. Two competing mechanisms have been proposed: either a pro-
convulsive role by initiation of seizures, or anti-convulsive role mani-
fested as longer inter-seizure intervals when inter-ictal discharges are
present.
Method: To explore possible mechanisms behind the observed phenom-
ena, we build a phenomenological mathematical model of the switching
between bistable high-firing (seizure) and low-firing neural population
state, that is driven by changes in global excitability. The excitability
dynamics entail a steady slow increase during the low-firing state and a
decreasing tendency during the seizure state.
Results: The dynamics give rise to periodic switching between the
model inter-ictal and ictal state. External perturbation to the mean poten-
tial variable can lead to both initiation and delay of seizures, based on the
timing and parameters of the perturbation. We further extend the study
by exploring whether similar dual mechanism of perturbation can be
demonstrated in more realistic computation models of epilepsy.
Conclusion: Using computational models of seizure generation, we have
demonstrated the possible dual role of inter-ictal discharges in seizure
initiation: both pro-convulsive and anti-convulsive, depending on the
timing and parameters of the perturbations.
p0150
EFFECTSOFRO 53-1908 ANDRO 04-5595
INTRAHIPPOCAMPALMICROPERFUSIONONTHE
PICROTOXIN SEIZURETHRESHOLD IN FREELY
MOVINGRATS
M. Fernandez-Garcıa*, A.R. €Alvarez*, P. Brea-Rivas*,
G. Sierra-Paredes†
*University of Santiago de Compostela, Santiago de
Compostela, Spain, †University of Santiago de Compostela,
Biochemistry and Molecular Biology, Santiago de Compostela,
Spain
Purpose: The role of NR2B-containig NMDA receptors in the develop-
ment of epileptic seizures is not yet well stablished. On kindling and pilo-
carpine animal models, activation of NR2A-, but not NR2B-, containing
NMDARs seems to be required for epileptogenesis. However, treatment
with highly selective antagonists of NMDA receptors containing the
NR2B subunit has been shown to reduce on the incidence of seizures on
several animal models. We have investigated the anticonvulsant effect of
the intrahippocampal microperfusion of Ro 53-1908 and Ro 04-5595,
two NR2B-containig NMDA receptor antagonists on seizure threshold in
picrotoxin-induced seizures in awake, freely moving rats.
Method: We used a CMA/120 system for freely moving animals. Rat
hippocampus was perfused with ringer fluid or 200 μg/ml Ro 53-1908 or
Ro 04-5595 dissolved in ringer fluid through CMA/12 microdialysis
probes during 3 h, with continuous EEG and videotape recording. After
2 h, a picrotoxin solution (100–300 μM) was perfused during 5 min. We
evaluated the lower picrotoxin concentration needed to induce a seizure
and the total seizure duration by Student’s T test.
Results: Perfusion of Ro 53-1908 or Ro 04-5595 alone at the concentra-
tions studied did not induce changes in the basal EEG. However, both Ro
53-1908 and Ro 04-5595 increased picrotoxin seizure thresholds in the
100% of the animals studied. Ro 53-1908 prevented seizures at picro-
toxin threshold level in in the 100% of the rats studied, while Ro 53-1908
prevented seizures at picrotoxin threshold level in in the 80% of the ani-
mals.
Conclusion: Our results show that treatment with highly selective antag-
onists of NMDA receptors containing the NR2B subunit prevent picro-
toxin-induced seizures when perfused into the rat hippocampus with no
observable toxic effects. The NMDA receptor NR2B subunit remains an
attractive target for potential antiepileptic drugs.
p0152
THE IPSC-DERIVEDNEURONSMADE BY 2
UNRELATED PROTOCOLSCURRENTLYUSED FOR
EPILEPTIC ENCEPHALOPATHYMODELINGREVEAL
DISTINCTIVE ELECTROPHYSIOLOGY FEATURES
F. Rosa*, N. Schwarz*, H. L€offler*, H. Lerche*, S. Maljevic*,†
*Hertie Institute for Clinical Brain Research, Experimental
Epileptology, T€ubingen, Germany, †Florey Institute, University
of Melbourne, Ion Channels and Human Diseases Laboratory,
Melbourne, VIC, Australia
Purpose: The growing number of genes related to epileptic encephalo-
pathies imposes the increased demand for the functional verification of
detected variants and simultaneously for pathophysiological explana-
tions. While the first task is sufficiently addressed in heterologous
expression systems, the second is more challenging, with the restrictions
introduced by unique human biology. Use of human induced pluripotent
stem cells (hiPSC)-derived neurons can overcome the stated problem.
However, little is known about the mechanisms of neuronal in vitro matu-
ration based on the use of different differentiation protocols. Therefore,
we investigated two different approaches aiming to match the derived
neurons to the particular phases of neuronal development and thus to
increase their relevance for disease modeling.
Method: hiPSC-derived neurons were generated using two differentia-
tion protocols, transgenic overexpression of NGN2 and embryoid body-
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based SMAD inhibition. The single cell electrophysiology was used to
assess the maturity of the differentiated neurons.
Results: NGN The2 based protocol provided homogenous populations
of firing neurons in less than three weeks of differentiation. In contrast,
embryoid body procedure required about three months to produce reli-
ably firing populations of neurons, often including cells at the different
stages of maturity. Amore precise look into passive membrane character-
istics including capacitance and input resistance, active membrane char-
acteristics such as sodium and potassium currents, or single-cell firing
and spontaneous network activity revealed significant differences
between the two protocols. NGN The2-derived neurons presented with
activity resembling early phases of neuronal development and were lack-
ing synaptic activity, while more mature neuronal and synchronized net-
work activity, resembling the activity of cortical neurons of human
foetus/newborn were found for the embryoid body-derived neurons.
Conclusion: We suggest that the observed differences in neuronal and
network maturity should be taken into consideration when designing
epileptic encephalopathy human in vitro models in order to match timing
of disease manifestation to the relevant neuronal maturity.
p0153
WHOLEGENOME SEQUENCINGTHEGENETIC
ABSENCE EPILEPSYRAT FROMSTRASBOURG, ITS
RELATEDNON-EPILEPTIC STRAINAND F THEIR2
PROGENY
P.M. Casillas-Espinosa*, K. Powell*, M. Zhu†, N. Jones*,
T. O’Brien*, S. Petrovski*,‡
*The University of Melbourne, Department of Medicine,
Parkville, VIC, Australia, †Duke University School of Medicine,
Duke University, Durham, NC, United States, ‡Institute for
Genomic Medicine, Columbia University Medical Center.
Columbia University, New York, NY, United States
Purpose: The Genetic Absence Epilepsy Rats from Strasbourg
(GAERS) are an inbreed Wistar rat strain widely used as a model of
genetic generalised epilepsy with absence seizures. As in humans, the
genetic architecture that results in genetic generalized epilepsy in
GAERS is poorly understood. Here we present the strain-specific variants
found among the epileptic GAERS and their related Non-Epileptic Con-
trol (NEC) strain. The GAERS and NEC represent a powerful opportu-
nity to identify neurobiological factors that are associated with the
genetic generalised epilepsy phenotype.
Method: We performed whole genome sequencing on GAERS and NEC
rats, a strain derived from the same original Wistar. We also generated
whole genome sequencing on four GAERS and NEC F2 selected for
high-seizing (n = 2) and non-seizing (n = 2) phenotypes.
Results: Specific to the GAERS genome, we identified 1.12 million sin-
gle nucleotide variants, 296.5K short insertion-deletions, and 1,457 puta-
tive copy number variants that result in complete or partial loss/
duplication of 65 genes. Based on overlaps with Mouse Genome Infor-
matics only two NEC strain-specific non-intronic CNVs were identified:
Kcnj6 (GIRK2) and Scn8a (NaV1.6). Subsequent screening against the
two F2 progeny sequenced for having the highest and two F2 progeny for
having the lowest seizure burden identified only the selected Cacna1 h
GAERS-private protein-coding variant as exclusively co-segregating
with the two high-seizing F2 rats. In the NEC, filtering of the specific
variants were found in genes that have been associated with epilepsy and
segregate with the two non-seizing F2 rats; Abat (4-aminobutyrate
aminotransferase), Cyp11b3 (11-beta-hydroxylase) and Cyp11b (aldos-
terone synthase).
Conclusion: This study highlights an approach for using whole genome
sequencing to narrow down to a manageable candidate list of genetic
variants in a complex genetic epilepsy animal model, and suggests utility
of this sequencing design to investigate other spontaneously occurring
animal models of human disease.
p0155
ANTI-OXIDANT INTERVENTIONDURING
EPILEPTOGENESIS DELAYSDISEASEONSETAND
BLOCKS ITS PROGRESSION INARATMODELOF
ACQUIRED EPILEPSY
A. Salamone*, G. Terrone*, A. Pauletti†, T. Shekh-Ahmad‡,
T. Ravizza*, M. Rizzi*, A. Pastore§, R. Pascente*, L.-P. Liang¶,
B. Villa*, S. Balosso*, A. Abramov‡, E. van Vliet**,
E. Aronica**,††, D. Antoine‡‡, M. Patel¶, M. Walker‡,
A. Vezzani*
*IRCCS-Mario Negri Institute for Pharmacological Research,
Department of Neuroscience, Milan, Italy, †University of Bonn,
Institute of Cellular Neurosciences, Bonn, Germany, ‡University
College London, Department of Clinical and Experimental
Epilepsy, London, United Kingdom, §Bambino Gesu’ Children’s
Hospital, IRCCS, Metabolomics and Proteomics Unit, Rome,
Italy, ¶University of Colorado, Department of Pharmaceutical
Sciences, Denver, CO, United States, **University of
Amsterdam, Department of (Neuro)Pathology, Academic
Medical Center, Amsterdam, Netherlands, ††Stichting Epilepsie
Instellingen Nederland, Amsterdam, Netherlands, ‡‡University
of Liverpool, MRC Centre for Drug Safety Science, Department
of Molecular & Clinical Pharmacology, Liverpool, United
Kingdom
Purpose: We studied the role of oxidative stress generated during
epileptogenesis in the onset and progression of epilepsy and whether
anti-oxidant drugs in medical use display therapeutic effects in a rat
model of acquired epilepsy.
Method: We studied oxidative stress during epileptogenesis in rats
exposed to electrically provoked status epilepticus (SE), a model associ-
ated with progressive seizures, cell loss and cognitive deficits. We mea-
sured GSSG/GSH levels in the hippocampus by HPLC and analyzed
oxidative stress markers (Nrf2, iNOS, Xct) by immunohistochemistry.
We also measured brain and plasma levels of disulfide HMGB1 by
LC-MS/MS since this neuroinflammatory molecule is sensitive to the
redox state and its oxidized (disulfide) isoform is implicated in seizures.
We tested the effects of N-acetyl-cysteine (NAC) and sulforaphane
(SFN), two anti-oxidant drugs in medical use -administered intraperi-
toneally 1 h post-SE for 2 weeks- on ROS production, HMGB1 oxida-
tion, and seizure onset and their progression by EEG analysis. Cognitive
deficits were assessed in the T maze and hippocampal neuronal death
was quantified by immunohistochemistry.
Results: The combined drugs decreased oxidative stress more efficiently
than each drug alone, and decreased the brain and blood generation of
disulfide HMGB1. As compared to vehicle-injected rats, the treatment
delayed the onset of spontaneous seizure (8.6  0.7 vs. 11.7  1.1 days,
n = 9, p < 0.01), blocked the 5-fold progression in the number of sei-
zures and reduced chronic spontaneous seizures by 70%
(p < 0.05). Drugs prevented the cognitive deficit and the loss of calre-
tinin-positive hilar interneurons and reduced CA1 pyramidal cells degen-
eration.
Conclusion: Reduction of oxidative stress during epileptogenesis with
medically used drugs delays disease onset and blocks its progression, and
is neuroprotective. This intervention should be considered for patients
exposed to potential epileptogenic insults.
p0160
FURTHEREVIDENCE FORADIFFERENTIAL SITEOF
ACTIONOF THEANTICONVULSANTS
BRIVARACETAMANDLEVETIRACETAMONTHE
SV2A PROTEIN
M.Wood*, Z. Sands*, F. Lebon*, M. Gillard*
*UCB Pharma, Braine l’Alleud, Belgium
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Purpose: Brivaracetam (BRV) and levetiracetam (LEV) are antiepilep-
tic drugs which interact with the synaptic vesicle 2A (SV2A) protein.
BRV differs from LEV in exhibiting more potent and complete seizure
suppression in animal models of epilepsy. We showed that an SV2A
modulator had a differential effect on the binding of [3H]BRV compared
to [3H]LEV.1 Thus, the modulator potentiated [3H]BRV binding mainly
by increasing affinity (Kd), but potentiated [
3H]LEV binding by increas-
ing binding capacity (Bmax). This suggested that BRV and LEV act at dif-
ferent sites or in a different way with the SV2A protein. We therefore
hypothesised that mutation of specific amino acid residues in the SV2A
protein may have a differential effect on this modulation.
Method: Based on modelling studies,2,3 several mutants were selected.
Saturation studies were performed using [3H]-LEV and -BRV in the pres-
ence and absence of the modulator in membranes from HEK293 cells
expressing human SV2A protein.
Results: A number of mutations reduced both [3H]BRV and [3H]LEV
binding (e.g. W300F; F277A; V661A; W666A; D670A). However,
mutation of two residues (S294A and I273A) had no effect on potentia-
tion of [3H]BRV binding by the modulator, but blocked potentiation of
[3H]LEV binding.
Conclusion: We have identified two residues which have a differential
effect on the modulation of [3H]BRV binding compared to that of [3H]
LEV, providing further evidence that BRV and LEV interact at different
sites on the SV2A protein. These two residues have previously been
shown to differentiate different chemical classes of SV2A ligand. This
suggests that BRV and LEV interact at closely overlapping yet distinct
sites on the SV2A protein, which may correlate with their different phar-
macological profiles.4UCB-supported
1.WoodMD, GillardM. Epilepsia 2017;58(2):255262.
2. Lee J, et al. PLoS One 2015;10(2):e0116589.
3. Shi J, et al. Biochem Soc Trans 2011;39(5):13411347.
4. Klitgaard H, et al. Epilepsia 2016;57(4):538548.
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ELECTROCLINICAL FEATURESOFNON-LESIONAL
ESES/CSWSASSOCIATEDWITHGENETIC
MUTATIONS
E. Gardella*,†, D. Terney*, D. Brix Kjelgaard‡, K. Olofsson§,
M.S. Petersen Khinchi§, M. Nikanorova†,§, S. Beniczky*,¶,
G. Rubboli**,††, S.R. Møller†,‡
*Danish Epilepsy Centre, Department of Clinical
Neurophysiology, Dianalund, Denmark, †University of Southern
Denmark, Odense, Denmark, ‡Danish Epilepsy Centre,
Dianalund, Denmark, §Danish Epilepsy Centre, Department of
Child Neurology, Dianalund, Denmark, ¶Arhus University,
Arhus, Denmark, **Danish Epilepsy Centre, Department of
Neurology, Dianalund, Denmark, ††University of Copenhagen,
Copenhagen, Denmark
Purpose: Encephalopathy with continuous spike and waves during sleep
(ESES or CSWS) is an age-related disorder, characterized by seizures,
cognitive regression and continuous and diffuse spike-and-waves during
NREM-sleep. Atypical EEG patterns (focal/multifocal) have been also
reported. (Tassinari et al, 2012) GRIN2A and recently CNKSR2 have
been proposed as ESES genes. We describe our series of non-lesional
ESES/CSWS associated with genetic mutations.
Methods: We reviewed the electroclinical data of patients with ESES/
CSWS recorded at the Danish Epilepsy Centre, selecting those with
genetic testing (gene panel, exome sequencing or array CGH). All sub-
jects underwent repeated clinical examination, neuropsychological tests
and twenty-four-hours-EEG recordings.
Results: 47 patients underwent genetic testing; all had normal cerebral-
MRI. They were classified as idiopathic (25 patients) or cryptogenic (22
patients) ESES, depending on their neurocognitive status before ESES
onset (normal or abnormal). In 8 subjects (17%) a pathogenic genetic
mutation was found in the following genes: (1) GRIN2A (2 patients),
PRRT2, HUWE1 for idiopathic ESES and (2) KCNA2, SCN2A,
SCL6A1 and dupl.15q11 for cryptogenic ESES. The mean age at ESES
diagnosis was earlier in idiopathic than in cryptogenic cases (4.3 vs.
5.5 years). In all cases, the EEG pattern was atypical (focal/multifocal)
and the maximum SWI (spike-and-wave-index) during NREM sleep was
80–96%. All patients had an electro-clinical improvement during steroid
treatment and a partial remission of the symptoms after ESES offset, con-
firming the correlation between cognitive deterioration and CSWS. Nev-
ertheless, some degrees of cognitive/behavioural deficits persisted in all
cases after ESES remission (3 idiopathic, 3 cryptogenic).
Conclusion: We confirm the recurrence of GRIN2A-mutations and we
describe miscellanea of other genetic mutations (but not CNKSR2-muta-
tions) in our series of non-lesional ESES. In none of them, we observed
the typical EEG pattern of ESES. Moreover, despite the heterogeneity of
their genetic and clinic background, all patients had cognitive/behavioral
sequelae after ESES-offset.
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A SYSTEMATIC REVIEWONDIAGNOSTIC
ACCURACYANDCLINICALVALUEOFNON-
INVASIVE LONGTERMVIDEO-EEGMONITORING IN
PRESURGICAL EVALUATIONOF PATIENTSWITH
EPILEPSY
T. Kobulashvili*, G. Kuchukhidze*,†, F. Brigo‡,§,
G. Zimmermann*,¶,**, J. H€ofler*, M. Leitinger*,
J. Dobesberger*, G. Kalss*, A. Rohracher*, C. Neuray*,
A. Wakonig*, F. Ernst*, E. Trinka*,¶,††
*Christian-Doppler-Klinik, Paracelsus Medical University of
Salzburg, Department of Neurology, Salzburg, Austria, †Medical
University of Innsbruck, Department of Neurology, Innsbruck,
Austria, ‡Biomedicine and Movement Science, University of
Verona, Department of Neuroscience, Verona, Italy, §Franz
Tappeiner Hospital, Department of Neurology, Merano, Italy,
¶Spinal Cord Injury and Tissue Regeneration Centre, Salzburg,
Austria, **Paris-Lodron University of Salzburg, Department of
Mathematics, Salzburg, Austria, ††Centre for Cognitive
Neuroscience, Salzburg, Austria
Purpose: The European Union-funded E-PILEPSY network aims to har-
monize and optimize the presurgical diagnostic procedures by creating
and implementing evidence-based guidelines and recommendations
across Europe.We evaluated the current evidence on diagnostic accuracy
and clinical value of Long-term video-EEG monitoring (LTM) in identi-
fying the epileptogenic zone in patients with epilepsy.
Method: Studies were identified by searching the MEDLINE,
EMBASE, CENTRAL and ClinicalTrails.gov databases. In order to eval-
uate the diagnostic accuracy of LTM, sensitivity and specificity were
assessed in subgroups of lesional and nonlesional temporal and extratem-
poral lobe epilepsy (TLE and ETLE) patients. We analyzed data descrip-
tively by logistic regression based on single patient analysis and
calculated sensitivity and specificity with respect to predicting seizure
freedom after surgery.
Results: 42 studies were included, comprising 424 patients who under-
went resective epilepsy surgery. Statistical analyses yielded a sensitivity
estimate of 0.83 (CI: 0.78–0.87) and a specificity estimate of 0.21
(CI : 0.14–0.30) in the lesional TLE group. In the lesional ETLE group,
sensitivity and specificity were 0.50 (CI : 0.33–0.67) and 0.39 (CI : 0.24–
0.57), respectively. In the nonlesional subgroups, sample sizes were too
small to calculate accuracy measures. An evaluation of the impact of cer-
tain etiologies on diagnostic accuracy of VEEG using logistic regression
analyses was possible only in the lesional TLE group. Hippocampal scle-
rosis was the most common histological finding within this group and
was associated with higher diagnostic accuracy of LTM, as indicated by
a sensitivity of 0.88 (SE 0.029) and a specificity of 0.17 (SE 0.051).
Conclusion: The study shows that the sensitivity of VEEG is remarkably
higher in lesional TLE compared to lesional ETLE. Furthermore, sensi-
tivity estimates within the lesional TLE group differ considerably
depending on etiology. Significant heterogeneity observed across the
studies indicates the need for an improvement in study design and quality
of results reporting.
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BURST SUPPRESSION IN FULL TERMNEONATES
P. Vilarinho*, D. Boothman*, A. Whiting†, S. Alagoda*
*Musgrove Park Hospital, Clinical Neurophysiology, Taunton,
United Kingdom, †Musgrove Park Hospital, Paediatrics,
Taunton, United Kingdom
Burst Suppression (BS) pattern of EEG consists of high amplitude parox-
ysmal bursts alternating with suppression of EEG activity. It is a poor
prognostic sign in most but not in all. Aetiology of BS in neonates
includes; hypoxia, cerebral malformations, early infantile encephalopa-
thy, metabolic errors and medications. Early diagnosis is essential for
effective management and we present an illustrative case of non-ketotic
hyperlycinaemia (NKH) picked up because of BS on EEG. A full term
male neonate, presented on day 1 of birth with grunting and feeding diffi-
culties. He had normal birth. Day 2, he developed hiccups, hypotonia and
poor respiratory drive, needing intubation and ventilation on day 4. He
made some improvement; extubated, started breast feeding, but remained
hypotonic. There were no clinical seizures, but EEG on day 9 showed BS
and frequent bilateral sharp waves. In the absence of hypoxic injury, he
was investigated further and diagnosis of NKH was made by detection of
elevated glycine in cerebrospinal fluid (CSF) and raised CSF/plasma gly-
cine ratio. MRI showed areas of high signal on T2 in keeping with NKH.
He was commenced on Sodium Benzoate and Dextromethorphan. EEG
at 3 weeks continuous background, sharp waves over the left hemi-
sphere. L-Dopa was introduced to manage dystonia. At 9 weeks, devel-
oped frequent jerks, EEG showed focal seizures arising independently
from both hemispheres. He was commenced on phenobarbitone, Leve-
tiracetam and ketogenic diet. EEG at 5 months showed clusters of epilep-
tic spasms, hypsarrhythmia and subclinical focal seizures. NKH is a rare
autosomal recessive inborn error of glycine metabolism, characterised by
a rapidly progressive course, often death within the first year. It is associ-
ated with BS pattern during neonatal period, later changing to hypsar-
rhythmia. There is no cure but early diagnosis and treatment may
possibly improve the prognosis. In that respect EEG demonstrating BS
had been helpful.
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PATTERNOF ICTAL INTRACEREBRAL EEGATTHE
STARTOFALTERATIONOFCONSCIOUSNESS
N. Campora*,†, S. Kochen*,†
*El Cruce Hospital, Buenos Aires, Argentina, †ENYS -
CONICET, Florencio Varela, Argentina
Purpose: The alteration of consciousness (AOC) during seizures is one
of the most striking features in patients with focal epilepsy and the subja-
cent mechanisms are incompletely known. Better defining of intracere-
bral EEGmorphological signal at seizure-onset and its propagation could
improve the understanding of such mechanisms.
Method: It was included 9 patients (45 seizures) with drug resistant epi-
lepsy. All of them had RM and steroelectroencephalogrphy (SEEG). The
SEEG were analysed independently by two reviewers blinded to clinical
information, and consensus was reached after discussion. We analysed
the patterns and localization of seizure onset and propagation, time of
propagation, beginning of clinical seizure, beginning of AOC, degree of
AOC and duration of seizure.
Results: In mesial temporal epilepsy, the seizures with AOC were
longer, the most commonly pattern of seizure-onset was sharp activity at
≤ 13 Hz and the AOC occurred with or following the propagation of
activity to contralateral hippocampus. In frontal epilepsy, the most com-
monly pattern of seizure-onset activity was low-voltage fast activity
>13 Hz and the AOC occurred following the propagation of the activity
to adjacent areas of the seizure-onset (overage 16 s after) without hip-
pocampal commitment. In insular epilepsy, the seizures with AOC were
longer and affected both anterior and posterior insular electrodes, without
commitment of hippocampus. The electrical beginning were sharp activ-
ity at ≤ 13 Hz without consideration of degree of AOC.
Conclusion: In our work, the AOC were mostly with of after the propa-
gation of the seizure-onset activity. In mesial temporal seizures, the most
of the AOC seizures were with contralateral hippocampus compromised.
Meanwhile in frontal and insular seizures the AOC occurred when the
area of discharged is enlarged without hippocampus compromised.
Future works that apply different techniques for signal analysis are neces-
sary to characterize functional connectivity between spatially distributed
regions and pathophysiological mechanisms during AOC.
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POST TRAUMATIC EPILEPSYDUETOTRAUMATIC
BRAIN INJURYBYTRAFFIC ACCIDENTS IN
NEUROPHYSIOLOGICAL EXPLORATIONS
LABORATORYOFMARRAKESHUNIVERSITY
HOSPITAL
A. Chahidi*,†, N. Adali*,‡, N. Louhab*,‡, M. Chraa*,‡,
N. Kissani*,‡
*CADI AYYADUniversity, Medical School, Marrakech,
Morocco, †Sorbonne University, ED 268, Paris, France,
‡Medical University Hospital Mohammed VI, Neurology
Department, Marrakech, Morocco
Purpose: Post traumatic epilepsy (PTE) is defined by two or more
unprovoked seizures after brain traumatic injury (BTI). PTE after TBI
can be secondary to traffic accidents. Its prevalence of 4 % increases after
penetrating brain injury. Cortical lesions play role of PTE genesis. Mor-
occo face a real” Road War” and Marrakesh city and its region is espe-
cially known by traffic accidents of motorcyclists.
Method: retrospective Study on PTE Cases registered over one year in
university hospital neurophysiology laboratory of Marrakesh. All cases
had a (EEG) with selection of cases with epileptic seizure caused by TBI.
Results: Among 385 patients with epilepsy who had EEG, 11 cases were
associated with a TBI caused by a traffic accident (Among a total of 20
cases with TBI). TBI was severe in 9 cases. average age was 27.5 years
(ranged from 17 to 72 years) with a male predominance (10 cases). PTE
diagnostic delay was 4 years after accident. Epilepsy seizures were
mainly partial (9 cases). The neurological examination was normal in 5
cases. Elsewhere we found confusion (2 cases), a limb motor paralysis (2
cases), pyramidal signs (1case) and multifocal lesions (1 case). The EEG
confirmed partial paroxystic abnormalities in 8 cases and was normal in
3 cases. All patients have cerebral CT scan showing hemorrhagic contu-
sions (3 cases), depressed skull (2 cases), frontal hematoma (2 cases).
Five patients were treated by valproate at the time of EEG realization
EEG.
Conclusion: PTE due to traffic accidents was seen in 55 % of all TBI
cases seen in our neurophysiologic laboratory. The majority of victims of
this “road war” are young active males with severe consequences in Mar-
rakesh region. In spite of the deployed efforts to decrease road deaths,
more prevention is needed with an early diagnostic and treatment of the
PTE victims.
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SLEEPRELATED EPILEPSY IN FOCALCORTICAL
DYSPLASIA TYPE II (FCD2): INSIGHTS FROMSLEEP
RECORDINGS
C. Eltze*, E. Landre†, C. Soufflet†,‡, F. Chassoux§
*Great Ormond Street Hospital for Children NHS Foundation
Trust, Neurology, London, United Kingdom, †Centre Hospitalier
Sainte-Anne-Paris, Service de Neurochirugie, Paris, France,
‡Ho^pital Universitaire Necker-Enfants Malades, Paris, France,
§Centre Hospitalier Sainte-Anne-Paris, Service de
Neurochirgie, Paris, France
Purpose: Sleep related epilepsy (SRE) defined by >70% of seizures
occurring during sleep, has been recently reported in FCD2, a common
neuropathological entity found in epilepsy surgery. We aimed to deter-
mine in a cohort of patients with histologically confirmed FDC2 and SRE
the relationship between ictal onset, sleep stage, preceding arousal, and
its value for localisation of the dysplasia.
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Methods: From a single centre surgical series of 109 FCD2 patients, 64
(59%) with SRE were identified. We reviewed scalp video-EEG data of
and selected patients in whom sleep recordings were available. FCD
location was based onMRI, histology, and surgical outcome.
Results: Sleep video-EEG with at last one recorded seizure were avail-
able for 53 patients (30 males, mean age 20.7 (SD  10.4) years, age at
seizure onset: 5.7 (SD 4.5) years). MRI was negative in 18 (34%) cases
or showed subtle abnormalities in 11 (21%), histological subtype was
FCD2a: 11 [21%], FCD2b: 42 [79%]. FCDs were located in frontal lobe
in 39 (74%) and in extra-frontal areas in 14 (26%; 2 temporal, 11 poste-
rior, 1 insular). Seizure onset relation to sleep stage could be determined
for 50/53 (94%) patients. Seizure onset occurred from NREM sleep in
35/50 (70%) patients (mostly from stage 2), after arousal in 13/50 (26%)
and in both conditions in 2/50 (4%). NREM sleep seizures were signifi-
cantly more frequent with frontal (29/34 [85.3%]) compared to extra-
frontal location (6/14 [43%]), whilst arousal preceded ictal onset more
often in extra-frontal (6/14 [43%]) compared to frontal location (5/34
[14.7%]); Fisher’s Exact Test p = 0.005.
Conclusion: FCD2 occurs very frequenty in drug-resistant SRE. The sei-
zure onset pattern arising from NREM sleep or preceded by arousal can
provide additional localising information and suggests topography
dependent impact on sleep related functional networks.
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USINGMEG-VIRTUALELECTRODES ATDEPTH
ELECTRODELOCATIONS TOCHARACTERIZE THE
SEIZUREONSET ZONE INREFRACTORYEPILEPSY
PATIENTS
E.L. Juarez-Martinez*,†, I.A. Nissen*, A. Hillebrand*,
E.C.W. van Straaten*
*VU University Medical Center, Clinical Neurophysiology and
MEGCenter, Amsterdam, Netherlands, †VUUniversity
Amsterdam, Amsterdam, Netherlands
Purpose: Epilepsy surgery can increase the chance of seizure freedom in
focal refractory epilepsy, provided that the seizure onset zone (SOZ) is
located and the epileptogenic zone removed safely. Depth electrode
recording (dEEG) is considered the gold standard in locating the SOZ
when non-invasive techniques fail, yet entails risk of complications. The
purpose of this study was to determine if potential SOZ biomarkers (i.e.
spectral analysis, functional connectivity and network centrality mea-
sures) derived from magnetoencephalography-based virtual electrodes
(MEG-VEs) could provide an accurate characterization and location of
the SOZ comparable to that of dEEG.
Method: DEEG and MEG recordings from nine refractory epilepsy
patients (who underwent surgical treatment) were analyzed. Beamform-
ing was used to place MEG-VEs at the exact dEEG electrode locations.
For both modalities, we computed spectral (relative power and peak fre-
quency) and connectivity measures (phase lag index and phase transfer
entropy). A minimum spanning tree graph was constructed and centrality
measures calculated. To characterize the SOZ, we compared the mea-
sures from the channels located in the resected area (SOZ channels) to
the non-resected channels (rest). Correlation coefficient, intraclass corre-
lation and Bland-Altman plots were determined between modalities for
each measure.
Results: The SOZ channels had significantly lower peak frequencies and
increased relative delta power, while relative alpha and beta power
decreased compared to the rest of the channels in both modalities. SOZ
channels showed high connectivity (increased PLI) and information flow
towards the rest of the channels (dPTE > 0.5). Peak frequency, relative
power (delta, alpha2 and beta), PLI and PTE were correlated, reliable and
agreed between modalities.
Conclusion: Spectral and functional connectivity measures character-
ized the SOZ in both modalities and can potentially be used as biomark-
ers. Non-invasive MEG-VEs measures gave comparable results to
dEEG. We suggest that MEG-VEs provides a promising tool to accu-
rately evaluate the SOZ.
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ANALYSIS OFHEARTRATEVARIATIONAFTER
ELECTRICAL STIMULATIONOFTHE INSULA
DURING SEEG
A. Sanchez Larsen*, A. Principe*, M. Ley Nacher*, G. Conesa†,
R. Rocamora*
*Hospital del Mar, Epilepsy Monitoring Unit, Department of
Neurology, Barcelona, Spain, †Hospital del Mar, Epilepsy
Monitoring Unit, Department of Neurosurgery, Barcelona,
Spain
Purpose: The insular cortex has been suggested to have a prominent role
in neurological control of the autonomic nervous system, but its specific
function and the precise location of these autonomic regulatory areas are
not completely known. We aimed to study the heart rate (HR) changes
induced by intracranial electrical stimulation of the insular cortex in
epileptic patients submitted to invasive stereo-electroencephalography
(SEEG) recordings.
Method: We selected 6 patients with non-insular epilepsy studied
through SEEG, in whom the insular cortex was explored. Insular elec-
trodes were precisely localized merging postoperative CT scans and pre-
operative MRIs. HR was analyzed during periods of 10 s previous to
stimulation (HRb), during insular stimulation (HRs) and during stimula-
tion of non-insular electrodes selected randomly on the same side (HRr).
Heart rate variability (HRV) was measured according to instantaneous
variations of beat-to-beat interval (DNN) that corresponds to its first
derivative.
Results: Six right-handed patients, three with left insular implantation
and three with right insular implantation, were enrolled. Thirty-six elec-
trodes were analyzed: 8 were implanted in the right anterior insula, 10 in
right posterior insula, 12 in left anterior insula and 6 in left posterior
insula. Stimulation of the right insula, and specifically of the anterior
region induced a significant decrease of DNN and an increase of 4 beats-
per-minute (bpm) on average as compared to HRb and HRr (p < 0.01).
Serendipitously, we also elicited an atypical insular seizure that provoked
a steep increase of HR (88 to 111 bpm). Stimulation of other areas of the
insular cortex did not produce significant HRV changes in comparison to
HRb or HRr.
Conclusion: In our study the electrical stimulation of the right anterior
insula induced a significant increase of the heart rate. Our data support an
important role of the human right insular cortex in the control of heart
rate dynamics.
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MODIFIED AUTOMATICR-PEAKDETECTION
ALGORITHMFORPATIENTSWITHEPILEPSY USING
A PORTABLE ELECTROCARDIOGRAMRECORDER:
FIRST STEPOF PORTABLE SEIZUREDETECTION
J. Jeppesen*, A. Fuglsang-Frederiksen*, P. Johansen†,
P. Sidenius‡, S. Beniczky*,§
*Aarhus University Hospital, Department of Neurophysiology,
Aarhus, Denmark, †Aarhus University, Department of
Engineering, Aarhus, Denmark, ‡Aarhus University Hospital,
Department of Neurology, Aarhus, Denmark, §Danish Epilepsy
Centre, Department of Clinical Neurophysiology, Dianalund,
Denmark
Purpose: Earlier studies have shown that short term heart rate variability
(HRV) analysis of ECG is a promising biomarker for detection of epilep-
tic seizures. A precise and accurate automatic R-peak detection algorithm
is a necessity in a real-time, continuous measurement of HRV, in a porta-
ble ECG device.
Method: We used the portable CE marked ePatch heart monitor to
record the ECG of 14 patients, who were enrolled in the video-EEG long
term monitoring unit for clinical workup of epilepsy. Recordings of the
first 7 patients (356 recording hours) were used as training set of data for
the R-peak detection algorithm and the recordings of the last 7 patients
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(467,6 recording hours) were used to test the performance of the algo-
rithm. We aimed to modify an existing QRS-detection algorithm to a
more precise R-peak detection algorithm to avoid the possible jitter
Q- and S-peaks can create in the tachogram, which causes error in short-
term HRV-analysis.
Results: The proposed R-peak detection algorithm showed a high sensi-
tivity (Se = 99,979%) and positive predictive value (P+ = 99,976%),
which was comparable with a previously published QRS-detection algo-
rithm for the ePatch ECG device, when testing the same dataset.
Conclusion: The novel R-peak detection algorithm designed to avoid jit-
ter has very high sensitivity and specificity and thus is a suitable tool for a
robust, fast, real-time HRV-analysis in patients with epilepsy. The R-
peak detection algorithm is the first important step in creating a portable
fully automatic real-time seizure detection for these patients.
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THE IMPACTOF THEEEG FINDINGSONTHE
STRATEGYOFTREATMENT INCHILDRENWITH
ADHD
I. Zaytsev*, D. Zaytsev*, N. Titov†
*Zaytsev’s Psichoneurological Center, Psychiatry, St.
Petersburg, Russian Federation, †Zaytsev’s Psichoneurological
Center, Neurology, St. Petersburg, Russian Federation
Purpose: According to the literature approximately 15% children with
ADHD have certain epileptic activity in long-term sleep EEG. In avail-
able literature we couldn’t find publications about the impact of EEG
findings on ADHD therapy strategy. To determine paroxysmal EEG
abnormalities in children with pure ADHD and treatment strategy
depending on EEG paroxysmal disturbances.
Method: We’ve examined 28 children aged 6–10 years with ADHD
(DSM-5 classification), without epilepsy and speech development delay.
All children were conducted neurological and psychiatric examination,
speech therapist examination and long-term sleep EEG recording. All
children underwent neuroimaging (CT, MRI) without any disturbances.
According to the EEG findings all children were divided into 2 groups:
group I (18 children) with epileptic activity, hypnagogic hypersynchrony
and it’s abnormal variants (with sharp waves on it); group II (10 children)
with normal EEG.
Results: Traditional drug methods of ADHD treatment showed signifi-
cant clinical improvement only in the group II.
Conclusion: Paroxysmal activity in EEG could be the reason for insuffi-
cient effect of traditional ADHD treatment.
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TRACKINGHEARTRATECHANGESDURING
SEIZURES: A NATIONAL STUDYUSING
RESEARCHKIT ANDAPPLEWATCHTOCOLLECT
BIOSENSORANDRESPONSEDATADURING
SEIZURES
Y.I. Carmenate*, E.M. Gonzalez*, A. Ge*, M.J. Collard*,
S.W. Lee*, N.E. Crone*, G.L. Krauss*
*Johns Hopkins University, Department of Neurology,
Baltimore, MD, United States
Purpose: Seizure apps using biosensors and mobile devices may be used
to develop non-EEG seizure detection and help support patients with epi-
lepsy. We implemented a national study called EpiWatch, which uses
Apple Watch to track heart rate, movements, and responsiveness during
seizures, with the goal of using this data to develop seizure detection. We
report an initial analysis of heart rate changes associated with seizures.
Method: Participants were e-consented using ResearchKit with
encrypted data transmission. Seizure tracking was initiated during auras
or by caregivers with heart rate (HR), accelerometer, and responsiveness
data collected for 10 min. This was followed by a post-seizure survey.
We performed preliminary analysis of participant HR changes during
various seizures.
Results: 704 participants (mean age: 31, range: 16–73), from nearly all
states, enrolled in the EpiWatch study. 47% of participants tracked sei-
zures (mean: 9.6 per participant), with 3026 seizures recorded. Seizure
types were typical of those expected for a national epilepsy population:
28% focal seizures and 9% tonic-clonic seizures. During tonic-clonic sei-
zures, HRs increased >30% in 38% and >50% in 23% of seizures. HR
changes were more variable with focal seizures: >15% increases in HR in
42% and decreases in 14% of seizures. We observed several temporal
patterns associated with HR changes: most seizures evolved with tachy-
cardia over a 30 second period, preceding visible and brisk accelerome-
ter fluctuations associated with bilateral seizure evolution; some seizure
activations had immediate elevated HR increases compared with pre-sei-
zure baselines, presumably due to late tracking activation.
Conclusion: Our study demonstrates that it is possible to rapidly imple-
ment a national study which collects biosensor and response data using
wearable technology to accelerate epilepsy research. Watch biosensors
captured early heart rate accelerations, particularly during tonic-clonic
seizures. These data, along with accelerometer and responsiveness data,
are being used to test seizure detection algorithms.
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EFFECTOFEMBELIN IN CHRONIC EPILEPSY
INDUCEDCOGNITIVE DYSFUNCTION IN THREE-
AXISMAZEMODELOFADULTZEBRAFISH
U.P. Kundap*, Y. Kumari*, I. Othman*, M.F. Shaikh*
*Monash University Malaysia, Neuropharmacology Research
Laboratory, Jeffrey Cheah School of Medicine and Health
Sciences, Bandar Sunway, Malaysia
Purpose: Chronic epilepsy is characterized by repeated unpredictable
seizures. Abnormal neurons firing electrical impulses, which can cause
the brain and body to behave strangely. Neurocognitive impairment is
frequently observed in epileptic patients. Most cognitive complaints in
adult patients are mental slowness, memory difficulties and attention def-
icits. Embelin is derived from plant Embelia ribes and used traditionally
in the treatment of various brain disorders and also as a brain tonic. Zeb-
rafish are capable of learning and executing spatial tasks from an egocen-
tric frame of reference. The three-axis maze is a conventional method to
test the learning ability and egocentric memory in zebrafish. In three-axis
maze, fish requires to navigate a route based on x (forward/backward), y
(horizontal) and z (vertical) axes. Egocentric navigation is an evidence
based process, where fish navigates to the feeding ring independent of
environmental cues and deals directly with the spatial relation between
subject and reward goal. The study, therefore, aims to assess whether
embelin can ameliorate chronic epilepsy (kindling) induced spatial mem-
ory impairment.
Method: Repeated administration of pentylenetetrazole (PTZ) for
10 days successfully induces kindling effect in zebrafish and also worsen
the memory function detrimental to egocentric navigation. Animal trea-
ted with embelin are observed for its cognitive performance, three-axis
maze behavior, performance errors and biochemical changes.
Results: Results demonstrate that doses of embelin (0.156 mg/kg,
0.312 mg/kg and 0.625 mg/kg) significantly improve maze navigation
times and reduced performance errors in three-axis maze.
Conclusion: Embelin improves both epileptic and egocentric spatial
memory condition. Three-axis maze analysis, locomotor behavior and
biochemical changes shows that embelin can reverse chronic epilepsy
associated learning and memory in zebrafish model.
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BONEMETABOLISM SERUMMARKERS IN ADULT
PATIENTSWITHEPILEPSY: EFFECTOFVITAMIND
SUPPLEMENTATIONON SEIZURES CONTROL
M. Tombini*, J. Lanzone*, G. Assenza*, A. Palermo†,
A. Benvenga*, C. Campana*, F. Assenza*, V. Di Lazzaro*
*Campus Bio-Medico University of Rome, Unit of Neurology,
Neurophysiology, Neurobiology, Department of Medicine,
Rome, Italy, †Campus Bio-Medico University of Rome,
Department of Endocrinology and Diabetes, Roma, Italy
Purpose: The aim of our study was to evaluate serum markers of bone
metabolism in adult patients with epilepsy treated with different
antiepileptic drugs (AEDs). Also, the effect of Vitamin D (VitD) supple-
mentation on seizure frequency was addressed.
Method: In 160 patients with epilepsy (PWE) on chronic therapy with
AEDs and 42 healthy control subjects serum levels of calcium, phos-
phate, intact parathyroid hormone (PTH) and 25-hydroxy Vitamin D
(25OHD) were evaluated. The levels of these markers were analysed tak-
ing into account the different features of epilepsy and treatment. Finally,
in a group of 48 patients the effect of oral administration of VitD for
3 months on seizures control was assessed at 6 months after the begin-
ning of supplementation.
Results: PWE showed significantly lower serum levels of 25OHD com-
pared to controls subjects, negatively correlated with the duration of
treatment. In 33,1% of patients a severe deficiency of VitD was detected,
VitD insufficiency in 41,9% and only 25% of PWE had normal values of
25OHD. Polytherapy and enzyme inducing AEDs showed more detri-
ments effects. Only in patients under the age of 65, a weak inverse corre-
lation between seizure frequency and levels of 25OHD was found, but
the administration of VitD for three months failed to significantly affect
seizures control.
Conclusion: We confirmed in adult patients with epilepsy a significant
decrease of serum levels of 25OHD, largely dependent on the features
and duration of treatment. The administration of oral VitD in a group of
patients did not show a clear anticonvulsant effect.
p0197
ASSOCIATION BETWEENBONEMINERALDENSITY
ANDUSEOFANTIEPILEPTIC DRUGS
S.S. Diemar*,†, A.-S. Sejling‡, P. Eiken†,‡, N.R. Jorgensen§,¶,
C. Suetta†,**, A. Sabers†,††, N.B. Andersen*
*Rigshospitalet, Department of Neurology, Glostrup, Denmark,
†University of Copenhagen, Faculty of Health and Medical
Sciences, Copenhagen, Denmark, ‡Nordsjællands Hospital,
Hillerød, Department of Cardiology, Nephrology and
Endocrinology, Hillerød, Denmark, §Rigshospitalet, Department
of Clinical Biochemestry, Glostrup, Denmark, ¶Odense
University Hospital/Institute of Clinical Research and
University of Southern Denmark, Odense Patient data
Explorative Network, Odense, Denmark, **Rigshospitalet,
Department of Clinical Physiology, Nuclear Medicine and PET,
Glostrup, Denmark, ††Rigshospitalet, Department of Neurology,
Copenhagen, Denmark
Purpose: Many patients on antiepileptic drugs (AEDs) develop meta-
bolic bone disease such as osteopenia and osteoporosis. This increases
the risk of pathological bone fractures, increases the risk of morbidity
and mortality and decreases life quality. Little is known regarding bone
disease in patients with epilepsy and its relation to treatment with AEDs.
The study aim was to investigate the occurrence of bone disease in an
unselected cohort of patients with epilepsy and the associations between
bone mineral density (BMD) and treatment with AEDs.
Methods: The study is a retrospective cohort study of 474 patients
(male:female ratio 1:1.2; age 48  16 years (meanSD); duration of
epilepsy 24  16 years) followed at a tertiary epilepsy out-patient-clinic
in Denmark. Data on BMD from Dual-energy X-ray absorptiometry
(DXA) scans were collected including
T- and Z-scores from lumbar region and femoral region. Information
regarding the patient’s medical history and epilepsy treatment was
obtained through the patient’s medical report.
Results: Of the 474 patients 59% received monotherapy and 40%
received polytherapy. The most frequently used AEDs were lamotrigine
(42%), levetiracetam (29%) and valproic acid (21%). In the cohort 12%
of the patients had osteoporosis and 22% had osteopenia. The only
monotherapy that was significantly associated with decreases in BMD
was carbamazepine (p = 0.04) whereas polytherapy including lamotrig-
ine, levetiracetam, valproic acid, and carbamazepine were significantly
associated with decreases in BMD (p ≤ 0.02). When looking at specific
combinations of therapy levetiracetam and topiramate, levetiracetam and
carbamazepine, and levetiracetam and valproic acid were all signifi-
cantly associated with decrease in BMD (p ≤ 0.042).
Conclusion: In the unselected cohort of patients with epilepsy 12% had
osteoporosis and 22% had osteopenia. Significant decreases in BMD
were primarily associated with polytherapy. This suggests an additive
negative effect of polytherapy on bone health. Our results further support
the need for focusing on bone health in patients treated with AEDs.
p0199
HIGH PREVALENCEOF INTELLECTUAL
DISABILITY, AUTISM, ADHDANDDIMINISHED
ADAPTIVE FUNCTIONING INDOOSE SYNDROME
(MAE)
S. Tang*,†, A. Smith*, A. Parker‡, S. Agrawal§, E. Hughes†,
K. Lascelles†, R. Williams*, P. Fallon¶, C. Ferrie**,
R. Robinson††, J.H. Cross‡‡, T. Hedderly†, C. Eltze††, T. Kerr¶,
A. Desurkar§§, N. Hussain¶¶, M. Kinali***, G. Vassallo†††,
W. Whitehouse‡‡‡, S. Goyal†, M. Absoud†, D.K. Pal*,†
*King’s College London, London, United Kingdom, †Kings
Health Partners, London, United Kingdom, ‡Addenbrooke’s
Hospital, Cambridge, United Kingdom, §Birmingham Children’s
Hospital, Birmingham, United Kingdom, ¶St Georges Hospital,
London, United Kingdom, **Leeds Teaching Hospitals NHS
Trust, Leeds, United Kingdom, ††Great Ormond Street Hospital
for Children, London, United Kingdom, ‡‡Institute of Child
Health, UCL, London, United Kingdom, §§Sheffield Children’s
Hospital, Sheffield, United Kingdom, ¶¶University Hospital of
Leicester NHS Trust, Leicester, United Kingdom, ***Chelsea
and Westminister Hospital, London, United Kingdom, †††Royal
Manchester Children’s Hospital, Manchester, United Kingdom,
‡‡‡Nottingham Universitiy Hospital, Nottingham, United
Kingdom
Myoclonic astatic epilepsy (MAE) is a rare childhood epilepsy with
unclear neurodevelopmental outcome. We aimed to deeply phenotyped
MAE patients utilising a series of standardised neuropsychological tests.
Patients with MAE were recruited from UK paediatric neurology cen-
tres from 2012 to 2016. Cases were assessed using the WPPSI III or Bay-
leys III for cognition; Developmental, Dimensional and Diagnostic
Interview (3di) and/or Social Communication Questionnaire (SCQ) for
autism spectrum disorder (ASD); the Conner’s Comprehensive Beha-
vioural Rating Scale (CBRS) for attention deficit hyperactivity disorder
(ADHD) (defined as T score > 70); the Strength and Difficulties ques-
tionnaire (SDQ) for behavioural screening; and Adaptive Behaviour
Assessment system (ABAS) for adaptive functional skills.
67 (49 Male, 18 Females) MAE cases were recruited. The mean age of
seizure onset was 33.9 (SD 14.8) months, and mean age at recruitment
was 97.3 (SD 48.4) months. Seizure types were remarkably similar to
previous published cohorts. Cognitive testing showed moderate to severe
intellectual disability (IQ< 55) in 10/25 (40%), and 4/25 (16%) with mild
intellectual disability (IQ 55–70). ASD symptoms were elicited in 20/64
(31.2%) cases through the 3di (9/22) and SCQ (16/61). Parents reported
ADHD on the CBRS in 21/52 (41.1%) cases, with 7/52 (13.4%) reaching
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threshold for both parent and teacher CBRS (P < 0.0001). In the SDQ,
high or very high scores were recorded in: conduct problems
(19/60, P < 0.0001), hyperactivity (22/60, P < 0.0001), peer prob-
lems (26/60, P < 0.0001), prosocial problems (29/60, P < 0.0001) and
psychosocial impact scores (35/60, P < 0.0001) compared to a normative
population. In the ABAS, 36/59 (61.0%) reported extremely low adaptive
scores (< 2nd centile) for conceptual, 25/59 (42.3%) for social and 42/59
(71.1%) for practical domains.
These findings reveal a surprisingly high severity and impact of neu-
rodevelopmental comorbidity in MAE and highlight the need for com-
prehensive evaluation and continued monitoring to guide intervention.
p0200
FACIAL EMOTION PERCEPTION IN PEOPLEWITH
EPILEPSY: A SYSTEMATIC REVIEWWITHMETA-
ANALYSIS
M. Edwards*, E. Stewart*,†, R. Palermo†,‡, S. Lah*,†
*The University of Sydney, School of Psychology, Sydney, NSW,
Australia, †ARC Centre of Excellence in Cognition and its
Disorders, Sydney, NSW, Australia, ‡The University of Western
Australia, School of Psychological Science, Perth, WA,
Australia
Purpose: The ability to perceive emotion is a fundamental social compe-
tency that develops from childhood into adulthood, and relies on a spe-
cialised, yet distributed, network of brain regions. Our aim was to
determine whether facial emotion perception is impaired in patients with
epilepsy, and related to epilepsy, treatment and demographic variables.
Method: Electronic databases were searched according to PRISMA
guidelines. Thirty studies (27 adult studies and 3 child studies) met inclu-
sion criteria, and comprised of patients with temporal lobe epilepsy
(TLE; 24 studies), frontocentral epilepsy (FCE; 2 studies), genetic gener-
alised epilepsy (GGE; 3 studies), and a mixed epilepsy sample (1 study).
Results: Meta-analysis revealed that compared to healthy controls
(n = 739), patients with epilepsy (n = 821) displayed an overall deficit
in facial emotion perception, as well as deficits of each individual emo-
tion (happiness, sadness, surprise, fear, disgust, anger) examined. While
the magnitude of the deficit was large in all epilepsy groups (Hedges’
g = 0.908 - 1.076), distinctive patterns of emotion-specific impairments
were also found. Specifically, patients with TLE were significantly
impaired on all emotions except surprise, while patients with GGE were
significantly impaired on anger, disgust, and fear, but not happiness, sad-
ness, or surprise. Meta-regression of emotion perception in patients with
TLE revealed that younger age at testing was associated with lower accu-
racy. Other epilepsy, treatment and demographic variables (including
side of seizure focus and surgical status) were not related.
Conclusion: Robust deficits in facial emotion perception are found in
epilepsy, with broader emotion-specific deficits in TLE than GGE.
p0201
THEACTUALMECHANISMBYWHICH PHENYTOIN
DISPLAYSMICHAELIS-MENTENKINETICS
P. Fagiolino*, M. Vazquez*, M. Ibarra*, S. Alvariza*,
C. Maldonado*
*Universidad de la Republica, Faculty of Chemistry,
Pharmaceutical Sciences, Montevideo, Uruguay
Purpose: Phenytoin (PHT) may saturate the hepatic enzymes and there-
after display a nonlinear concentration-dose relationship. This has been
appropriately described by the Michaelis-Menten equation. However, an
alternative hypothesis based on its ability of inducing efflux transporters
was reported [Clin Pharmacokinet 50:75-80(2011)]. This inductive effect
in rats was demonstrated to be time- and concentration-dependent [Phar-
macol Rep 66:946-51(2014); Epilepsy Res 107:51-5(2013)].
Method: In order to evaluate this inductive-based mechanism in humans
two different dosage regimes, both having the same input rate of
8.33 mg/h of PHT, were implemented in 6 healthy volunteers throughout
a ten-day period, under a crossover design with a 5-day washout interval:
A) 100 mg every 12 h, and B) 600 mg every 72 h. After the last dose,
saliva and plasma PHT concentrations throughout time were measured.
Results: Treatment B yielded a higher (p < 0.01) mean plasma PHT
concentration (3.85  2.77 vs. 2.81  1.99 mg/L). Secondary peaks
were noticed after B. Being the liver the most relevant site where PHT is
metabolized in humans, the induction of efflux transporter located at the
apical site of the hepatobiliary membrane would deviate the drug from
the inner space of the hepatocyte to the bile, and then recovered by the
systemic space via intestinal reabsorption. Conversely, saliva-to-plasma
drug concentration ratio was higher (p < 0.05) after treatment A
(0.111  0.019 vs. 0.089  0.012). Since efflux transporters are also
placed in the apical membrane of salivary ducts, a higher induction of
their expression was attributed to the more sustained PHT level achieved
under treatment A.
Conclusion: The final effect of increasing PHT concentration at the hep-
atocytes is a progressive loss of their metabolic capacity as it could be
expected if the hepatic enzymes would become saturated. A higher brain-
to-plasma transportation of PHT would be envisaged after frequent dos-
ing.
p0203
ADVERSE EVENTS ARETHEMAINREASON FOR
NON-ADHERENCE TO PHARMACOLOGICAL
TREATMENTOFEPILEPSY IN BRAZIL
H.H. Siqueira*,†, J.S. Dalbem*,†, M. Schiavini†, P.E. Silva†,
T.B.P. Costa†, B. Koech‡, L.H.V.G. Miller‡, C.A. Androlage‡,
P. Wolf†,§, R. Walz†, K. Lin†
*UFMT, Cuiaba, Brazil, †UFSC, Florianopolis, Brazil, ‡UNIC,
Cuiaba, Brazil, §Danish Epilepsy Center, Dianalund, Denmark
Purpose: Non-adherence rates among people with epilepsy (PWE) are
widely variable, ranging from 26% to 95.4%. We aimed to identify non-
adherence in Brazil, its predictive factors and its impact on patient´s man-
agement.
Method: A multicenter observational case-control study was conducted
between March 2015 and October 2016, when 153 subjects were
included. Subjects´ clinical-epidemiological data were surveyed along
with the Morisky-Green Test (MGT), Liverpool Adverse Effect Profile
(LAEP) and the Brief Medication Questionnaire (BMQ).
Results: 103 PWE and 50 controls with other chronic conditions were
interviewed, both groups were matched according to age and socio-edu-
cational level. PWE were aged 36.5  13.86 (range 18–67), 55% were
women, mean age of epilepsy onset was 18.2  12.5 years, 51% had
uncontrolled seizures and 58% were in monotherapy. 74.8% of PWE
were non-adherent to treatment according to MGT, while 74.0% among
controls (p = 0.58); according to BMQ domains, “Recall barrier” was
associated with non-adherence in 78% of PWE and 76% of controls
(p = 0.84). Multiple binary regression analysis revealed only LAEP and
self perception of frequency of forgetfulness on the last three months as
the predictive factors for non-adherence [LAEP = OR 3.1 (95%CI = 1.2–
8.3; p = 0.02) and forgetfulness [OR 17.2 (95%CI = 2.2–136.0;
p = 0.007)]. Non-adherent subjects did not seek emergency treatment
more than adherent ones.
Conclusion: Adherence assessment should be routine throughout epi-
lepsy treatment as well as interventions aimed at improving it. Since
adverse events are important predictors of adherence, they should be con-
sidered when choosing the initial antiepileptic drug.
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USE PATTERNANDADVERSEDRUGREACTION
PROFILEOFNEWERANDCONVENTIONAL
ANTIEPILEPTIC DRUGS INA TERTIARYCARE
HOSPITAL
S.C. Sarangi*, S. Kumar*, M. Tripathi†, Y.K. Gupta*
*All India Institute of Medical Sciences, Pharmacology, New
Delhi, India, †All India Institute of Medical Sciences, Neurology,
New Delhi, India
Purpose: Newer anti-epileptic drugs (AEDs) are being preferred over
conventional AEDs because of better safety profile and efficacy. The pre-
sent study was conducted as part of Pharmacovigilance Programme of
India and evaluated the use pattern and adverse drug reactions (ADRs)
profile of AEDs prescribed in a tertiary hospital.
Method: This prospective, cross-sectional and observational study was
conducted in persons with epilepsy (PWE) attending Neurology Outpa-
tient Department, AIIMS, New Delhi from June 2014 to May 2016, who
were presented with any ADR. Causality assessment of suspected ADRs
was performed according toWHO-UMC scale.
Results: Of the 1452 PWE on AEDs, 905 were male; the ratio of adult:-
pediatric subject was 880/572; and 374 were on newer AEDs either as
mono or polytherapy. Among PWE on monotherapy (34%), AEDs used
are levetiracetam >valproic acid >carbamazepine >phenytoin >other
AEDs. Commonly encountered ADRs in PWE on any AEDs vs. newer
AEDs include anger and aggression (49.4% vs. 13.1%), somnolence
(38.0% vs. 9.4%), memory loss (33.3% vs. 7.7%), tremor (16.8% vs.
4.1%), agitation (14.8% vs. 3.1%), appetite lost (14.3% vs. 3.8%), and
hair loss (13.8% vs. 4.7%). Causality of ADRs revealed 81.7% were hav-
ing possible, 16.6% probable, 1.0% unlikely and 0.7% certain in relation
with AEDs. The major AEDs implicated for ADRs having certain and
probable relationships are levetiracetam (39.4%), valproic acid (21.2%),
phenytoin (18.3%) and carbamazepine (17.4%). Among these, the related
AED was stopped (3.3 %), reduced in dose (96.3%) or continued as
before (0.4%); however, in most cases the dose reduction is a part of rou-
tine tapering of AED.
Conclusion: ADR profile does not support the belief of lesser ADR with
newer AEDs. In this study, levetiracetam is commonly prescribed newer
AED and is typically associated with neurological ADRs. Thus the expe-
rience of better efficacy should still be the guiding consideration for
AEDs use.
p0208
EPILEPTIC SPASMSANDTONIC SEIZURES IN
CHILDRENWITHTUBEROUS SCLEROSIS COMPLEX:
ANEW INDICATION FORVIGABATRIN?
E.A. van der Poest Clement*, M. Sahin†, J.M. Peters*
*Boston Children’s Hospital, Epilepsy and Clinical
Neurophysiology, Boston, MA, United States, †Boston
Children’s Hospital, Translational Neuroscience Center,
Boston, MA, United States
Purpose: Vigabatrin (VGB) is recommended as first-line treatment for
infantile spasms (IS) in Tuberous Sclerosis Complex (TSC). Outside of
TSC, it is also approved as adjunct treatment for refractory complex par-
tial seizures in adults, but other indications in pediatric patients with TSC
are less known. Clinical experience in our TSC clinic suggested efficacy
for epileptic spasms and tonic seizures, prompting the examination of
VGB used for all indications other than infantile spasms.
Method: We reviewed 201 children with TSC seen in our Multidisci-
plinary Tuberous Sclerosis Program from 1995–2016 and identified 27
patients started on VGB after age 1 and collected data on demographics,
history of IS, genetic testing, seizure types, age of onset, EEG prior to
VGB and frequency of seizures targeted with VGB. Treatment variables
included age of onset at VGB treatment, anti-epileptic drugs (AEDs)
prior and during VGB use, the maximum dose of VGB, response to VGB,
length of time from start of VGB to best perceived therapeutic response,
timing of weaning of VGB, recurrence of seizures and medication
regimen after the wean, and duration of follow up. Side-effects and oph-
thalmological surveillance during VGB treatment was reviewed.
Results: Six patients had insufficient data. In 21 patients, the indication
for VGB was epileptic spasms (n = 13), tonic seizures (n = 5), both
(n = 2), and status epilepticus (n = 1). The mean age of treatment onset
was 4.0 years (range 1.1–18.3). All but one patient (95%) had a reduction
in seizures. Ten patients (48%) became seizure free and four (19%) had
an improvement of >90%. In nine patients, VGB was tapered success-
fully after 8–33 months. Side effects reported included rash (n = 1),
behavioral decline (n = 1), and no retinal toxicity was detected.
Conclusion: In conclusion, VGB may be an effective and safe treatment
for epileptic spasms and tonic seizures beyond the infantile age in
patients with TSC.
p0211
EFFECTOFLEVATIRECETAMMONOTHERAPYON
COMPLETE BLOODCOUNT, IMMUNOGLOBULIN
LEVELS ANDLYMPHOCYTE SUBSETS IN CHILDREN
ANDADOLESCENTSWITHEPILEPSY
P.K. Mısırlıoglu*, I. Erol†, T. Savas†, S. Cagla‡, I. Kozanoglu§
*Baskent University Faculty of Medicine, Adana Teaching and
Medical Research Center, Department of Pediatrics, Adana,
Turkey, †Baskent University Faculty of Medicine, Adana
Teaching and Medical Research Center, Department of
Pediatrics, Division of Neurology, Adana, Turkey, ‡Baskent
University Faculty of Medicine, Adana Teaching and Medical
Research Center, Division of Biostatistics, Adana, Turkey,
§Baskent University Faculty of Medicine, Department of
Physiology, Adana, Turkey
Purpose: The aim of this study is to investigate the effects of levatirec-
etam monotherapy on complete blood count parameters, immunoglobu-
lin levels and lymphocyte subsets in children and adolescents with
epilepsy.
Method: A total of 31 children and adolescents with epilepsy (23 gener-
alized, 8 focal seizures; age range, 4–16 years; mean, 8,82  3,92) and
43 aged- and sex- matched controls were included in the study. All the
patients were investigated for frequency and types of infections in the
past month and past year. Complete blood count parameters (haemoglo-
bin, lymphocyte, leukocyte, neutrophil, platelet), immunoglobulin levels
(IgA, IgM, IgG, IgE) and lymphocyte subsets (CD3, CD4, CD8, CD4/
CD8 ratio, CD19, CD56, NKT cells and Treg cells) were measured in
patients with epilepsy and those in controls.
Results: Both groups were similar in terms of frequency and types of
infections in the past month and past year. There were no significant dif-
ferences in complete blood count parameters, lymphocyte subsets, and
immunglobulin levels between patients with epilepsy and those in con-
trols. In the epilepsy group, while complete blood count parameters and
immunglobulin levels were similar in patients with focal and generalized
seizeure, CD4/CD8 ratio was significantly lower in patients with focal
seizure (p = 0,006).
Conclusion: This is the first study which evaluate the effect of levatirec-
etam monotherapy both on complete blood count, humoral and cellular
immunity during interictal period in children and adolescents with epi-
lepsy. It was shown that levatirecetam monotherapy did not increase the
incidence of infection and there were no significant effects on humoral or
cellular immune system in epileptic children and adolescents.
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MODELLINGCOVARIATESWHICH INFLUENCE
LAMOTRIGINE PHARMACOKINETICS IN
PAEDIATRIC PATIENTS
H. Shabbi*, D. Soler†, G. Grech‡, C. Saliba‡, D. Duca*,
I. Gabnar§, J. Mifsud¶
*University of Malta, Msida, Malta, †Mater Dei Hospital,
Department of Paediatrics, Msida, Malta, ‡University of Malta,
Department of Pathology, Msida, Malta, §University of
Ljubjana, Ljubjana, Slovenia, ¶University of Malta, Department
of Clinical Pharmacology and Therapeutics, Msida, Malta
Purpose: Paediatric populations with epilepsy offer a specific challenge
in dose individualisation since they undergo significant developmental
changes from childhood to adulthood. Population pharmacokinetic mod-
elling is able to analyze sparse data sets such as that frequently available
in paediatric populations. This study investigated the population pharma-
cokinetics of lamotrigine, in a paediatric population.
Method: In this study, pharmacokinetic models were developed using
nonlinear mixed effects modelling, NONMEM, and used in the individ-
ualisation of new-generation anti-epileptic drug therapy in paediatric epi-
lepsy. These models included the influence of covariates such as drug
plasma concentration, age, body mass index and co-administered
antiepileptic drugs.
Results: Seventeen patients were identified and plasma samples taken to
determine various parameters including drug plasma levels needed in this
study. Pharmacokinetic models developed using NONMEM investi-
gated the possible correlation of metabolising enzymes such as CYPs and
UGTs, to population pharmacokinetics. The preliminary results obtained
indicate that even though patients were of similar age and taking the same
dose of LTG, plasma concentrations differed due to possible effect of
these metabolising enzymes.
Conclusion: This research investigated how population pharmacokinet-
ics can improve therapeutic outcomes for paediatric populations with epi-
lepsy, by contributing to the individualization of drug therapy and
development of personalised medicine.
p0214
SYSTEMATIC REVIEWOFADJUNCTIVE
PHARMACOTHERAPIES FOR PRIMARY
GENERALIZED TONIC-CLONIC SEIZURES
W. Tsong*, D. Gomez-Ulloa†, H. Li*, P. Kwan‡
*Eisai Inc., Woodcliff Lake, NJ, United States, †IMS Health,
Barcelona, Spain, ‡University of Melbourne and Royal
Melbourne Hospital, Parkville, VIC, Australia
Purpose: This review compares the clinical efficacy and safety of
adjunctive treatments for primary generalized tonic-clonic seizures
(PGTCS) to assist decision-makers with making informed decisions on
treatment and reimbursement.
Method: A systematic literature review was conducted by 2 reviewers
searching Embase, Medline, and the Cochrane database. Inclusion crite-
ria: randomized, controlled trials (RCT) of antiepileptic drugs (AEDs)
approved for the adjunctive treatment of PGTCS; original research;
phase III or phase II/III; primarily adult population; English language;
and published in the years 1989–2014. Exclusion criteria: nonhuman;
intravenous drugs or surgery; case reports; studies with less than 10
patients per arm; double-blind follow-up is less than 3 months; age
groups cannot be clearly identified; and abstracts without full papers.
Indirect treatment comparisons (ITC) were performed using a network
meta-analysis approach based on Bayesian theory.
Results: Six trials were included, one each for: topiramate (TPM)
[n = 80], lamotrigine (LTG) [n = 117], levetiracetam (LEV) [n = 164],
lamotrigine-XR (LTG-XR) [n = 153], perampanel (PER) [n = 164],
gabapentin (GBP) [n = 129]. LEV and PER were the only AEDs to
report significant improvements over placebo on GTC seizure freedom.
PER was the only AED with a significant improvement on total seizure
freedom. A qualitative review of the individual adverse events (AEs)
reveals a unique spectrum for TPM (gastrointestinal) and some similari-
ties between LEV and PER (behavior). ITC results revealed no statisti-
cally significant differences between AEDs on 50% or 100% responder
or seizure freedom variables for PGTCS or total seizures. No significant
differences were observed between AEDs on withdrawal due to AEs.
Conclusion: ITC results did not show differences between AEDs on effi-
cacy or withdrawal due to AEs. It is important to note that RCTs are not
powered to show differences in ITCs. Qualitative reviews of between
trial differences may be informative in making decisions to prefer some
AEDs over others.
p0217
ANTIEPILEPTIC DRUGWITHDRAWAL FOR
TERMINALREMISSION IN PATIENTSWITH
EPILEPSY IN THEGENERAL POPULATION
G. Giussani*, E. Bianchi*, G. Erba†, J. Sander‡,§,¶, E. Beghi*,
EPIRES Study Group
*IRCCS-Mario Negri Institute for Pharmacological Research,
Milano, Italy, †University of Rochester, Department of
Neurology, SEC, Rochester, NY, United States, ‡Stichting
Epilepsie Instellingen Nederland SEIN, Heemstede, Netherlands,
§NIHR University College London Hospitals Biomedical
Research Centre, UCL Institute of Neurology, London, United
Kingdom, ¶Chalfont Centre for Epilepsy, Chalfont St Peter,
United Kingdom
Purpose: Rate, reasons and predictors of antiepileptic drug (AED) dis-
continuation for terminal remission in representative samples of patients
with epilepsy are poorly understood.
Method: The history of AED usage in children and adults with epilepsy
registered with 123 family physicians in an area of Northern Italy was
recorded. Cumulative probabilities of AED withdrawal with specific rea-
sons were estimated using cumulative incidence functions. The probabil-
ity of withdrawing AEDs for terminal remission was evaluated. The roles
of sex, age at diagnosis, seizure types, duration at diagnosis and syn-
drome were assessed with hazard ratios (HR) and 95% confidence inter-
vals (95%CI).
Results: 731/747 individuals were treated with at least one AED. The
three commonest drugs were valproate, carbamazepine and phenobarbi-
tal. Terminal remission was the most frequent reason for AED discontin-
uation followed by ineffectiveness and adverse events. The probability of
withdrawing the first AED for terminal remission was 1.0% at one year
and increased to 20.0% at twenty years. At 20 years, the variables associ-
ated with first AED withdrawal due to seizure freedom were age at diag-
nosis, sex and epilepsy syndrome. Corresponding rates for the second
drug was 13.3% and for third drug 4.3%. The 20-year probability of with-
drawal for terminal remission was 12.9% for carbamazepine, 14.8% for
phenobarbital and 27.4% for valproate. Variables associated with drug
withdrawal due to seizure freedom were sex for carbamazepine and age,
sex and syndrome for valproate. No predictors were found for phenobar-
bital.
Conclusion: Terminal remission was the commonest reason for AED
discontinuation, it could be predicted by age at diagnosis, sex and clinical
characteristics and varies among drugs.
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USEOFCANNABIDIOL (RSHO) IN THETREATMENT
OFREFRACTORYEPILEPSY (LENNOX-GASTAUT
SYNDROME), EXPERIENCEOF 38 CASES
S.J. Garza Morales*, O. Benavides Aguilar†, E. Bastida
Mercado‡
*National Institute of Perinatology, Neuroscience,
Huixquilucan, Mexico, †Hospital Espa~nol, Unidad de
Neurodesarrollo, Pediatrıa, Mexico City, Mexico, ‡Instituto
Mexicano del Seguro Social, Hosp. General Regional 251,
Toluca, Mexico
Introduction: The LGS remains as one of the most severe childhood
encephalopathies with high seizure frequency (sudden falls, myoclonic
and tonic), progressive cognitive impairment and antiepileptic drugs
(AED) resistance.
Method: Between January 2016 and February 2017 we included in the
study 45 patients with Lennox-Gastaut Syndrome (According to the crite-
ria of the ILAE) with persistence of various seizures per day despite tak-
ing at least three anti-epileptic drugs. Seven patients were excluded from
the study (one having started with a THC-containing compound and six
who decided not to start the treatment).
Results: The remaining 38 cases took cannabidiol 100 pure (RSHO
5000) in progressive doses of up to 5–7 mg/kg for at least 6 months of
follow-up. All patients had imaging studies (CT or MRI) and at least two
EEG studies. 50% presented hypoxic-ischemic encephalopathy or corti-
cal malfromations. All patients continued to take basal AED (3.7 per
patient). The age was of 10.9  6 years (23/38 patients are male). All
patients had various types of seizures (3.5/patient), dominating the atonic
(73%) and focal (86%). 4 patients were callotomized for refractory epi-
lepsy. A significant reduction in the frequency of seizures (≥ 50%) was
obtained in 86% of the cases (33/38) and 55% of the cases achieved an
overall reduction of over 75% (21/38). A complete control of the events
for at least 4 months was achieved in 5 cases (13%), an outstanding result
for this type of patient. The seizures that achieved better results were ato-
nic, absent and generalized tonic (30–100%), while focal seizures
responded less to treatment (0–70%). Other benefits were observed in
89% of patients: alertness (43%), social interaction (40%), attention
(30%), etc.
Conclusion: Addition treatment with 100% Cannabidiol is a good alter-
native for patients with LGS and reduces the use and potential effects of
tetrahidrocanabinol (THC).
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TOLERABILITYOFANTIEPILEPTIC DRUGS
B.A. Alsfouk*, M.J. Brodie*
*Epilepsy Unit, West Glasgow ACH-Yorkhill, Glasgow,
Scotland, United Kingdom
Purpose: To evaluate the rate of adverse effects in a cohort of adult
patients with newly diagnosed epilepsy. We also aimed to assess the
association between poor tolerability and associated factors, including
individual antiepileptic drugs (AEDs), dosage, age, gender, epilepsy clas-
sification, psychiatric comorbidities and number of concomitant agents.
Method: We retrospectively reviewed the medical records of all newly
diagnosed patients aged ≥ 18 followed up in the Epilepsy Unit for at least
two years after starting AED therapy during a 30-year period from July
1982 until November 2012.
Results: The study cohort included 1528 patients aged 18 to 93 years
(median 37 years). Overall, 849 (56%) were men and 1290 (84%) had
focal epilepsy. The incidence of adverse effects was 28% (n = 815/
2911). Tiredness was the most frequent problem associated with AED
usage. The incidence was 5.2% (n = 152/2911), which represented 19%
(n = 152/815) of all patients reporting adverse effects. Among seventeen
different AEDs, lamotrigine appeared to be best tolerated (15%,
n = 143/962), while retigabine had the highest level of reported adverse
effects (42%, n = 8/19).The rash rate was higher with carbamazepine
(6.6%, n = 33/496) than with lamotrigine (4.2%, n = 40/962). Levetirac-
etam was poorly tolerated in 9% (n = 46/514) of patients due to
psychiatric side effects, which accounted for 41% (n = 46/112) of leve-
tiracetam’s overall poor tolerability. Female gender, focal seizures and
psychiatric comorbidities were associated with higher rates of adverse
effects. Likewise, an increasing number of co-prescribed AEDs corre-
lated with poor tolerability. However, older AEDs usage was not signifi-
cantly associated with poorer outcomes.
Conclusion: The incidence of adverse effects with AEDs was 28%, of
which tiredness was the most frequent problem. Lamotrigine was the best
tolerated AED, while retigabine was associated with the highest rate of
adverse effects. Poor tolerability was higher in females and in patients
with focal epilepsy, psychiatric comorbidities and those established on
AED polytherapy.
p0230
EVALUATIONOF PERAMPANEL IN PATIENTSWITH
INTELLECTUALDISABILITYANDEPILEPSY
F.M. Snoeijen-Schouwenaars*, J.S. van Ool*, I.Y. Tan*,
H.J. Schelhaas†, H.J.M. Majoie†,‡,§
*Academic Centre for Epileptology Kempenhaeghe, Department
of Residential Care, Heeze, Netherlands, †Academic Centre for
Epileptology Kempenhaeghe, Department of Neurology, Heeze,
Netherlands, ‡School of Mental Health and Neuroscience,
Maastricht University Medical Center, Maastricht, Netherlands,
§School of Health Professions Education, Maastricht University,
Faculty of Health, Medicine and Life Sciences, Maastricht,
Netherlands
Purpose: Initial registration studies of Perampanel (PMP) have now
been followed up by ‘clinical’ studies that confirmed the efficacy and
safety in patients with refractory epilepsy. This study extends the knowl-
edge for patients with both ID and epilepsy and specifies behavioral side
effects of PMP in this specific population.
Method: Retrospective evaluation of medical records at 3, 6 and
12 months of follow-up after the initial start of PMP.
Results: 62 patients were included. All patients had complete data of
6 months follow-up and 42 patients were reviewed with a 1-year follow-
up. Level of ID varied from borderline to profound, mild ID was most
common (43.5%). The mean maximum dosage PMP was 5.6 mg (range
1–12 mg). Retention rates for PMP were 87.1% and 67.7% after three
and six months. A trend indicated a longer mean retention time in patients
with a more severe ID. Seizure reduction was achieved in 53.2%. 36
patients (58.1%) experienced adverse effects, 80.6% within 3 months.
45.2% of the patients experienced somatic adverse effects like fatigue &
sleep problems, motor problems & unsteadiness, and gastrointestinal
problems. Behavioral adverse effects were present in 40.3%. Most com-
mon were aggression, agitated behaviour, disruptive behaviour and mood
symptoms. Reasons for discontinuation of PMP were lack of efficacy in
14.8%, intolerable adverse effects in 44.4%, and a combination of both in
40.7%. Altogether, 24.2% of the patients achieved seizure reduction
without experiencing adverse effects, though none reached seizure free-
dom.
Conclusion: The use of PMPmight lead to an effective seizure reduction
without experiencing adverse effects in a minority of patients with both
epilepsy and ID. Pre-existing behavioral problems or polypharmacy do
not predict the occurrence of additional behavioral adverse effects.
Patients should, ideally, be monitored at a multidisciplinary clinic.
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LACOSAMIDE IN PATIENTSWITHBRAIN TUMOR
RELATEDEPILEPSY: EFFECTON SEIZURE
CONTROLANDQUALITYOFLIFE
M.Maschio*, A. Zarabla†, A. Maialetti†, A. Fabi‡, A. Vidiri§,
V. Villani¶, D. Giannarelli**
*Regina Elena National Cancer Institute, Center for Tumor-
Related Epilepsy- UOSD Neurology, Rome, Italy, †Regina Elena
National Cancer Institute, Center for tumor-related epilepsy-
UOSD Neurology, Rome, Italy, ‡Regina Elena National Cancer
Institute, Department of Oncology, Rome, Italy, §Regina Elena
National Cancer Institute, Department of Radiology, Rome,
Italy, ¶Regina Elena National Cancer Institute, UOSD
Neurology, Rome, Italy, **Regina Elena National Cancer
Institute, Biostatistic Unit, Rome, Italy
Purpose: We propose a prospective study with a historical control group
to evaluate the effect of Lacosamide (LCM) as add-on on seizure control
and quality of life in patients with brain tumor-related epilepsy (BTRE).
This study has been designed to test the superiority of Lacosamide over
Levetiracetam as an add-on.
Method: We recruited 25 patients (M 18, F 7; mean age 41.9). Patients
were evaluated at baseline, after 3 months and at final follow-up at
6 months. Patients underwent QoL tests and test for adverse events.
Results: Twelve patients had high-grade gliomas, thirteen low-grade
gliomas. Thirteen patients underwent chemotherapy, three radiotherapy
and five had disease progression. Four patients dropped out due to poor
compliance and 1 for inefficacy. Mean number of seizures significantly
decreased from baseline (9.4) to 3 months (0.8) (P = 0.005) and to
6 months (1.2) (P = 0.005). At final follow-up in the subgroup of 22
evaluable patients (i.e. LCM dose greater than 100 mg/day) 7 patients
were seizure free, 12 patients have significant reduction of seizures ≥
50%, 2 patients were stable and 1 patient number of seizures increased.
The Responder Rate was 86.4%. No clinical side effects were observed.
No significant differences were observed at 3 and 6 months for all QoL
tests. We found a significant reduction in the mean score of Karnofsky
Performance Status and Barthel Index between baseline and final follow-
up (KPS p = 0.003; BI p = 0.007). Comparing the LCMwith the histori-
cal group treated with LEV in add-on (n = 19), we observed that both
drugs have comparable clinical efficacy.
Conclusion: Our preliminary data seem to indicate that LCM showed
good efficacy in patients with BTRE and seems not to induce significant
side effects. We did not observe any significant changes in QoL tests,
indicating stability in all QoL domains explored, despite the objective
worsening in their functional status.
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ANOBSERVATIONAL, POST-MARKETING STUDYOF
ADJUNCTIVE BRIVARACETAM IN PATIENTSWITH
FOCAL SEIZURES IN EUROPE: INTERIMANALYSIS
OF 6-MONTHDATA
B.J. Steinhoff*, Y. Weber†, T. Mayer‡, L. Joeres§, J. Sacre¶,
C. Loesch§, M. De Backer¶, A. Diaz**, C. Elger††
*Kork Epilepsy Centre, Kehl-Kork, Germany, †University of
T€ubingen, T€ubingen, Germany, ‡Saxon Epilepsy Centre
Radeberg, Radeberg, Germany, §UCB Pharma, Monheim,
Germany, ¶UCB Pharma, Brussels, Belgium, **UCB Pharma,
Smyrna, GA, United States, ††University of Bonn, Bonn,
Germany
Purpose: To report interim results after 6 months of treatment from an
observational study of patients ≥16 years old with focal (partial-onset)
seizures receiving adjunctive brivaracetam (BRV) in real-world clinical
practice in Europe.
Method: In this multinational, non-interventional, post-marketing study
(NCT02687711), patients received adjunctive BRV according to normal
clinical practice. Planned recruitment is 430. Patients will be evaluated at
baseline, 3, 6 and 12 months. Analyses at cut-off (5 October 2016)
included 3- and 6-month retention rate and ≥50% responder rate (focal
seizures). Therefore, data are not final.
Results: To date, 109 patients have been recruited (all in safety set and
full analysis set; Germany n = 100; Denmark n = 6; UK n = 3); 39 dis-
continued the study. Patients had a mean duration of epilepsy 24.6 years,
baseline median focal seizure frequency/28 days 6.2, 53.2% had taken
>6 and 22.9% had taken 4–6 previous antiepileptic drugs. Most common
reason for initiating BRV was lack of efficacy of previous treatment
(88.1%). The majority (91/95; 95.8%) started BRV treatment at a thera-
peutic dose (50–200 mg/day); 73/95 (76.8%) started according to licence
with 50 or 100 mg/day dose. Retention rate was 86.3% at 3 months;
63.2% at 6 months. ≥50% responder rate was 43.9% at 3 months (25/
57); 55.6% at 6 months (10/18). Incidence of treatment-emergent
adverse events (TEAEs): 46/109, 42.2%; serious TEAEs: 8/109, 7.3%;
discontinuations due to TEAEs: 17/109, 15.6%; drug-related TEAEs (ad-
verse drug reactions [ADRs]): 28/109, 25.7%. Most frequent ADRs
(>5%) were fatigue (6/109; 5.5%) and seizure (discontinuation due to sei-
zure worsening, seizure increase, seizure worsening, seizures) (6/109;
5.5%).
Conclusion: This interim analysis of 6-month data from an observa-
tional, post-marketing European study in clinical practice suggested
BRV had good tolerability in this highly refractory population. Final
retention rate including data from other countries may differ from this
data cut. Study supported by UCB Pharma.
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ADJUNCTIVE BRIVARACETAM IN PATIENTSWITH
SECONDARILYGENERALIZED TONIC-CLONIC
SEIZURES ATBASELINE: POOLEDRESULTS FROM
LONG-TERMFOLLOW-UP STUDIES
B.D. Moseley*, A. Diaz†, S. Elmoufti‡, J. Whitesides‡
*University of Cincinnati, Cincinnati, OH, United States, †UCB
Pharma, Smyrna, GA, United States, ‡UCB Pharma, Raleigh,
NC, United States
Purpose: Brivaracetam (BRV), a selective, high-affinity ligand for
synaptic vesicle protein 2A (SV2A), is a new antiepileptic drug (AED)
for adjunctive treatment of focal (partial-onset) seizures in adults. This
post-hoc analysis evaluated long-term efficacy and tolerability of adjunc-
tive BRV in patients with baseline secondarily generalized tonic-clonic
seizures (SGTCS; Type IC).
Method: Adults with focal seizures with SGTCS among their baseline
seizures were identified from core Phase III studies (NCT00490035,
NCT00464269, NCT01261325), as were those who entered the subse-
quent open-label, long-term follow-up (LTFU) studies (NCT00175916,
NCT00150800, NCT01339559). Patients received BRV ≤200 mg/day
during LTFU. Efficacy data for protocol-specified time points
≤60 months and tolerability data over 1–60 months of follow-up are
reported for patients who had received placebo or BRV 50–200 mg/day
in core studies.
Results: At core study baseline, patients had mean duration of epilepsy
of 22.2 years; 28.4%, 38.9% and 32.8% had received 01, 24 and ≥5
previous AEDs. Baseline median seizure frequency/28 days was 8.1 (fo-
cal) and 3.0 (SGTCS only). Of 409 patients with baseline SGTCS, 325
entered LTFU studies. In the 12-, 24-, 36-, 48- and 60-month cohorts,
respectively, 150, 89, 73, 68 and 57 patients had BRV exposure and sei-
zure diary data, and ≥50% responder rates for SGTCS were 75.3%,
78.7%, 80.8%, 79.4% and 78.9%. Median percent reduction from base-
line in SGTCS frequency/28 days was 81.1%, 84.0%, 89.2%, 91.0% and
90.6%, respectively. In 296 patients with SGTCS at baseline (safety pop-
ulation), incidence of treatment-emergent adverse events (TEAEs) over
1–60 months’ LTFU was 222/296 (75.0%); discontinuations due to
TEAEs: 25/296 (8.4%); drug-related TEAEs: 111/296 (37.5%); serious
TEAEs: 52/296 (17.6%); drug-related serious TEAEs: 14/296 (4.7%);
deaths: 4/296 (1.4%).
Conclusion: Long-term adjunctive BRV treatment reduced SGTCS fre-
quency and was generally well tolerated up to 60 months in patients with
SGTCS at baseline. Study supported by UCB Pharma.
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BANISHINGVALPROIC ACIDDURING PREGNANCY:
ALWAYSREWARDING? SEIZURE FREQUENCYAND
ANTIEPILEPTIC DRUGTREATMENTDURING
PREGNANCYANDDELIVERY INWOMENWITH
EPILEPSY - A RETROSPECTIVE SINGLECENTER
STUDY
B. Shihman*, N. Amiel*, F. Benninger*
*Rabin Medical Center, Neurology, Petah Tikva, Israel
Purpose: Antiepileptic drugs (AED) are common teratogenic drugs pre-
scribed to women of childbearing age. AED can induce both anatomical
and behavioral teratogenicity; the risk is markedly increased by the use
of Valproic Acid (VPA). On the other hand, the benefit of preventing sei-
zures by AED treatment during pregnancy is still controversial. Our pri-
mary goal was to observe and AED treatment policy regarding a
relatively long period.
Method: We investigated all cases of female epileptic patients admitted
for labor at the Rabin Medical Center, Petah Tikva, Israel, from 2005 to
2015.
Results: 297 deliveries were recorded in 235 women with known epi-
lepsy. 135 labors occurred in 2005–2010 (27/y) and 162 in 2011–2015
(32.4/y; increase of 20%). The percentage of women experiencing sei-
zures during pregnancy was 23.3 % and unchanged during the observed
period (2005–2010: 22.9% vs. 2011–2015: 23.0%; p = 0.92). A trend for
decreased seizures at delivery was observed (13.3% vs. 10.5%) but not
significant (p > 0.05). Our cohort was treated with ten different AED.
Lamotrigine (LTG) and Carbamazepine (CBZ) were the most commonly
used (35% and 36% respectively; total: 60.9%). Their use did not change
over the examined period (LTG: 35% vs. 36.4%; CBZ: 24% vs. 26%;
p > 0.05). The use of VPA for pregnant women with epilepsy was less
compared to LTG or CBZ (13.5% vs. 60.9%) and its use decreased dra-
matically by 50% regarding the two time episodes observed (18% vs.
9.3%; p = 0.04). However, the percentage of women with combination
of several AED increased from 10.4% to 13.6%.
Conclusion: We detected a general increase of pregnancies in epileptic
patients during 2005–2015. There is a tendency for a reduction in seizure
frequency on delivery without difference of seizures quantity during
pregnancy. We can confirm a marked 50% decline in the use of VPA but
with 20% elevation of AED combination use.
p0237
THERAPEUTIC DRUGMONITORING FOR
PERAMPANEL IN JAPANESE PATIENTSWITH
EPILEPSY
Y. Yamamoto*, N. Usui*, T. Nishida*, Y. Takahashi*, K. Imai*,
Y. Inoue*
*National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy
and Neurological Disorders, Clinical Research, Shizuoka, Japan
Purpose: Perampanel is a novel antiepileptic drug (AED) that is metabo-
lized by cytochrome P450 (CYP) 3A4. The purpose of this study was to
evaluate the influence of concomitant AEDs on serum perampanel con-
centration.
Methods: A total of 242 serum samples obtained from 83 patients (aged
12 years to 69 years) were analyzed using routine therapeutic drugmoni-
toring data, and the concentration-to-dose ratio (CD ratio) of perampanel
was compared among patients on various AED regimens. The study pro-
tocol was approved by the ethical committee of National Epilepsy Center
(Shizuoka, Japan).
Results: There was a strong linear correlation between the dose of per-
ampanel and its concentration in patients with and without enzyme induc-
ing AEDs. The mean CD ratio in patients without enzyme inducing
AEDs was 3,962 ng/mL/mg/kg. In contrast, the mean CD ratio in
patients receiving enzyme inducing AEDs, such as phenytoin, phenobar-
bital, and carbamazepine was 1780, 2,465, and 1,268 ng/mL/mg/kg,
respectively, and carbamazepine significantly reduced the CD ratio in
comparison with phenytoin or phenobarbital (p < 0.001).
Conclusions: Perampanel shows large variation of its dose to serum con-
centration relationship depending on the concomitant AEDs, because its
metabolism is highly susceptible to interactions with enzyme inducing
drugs. Our findings show that therapeutic drug monitoring for peram-
panel is clinically useful to estimate CYP3A4-mediated metabolic reac-
tions.
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TREATMENTWITHCANNABIDIOL (CBD)
SIGNIFICANTLYREDUCES DROP SEIZURE
FREQUENCY IN LENNOX-GASTAUT SYNDROME
(LGS): RESULTSOFAMULTI-CENTRE,
RANDOMISED, DOUBLE-BLIND, PLACEBO-
CONTROLLED TRIAL (GWPCARE4)
M.Mazurkiewicz-Beldzinska*, E.A. Thiele†, S. Benbadis‡,
E.D. Marsh§, C. Joshi¶, J.A. French**, C. Roberts††, A. Taylor††,
K. Sommerville‡‡
*Medical University of Gdansk, Gdansk, Poland,
†Massachusetts General Hospital, Boston, MA, United States,
‡University of South Florida, Tampa, FL, United States, §The
Children’s Hospital of Philadelphia, Philadelphia, PA, United
States, ¶Children’s Hospital Colorado, Aurora, CO, United
States, **NYU Langone Medical Center, New York, NY, United
States, ††GWResearch, Ltd, Cambridge, United Kingdom,
‡‡Greenwich Biosciences, Inc, Carlsbad, CA, United States
Purpose: Evaluate efficacy of CBD added to antiepileptic drug (AED)
therapy for the treatment of seizures associated with LGS.
Method: Eligible patients were 2–55 years old and had a clinical diag-
nosis of LGS, ≥8 drop seizures during 4 week baseline (≥2/week), and
documented failures on ≥1 AED. Patients were randomised (1:1) to
receive 20 mg/kg/day CBD (oral solution) or matched placebo for
14 weeks (2-week titration; 12-weekmaintenance). The primary efficacy
endpoint was percentage change from baseline in drop seizure frequency
over the entire 14-week treatment period for patients on CBD vs. pla-
cebo.
Results: 171 patients were randomised (86 CBD; 85 placebo); 14 CBD
and 1 placebo patient withdrew. Groups were similar at baseline; mean
age was 15 years (34% of patients ≥18 years) and median drop seizures/
month was 74. Patients had previously taken a median of 6 AEDs, and
were taking a median of 3 concomitant AEDs. CBD resulted in a signifi-
cantly greater median percent reduction in monthly drop seizures than
placebo (44% vs. 22%; p = 0.0135) and a significantly greater ≥50%
responder rate (44% vs. 24%; p = 0.0043). The treatment difference was
established in first 4 weeks of the maintenance period. Adverse events
(AEs) were reported in 86% of CBD and 69% of placebo patients, and
were mostly mild to moderate; those >10% were diarrhoea, somnolence,
pyrexia, decreased appetite, and vomiting. Treatment-related serious
AEs were reported in 9 CBD patients and 1 placebo patient. Some eleva-
tions in transaminases were noted without elevations of bilirubin; most
were on concomitant valproate and all resolved. There was 1 death (CBD
group), considered unrelated to treatment.
Conclusion: Results from this trial suggest that CBD add-on therapy for
the treatment of drop seizures associated with LGS may be efficacious,
with more AEs than placebo, but generally well tolerated. (Funded by
GWResearch, Ltd; NCT02224690)
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CANNABIDIOL (CBD) IN DRAVET SYNDROME: A
RANDOMISED, DOSE-RANGING
PHARMACOKINETICS AND SAFETYTRIAL
(GWPCARE1)
S. Wright*, O. Devinsky†, E.A. Thiele‡, M.H. Wong§,
R. Appleton¶, A.D. Patel**, C.L. Harden††, K. Sommerville‡‡,
S. Greenwood*, G. Morrison*
*GWResearch, Ltd, Cambridge, United Kingdom, †NYU
Langone Medical Center, New York, NY, United States,
‡Massachusetts General Hospital, Boston, MA, United States,
§Wake Forest Baptist Medical Center, Winston-Salem, NC,
United States, ¶Alder Hey Children’s Hospital, Liverpool,
United Kingdom, **Nationwide Children’s Hospital, Columbus,
OH, United States, ††Mount Sinai Health System, New York, NY,
United States, ‡‡Greenwich Biosciences, Inc, Carlsbad, CA,
United States
Purpose: Evaluate the dose-ranging safety, tolerability, and pharma-
cokinetics (PK) of CBD in children with Dravet syndrome (DS).
Method: Patients aged 4–10 years completed a 4-week baseline period
and were randomised 4:1 to 1 of 3 CBD doses (5, 10, 20 mg/kg/day) or
placebo as add-on therapy for 3 weeks. CBD (25 or 100 mg/mL oral
solution) was administered BID starting at 2.5 mg/kg/day and increasing
by 2.5 mg/kg QOD to randomised dose. On Days 1 and 22, PK exposures
were expressed as AUC0-t. Dose proportionality was assessed on Day 22
by regression analysis. Adverse events (AEs) were recorded daily.
Results: 34 patients were randomised to CBD 5 mg/kg/day (n = 10),
10 mg/kg/day (n = 8), 20 mg/kg/day (n = 9), or placebo (n = 7).
Patients took a median 3 antiepileptic drugs (AEDs). On Day 22, expo-
sures to CBD and major metabolites increased dose-proportionally; there
was minimal change in clobazam levels, but concentrations of cloba-
zam’s metabolite, N-clobazam, increased independent of CBD dose,
except in patients on stiripentol. There was no demonstrable effect on
other AEDs (valproic acid, topiramate, stiripentol, levetiracetam). Most
common AEs (CBD vs. placebo) were pyrexia (22% vs. 0%), somno-
lence (19% vs. 14%), decreased appetite (19% vs. 0%), and sedation
(15% vs. 0%). Treatment-related serious AEs occurred in 2 patients on
CBD and discontinuations due to AEs occurred in 2 patients on CBD.
Increases in ALT or AST (levels >3 9 ULN) occurred in 6 patients on
CBD, all on valproic acid; none had elevated bilirubin and all recovered.
Conclusion: CBD was well tolerated and 20 mg/kg/day was chosen for
further development. Exposure to CBD and its metabolites increased
dose-proportionally. A PK interaction of CBD on N-clobazam was
observed, likely mediated through CYP2C19 inhibition, except with
stiripentol, presumably from prior saturated inhibition of CYP2C19 by
stiripentol. (Funded by GWResearch, Ltd; NCT02091206)
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EPIDEMIOLOGY IN PRECLINICAL EMERGENCY
CARE IN EPILEPSY - VALIDATIONOF PREHOSPITAL
EPILEPSY EMERGENCY SCORE (PEES)
T. Kniess*, H. Stefan†
*Clinic of Neurology, Bad Neustadt, Bad Neustadt, Germany,
†University of Erlangen, Clinic of Neurology, Erlangen,
Germany
Purpose: In preclinical emergency cases of sudden loss of consciousness
it is difficult to distinguish between syncope and epileptic seizure. There-
fore the risk of false diagnosis or mistreatment increases and this however
leads to an increase in mortality and morbidity of status epilepticus. We
aim to develop an easy to handle score for the preclinical setting which is
able to discriminate between syncope and epileptic seizure based on easy
clinical signs.
Method: Open label longitudinal epidemiological study with statistical
analysis of all emergency care reports in patients with seizure or loss of
consciousness in the emergency room in the time between 2016/01/01
and 2016/09/30. In the emergency room PEES will be raised by rescue
service members of our medical team. After hospital stay and diagnostic
investigation initial PEES will be compared to the final diagnosis in order
to distinguish between syncope and seizure by a cut-off value ≥ 5 points
in PEES. Additionally we will validate sensitivity and specificity.
Results: N = 141 are statistically analysed.Preclinical emergency medi-
cation given by rescue team n = 28 (20%), intravenous midazolam 62%,
diazepam 35%, given by layman or family members n = 4 (5%), only
lorazepam oral. Seizure associated injuries n = 27 (19%) from that 17%
were serious cases with medical treatment consequences. Seizure relapse
occur 4 time (3%) during transportation to ER.The total-sum-score
demonstrates results with respect to sensitivity 0.62 and specificity 0.71.
Conclusion: The PEES records basic clinical signs for both, syncope
and epileptic seizures. By a cut-off value for seizures defined as 5 or more
points the score system showed moderate sensitivity and better speci-
ficity. Due to the recent results under real conditions in the emergency
room, the score should be tested in a field project in prehospital emer-
gency situations.We expect ever higher sensitivity and specificity.
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SEROTONIN REUPTAKE INHIBITORUSEAND
MORTALITY IN EPILEPSY: FINDINGS FROMA
CONTEMPORARY LINKEDELECTRONICHEALTH
RECORDSCOHORT STUDY
C. Josephson*,†,‡,§, A. Gonzalez-Izquierdo¶,**, S. Denaxas¶,**,
N. Fitzpatrick¶,**, T. Sajobi†,‡,§,††, J. Engbers‡‡, S. Patten†,‡,§,§§,
N. Jette*,†,‡,§, S. Wiebe*,†,‡,§,††
*University of Calgary, Clinical Neurosciences, Calgary, AB,
Canada, †University of Calgary, O’Brien Institute of Public
Health, Calgary, AB, Canada, ‡University of Calgary, Hotchkiss
Brain Institute, Calgary, AB, Canada, §University of Calgary,
Community Health Sciences, Calgary, AB, Canada, ¶Farr
Institute of Health Informatics Research, London, United
Kingdom, **University College London, Institute of Health
Informatics, United Kingdom, ††University of Calgary, Clinical
Research Unit, Calgary, AB, Canada, ‡‡Desid Labs Inc.,
Calgary, AB, Canada, §§University of Calgary, Psychiatry,
Calgary, AB, Canada
Purpose: To examine whether serotonin reuptake inhibitors (SRIs) are
associated with improved all-cause and possible seizure-specific mortal-
ity in patients with epilepsy.
Methods: We extracted a cohort of patients with epilepsy from The Clin-
icAl Research using LInked Bespoke studies and Electronic health
Records (CALIBER) resource. Active epilepsy patients were defined by
failure to achieve 12-month seizure-freedom over the duration of follow-
up. The outcomes were all-cause and possible seizure-specific mortality
(a composite outcome) treating SRI use as a time varying covariate (ex-
posure occurred after the second SRI prescription). Cox regression and
competing risk models with Firth correction were used in these analyses.
Results: We identified 2,718,952 eligible patients in CALIBER of
whom 16,379 (060%) had epilepsy and 11,938 had active epilepsy. Med-
ian age and follow-up were 44 (interquartile range [IQR] 30–62]) and
5.9 years (IQR 2.7–10.2 years) respectively. A total of 1526 patients
(13%) had at least two SRI prescriptions. The hazard of all-cause mortal-
ity was significantly elevated following a second prescription for an SRI
(hazard ratio [HR] 161, 95% confidence interval [95%CI] 1.37–1.89;
p < 0001). A higher risk was found in 180,199 age, sex, and GP practice
matched controls without epilepsy (HR 205, 95%CI 1.91–2.18;
p < 0001). There was no significant difference in the hazard of possible
seizure-related death whether analysed by time-varying exposure to a
second SRI (HR 1.01, 95%CI 0.46–2.20; p = 0.972) or during discrete 6-
and 12-month epochs.
Conclusion: Patients with active epilepsy exposed to an SRI appear to
be at increased risk of all-cause mortality, though the risk is lower than
that for a matched population without epilepsy. Randomized controlled
trials are impractical based on these data, therefore indicating that large
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studies with systematically collected clinical data are needed to shed fur-
ther light on these findings.
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ANTIEPILEPTIC DRUGS-INDUCEDHYPONATREMIA:
REVIEWANDANALYSIS OF 560 PATIENTS
T. Intravooth, M. Bacher, B. Hillenbrand, R. Kornmeier,
C. Kurth, A.M. Staack, J. Stockinger, B.J. Steinhoff
Epilepsy Center Kork, Kehl-Kork, Germany
Purpose: It has been supposed that eslicarbazepine actetate (ESL) might
be an appropriate alternative to carbamazepine (CBZ) and oxcarbazepine
(OXC) due to better efficiency. One crucial aspect of safety is the drug-
induced hyponatremia. We investigated the impact on serum sodium
levels in 560 adult patients under antiepileptic drug therapy including
CBZ, ESL and OXC.
Method: We reviewed medical records of patients with epilepsy in our
in-patient clinic for adults at our center in 2015. We analysed the serum
sodium levels and attempted to identify the association between hypona-
tremia and various factors in epilepsy patients.
Results: Hyponatremia was present in 76 (14%) of our 560 patients. The
hyponatremia was mostly mild (10%). After adjusting for age and gen-
der, OXC and ESL remained a significant risk factor for hyponatremia.
No statistically significant differences in frequency of hyponatremia
between OXC (47%) and ESL (33%) groups were observed. We also
found that the serum sodium level was correlated with the dose of OXC
(r = -.19, p = .03) and the blood serum level of OXC (r = -.23, p = .01)
but not with the dose or the serum level of ESL. The multiple regression
analysis identified the significant interaction between age and ESL on
sodium serum level (p < .03), suggesting that the effect of age on the
sodium serum level depended on whether or not the patients received
ESL. In other words, elderly patients who received ESL were more sus-
ceptible to hyponatremia.
Conclusion: The frequencies of hyponatremia induced by ESL and by
OXC are not different. Unlike the OXC-induced hyponatremia, the
ESL-induced hyponatremia is not dose related and occurs more distinct
in elderly epilepsy patients. In elderly patients ESL should be considered
with caution.
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BREAKTHROUGH SEIZURES - FURTHERANALYSIS
OF THE STANDARDVS. NEWANTIEPILEPTIC DRUGS
(SANAD) STUDY
L. Bonnett*, G. Powell†, C. Tudur Smith*, A. Marson†
*University of Liverpool, Department of Biostatistics, Liverpool,
United Kingdom, †University of Liverpool, Department of
Molecular and Clinical Pharmacology, Liverpool, United
Kingdom
Purpose: A breakthrough seizure is an epileptic seizure that occurs fol-
lowing a period of seizure freedom on antiepileptic drugs. Despite the
severity and consequences of breakthrough seizures very few publica-
tions exist that examine factors associated with a breakthrough seizure
and outcomes following such a seizure. We therefore developed prognos-
tic models for risk of a breakthrough seizure, risk of seizure recurrence
after a breakthrough seizure, and likelihood of achieving 12-month
remission following a breakthrough seizure.
Methods: We analysed data from the SANAD study. This long-term ran-
domised trial compared treatments for patients with newly diagnosed epi-
lepsy. Multivariable regression modelling was used to investigate how
clinical factors affect the probability of each outcome.
Results: 34% of recruited patients had a breakthrough seizure. Of these,
44% achieved a subsequent period of 12-month remission. Significant
factors for risk of a breakthrough seizure following 12-month remission
were neurological insult, number of tonic-clonic seizures by achievement
of 12-month remission, and time taken to achieve 12-month remission.
Significant factors for risk of seizure recurrence following a break-
through seizure were total number of drugs attempted to achieve
12-month remission, time to achieve 12-month remission prior to break-
through seizure, and breakthrough seizure treatment decision. Significant
factors for likelihood of achieving 12-month remission after a break-
through seizure were gender, age at breakthrough seizure, time to achieve
12-month remission prior to breakthrough, and breakthrough seizure
treatment decision.
Conclusions: The describedmodels can be used to identify patients most
likely to have a breakthrough seizure, most likely to have a seizure recur-
rence following a breakthrough seizure, and most likely to achieve
12-month remission following a breakthrough seizure. This will help to
stratify patients for likely outcome following a breakthrough seizure, as
for some the breakthrough heralds the development of treatment refrac-
toriness, whilst for the majority seizure control will be regained.
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ANATIONAL PROFILEOFNEURODEVELOPMENTAL
DISABILITIES IN CANADIANCHILDREN: DATA
FROMTHENATIONALLONGITUDINAL STUDYOF
CHILDRENANDYOUTH
A. Prasad*,†, B. Corbett‡,§
*Faculty of Medicine, Schulich School of Medicine & Dentistry,
Pediatrics and Clinical Neurosciences, London, ON, Canada,
†Children’s Hospital, London Health Sciences Centre,
Pediatrics and Clinical Neurosciences, London, ON, Canada,
‡Western University, Ivey School of Business, London, ON,
Canada, §Rajamangala University of Technology, Thanyaburi,
Thailand
Purpose: National data on the prevalence of various developmental dis-
abilities in Canada are not presently available. There are larger implica-
tions for health care costs and development of targeted health care
interventions.
Methods: We analyzed data from 3 cycles of Canada’s National Longi-
tudinal Survey of Children and Youth. The presence of neurodevelop-
mental disabilities (NDD) was self-reported and included; Epilepsy,
Cerebral palsy, Intellectual disability, Learning disability, Emotional and
nervous difficulties. Information on parental income status (income ade-
quacy groups; Low, Middle, High) and residence (Rural vs. Urban loca-
tion) was also surveyed in cycle 3.
Results: Cross sectional prevalence rates for the four NDD in children
from birth- 15 years across cycle 1–3 of the NLSCY show an increasing
trend over the years 1994 to 1999. Population based estimates were also
calculated from Census data. There was a clear male preponderance
observed across all the four neurological conditions surveyed. There was
a statistically significant relationship between income adequacy and epi-
lepsy (Low Exp(B)1.105 (95% CI 1.053, 1.159), and emotional nervous
disorders (Low, Exp(B)=1.50 (95% CI 1.03, 2.18; p = 0.035) High Exp
(B)=-0.55 (95% CI 0.41, 0.75; p = 0.001). Children in rural locations
had a lower odds of learning disability (Exp(B)=-0.73 (95%CI 0.58;
0.91), and emotional nervous difficulties (Exp(B)=-0.68; 95% CI 0.48,
0.96; p < 0.030).
Conclusion: Prevalence rates show an incremental trend. Male children
are more likely to experience NDD than females across the spectrum.
Income adequacy (low income groups) carries higher odds of epilepsy
and emotional nervous problems) while children in rural locations carry
lower odds for learning disabilities, emotional behavioural problems.
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INCIDENCEOFACUTE SYMPTOMATIC AND
UNPROVOKED SEIZURES, EPILEPSIES AND
EPILEPSY SYNDROMES INACOHORTOFCHILDREN
ACCESSINGGOVERNMENT PRIMARY SCHOOLS
ANDORGANIZATIONOF SEIZURES ANDEPILEPSIES
USING ILAE 2010 SYSTEM: A STUDY IN SOUTH INDIA
S.K. Jaiswal*, J. Murthy*, P.M. Reddy†, S. Sri Krishna†
*CARE Institute of Neurological Sciences, Department of
Neurology, Hyderabad, India, †NICE Hospital & NICE
Foundation, Department of Peadiatrics, Hyderabad, India
Purpose: There are no incidence studies of acute symptomatic seizures
and unprovoked seizures and epilepsies in children from developing
nations.
Method: Study cohort included 7408 children accessing education in 18
government primary schools in Hyderabad district, India. The children
registered on rolls as on January 1, 2006 were followed through first to
firth standard for new-onset seizure between January 1, 2006 to Decem-
ber 31, 2012.The data collected included demographic data, seizure
semilogy, date of seizure, neurologic findings, CT and EEG findings,
antiepileptic drugs, and follow-up data. The recent definition of epilepsy
and the system for organization of seizures and epilepsies by ILAE
(2010) were used to organize the seizure and epilepsies.
Results: During the study period, 58 children had new onset seizures:
acute symptomatic seizures in 21 [annual incidence 40.5 (95%CI 25.1–
61.9) per 100,000] and unprovoked seizures in 37 [annual incidence
71.35 (95%CI 50.2–98.35) per 100,000] children. Of the 21 children with
acute symptomatic, in 19 it was due to NCC-solitary cysticercus granu-
loma [annual incidence 36.64 (95%CI 22.1–57.2) per 100,000]. Of the 37
children with unprovoked seizure, 30 (80%) met the criteria of the new
definition of epilepsy. The annual incidence of epilepsy was 57.85 (95%
CI 39.0–82.6) per 100,000 respectively. Using new organization system
epilepsies were organized into (1) electro-clinical syndromes (genetic):
11 (36.6%), (2) non-syndromic epilepsy due to structural/metabolic
lesions: 14 (46.6), and (3) non-syndromic epilepsies due to unknown
cause: 5 (16.6%). The annual incidence rates per 100,000 were: genetic
epilepsies, both focal and generalized, 21.21 (95%CI 10.6–38.0); epilep-
sies due to structural/metabolic: 27.0 (95%CI 14.8–45.3), and epilepsies
due to unknown cause: 9.64 (95%CI 3.1–22.5).
Conclusion: This study suggests that the new definition of epilepsy and
ILAE proposed organization of seizures and epilepsies can be practiced
in the community-based studies with minimal data: seizure semiology,
EEG and CT.
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INCIDENCEOF SUDDENUNEXPECTEDDEATH IN
EPILEPSY INCOMMUNITY-BASEDCOHORT IN
CHINA
Y. Ge*, D. Ding†, Q. Zhang‡, P. Kwan§, Z. Hong¶,
J.W. Sander**,††
*Fudan University Huashan Hospital, Department of
Neurology, Shanghai, China, †Institute of Neurology, Fudan
University Huashan Hospital, Shanghai, China, ‡Ningxia
Medical University Affiliated Hospital, Department of
Neurology, Yinchuan, China, §University of Melbourne & Royal
Melbourne Hospital, Department of Medicine and Neurology,
Melbourne, VIC, Australia, ¶Huashan Hospital, Fudan
University, Department of Neurology, Shanghai, China, **NIHR
University College London Hospitals Biomedical Research
Centre, UCL Institute of Neurology, London, United Kingdom,
††Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands
Purpose: Sudden unexpected death in epilepsy(SUDEP) is associated to
the high premature mortality observed amongst people with epilepsy. It
is, however, considered a rare event in China, probably due to lack of
awareness and limitation of studies in the country. We aimed to provide
some initial estimation of the burden of SUDEP in China.
Method: We established a large Chinese community-based cohort of
people with epilepsy between January 2010 and December 2011. For any
participant who died during follow up, detailed information on cause of
death was obtained using a specifically designed Verbal Autopsy Ques-
tionnaire. All cases were reviewed by a multidisciplinary expert panel
and re-investigated if necessary. SUDEP incidence rates were estimated
and case details provided.
Results: The cohort consisted of 1,562 people with epilepsy and during a
median 5 years follow-up, 72 deaths were reported. The all-causes death
incidence was 11.23(95%CI 8.86–14.07) per 1,000 person-years. Fifteen
of the deceased died suddenly and unexpectedly in a reasonable state of
health in the week preceding death. We recorded detailed information of
these 15 deaths. Thirteen were considered to be probable SUDEP and
two possible SUDEP. The incidence of probable SUDEP was 2.03(95%
CI 1.13–3.38) per 1,000 person-years and the incidence of all suspected
(probable and possible) SUDEP was 2.34(95%CI 1.36–3.77) per 1,000
person-years.
Conclusion: The incidence of SUDEP was relatively high among Chi-
nese people with epilepsy when compared with previous community-
based studies from high-income countries. The burden of SUDEP in
China requires assessments.
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PREVALENCE, TREATMENTGAPAND
MISCONCEPTIONS ABOUTEPILEPSYAMONG
GENERAL POPULATION IN ECUADOR
J. Luna*, M. Nizard*, D. Becker†, A. Cruz‡, M. Dumas§,
M. Cruz¶, P.-M. Preux§
*Univ. Limoges, UMR_S 1094, Tropical Neuroepidemiology,
Institute of Neuroepidemiology and Tropical Neurology,
Limoges, France, †Hospital of the University of Pennsylvania
Medical Center, Penn Epilepsy Center, University of
Pennsylvania Medical Center, Pennsylvania, PA, United States,
‡NeuroLogic International, Quito, Ecuador, §INSERM, U 1094,
Tropical Neuroepidemiology, Limoges, France, ¶Ecuadorian
Academy of Neuroscience, Quito, Ecuador
Purpose: To report epidemiological data from a cross-sectional door-to-
door survey concerning prevalence, treatment gap and misconceptions
about epilepsy in urban and rural areas in Ecuador.
Method: A study to determine the barriers to access to antiepileptic
drugs was conducted in Ecuador from January 2015 until May 2016. A
door-to-door survey was performed in Turubamba (urban district in
Quito city, Andean region) and Archidona (rural district in Napo pro-
vince, Amazonian region). All study participants were 15 years of age or
older and lived more than 6 months in the study areas. A probabilistic
systematic sampling was used to determine the selected households. Par-
ticipants were interviewed using a validated and standardized question-
naire for epilepsy in tropical countries. A neurologist evaluated all the
suspected cases to confirm epilepsy diagnosis. Treatment gap was esti-
mated to a direct method. A specific questionnaire was administered con-
cerning knowledge, attitudes and practice toward epilepsy in general
population.
Results: Two hundred eighteen suspect cases were identified from 1,531
screened subjects, and 17 cases were confirmed with epilepsy in the
urban area. Two hundred forty-three suspect cases were identified from
1,551 screened, and 21 cases were confirmed in the rural area. The crude
prevalence was 11.1/1,000 [confidence interval (IC) 95%, 5.8 - 16.3] in
the urban area and 13.5/1,000 [IC 95%, 7.8 - 19.2] in the rural area. The
treatment gap was 47.1% and 66.7% in the urban and rural area, respec-
tively. Epilepsy was related to supernatural or insanity. Significant differ-
ences were found concerning misconceptions about epilepsy in the study
areas and ethnic groups.
Conclusion: The crude prevalence is similar compared to reports from
Latin America. Treatment gap continues to be a disturbing issue mainly
in rural areas. Misconceptions about epilepsy compromise the access to
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treatment. Thus, socio-cultural education strategies are needed to
increase knowledge and understanding of epilepsy.
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POSTERIORREVERSIBLE ENCEPHALOPATHY
SYNDROME IN ACUTECHILDHOODLEUKEMIA
I.G. Lee*, S.J. Kim*, D.H. Yoon*, N.G. Chung*, B. Cho*,
S.A. Im†
*Catholic University/Seoul St. Mary’s Hospital, Pediatrics,
Seoul, Korea, †Catholic University/Seoul St. Mary’s Hospital,
Radiology, Seoul, Korea
Purpose: Clinical and radiographic abnormalities of Posterior reversible
encephalopathy syndrome (PRES) usually involve a transient course with
favorable outcomes. However, clinical course of PRES varies, depending
on the underlying diseases, especially, in hematology-oncology patient-
s.This study was designed to investigate clinical manifestations, radio-
graphic features, predisposing factors and long-term neurologic and
radiologic outcomes of PRES as a complication during treatment of acute
childhood leukemia.
Method: 648 patients aged less than 18 years were treated for acute leu-
kemia at the Department of Pediatrics, Seoul St. Mary’s hospital between
January 2003 and May 2011. Among them, PRES was evident in 19 (12
males, 7 females) patients who were monitored for an average of
40.3 months after developing the complication of PRES. A retrospective
chart review was conducted on these patients to evaluate demographic
data, primary diagnoses, treatment protocols, clinical manifestations,
types of acute therapy, brain MRI and EEG findings, and neurologic and
seizure outcomes.
Results: The mean ages at time of diagnosis of PRES and primary leuke-
mia were 6.7 years and 5.4 years, respectively. Seizures comprised the
most common clinical sign (18 cases), followed by headache, confusion,
or visual disturbance. Hypertension was observed before the onset of
PRES in 6 patients. Among 18 patients who manifested seizures, 9
required long-term anticonvulant therapy because of continued epilepti-
form discharges in EEG or repeated seizure episodes. 3 patients mani-
fested recurrent seizures although they were receiving more than three
kinds of antiepileptic drugs. High signal intensities were observed at the
posterior parietal lobe (16 cases) or occipital lobe (19 cases) in brain
MRI.
Conclusion: The main predisposing factors for PRES during induction
chemotherapy seemed to include all chemotherapy regimens. When
PRES develops as a complication of acute childhood leukemia, long-term
anticonvulsant therapy is frequently required, and intractable seizures
may develop.
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CLINICAL FEATURESOF SEIZURES INHIV
PATIENTSWITHTOXOPLASMAENCEPHALITIS
A.M. Magnerou*, V. Sini†, Y. Fogoum Fogan*,
H.F.S. Ngoungoure*, L. Kaptue‡
*Cheikh Anta Diop University/Fann National Teaching
Hospital, Neurology, Dakar, Senegal, †General Hospital of
Yaounde, Neurology, Yaounde, Cameroon, ‡Universite des
Montagnes, Infectious Disease, Bangante, Cameroon
Purpose: Toxoplasma encephalitis in human immunodeficiency virus
(HIV) patients have a higher burden of seizures, but few studies in Africa
have examined seizures due to toxoplasmosis in HIV infected patients.
Methods: A prospective study was conducted in Yaounde central hospi-
tal during 2 years;the aim of the study was to determine the epidemiol-
ogy, clinical and CT-scan characteristics of seizures due to toxoplasma
encephalitis in HIV infected patients.
Results: Among a total of 60 HIV infected patients with toxoplama
encephalitis ; 24 (40%) had new-onset seizures, none of these individuals
had epilepsy before HIV infection. Most patients exhibited low (below
100, n = 16) CD4 counts. The most common seizure presentation was
partial (n = 14), followed by secondarily generalized (n = 6) and gener-
alized seizure (n = 4). Imaging studies revealed brain lesions in all
patients, all were heterogeneous with contrast enhancement in 80 % of
cases. Lesions were multiple, supratentorial in 70% of cases. Most sei-
zures were controlled without antiepileptic drugs (n = 18) or with a sin-
gle antiepileptic drugs (benzodiazepine n = 3, valproic acid n = 3 for a
few weeks). All patients received treatment for toxoplasmosis and
antiretrovirals.
Conclusion: Often occur in severe immunosuppressive conditions, new-
onset seizures due to toxoplasma encephalitis in HIV infected patient are
common, with a benign clinical course and few complications, these sei-
zures do not require antiepileptic drugs.
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REDUCINGTHEEPILEPSY TREATMENTGAP IN
RURALNEPALUSINGEPILEPSY FIELDWORKERS
ANDTELEPHONETELEMEDICINE
P. Paudel*,†,‡, H. Rajbhandari†,§, V. Patterson†
*Kathmandu Model Hospital, Neurosurgery, Kathmandu,
Nepal, †Nepal Epilepsy Association, Kathmandu, Nepal,
‡National Academy of Medical Sciences, Kathmandu, Nepal,
§Kathmandu Model Hospital, Kathmandu, Nepal
Purpose: The epilepsy treatment gap is over 50% in poorer countries,
often because of bad access to doctors. TheWHO has suggested that non-
physician health workers take a bigger role in management.
Method: We have trained two people with no previous training in health
as epilepsy field workers (EFWs) and used them to identify people with
epilepsy in their surrounding villages. They used an app to determine if
epileptic seizures were likely. They then contacted a neurosurgeon by
telephone. The neurosurgeon suggested treatment which the EFW
started. The patient was reviewed by the neurosurgeon face-to-face to
decide whether the management was appropriate.
Results: The EFWs identified 62 people with possible epilepsy during
nine months (from May 2016 to January 2017). Out of 62 patients 16
were already diagnosed and treated as epilepsy while 46 were newly
identified; two-thirds were male, most were 20–40 years old (53%, mean
age 25 yr) and more than half (54%) were married. Of the 46, 33 had app
scores suggesting epileptic seizures (≥80), 3 patients had scores which
suggested non-epileptic episodes (<30) and in 10 the app score was
uncertain (30–80). Telephone consultation suggested that five patients
had epileptic events not requiring treatment (febrile convulsions, alcohol
withdrawal seizures) while 14 had non-epileptic conditions like faints or
non-epileptic attack disorder. Twenty-seven had epilepsy which was
untreated. After in-person examination diagnosis and management was
appropriate in 78%.
Conclusion: The epilepsy treatment gap can be significantly reduced in
a rural setting by EFWs using mobile apps with telephone telemedicine
to a specialized clinician. Regular training of EFWs and frequent com-
munication with a physician might increase the reliability of manage-
ment. This is a promising means to identify and treat epilepsy in rural
settings in a country like Nepal where access to health care is very lim-
ited.
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QUALITYOFCARBAMAZEPINE IN RESOURCE-
LIMITED SETTINGS: ANCILLARYRESULTS FROM
THEQUAEDAF (QUALITYOFANTIEPILEPTIC
DRUGS IN SUB-SAHARANAFRICA) STUDY
J. Jost*, T.T. Nguyen†, V. Ratsimbazafy*, E. Auditeau*,
A. Raharivelo*,‡, C.R. Newton§, H. Dufat†, P.-M. Preux*
*INSERM, University Limoges, CHU Limoges, UMR_S 1094,
Tropical Neuroepidemiology, Institute of Neuroepidemiology
and Tropical Neurology, Limoges, France, Limoges, France,
†Faculty of Pharmacy of Paris, Paris Descartes University,
France, Department of Pharmacognosy - UMR/CNRS 8638,
Paris, France, ‡Hospital Joseph Raseta Befelatanana,
Antananarivo, Madagascar, Antananarivo, Madagascar,
§KEMRI-Welcome Trust Programme - Center for Geographical
Medicine Coast Kenya Medical Research Institute, Kilifi, Kenya
Purpose: Epilepsy is a common disorder affecting 70 million people
worldwide, with 90% in resource-limited countries. in these countries,
few standard antiepileptic drugs (AEDs) are used and concerned with
quality issues. Often, the attention is focused on assay of active ingredient
(AI). However, other pharmaceutical parameters are important, such as
the dissolution profile that could be influenced by environmental factors.
The main objective was to assess the stability of AEDs under stressed
conditions.
Methods: This study has been performed on 8 solid formulations of car-
bamazepine. Eight were gathered on the field in Madagascar (4 manufac-
tured in China, 1 in India) and three manufactured in Europe were
purchased directly from the manufacturer. The samples were exposed
during three months to: i) 45°C + 75.0% of relative humidity (RH) and
ii) 45°C + 99.9% RH. Assay of AI (by liquid chromatography and UV
detection), dissolution and chemical stability measured by attenuated
total reflection-Fourier transform infrared spectroscopy and differential
scanning calorimetry were performed at T0 (baseline), one (T1) and three
months (T3).
Results: The assay of AI were successful for all the samples within the
three months. No chemical degradation of the AI has been observed
between T0 and T3. The dissolution profile was unsatisfactory for all
samples from India and China, with a final proportion of dissolution
ranging under 73.3% to 3.2% (Norms: 75–100%). At T0, all samples
showed the presence of the anhydrous polymorphic form III of carba-
mazepine. At T1 and T3, a dihydrate polymorphic form has been
observed in sample from China and India.
Conclusion: The modification of dissolution behaviors was due to the
polymorphism of the carbamazepine. These results have shown that an
inhomogeneity of manufacturing process could lead to inefficient pro-
duct unable to release the AI, but further analyses will have to be per-
formed to strengthen our conclusion.
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A SCREENINGQUESTIONNAIRE FORCONVULSIVE
SEIZURES: A THREE-STAGE FIELD-VALIDATION IN
RURAL BOLIVIA
L. Giuliano*, C.E. Cicero*, E.B. Crespo Gomez†, S. Padilla‡,
V. Sofia*, A. Nicoletti*
*University of Catania, Department ‘G.F. Ingrassia’, Section of
Neurosciences, Catania, Italy, †Hospital Universitario
Hernandez Vera, Santa Cruz, Bolivia, ‡Center of
Anthropological Researches of the Teko Guaranı, Gutierrez,
Bolivia
Purpose: Epilepsy is one of the most common neurological diseases in
Latin American Countries (LAC) and epilepsy associated with convul-
sive seizures is the most frequent type. Therefore, the detection of con-
vulsive seizures is a priority, but a validated Spanish-language screening
tool to detect convulsive seizures is not available. We performed a field
validation to evaluate the accuracy of a Spanish-language questionnaire
to detect convulsive seizures in rural Bolivia using a three-stage design.
The questionnaire was also administered face-to-face, using a two-stage
design, to evaluate the difference in accuracy.
Method: The study was carried out in the rural communities of the Gran
Chaco region. The questionnaire consists of a single screening question
directed toward the householders and a confirmatory section adminis-
tered face-to-face to the index case. Positive subjects underwent a neuro-
logical examination to detect false positive and true positive subjects. To
estimate the proportion of false negative, a random sample of about 20%
of the screened negative underwent a neurological evaluation.
Results: 792 householders have been interviewed representing a popula-
tion of 3,562 subjects (52.2% men; mean age 24.5  19.7 years). We
found a sensitivity of 76.3% (95% CI 59.8 - 88.6) with a specificity of
99.6% (95% CI 99.4 - 99.8). The two-stage design showed only a slightly
higher sensitivity respect to the three-stage design.
Conclusion: Our screening tool shows a good accuracy and can be easily
used by trained health workers to quickly screen the population of the
rural communities of LAC through the householders using a three-stage
design.
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HISTORYOF SURGERY FORTEMPORAL LOBE
EPILEPSY
A.A. Asadi-Pooya*,†
*Thomas Jefferson University, Neurology, Philadelphia, PA,
United States, †Shiraz Neurosciences Research Center, Shiraz,
Iran, Islamic Republic of
Purpose: The current work reviews the historical advancement from
trepanation for the treatment of epilepsy in ancient times to stereotactic
laser thermo-ablation for the treatment of drug-resistant TLE in the mod-
ern world.
Method: This is a literature review.
Results: Evidence of trepanation (making a burr hole in the skull) was
found in the excavated prehistoric human remains from Neolithic times,
and cave paintings suggest that ancient people believed this procedure
would cure epilepsy, migraines, and mental disorders; though, no firm
evidence has been discovered to support any medical explanation for
trepanation. Evidence for temporal lobe epilepsy (TLE) goes back thou-
sands of years to the pharaohs of ancient Egypt´s eighteenth dynasty. The
collaborative work of a team led by Penfield and Jasper in 1930s helped
to define the significant role of neurophysiological studies in epilepsy
surgery. As a result, the importance of removing the mesial temporal
structures in patients with TLE became established. The first series of
temporal lobectomies for the treatment of epilepsy were reported by Pen-
field and Flanigin (1950). They selected their patients for surgery based
on the seizure pattern, EEG and pneumographic and roentgenologic evi-
dence. Their practice was curative for 53% of their patients, and an addi-
tional 25% of their patients experienced a worthwhile (≥50%)
improvement in seizure frequency. Subsequently, Bailey and Gibbs
(1951) promoted identifying TLE (formerly called “psychomotor epi-
lepsy”) by EEG and treating it by temporal lobe resective surgery.
Conclusion: As neuroscience related technologies have progressed, our
understanding of the underlying causes and pathophysiology of epilep-
sies has advanced tremendously. In addition, with the help of these ancil-
lary technologies we may now offer surgery as a therapeutic option to
more patients who are suffering from drug-resistant epilepsy. However,
the progress in technologies has not been matched by the degree of
improvement in surgery outcome in these patients.
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FOCALCORTICALDYSPLASIA: SEIZURE FREEDOM
AND IMPACTONQUALITYOFLIFE AFTER SURGERY
J. Chaturvedi*, M. Bhaskara Rao*, S. Sinha†, A. Mahadevan‡,
A. Arivazhagen*, P. Nupur*, J. Rajeswaran§, J. Saini¶
*National institute of Mental Health and Neurosciences
NIMHANS, Neurosurgery, Bangalore, India, †National institute
of Mental Health and Neurosciences NIMHANS, Neurology,
Bangalore, India, ‡National institute of Mental Health and
Neurosciences NIMHANS, Neuropathology, Bangalore, India,
§National institute of Mental Health and Neurosciences NIMHANS,
Clinical Psychology, Bangalore, India, ¶National institute of
Mental Health and Neurosciences NIMHANS, Neuroimaging and
Inteventional radiology, Bangalore, India
Purpose: Prospective study,approved by Institute Ethics Committee,
was aimed to find out outcomes of surgery intended to cure epilepsy in
terms of seizure control and degree of improvement in quality of life
(QOLIE-89) among patients who had Drug resistant epilepsy secondary
to Focal Cortical Dysplasia.
Method: Study duration was January 2008 to November 2016.Recent
Blumcke et.al 2011 classification was used for histo-pathological catego-
rization of FCD. Engel outcome scale and seizure severity scale were
used for defining seizure outcome and seizure burden. QOL was assessed
with QOLIE-89 questionnaire (measures 17 different health domains),
first time in Indian population. Clinical, V-EEG, MRI, Magneto-ence-
phalogram (MEG), PET-CT,SPECT and Neuro-psychological factors
were evaluated.
Results: Total 52 patients were analyzed with mean age at onset of epi-
lepsy,mean duration of epilepsy & mean age at surgery being
7.94  6.23 years(1 month-40 years,median:
5 years),12.95  9.56 years(11 months-39 years, median:12 years) &
20.88  12.51 years (1–60 years, median: 20 years) respectively.Type
II was the most common type (50%) of FCD encountered in this cohort.
At median duration of 3.7 years after surgery, 84% of patients had
Engel’s Ia outcome. QOLIE-89 scores improved from 38.33  4.7
(range:31.14–49.03) before surgery to 75.21  8.44 (range:56.49–
90.49) at median follow-up after surgery. Seizure worry, emotional well
being, medication effects, role limitation due to emotional factors and
overall quality of life were the health domains with most significant
improvement.
Conclusion: In present series we conclude that an early age of the patient
(<20 years) at surgery (78.26% Vs 62.96%, p = 0.013), lower pre-op
score (<9) on seizure severity scale (90.00% Vs 56.66%, p = 0.012),
focal discharges without propagation on ictal V-EEG(90.50% Vs
66.70%, p < 0.001), absence of early post-op seizures after surgery
(81.00% Vs 12.50%, p < 0.001) and Type II FCD (76.92% vs. 62.58%
p = 0.045) were the strongest significant variables to predict Engel Ia
outcome on both Uni-variate and multi-variate analysis.
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SURGICALOUTCOMES IN TWODIFFERENT AGE
GROUPS SHARING FOCALCORTICALDYSPLASIA
TYPE II: ANYREALDIFFERENCE?
J.L. Ramirez Molina*,†, R. Di Giacomo‡, V. Mariani§,¶,
F. Deleo**,††, F. Cardinale¶, A.M. Uscategui-Daccarett†,‡‡,
P. Lorenzana*,†, L. Tassi¶
*Universidad Nacional de Colombia, Neurology Unit, Bogota,
Colombia, †Fundacion Liga Central Contra la Epilepsia,
Bogota, Colombia, ‡University ‘G.D’Annunzio’, Department of
Neuroscience, Imaging and Clinical Sciences, Chieti, Italy,
‡University ‘G.D’Annunzio’, Department of Neuroscience,
Imaging and Clinical Sciences, Chieti, Italy, §’C. Mondino’
National Neurological Institute, Pavia, Italy, ¶Niguarda
Hospital, ‘Claudio Munari’ Epilepsy Surgery Centre, Milan,
Italy, **Istituto Neurologico ‘Carlo Besta’, Clinical
Experimental Epileptology Unit, Milan, Italy, ††Montreal
Neurological Institute and Hospital, Department of Neurology,
Montreal, QC, Canada, ‡‡Universidad Nacional de Colombia,
Neuropediatrics Unit, Pediatrics Department, Bogota,
Colombia
Objective: Focal Cortical Dysplasias (FCDs) represent a common corti-
cal disorder underlying drugresistant focal epilepsy. Data are still scare
concerning comparison between patients harbouring Type II FCD oper-
ated at young and adult age, investigating whether age at surgery is an
important factor influencing surgical outcome. Aim of our study is com-
paring presurgical clinical features and surgical outcomes of patients
with FCD type II that underwent surgery at an earlier or late age.
Methods: We retrospectively analyzed 1660 consecutive patients oper-
ated at “Claudio Munari” Epilepsy Surgery Centre. Among 289 patients
(17,4%) with neuropathological diagnosis of FCD, we included two dif-
ferent groups, the first one including patients operated on at less than
6 years, the second sharing the same onset age but with delayed surgery
after the age of 20. Seizure characteristics, neuropsychological and post-
operative seizure outcome were evaluated by study groups.
Results: Forty patients underwent surgery before age of 6 and 66 patients
after age of 20. Surgical outcome was favorable in the population (72.6%
were classified in Engel’s Class Ia+Ic), independently from age at sur-
gery. In children group, 32 patients were classified in Class I, including
30 (75%) children in classes Ia and Ic. In adult group, 53 belonged to
Class I of whom 47 (71%) patients to classes Ia and Ic. No statistically
significant differences were found between groups concerning presence
of permanent complications, surgical outcomes and AEDs withdrawal
with age at surgery.
Conclusion: Our results indicate that there is not difference between the
groups, permitting to hypothesize outcome depends mainly on the histo-
logical findings and not on timing of surgery.
p0280
COMPARISON INOUTCOMESOFDOMINANTVS.
NON-DOMINANT TEMPORALLOBECTOMYFOR
EPILEPSY
C. Pringle*,†, K. Schumacher*,†, V. Josan*,†
*Salford Royal Foundation NHS Trust, Neurosurgery,
Manchester, United Kingdom, †Royal Manchester Children’s
Hospital, Neurosurgery, Manchester, United Kingdom
Purpose: To compare seizure outcomes and neurological complications
in dominant vs. non-dominant temporal lobectomy for temporal lobe epi-
lepsy.
Method: Retrospective case note analysis of patients undergoing tempo-
ral lobectomy for TLE between 2008 and 2016. Engel Classification at
one year follow up was recorded. Surgical and neurological complica-
tions were documented with a special focus on speech outcomes.
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Dominant side surgery was restricted to 4.5 cm from the pole; non-domi-
nant surgery was extended to 5.5–6 cm.
Results: A total of 78 patients (41 adults and 37 children) underwent
temporal lobectomy for epilepsy (40 female, 38 male). Age range
9 months - 60 years. Dominant side surgery in 32 cases (18 adults; 14
children). Histology included hippocampal sclerosis, focal cortical dys-
plasia, cavernomas and tumours. Good seizure control (Engel I and II)
was achieved in 80% patients overall [35/37 (95%) paediatric cases and
27/41 (66%) adults]. 78% dominant side surgery had good seizure out-
come compared to 83% non-dominant cases. 8 patients experienced
expressive dysphasia (6 adults, 2 paediatric). 1 adult and 1 paediatric
cases had persisting expressive dysphasia. Both were dominant side
cases. 9 patients experienced visual field deficits (3 adult, 6 paediatric).
This persisted in 2 adult and 5 paediatric patients. 5 patients had frontalis
weakness, all resolved. 2 patients developed hemiparesis (1 adult, 1 pae-
diatric). These were due to capsular infarcts. The paediatric case fully
recovered. The adult case experienced ongoing hemiparesis. 2 paediatric
patients developed pseudomeningoceles; 1 required a subgaleal shunt. 1
adult and 1 paediatric patient suffered 4th nerve palsies. The adult case
still persists 2 years post-operatively although has significantly
improved. 2 patients had extra-axial collections requiring surgical evacu-
ation.
Conclusion: Temporal lobe epilepsy surgery offers good seizure control
with an acceptable complication profile. No statistical difference in sei-
zure control was noted between dominant and non - dominant temporal
lobectomy.
p0285
DIAGNOSTIC ANDOUTCOMEAFTER SURGICAL
TREATMENTOFTEMPORAL EPILEPSY IN
CHILDREN
K. Abramov, D. Sarsembaeva, S. Mirkhaydarov,
R. Khachatryan, M. Mamatkhanov, K. Lebedev, G. Odintsova,
K. Samochernikh, Y. Zabrodskaya, V. Sebelev, D. Ryzhkova,
W. Khachatryan
*Russian Neurosurgery Research Institute in Honor of Professor
Polenov A.L., Branch of the Almazov Federal North-West
Medical Research Centre, Ministry of Healthcare, Saint
Petersburg, Russian Federation
Purpose: Demonstrate the results of complex diagnostic and surgical
treatment in children with medically intractable temporal epilepsy.
Method: A retrospective study was analyzed a surgical treatment in 80
(41 male) children with medically intractable temporal epilepsy at the
child´s department of The Russian Neurosurgical Institute in honor of
professor Polenov A.L. during the period from 2011 to 2016. The age of
the patients was 3 to 17 years. The follow-up was 1 to 6 years (on aver-
age 3.3 years).
Results: The duration of disease was from 3 months till 16 years (on
average 71,75 months). According to magnetic resonance imaging
(MRI) of 60 (75.9%) patients structural changes of the brain were
revealed. Local epileptic foci in temporal lobe were found in 60% and
30% by EEG monitoring and ECoG respectively. Bitemporal foci were
found in 10% of cases by electrophysiological investigation. Epileptic
foci were lateralized by PET in 28 of 29 cases. Right-side resection was
performed in 34 (42,5%)cases, left-side resection was done in 46 (57,5%)
cases. Favorable long-term outcome of surgical treatment epilepsy (class
Engel I) are reached at 72.5%. Pathomorphologic investigation revealed:
focal cortical dysplasia- 48,75% of cases (FCD Ia-2, FCD IIa-9, FCD IIb-
6, FCD IIIa-1, FCD IIIb-5, FCD IIIc-1, FCD IIId-15), epileptic
encephalopathy- 11 (13,75%) cases, benign tumors- 9 (11,25%) cases,
cystic-atrophic changes- 6 (7,5%) cases, malignant tumors of the brain- 4
(5%) cases, vascular malformations- 2 (2,5%) cases, tuberous sclerosis- 2
(2,5%) cases, others- 7(8,75%).
Conclusion: The most important predictive factors of achievement
favorable results after surgical treatment of epilepsy are: identification of
epileptogenic morphological changes of the brain, completeness of resec-
tion of the epileptic and epileptogenic zone, and lack of seizures after
surgery as well.
p0288
INDIRECTREVASCULARIZATION SURGERY IN
CHILDRENWITH SYMPTOMATIC EPILEPSY
W. Khachatryan*, P. Litvinenko†, M. Nikolaenko†
*Federal Almazov North-West Medical Research Centre, St.
Petersburg, Russian Federation, †Federal Almazov North-West
Medical Research Centre, Pediatric Neurosurgery, St.
Petersburg, Russian Federation
Purpose: To study indirect revascularization surgery outcomes in
patients with symptomatic epilepsy which started as a result of moy-
amoya disease or syndrome, ischemic strokes, birth traumas and hemor-
rhages.
Method: We analyzed study outcomes and surgical results in 11 patients
who had been receiving treatment at the RNI Department of Pediatric
Neurosurgery from 2002 to 2016 with effects of perinatal traumatization
(7 patients) and effects of ischemic stroke (4 patients).We used neurolog-
ical and neuropsychological examinations, neurosonography, EEG, CT
and MRI data, triplex ultrasonography of the neck and head vessels, CT
and MR angiography, MRI brain perfusion. Revascularization surgery as
a method of choice was applied in 3 patients with moyamoya disease, in
8 patients - as a supplement to cysts excision, in 2 patients - as a supple-
ment to ventriculoperitoneal shunting, in 2 patients - as a supplement to
electrocortiorgaphy and seizure focus excision, in 2 patients - as a supple-
ment to chronic hematoma drainage.
Results: According to Engel epilepsy surgery outcome scale, Class I out-
come was achieved in 7 children, 2 of which had moyamoya disease.
Class II and Class III were achieved in 1 patient each. Two patients with
effects of ischemic stroke showed negative dynamics in the form of
increase in seizure frequency and transformation of the seizures struc-
ture.
Conclusion: Indirect revascularization have a positive impact on clinical
and electroencephalographic manifestations of the disease, which indi-
rectly indicates the value dissemina processes in the pathogenesis of epi-
lepsy. The occurrence of epileptic seizures in some patients after
revascularization operations due to changes in perfusion of the brain and
the local irritative effect of the anastomosis. Inderect brain revasculariza-
tion, removal of cysts, scars, calcifications (epileptic foci) are the method
of choice in the treatment of occlusally processes in combination with
epileptic seizures.
p0291
LONG-TERM INVASIVEMONITORINGVS.
INTRAOPERATIVE CORTICOGRAPHY: DIAGNOSTIC
EFFICACY IN SYMPTOMATIC EPILEPSY
M. Alexandrov*, A. Chukhlovin*, I. Kostenko*, A. Ulitin†,
S. Malyshev‡, N. Arkhipova‡, K. Abramov§
*Federal Almazov North-West Medical Research Centre,
Department of Clinical Neurophysiology and Epileptology,
Saint Petersburg, Russian Federation, †Federal Almazov North-
West Medical Research Centre, Neurosurgical Department,
Saint Petersburg, Russian Federation, ‡Federal Almazov North-
West Medical Research Centre, Neurology Department, Saint
Petersburg, Russian Federation, §Federal Almazov North-West
Medical Research Centre, Saint Petersburg, Russian Federation
Purpose: In tumor related epilepsy (TRE) electrocorticography (ECoG)
is routinely used for localizing the epileptogenic zone during surgery. At
present the efficacy of this technique is debated. It is considered by some
authors that epilepsy surgery approach for TRE may be beneficial for the
patients. In this study we investigated the efficacy of intraoperative
ECoG (iECoG) vs. prolonged extraoperative ECoG (peECoG).
Method: The study included 63 patients (37 females, age 26–76) with
TRE assigned for presurgical evaluation and tumor resection at Prof.
Polenov´s Neurosurgical Institute. All patients had epileptiform patterns
on presurgical EEG-recordings, except one patients with left temporal
lobe tumor and 10-year history of seizures.
S62
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Results: In these patients during iECoG epileptiform activity was
detected in 18 patients next to the tumor margin and this areas were
resected with regard to eloquent cortex. Postoperatively, in 13 patients
epileptiform activity was recorded on EEG . The patient without any
epileptiform activity on EEG and video-EEG-monitoring was assigned
for a staged surgery. As a first stage after the inconclusive iECoG a sub-
dural grid-electrode (4x5 contacts) was implanted covering the presum-
able location of the tumor and adjoining areas. Prolonged
electrocorticography was recorded for the next few days after the implan-
tation of grid-electrodes until the area generating interictal epileptiform
discharges was defined by neurophysiologists. This area was located
beyond the standard margins of tumor resection and did not overlay any
eloquent zone. During the second stage the tumor and the defined area
were resected . No signs of epileptiform activity were registered in any
accessible area of the cortex after resection. Postoperative EEG did not
show any epileptiform patterns.
Conclusion: This observation suggests that in the context of prolonged
TRE long-term invasive monitoring may be superior to traditional intra-
operative ECoG, although a long-term follow-up is necessary to evaluate
the seizure outcome.
p0293
MISSEDOPPORTUNITIES IN THE SURGICAL
MANAGEMENTOFREFRACTORY FOCALEPILEPSY:
THEROLEOFMAGNETOENCEPHALOGRAPHY
I. Mohamed*,†, A. Bouthillier‡, A. Berube§, P. Cossette§,
P. Finet‡, J.-M. Saint-Hilaire§, M. Robert¶, D. Nguyen§
*University of Alabama, Department of Pediatrics, Division of
Neurology, Birmingham, AL, United States, †IWKHealth
Centre, Dalhousie University, Halifax, NS, Canada, ‡Division of
Neurosurgery, Notre-Dame Hospital CHUM, University of
Montreal, Montreal, QC, Canada, §Division of Neurology,
Notre-Dame Hospital CHUM, University of Montreal, Montreal,
QC, Canada, ¶Neuropsychology and Cognition Research
Center, Psychology Department, University of Montreal,
Montreal, QC, Canada
Purpose: For patients with nonlesional refractory focal epilepsy
(NLRFE), localization of the epileptogenic zone is more arduous, and
intracranial EEG (icEEG) is frequently required. In the present study, we
report our experience with magnetoencephalography (MEG) in a series
of NLRFE patients evaluated for epilepsy surgery.
Method: Observational MEG case series involving 31 consecutive
NLRFE patients in an academic adult epilepsy center. For various rea-
sons MEG data were not analyzed in a timely manner to be included in
the decision making process. The presumed impact of MEGwas assessed
retrospectively.
Results: MEG would have retrospectively changed the initial manage-
ment in 21/31 (68%) had MEG results been available by reducing the
number of intracranial electrodes, modifying their position, allowing for
direct surgery, canceling the intracranial study or providing enough evi-
dence to justify one. 18 patients completed an icEEG study and 17
patients proceeded to epilepsy surgery. Good surgical outcome (Engel
class I & II) was achieved in 11 patients. 9/11 had MEG clusters corre-
sponding to the resection area and MEG findings would have allowed for
direct surgery avoiding, icEEG in 2/11. Six patients had poor outcome
(Engel class III & IV) including three patients where MEG would have
significantly changed the outcome by modifying the resection margin.
MEG provided concordant data to icEEG recordings in 8/18 subjects and
superior information in 3 patients where inadequate coverage precluded
accurate mapping of the epileptogenic zone.
Conclusion: MEG affects patient management, icEEG planning and sur-
gical outcome in a significant percentage of patients with NLRFE and
should be included in the presurgical workup in those patients.
p0295
EFFECTIVENESS OF TRANSCRANIALMOTOR
EVOKED POTENTIALMONITORINGDURINGTHE
SURGICALTREATMENTOFMESIAL TEMPORAL
LOBEEPILEPSY
W.G. Lee
Kosin University College of Medicine, Pusan, Korea
Purpose: Anteromesial temporal lobectomy (AMTL) is the most com-
monly performed standard surgical procedure in patients with temporal
lobe epilepsy. However, this has been associated with the occurrence of
some rare but potentially serious motor deficits.We have assessed the
effectiveness of transcranial motor evoked potential (TcMEP) monitor-
ing and its influences on surgical complications after temporal lobe resec-
tion for the treatment of mesial temporal lobe epilepsy.
Method: We have evaluated motor deficits occurred before and after the
adaptation of TcMEP monitoring to AMTL in patients with temporal
lobe epilepsy during the period between January 1, 1995, and February
28, 2017. A total intravenous anesthesia was induced and maintained
with continuous infusion of propofol and vecuronium and supplementa-
tion with intravenous opioid. Transcranial motor stimulation was carried
out using subdermal electrodes placed at C3 and C4 positions by constant
voltage stimulation and MEP responses was recorded in the bilateral
upper extremity muscles and lower extremity muscles. A more than 50%
loss of MEP amplitudes compared with baseline data was used as warnig
criteria and promptly reported to the epilepsy surgeon. Neurological
examination focused on the motor status was evaluated preoperatively,
immediately after surgery, one day after surgery, and at discharge.
Results: Before the introduction of Tc MEP, a newly identified motor
deficit was observed in 7 of 593 patients. On the other hand, no new
motor deficit was occurred in 290 patients operated under Tc MEP moni-
toring. More than 50% decrement of MEP was recorded in 8 patients, and
recovered in all after prompt corrective procedures by the epilepsy sur-
geon.
Conclusion: Transcranial MEPmonitoring is a reliable and reproducible
modality for the evaluation and prediction of the possible motor deficits
during epilepsy surgery. The motor deficits will be significantly dimin-
ished through prompt corrective measures under the control of TcMEP
monitoring during the epilepsy surgery.
p0296
OUTCOMEANDPROGNOSTIC FACTORSOF
EPILEPSY SURGERY INCHILDRENWITH FOCAL
CORTICALDYSPLASIA
S.A. Choi*, S.Y. Kim†, H. Kim†, H. Kim*, B.C. Lim†, H. Hwang*,
J.E. Choi‡, J.H. Chae†, K.J. Kim†
*Seoul National University Bundang Hospital, Gyeonggi-do,
Korea, †Seoul National University Children’s Hospital, Seoul
National University College of Medicine, Seoul, Korea, ‡Seoul
National University BoramaeMedical Center, Seoul, Korea
Purpose: Focal cortical dysplasia (FCD) is the most common cause of
intractable focal epilepsy in children. Epilepsy surgery is one of the valu-
able treatment options to achieve seizure freedom in these intractable
focal epilepsy patients. We aimed to analyze surgical outcome and prog-
nostic factors of epilepsy surgery in children with FCD.
Methods: Eighty four children who had resective epilepsy surgery from
January 2004 to December 2013, histologically proven FCD, and a fol-
low-up period of at least 2 years were included. Medical records regard-
ing demographics, epilepsy details, types of FCD, presurgical
evaluations, longitudinal analysis of seizure control, and postoperative
complications were retrospectively analyzed.
Results: The mean age at epilepsy onset was 5.2 years and the mean age
at epilepsy surgery was 10.7 years. The mean postoperative follow-up
duration was 5.2 years. Patients with FCDII had significantly early onset
of epilepsy, higher seizure frequency, and underwent surgery at a signifi-
cantly younger age compared to the other types. Of 84 patients, Engel
class I was achieved in 66% of patients at postoperative 1 year, 60% at
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postoperative 2 year, and 53% at last follow-up. Focal lesion onMRI and
complete resection are major prognostic factors for postoperative seizure
outcome. Thirty percent of 84 patients had incomplete resection, and the
most important reason was overlap of dysplastic cortex and motor cortex.
In 45 patients who had postoperative seizures, 84.5% of them had seizure
recurrence within postoperative 2 years and the long term seizure-free-
dom rates remain stable. Fourty-four percent of 84 patients discontinued
antiepileptic medication successfully.
Conclusion: Postoperative seizure outcome was favorable in children
with FCD. Comprehensive presurgical evaluations and multidisciplinary
team approach would enhance the chance for detecting epileptogenic
region associated with cortical dysplasia. Constant and systematic
presurgical, or surgical variables to predict postoperative outcome would
help selecting the ideal candidate for epilepsy surgery.
p0298
PRESURGICAL FEATURES ANDOUTCOMES IN
CHILDRENWITHFOCALCORTICALDYSPLASIA
N. Pietrafusa*, L. De Palma*, A. De Benedictis†, M. Trivisano*,
S. Cappelletti‡, D. Longo§, C.M. Rossi Espagnet§,
A. Napolitano¶, C.E. Marras†, F. Vigevano*, N. Specchio*
*’Bambino Gesu’Children’s Hospital, Department of
Neurosciences and Neurorehabilitation, Neurology Unit, Rome,
Italy, †’Bambino Gesu’ Children’s Hospital, Department of
Neurosciences and Neurorehabilitation, Neurosurgery Unit,
Rome, Italy, ‡’Bambino Gesu’Children’s Hospital, Department
of Neurosciences and Neurorehabilitation, Psicology Unit,
Rome, Italy, §’Bambino Gesu’Children’s Hospital, Department
of Imaging, Neuroradiology Unit, Rome, Italy, ¶’Bambino Gesu’
Children’Hospital, Medical Physics Department, Rome, Italy
Purpose: The aim of the study was to characterize a cohort of FCD pedi-
atric patients according to clinical, EEG, neuro-imaging, neuropsycho-
logical features, and surgical outcome.
Method: We retrospectively analysed consecutive children who under-
went to surgical treatment from 2009 to 2015 with untreatable focal epi-
lepsy and a histopathologic diagnosis of FCD with at least 12 months
follow-up.
Results: Forty-one children were identified. FCD type I was identified in
8, FCD type II in 19 patients and FCD III in 14. The mean age at seizure
onset was 4.45 years (range, 0.5 -15): FCD III patients were significantly
older than FCD I and II at epilepsy onset (p = 0.035). A developmental
delay and an IQ less than 70 was more frequent in FCD I patients
(p = 0.0008 and p = 0.002). Seizure frequency was higher in FCD I and
II (p = 0.0003). Slow EEG abnormality were significantly more common
in patients with FCD type I (p = 0.013) while a normal EEG was more
frequent in FCD III patients. FCD I brain MRI were characterized by
regional reduction of the white matter volume while FCD type II was
characterized by increased cortical thickness, transmantle sign, grey mat-
ter signal change in FLAIR. FCD III had the same MRI characteristic of
FCD. A binomial logistic regression was performed in order to find prog-
nostic factor: incomplete resection of epileptogenic area and long disease
duration before surgery were poor independent outcome predictors on
multivariate analysis.
Conclusion: We confirmed the presence of important differences in chil-
dren with distinct FCD subtypes.
p0300
MEANINGFULCOGNITIVEDECLINE AFTERMESIAL
TEMPORAL LOBEEPILEPSY SURGERY IN
BRAZILIAN PATIENTS
C. Pauli*, M.L. Schwarzbold*, A.P. Diaz*, M.E.R.O. Thais*,
J. Ben*, M.N. Linhares*, H.J. Markowitsch†, P. Wolf*,‡, K. Lin*,
R. Walz*
*Federal University of Santa Catarina, Florianopolis, Brazil,
†University of Bielefeld, Bielefeld, Germany, ‡Danish Epilepsy
Center, Dianalund, Denmark
Purpose: To investigate if subjective perception of cognitive decline
correlates with objective cognitive decline in neuropsychological tests
(NPT) following surgery and to determine the predictors of meaningful
NPT impairment in Brazilian patients submitted to mesial temporal lobe
epilepsy (MTLE) surgery.
Method: Forty-eight adult patients with MTLE (27 right HS, and 23
male) were classified as reporting (Decline group, n = 08) or not (No-
Decline group, n = 40) a cognitive function decline based on the changes
in their scores of the cognitive function domain of QOLIE-31 applied
before and one year after surgery. Objective cognitive changes deter-
mined by the difference between the baseline pre-surgical raw scores of
NPT were compared between the Decline and No-Decline groups. Sensi-
tivity, specificity, and predictive values at the best cutoff points of the
ROC curve (95% CI) were determined for the NPT significantly associ-
ated with cognitive decline reported by patients.
Results: Among the 25 cognitive tests analyzed, only baseline-retest dif-
ference in the Boston Naming Test (BNT) showed a concordance with
the cognitive decline reported by patients. A reduction of more than 7
points in the raw score of BNT after surgery showed 88% of sensitivity
and 50% specificity for meaningful cognitive function decline to the
patient. Left-sided surgery and age > 40 years were more associated with
a meaningful BNT decline reported by patients (overall accuracy of
91.7%).
Conclusion: Similarly to American patients, the BNT decline is the only
meaningful NPT impairment in Brazilian patients after surgery. Surgical
side and age are good predictors for no-decline in the BNT (95%), but
showed a lower accuracy to predict its decline (75%). Our findings rein-
force the external validation for the BNT as a patient centered measure-
ment of cognitive outcome with implications for the surgical
management of MTLE patients.
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EARLY-ONSET EPILEPSY AND SEVERECOGNITIVE
IMPAIRMENT IN SIX PATIENTSWITHTHEDENOVO
P.GLU590LYS VARIANTOFCUX2
N. Chatron*,†,‡, R.S. Møller§,¶, N.L. Champaigne**,
A. Kuechler††,‡‡, A. Labalme*, L. Baggett**, D. Wieczorek††,§§,
d.V. Portes‡,¶¶, P. Edery*,†,‡, E. Gardella***,†††,
I.E. Scheffer‡‡‡,§§§, H. Mefford¶¶¶,****, D. Sanlaville*,†,‡,
G.L. Carvill††††, G. Lesca*,†,‡
*Groupement Hospitalier Est, Department of Medical Genetics,
Bron, France, †CNRS UMR 5292, INSERMU 1028, CNRL,
Bron, France, ‡University Claude Bernard Lyon 1, Lyon,
France, §Danish Epilepsy Centre, Dianalund, Denmark,
¶University of Southern Denmark, Institute for Regional Health
research, Odense, Denmark, **Greenwood Genetic Center,
Greenwood, SC, United States, ††Institut f€ur Humangenetik,
Universit€atsklinikum, Essen, Germany, ‡‡Universit€at Duisburg-
Essen, Essen, Germany, §§Institut f€ur Humangenetik,
Universit€atsklinikum D€usseldorf, D€usseldorf, Germany, ¶¶Lyon
University Hospital, Department of Neuropediatrics, Bron,
France, ***Danish Epilepsy Center, Department of Clinical
Neurophysiology, Dianalund, Denmark, †††University of
Southern Denmark, Institute for Regional Health Research,
Dianalund, Denmark, ‡‡‡Florey Institute, University of
Melbourne, Melbourne, VIC, Australia, §§§Austin Health and
Royal Children’s Hospital, Melbourne, VIC, Australia,
¶¶¶Division of Genetic Medicine, Department of Pediatrics,
Seattle, WA, United States, ****University of Washington,
Seattle, WA, United States, ††††Northwestern University
Feinberg School of Medicine, Department of Neurology and
Pharmacology, Chicago, IL, United States
Purpose: Cut homeodomain transcription factor CUX2 plays an impor-
tant role in dendrite branching, spine development, and synapse forma-
tion in layer II-III neurons of the cerebral cortex. Abnormal dendrites and
synapses in Cux2(-/-) mice correlate with reduced synaptic function and
defects in working memory. A de novo CUX2 p.Glu590Lys variant was
reported in two patients involved in large-scale whole-exome sequencing
(WES) studies on intellectual disability and epileptic encephalopathies.
We report on clinical data of six patients carrying the de novo
p.Glu590Lys variant.
Methods: We reviewed clinical, MRI and EEG data from 6 patients,
including 2 previously reported and 4 additional cases. The p.Glu590Lys
variant was identified by WES in 3 and through a targeted gene panel in
three. It had occurred de novo in all of them.
Results: There were 4 males and 2 females. Mean age at inclusion was
13.6 years [8–21]. Epilepsy occurred in all patients. Age at onset of sei-
zures ranged from 2 months to 1 year [mean = 6.6 months]. Seizure
types at onset were myoclonic seizures, atypical absence with myoclonic
component, and focal seizures. Seizures were drug-resistant in all
patients but one. EEG initially showed generalized polyspikes and waves
(4) or multifocal epileptiform discharges (2). Two patients are seizure-
free under treatment whereas the others still have persistent seizures.
Cognitive regression was noticed in childhood at least for two patients, at
8 and 12 years, respectively. All patients had severe cognitive impair-
ment and autistic features were present in 4. Two patients had ataxic gait.
Brain MRI only showedminor and non-specific anomalies.
Conclusions: This study shows that patients carrying the p.Glu590Lys
variant of CUX2 display a relatively homogeneous clinical presentation
with infantile-onset epilepsy frequently including myoclonic jerks with
polyspikes and waves or multifocal epileptiform discharges. Patients
have severe cognitive impairment sometimes associated with psychomo-
tor regression in childhood.
p0307
LESS DESTRUCTIVE AND INTRONIC SCN1A
MUTATIONS AREASSOCIATEDWITHPARTIAL
EPILEPSYWITHANTECEDENT FEBRILE SEIZURES
L. Yu*, H. Meng†, B. Tang‡, H.-Q. Xu‡, X.-Q. Cai ‡, Y.-H. Yi‡, Y.-
W. Shi‡, W.-P. Liao‡
*First Affiliated Hospital of Guangxi Medical University,
Department of Neurology, Nanning, China, †First Affiliated
Hospital of Jinan University, Department of Neurology,
Guangzhou, China, ‡Second Affiliated Hospital of Guangzhou
Medical University, Institute of Neuroscience, Guangzhou,
China
Purpose: Partial epilepsy with antecedent febrile seizures (PEFS+) is
common clinically. SCN1A mutations located in the intronic regions are
mostly associated with severe myoclonic epilepsy in infancy (SME). It is
suspected that SCN1A intronic mutations are also associated with milder
PEFS+ and lead to epileptogenisis by affecting splicing but differ from
SME.
Method: SCN1A intronic mutations were scanned in patients with
PEFS+. The consequence of SCN1A intronic mutations and their effect
on splicing were investigated qualitatively and quantitatively by using an
in vitro minigene strategy. Mutations at invariant splice-site junctions
(ISJ), which were identified in SME and located within the minigene sys-
tems, were selected for comparison.
Results: Among the 27 heterozygous SCN1A mutations identified in
238 unrelated patients with PEFS+, three were outside exons.
c.473 + 5G>A and c.473 + 5G>C were 3 bp away from ISJs; c.4853-
25T>A was located deep in intronic sequences. Two minigene systems
containing c.473 and c.4853 were established according to these muta-
tions and two SME associated hot-spot mutations c.602 + 1G>A and
c.4853-1G>C. All these mutations resulted in aberrant splicing, as shown
by abnormal bands of RT-PCR products, indicating frameshift and trun-
cation of Nav1.1 proteins. Mutations from PEFS+ produced normal tran-
scripts also, while mutations from SME produced only aberrant
transcripts visible. Real-time PCR determined that the level of aberrant
transcripts from PEFS+ was significantly lower than that from SME,
while the level of normal transcripts from PEFS+was significantly lower
than that of Wild-type (WT). Mutation c.4853-25T>A resulted in 28.8%
reduction of the normal transcripts than that from WT, and incomplete
penetrance was observed in the family.
Conclusion: SCN1A intronic mutations found in PEFS+ extended the
spectrum of SCN1A-associated epilepsy. It provides direct evidence and
new insights into the mechanism that decreased expression of SCN1A,
besides null expression that leads to haploinsufficiency, is associated
with phenotype variation of epilepsy.
p0309
DETERMINING THEBURDENOFCOPYNUMBER
VARIATION IN PATIENTSWITHEPILEPSY
T.K. de Araujo*,†, F. Torres*,†, R. Secolin*,†, M.K.M. Alvim†,‡,
C.S. Rocha†,§, M. Morita†,‡, C.L. Yasuda†,‡, B.S. Carvalho†,§,
F. Cendes†,‡, I. Lopes-Cendes*,†
*University of Campinas/UNICAMP - School of Medical
Sciences, Department of Medical Genetics, Campinas, Brazil,
†Brazilian Institute of Neuroscience and Neurotechnology
BRAINN, Campinas, Brazil, ‡University of Campinas/
UNICAMP - School of Medical Sciences, Department of
Neurology, Campinas, Brazil, §University of Campinas/
UNICAMP - School of Medical Sciences Institute of
Mathematics, Statistics and Scientific Computing, Department of
Statistics, Campinas, Brazil
Mesial temporal lobe epilepsy (MTLE) and genetic generalized epilepsy
(GGE) are common epilepsies syndromes. Genomic copy number varia-
tions (CNVs) have been identified as a risk factor for some types of
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epilepsy syndromes. We aim to investigate CNV distribution in patients
with MTLE and GGE, as well as in control subjects; to evaluate CNVs
recurrence in patients and to identify genes involved in predisposition to
MTLE and GGE. We have studied 750 individuals (340 MTLE patients,
70 GGE patients, 340 control subjects). CNVs were assessed by SNP 6.0
array (Affymetrix). The analysis of MTLE patients identified 2,246
CNVs. of the total, 20.3% CNVs were found only in patients and affect
652 genes. Analysis using Metacore software revealed genes associated
with neurogenesis development, synaptogenesis, learning, memory, cog-
nition, ion transport, protein complex involved in synapse maturation. In
GGE patients, we identified 340 CNVs; 17.4% were found only in
patients and affecting 59 genes. Analysis using Metacore revealed genes
associated with lithium effect on synaptic transmission and autophagy,
glutamic acid regulation, mitochondrial dysfunction in neurodegenera-
tive diseases, dopamine-D2 receptor transactivation, GABA-B receptor-
mediated regulation of glutamate signaling. Finally, analysis of the con-
trol group identified 2,100 CNVs. Chromosomal regions more affected
in controls are 1q21.1, 1q21.2, 1p36.13, 2q11.2, 3q26.1, 4q13.2, 8p11.22,
8p23.1, 10q11.22, 14q11.2, 15q11.2, 15q11.1, 16p11.2, 17q21.31. Our
results clearly show that there is an increased burden of CNVs in specific
chromosomal regions of the genome in patients with epilepsy. These
regions are distinct in patients with MTLE as compared to GGE, indicat-
ing that the genetic burden, in these different epilepsy syndromes, is dis-
tinct. Interestingly, CNVs previously associated with epilepsy
syndromes in the literature were identified in our control group. Support:
FAPESP, CNPq.
p0311
PROTEOMICANALYSIS OF SERUMFROMPATIENTS
WITHTEMPORALLOBE EPILEPSY
L. Chanwoo*,†, J. Lee†
*Wonkwang University, Iksan, Korea, †Wonkwang University,
Gunpo, Korea
Purpose: Epilepsy affects more than 0.5% of the world`s population. It
has a large genetic component and is caused by electrical hyperexcitabil-
ity in the central nervous system. Despite its prevalence, the disease lacks
definitive diagnostic serological biomarkers. To identify potential
biomarkers for epilepsy by a convenient method, we analyzed the expres-
sion of serum proteins, reflecting alterations in the patient`s proteomes.
Method: We compared two-dimensional electrophoretic band patterns
of human sera from eight patients with temporal lobe epilepsy (TLE)
with those of eight control subjects. The differentially expressed bands
were identified using matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry and electrospray ionization quadrupole time-of-
flight mass spectrometry.
Results: Twelve proteins were differentially expressed in the TLE
group, of which 6 were identified. Expression of haptoglobin Hp2,
PRO2675, immunoglobulin heavy chain constant region gamma 2, an
unnamed protein, and three unidentified proteins were upregulated in
serum from the patients with TLE, whereas those of major histocompati-
bility complex (MHC) class I antigen, plasma retinol-binding protein pre-
cursor, and three unidentified proteins were downregulated in these
patients. After resection of the epileptogenic zone, the expressions of
MHC class I antigen, immunoglobulin heavy chain constant region
gamma 2, two of the downregulated unidentified proteins, and one of the
upregulated unidentified proteins returned to the normal range.
Conclusion: The 12 serum proteins in this study are potentially useful
biomarkers for the diagnosis and monitoring of temporal lobe epilepsy.
p0312
DIFFUSIONWEIGHTEDMAGNETIC RESONANCE
IMAGING INCHILDCEREBRAL PALSYWITH
SYMPTOMATIC EPILEPSY
K. Aminov
Tashkent Institute for Postgraduate Medical Education, Medical
Radiology, Tashkent, Uzbekistan
Purpose: The purpose of the study was to determine the characteristics
of diffusion weighted Magnetic Resonance imaging indicators in chil-
dren with symptomatic epilepsy with cerebral palsy.
Method: The study was based on the results of the study 54 children with
symptomatic epilepsy with cerebral palsy aged 1 - 11 years. All patients
underwent standard clinical and neurological examination, with the
inclusion of routine MRI. All of 54 studied children underwent routine
Magnetic Resonance imaging with diffusion weighted sequence. Main
group consisted of 26 epilepsy patients with cerebral palsy. The control
group consisted of 20 children without clinical manifestations of epilepsy
and no signs of seizure activity on EEG. FA (fractional anisotropy), val-
ues andMD (mean diffusion) were calculated on the same sections for all
the resulting images.
Results: In the study these children with symptomatic epilepsy on the
background of cerebral palsy we found a significant decrease in the FA
values in fronto-temporal areas (P < 0.01). In other areas studied FA val-
ues were within the normative range. To evaluate the results of MRI dif-
fusion is used as indicator of the mean diffusion (MD), an increase of
values is associated with a defect in neurogenesis or loss of cells,
followed by an increase in the extracellular space. In children with symp-
tomatic epilepsy cerebral palsy was observed the significant increase the
MD values in all studied areas (P < 0.01).
Conclusion: The obtained results prove that diffusion weighted MRI in
children with symptomatic epilepsy and cerebral palsy reveals the struc-
tural changes of white matter of brain. A significant increase of diffusion
capacity of the brain due to lower fractional anisotropy in the fronto-tem-
poral lobe indicates the permeability and damage of the myelin sheath in
white matter.
p0318
AMULTIMODALNEUROIMAGING STUDYOF
PSYCHOSIS OF EPILEPSY (POE)
J. Allebone*,†, R. Kanaan*,†, D. Parker†, D. Vaughan‡,
T. O’Brien§, S. Mullen¶, M. Cook**, S. Adams§, S. Voigrin**,
P. Kwan§, S. Berkovic¶, W. D’Souza**, D. Velakoulis§,
G. Jackson†,‡, A. Connelly†,‡, S.J. Wilson*,†,‡
*Melbourne School of Psychological Sciences, The University of
Melbourne, Melbourne, VIC, Australia, †The Florey Institute of
Neuroscience and Mental Health, Melbourne, VIC, Australia,
‡Comprehensive Epilepsy Program, Austin Health, Melbourne,
VIC, Australia, §The Royal Melbourne Hospital, Melbourne,
VIC, Australia, ¶Austin Health, Melbourne, VIC, Australia, **St
Vincent’s Hospital, Melbourne, VIC, Australia
Purpose: Approximately 7% of epilepsy patients develop psychosis of
epilepsy (POE), a devastating condition that carries a high risk of suicide.
Unfortunately, we do not understand why some people with epilepsy
develop psychosis while others do not. Moreover, there is no current
model that accounts for the differing presentations and severity of POE.
A leading model of psychosis in schizophrenia holds that the aberrant
assigning of “salience” (i.e. significance) to stimuli underpins psychotic
symptoms. Research suggests that aberrant salience reflects dysfunction
in the ‘salience network’ (SN) - a brain network anchored on the insula
and anterior cingulate cortex. The purpose of this study was to assess the
salience model of POE through multimodal imaging analysis of white
matter tracts and resting state functional connectivity of the SN. We
hypothesised changes in fibre density and altered functional connectivity
in the SN in POE relative to epilepsy patients without psychosis (EPY-
NP) and healthy controls (HC).
Method: POE patients were recruited from three major epilepsy services
in Victoria, Australia. High resolution MRI scans of 12 POE patients
were matched with 12 EPY-NP patients, and 12 HC, and analysed to
assess changes in white matter and resting state functional connectivity
in the SN.
Results: Reduced fibre bundle cross-section in the longitudinal fascicu-
lus was identified in POE as compared to EPY-NP (p < 0.05), and in the
cingulum bilaterally in POE compared to HC (p < 0.05). Correlations in
functional connectivity between nodes of the SN were similar between
POE and HC, and were less extensive in EPY-NP group.
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Conclusion: The results suggest that POE is characterised by structural
macroscopic changes in white matter fibre bundles that do not appear to
result in differences in resting state co-activation of the SN. This research
highlights that altered structure of specific white matter tracts may con-
stitute a neurobiological marker of POE.
p0319
DATAMININGMR IMAGE FEATURESOF SELECT
STRUCTURES FORLATERALIZATIONOFMESIAL
TEMPORAL LOBEEPILEPSY
K. Elisevich*, F. Mahmoudi†, H. Bagher-Ebadian‡, M.-
R. Nazem-Zadeh§, J. Schwalb¶, M. Kaur¶, H. Soltanian-Zadeh§,
**
*Spectrum Health Medical Group, Clinical Neurosciences,
Grand Rapids, MI, United States, †Islamic Azad University,
Qazvin Branch, , Iran, Computer and IT Engineering Faculty,
Qazvin, Iran, Islamic Republic of, ‡Oakland University, Physics,
Rochester, MI, United States, §Henry Ford Hospital, Imaging
Research, Department of Radiology, Detroit, MI, United States,
¶Henry Ford Hospital, Neurosurgery, Detroit, MI, United States,
**University of Tehran, CIPCE, School of Electrical and
Computer Engineering, Tehran, Islamic Republic of Iran
Purpose: This study systematically investigates the predictive power of
volumetric imaging feature sets extracted from select neuroanatomical
sites in lateralizing the epileptogenic focus in mesial temporal lobe epi-
lepsy (mTLE) patients.
Method: A cohort of 68 unilateral mTLE patients who had achieved an
Engel class I outcome postsurgically were studied retrospectively. The
volumes of multiple brain structures were extracted from preoperative
magnetic resonance (MR) images in each. The MR image data set con-
sisted of 54 patients with qualitatively identified (positive) hippocampal
sclerosis (HS-P) and 14 patients without (HS-N). Data mining techniques
(i.e., feature extraction, feature selection, machine learning classifiers)
were applied to provide measures of the relative contributions of struc-
tures and their correlations with one another. After removing redundant
correlated structures, a minimum set of structures was determined as a
marker for mTLE lateralization.
Results: Using a logistic regression classifier, the volumes of both hip-
pocampus and amygdala showed correct lateralization rates of 94.1%.
This reflected about 11.7% improvement in accuracy relative to using
hippocampal volume alone. The addition of thalamic volume increased
the lateralization rate to 98.5%. This ternary-structural marker provided a
100% and 92.9% mTLE lateralization accuracy, respectively, for the
HS-P and HS-N groups.
Conclusion: The proposed ternary-structural MR imaging biomarker
provides greater lateralization accuracy relative to single- and double-
structural biomarkers and thus, may play a more effective role in the sur-
gical decision-making process. Also, lateralization of the patients with
insignificant atrophy of hippocampus by the proposed method supports
the notion of associated structural changes involving the amygdala and
thalamus.
p0320
PHOTOSENSITIVE EPILEPSY IS ASSOCIATEDWITH
ABNORMALEXCITABILITYOFALPHARHYTHM
GENERATINGNETWORKS
A.E. Vaudano*, A. Ruggieri*, P. Avanzini†, G. Gessaroli‡,
G. Cantalupo§, A. Coppola¶, S. Sisodiya**, S. Meletti*,‡
*University of Modena and Reggio-Emilia, Department of
Biomedical, Metabolic and Neural Science, Modena, Italy,
†University of Parma, Department of Neuroscience, Parma,
Italy, ‡AUSLModena, Neurology Unit, Modena, Italy,
§University of Verona, Department of Life and Reproduction
Sciences, Verona, Italy, ¶Federico II University, Department of
Neuroscience, Odontostomatology and Reproductive Sciences,
Naples, Italy, **UCL, Institute of Neurology, Department of
Clinical and Experimental Epilepsy, London, United Kingdom
Purpose: To investigate the brain circuits generating spontaneous alpha
rhythm fluctuations in photosensitive patients and in people without pho-
tosensitivity.
Method: 44 epileptic patients and 16 healthy controls underwent an
electroencephalography-correlated functional magnetic resonance imag-
ing study. In the patients group, 16 subjects were affected by Genetic
Generalized Epilepsy (GGE) with documented photosensitivity (GGE
PS+), 13 by GGE without photosensitivity (GGE PS-) and 15 by Focal
Epilepsy (FE). The alpha power variations were convolved with the stan-
dard hemodynamic response function and used as a regressor in a single
general linear model. Within and between groups second level analyses
were performed as appropriate. Whole brain functional connectivity was
evaluated for two thalamic regions of interest based on the BOLD find-
ings that included the posterior thalamus (pulvinar) and the medio-dorsal
thalamic nuclei.
Results: GGE PS+ demonstrated a significant greater mean alpha-power
with respect to controls and other epilepsy groups. In photosensitive epi-
lepsy, alpha-related BOLD signal changes demonstrated lower BOLD
deactivation relative to all other groups at the occipital, sensory-motor,
anterior cingulate and supplementary motor cortex. The same brain
regions demonstrated an abnormal connectivity with the visual thalamus
only in GGE PS+.
Conclusion: The cortical-subcortical network generating the alpha oscil-
lation at rest is different in people with epilepsy and visual sensitivity
with respect to other epilepsy syndromes and healthy controls. Such dif-
ference consists of a decreased alpha-related inhibition of the visual cor-
tex and sensory-motor networks. Our findings provide evidences of a
functional link between the circuits triggering the visual sensitivity
phenomenon and the posterior alpha rhythm generation.
p0321
THEADDEDVALUEOFHIGH-FIELDMRI AT 7T FOR
PRE-SURGICAL EVALUATIONOFDRUG-RESISTANT
EPILEPSY
T. Gholipour*,†, M. Hibert†, N. Tanaka†, G. Young*,
S. Stufflebeam†, E. Bubrick*
*Brigham andWomen’s Hospital / Harvard Medical School,
Boston, MA, United States, †Massachusetts General Hospital,
Martinos Center for Biomedical Imaging, Charlestown, MA,
United States
Purpose: High-field MRI offers higher resolution and signal to noise
ratio for structural imaging, and is often utilized for detection of surgical
targets in drug-resistant epilepsy when no definite lesion is seen on con-
ventional clinical MRI. Here we evaluate whether 7T MRI improves the
diagnostic accuracy for potential surgical candidates at a tertiary epilepsy
surgery center.
Method: We obtained high-field 7T MRI on 13 patients who were
undergoing standard pre-surgical workup. Four of these had no detected
lesion (“non-lesional”) on conventional 3T MRI, 9 had at least one sus-
pected abnormality on clinical 3T MRI. Ten patients had temporal
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(including mesial and neocortical focus) and 3 had extra-temporal epi-
lepsy, determined by their clinical picture and ictal EEG. Patients with
large malformations or prior brain surgery were excluded. High-fieldMR
images were obtained using a 7T scanner (Siemens, Germany) with a
32-channel coil prior to any invasive recording or procedure, and were
interpreted by a neuroradiologist with expertise in high-field imaging.
Institutional review board approval was obtained for this study and
patients signed an informed research consent form.
Results: Of the patients with at least one suspected abnormality on their
3T MRI, 5/9 suspected abnormalities were confirmed and better charac-
terized by 7T. Three were not confirmed using the higher resolution and
contrast of 7T, hence were re-categorized as non-lesional. Of the 4
patients with no abnormalities on 3T, 1 was found to have a previously
undetected focal cortical dysplasia.
Conclusion: The use of 7T MRI can improve diagnostic accuracy in the
evaluation for epilepsy surgery, not only by finding relevant abnormali-
ties in previously non-lesional cases, but also by further characterizing
suspected abnormalities such as mild mesial temporal sclerosis, cortical
dysplasias, and vascular lesions or anomalies. The additional information
provided by 7T MRI can significantly affect planning for invasive
recordings and surgical treatments.
p0322
ISMTLE-HS A FOCAL EPILEPSY SYNDROME?A
DIFFUSION TENSOR STUDY
A. Radhakrishnn*, A. Chandran*, R. Menon*, A. Cherian*,
B. Thomas*, C. Kesavadas*, M. Abraham*, G. Vilanilam*,
S. Thomas*
*R. Madhavan Nayar Center for Comprehensive Epilepsy Care,
Department of Neurology, Sree Chitra Tirunal Institute for
Medical Sciences and Technology, Trivandrum, India
Purpose: To study the extent of white matter abnormalities through dif-
fusion tensor imaging and tractography in a large cohort of patients with
TLE with unilateral mesial temporal lobe (hippocampal) sclerosis
(MTLE-HS).
Methods: DTI measurements were obtained from tractography for arcu-
ate fasciculus(ARF), cingulum, corticospinal tract, inferior longitudinal
fasciculus(ILF); inferior frono-occipito fasciculus(IFOF), optic radiation
(OR), superior longitudinal fasciculus and uncinate fasciculus(UNF) in
50 patients with MTLE-HS and were compared to 50 age and sex-
matched controls. Paired t-test was performed to compare the tracts in the
affected left and right hemisphere of patients with corresponding left and
right hemisphere in controls.
Results: Compared to controls, significant differences in fractional
anisoptropy (FA) values of ARF, IFOF, and OR and apparent diffusion
co-efficient (ADC) of OR in right hemisphere of right MTS patients was
noted. In left MTS patients, significant differences were found in both
FA and ADC values of cingulum and IFOF and FA value alone in OR of
left hemisphere. Results showed significant decrease in FA values of
three tracts (ARF, p = 0.009; IFOF, p = 0.002 and OR, p = 0.0003) in
the affected hemisphere in the case of right MTS patients compared to
the normal controls. In left MTS patients, two tracts (cingulum,
p = 0.004; OR, p = 0.001) showed significant decrease in FA values.
ADC values of two tracts in left MTS patients (cingulum, p = 0.042; and
IFOF, p = 0.002) also showed significant decrease as compared to con-
trols. On comparison of left and right hemispheres, ADC values of UNF
(p = 0.050) in right MTS patients and ARF (p = 0.022) in left MTS
patients showed significant low values.
Conclusions: Widespread changes in other parts of limbic system occurs
in MTLE-HS. This could account for a less than optimal outcome in
patients even when a focal abnormality like HS is resected for drug-resis-
tant TLE. An early surgery for MTLE-HS with drug-resistant TLE there-
fore should be advocated.
p0323
TIME IS BRAIN? A SYSTEMATIC REVIEWANDMETA-
ANALYSIS ON PROGRESSIVEATROPHY IN DRUG-
RESISTANT TEMPORAL LOBE EPILEPSY
L. Caciagli*,†, A. Bernasconi†, S. Wiebe‡, M.J. Koepp*,
N. Bernasconi†, B.C. Bernhardt†,§
*UCL Institute of Neurology, Department of Clinical and
Experimental Epilepsy, London, United Kingdom, †Montreal
Neurological Institute and Hospital, Neuroimaging of Epilepsy
Laboratory, Montreal, QC, Canada, ‡University of Calgary,
Department of Clinical Neurosciences, Calgary, AB, Canada,
§Montreal Neurological Institute and Hospital, Multimodal
Imaging and Connectome Analysis Laboratory, Montreal, QC,
Canada
Purpose: It remains unclear whether drug-resistant temporal lobe epi-
lepsy (TLE) is associated with cumulative brain damage, with no expert
consensus and no quantitative syntheses of the available evidence. We
conducted a systematic review and meta-analysis on previous MRI stud-
ies addressing progressive atrophy in TLE.
Method: We searched PubMed and Ovid-Medline databases for cross-
sectional and longitudinal MRI studies on drug-resistant TLE, and
included studies i) conducted on human cohorts, with ii) participants
evaluated using quantitative MRI methods and iii) analyses addressing
disease progression through correlations with epilepsy duration, correla-
tions with seizure counts, or longitudinal design, at hippocampal and/or
whole-brain level. Animal studies, case reports or case series with n ≤ 5
were excluded.
Results: We screened 2,976 records and assessed eligibility of 248 full-
text articles. Forty-two articles met the inclusion criteria for quantitative
evaluation. We observed a predominance of cross-sectional studies,
using different clinical indices of progression, and high heterogeneity in
age-control procedures. Meta-analysis of 18/1 cross-sectional/longitudi-
nal studies on hippocampal atrophy (n = 979 patients) yielded a pooled
effect size of r = -0.42 for ipsilateral atrophy related to epilepsy duration
(95%CI: -0.51 to -0.32; p < 0.0001; I†=65.22%) and r = -0.35 related to
seizure frequency (95%CI -0.47 to -0.22; p < 0.0001; I†=61.97%). Sensi-
tivity analyses did not change the results. Narrative synthesis of 25/3
cross-sectional/longitudinal studies on whole-brain atrophy (n = 1504
patients) indicated that >80% of papers reported duration-related pro-
gression in extra-temporal cortical and subcortical regions. Analysis of
study design features yielded low-to-moderate levels of evidence for pro-
gressive atrophy across studies, due to dominance of cross-sectional over
longitudinal investigations, use of diverse measures of seizure estimates,
and absence of consistent age control procedures.
Conclusion: While the neuroimaging literature is overall suggestive of
progressive atrophy in drug-resistant TLE, published studies have
employed rather weak designs to directly demonstrate it. Longitudinal
multi-cohort studies are needed to unequivocally differentiate aging from
disease progression.
p0325
DO SUBTLEHIPPOCAMPAL STRUCTURALCHANGES
ONMRI SERVEAS BIOMARKERS FOR SEIZURE
RECURRENCE IN A PROSPECTIVE FIRST SEIZURE
COHORT?
M. Ghuman*, C.E. Crocker*,†, K. Legg‡, M.H. Schmidt*,
B. Pohlmann-Eden‡,§
*Dalhousie University, Department of Diagnostic Radiology,
Halifax, NS, Canada, †Dalhousie University, Department of
Psychiatry, Halifax, NS, Canada, ‡Division of Neurology,
Department of Medicine, Halifax, NS, Canada, §Dalhousie
University, Brain Repair Centre, Halifax, NS, Canada
Purpose: Etiology and abnormal EEG have been described as the stron-
gest predictors for seizure recurrence (SR) after a first seizure (FS). There
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is an urgent need for more subtle biomarkers to individually predict SR
and better understand epileptogenesis. Systematic longitudinal first sei-
zure cohorts with research-driven MRI protocols are scant. The Halifax
First Seizure Clinic cohort provided the opportunity to determine
whether hippocampal malrotation (HIMAL) and loss of hippocampal
internal architecture (HIA) are biomarkers for SR.
Method: 51 adult patients (15 - 74 years) with FS or new-onset epilepsy
(NOE ≥ 2 seizures in < 12 months) were recruited excluding primary
generalized epilepsy. Within 6 weeks, patients received 1.5 Tesla MRI
imaging using an epilepsy protocol (3 mm coronal T2 FSE images,
angled to the hippocampi, sagittal cube T2 and FLAIR, axial 3D-FSPGR,
axial DTI whole brain, and single-voxel proton spectroscopy of mesial
temporal lobes). Two independent readers examined HIMAL and HIA
following a published scoring system.
Results: 28 FS and 23 NOE patients were identified. 10 FS patients con-
verted to NOE (1-year follow-up). MRI pathologies encompassed hip-
pocampal sclerosis (n = 1), dysembryoplastic neuroepithelial tumor
(n = 1), occipital band heterotopia (n = 1), and a cystic temporal stem
lesion (n = 1). Based on consensus scores, subtle hippocampal changes
were found in 26 patients, 11 presenting with HIMAL and 15 with loss of
HIA. No significant association was found between HIMAL and NOE,
nor between HIMAL and conversion from FS to NOE. Loss of HIA and
NOE at presentation was also not significantly correlated. However, loss
of HIA was significantly associated with conversion from FS to NOE
(p = 0.0427, one-tailed Fisher´s exact test).
Conclusion: Our data support that HIMAL represents a normal variation
of the hippocampal structure. The loss of HIA is possibly a biomarker for
epileptogenesis.
p0326
MORPHOMETRIC FEATUREANALYSIS OF
PAEDIATRIC FOCALCORTICALDYSPLASIAS
S. Adler*,†, K. Wagstyl‡, R. Gunny†, D. Carmichael*,†,
J.H. Cross*,†, T. Baldeweg*,†
*UCL Great Ormond Street Institute of Child Health,
Developmental Neurosciences, London, United Kingdom,
†Great Ormond Street Hospital, London, United Kingdom,
‡University of Cambridge, Brain Mapping Unit, Cambridge,
United Kingdom
Purpose: Focal cortical dysplasias (FCDs) are the leading cause of surgi-
cally remediable drug-resistant epilepsy in children. Radiological identi-
fiers include abnormal cortical thickness, signal intensity and folding
patterns. Automated computational techniques have quantified FCD fea-
tures in adults, but have not yet been applied to developing brains. Here,
we quantify FCD lesion characteristics in a paediatric cohort to identify
features that may assist lesion delineation.
Method: Cortical reconstructions were generated in 22 patients with
radiologically defined FCD. The following surface-based metrics were
calculated: cortical thickness, grey-white signal intensity contrast,
FLAIR signal intensity, sulcal depth, curvature, local gyrification index
(LGI) and local cortical deformation (LCD). Features underwent intra-
and inter-subject normalisation using 28 controls. Mean feature values
were calculated for each patient within the manually created lesion mask
and the same mask applied to the contra-lateral, homotopic area. Kernel
density profiles were created for each feature.
Results: In contrast to the feature profiles of homotopic, healthy cor-
tices, which are normally distributed and centre around zero, feature pro-
files of lesions often have increased variance or skewed distributions.
FLAIR signal intensity and grey-white matter intensity contrast profiles
are negatively skewed; lesional cortical thickness and LCD have
increased variance
(Levene’s test p < 0.05); whereas sulcal depth has a bimodal distribu-
tion indicating a small proportion of lesions are characterised by
increased sulcal depth. The profiles of curvature and LGI are less distin-
guishable from homotopic areas, indicating limited use in lesion profil-
ing.
Conclusion: Quantitative analysis of paediatric FCDs can capture char-
acteristic radiological features like abnormal cortical thickness, grey-
white matter blurring, signal abnormalities and irregular cortical folding
patterns. However, as some profiles, such as cortical thickness, demon-
strate no difference in mean value but increased variance, their utility in
lesion delineation and in vivo FCD subtyping will require nonlinear
approaches, such as incorporation of multiple features into nonlinear
machine-learning classifiers.
p0328
ALTERED STRUCTURALCORRELATIONNETWORKS
(SCN’S) IN CRYPTOGENIC LOCALIZATION-RELATED
EPILEPSY (CLRE) AREASSOCIATEDWITH SEIZURE
FREQUENCY
G.S. Drenthen*,†, W.H. Backes*, M.C.G. Vlooswijk‡,
M.H.J. Majoie†,‡, P.A.M. Hofman*,†, A.P. Aldenkamp†,‡,
J.F.A. Jansen*
*Maastricht University Medical Center, Department of
Radiology and Nuclear Medicine, Maastricht, Netherlands,
†Epilepsy Center Kempenhaeghe, Heeze, Netherlands,
‡Maastricht University Medical Center, Department of
Neurology, Maastricht, Netherlands
Purpose: In previous studies, altered structural correlation networks
(SCN’s) based on cortical thickness have been observed in patients with
epilepsy. However, as SCN’s can only be determined on a group level,
associating altered networks with clinical (e.g. epilepsy related) charac-
teristics is not straightforward. in a previous study, a method to obtain
individual variations in SCN’s was introduced (Sagger et al. Neuroimage
2015). We applied this method in cryptogenic localization-related epi-
lepsy (CRLE) and investigated whether altered SCN’s are associated
with full-scale IQ (FSIQ), seizure frequency, and onset age.
Method: Fifty-nine participants are included in this study, 38 patients
with CRLE (18 females, age 40  12y) and 21 controls (6 females, age
40  14y). T1-weighted images (voxel size, 1x1x1 mm) obtained by a
3.0-TMRI scanner (Philips Achieva) were used to extract the mean corti-
cal thickness for 68 regions. These thicknesses were first corrected for
age, gender, and total intracranial volume. Adjacency matrices were
obtained by calculating the Pearson’s correlation coefficient between the
corrected cortical thicknesses for each region pair. Individual contribu-
tion of a patient is measured by adding the respective patient to the native
control group before calculating the network. Two well-known network
metrics, characteristic path length and cluster coefficient, were computed
and both are normalized with respect to 100 random networks to correct
for variations in network topology.
Results: A significant positive correlation was found for the cluster coef-
ficient and seizure frequency (rho=0.361, p = 0.026). A trend towards
negative correlation was also found for local clustering and onset age
(rho=-0.291, p = 0.076). Moreover, a significant negative correlation
was found between clustering and FSIQ (r = -0.399, p = 0.013).
Conclusion: In the current study it is shown that an increase in clustering
is related to worse seizure control and decreased cognitive performance.
These results might hint that seizure propagation is accommodated by
highly clustered cortical networks.
p0329
FUNCTIONALMRIOF LANGUAGEANDMEMORY
LATERALISATION TOAID PRESURGICAL
EVALUATIONOF PAEDIATRIC EPILEPSY
S. Buck*, R. Elward*, D. Carmichael†, T. Baldeweg*,
F. Vargha-Khadem*
*University College London, Cognitive Neuroscience and
Neuropsychiatry, London, United Kingdom, †University College
London, Developmental Imaging and Biophysics Section,
London, United Kingdom
Purpose: Temporal lobe surgery is an effective treatment for medica-
tion-resistant paediatric temporal lobe epilepsy (TLE); however, this pro-
cedure can result in language and memory deficits that compromise
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educational performance. It is therefore crucial to assess language and
memory lateralisation prior to surgery. We have developed an fMRI
paradigm to assess memory and language in children during a single
scanning session.
Method: Functional scans were acquired on a 3T Siemens system in 18
healthy volunteers (aged 8-18 years). Language laterality was assessed
through a verb generation task. Memory laterality was assessed through
cued recall, where cues were presented to guide recall of previously
encoded words (in the verb generation task). The baseline task involved
making an odd/even decision to numbers and served as a delay period
between encoding and recall. Lateralisation in individual participants
was determined using the LI toolbox.
Results: Across the group, block-wise comparisons for the language task
demonstrated activations in posterior inferior frontal gyrus (Broca’s area)
and in superior temporal gyrus bilaterally (p < 0.05, FWE corrected).
Memory function was explored using event-related analyses for correctly
retrieved words, and hippocampal activations were observed bilaterally
(p < 0.01). At the individual level, laterality indices suggest that all par-
ticipants were left lateralised for language, with LIs ranging from +0.61
to +0.98. Most participants were also left lateralised for memory (n = 11;
LI: +0.25 to +1) whilst three had LI in the bilateral range (-0.16 to +0.12)
and three were lateralised to the right (-0.37 to -0.67).
Conclusion: Our findings show robust activations in language and ver-
bal memory networks and confirm the feasibility of assessing lateralisa-
tion of language and memory in children. This protocol has the
advantage of lateralising language and memory functions within one sin-
gle scanning session and could prove useful for the pre-operative assess-
ment of paediatric candidates for epilepsy surgery.
p0330
EXECUTIVE FUNCTIONS IMPAIREMENTS IN
CHILDRENWITHROLANDIC EPILEPSY
N. Canario*, M. Veiga†, N. Abreu*
*Universidade Federal da Bahia - UFBA, Instituto de
Psicologia, Salvador, Brazil, †Universidade Federal da Bahia,
Salvador, Brazil
Purpose: The primary aim of this study was to compare the core execu-
tive functions (EF) in children with rolandic epilepsy (RE) and healthy
controls. As a secondary aim, we compared typical and atypical RE chil-
dren’s EF.
Method: 24 children (11 females) with RE (typical, n = 18, or atypical,
n = 16) and 33 healthy controls (19 females), aged 6 to 13 years, were
assessed for intelligence (WASI), working memory (subtest Digits-
WISC IV and Corsi Block-Tapping task - CBT), inhibitory control
(TAVIS 4) and cognitive flexibility (Five Points Test - FPT). Their par-
ents answered sociodemographic questionnaires and a ADHD/ODD
symptoms scale (MTA-SNAP-IV). The groups were homogeneous
(p>,05) regarding age, intelligence, income and ADHD/ODD symptoms.
Mann-Whitney U and Kruskal-Wallis tests were performed to ascertain
differences between groups.
Results:
Compared to controls, the clinical group had worse performance in
the CBT-forward´s trials: (U = 264,5; r = -0,27; p< ,05) and in the
FPT total perseverative errors (U = 197,5; r = -0,36; p< ,05), and better
performance in FPT total drawings (U = 264,5; r = -0,27; p< ,05). Chil-
dren with typical and atypical RE didn´t differ in EF measurements.
Compared to control group, children with atypical RE had lower
weighted scores in Digits backward (U = 39,5; r = -0,37; p< ,05). Chil-
dren with typical RE showed worse performance than controls in the
CBT-forward´s trials (U = 184,5; r = -0,3; p< ,05), FPT total persevera-
tive errors (U = 118,5; r = -0,46; p< ,01) and perseverative errors per-
centage (U = 159,5; r = -0,32; p< ,05), and a better performance in the
FPT total number (U = 156; r = -0, 38; p< ,01) and correct (U = 195;
r = -0,28; p < ,05) drawings.
Conclusion: Impairments in working memory and cognitive flexibility
in RE patients were observed. The results also point to failures in visuo-
spatial attention and behavioral monitoring. Differences between RE
forms may have been underestimated due to the size of the atypical RE
group.
p0333
THECONTRIBUTIONSOFCOGNITIVEABILITIES TO
ACADEMIC PROFILE INNEW-ONSETCHILDHOOD
ABSENCE EPILEPSY
D. Cheng, C. Qian, X. Yan, Z. Gao, K. Xu
Capital Institute of Pediatrics, Department of Pediatric
Neurology, Beijing, China
Purpose: Neuropsychological studies indicate that new-onset childhood
absence epilepsy (CAE) is associated with deficits in attention and execu-
tive functioning. However, the contribution of these deficits to impaired
academic performance remains unclear. We aimed to examine whether
attention and executive function deficits account for the academic diffi-
culties prevalent in patients with new-onset CAE.
Method: Neuropsychological tests were used to assess the cognitive per-
formance in several domains, including language, mathematics, psy-
chomotor speed, spatial ability, memory, intelligence, attention, and
executive functioning, in 35 children with new-onset CAE and 33 control
participants. One-way analysis of variance (ANOVA) compared perfor-
mance on all tests between the new-onset CAE group and the control
group. Analysis of covariance (i.e., ANCOVA) was conducted to exam-
ine the relationships among general cognitive processing, language pro-
cessing, and mathematical abilities.
Results: Patients with new-onset CAE exhibited deficits in mathematics,
intelligence, attention, and executive functioning. They showed pre-
served performance in language, psychomotor speed, spatial ability and
memory. Furthermore, attention deficits, as measured by a visual tracing
task, accounted for impaired arithmetic performance in the CAE group.
Conclusion: Children with new-onset CAE exhibit deficits in attention
and executive functioning, and is associated with impaired academic per-
formance in mathematics Attention deficits, rather than impaired intelli-
gence or executive functioning, is the fundamental cognitive mechanism
underlying mathematical performance impairments in patients with new-
onset CAE.
p0337
ROLANDIC EPILEPSY: RELATIONS BETWEEN
CLINICAL FEATURES ANDEXECUTIVE FUNCTIONS
N. Canario*, M. Veiga†, N. Abreu*
*Universidade Federal da Bahia, Instituto de Psicologia,
Salvador, Brazil, †Universidade Federal da Bahia, Salvador,
Brazil
Purpose: We verified relations between executive functions (EF) and
laterality of the epileptic focus, age of onset, frequency of seizures, epi-
lepsy duration and use of antiepileptic drugs (AED) in children with
rolandic epilepsy (RE).
Method: 24 children (11 females) with RE, aged 6 to 13 years, were
assessed for working memory (subtest Digits-WISC IV and Corsi Block-
Tapping task - CBT), inhibitory control (TAVIS 4) and cognitive flexibil-
ity (Five Points Test - FPT). Their parents answered the epilepsy ques-
tionnaire created for the study. Three groups were formed based on the
epileptic discharges: lateralized/predominant in left hemisphere (LH);
lateralized/ predominant in right hemisphere (RH); without predomi-
nance (WP). Spearman Correlation and Mann-Whitney U tests were per-
formed.
Results: Age of onset was associated with: Digits-backward0s span
(q = 0.57; p < 0.01) and weighted score (q = 0.47; p < 0.01); CBT-for-
ward0s trials (q = 0.43; p < 0.05) and spanXtrials (q = 0.45; p < 0.05);
CBT-backward0s span (q = 0.49; p < 0.05), trials (q = 0.51; p < 0.05)
and spanXtrials (q = 0.52; p < 0.01); TAVIS-T30s time (q = 0.46;
p < 0.05) and commission errors (q = 0.43; p < 0.05). Number of
AED was associated with Digits-forward0s weighted score (q = 0.43;
p < 0.05) and TAVIS-T30s commission errors (q = 0.42; p < 0.05). Epi-
lepsy duration was correlated with Digits-forward0s weighted score
(q = 0.44; p < 0.05) and TAVIS-T10s ommission errors (q = 0.43;
p < 0.05). LH performed superiorly than WP on Digits-forward0s
weighted score (U = 5.5; r = 0.6; p < 0.05) and TAVIS-T10s
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commission errors (U = 3; r = 0.7; p < 0.01). LH was better than RH
in TAVIS-T10s commission errors (U = 0; r = 0.8; p < 0.01).
Conclusion: The earlier the onset and the longer the RE, the worse the
children performance on working memory and inhibitory control. Bilat-
eral epileptiform discharges also resulted worse performance in these
functions The relation between the number of AED and the inhibitory
control may be due to their adverse effects or the disease severity.
p0340
WATCHTHELANGUAGE!LANGUAGEAND
LINGUISTIC-COGNITIVE ABILITIES IN CHILDREN
WITHNOCTURNAL EPILEPTIFORMACTIVITY
S. Systad*,†, M. Bjørnvold‡, R. Markhus‡, S.-A.H. Lyster†
*Department of Refractory Epilepsy - SSE, Solberg School, Oslo
University Hospital, Oslo, Norway, †Department of Special
Needs Education, University of Oslo, Oslo, Norway,
‡Department of Refractory Epilepsy - SSE, Oslo University
Hospital, Oslo, Norway
Purpose: The purpose of the study was two folded: First, we wanted to
explore in what ways the language abilities of children with nocturnal
epileptiform activity (NEA) differ from those of typically developing
children. Second, we wanted to explore how NEA-related factors affect
the language abilities of children with NEA.
Method: We included a group of children with nocturnal epileptiform
activity (NEA; N = 33) hospitalized at a tertiary epilepsy hospital (inclu-
sion criteria: more than four times increase of epileptiform activity from
daytime to sleep state, no seizures the last six weeks and not any known
diagnosis such as mental retardation, cerebral palsy and autism). The
children were compared with two groups of typically developing chil-
dren: one group matched on age and gender (N = 33) and one group
matched on language ability (vocabulary) and gender (N = 66).
Results: In general, the children with NEA showed delayed language
abilities. The data suggested a trend for the children to perform especially
poorly on phonology and naming speed. However, a subgroup of NEA-
children who could read performed especially poorly only on phonology.
Overall, we did not find firm evidence that NEA-related factors (the
amount of NEA, the use of antiepileptic drugs (AEDs), and the lateraliza-
tion and localization of NEA) affected language abilities. Nevertheless,
children with right-lateralized epileptiform activity seemed to have
specific difficulties with naming speed and children with NEA located in
the centrotemporal areas seemed to have specific difficulties with
phonology and orthographic skills.
Conclusion: First, the children with NEA showed delayed language abil-
ities and a trend for difficulties with phonology and naming speed in par-
ticular compared to typically developing children. Second, the NEA-
related factors did not affect language abilities. However, we found some
support for the idea that laterality and localization of NEA might affect
the difficulties.
p0341
THEVALUEOF EEG INASSESSINGCHILDRENWITH
SPEECHANDLANGUAGE IMPAIRMENTS
S. Systad*,†, M. Bjørnvold‡, C. Sørensen*, S.-A.H. Lyster†
*Department of Refractory Epilepsy - SSE, Oslo University
Hospital, Solberg School, Oslo, Norway, †Department of Special
Needs Education, University of Oslo, Oslo, Norway,
‡Department of Refractory Epilepsy - SSE, Oslo University
Hospital, Oslo, Norway
Purpose: The purpose of this study was to estimate the prevalence of iso-
lated epileptiform activity (IEA) in children with speech and language
impairments. Also, we wanted to discuss the utility of an electroen-
cephalogram (EEG) in assessing these children.
Method: A systematic review was conducted. We searched for eligible
studies in eight databases and included all languages.Meta-analyses were
performed.
Results: Eight studies included a comparison group with typically devel-
oping children. The results showed that the odds of having IEA were six
times greater for children with speech and language impairments than for
typically developing children. In total, we found 55 unique estimates of
the prevalence of IEA in children with speech and language impairments.
Overall, the pooled prevalence of IEA was 27.3%. However, a wide vari-
ation was found between the unique estimates. This variation could be
explained in different ways. First, type of speech and language impair-
ment could to a certain degree explain the wide variation. IEA were
found in 8.1% of children with speech impairments (e.g. dysfluent speech
and speech sound disorder), 25.8% of children with language impair-
ments (e.g., specific language impairments (SLI) and developmental dys-
phasia (DD)), and 51.5% of children with language regression. Second,
sleep EEGs detected a significantly higher prevalence of IEA than awake
EEGs. Last, significantly higher prevalence rates of IEA were found
when epilepsy was present versus if epilepsy was not present. However,
in additional analysis 33.5% of language-impaired children without epi-
lepsy were found to have IEA in sleep EEGs.
Conclusion: IEA is a frequent finding in children with language impair-
ment. We argue that while EEG is of questionable value when assessing
children with solely speech impairments, sleep EEG would be valuable
when assessing children with language impairments and children who
experience language regression.
p0343
MRI-NEGATIVE TLE IS NOTCOGNITIVELY BENIGN:
LOOKINGBEYONDLESIONS FORCAUSESOF
NEUROPSYCHOLOGICAL IMPAIRMENT
G. Rayner*,†, C. Tailby*, G. Jackson*, S. Wilson†
*Florey Instiute of Neuroscience andMental Health, Epilepsy
Imaging, Heidelberg, VIC, Australia, †Melbourne School of
Psychological Sciences, The University of Melbourne,
Melbourne, VIC, Australia
Purpose: Cases of MRI-negative and lesional TLE are similar in their
semiology and electroclinical profile. It remains unclear, however,
whether they are also similar in their memory and mood profiles, as pre-
vious studies have generally been low powered and report mixed find-
ings. This study aims to clarify whether a structural lesion leads to an
additional decrement of neuropsychological function, over and above
that caused by the brain network disruption that is characteristic of all
epilepsies.
Method: In total, 152 adults participated: 79 TLE patients and 73
sociodemographically-matched healthy controls. On the basis of 3T-
MRI, 19 (24%) of patients had a lesion consistent with hippocampal scle-
rosis (HS-TLE), 30 (38%) had a lesion other than HS (MRI-pos TLE),
and 30 (38%) were deemed lesion negative (MRI-neg TLE). Memory
and mood were assessed using measures well-established for use in epi-
lepsy.
Results: Relative to controls, people with MRI-neg TLE showed signifi-
cantly impaired verbal, visual, and autobiographic memory (p < 0.05–
0.001); they also reported significantly higher depression and anxiety
(p < 0.05–0.01). Mood and memory decrements in MRI-neg TLE were
equivalent to those seen in patients with lesions (p > 0.05), but were pre-
dicted by distinct factors. In MRI-neg, memory deficits were under-
pinned by younger onset of seizures, reduced intellectual capability, and
previous depressive disorder. Memory deficits of HS-TLE patients were
linked to the refractoriness of seizures as well as depressive symptoms,
and in MRI-pos TLE, more years of education.
Conclusion: MRI-negative TLE is associated with memory and mood
dysfunction equivalent to that seen in patients with HS and other struc-
tural pathologies. This suggests that neuropsychological impairments in
TLE are not contingent upon a macroscopic structural lesion, and might
be better conceptualised as an intrinsic property of the underlying net-
work disease. Additional vulnerability to behavioural dysfunction is con-
ferred by clinical, cognitive, and psychological mechanisms specific to
TLE subtype.
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NEUROPSYCHOLOGICAL PROFILEOF PATIENTS
WITH SLEEP-RELATEDHYPERMOTOREPILEPSY
(SHE)
L. Licchetta*,†, R. Poda*, L. Vignatelli*, C. Zenesini*,
N. Pilolli†, V. Menghi*,†, B. Mostacci*, L. Di Vito*,
F. Provini*,†, P. Tinuper*,†, F. Bisulli*,†
*IRCCS Istituto delle Scienze Neurologiche Bologna, Bologna,
Italy, †Department of Biomedical and Neuromotor Sciences,
University of Bologna, Bologna, Italy
Purpose: To assess the cognitive functions of a representative cohort of
SHE patients by a systematic neuropsychological study.
Methods: Cross-sectional study carried out over 2013–2016, including
patients with video/video-EEG-documented SHE according to the novel
diagnostic criteria. All patients underwent an assessment of intelligence
(WAIS) and cognitive status (MMSE); individuals with normal scores
(IQ > 80; MMSEc > 23.8) underwent a standardized neuropsychologi-
cal battery. Fisher’s exact test and Wilcoxon Rank-Sum highlighted pos-
sible correlations with clinical determinants.
Results: We enrolled 60 individuals (M/F: 28/32, mean age
38.2  12.43 years; mean age at onset 12.62  8.15 years): 38
(63.33%) had unknown etiology, 11 (18.3%) showed brain lesions and 11
(18.3%) were genetic.
IQ scores (range: 45–138) were significant worse in verbal compared
to performance abilities (mean: 93.38  19.50 vs 101.35  21.10;
p < 0.0001). Thirteen patients (11 with cognitive deficits, 2 drop-out)
did not complete the extensive battery. Of the remaining 49 individuals,
23 (46.9%) showed deficits in at least one test: phonemic fluency, 12
(24.5%); verbal/visuospatial memory, 12 (24.5%); Stroop, 11 (22.4%);
working memory, 5 (10.2%). At univariate analysis, pathological neuro-
logical examination (NE) correlated with worse scores at WAIS (66.67%
vs 7.69%, p: 0.029) and MMSE (24.52  5.7 vs 28.03  1.45, p:
0.010); “Any underlying brain disorder” (pathological NE and/or brain
MRI) was associated with deficits in verbal memory (30% vs 2.63%, p:
0.025) and attention/inhibitory control (50% vs 15.38%, p: 0.033), with
significant worse performances in shifting abilities (99.9  30.9 vs
73.38, p: 0.027). This result regards also patients with status epilepticus
(65.4  18.51 vs 46.18  23.15, p: 0.035) and poor prognosis
(50.12  23.47 vs 30.83  8.9, p: 0.02). Bilateral convulsive seizures
correlated with worse working memory (3.56  1.04 vs 4.27  1.06, p:
0.049).
Conclusions: Neuropsychological deficits are frequent in SHE. The pro-
file of neuropsychological impairment is characterized by significant
worse scores in verbal IQ and deficits in phonemic language, memory
and selective executive functions. Pathological brain MRI and NE,
together with variables of clinical severity (but not genetics) significantly
correlated with worse performances in cognitive tests, long-term verbal
memory and attention/inhibitory control.
p0346
EXAMININGRELATIONSHIPS BETWEENMEMORY
SCORESANDDEPRESSION IN EPILEPSY PATIENTS
WHOUNDERGOMEMORYTRAINING
Z. Thayer*,†, L. Miller*,†
*Royal Prince Alfred Hospital, Neuropsychology Unit, Institute
of Clinical Neurosciences, Camperdown, NSW, Australia,
†University of Sydney, Australian Research Council, Centre of
Excellence in Cognition and its Disorders, Sydney, NSW,
Australia
Purpose: To investigate the relationships between subjective memory
rating, performance on an objective measure of association memory and
symptoms of depression in outpatients with epilepsy undergoing memory
rehabilitation.
Method: One hundred and seven adult patients with epilepsy and mem-
ory complaints completed a group-based, 6-week memory rehabilitation
training program (Radford et al., 2010) as well as pre- and post-training
assessments. Scores included
(1) a Likert-scale subjective Self-rating of overall memory function;
(2) number correct on an Identity Association Memory Test (with two
alternative versions and randomised administration; not practiced in
the memory course.)
(3) Depression symptom score from the Depression, Anxiety and Stress
Scale. Non-parametric statistics were used to examine the relation-
ships between subjective memory ratings, objective memory scores
and presence of depression.
Results: Prior to memory training, Self-rating of memory and Depres-
sion were negatively correlated, but neither Depression nor Self-rating-
of-memory score correlated with objective memory performance. Simi-
larly, we found a negative correlation between change (pre- to post-train-
ing) in Depression and change in Self-rating of memory, but correlations
between the other change scores were not significant. When subjects
were divided into depressed and non-depressed groups, they both showed
significant (and similar) pre- to post-training gains in Identity Associa-
tionMemory.
Conclusion: Level of pre-training depression helps to predict memory
self-ratings, but it does not predict objective memory test performance.
Furthermore, changes in objective memory post-training were not
reflected in patients’ self-rated memory. The presence of depression does
not influence who will benefit from this memory training program.
p0352
RESPONSIVE NEUROSTIMULATION THERAPY FOR
SUPER-REFRACTORY FOCAL STATUS EPILEPTICUS:
A CASEREPORT
M. Kellogg*, L. Ernst*, P. Motika*, M. McCaskill*, N. Joseph*,
A. Raslan*, C. Hamilton†, D. Spencer*
*Oregon Health & Sciences University, Neurology, Portland,
OR, United States, †NeuroPace Inc., Mountain View, CA, United
States
Purpose: To describe one institution’s experience with responsive neu-
rostimulation after urgent placement of the RNS System in a patient with
super-refractory focal status epilepticus (FSE) due to focal cortical dys-
plasia (FCD) in primary motor cortex. Since FDA approval in 2013, this
is the second known case in which the RNS System was urgently
implanted for super-refractory FSE.
Method: Case report.
Results: A 35-year-old man with medically-refractory focal epilepsy
(onset age 2) due to a 2.5 cm FCD in the right sensorimotor strip pre-
sented with his third episode of super-refractory FSE. Despite treatment
with six AEDs, anesthetic agents and ketogenic diet, the patient’s right
frontal-parietal seizures persisted for 3 weeks. The patient had previ-
ously been evaluated with Phase II monitoring confirming seizure local-
ization to the FCD and had repeatedly refused lesionectomy given high
risk of left hemiparesis; however, he was actively considering RNS Sys-
tem placement. Since he was in a therapeutic coma during the admission
and sedation wean attempts were complicated by persistent FSE with
failure to regain consciousness, his family consented for the procedure.
RNS System placement with two cortical strip leads over the FCD was
uncomplicated. Initial therapy was associated with brief seizure freedom
postoperatively, permitting rapid sedation wean, but then focal seizures
resumed. With optimization of device seizure detection and stimulation
parameters, the focal seizures markedly decreased and the patient clini-
cally stabilized. He was discharged to a rehabilitation center, then home,
with functional improvement to near baseline.
Conclusion: There may be a role for urgent RNS System placement in
cases of refractory FSE with localized seizure onset, but further studies
are needed to determine optimal seizure detection and stimulation param-
eters post-implant. FSE is a more dynamic process than chronic focal epi-
lepsy given daily clinical and medication changes, so close monitoring
and more frequent programming adjustments are required.
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FUNCTIONAL TRACTOGRAPHYREVEALS LARGE-
SCALECONNECTIVITY PATTERNS
L. Trebaul*, D. Rudrauf*, P. Deman*, V. Tuyisenge*,
M. Bhattacharjee*, B. Chanteloup-Foret*, C. Saubat*,
P. Kahane†, D. Taussig†, L. Maillard†, S. Francione†,
I. Mindruta†, C. Adam†, A. Nica†, M. Pail†, F. Dubeau†,
S. Rheims†, F. Bartolomei†, H. Wang†, S. Liu†,
T. Blauwblomme†, L. Mets€ahonkala†, E. Landre†, W. Szurhaj†,
R. Rocamora†, O. David*
*Grenoble Institute of Neuroscience - Inserm U 1216, La
Tronche, France, †F-TRACT Consortium, f-tract.eu, France
Purpose: In patients with pharmaco-resistant focal epilepsies investi-
gated with intracranial electroencephalography (iEEG), direct electrical
stimulations of a cortical region induce cortico-cortical evoked potentials
(CCEP) in other regions, which properties can be used to infer large scale
brain connectivity. In the F-TRACT project*, we use CCEPs to create a
probabilistic atlas of human cortico-cortical connections. Several thou-
sand stimulation runs performed in several hundred patients will be
included in the study to reach a nearly full coverage of the cortex.
Methods: The database includes more than 500 patients, half of which
have been processed yet: automatic detection of each stimulation run
from raw iEEG, bad channels detection with machine learning, stimula-
tion artifact correction with a model-based method (Trebaul et al., 2016).
Effective connectivity is then inferred from the properties of the CCEP
first component, i.e. amplitude and delay (David et al., 2013). Imaging
data (MRI or CT scans before and after electrode implantation) are used
to locate electrodes and compute for each patient different atlases parcel-
lations. We gather CCEP characteristics according to stimulation and
recording parcels to build connectivity maps of each parcels of available
anatomical atlas.
Results: F-TRACT database provides connectivity probability values
for 85% of possible intrahemispheric connexions. Data show that inter-
subject variability of large connectivity increases with the length of
tracts. Larger distance also implies larger CCEP latency because of con-
duction delay. Stimulation energy (pulse duration*intensity) also impacts
inferred connectivity.
Conclusion: This large database allows us to investigate the stimulation
parameters variability and highlight common connectivity patterns. This
study will help understanding relationships between CCEP studies, gath-
ering generally way fewer patients and using different stimulation para-
digms. F-TRACT connectivity maps can be downloaded at f-tract.eu.
*Funding: European Research Council under the European Union0s
Seventh Framework Programme (FP/2007–2013) / ERC Grant Agree-
ment n. 616268 F-TRACT.
p0355
REAL-TIME SUPPRESSIONOFTEMPORAL LOBE
EPILEPTIFORMDISCHARGES BYCLOSED-LOOP
OPTOGENETIC STIMULATION
B.-H. Lin*, M.-S. Ju*, C.-C. Lin†
*National Cheng Kung University, Mechanical Engineering,
Tainan, Taiwan, China, †National Cheng Kung University,
Neurology, Tainan, Taiwan, China
Purpose: The main goal of this study was to develop a control system to
suppress temporal lobe epileptiform discharges in real time by optoge-
netic stimulation.
Method: Thy1-ChR2-YPF transgenic mice were adopted as the subjects.
Two electrodes, each to one side of hippocampus, for deep EEG record-
ing and an optical fiber to the right hippocampus for photic stimulation
were inserted by the stereotactic technique. Seizure was induced by
lithium and pilocarpine. The EEG signal from the left hippocampus was
digitalized to calculate approximate entropy (AE) as an indicator of the
severity of epileptiform discharge. Proportional control was implemented
and the magnitude of AEwas used to regulate the intensity of photic stim-
ulation using a piece-wise linear control law.
Results: The results from six subjects showed that the average detection
rate of continuous or clustered epileptiform discharge was greater than
85% at acute stage but was slightly lower at chronic stage. The seizure
suppression was successful in both the acute stage of status epilepticus
(success rate: 72%) and the chronic stage of episodic attacks (success
rate: 80%). The suppression was quicker in the chronic stage than in the
acute stage. We think the reason is that the intensity of epileptiform dis-
charge was lower in the chronic stage. Sometimes, the intensity of photic
stimulation reached the upper limit during seizure suppression in the
acute stage.
Conclusion: A novel optogeneic closed-loop control system was devel-
oped and the experiment results indicated that it could effectively sup-
press epileptiform discharges in both acute and chronic stages.
p0357
VAGUSNERVE STIMULATION (VNS): EXPLORATORY
ANALYSISWITHREAL LIFEDATA FROMABELGIAN
HEALTH INSURER, 2011–2015
R. Van Tielen*, D.C.R. Van Woensel*, G. Karakaya*,†,
W. Kestens*
*MLOZ - Mutualites Libres - Onafhankelijke Ziekenfondsen,
Representation and Studies, Brussels, Belgium, †Department of
Economics (DULBEA), Solvay Brussels School of Economics
and Management, ULB - Universite Libre de Bruxelles, Brussels,
Belgium
Purpose: To assess change in healthcare resources, consumption and
costs from 12 months pre- to 12 months post-initiation of VNS among
refractory epilepsy patients.
Method: 36 patients (1–36 years, 20 male) treated with anti-epileptic
drugs (AEDs) and implanted with VNS were identified using a Belgian
administrative database of health insurer MLOZ (2 million affiliates).
Patients were studied in a mirror-image design to assess change in health
care utilization variables (2011–2015). Costs were estimated from the
health service payer’s perspective. Paired t-test compared epilepsy-asso-
ciated annual direct healthcare costs and use of medical services: hospi-
talisations, consultations, ambulatory treatments, pharmaceuticals.
Results: There were no changes in hospitalizations in pre- and post-
implant (p > 0.05), but hospitalization rates via emergency services
declined by 50%, while the mean hospitalization duration remained
around 3 days (3.2 days vs. 3.5; p > 0.05). There was a significant
decline in the median and Q3 length of stay (respectively from 2 to 1 day
and from 4 to 2.6 days). Total health care costs declined from €9,059 to
€7,786 (p > 0.05) and total AED costs increased by 10% (from € 1,641€
to 1,814€; p > 0.05). The relative part of AEDs in the total pharmaceuti-
cal costs remained stable at 90%. Epileptic patients mainly consulted
GPs and neurologists. After VNS initiation, only neurologist’s visits
increased significantly from 2.7 to 5.7 visits a year and the number of
AEDmolecules remained at 3 after one year.
Conclusion: VNS is relatively rare in Belgium but is rather expensive
(€11,000). VNS was not associated with a decline in hospitalization vari-
ables except via emergency services. Volumes (hospitalizations, visits,
DDDs,..) remained stable. Total healthcare costs including pharmaceuti-
cal costs did not decline the year after initiation. Treatment with VNS
may be not as cost-effective as expected from payer’s perspective,
although patients may have clinical benefits (seizure reduction, quality of
life, etc.).
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AUTOMATIC BADCHANNELS DETECTION FROM
INTRACRANIAL EEGDATASETS USINGMACHINE
LEARNING
V. Tuyisenge*, L. Trebaul*, M. Bhattacharjee*, B. Chanteloup-
Foret*, C. Saubat*, I. Mindruta†, S. Rheims†, L. Maillard†,
P. Kahane†, D. Taussig†, O. David*
*Grenoble Institute of Neurosciences - Inserm U 1216, La
Tronche, France, †F-TRACT Consortium, f-tract.eu, France
Purpose: Stereoelectroencephalogram (SEEG) recordings is an invasive
method used to localise the epileptogenic zone for some patients with
drug resistant focal epilepsy. However, SEEG recordings come with non-
neuronal signals resulted from disconnected electrodes, sensors malfunc-
tioning or other parasitic electrical activity picked up by amplifier and
current drift. Those signals, known as bad channels, are excluded (so far
manually) from datasets for further analysis. Our purpose is to design a
method that detects automatically SEEG bad channels.
Method: We acquired datasets from 206 epileptic patients (93 from
Rothschild Foundation, 67 from CHU Grenoble-Alpes, 32 from CHU
Nancy, 11 from CHU Lyon, and 3 from Bucharest Hospital) who under-
went SEEG recordings and direct electrical stimulation at 1 Hz as part of
the presurgical evaluation. From stimulation runs, channel features (cor-
relation, variance, deviation, amplitude, gradient, Hurst exponent and
kurtosis) have been extracted. We then trained an ensemble bagging clas-
sifier on stimulation runs whose bad channels were visually identified by
experts. The trained model was applied on new dataset for bad channels
prediction.
Results: This method effectively detected different types of bad chan-
nels and showed a detection ability that matches a manual one by experts
at an agreement of 99.77%. The classification performance is thus not
impacted by the multicentric nature of data.
Conclusion: The proposed method demonstrated promising results and
can be envisaged to be used on larger datasets for automatic quality con-
trol of SEEG data. The property of the method is the use of different fea-
tures and ensemble bagging classifier not only to identify the bad
channels but also to cope with datasets with imbalanced class distribu-
tions.
*Funding: ERC under the European Union0s Seventh Framework Pro-
gramme (FP/2007–2013)/ERCGrant Agreement n. 616268 F-TRACT.
p0361
FACTORS INFLUENCINGTHECONFIDENCEOF
TEACHERS IN THEMANAGEMENTOFEPILEPSY IN
MAINSTREAMEDUCATIONWITHIN THEBELFAST
EDUCATIONALAUTHORITYAREA
M. Taylor*, C. McNeice†, S. Mike*, J. Bothwell†
*Belfast Health and Social Care Trust, Paediatrics, Belfast,
United Kingdom, †Belfast Health and Social Care Trust,
Community Paediatrics, Belfast, United Kingdom
Purpose: There is a relative paucity in the literature regarding the confi-
dence of teachers in the management of epilepsy. The aim of this study
was to establish what factors influenced this.
Method: School principals in Belfast Area were contacted via email to
introduce the survey. A link to an electronic survey was subsequently for-
warded to the schools for completion by the Special Educational Needs
Co-ordinator (SENCO).
Results: Out of the 149 schools contacted 88 (59.1%) mainstream
schools responded.Educational Stage: nursery 12, primary 47, post pri-
mary 24 and 1 primary with attached nursery unit (4 non-responders).
v2 = 0.2101.Health professional on site: Yes 13 (14.8%), No 71 (80.7%)
(4 (4.5%) non-responders). Mean difference (1–5) 1.19. (95% CI 0.53–
1.85, p = 0.0006). Awareness of epilepsy training: No 42 (47.8%) vs.
Yes 41 (46.5%) (5 (5.7%) non-responders). Mean difference (1–5) 0.844
(95% CI 0.36–1.33, p = 0.0008). Previously witness a seizure: Yes 40
(45.4%) vs No 48.9% (5 (5.7%) non-responders). Mean difference (1–5)
0.56. (95% CI 0.06–1.06, p = 0.0274). Previously taught a child with
epilepsy: Yes 55 (62.5%) vs No 28 (31.8%) (5 (5.7%) non-responders).
Mean difference (1–5) 0.37 (95% CI0.17 to 0.91, p = 0.1742). Friend/
Relative with epilepsy: Yes 32 (36.4%) vs 51 (57.9%) (5 (5.7%) non-
responders). Mean difference (1–5) 0.79 (95% CI 0.29–1.30,
p = 0.0023).
Conclusion: Significant factors include healthcare staff on site, previous
seizure exposure, friend/relatives with epilepsy & epilepsy training.
There was no significance of school level or previously having taught a
child with epilepsy.
p0363
ASSESSMENTCEREBRAL POSTHYPOXIC
STRUCTURALCHANGESONBASEOF
DETERMINATION TRANSIENT EEG PATTERNS IN
PRETERM INFANTSWITHVERYLOWBIRTH
WEIGHT
V.I. Guzeva*, V.V. Guzeva*, T.V. Melashenko†, O.V. Guzeva*
*Department of Neurology, Neurosurgery and Medical
Genetics, St. Petersburg State Pediatric Medical University, St.
Petersburg, Russian Federation, †Perinatal Center Intensive
Care unit of Newborns, St. Petersburg State Pediatric Medical
University, St. Petersburg, Russian Federation
Electroencephalography (EEG) is irreplaceable method of research in
complex diagnostics and evaluation of cerebral status in newborn chil-
dren. EEG in healthy premature infants of different gestational age are
recorded various morphological transient patterns (STOP, PTӨ, delta-
brushes), which characterize morphological and functional development
of the brain at different stages of early ontogenesis. Detection of distur-
bance of formation of bioelectrical activity, based on the data of age-
dependent appearance of transient patterns contributes to the early diag-
nosis of brain injury in premature infants.
Purpose: To identify appearance of age-dependent transient EEG pat-
terns in preterm infants with posthypoxic structural changes in brain on
MRI and to determine early marker of structural brain damage in prema-
ture infants with very low birth weight (VLBW).
Study involved 43 preterm infants with VLBW and gestational age
24–29 weeks. Allocated 2 groups of patients: first - preterm infants with
posthypoxic structural changes in brain on MRI (n = 21), second - pre-
term infants without brain pathology onMRI (n = 22).
Results and conclusion: Study found that bioelectrical activity in
most part of preterm infants without brain changes on MRI pattern
of delta-brushes are recorded in corresponding to physiological
brain development. In patients with posthypoxic structural changes
in brain on MRI pattern of delta-brushes registrated significantly
later (only in 2 infants it was determined before 30 weeks). Late
appearance of transient delta-brushes (after 30 weeks) is identified
as early marker of brain pathology.
Changes in development of spontaneous brain activity in patients with
cerebral structural changes in neonatal period identified in present study
also included changes in severity and age of onset of registration of tran-
sient patterns STOP and PTh .These patterns were registrated in less
quantity of patients of first group (correspondingly in 9/43% and 8/39%)
in comparison to patients of second groupA (correspondingly in 16/71%
and 13/58%).
p0364
LONG-TERMNETWORKEFFECTSOFCORPUS
CALLOSOTOMY IN PATIENTSWITHLENNOX-
GASTAUT SYNDROME
D. Lee*, L. Junge†, N.-Y. Kim†, H.D. Kim*,‡
*Epilepsy Research Institute, Yonsei University College of
Medicine, Seoul, Korea, †Kwangwoon University, Seoul, Korea,
‡Department of Pediatrics, Yonsei University College of
Medicine, Seoul, Korea
S74
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Purpose: Lennox-Gastaut syndrome (LGS) is one of the most severe
childhood-onset epilepsies. Corpus callosotomy (CC) is considered as a
palliative surgical treatment in LGS patients when anti-epileptic drugs
fails to treat the patients and when there is no evident focal pathologic
brain region. We previously showed immediate network effects of CC. In
the current study, we followed patients up 2 years after the surgery. We
examined network changes over time and its relationship with the clinical
outcomes.
Method: We enrolled fourteen LGS patients who underwent CC during
2010–2012 at Severance Children’s Hospital of Korea. Scalp EEG data
based on the 10–20 international system were recorded at a sampling rate
of 200 Hz before CC, and 3 months, 1 year, and 2 years after CC. EEG
data were band-filtered between 1 and 70 Hz. We first randomly selected
EEG data with no visible epileptiform discharge.We then took 2 second-
long iEEG data from 20 different recording time periods for each subject.
We estimated functional connectivity between broadband EEG channels
by calculating mutual information (MI). MI matrices of each epoch and
frequency band were calculated, and then, 20MI matrices were averaged.
The following graph measures were calculated: averaged degree, cluster-
ing coefficient, global efficiency, and local efficiency.
Results: We found, after the CC, that clustering coefficient and averaged
degree did not significantly change after 1 year of CC but it decreased
significantly at 2 year follow-up. However, global and local efficiencies
remained stable over time.
Conclusion: We investigated long-term functional connectivity changes
of CC in patients with LGS. We found that reorganized brain network
after CC remained stable for 1 year but some graph measures signifi-
cantly changed after that. We speculate that tissue regeneration changed
the structural brain connection and ultimately affected the functional net-
work properties.
p0365
CLASSIFICATIONOFNEONATAL SEIZURES: THE
RESULTS FROMARECENT TESTOFTHE ILAE
COMMISSIONONCLASSIFICATION&
TERMINOLOGY PROPOSEDNEONATAL SEIZURE
FRAMEWORK
E. Yozawitz*, M.R. Cilio†, M. Lahorgue Nunes‡, S. Vanhatalo§,
S. Zuberi¶, P. Plouin**, E. Mizhari††, S. Moshe*, R. Pressler‡‡
*Montefiore Medical Center, Bronx, NY, United States,
†University of California, San Francisco, CA, United States,
‡Pontificia Universidade Catolica do Rio Grande do Sul, Brain
Institute (BraIns), Porto Alegre, Brazil, §Helsinki University
Central Hospital and University of Helsinki, Helsinki, Finland,
¶Royal Hospital for Sick Children, Glasgow, United Kingdom,
**Saint Vincent de Paul and in Necker Hospital, Paris, France,
††Baylor College of Medicine, Baylor, TX, United States,
‡‡Great Ormond Street Hospital for Children NHS Foundation
Trust, London, United Kingdom
Purpose: The objective of this study was to inquire what classification
of neonatal seizures is currently being used and to test the proposed sys-
tem by the ILAENeonatal Task Force.
Method: The Task Force on Neonatal Seizures, established in 2014, pro-
posed a proposed neonatal seizure framework that can be integrated into
the ILAE classification of the epilepsies. At the 2016 ILAE European
Congress on Epileptology in Prague, neurologists, neurophysiologists,
neonatologists, pediatricians, EEG technicians, students, nurses, and fel-
lows participated in a test. They were introduced to the proposed neonatal
classification system with a “teaching video,” then asked to apply the
proposed framework to rate seizure types for each of five babies pre-
sented on a subsequent “clinical video.” Raters additionally provided
information about their preferred system for classifying seizures. This
information and obtained ratings using the proposed framework were
compiled and analyzed.
Results: Responses of 100 raters were collected and included adult/pedi-
atric neurologists and epileptologists, pediatricians, neurosurgeons, tech-
nicians, residents/fellows, nurses, and students. Most raters reported that
they use the current ILAE classification system to classify neonatal sei-
zures. However, 76% of raters judged the proposed classification system
as better than the current system. Since the last revision of the ILAE clas-
sification system in 2009, neonatal seizures no longer are regarded as a
separate entity. Using the proposed framework, 79–92% of raters cor-
rectly identified the main seizure type for each baby as presented in the
videos.
Conclusion: The results of the test of the ILAE Commission on Classifi-
cation & Terminology Proposed Neonatal Seizure Framework suggested
there is a need for a new neonatal seizure classification system. The pro-
posed framework was judged as better than the current system by 76% of
raters. Furthermore, 79–92% of raters were able to employ it to correctly
identify main seizure types.
p0368
RECESSIVE EARLYONSET EPILEPTIC
ENCEPHALOPATHIES
X. AlQahtani*, A. AlHashem†, A. AlGhamdi*, K. Hundallah*,
S. AlShahwan*, F. AlKuraya*, B. Tabarki*
*Division of Pediatric Neurology, Prince Sultan Military
Medical City, Riyadh, Saudi Arabia, †Division of Genetics,
Department of Pediatrics, Prince Sultan Military Medical City,
Riyadh, Saudi Arabia
Background: Early onset epileptic encephalopathies (EOEE) present a
significant diagnostic challenge with variable underlying causes.
Advances in genomic technologies are facilitating the discovery of both
common and rare genetic mutations causing EOEE. Autosomal recessive
inheritance has been reported, but most cases of EOEE are sporadic (de
novomutations).
Purpose: To identify the underlying genetic defects in patients with
unexplained EOEE in a highly consanguineous population.
Method: We performed genetic studies (Whole exome sequencing or
genes panel) is a cohort of patients with unexplained EOEE from 2 cen-
ters in Riyadh: Prince Sultan Military Medical City and Research Centre
in King Faisal Specialist Hospital. We characterized all phenotypes in
detail and classified children according to known electroclinical syn-
dromes where possible. Infants with previous genetic diagnoses, causa-
tive brain malformations, hypoxic ischemic insult, or inborn errors of
metabolismwere excluded.
Results: 128 patients with unexplained EOEE were included. We identi-
fied disease-causing variants in 113 children (88%), including mainly the
following genes: SLC13A5 (n = 8), FRRS1L (n = 7), ADAT3 (n = 6),
ARV1 (n = 4), PLCB1 (n = 2), etc. 104 variants were recessive, and
only 9 variants were de novo. Phenotypes were broadened for some vari-
ants identified.
Conclusion: Our study provides for the first time comprehensive epi-
demiologic information, epilepsy phenotype, and recessive genes on a
large cohort of EEOE. Diagnosis of the underlying causes of epileptic
encephalopathy is essential for treatment, prognosis and genetic counsel-
ing.
p0369
BDNF INCHILDRENWITHEPILEPSY
S. Hadjiu*,†, C. Calcii*, N. Revenco*
*Clinic of Child’s Neurology, State University of Medicine and
Pharmacy ‘Nicolae Testemitanu’, Department of Pediatrics,
Chisinau, Moldova, †PMI Institute of Mother and Child,
Chisinau, Moldova
Purpose: Assessment of serum BDNF levels in children with epilepsy.
Method: We followed 51 children, aged between 3 month and
12 month old. We assessed serum BDNF levels via immunoenzymatic
method (ELISA) in the blood of 26 children, aged 3 months to
12 months, presenting epilepsy, who had CNS perinatal hypoxic-
ischemic antecedents, and 25 healthy controls. Also were performed
imaging and neurophysiological exams. For statistical analysis of the
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obtained results was applied arithmetic mean, standard error, relative fre-
quency, correlation coefficient (Pearson) and test ANOVA.
Results: They found decreased serum BDNF at 3 months of age in chil-
dren who developed epilepsy as compared to the control group
(p < 0.001). BDNF levels were much lower as the neurophysiological
changes (rxy = 0.72, p < 0.05) and imaging (rxy = 0.68, p < 0.05)
were severe. Also appreciated a significant increase in BDNF levels in
children with epilepsy at the age of 1 year (25.3%) compared with
healthy children (1.5%), but lower compared to this lot (rxy = 0.876,
p < 0.001).
Conclusion: Serum BDNF levels were significantly lower in children
with structure epilepsy (aged 3 months to 12 months) in comparison to
controls, which increased immaturity of brain tissue notify them. This
could suggest a delayed increase of BDNF levels during those children’s
development. With parental serum BDNF increases, notifying involve-
ment in neurodevelopmental processes. Thus, low BDNF levels are nega-
tively correlated with the severity of structure epilepsy and structural
abnormalities of brain tissue, as a neuronal lesion biomarkers. The signif-
icant increase in BDNF levels in children with epilepsy compared to
those health andmake him play an important role in the process of epilep-
togenes.
p0370
BEHAVIORALDISTURBANCES IN CHILDRENWITH
EPILEPSY
S. Hadjiu*, C. Calcii*, N. Revenco*,†
*Clinic of Child’s Neurology, State University of Medicine and
Pharmacy ‘Nicolae Testemitanu’, Department of Pediatrics,
Chisinau, Moldova, †PMI Institute of Mother and Child,
Chisinau, Moldova
Purpose: The aim of this study was to evaluated the role of the behav-
ioral influence quality of life of children with epilepsy.
Method: We used a group of 241 children, aged 3 months - 5 years (fol-
lowed for five years after birth), diagnosed with structural epilepsy (con-
sequences of perinatal hypoxic-ischemic encephalopathy). Behavioral
disorders were defined according to the criteria of ICD-10 and DSM-V.
They were applied to the following statistical evaluationmethods for ana-
lyzing the results: arithmetic mean, standard error, correlation coeffi-
cient, Student test, relative frequency.
Results: Behavioral disorders were diagnosed in 163 (67.6% 95CI
64.59–70.61) patients with structural epilepsy predominantly expressed
by hyperactivity (19.0% 95CI 15.93–22.07), inattention (22.7% 95CI
19.42–25.98), conduct disorder (22.1% 95CI 18.85–25.35) and bouts of
aggression (36.2% 95CI 32.44–39.96). Age of onset of behavioral disor-
ders ranked between 2 and 3 years. Behavioral disorders correlated with
the severity of epilepsy (rxy = 0.29).
Conclusion: So, behavioral disorders in children with epilepsy often
begins in context, is characterized by a clinical variability, correlates with
the severity of epilepsy, can be considered risk factors for this and require
psychiatric and psychotherapeutic treatment.
p0371
U-FIBRE NEURONALDISPERSIONAND SYNAPTIC
PLEXI BENEATHEPILEPTOGENIC FOCAL
CORTICALDYSPLASIAS IN CHILDREN
H.B. Sarnat*,†, W. Hader‡, L. Bello-Espinosa§, L. Flores-
Sarnat†,§
*Paediatrics, Pathology (Neuropathology), Clinical
Neurosciences, University of Calgary, Calgary, AB, Canada,
†Alberta Chidren’s Hospital Research Institute, Calgary, AB,
Canada, ‡Clinical Neurosciences (Neurosurgery), University of
Calgary, Calgary, AB, Canada, §Paediatrics (Neurology),
Clinical Neurosciences, University of Calgary, Calgary, AB,
Canada
Purpose: To demonstrate excessive neurons within U-fibres beneath
focal cortical dysplasias (FCD) that form synaptic plexi that mightcon-
tribute to epileptic circuitry. Axons of these neurons are to be demon-
strated by synaptophysin imunoreactivity. Mitochondrial enzyme
histochemistry can demonstrate neuronal hypermetabolism. Glial a-B-
crystallin identifies epileptic foci.
Methods: Synaptophysin, NeuN, calretinin, NFP, GFAP, a-B-crystallin
antibodies were applied to surgical resections for epilepsy to investigate
subcortical axonal networks in 26 infants and children, 2 mos to 17 yrs:
10 FCDI; 6 FCDII; 3 FCD III; 4 hemimegalencephaly (HME); 3 TSC.
Bielschowsky impregnations also were prepared. Eight normal age-
matched brains provided controls. Frozen section histochemistry demon-
strated mitochondrial enzymes.
Results: The U-fibre layer at gyral bases and depths of sulci exhibited
neuronal dispersion and elaborate synaptic plexi; many axons projected
into cortex. Deep white matter in FCDII, HME, TSC also showed exces-
sive neurons, often forming clusters. Their axons formed local plexi but
did not penetrate the U-fibre layer to extend to cortex; an exception was
transmantle dysplasias continuous with cortex. Most subcortical neurons
reacted to NeuN, rarely to calretinin. Synaptophysin demonstrated elabo-
rate white matter axonal plexi better than NFP or Bielschowsky. Many
subcortical neurons in all cases exhibited intense mitochondrial activity.
Regional glia expressed cytoplasmic a-B-crystallin.
Conclusions: U-fibre neurons beneath FCD have complex synaptic plexi
that contribute to epileptic circuitry. They are not calretinin-reactive,
hence excitatory rather than inhibitory. Frequently depolarizing hetero-
topic white matter neurons are hypermetabolic; pre- and intra-operative
ECoG may demonstrate their discharges. FCD resections that include U-
fibres may prevent epileptic spread to adjacent gyri. Neuropathology
reports of epilepsy resections should describe dispersed white matter neu-
rons and their synaptic plexi. U-fibre plexi, but not deep white matter
heterotopia, are an integral component of epileptic networks.
p0376
ASSOCIATION BETWEEN SEIZURE FREQUENCYAND
FATIGUELEVELS IN CHILDRENWITHEPILEPSY
H. Kanemura*, F. Sano*, T. Ohyama*, K. Sugita*, M. Aihara†
*Faculty of Medicine, Department of Pediatrics, University of
Yamanashi, Yamanashi, Japan, †Graduate Faculty of
Interdisciplinary Research, Graduate School, University of
Yamanashi, Yamanashi, Japan
Purpose: Fatigue has been largely overlooked in the assessment and
management of patients with epilepsy. The objective of this study was to
examine the association between seizure-related features and fatigue
levels in children with epilepsy.
Method: The study participants comprised 58 children with epilepsy.
The inclusion criteria were as follows:
1 12–18 years of age at enrollment;
2 ³ 12 months after epilepsy onset;
3 The ability to read and speak Japanese; and
4 Currently taking a stable regimen of one antiepileptic drug (AED).
All children were classified into three subgroups based on the state of
their seizure control: well-controlled epilepsy (WCE; seizure-free); inter-
mediate controlled epilepsy (ICE; seizure frequency <19/month); and
uncontrolled epilepsy (UCE; seizure frequency > 19/month). Fifteen
healthy, seizure-free children were included as a control group. Partici-
pants were asked to rate on a 7-point scale, from 1 (strongly disagree) to 7
(strongly agree), how often they felt the ways described by nine items on
the Fatigue Severity Scale (FSS). A higher score is suggestive of greater
fatigue.
Results: The mean FSS scores of the children with epilepsy were signifi-
cantly higher than those of controls (4.40 vs. 1.55, respectively;
p < 0.0001). The responses of the children with epilepsy differed
depending on their clinical characteristics. Multiple regression analysis
showed that seizure frequency was the only characteristic significantly
associated with fatigue (p < 0.0001). In the three epilepsy subgroups, the
mean FSS scores for the WCE, ICE, and UCE groups were 2.30, 3.97,
and 6.28, respectively. A higher seizure frequency was associated with
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more severe fatigue. In particular, children in the UCE group had signifi-
cantly more severe fatigue than those in theWCE group (p < 0.0001).
Conclusion: Seizure frequency may be associated with fatigue in chil-
dren with epilepsy, namely, children with uncontrolled seizures may
have more severe fatigue than healthy, seizure-free children.
p0379
FAST (40–150 HZ) OSCILLATIONS AREASSOCIATED
WITH POSITIVE SLOWWAVES IN THE SCALP ICTAL
EEGSOF EPILEPTIC SPASMS INWEST SYNDROME
K. Kobayashi*, T. Akiyama*, M. Oka*, F. Endoh*,
M. Akiyama*, T. Shibata*, Y. Hanaoka*, H. Yoshinaga*,†
*Department of Child Neurology, Okayama University
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences and Okayama University Hospital, Okayama, Japan,
†Minami-OkayamaMedical Center, Hayashima, Japan
Purpose: To elucidate the generative mechanisms of epileptic spasms
(ESs) in West syndrome, we investigated the temporal relationship
between scalp fast (40–150 Hz) oscillations (FOs) and slow waves in the
ictal electroencephalograms (EEGs) of ESs.
Methods: In 11 infants with WS, ictal FOs were detected in a bipolar
montage based on spectral and waveform criteria. Their temporal distri-
bution was analyzed in terms of the positive peaks (trough point, TT) of
identical EEG data in a referential montage. Among six EEG data sec-
tions defined according to TT, the number of FOs, peak power values,
and peak frequencies were compared.
Results: We identified a total of 1014 FOs (946 gamma and 68 ripple
oscillations), which clustered closely at TT. The number of gamma oscil-
lations in the 1 s epoch including TT was significantly higher than those
in the prior and subsequent phases. Peak power values and frequencies
tended to be higher in these positive phase sections.
Conclusions: The temporal association of FO clustering and positive
slow waves in the ictal EEGs of ES indicated that active neuronal firing
related to FOs underlies the generation of ESs and their ictal slow waves.
p0384
KETOGENIC VERSUSMODIFIEDATKINS DIET FOR
PAEDIATRIC EPILEPSY: A SINGLECENTRE
EXPERIENCE FROMSINGAPORE
H.T. Ong*,†, J. Chiam*, F.S. Wang*, C. Lin‡, T. Teo‡,
P.S. Low*,†, S.K.H. Tay*,†
*Khoo Teck Puat - National University Children’s Medical
Institute, National University Hospital, National University
Health System, Paediatrics, Singapore, Singapore, †Yong Loo
Lin School of Medicine, National University of Singapore,
Paediatrics, Singapore, Singapore, ‡National University
Hospital, Dietetics, Singapore, Singapore
Purpose: To evaluate the efficacy and tolerability between ketogenic
diet (KD) and modified Atkins diet (MAD) for paediatric patients with
epilepsy.
Method: This is a retrospective study of 46 children with epilepsy
receiving KD and MAD from year 2004 to 2016 inclusive. Patient demo-
graphics, epilepsy history and the diet type initiated were collated. The
reasons for diet cessation were obtained.
Results: The age ranges for KD (31 patients) and MAD (15 patients) ini-
tiation were from 1 to 15 years old and 1 to 22 years old respectively. All
the patients in the KD group and the majority in the MAD group have
pharmacoresistant epilepsy with developmental delay or mental disabil-
ity. At 6 months, 25% and 20% achieved seizure freedom on KD and
MAD respectively, with the difference being not statistically significant.
In our series, 68% of the patients in both groups (KD andMAD) tolerated
the diet well. However, 2 patients in the MAD group did not achieve ade-
quate ketosis. Reasons for diet cessation for KD group before 6 months
were lack of efficacy in seizure control (6 patients), refusal of KD meals
(5 patients), and increased irritability (1 patient). Reasons for diet cessa-
tion for MAD group before 6 months were refusal of MAD meals (2
patients) and lack of efficacy in seizure control (1 patient).
Conclusion: At 6 months, both the ketogenic diet and modified Atkins
diet were comparably effective in seizure control and generally well tol-
erated. The main reasons for diet cessation regardless of diet type were
lack of efficacy in improving seizure control and food refusal. The results
of the efficacy and tolerability of these diets are similar to those obtained
from other Asian countries.
p0385
THE IMPACTOF SEIZUREONSETAGEON
COGNITIVEOUTCOME INCHILDRENWITH
STURGE-WEBER SYNDROME
A. Luat*,†, M. Behen*,†, E. Bosnyak*, H. Chugani*,†,‡,
C. Juhasz*,†
*Pediatrics and Neurology, Wayne State University, Detroit, MI,
United States, †Children’s Hospital of Michigan, Detroit
Medical Center, Detroit, MI, United States, ‡Nemours A.I.
DuPont Hospital for Children, Pediatric Neurology,
Wilmington, DE, United States
Purpose: Most children with Sturge-Weber syndrome (SWS) develop
seizures that may contribute to their neuro-cognitive decline (Bosnyak
et al., Ped Neurol, 2016: 61:38–45). Pre-symptomatic treatment with
anti-seizure medication may delay seizure onset (Ville et al., Seizure,
2002;11: 145–50) but its potential effect on cognitive outcome is
unknown. In this study, we analyzed the impact of seizure onset age on
cognitive outcome in SWS.
Method: Subjects participated in our prospective longitudinal clinical
and neuroimaging SWS study at the Children’s Hospital of Michigan,
Detroit. Inclusion criteria were
a) unilateral SWS on brainMRI,
b) history of epilepsy,
c) age of <13 years,
d) age at neurocognitive assessment >2.5 years,
e) at least one year follow-up.
None of the children had epilepsy surgery. Cognitive functioning (IQ)
assessed by WPPSI-III or WISC-III was correlated with age at seizure
onset, extent of MRI involvement and epilepsy duration at IQ testing.
Results: Thirty-four children (22 girls) were included. Mean age at sei-
zure onset and IQ test were 1.3 years (0.1–6 years) and 6.1 years (2.6–
12.5 years), respectively. The mean IQ was 86 (45–118). IQ showed a
strong positive correlation with seizure onset age (Spearman’s rho
[r] = 0.59, p < 0.001) and negative correlation with epilepsy duration
(r = 0.51, p = 0.002) and extent of MRI involvement (r = 0.36,
p = 0.04). The effect of seizure onset age on IQ was non-linear, showing
the maximum impact below age 1 year. In a multivariate analysis, low
age at seizure onset and long duration of epilepsy contributed to low IQ
independently.
Conclusion: Young age at seizure onset, particularly below age 1 year,
is a strong, independent risk factor for poor cognitive outcome in children
with SWS. The findings suggest that even a moderate delay of seizure
onset by prophylactic anti-seizure medication in children < 1 year of
age could have a positive impact on their cognitive outcome.
p0386
SEIZUREOUTCOMESOFCHILDHOODEPILEPSY
K.M. Aaberg*,†, P. Suren†, I.J. Bakken†, M.I. Lossius*, R. Chin‡
*National Center for Epilepsy, Oslo University Hospital, Oslo,
Norway, †Norwegian Institute of Public Health, Oslo, Norway,
‡Muir Maxwell Epilepsy Centre, University of Edinburgh,
Edinburgh, Norway
Purpose: Seizure outcomes of childhood epilepsy range from remission
to drug-resistant epilepsy (DRE). Recent diagnostic and therapeutic
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improvements may have improved outcomes, but contemporary popula-
tion-based data examining this are limited. From the Norwegian Mother
and Child Cohort Study (MoBa), the largest prospective pregnancy
cohort worldwide, we report seizure outcomes in children with epilepsy
(CWE), and associations with clinical and socio-demographic character-
istics.
Method: CWE were identified among the 112,744 MoBa participants
through registry linkages and sequential MoBa parental questionnaires.
Clinical characteristics, seizure outcomes, medication, and investigation
results were obtained through medical record reviews and/or parental
telephone interviews. Socio-demographic data were obtained fromMoBa
questionnaires. DRE was defined as not seizure-free at end of follow-up
despite having tried ≥2 antiepileptic drugs. 1-year and 2-year-remission
were defined as seizure-free at end of follow-up for at least 1 and 2 years,
respectively. Only CWEwith ≥2 years of follow-up were included.
Results: We identified 475 CWE with ≥2 years follow-up (mean
5.3 years). Of these, 170 CWE (36%, 95%CI 32–40%) had DRE. 247
CWE (52%, 95%CI 47–56%) had achieved 1-year remission (144 medi-
cation-free), 178 (37%, 95%CI 33–42%) had achieved 2-year remission
(127 medication-free). DRE was positively associated with a number of
epilepsy characteristics, all with p < 0.01: a history of neonatal seizures,
early age of onset, symptomatic (including structural) etiology, ≥2 sei-
zure types, previous status epilepticus, comorbid neurological/develop-
mental disorders, abnormal neurological examination findings,
pathological EEGs, pathological MRIs, and use of ≥2 antiepileptic drugs.
These factors were all inversely associated with 2-year remission medi-
cation-free at end of follow-up.Parental age, education and marital status
were not predictive of seizure outcomes.
Conclusion: Despite advances in diagnostics and therapeutics, a third of
CWE have DRE. Seizure outcomes in CWE in this population were influ-
enced by epilepsy characteristics but not by examined socio-demo-
graphic factors.
p0395
ATYPICAL PRESENTATIONOF PYRIDOXINE-
DEPENDENT EPILEPSYREVISITED
A. Alghamdi*, A. Alhakeem*, A. Alsamman†, B. Tabarki
Melaiki*
*Prince Sultan Military Medical City, Pediatric, Riyadh, Saudi
Arabia, †King FahadMedical City, Riyadh, Saudi Arabia
Purpose: Pyridoxine-dependent epilepsy is an autosomal recessive
epileptic encephalopathy caused by antiquitin (ALDH7A1) deficiency.
Beside the classical presentation in form of early refractory epileptic
encephalopathy, numerous neurological manifestations and metabolic/
biochemical findings have been reported.
Method: Case series.
Results: We report 5 patients with atypical presentation of PDE: all pre-
sented with early onset seizures (<3 months), associated with non-
immune hydrops fetalis (1 patient), obstructive hydrocephalus (1
patient), extreme prematurity with intra-ventricular hemorrhage (1
patient), regression of milestones non related to the severity of seizures
(1 patient), and benign epilepsy (1 patient).
Conclusion: Since the description of the biomarkers, and the genetic
background of PDE, the phenotypic spectrum of PDE expanded. It
includes persistent hypoglycemia, lactic acidosis, CNS malformations,
or perinatal asphyxia. These atypical presentation may mask the diagno-
sis, and delay the treatment. All infants presenting with unexplained sei-
zures should be screened for antiquitin deficiency by determination of
alpha-aminoadipic semialdehyde and ALDH7A1 molecular analysis.
Early treatment with pyridoxine/folinic acid with L-arginine or lysine
restricted diet provide good prognosis.
p0396
WEST SYNDROME INDOWN SYNDROME INFANTS
A. Lopes, M.C. Bet, A.C. Cripp, A.S. Antoniuk, M.N. Lima Cat,
B.E. Bagatin Veleda Bermudez
Universidade Federal do Parana, Pediatria, Curitiba, Brazil
Purpose: To determine the prevalence, clinical characteristics and
response to treatment in a cohort of Down syndrome (DS) patients with
West syndrome (WS) amongst treated in a tertiary hospital in Curitiba-
PR, Brazil.
Method: Cross-sectional, retrospective study of 1212 patients with DS
followed at a tertiary hospital in Curitiba-PR. All data were collected
from medical records: peri and neonatal characteristics, genetics, associ-
ated diseases, psychomotor development and mother0s age at child0s
birth. Data on gender, genetics, age of onset, treatment response and neu-
rodevelopmental and autistic outcomes in patients with DS and WS were
extracted. Statistical analysis was performed by Student t test, Mann-
Whitney test, Fisher exact test and chi-square test, with significance level
of 5%.
Results: The prevalence of WS in the DS cohort was 1.9%. 22 patients
were identified. Male to female ratio was 1:1. Onset of spasms occurred
at a median of 7 months (3–57). Patients received Vigabatrin as first line
treatment with total control of spasms in 81.8%. All patients displayed
neurodevelopmental delay. Five patients (22.7%) developed epilepsy.
One of the patients developed Lennox-Gastaut syndrome. There was no
significant difference between the groups regarding the general charac-
teristics of the patients (peri and neonatal characteristics, genetics, asso-
ciated diseases, psychomotor development and mother0s age at child0s
birth). A higher frequency of mosaicism (11.8% versus 2.2%, p = 0.02),
autism (29.4% versus 5.9%, p < 0.001), seizures (17.6% versus 2.8%,
p < 0.001) and clubfoot (11.8% versus 2.3%, p = 0.08) were observed in
DS patients withWS than in DS patients withoutWS.
Conclusion: Pediatricians and pediatric neurologists with better knowl-
edge about this association would reduce the time to diagnosis and delay
to treatment in order to improve neurodevelopmental outcomes and qual-
ity of life of these infants. Vigabatrin therapy was effective with good
control of seizures.
p0400
REDUCED STEROIDOGENESIS IN PATIENTSWITH
PCDH19-FEMALELIMITED EPILEPSY
C. Lucchi*,†, M. Trivisano‡, C. Rustichelli§, A. Terracciano¶,
R. Cusmai‡, G.M. Ubertini**, G. Giannone††, E.S. Bertini¶,
F. Vigevano‡, J. Gecz‡‡,§§, G. Biagini*,†, N. Specchio‡
*University of Modena and Reggio Emilia, Department of
Biomedical, Metabolic and Neural Sciences, Modena, Italy,
†NOCSAE Hospital, Department of Neurosciences, Modena,
Italy, ‡Bambino Gesu Children’s Hospital, IRCCS, Department
of Neuroscience, Neurology Unit, Rome, Italy, §University of
Modena and Reggio Emilia, Department of Life Sciences,
Modena, Italy, ¶Bambino Gesu Children’s Hospital, IRCCS,
Department of Neuroscience, Unit of Molecular Medicine,
Rome, Italy, **Bambino Gesu Children’s Hospital, IRCCS,
Department of Pediatrics, Unit of Endocrinology and Diabetes,
Rome, Italy, ††Bambino Gesu Children’s Hospital, IRCCS,
Department of Chemistry, Rome, Italy, ‡‡School of Medicine and
the Robinson Research Institute, The University of Adelaide,
Adelaide, SA, Australia, §§South Australian Health and Medical
Research Institute, Adelaide, SA, Australia
Purpose: Patients affected by protocadherin 19 (PCDH19)-female lim-
ited epilepsy (PCDH19-FE) present a remarkable reduction in allopreg-
nanolone blood levels. However, no information is available on other
neuroactive steroids and the steroidogenic response to hormonal stimula-
tion.
Method: We evaluated allopregnanolone, pregnanolone and preg-
nenolone sulfate by liquid chromatographic procedures coupled with
electrospray tandem mass spectrometry in 12 unrelated patients and 15
age matched controls. We also tested cortisol, progesterone and 17OH-
progesterone by standard immunoassays. These hormones were evalu-
ated in basal condition and after stimulation with adrenocorticotropic
hormone (ACTH).
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Results: A generalized decrease in blood levels of almost all measured
neuroactive steroids was found.While administration of ACTH increased
neuroactive steroid levels in the PCDH19-FE girls, these fell short of the
level of the age matched controls.
Conclusion: Our findings point to multiple defects in steroidogenesis
associated with and potentially relevant to PCDH19-FE.
p0402
ADJUNCTIVE TREATMENTWITH PREGABALIN FOR
PARTIALONSET SEIZURES IN PAEDIATRIC
PATIENTS: A RANDOMIZEDCONTROLLED TRIAL
J. Antinew*, B. Pitrosky†, L. Knapp*, M. Almas‡, V. Farkas§,
M.K. Farkas§
*Pfizer Global Research and Development, Groton, CT, United
States, †Pfizer Global Product Development Group, Paris,
France, ‡Pfizer Inc, New York, NY, United States, §Semmelweis
University, Budapest, Hungary
Purpose: Pregabalin is approved as adjunctive therapy for partial onset
seizures (POS) in adults in the US and EU. This placebo-controlled study
evaluated pregabalin’s efficacy and safety (2 dose levels) as adjunctive
treatment for paediatric patients with POS.
Methods: This double-blind, international study had 3 periods:
1) an 8-week baseline,
2) a 12-week double-blind (2-week dose escalation and 10-week fixed-
dose), and
3) a 1-week taper. Subjects were selected for being 4–16 years of age,
experiencing POS, and being treated with 1–3 antiepileptic drugs
(stable regimen).
Study treatments were pregabalin 10-mg/kg/day (maximum 600 mg/
day) or 2.5-mg/kg/day (maximum 150 mg/day). The primary efficacy
endpoint was loge(28-day seizure rate) during the double-blind period,
which was analyzed with a linear model with fixed-effect terms for base-
line loge(28-day seizure rate), geographic region, treatment, and weight
(<30 kg, ≥30 kg). Achieving a ≥50% responder rate and safety and toler-
ability were also evaluated.
Results: The study enrolled 295 patients who were mean age 10.2 years,
55%male, and 69%white. These patients were randomized to 10-mg/kg/
day pregabalin (n = 97), 2.5-mg/kg/day (n = 104), and placebo
(n = 94). The placebo-adjusted percent improvement in loge(28-day sei-
zure rate) was statistically significant with 10-mg/kg/day pregabalin
(19.9%, p = 0.0185) and was numerically but not statistically signifi-
cant with 2.5-mg/kg/day (9.9%, p = 0.2577). Compared with placebo
(22.6%), the 50% responder rate significantly favored 10-mg/kg/day pre-
gabalin (40.6%, p = 0.0092) and was higher (but not significantly) with
2.5-mg/kg/day (29.1%, p = 0.8024). Adverse events occurring in ≥10%
of any treatment group included somnolence (10-mg/kg/day 25.8%, 2.5-
mg/kg/day 17.3%, placebo 13.8%), increased weight (10-mg/kg/day
13.4%, 2.5-mg/kg/day 3.8%, placebo 4.3%), and increased appetite
(10-mg/kg/day 10.3%, 2.5-mg/kg/day 6.7%, placebo 4.3%). These were
consistent with the known safety profile observed in adults treated with
pregabalin.
Conclusions: Relative to placebo, 10-mg/kg/day pregabalin demon-
strated efficacy for seizure frequency reduction, and both 10-mg/kg/day
and 2.5-mg/kg/day were well tolerated.www.clinicialtrials.gov identifier
NCT01389596
p0405
FAMILIAL PREDISPOSITION IN EPILEPTIC
ENCEPHALOPATHYWITHCONTINUOUS SPIKEAND
WAVEDURING SLEEP: TWOCASES FROMTHE SAME
FAMILY
Z. Aydın-€Ozemir, A.D. Yalcın, D. Polisci
Department of Neurology, €Umraniye Research and Education
Hospital, University of Health Sciences, Istanbul, Turkey
Purpose: Epileptic encephalopathy with continuous spike and wave dur-
ing sleep is a syndrome characterized by almost continuous slow (typical
1.5–2 Hz) spike and wave during slow sleep (CSWS), different type of
seizures and progressive decline in cognitive, behavioral and psychiatric
functions. The pathogenesis of CSWS remains unknown. On the basis of
few recently published cases related to gene abnormalities, a familial pre-
disposition gains gradual importance. In this study we present two
patients with CSWS from the same family.
Case: An eleven-year-old girl with normal mental and motor develop-
ment until 7 years was admitted to our Epilepsy Outpatient Clinic
because of intractable seizures. She was suffering from complex partial
seizures characterized by staring, unresponsiveness, vocalization, repeti-
tive stereotypic movement of hand clapping and body shaking. Seizures
were lasting a few minutes and repeating a few times weekly. Six months
later the frequency and the duration of seizures increased and cognitive
decline developed. The repeated sleep EEG’s showed generalized spike-
wave discharges compatible with CSWS. Her MRI was normal. Her neu-
ropsychological assessment revealed global cognitive decline in all
domains particularly in language function. Despite corticosteroid therapy
and various combinations of different antiepileptic drugs she still has sei-
zures almost every day. Her school performance improved a little bit. We
found out that her brother also has decline in school performance but no
seizure. Like his sister, CSWSwas detected in his sleep EEG.
Conclusion: The pathophysiology of CSWS is not completely under-
stood, but corticothalamic neuronal network related to sleep patterns is
thought to be involved. Our patient has intractable epilepsy and her prog-
nosis is poor. In the context of this case we want to draw attention to the
familial predisposition in CSWS patients and poor outcome. Further
studies are required to confirm this relation.
p0407
DISCUSSING SUDEPAS PARTOF STANDARD
PAEDIATRIC EPILEPSYCARE: PAEDIATRIC
HEALTHCARE PROFESSIONAL SURVEYAND
LITERATUREREVIEW
N. McCrea*, A. Hosking†, M. Ottayil‡, C. Eltze*
*Great Ormond Street Hospital, Neurosciences, London, United
Kingdom, †Bart’s and the London School of Medicine and
Dentistry, London, United Kingdom, ‡Broomfield Hospital,
Paediatrics, Chelmsford, United Kingdom
Purpose: To determine compliance with UK national guidelines recom-
mending tailored provision of information on Sudden Unexpected Death
in Epilepsy (SUDEP) to all children and families diagnosed with epi-
lepsy.
Method: UK healthcare professionals (HCPs) were contacted via regio-
nal epilepsy networks and the British Paediatric Neurology Association
and asked to complete an online survey. A systematic literature review
was performed on 3rd January 2017, searching MEDLINE for physician
practices in discussing SUDEP.
Results: One hundred and seventy-six HCPs responded, including paedi-
atricians (n = 78, 44%), paediatric neurologists (n = 42, 24%), and epi-
lepsy-nurse specialists (n = 19, 11%). Respondents provided
information on SUDEP: to all patients with epilepsy (n = 49, 28%),
selected patients only (n = 106, 60%), or not at all (n = 20, 11%). Of
those who give information only to selected patients, selection criteria
include intractable or nocturnal seizures, symptomatic epilepsies, surgi-
cal candidates, medication non-compliance, and adolescents. Most dis-
cussions take place around the time of diagnosis. Common challenges
and barriers to discussing SUDEP were worry about frightening the fam-
ily, misinterpretation of risk by families, uncertainty of facts and figures,
lack of confidence, time constraints, and in childhood absence epilepsy.
Sixty-five per cent of respondents wanted more guidance, including
specific training, peer discussion and/or standardised written information
for families. We found 9 similar surveys in the literature, all published
within the last 11 years, featuring mostly adult and paediatric neurolo-
gists in the UK and worldwide. Of 2607 respondents, 189 (7%) discuss
SUDEP with all patients, 971 (37%) rarely discuss, and 331 (13%) never
discuss it.
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Conclusion: Despite national guidelines, discussing SUDEP with
patients and families remains challenging, with great variability in prac-
tice. Our national survey demonstrated that in the UK more HCPs pro-
vide information to all patients/families compared to international survey
data. However a significant proportion still do not routinely discuss this
topic, demonstrating a need for additional training and guidance.
p0412
EPILEPSY INAUTISM SPECTRUMDISORDER: A
LONG-TERMELECTROCLINICALANALYSIS OF 36
CASES
S. Pellegrin, G. Cantalupo, T. Zordan, E. Castino, R. Solazzi,
B. Berlese, L. Zoccante, F. Darra, B. Dalla Bernardina
Child Neuropsychiatry, University of Verona, Verona, Italy
Purpose: To analyze the electroclinical features of epilepsy in a popula-
tion of patients affected by autism spectrum disorder (ASD), in order to
verify if precise electroclinical syndromic entities can be identified.
Methods: In a population of 207 patients with initial diagnosis of ASD
admitted to our Unit of Child Neuropsychiatry between 1988 and 2012
(genetic epileptic encephalopathies and cases in which the autistic fea-
tures appeared after the epileptic encephalopathy onset were excluded),
36 patients fulfilled the following criteria: (1) diagnosis of Autism Spec-
trum Disorder following the DSM-5 (Autistic Disorder or Asperger Syn-
drome or Pervasive Developmental Disease Non Otherwise Specified,
following the DSM-IV criteria) and (2) diagnosis of Epilepsy.
Clinical data, EEG, MRI findings, genetic analysis, ASD-features, and
cognitive profile were reviewed. We analyzed particularly the clinical
characteristics of seizures and the EEG features. We further analyzed the
possible correlation between electroclinical picture, ASD-type and cog-
nitive outcome.
Results: The mean age at follow-up was 13.2 years (from 4 to 22 years).
We could identify 3 groups:
- “Self-limited Focal Epilepsies-like” (n = 7): age-dependent forms
similar to the one previously known as benign childhood epilepsy with
centrotemporal spikes.
- “Structural or unknown etiology Focal Epilepsies” (n = 13): forms
otherwise called Symptomatic or Cryptogenic Focal Epilepsy (mainly
temporal lobe epilepsy) which tend to persist in time.
- Unclassified Epilepsies (n = 16): forms characterized by electroclini-
cal and evolutive pattern variable and difficult to define. In the major-
ity of cases both seizure types and etiology are unknown.
Conclusion: We confirmed that Epilepsy in ASD patient is a frequent
comorbidity (17.3% of our ASD population). In the majority of cases
(44.4%) epilepsy is unclassified and prognosis is not predictable. How-
ever we found two relatively homogenous groups in the remaining cases:
a group of focal epilepsies (36.1%), mostly temporal, with variable prog-
nosis, and the second of self-limited focal epilepsy (19.5%).
p0413
APOLIPOPROTEIN E – POTENTIAL BIOMARKER IN
EPILEPSY
M. Kukuruzovic, M. Malenica, I. Separovic
UHC Sestre Milosrdnice, Zagreb, Croatia
Purpose: To determine a role of particular apolipoprotein E alleles and
as well as the blood lipid profile in presentation of different types of epi-
lepsy in children.
Method: Alleles of apolipoprotein E gene, blood cholesterol (total
cholesterol, HDL and LDL) and triglycerides levels were analysed from
blood samples obtained from 111 children with epilepsy and 118 children
of the same age as the control group. After PCR amplification, APOE
fragments were genotyped by melting curve analysis using allele-specific
probes.
Results: The distribution of APOE alleles was the same in both the
experimental and the control group. Significantly increased values of the
total cholesterol (p = 0.00039) and the low-density lipoprotein (LDL;
p = 0.000034) were observed in the control group compared to the exper-
imental group.
No statistically significant difference was found between the genotype
of children with idiopathic and symptomatic epilepsy. However, in
regard to the type of epilepsy, patients with symptomatic epilepsy
showed significantly higher plasma levels of the total cholesterol
(p = 0.014) and LDL cholesterol (p = 0.0009). Surprisingly, genotype
showed a correlation to plasma LDL levels (p = 0.02).
Conclusion: Although this study confirmed no connection between
APOE and the type of epilepsy in children, it showed that the children
with epilepsy have lower total cholesterol and LDL levels, as well as
those with idiopathic epilepsy compared to patients with symptomatic
condition.
p0414
EFFICACYANDTOLERABILITYOF PERAMPANEL
(PER) ADD-ON THERAPY INCHILDRENWITH
REFRACTORY FOCALEPILEPSIES
M. Nikanorova, P. Gellert, K. Olofsson, B. Jepsen,
H. Breitenstein, M. Soendergaard
Danish Epilepsy Center (Filadelfia), Dianalund, Denmark
Purpose: To assess the clinical efficacy and tolerability of PER in chil-
dren with refractory focal epilepsies.
Method: The study population comprised 68 children (34 boys, 34 girls,
aged between 4–17 years) with refractory focal and multifocal epilep-
sies. PER was given as add-on therapy at the doses 4–12 mg/day. Prior to
PER treatment the patients have tried 4–12 antiepileptic drugs. The treat-
ment duration varied between 3 and 46 months. PER clinical efficacy
was analyzed in the whole group and dependent on the seizure types and
patient0s age. PER tolerability was evaluated during the course and at the
end of follow-up.
Results: The complete seizure control and reduction of seizure fre-
quency for >50% were observed in 9 (13.2%) and 31 (45.6%) patients
respectively. PER efficacy did not vary significantly in the young (4–
12 years) and elder children (13–17 years). PER was mostly effective in
patients with focal motor, secondary generalized and tonic seizures while
in children with focal hypomotor seizures and epileptic spasms its effi-
cacy was not significant. The adverse events (aggressiveness, restless-
ness, apathy, nausea, dizziness) occurred in 11/68 patients (16.2%), and
in 7 of them PER therapy was stopped after 3–4 months since treatment
initiation.
Conclusion: PER showed 50–100% seizure reduction in 58.8% of
patients with refractory focal/ multifocal epilepsy with the highest effi-
cacy against focal hypermotor, secondary generalized and tonic seizures.
PER was equally effective in the younger and elder age groups. Adverse
events were not frequently observed and led to earlier therapy termina-
tion in 7/68 (10.3%) of patients.
p0415
ICTALANDPERI-ICTALCARDIORESPIRATORY
ABNORMALITIES IN PAEDIATRIC SEIZURES:
POSSIBLERELATIONWITH SUDEP?
G. Randazzo*,†, P. Bonanni*, P. Borrelli‡, P. Veggiotti†
*Epilepsy Unit, IRCCS E. Medea, Conegliano, Italy, †IRCCS C.
Mondino, Department of Child Neurology, Pavia, Italy,
‡University of Pavia, Department of Public Health Experimental
and Forensic Medicine, Pavia, Italy
Purpose: Autonomic and cardiopulmonary regulation play an important
role in the cascade of events which results in SUDEP (Sudden Unex-
pected Death in Epilepsy).Our objective was to assess the frequency of
ictal cardiorespiratory abnormalities in a large cohort of paediatric
epileptic patients, with the final aim of early detection of potential risk
factors for SUDEP.
Method: We retrospectively analysed seizures recorded with video-poli-
graphic-EEG, between 2013 and 2015, in two third level epilepsy centres.
Inferential analysis, crude odds ratios and logistic regression were
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performed to evaluate association of ictal cardiorespiratory findings with
seizures characteristics, demographics and peri-ictal cardiorespiratory
abnormalities.
Results: The inclusion criteria were valid for 193 seizures in 163 chil-
dren. Heart rate (HR) variation was found in 70% of seizures (90% tachy-
cardia, 12% bradycardia); breath rate (BR) abnormalities in 80% (58%
tachypnea/hyperpnea, 39% bradypnea, 12% apnoea). The risk of ictal
tachycardia/bradycardia increased with age (OR = 1.01, p = 0.012), in
seizures during sleep (OR = 7.91, p < 0.0001) and related with pre-ictal
tachycardia (OR = 8.93, p = 0.05) and post-ictal tachycardia
(OR = 11.5, p = 0.001). Compared to patients with age-related epilepsy,
the risk of HR abnormalities increased in infantile cerebral palsy/ac-
quired cerebropathies (OR 12.04, p = 0.005), in genetic syndromes
(OR = 14.54, p = 0.001) and in cortical malformations/cerebral tumors
(OR = 45.05, p < 0.0001). The risk of ictal BR alteration increased in
children with ictal tachycardia (OR = 9.51, p < 0.0001), with post-ictal
bradypnea (OR = 3.21, p = 0.039), with post-ictal tachypnea/hyperpnea
(OR = 18.60, p = 0.007) and it is reduced to the increase of each month
of epilepsy age onset (OR = 0.99, p = 0.04).
Conclusion: In paediatric epileptic seizures there is high rate of car-
diorespiratory abnormalities, that relate to age, early onset epilepsy,
sleep, infantile cerebral palsy/acquired cerebropathies and malformative/
genetic syndromes. These data help in the early detection of patients
potentially more at risk of SUDEP, with a significant implication in terms
of prevention.
p0418
ELECTROENCEPHALOGRAPHIC ANDDIFFUSION
TENSOR IMAGINGCHANGES IN IDIOPATHIC
EPILEPTIC CHILDREN IMANE
I. Yassine*, A.O. Hosny*, Y.A. Ashour*, W.M. El-Deeb*,
K.A. Gad†
*Neurology, Suez Canal University, Ismailia, Egypt, †Radiology,
Suez Canal University, Ismailia, Egypt
Purpose: Neurocognititive impairement represent one of the most com-
mon co-morbididties occurring in school-aged children with idiopathic
epilepsy. Diagnosis of the idiopathic form of epilepsy requires absence of
any macrostructural abnormality in the conventional MRI, though
changes can be found at the microstructural level using advanced imag-
ing techniques as Diffusion tensor imaging (DTI). The purpose of the cur-
rent study is to assess the correlation between the microstructural white
matter DTI abnormalities, the electroencephalographic changes and the
cognitive dysfunction in children with idiopathic active epilepsy.
Method: A comparative cross sectional study included 60 children with
idiopathic active epilepsy. Based on the Stanford binet 5th edition scores,
patients were equally allocated to normal cognitive functions or cognitive
dysfunction group. History of the epileptic condition was gathered by
personal interview. All patients underwent brain EEG and DTI which
was interpreted using FSL.
Results: Fractional anisotropy (FA) was significantly higher while mean
diffusivity (MD) was significantly lower in the normal cognitive func-
tions than in the cognitive dysfunction group. This altered microstructure
was related to the degree of the cognitive performance of the studied
epileptic children. The microstructural alterations of the neural fibers in
the epileptic patients with cognitive dysfunction were significantly
related to younger age of onset of epilepsy, poor control of the clinical
seizures and the use of multiple antiepileptic medications.
Conclusion: Epileptic children with normal cognitive functions differ in
the white matter integrity as measured by DTI compared to those with
cognitive dysfunction. Individual tract integrity is linked to the type of
cognitive dysfunction in the epileptic brain. These changes have impor-
tant cognitive consequences.
p0419
CHILDHOODABSENCE EPILEPSY, COGNITIVE
OUTCOME
A. Shadrova*,†, I. Shchederkina‡,§, I. Koltunov‡,¶,
N. Zavadenko**
*Morozovsky Child Hospital, Neurology, Moscow, Russian
Federation, †Russian National Research Medical University,
Moscow, Russian Federation, ‡Morozovsky Child Hospital,
Head of Hospital, Moscow, Russian Federation, §Paediatric,
Morozovsky Child Hospital, Moscow, Russian Federation,
¶Paediatric, Russian National Research Medical University,
Moscow, Russian Federation, **Neurology, Russian National
Research Medical University, Moscow, Russian Federation
Purpose: A high risk of academic failures and attention deficit was
found out in children suffering from childhood absence epilepsy.
Aim: To estimate the peculiarities of CAE course in two groups:
1) With criteria C.P.Panayiotopoulos, 2005;
2) Patients with absence seizures, not included in group 1.
Method: Retrospective analysis of 186 cases of patients with CAE,
observed in Morozov State Children’s Clinical Hospital, EEG, AED
response, neuropsychological assessment by GMDS-ER (2–8).
Results:
* 1
st group consisted of 124 patients, average age 8.7 years, 2nd group -
64 patients, average age 11.2 years.
* 70.8% patients from the 1
st group achieved remission, there were no
cases of GTCS or myoclonic seizures, the average duration of therapy
was 2.8 years (2.5–3.3), more than one AED was prescribed in 10.4%
of cases.
* 51.6% of patients from the 2
nd group achieved remission, 30.6% had
myoclonic seizures, 51.6% - GTCS; the average duration of therapy
was 4.2 years (3.6–5.1), polytherapy was needed in 48.3% of cases.
* Neuropsychological assessment (GMDS-ER 2–8) revealed impaired
mental function of varying severity in both groups. In the 1st group
60% of patients had mild or moderate deviation (max.15.5 months),
especially in locomotor, personal-social, eye and hand co-ordination
subscales; 40% had more severe (max.33.5 months) delay, especially
in personal-social, performance and practical reasoning subscales.
* In the 2
nd group 75% of patients had mild cognitive deficits (average
age delay did not exceed 7.5 months); 25% - moderately balanced
delay in most subscales (on the average, 13.5 months).
Conclusion: GTCS and myoclonic seizures in combination with
absences do not always determine unfavorable prognosis of comorbid
cognitive and psycho-emotional disorders. The delay of neuropsycholog-
ical development in patients with CAE may vary widely. Apparently,
CAE is genetically heterogeneous, which may determine the course and
outcome peculiarities.
p0421
RISKOF SUICIDE, AFFECTIVEDYSPHORIC
DISORDERS ANDQUALITYOF LIFE PERCEPTION IN
PATIENTSWITHFOCALREFRACTORYEPILEPSY
A. Garcıa Espinosa*, R. Andrade Machado†, M. Ochoa Urrea†
*CES University, Psychiatry, Antioquia, Colombia, †National
Institute of Neurology, Antioquia, Colombia
Purpose: To find the frequency of the risk of suicide in patients with
focal refractory epilepsy and its possible association with factors like per-
ceived QOL (quality of life) and ASDD (affective-somatoform dysphoric
disorder), using the 2007 ILAE’s proposal to classify affective disorders
of epilepsy.
Method: A total sample of 82 patients was divided into two groups
depending on the presence of suicidal risk: study group (A) with suicidal
risk and control group (B) without suicidal risk. Questionnaires, scales,
interviews and clinical charts were evaluated by professionals with
expertise in Neurology and Epileptology (RAM, AGA), Psychiatry
(AGE) and Neuropsychology (FGR). Suicidal risk was evaluated with
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the M.E.P.I (International Psychiatry Mini-interview) suicidal module
that specifies the current suicidal risk based on scores. QOL was evalu-
ated with the Quality of Live in Epilepsy Inventory-31 survey (QOLIE-
31). Logistic regression was conducted to ascertain if ASDD and QOL
significantly predicted suicidal risk were considered statistically signifi-
cant when p value was <0.05.
Results: Suicidal risk was present in 40.3% (33 patients). It was classi-
fied as severe in 31.7%, and it was only present in temporal lobe epilepsy
cases p = 0.002. More than half of patients with ASDD had risk of sui-
cide (52%) (p = 0.006). The presence of ASDD was found to be a risk
factor for suicidal risk (OR 3.86; IC 1.3–12.2). Patients with suicidal risk
had a worse QOL score than patients without risk of suicide
(57.8  16.9 vs 46.0  18.2; p < 0.05) and an affected QOL signifi-
cantly increased suicidal risk (OR 2.9; CI 1.3–7.8). Multivariate analysis
demonstrated that an impaired QOL (OR 2.2) and the presence of ASDD
(OR 4.1) significantly increased the probability of having suicidal risk
(x2 = 13.6; OR 5.2, p = 0.009).
Conclusion: ASDD and low QOL perception increase, independently,
the risk of suicide.
p0423
STUDYOF PERSONALITY TRAITSOF JAPANESE
PATIENTSWITHEPILEPSYUSINGNEO-PI-R AND
BDI-II
M. Okazaki*, M. Ito†, N. Adachi‡, A. Sunaga*, N. Shimmitsu§,
R. Muramatsu¶
*National Center Hospital of Neurology and Psychiatry,
Department of Psychiatry, Kodaira, Japan, †Jozen Clinic,
Sapporo, Japan, ‡Adachi Mental Clinic, Saporo, Japan, §Adachi
City Office, Adachi, Japan, ¶Musashino Kokubunji Clinic,
Kokubunji, Japan
Purpose: NEO-PI-R, a widely used self-completed questionnaire
method for character research, evaluates character with a five-domain
scale (N: Neuroticism, E: Extraversion, O: Openness, A: Agreeableness,
C: Conscientiousness) and 30 subclassification facets. We assessed sub-
jective character traits of patients with epilepsy (PWE) using NEO-PI-R
and then examined the relation between each NEO-PI-R item and BDI-II
(self-completed questionnaire of depressive symptoms) score.
Method: One hundred forty-five outpatients (77 women, 68 men; age
33.8  10.2 years; focal epilepsy [n = 118], IGE [n = 27], inherited
epilepsy [n = 2]) completed the NEO-PI-R (Japanese version). Scales
were scored with the T-score normalized by gender and age group in a
general population. The average T-score was “high”when >55 and “low”
when <45. The last 41 patients (22 women, 19 men; age
32.4  10.1 years; all focal epilepsy) simultaneously completed the
BDI-II.
Results: In the five domain scales, we found the “high” trait in N (aver-
age  SD: 57.5  12.0). In the facet scales, we found “high” traits in
N1 (Anxiety, 57.4  10.7), N3 (Depression, 57.8  12.1), and N6 (Vul-
nerability, 58.0  11.2) and a “low” trait in C1 (Competence,
44.8  10.5). Differences between left (n = 21) and right (n = 25) tem-
poral lobe epilepsy (TLE) or between TLE (n = 52) and extra TLE
(n = 26) were not significant (Mann-Whitney U test, p < 0.05). BDI-II
scores in the 41 patients correlated highly positively with N, N1, N2
(Angry Hostility), N3, N4 (Self-Consciousness), N5 (Impulsiveness),
N6, and O1 (Fantasy) and highly negatively with A and C1 (Spearman0s
rank correlation coefficient, |r|>0.4, p < 0.01).
Conclusion: No consistent personality trait in PWE or clear difference
provided for the personality trait by lateralization or focus localization.
However, comorbid depression must be addressed when discussing
patients’ personality traits because of the high prevalence of depression
in PWE and the possibility that their depression may affect the scales
assessing personality traits.
p0424
A STUDYONBIDIRECTIONALRELATIONSHIP
BETWEENEPILEPSY ANDDEPRESSION
M. Ito*, N. Adachi†
*Jozen Clinic, Sapporo, Japan, †Adachi Mental Clinic, Sapporo,
Japan
Purpose: It is well known that depression is observed more frequently in
patients with epilepsy (PWE) than in the general population with the sug-
gested reasoning being that pathophysiologic mechanisms common with
idiopathic depression may be responsible because of their similar clinical
symptoms and the bi-directional relationship between both disorders. To
investigate shared pathophysiologic mechanisms with depression and
epilepsy, clinical characteristics between epilepsy patients with and with-
out depression were compared and identified the risk factors for develop-
ing depression in PWE.
Method: Subjects consisted of 72 PWEwith depressive disorder or a his-
tory of depressive disorder. For control, 300 other PWE without psychi-
atric disorder were studied. Demographic and clinical items were
reviewed through direct interview or medical records. Secondly, the sub-
jects were examined the depression related factors including age of onset,
duration from onset of epilepsy to that of depression, subtype of depres-
sion, triggering factors for depression and comorbid psychiatric disorder.
Results: Women and family histories of psychiatric disorder were seen
more frequently in patients with depression than without. Significant dif-
ferences in epilepsy related factors were not observed between both
groups. Onset of depression was relatively young (<20 years) and
depression preceded epilepsy onset in 20%. Comorbid psychiatric disor-
ders existed in approximately 40% of patients with direct seizure distress
rarely inducing depression.
Conclusion: Depression may develop more on a basis of biological than
psychosocial factors in PWE due to the existence of a bidirectional rela-
tionship. The frequent existence of a family history of psychiatric or
comorbid psychiatric disorders may indicate a predisposition to depres-
sion. With seizures themselves proved of little influence on the occur-
rence of depression, we suggest that patients with biological
vulnerabilities may develop depression when the psychosocial distur-
bances associated with epilepsy are added.
p0426
PSYCHOTIC STATES IN LENNOX-GASTAUT
SYNDROME
S. Yasumoto*, H. Motooka*, Y. Ito*, M. Mashimoto*, S. Ishida†,
N. Uchimura*
*Kurume University School of Medicine, Department of
Neuropsychiatry, Fukuoka, Japan, †AkenoMedical Clinic,
Yokoo Oita, Japan
Purpose: Although psychotic states often occur in patients with epi-
lepsy, there are few reports about psychosis with symptomatic/crypto-
genic generalized epilepsy (SGE). We investigated the characteristics of
four cases of psychoses with Lennox-Gastaut syndrome (LGS).
Method: We selected 984 patients with epilepsy treated in the Neu-
ropsychiatry Department of Kurume University Hospital from April
2010 to March 2016. Four of 37 (10.8%) patients with SGE presented
interictal psychosis (IIP). All of them were diagnosed with LGS. We
investigated medical records retrospectively and obtained the clinical
data from 4 IIP patients with LGS.
Results: All patients had schizophrenia-like psychosis. Although posi-
tive symptoms, such as auditory hallucinations and delusions, were
remarkable in all four patients, negative symptoms, such as blunted affect
and emotional withdrawal, were less common. Three patients had tran-
sient psychotic periods about within one year, and their psychotic states
remitted completely. Only one patient demonstrated a persistent chronic
psychotic state for 2 years.
Three patient showed psychoses that correlated with improvement in
seizure frequency.
All patients showed frequent epileptic discharges on EEG, such as dif-
fuse spike-wave bursts and diffuse rapid rhythms, during the remission of
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psychosis. Two patients showed the disappearance of epileptic dis-
charges during the development of psychosis that correlated with inhibi-
tion of seizures.
SPECT was performed in three cases and they all showed hypoperfu-
sion of the frontal lobe. SPECT was performed during both the psychotic
and remitted states in only one case. An increase in blood flow to the
bilateral frontal lobes was found during the psychotic state compared to
that seen during remitted states.
Conclusion: These results suggest that changes in epileptic activities
may tend to cause the development of psychosis in LGS. Furthermore,
SPECT findings suggested an association between psychosis and distur-
bance of frontal lobe blood flow.
p0432
SCHOOL-AGEDCHILDRENAND PARENTS’
EXPERIENCESOF EPILEPSYANDCARE: A
QUALITATIVE STUDY
R.E.P. Black*, J. Harden†, M. Pickersgill†, R. Chin*
*Muir Maxwell Epilepsy Centre, University of Edinburgh,
Edinburgh, United Kingdom, †Usher Institute of Population
Health Sciences, University of Edinburgh, Edinburgh, United
Kingdom
Purpose: Epilepsy holds a variety of implications for the child and their
family beyond seizures, including intricate and multidimensional care
arrangements. Despite recognition of the importance of listening to and
consulting with children regarding their healthcare, children’s accounts
regarding their epilepsy and their involvement in associated care is under
examined.
We present data from a study exploring everyday experiences of chil-
dren with active epilepsy (CWE) (on anti-epileptic drug(s) and or has had
a seizure in the last year) and their involvement in their own healthcare in
formal clinical and informal home contexts.
Method: CWE and their parent(s) were interviewed separately twice.
Semi-structured interviews were used to examine, in detail, themes asso-
ciated with everyday and care experiences of epilepsy. Observation of
clinical consultations guided the second interview, generating deeper dis-
cussions. Participatory tools were used in child interviews to facilitate
conversation. Interviews were recorded and transcribed using NVivo;
inductive thematic data analysis was conducted. The study was approved
by two Scottish NHS Research Ethics Committees.
Results: 23 children (12F; 7–14 years) with different types of epilepsy
(e.g. Childhood Absence and Rolandic Epilepsy) and 31 of their parents’
(25F) from varied socioeconomic backgrounds were interviewed.
Taking medication was a major aspect of epilepsy for CWE, often con-
sidered burdensome. Parent’s discussions of medication taking included
emotional turmoil and complex negotiation strategies. Many CWE
reported epilepsy did not interfere with daily life, although some did have
restrictions on activities by parents due to perceived risks. CWE differed
in their desire for and comfort with involvement in their care. Age was a
major factor in how parents determined their child’s autonomy and com-
petence of self-care. Parents saw themselves as gatekeepers of epilepsy
information, being selective in what they told their child. CWE and their
parents have unmet support and information needs regarding the future
of their epilepsy.
p0434
THE STIGMAOF EPILEPSY FROMTHE
PERSPECTIVEOF PATIENTSWITHEPILEPSY AND
PEOPLE FROMTHE ITALIANCOMMUNITY
M. Tombini, L. Ricci, G. Assenza, M. Ulivi, F. Assenza,
V. Di Lazzaro
Campus Bio-Medico University of Rome, Unit of Neurology,
Neurophysiology, Neurobiology, Department of Medicine,
Rome, Italy
Purpose: To assess the stigma related to epilepsy from the perspective
of both epileptic patients and people from the Italian community; more-
over, the impact of the perceived stigma on the mood and quality of life
of patients was also addressed.
Method: We enrolled 53 patients with epilepsy (21 males, mean age
50.3  17.9 years; 30 patients seizure free/23 with refractory epilepsy)
and 205 non-epileptic subjects (71 males, mean age 35.4  15.3 years).
Both epileptic (ES) and non-epileptic subjects (NES) were interviewed
on an individual basis and completed the Stigma Scale of Epilepsy
(SSE), a 24-items questionnaire that has been demonstrated to allow the
quantification of the perception of stigma by patients and people from
community. Moreover, the ES fulfilled a 3-item stigma scale, QUOLIE-
31 (Q31) and Beck Depression Inventory 2 (BDI-2) questionnaires for
the evaluation of quality of life and depressive symptoms. The results of
SSE were correlated with clinical and demographic details of both ES
and NES, as well as the Q31 and BDI-2 scores in ES.
Results: The SSE scores were significantly higher in NES with respect
to ES (respectively 59.6 vs 44.8). Fifty percent of ES reported feeling
stigmatised, with 8% reporting feeling highly stigmatised. SSE scores in
ES were highly correlated with depressive symptoms and perceived
stigma, as measure by SSE, had a negative impact on the overall score of
the Q31, as well as on all subscales of Q31, except for the seizure worry.
Conclusion: Our study evidenced higher levels in the perception of
stigma in NES than in ES. The people with epilepsy still experience feel-
ings of high stigmatisation, strongly correlated with depressive symp-
toms and lower scores of quality of life. Finally, all aspects of the quality
of life of ES, except the seizure worry, correlated negatively with the
severity of perceived stigma.
p0436
EPILEPSY, STIGMAAND FAMILY
G.M. Tedrus*, R. Pereira†, M. Zoppi‡
*Pontificia Universidade Catolica de Campinas, Faculdade de
Medicina, Campinas, Brazil, †Pontificia Universidade Catolica
de Campinas, Medicina, Campinas, Brazil, ‡Pontificia
Universidade Catolica de Campinas, Psychology, Campinas,
Brazil
Purpose: Epilepsy is surrounded by prejudice and stigma. Little is
known about the perception of stigma in family members.
Objective: To study how consecutive adult patients with epilepsy
(PWE) and cohabiting relatives (CR) perceive the stigma of epilepsy and
its correlations with the clinical aspects of epilepsy and quality of life
(QoL).
Method: The study investigated possible associations of theStigma
Scale of Epilepsy (SSE) of 148 consecutive PWE with the SSE of 90 CR,
clinical aspects of epilepsy, and QOLIE-31. The significance level was
set at 5% (p < 0.05).
Results: The SSE scores of the PWE were correlated with those of the
CR (Pearson’s correlation: 0.214; p = 0.01). SSE scores were signifi-
cantly higher in PWE with exclusively generalized seizures. Higher SSE
scores in PWE were correlated with longer epilepsy duration (0.385;
p = 0.001). The CR of PWE with depressive disorder had higher SSE
scores (46.3  14.1 x 37.6  12.8; t-test; p = 0.004). Higher stigma
(PWE and CR) was correlated with worse QoL in PWE.
Conclusion: Perceived stigma was high. Stigma perceived by PWE and
CR are correlated. The clinical aspects of epilepsy are related to per-
ceived stigma (PWE and CR). Worse QoL of PWE is associated with
higher perceived stigma (PWE and CR).
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HYPOCAPNEAWITHMECHANICALVENTILATION
AND POOROUTCOMEOFREFRACTORY STATUS
EPILEPTICUS
J. Oh*, B.S. Kang†, Y.-S. Kim‡
*Jeju National University Hospital, Jeju, Korea, †Yangpyeong
Hospital, Yangpyeong, Korea, ‡Gyeongsang National
University, Jinju, Korea
Purpose: To determine optimal protocol of mechanical ventilation dur-
ing intravenous anesthetics to control refractory status epilepticus (RSE)
RSE represents a life-threatening condition, requiring anesthetic treat-
ment and neurointensive care with respiratory support. However, it is
unknown which protocol of mechanical ventilator was better in case of
RSE. Hyperventilation is a well-established procedure for seizure provo-
cation during performance of EEG whereas CO2 has long been known
for its anticonvulsant properties in several experimental studies. In the-
ory, initial hypocapnea during mechanical ventilation in case of RSE
could be associated with worsen outcome.
Method: The status epilepticus (SE) cohort consisted of patients from
the epilepsy centers of eight academic tertiary medical centers in South
Korea. The clinical data including pCO2 level for all adult patients with
SE from January 2013 to February 2016 were derived from a prospective
SE database. The cases with RSE who underwent anesthetic therapy with
mechanical ventilation were included. The primary outcome variable
was defined as in-hospital death. The secondary outcome variable was
defined as a poor functional outcome, i.e., a score of 1–3 on the Glascow
Outcome Scale (GOS) at discharge.
Results: Among the 31 patients with RSE recruited into the study, and
excluding those who need ICP control, 11 (35.5%) died in the hospital
and 23 (74.2%) were discharges with a poor functional outcome. In 12
patients, initial level of arterial carbon dioxide was below 32 mmHg
(hypocapnea). The initial hypocapnea was not associated with in hospital
death (33.3% in hypocapnea versus 36.8% in non-hypocapnea,
p > 0.99), but a trend toward poor functional outcome at discharge
(84.2% of hypocapnea versus 58.3% of non-hypocapnea, p = 0.206).
Conclusion: Hypocapnea with hyperventilation might be avoided in
cases with intravenous anesthetic treatment and mechanical ventilation
to control RSE.
p0441
DECREASEDALLOPREGNANOLONE LEVELS IN
CEREBROSPINAL FLUIDOF PATIENTSWITH
STATUS EPILEPTICUS
G. Monti*,†, G. Giovannini*,†, C. Lucchi*, R. Bedin*,†,
T. Trenti‡, C. Rustichelli§, G. Biagini*,†, S. Meletti*,†
*Department of Biomedical, Metabolic and Neural Sciences,
University of Modena and Reggio Emilia, Modena, Italy,
†Department of Neurosciences, NOCSAE Hospital, AUSL
Modena, Modena, Italy, ‡Department of Laboratory Medicine
and Pathological Anatomy, NOCSAE Hospital, AUSLModena,
Modena, Italy, §Department of Life Sciences, University of
Modena and Reggio Emilia, Modena, Italy
Purpose: Neuroactive steroids are increasingly considered as relevant
modulators of neuronal activity. Especially allopregnanolone (AP) and
pregnenolone sulfate (PS) have been shown to possess, respectively, anti-
convulsant or proconvulsant properties, by modulation of GABAA recep-
tor. In view of the potential role of these steroids, we aimed at evaluating
AP and PS levels in cerebrospinal fluid (CSF) and blood samples
obtained from patients during status epilepticus (SE).
Material and methods: To this purpose, we enrolled 41 patients
affected by SE that undergone lumbar puncture to exclude CNS infection
and 41 subjects investigated for suspected non-epileptic neurological dis-
orders with normal CSF parameters. Liquid chromatographic procedures
coupled with electrospray tandem mass spectrometry and routine labora-
tory investigations were performed.
Results: Significantly lower AP levels were found in CSF of patients
affected by SE (30%; p < 0.05, Mann-Whitney test). Notably, AP was
not detectable in 28 out of 41 patients affected by SE (p < 0.01 vs con-
trols, Fisher’s exact test). In serum, AP levels did not differ in the two
considered groups. Conversely, PS was present at similar levels in the
investigated groups. Finally, differences in AP levels could not be
explained by a variation in CSF albumin content. These findings indicate
that AP is defective in the CSF of patients affected by SE. This phe-
nomenon was not dependent on carriers for steroids, such as albumin.
Conclusions: AP reduction in CSF of patients with SE may contribute to
support the epileptic activity. In such a case, to re-establish the level of
this steroid may be an important therapeutic target in patients affected by
SE, to avoid refractory evolution. Indeed, the limited, but encouraging
evidence obtained in paediatric patients treated with AP to stop super-
refractory SE is in agreement with our hypothesis.
p0444
EFFICACYAND SAFETYOF PERAMPANELORAL
LOADING IN POST-ANOXIC SUPER-REFRACTORY
STATUS EPILEPTICUS: A CASE SERIES
S. Beretta*, G. Padovano*, A. Stabile*, A. Coppo†, G. Bogliun*,
L. Avalli†, C. Ferrarese*
*Epilepsy Center, San Gerardo Hospital ASSTMonza,
University of Milano Bicocca, Monza, Italy, †San Gerardo
Hospital ASSTMonza, Deparment of Intensive Care, Monza,
Italy
Purpose: Super-refractory non convulsive status epilepticus (NCSE)
occurs in 20–25% of patients with post-anoxic encephalopathy following
cardiac arrest. In selected patients with favorable multimodal prognostic
indicators, treatment of super-refractory NCSE may lead to good neuro-
logical outcome.
Method: We analyzed acute EEG changes, neurological outcome and
adverse effects in consecutive post-anoxic patients with super-refractory
NCSE treated with add-on oral loading of perampanel. Efficacy was
defined when Perampanel was the last antiepileptic drug introduced into
the antiepileptic therapy within 72 h before the cessation of NCSE and
without changes in the comedication.
Results: Eight post-anoxic patients with super-refractory NCSE were
treated with perampanel (median initial dose 6 mg, range 6–12 mg)
administered via nasogastric tube. Median age was 52 years (range 26–
71). All patients had continuous EEGmonitoring showing definite gener-
alized NCSE with coma, diagnosed according to the Salzburg criteria.
All patients had favorable multimodal prognostic indicators (presence of
brainstem reflexes; presence of bilateral N20 responses; absence of peri-
odic discharges/GPEDs). Perampanel was given after a median number
of 3 antiepileptic drugs (range 2–5) and 3 anesthetic drugs (range 1–4),
after a median time of 9.5 days (range 4–35). In 6 patients (75%), status
epilepticus resolved within 72 hours after administration of Perampanel,
without changing the comedication. Neurological outcomes at 3 months
were return to normal or minimal disability in 4 patients (CPC 1–2,
50%), minimally conscious state in 1 patient (CPC 4, 12.5%) and death in
3 patients (CPC 5, 37.5%). No cardiorespiratory or cutaneous adverse
effects was reported. A reversible cholestasis, which required no specific
treatment, was observed in 5 patients (62.5%).
Conclusion: Perampanel 6–12 mg oral loading appeared an effective
and safe option in selected patients with post-anoxic super-refractory
NCSEwith good prognostic indicators.
p0447
SEXUALDISORDERS INWOMENWITHEPILEPSY
N. Rashidova*, K. Khalimova†, G. Rakhimbaeva†,
B. Kholmuratova†
*Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan,
†Tashkent Medical Academy, Tashkent, Uzbekistan
Most women with epilepsy maintain normal reproductive cycles and sex-
ual lives. However, a significant minority, approximately 20–30%, have
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some degree of sexual dysfunction, including problems with seizure
exacerbation, libido, arousal, and orgasm. Fluctuating hormone levels
may contribute to an array of reproductive cycling abnormalities. With
regard to sexual dysfunction, there is some evidence of reduced genital
blood flow in women with temporal lobe epilepsy. Other studies suggest
that psychosocial factors, such as depression, feeling stigmatized, and
being anxious about having seizures during sex, may contribute to the
higher rates of sexual dysfunction in this patient population. Some
antiepileptic drugs may adversely affect normal reproductive cycling and
sexual function, particularly drugs that increase serotonergic transmis-
sion. Conversely, resective epilepsy surgery has been shown to restore
sexual function. Treatments for sexual dysfunction include testosterone
replacement, although transdermal testosterone replacement is not yet
approved by the Food and Drug Administration for women. Given the
possibility that women with epilepsy may experience inadequate vaso-
congestion during arousal, sildenafil may have a useful role, though it has
not proved effective for women in general. This review focuses on poten-
tial sexual problems that are faced by women with epilepsy, with the sug-
gestion that proper treatment may alleviate these problems.
p0449
PHARMACOKINETIC VARIABILITYOFVALPROATE
INWOMENWITHEPILEPSYDURING PREGNANCY
C. Johannessen Landmark*,†, A.H. Farmen‡, M.L. Burns§,
A. Baftiu¶, M.I. Lossius**, S.I. Johannessen††, T. Torbj€orn‡‡
*Department of Life Sciences and Health, Oslo and Akershus
University College of Applied Sciences, Oslo, Norway,
†Department of Pharmacology, Oslo University Hospital, The
National Center for Epilepsy Oslo, Norway, ‡Department of
Neurology, Innlandet Hospital Trust, Lillehammer, Norway,
§Department of Pharmacology, Oslo University Hospital, Oslo,
Norway, ¶Department of Life Sciences and Health, Oslo and
Akershus Unviersity College of Applied Sciences, Oslo, Norway,
**Oslo University Hospital, National Center for Epilepsy, Oslo,
Norway, ††Department of Pharmacology, Oslo University
Hospital, National Center for Epilepsy Oslo, Norway,
‡‡Department of Clinical Neuroscience, Karolinska Institute,
Stockholm, Sweden
Purpose: Use of valproate in women of child-bearing age is currently
controversal. The risk of teratogenicity is dose-dependent, and recom-
mendations based on dose-event relationships. The purpose was to eluci-
date pharmacokinetic variability of valproate during pregnancy for
improved insight and patient safety.
Method: Anonymized retrospective data from a therapeutic drug moni-
toring (TDM)-database (2006–2015) and pregnancy data from Oppland
Perinatal Database (1994–2015) were used. Included samples were
trough total concentrations of valproate at assumed steady-state. The
study was approved by the Regional Ethics Committee.
Results: Data from 51 pregnancies in 33 women with epilepsy was used
(1–4 pregnancies per woman), mean age 29 years (range 19–40). There
were 1–7 TDM samples per woman. Mean dose and serum concentration
of valproate before pregnancy was 938 (SD = 342) mg/day and 427
(SD = 97) lmol/L, respectively. In total, 58% had serum concentrations
within the reference range (300–600 lmol/L). The variability in concen-
tration/dose (C/D)-ratios between women was 13-fold, and mean inter-
patient variability 2.3-fold (up to 5-fold). 17 (52%) women used
<700 mg/day, with 5-fold variability in C/D-ratio. There was a signifi-
cant 46% reduction in C/D-ratios, 0.53–0.29 lmol/L/ mg, before preg-
nancy to third trimester, reflecting increased clearance. Unfortunately,
free valproate concentrations were only measured in three patients. Addi-
tional clinical data was available in 21 women/38 pregnancies: 13 gener-
alised epilepsies, 6 seizure free during pregnancy, and 1 major
malformation noted.
Conclusion: Pharmacokinetic variability of valproate during pregnancy
was pronounced, demonstrating that dose is a poor approximation of fetal
drug exposure. Implementation of TDM and measurement of free
valproate concentrations should be aimed at during pregnancy and in fur-
ther studies.
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MISCARRIAGES IN PREGNANTWOMENWITH
EPILEPSY: FINDINGS FROMTHEMONEAD STUDY
K.J. Meador*, P.B. Pennell†, R.C. May‡, F.T. McElrath†,
E. Gerard§, L. Kalayjian¶, N. Velez-Ruiz**, E. Gedzelman**,
P. Penovich††, J. Cavitt‡‡, S. Hwang§§, A. Pack¶¶, E. Moore**,
D.M. Ippolito‡, M. Sam***, MONEAD Investigator Group
*Stanford University, Neurology, Palo Alto, CA, United States,
†Brigham&Women’s Hospital. Harvard Medical School,
Neurology, Bostoin, MA, United States, ‡Emmes Corporation,
Rockville, MD, United States, §Northwestern University,
Chicago, IL, United States, ¶University of Southern California,
Los Ageles, CA, United States, **Emory University, Atlanta, GA,
United States, ††Minnesota Epilepsy Group, Minneapolis, MN,
United States, ‡‡University Cincinnati, Cincinnati, MO, United
States, §§Northwell Heath, New Hyde Park, NY, United States,
¶¶Columbia University, New York, NY, United States, ***Wake
Forest University, Winston-Salem, NC, United States
Purpose: Many miscarriages go undetected when early in pregnancy. In
recognized pregnancies, miscarriages range 8–25% for the general popu-
lation. In women with epilepsy or treated with antiepileptic drug (AED),
some studies have reported slightly higher spontaneous miscarriage rates
than comparison groups. Here, we report the occurrence of miscarriages
in the Maternal Outcomes and Neurodevelopmental Effects of
Antiepileptic Drugs (MONEAD) study, which is an NIH-funded,
prospective, observational, multi-center investigation of pregnancy out-
comes for both mother and child.
Methods: Women were enrolled across 20 USA sites (2012–2016).
Inclusion criteria for PWWE included ages 14–45 years and <20 weeks
gestational age. Exclusion criteria included history of psychogenic non-
epileptic spells, expected IQ < 70, other major medical illness, progres-
sive cerebral disease, and switching AED in pregnancy prior to enroll-
ment.
Results: 351 pregnant women with epilepsy (PWWE), 105 pregnant
women without epilepsy (PWWoE), and 109 non-pregnant women with
epilepsy were enrolled. For PWWE at enrollment, 74% were on
monotherapy, 22% on polytherapy, and 4% on no AEDs. The most com-
mon AED monotherapies were lamotrigine (42%), levetiracetam (38%),
carbamazepine (5%), zonisamide (5%), oxcarbazepine (5%), and topira-
mate (3%). This analysis is limited to spontaneous miscarriages; which
occurred in 3.3% of pregnancies in PWWE and 0% in PWWoE. Mean
gestational ages at enrollment were 13.7 weeks in PWWE and
15.4 weeks in PWWoE. Rates did not appear to differ significantly
across different antiepileptic drugs. No major congenital malformations
were reported in the miscarriages.
Conclusions: Miscarriage rates were low in both PWWE and PWWoE.
These low rates are likely related to the advanced gestational ages at
enrollment. Future analyses will examine other pregnancy outcomes in
the mothers and children.Study supported by: NIH NINDS, NICHD
#U01-NS038455.
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THE INFLUENCEOFETHNIC BACKGROUNDON
PARTICIPATIONAND PREGNANCYOUTCOMES IN
THEAUSTRALIAN PREGNANCYREGISTER
N. Hao*,†, J. Graham‡, A. Hitchcock‡, T. O’Brien*, F. Vajda*
*Department of Medicine, University of Melbourne, Melbourne,
VIC, Australia, †Department of Neurology, Sichuan University,
Chengdu, China, ‡Department of Neurology, Royal Melbourne
Hospital, Melbourne, VIC, Australia
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Purpose: Anti-epileptic Drug (AED) Registers are now well established
and have provided important information regarding outcomes of preg-
nancies exposed to AEDs. Participation by pregnant women in a register
may be influenced by the ethnicity of the population, which may influ-
ence the applicability of the findings. This issue has received little scien-
tific investigation. Aim of this study is to identify the effects of ethnicity
on participation and pregnancy outcomes of the Australian Pregnancy
Register (APR). We particularly focused on those of Asian background,
as this represents the largest non-European ethic group in Australia.
Method: Since 1999, the APR has recruited 2380 eligible pregnant
women with epilepsy, or taking AEDs for another indication. Details
about social demography, pregnancy, and epilepsy were obtained. Eth-
nicities of the participants were defined according to standard classifica-
tion for sociological research in Australia. Logistic regression analysis is
used to examine the association between ethnicity, AEDs, epilepsy and
pregnancy outcomes.
Results: 856 participants were tentatively identified as being born from
outside Australia and were contacted, 458 replied, 49 participants were
identified as having Asian ancestry, which was much less than the
expected based on general population demographics. Asian-Australians
were less likely to have had a convulsive seizure during the first trimester
(OR 0.110, CI 0.015–0.803, p 0.03), but more likely to take multiple
AEDs during pregnancy (OR 2.126, CI 1.197–3.776, p 0.01). Although
no significant differences were found in terms of pregnancy outcome,
there was a trend that Asians were less likely to have poor pregnancy out-
comes (OR 0.194, CI 0.027–1.417, p 0.106).
Conclusion: Ethnicity appears to have a significant influence on partici-
pation in voluntary Registers, with reduced participation rate among
Asian-Australians in the APR. It is possible that Ethnicity may also influ-
ence outcomes of pregnancy exposed to AEDs, and this is an area that
warrants further dedicated research.
p0454
EFFICACYOFCONSULTINGWOMENWITH
EPILEPSYCONCERNING PREGNANCYRELATED
KNOWLEDGE. RESULTS FROMAN INTERNET BASED
SURVEY INGERMAN SPEAKINGCOUNTRIES
C. Dierking*, T. Porschen†, J. R€osche‡
*Department of Neurology, University of Rostock, Rostock,
Germany, †Association for Epilepsy Self-Help North Rhine-
Westphalia, Association for People with Epilepsy, Koeln,
Germany, ‡Klinik Lengg, Z€urich, Switzerland
Purpose: We tried to determine the influency of consulting by a neurolo-
gist on the level of pregnancy-related knowledge of women with epilepsy
in German speaking countries.
Method: A questionnaire was placed on the internet platform of a
patient’s organisation from 4th August 2015 to 31st to December 2015.
The questionnaire consisted of 18 questions addressing the characteris-
tics of the syndromes of epilepsy, the patients experience with pregnancy
and the sources of their pregnancy-related knowledge. Another 20 items
addressed the level of pregnancy-related knowledge. Each of these items
consisted of a 5-point Likert scale. We considered Likert scale answers
of 1 and 2 as equivalent to disagreement and of 4 and 5 as agreement with
the statement in question.
Results: 192 women (179 patients, 13 relatives) aged 30.5 years on
average (SD 10.8) participated. Most women got information and advice
concerning the treatment of epilepsy from a neurologist (80.73%). Major-
ity of women obtained information concerning driving licence (71.88%)
followed by information about pregnancy and delivery (60.42%). On the
average only 45.7% of the questions addressing pregnancy-related
knowledge were answered correctly. Women, who were counselled by a
neurologist gave more correct answers than the others (49% SD 19% vs.
33% SD 24%, p < 0.0002). Women, who remembered being counselled
about pregnancy related matters gave more correct answers than the
others (51% SD 17% vs. 38% SD 24%, p < 0.011).
Conclusion: Counselling about pregnancy related matters proved to be
effective. But even after this huge information needs concerning preg-
nancy related issues remained.
PostersMonday 4th September, 2017
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JUVENILEMYOCLONIC EPILEPSY: LONG-TERM
PROGNOSIS AND TREATMENTWITHDRAWAL
A. Viloria Alebesque, E. Bellosta Diago, S. Santos Lasaosa,
J.A. Mauri Llerda
Hospital Clınico Universitario Lozano Blesa, Neurology,
Zaragoza, Spain
Introduction: Juvenile myoclonic epilepsy (JME) is a well-known
epileptic syndrome, but there are still doubts about its long-term thera-
peutic management.
Method: Single centre retrospective study reviewing medical records of
patients with JME diagnosis more than 20 years after onset.
Results: A sample of 20 patients with a diagnosis of JME with a mean
follow-up time of almost 30 years (29.95, 21–47 years) was obtained.
The mean age was 44.1 years, and 55% were men. The most common
subtype of JME was classic JME in 75% of the cases, with myoclonus
plus generalized tonic-clonic seizures (GTCS) being the most common
seizure presentation in 70%. 55% of the patients were in monotherapy,
25% were drug-resistant, and 60% had been seizure-free for more than
five years. The presence of psychiatric comorbidity and GTCS preceded
by myoclonus have been observed as factors associated with drug resis-
tance (p < 0.05). Four patients (20%) had been tried to withdraw the
antiepileptic drugs (AEDs) at some point in their evolution; two of them
were seizure-free off AEDs, they had a mean age of 44.5 years and car-
ried an average of 5.5 years without treatment; the mean age at which
treatment was discontinued was 39 (36 and 42 years), unlike the two
patients who relapsed in whom the mean withdrawal age was 23 years.
Conclusion: JME is an epileptic syndrome with a good long-term clini-
cal prognosis. In spite of being a small sample, in our opinion our work
supports the possibility of remission off AEDs in patients with seizure
freedom maintained over time, highlighting some factors to consider
such as psychiatric comorbidity, type of seizures and age of withdrawal.
p0459
SEIZURE SEMIOLOGYVERSUS SUBJECTIVITY: A
LINGUISTIC APPROACHTOUNDERSTANDING
FOCALAWARE SEIZURES
J. Sanchez-Davies
Centre of Research in Applied Linguistics, University of
Nottingham, Nottingham, United Kingdom
Purpose: Diagnosing some types of epilepsy can be a long and difficult
process. Tests can be inconclusive and may not reveal any abnormalities
or seizure activity, meaning that the practitioner must often rely on the
patient’s articulation of the symptoms and also witness accounts. Focal
aware seizures are known for their subjective nature and their wide range
of symptoms, often making them difficult to describe. These symptoms
can easily be misinterpreted resulting in a prolonged diagnosis or even
misdiagnosis. This calls for research to investigate whether it is possible
for these types of seizures to be attributed a linguistic profile, with the
long-term goal of contributing a referential resource for both practition-
ers and patients.
Method: Using corpus linguistic methods (a computer-aided method of
linguistic analysis), this paper analyses a sample of first-person narratives
from the Epilepsy Foundation’s online forum where persons with epi-
lepsy describe their experiences of these seizures. The analysis is con-
ducted in comparison to the symptomatic description provided on the
United Kingdom’s National Health Service’s website, 0NHS Choices0, to
identify any discrepancies between the two sources.
Results: The description of focal aware seizures provided by the NHS
Choices website is a very general, symptomatic list, which describes a
‘classic’ focal aware seizure. The subjectivity and variability of these sei-
zures means that capturing their nature in a condensed, decontextualised,
and atemporal list can run the risk of neglecting important information.
However, the qualitative computer-aided analysis of the patient narra-
tives provides a richer, experience-based overview of these seizures.
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Conclusion: This paper demonstrates how patient/ practitioner commu-
nication in cases concerning focal aware seizures can be enhanced in the
long-term through linguistic research. The analysis demonstrates how the
subjective accounts offered in these online forums are an invaluable asset
which can be systematically analysed and fed back into professional
healthcare.
p0460
SEIZUREAS A STROKEMIMIC: FREQUENCY,
CHARACTERISTICS ANDRESULTSOF
NEUROIMAGING
S.J. Kim, J.H. Jin, D.W. Kim
Konkuk University Hospital, Seoul, Korea
Purpose: Widespread use of thrombolytic agents in acute stroke necessi-
tates the early differentiation of acute stroke from other ‘stroke mimics’.
Brain perfusion imaging is commonly used in emergency setting to eval-
uate patients presenting with stroke-like symptoms, and seizure is one of
the most commonly encountered diagnosis among the stroke mimics,
because epilepsy patients frequently show focal neurological deficits
with perfusion changes in neuroimaging. The aim of this study was to
analyze the frequency, characteristics and results radiological evalua-
tions including CT perfusion in patients with seizure who initially pre-
sented as a stroke mimic.
Methods: We retrospectively reviewed the medical records of patients
who presented to the emergency room and undertook the CT perfusion
scan under the suspicion of acute stroke between 2008 and 2016. We
studied the frequency and characteristics of patients with seizure who
presented as stroke mimic and the results of neuroimaging including CT
perfusion were further analyzed in correlation with the clinical features.
Result: Among the 4691 patients with stroke-like symptoms at the emer-
gency department, seizure was the second common diagnosis (171
patients, 4.1%) as a stroke mimics followed only by vertigo. Additional
24 patients suffered from symptomatic seizure from acute stroke. Seizure
occurred in previously diagnosed epilepsy or epileptogenic lesions in 162
patients, while nine patients suffered from acute symptomatic seizure
other than acute stroke. Thrombolytic therapy was applied in only 1
patient. CT perfusion showed increased perfusion in 14 patients,
decreased perfusion in 15 patients.
Discussion: Epilepsy is one of the common causes of stroke mimics and
its diagnosis may be complicated when the patients had no previous his-
tory of epilepsy. Because patients with epilepsy may show changes in
perfusion imaging, careful interpretation of results of neuroimaging is
necessary for the accurate differentiation of patients with epilepsy from
stroke.
p0461
NEURONALANTIBODIES IN EPILEPSY PATIENTS
WITHREFRACTORY SEIZURES
C. Ozen Aydın*, S. Velioglu*, S. Gazioglu*, E. Tuzun†
*Karadeniz Technical University Medical Faculty, Neurology,
Trabzon, Turkey, †Research Institute of Experimental Medicine,
Neuroscience, Istanbul University, Istanbul, Turkey
Purpose: Over recent years, it has been detected that neuronal autoanti-
bodies were associated with many neurological disorders. The presence
of various autoantibodies have been discussed in autoimmune epilepsies.
Our aim was to investigate the presence of neuronal antibodies in patients
with epilepsy resistant to antiepileptic drugs (AEDs) with normal brain
Magnetic Resonance Imaging (MRI).
Method: AEDs-resistant epilepsy patients with normal brain MRI, who
followed in our epilepsy clinic between January 2015 and October 2016
were included in the study. Antibodies against GAD, VGKC, LGI1,
Caspr2, NMDAR, AMPAR and GABAR proteins were analyzed by
immunofluorescence, RIA or ELISAmethods in all serum samples.
Results: Fifty epilepsy patients, 27 (54%) were female, and 50 healty
volunteers were included in this study. The mean age of the patients was
30.54  9.41 years. The mean age at onset of seizure was
12.37  8.54 years. Thirty seven of the patients (74%) were diagnosed
focal epilepsy and 7 of them (14%) were generalized epilepsy. Other six
patients (12%) could not be classified as having either generalized or
focal epilepsy. Eight patients (16%) were positive for neuronal autoanti-
bodies. One patient had antibody against GAD and seven patients had
antibodies against VGKC-complex antigens. Depression was signifi-
cantly more frequent in the patients with VGKC complex antibodies
(p = 0.048). However, although the percentage was higher in the anti-
body-positive group, there was no significant difference between the
groups in terms of the results such as autoimmune disease, psychiatric
disease, febrile convulsion, status epilepticus.
Conclusion: Although the clinical significance of neuronal autoantibod-
ies is not fully understood, recent studies have shown that epileptic
patients with autoimmune etiology are more resistant to treatment. So,
we think that it is important to investigate autoantibodies in patients with
resistant epilepsy even if patients have normal MRI.
p0467
CLINICALCHARACTERISTICS AND SEMIOLOGICAL
FINDINGSOF PATIENTSWITH PSYCHOGENIC NON
EPILEPTIC SEIZURES (PNES)
B. Rosso, J.C. Avalos, A.G. Besocke, C. Cominotti,
M.D.C. Garcıa
Hospital Italiano Buenos Aires, Neurologia, Buenos Aires,
Argentina
Purpose: Non-epileptic events misdiagnosed as epilepsy lead to a risk of
iatrogenic morbidity increasing health costs. Among patients affected by
non epileptic events 11–46% are of psychogenic origin. The objective is
to analyze clinical characteristics of patients with PNES in our epilepsy
program using the new semiologic classification proposed by Magaudda
et al.
Method: Retrospective review of medical records of 143 patients diag-
nosed with PNES in our epilepsy monitoring unit from April 2007 to
December 2016.
Results: One hundred seventeen of 143 patients (81.8%) were female;
mean age: 33.74 years (range 18–83); 31.5% of the them had also epi-
lepsy. Duration of disorder to correct diagnosis was: 0–2 years (49%), 2–
5 (18.9%), 5–10 (11.2%), more than 10 years (21%). There were no sig-
nificant differences between patients with and without epilepsy.
Abnormal EEG was found in 44.1%. Abnormal findings (epileptiform
and non-epileptiform) were seen in 80% of the patients with both, epilep-
tic and PNES, and in 27.6% of those with only PNES.
Mean number of antiepileptic drugs (AEDs) prescribed per patient:
2.3; 32 patients (22.4%) required at least one hospitalization for PNESs.
Psychiatric comorbidity was seen in 48.3%, with no gender difference.
Following the semiological classification proposed by Maggauda,
events were classified as: hypermotor 58%; subjective symptoms 21.7%;
akinetic 14.7% and motor focal 5.6%. Hypermotor predominated in both
genders, followed by subjective symptoms in women (23.9%) and aki-
netic in men (19.2%). In patients without epilepsy was: hypermotor in
59.2%, subjective 23.5%, akinetic 11.2% and motor focal 6.1%.
Conclusion: Hypermotor semiology was the most frequent finding in
our serie, followed by subjective symptoms and akinetic events. In one
third of the patients diagnosis was delayed for more than 10 years requir-
ing at least one hospitalization, while using at least 2 AEDs in average.
Early clinical suspicion based on semiology allows to make a correct
diagnosis, reducing morbidity and health costs.
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EEG FEATURESOF TYPICALABSENCE SEIZURES IN
PATIENTSWITH IDIOPATHICGENERALIZED
EPILEPSY
D. Coskun, T. Abbaslı, D. Kinay
Okmeydanı Education and Research Hospital, Istanbul, Turkey
Purpose: We investigated EEG features of absence seizures in newly
presenting patients with idiopathic generalized epilepsy. We examined
whether the features of generalized spike and wave discharges (GSW)
during absence seizures were determined by specific factors such as epi-
lepsy syndrome, sleep and hyperventilation (HV) or intermittent photic
stimulation (IPS).
Method: Patients with typical absence seizures were studied using
video-EEG recording prior to the initiation of antiepileptic drug treat-
ment. Forty patients were classified into IGE syndromes. The impact of
level of arousal, provocation, and epilepsy syndrome on the EEG features
of typical absence seizures was evaluated.
Results: Forty patients with idiopathic generalized epilepsy with typical
absence seizures were evaluated. Childhood absence epilepsy (CAE) was
found in 12 patients, juvenile absence epilepsy (JAE) in 8, juvenile myo-
clonic epilepsy (JME) in 14 and eyelid myoclonia with absences (EMA)
in 6 patients. Polyspikes were seen only during sleep in patients with
CAE, while they were seen during wakefulness, sleep, hyperventilation
and photic stimulation in patients with JME and EMA. The duration of
ictal discharge during absence seizures was shorter in patients with JME
and EMA than in other syndromes. Polyspikes and disorganized dis-
charges were more likely to occur in patients with JME and EMA com-
pared to those with CAE and JAE. In patients with absence seizures
during photic stimulation, the number of spikes per wave was signifi-
cantly higher than that of waking, sleeping and hyperventilation. Disor-
ganized discharges were most commonly seen during sleep and during
photic stimulation. In patients with EMA, generalized discharges were
disorganized in all states.
Conclusion: EEG features of typical absence seizures are affected by
epilepsy syndrome, the level of aurosal, hyperventilation and photic stim-
ulation. JME and EMA are more frequently associated with polyspikes
and disorganization of generalized discharges.
p0470
PERFORMANCECOGNITIVE POTENTIAL P300 IN
IDIOPATHIC AND SYMPTOMATIC FORMSOF
EPILEPSY IN TASHKENT
S. Gazieva, A. Umarov, R. Azizova
Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan
Purpose: To study features of cognitive evoked potentials in symp-
tomatic and idiopathic forms of epilepsy.
Method: The research is based on data from a survey of 72 patients with
epilepsy, including 38 patients with symptomatic epilepsy (SE) and 34
patients with idiopathic epilepsy (IE). The average age of the surveyed
patients was 48.0  25.3 years. The control group consisted of 10
healthy individuals matched by age.
Results: In patients with symptomatic and idiopathic epilepsy observed
characteristic changes in parameters P300, accompanied by a gross
change in idiopathic epilepsy. This is probably due to a higher frequency
of epileptic seizures, longer duration of the disease and, consequently, a
longer taking anticonvulsants. When idiopathic and symptomatic forms
revealed the absence of inter-hemispheric asymmetry of the P300 wave
amplitude, which indicates that dysfunctional disorders. Indicators of
increased latency of P300 in symptomatic epilepsy, unlike idiopathic and
reflect slowing of cognitive processes.
Conclusion: Thus, in patients with epilepsy neuropsychological cogni-
tive evoked potentials indicators objectively reflect the status of higher
brain function in epilepsy and depend on its form.
p0476
CANWEPREDICTDRUGRESPONSE BYGLOBAL
CONNECTIVITY INNEWLYDIAGNOSED EPILEPSY?
H.C. Kim, S.E. Kim, J. Lee
Haeundae Paik Hospital, Inje University College of Medicine,
Neurology, Busan, Korea
Purpose: The aim of this study was to investigate whether global con-
nectivity could predict a response to antiepileptic drugs in patients with
newly diagnosed partial epilepsy.
Method: Fifty-three patients with newly diagnosed partial epilepsy of
unknown etiology and healthy subjects were enrolled in this study. First,
we conducted correlation analyses between the volumes of the corpus
callosum and mean diffusion measures in healthy subjects. Second, we
analyzed the differences in the volumes of the corpus callosum between
patients with epilepsy and healthy subjects. Third, we divided patients
with epilepsy into antiepileptic drug responders and drug non-responders
groups, according to their seizure controls, and evaluated the differences
in the volumes of the corpus callosum between the groups.
Results: We found that the volumes of the corpus callosum were signifi-
cantly correlated with the mean diffusion measures (fractional aniso-
tropy, r = 0.408, p = 0.0027; mean diffusivity, r = 0.403,
p = 0.0028). The volumes of the corpus callosum in patients with epi-
lepsy were significantly lower than those in normal controls
(p = 0.0001). Among epilepsy patients, the volumes of the corpus callo-
sum were significantly lower in antiepileptic drug responders compared
with non-responders (p = 0.0481), which was the only independent vari-
able for predicting antiepileptic drug response (OR = 10.07,
p = 0.0434).
Conclusion: We found that the volumes of the corpus callosum reflected
global connectivity. In addition, we demonstrated that the volumes of the
corpus callosum were different according to antiepileptic drug responses
in patients with newly diagnosed partial epilepsy, which may suggest that
global connectivity could be a biomarker for predicting responses to
antiepileptic drugs.
p0478
EFFECTSOF STATIN THERAPYONTHE
CIRCULATORYMARKERS FORVASCULARRISK IN
EPILEPSY PATIENTS
J.H. Jin, D.W. Kim
Konkuk University Hospital, Seoul, Korea
Purpose: While it is well documented that long-term therapy with
antiepileptic drugs (AEDs) leads to an increase in risk for atherosclerosis,
there has been only a few attempts to reduce the increased vascular risk
in epilepsy patients.
Method: We conducted a prospective longitudinal study to assess the
effects of HMG-CoA reductase (statin) therapy on the increased circula-
tory markers for vascular risk in epilepsy patients. We recruited adult epi-
lepsy patients with increased vascular risk such as diabetes mellitus, a
previous history of cardiovascular/cerebrovascular diseases, and high in
total cholesterol or low-density lipoprotein (LDL) cholesterol. With the
education of lifestyle modification, statin therapy was recommended to
reduce the increased vascular risk. Circulatory markers of vascular risk
were measured twice before and after a 3-month’s intervention.
Results: A total of 76 patients completed the study, and 32 of them chose
to be treated with statin.
A 3-months’ intervention with statin results in significant decreases in
homocysteine (p < 0.01) and C-reactive protein (p = 0.03) as well as
low-density lipoprotein (LDL) cholesterol (p < 0.01) and total choles-
terol (p < 0.01), while there was no significant change in lifestyle modi-
fication group.
Conclusion: There was no report of serious adverse events or seizure
aggravation related to the statin treatment. Our findings suggest that
treatment with statins would be an effective option in patients who had
increased circulatory markers of vascular risk.
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ONLINEHYDROGEN PEROXIDEMEASUREMENT
DURINGOXIDATIVE STRESSGENERATED BY
SEIZUREACTIVITYUSINGAHIGHTEMPORAL
RESOLUTION TECHNIQUE
K. Pardo-Pe~na, A. Sanchez-Lira, A. Morales-Villagran
University of Guadalajara, Cell and Molecular Biology,
Zapopan, Mexico
Purpose: The objective of this work was to detect the hydrogen peroxide
(H2O2) during oxidative stress produced by seizures using an online
technique with high a temporal resolution in rats treated with intra-ventri-
cular pilocarpine. Additionally to H2O2 measurment, the electrophysio-
logical activity was simultaneously recorded to relate changes in H2O2
concentrations during epileptiform activity.
Method: Male Wistar rats weighing 200–250 grs were used to induce
status epilepticus (SE) by pilocarpine. Rats were implanted with a guide
cannula for the pilocarpine administration in the right lateral ventricle
(2.4 mg / 2 ll); another cannula having an electrode was placed into the
hippocampus to place further a microdialysis probe to obtain the dialy-
sate and record the epileptic activity. This technique consists in mixing
the microdialysate with an enzymatic reactor that produces a fluorescent
compound. The reactor are composed by Amplex Ultra-Red which in
presence of horse radish peroxidase generates resorufin that fluoresces at
590 nm, the fluorescence intensity was measured every second with a
photomultiplier, and was proportional to the H2O2 concentration.
Results: It was possible to detect the temporal course in H2O2 concentra-
tions during pilocarpine administration and its subsequent epileptic
effects, obtaining an increase of 13.5% with respect to its baseline
observing progressive changes in epileptic behavior until the SE was
established the H2O2 concentration reached 84.6%. Regarding the elec-
trical activity, discharges characterized by spikes of large amplitude were
observed during SE, increasing from 128.5 to 1300 lV and from 1.75 to
8.5 Hz. These results are consistent with the H2O2 concentration
increased during SE.
Conclusion: These results show that with the use of this technique can
detect with an improved temporal resolution the oxidative stress that
occurs during the seizures and simultaneously relate the changes with the
electrical activity to understand better the role of H2O2 during epileptoge-
nesis.
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DIFFERENT PHYSICAL EXERCISEMODELS ALTER
THECYTOKINES LEVELS IN THEHIPPOCAMPUSOF
RATSWITHEPILEPSY
R.M. Arida*, G.M. Lopim*, F.R. Cabral†, A.A. de Almeidda*
*Physiology, Federal University of Sao Paulo, Sao Paulo,
Brazil, †Faculdade de Cie^ncias Medicas da Santa Casa de Sao
Paulo, Sao Paulo, Brazil
Purpose: The contribution of inflammatory processes in epileptogenesis
and establishment of a chronic epilepsy has been increasingly recog-
nized. Altered expression of cytokines has been observed in patients with
epilepsy and in animal models. Beneficial effects of physical exercise for
people with epilepsy have increasingly been reported. However, the
mechanisms responsible for this occurrence are not totally clear. Consid-
ering that exercise programs can attenuate neuroinflammation in neuro-
logical diseases, we evaluated the hippocampal levels of cytokines in rats
with epilepsy submitted to voluntary or forced exercise.
Method: Thirty-seven Wistar rats were divided into the following
groups: control (C; n = 9), epilepsy (E; n = 9), epilepsy voluntary exer-
cise (EV; n = 10) and epilepsy forced exercise (EF; n = 9). Exercise
groups were submitted to wheel (EV) or treadmill (EF) running during 30
consecutive days. Twenty-four hours after the last exercise session, rats
were decapitated, hippocampi dissected and pro (IL-1b, IL-6 and TNFa)
and anti (IL-4 and IL-10) inflammatory cytokines were quantified by
multiplex microbead immunoassay. Non-parametric tests were used by
compare the results.
Results: IL-1b levels increased in E group when compared to C group
(p < 0.05) and both exercise models (EV and EF) reduced IL-1b levels
compared to C and E groups (p < 0.05). IL-1b/IL10 ratio increased in E
group when compared to C group and both exercise models reduced this
ratio to C levels (p < 0.05). Thus, forced exercise (EF) reduced IL-1b/
IL10 ratio compared to E group. Reduced IL-6 levels were observed in
EF group compared to C and E groups (p < 0.01). Increased TNFa/IL-10
ratio was observed in EF group compared to C and E groups (p < 0.01).
No significant alterations were observed in IL-4, IL-10 and TNFa levels
between groups (p > 0.05).
Conclusion: Our findings suggest that voluntary and forced exercise can
attenuate neuroinflammation in rats with epilepsy.
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THE EFFECTOFCANNABIDIOL (CBD) ONHUMAN
CNS-EXPRESSEDVOLTAGE-GATED SODIUM
CHANNELS
C.E. Roberts, R.A. Gray, C.G. Stott, N.A. Jones, S. Wright
GW Research, Ltd, Cambridge, United Kingdom
Purpose: The anticonvulsant mechanism of action of CBD has not been
fully elucidated and a systematic examination of the effect of CBD on
human voltage gated sodium channel (Nav) function has yet to be
described. The purpose of this study was to determine the effect of physi-
ologically relevant concentrations of CBD on CNS-expressed human
voltage-gated sodium channel (Nav) function.
Method: Human recombinant Nav channel-expressing HEK-293 cells
were cultured in standard conditions. Functional selectivity was tested
using a pulse train protocol to examine use-dependent block by auto-
mated patch clamp electrophysiology (IonWorks). Tetracaine, a non-
selective use-dependent Nav channel blocker was used as a positive con-
trol. Concentration response curves for CBD (0.6 nM - 33 lM) were
constructed describing inhibition of 1st and final pulse of each train. Data
were analyzed using IonWork’s Quattro and GraphPad Prism software
and fitted to a 4-parameter logistic equation for the determination of
IC50.
Results: CBD inhibited the peak transient sodium current with an
IC50 > 33 lM for all Nav subtypes tested (human Nav 1.1, 1.2, 1.3, 1.6
and 1.7). The positive control Nav channel inhibitor tetracaine inhibited
all Nav subtype currents elicited by sequential depolarizing pulses in a
concentration and use-dependent fashion. In contrast, no such inhibition
was observed in the presence of 0.6 nM to 33 lM CBD at Nav 1.1, 1.2,
1.3, 1.6 and 1.7.
Conclusion: The data presented confirm that CBD does not inhibit peak
transient current of wild-type CNS-expressed human Nav channels at
physiologically relevant concentrations. Previously, the anti-epileptiform
activity of CBD at ≥10 nM was demonstrated using classic in vitro mod-
els of epileptiform activity. Thus, the mechanism by which CBD is able
to confer its anti-convulsant activity is unlikely to be mediated by inhibi-
tion of peak transient voltage-gated sodium channel current.
(Funded by GWResearch, Ltd).
p0484
AN INTEGRATIVEANALYSIS OFGENOME-WIDE
PROFILINGOFDNAMETHYLATIONANDGENE
EXPRESSION IN FOCALCORTICALDYSPLASIA
D. Sharma*, A. Dixit†, J. Banerjee†, M. Tripathi*,
P.S. Chandra*
*All India Institute of Medical Sciences, New Delhi, India,
†National Brain Research Center, Gurgaon, India
Purpose: In an attempt to decipher the molecular basis of the pathologic
modifications in neuronal circuits in Epilepsy, studies have revealed a
remarkably diverse pattern of gene expression resulting from epigenetic
changes. DNA methylation is a pertinent type of epigenetic modification
which influences brain development, function, and aging. Here Microar-
ray profiling of methylated DNA and RNA sequencing have been used to
investigate gene expression in the human tissue samples of Focal Cortical
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Dysplasia (FCD), with the aim of identifying functional pathways which
are significantly activated or repressed during epileptogenesis.
Method: Methylated DNAwas immunoprecipitated using anti-5-methyl
cytidine antibody from surgically resected tissues of FCD patients and
controls from Autopsy. Whole Genome Amplification and Microarray
Hybridization was then carried out using Agilent ChIP on ChIP kit
G4495A. RNA sequencing was performed using standard protocols on
Illumina HiSeq 2500 platform. Differential gene expression analysis was
done using Cuffdiff. Gene Spring Software was used for quantification of
methylation and its co-relation with RNA Sequencing data. qPCR was
used for validation of the gene expression.
Results: A total of 918 genes were identified to be differentially
expressed, whose gene expression directly correlated with methylation
status. Out of these, 604 genes were hypermethylated and their gene
expression depressed. 314 genes were overexpressed and hypomethy-
lated. 176 of these genes were present in the promoter region. Gene
Ontology and pathways analysis revealed important pathways like PDGF
signaling, mTOR pathway among others, involving aberrantly expressed
genes. Gene expression of 9 of these genes was further validated by
qPCR. Our results showed significant alteration in BRCA1, EGFR,
RPS6KA3, PRKAA1.
Conclusion: These may prove to be potential prognostic and diagnostic
biomarkers in FCD. Hence a better understanding of the mechanism may
provide new avenues for therapeutic intervention.
p0488
POST-STATUS EPILEPTICUS BEHAVIORAL
ALTERATIONS IN RATS: ASSOCIATIONWITH
CHRONIC EPILEPSYANDMODULATION BY
ENDOCANNABINOID RECEPTORACTIVATION
E.M. Suleymanova*, M.A. Borisova†, L.V. Vinogradova*
*Institute of Higher Nervous Activity and Neurophysiology RAS,
Moscow, Russian Federation, †Lomonosov Moscow State
University, Moscow, Russian Federation
Purpose: Temporal lobe epilepsy (TLE) is associated with behavioral
disorders and cognitive deficit. Lithium-pilocarpine model in rodents
reproduces many features of human status epilepticus (SE) and subse-
quent TLE. In this model, behavioral abnormalities could be conse-
quences of either developed chronic epilepsy or SE-induced damage.
Our purpose was to investigate behavior in rats developing spontaneous
seizures and in seizure-free rats 5 months after SE.
Method: The study was carried out on the lithium-pilocarpine model of
SE. SE continued for 90 min and was terminated by pentobarbital; 4 h
after SE rats were treated with endocannabinoid receptor agonist WIN-
55,212-2 or vehicle. 5 months after SE rats were videomonitored for
spontaneous seizures; then behavioral tests were performed: elevated
plus-maze, light-dark box, open field test, andMorris water maze.
Results: Five months after SE, 54% of rats developed spontaneous sei-
zures, the rest were seizure-free. Presence of spontaneous seizures corre-
lated with hyperactivity in the open field: rats with seizures were
hyperactive while no difference was found between seizure-free animals
and controls. No signs of anxiety-like behavior were found in rats experi-
enced SE, but they spent more time in the open arms of the plus-maze,
the light compartment of the light-dark box, and the center of the open
field arena in comparison with controls (no SE). Morris water maze test
showed that rats after SE had severely impaired spatial memory, irrespec-
tively of spontaneous seizure development. Administration of endo-
cannabinoid receptor agonist early after SE did not prevent seizure
development, but reduced behavioral impairment in the elevated plus-
maze but not in the other tests.
Conclusion: Different behavioral impairments found in the chronic per-
iod after SE can result from the initial impact of SE or accompany the
development of epilepsy, suggesting that different mechanisms can
underlie even seemingly close types of behavioral comorbidities.
p0492
MULTIFACETEDROLEOF INTERICTAL
DISCHARGES IN ICTOGENESIS
W.-C. Chang*, J. Hlinka†, J. Kudlacek‡, J. Otahal‡, J. Chvojka‡,
M. Palus†, V. Kumpost‡, J. Jefferys§, P. Jiruska‡
*Faculty of Veterinary Medicine, University of Helsinki,
Helsinki, Finland, †Department of Nonlinear Dynamics and
Complex Systems, Institute of Computer Science, The Czech
Academy of Sciences, Prague, Czech Republic, ‡Department of
Developmental Epileptology, Institute of Physiology, Academy
of Sciences of Czech Republic, Prague, Czech Republic,
§Department of Pharmacology, University of Oxford, Oxford,
United Kingdom
Purpose: Interictal epileptiform discharges (IEDs) display multiple roles
in ictogenesis. It has been demonstrated that IEDs can have either pro-
ictogenic or anti-ictogenic effects, while certain studies claim that IEDs
do not interfere with the transition to seizure. In this study, we have
explored the multifaceted role of IEDs from a dynamical perspective.
Method: The experiments were performed in vitro in intact hippocampal
and isolated CA1 slices perfused with artificial CSF containing high
potassium (>8 mM). Field potentials from the hippocampal CA1 and
CA3 regions were recorded using extracellular electrodes.
Results: In both preparations, seizures originated in the CA1 region. In
isolated CA1slices, the duration of inter-seizure period was 50.3  2.4 s
and the seizure onset pattern was characterized by the slow spread of ictal
activity to adjacent electrodes (639.3  63.2 ms). In intact slices, the
presence of IEDs was associated with a prolonged inter-seizure period
(69.8  2.1 s) and with hypersynchronous seizure onset across the entire
CA1 area due to an incoming IED (10.4  2.1 ms). To evaluate the rela-
tionship between IEDs and the dynamical state of the CA1 network, we
have estimated the resilience of the CA1 region from the parameters of
high-frequency activity. The results showed that pro-ictogenic effect of
IEDs occurred during the dynamical state characterized by low resili-
ence.
Conclusion: This study suggests that the pro- or anti-ictogenic effect of
IEDs does not have to be determined exclusively by the existence of
specific cellular mechanisms. The effect of IEDs can be defined by the
dynamical state of the seizure-generating network at the moment of the
discharge occurrence. If the CA1 network displays low resilience to per-
turbations, then the originally anti-ictogenic IEDs develop a capacity to
shift the dynamics of the CA1 network into the ictal regime.
This study was supported by GACR 14-02634S, AZV 15-29835A and
Epilpesy Research UK grants.
p0493
INHIBITIONOFMTORPATHWAYBYRAPAMYCIN
DECREASES P-GLYCOPROTEIN EXPRESSIONAND
SPONTANEOUS SEIZURES IN PHARMACORESISTANT
EPILEPSY
X. Chi*, Li. R†, H. Cheng*, W. Wang*, D. Zhou*
*Department of Neurology, West China Hospital, Sichuan
University, Chengdu, China, †Key Lab of Transplant
Engineering and Immunology, MOH, West China Hospital,
Sichuan University, Chengdu, China
Purpose: The mammalian target of rapamycin (mTOR) has been
demonstrated to mediate multidrug resistance in various tumors by
inducing P-glycoprotein (P-gp) overexpression (Potschka, 2010). Here,
we investigated the correlation between the mTOR pathway and P-gp
expression in pharmacoresistant epilepsy.
Method: Temporal cortex specimens were obtained from patients with
refractory mesial temporal lobe epilepsy (mTLE) and age-matched con-
trols who underwent surgeries at West China Hospital of Sichuan Univer-
sity between June 2014 and May 2015. We established a rat model of
epilepsy kindled by coriaria lactone (CL) and screened pharmacoresistant
rats (non-responders) using phenytoin. Non-responders were treated for
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4 weeks with vehicle only or with the mTOR pathway inhibitor rapamy-
cin at doses of 1, 3, and 6 mg/kg.. Western blotting and immunohisto-
chemistry were used to detect the expression of phospho-S6 (P-S6) and
P-gp at different time points (1 h, 8 h, 1 d, 3 d, 1 w, 2 w and 4 w) after the
onset of treatment.
Results: Overexpression of P-S6 and P-gp was detected in both refrac-
tory mTLE patients and non-responders rats. Rapamycin showed an inhi-
bitory effect on P-S6 and P-gp expression 1 week after treatment in rats.
In addition, the expression levels of P-S6 and P-gp in the 6 mg/kg group
were significantly lower than those in the 1 mg/kg or the 3 mg/kg group
at the same time points (all p < 0.05).Moreover, rapamycin decreased
the duration and number of CL-induced seizures, as well as the stage of
non-responders (all p < 0.05).
Conclusion: The current study indicates that the mTOR signaling path-
way plays a critical role in P-gp expression in drug-resistant epilepsy.
Inhibition of the mTOR pathway by rapamycin may be a potential thera-
peutic approach for pharmacoresistant epilepsy.
p0494
RAPID FOCALCOOLINGTERMINATES CORTICAL
EPILEPSYONMONKEYS
G. Ren*,†, J. Yan‡, G. Tao§, Y. Gan§, D. Li*,†, X. Yan*,†, Y. Fu*,
W. Wang*, L.W. Wang*, G. Zhang*, F. Yue§, X. Yang*,†
*Xuanwu Hospital, Capital Medical University, Beijing, China,
†Beijing Institute for Brain Disorders, Beijing, China, ‡North
China University of Technology, Beijing, China, §Wincon
TheraCells Biotechnologies Co., Ltd, Nanning, China
Purpose: Rapid focal cooling is an attractive nondestructive strategy to
terminate and possibly prevent focal seizures. However, the temperature
threshold necessary to abort seizures in primates is still unknown. Here,
we explored this issue in a primate epilepsy model and observed the
effect of rapid cooling on different electroencephalogram frequency
bands, aiming at providing necessary experimental data for future clinical
translational studies and exploring the mechanism of focal cooling in ter-
minating seizures.
Method: We induced focal neocortical seizures using microinjection of
4-aminopyridine into premotor cortex in five anesthetized cynomolgus
monkeys. The rapid focal cooling was implemented by using a thermo-
electric (Peltier) device.
Results: As a result, the average durations of seizures and interictal inter-
vals before cooling were 94.3  4.0 seconds and 62.3  6.9 seconds,
respectively. When the cortex was cooled to 20 °C or 18 °C, there was no
effect on seizure duration (109.4  30.0 seconds, 91.3  19.3 seconds)
or interictal duration (99.4  26.8 seconds, 83.2  11.5 seconds,
p > 0.05). But when the cortex was cooled to 16 °C, the seizure duration
was reduced to 54.1  4.9 seconds and the interictal duration was
extended to 175.0  16.7 seconds (p < 0.05). Electroencephalogram
spectral analysis showed that the power of delta, alpha, beta, gamma and
ripples bands in seizures were significantly reduced at 20 °C and 18 °C.
At 16 °C, the power of theta band in seizures was also significantly
reduced along with the other bands.
Conclusion: Our data reveal that the temperature threshold in rapid focal
cooling required to significantly shorten neocortical seizures in nonhu-
man primates is 16 °C, and inhibition of electroencephalogram broad-
band spectrum power, especially power of theta band, may be the
underlying mechanism to terminate seizures.
p0496
EVALUATIONOFTHEVARIATIONS IN REST/NRSF
EXPRESSION IN PATIENTSWITHTEMPORAL LOBE
EPILEPSY
V. Navarrete-Modesto*,†, I.A. Feria Romero*, S.A. Orozco-
Suarez*, M.A. Alonso-Vanegas‡, L. Rocha†
*S. XXI National Medical Center, Unit for Medical Research in
Neurological Diseases, Mexico City, Mexico, †Center for
Research and Advanced Studies of the National Polytechnic
Institute (CINVESTAV), Department of Pharmacobiology,
Mexico City, Mexico, ‡National Institute of Neurology and
Neurosurgery ‘Manuel Velasco Suarez’, Epilepsy Clinic, Mexico
City, Mexico
Purpose: The aim of this study was to evaluate the variations in the
expression of REST/NRSF in hippocampus of patients with pharmacore-
sistant Mesial Temporal Lobe Epilepsy (MTLE) and investigate if clini-
cal variables, like age, gender, treatments, etc., are associated with the
results obtained.
Method: Hippocampal tissue was used from patients (n = 28) with tem-
poral lobe epilepsy and as a control, autopsy hippocampus was used
(n = 7). The expression of REST/NRSF at the transcriptional (RNA) and
translational level (protein) was evaluated by real-time PCR and western
blot respectively. Finally, we evaluated the correlation with clinical vari-
ables.
Results: The results show that expression of mRNA of REST/NRSF in
hippocampus of patients with MTLE increasing 141.63% and protein
levels increasing 181.2%, both compared to autopsy tissue (p < 0.05).
However, this increase in protein was not general, a group of patients did
not show changes with respect to autopsy levels. Overexpression of
mRNA and protein of this factor did not correlate with clinical data,
except with the drugs administered prior to surgery, where valproic acid
(VPA), clonazepam (CNZ), levetiracetam (LVT) and topiramate (TPM)
may regulate the expression of REST/NRSF at the transcriptional level.
Conclusion: We conclude that in patients with TLE, REST/NRSF is
overexpressed both at the transcriptional and translational level, regard-
less of the clinical variables, but treatment with VPA, CNZ, TPM and
LVTmodify the genic overexpression.
p0497
BEHAVIORAL, EEGRAPHIC ANDCHEMICAL
CHARACTERIZATIONOF THEANTICONVULSANT
EFFECTSOF THE PREDATORODOR (TMT) IN THE
FAST ELECTRICALKINDLINGMODELOF
TEMPORAL LOBE SEIZURES
N. Garcia-Cairasco*,†, P. Delfino Pereira†, P. Bertti†,
F.L. Primo‡, C.F. Amantino‡, J.A. Cortes de Oliveira*,
D. Cestari§, D. Medeiros¶, M.F. Dutra Moraes¶, E. Mendes**,
J. Rosa§, A.C. Tedesco‡, N. Peporine Lopes††
*FMRP-USP, Physiology, Ribeir~ao Preto, Brazil, †FMRP-USP,
Neuroscience/Behavioral Sciences, Ribeir~ao Preto, Brazil,
‡Faculty of Philosophy and Letters - University of S~ao Paulo,
Chemistry, Ribeir~ao Preto, Brazil, §Institute of Mathematics and
Computer Sciences - University of S~ao Paulo, Computer
Science, S~ao Carlos, Brazil, ¶Biological Sciences Institute -
Federal University of Minas Gearais, Physiology and
Pharmacology, Belo Horizonte, Brazil, **Federal University of
Minas Gerais, Electronic Engineering, Belo Horizonte, Brazil,
††Pharmaceutical Sciences - University of S~ao Paulo, Physic
and Chemistry, Ribeir~ao Preto, Brazil
Purpose: Fast amygdala kindling (FAK) models temporal lobe epilepsy
(TLE). Clinical and experimental evidences indicate olfactory modula-
tion of TLE seizures. Our hypothesis is that 2,5-dihydro-2,4,5-tri-
methylthiazoline (TMT) induces fear and influences TLE seizures. We
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aimed to detect TMT behavioral response of fear, to standardize TMT
(time/concentration in the chamber), and to evaluate behavioral and elec-
troencephalographic (EEG) effects on FAK inWistar rats.
Method: Chemical and behavioral responses to different concentrations
of TMT (or nanoemulsion) were evaluated in male Wistar rats. Another
group was submitted to electrical stimulation (FAK protocol), 10 daily
electrical stimulations, two days and, at 21st stimulus (third day) testing
TMT anticonvulsant activity. Behavior was analyzed with seizure sever-
ity index (SSI) and neuroethology. EEG spectral analysis (Fast Fourier
Transform, FFT) compared afterdischarges in TMT/control groups at
21st stimulus mean EEG frequency/peak power/frequency at the peak
power/total power in amygdala (A), hippocampus (HIP), piriform cortex
(PC). EEG basal/seizure periods were analyzed by power spectrum den-
sity and total coherence at 20th and 21st stimuli.
Results: TMT nanoemulsion induced significant reduction of behavioral
activity, compared to vehicle. TMT triggered fear reactions and reduced
motor activity/grooming behavior. Gas chromatography detected cham-
ber concentrations/time for homogeneous saturation (30 minutes), desat-
uration. Pure TMT in FAK significantly reduced behavioral seizures (SSI
and sequences). FFT EEG analysis (21st stimulus) showed that TMT
altered significantly the mean frequency/peak power in (A) in all fre-
quencies, except gamma (p < 0.05; Mann-Whitney-U test). Average fre-
quency (whole spectrum) in PC, also differed between groups (p < 0.05;
Mann-Whitney-U test). TMT (21st stimulus) reduced coherence value
between PC and HIP on basal period and decreased the HIP power den-
sity on seizure period (20th versus 21st stimulus; p < 0.05; paired T-Stu-
dent test).
Conclusion: Chemical/behavioral/EEG data confirm that TMT-induced
fear has potent anticonvulsant effects in FAKmodel.
Funding: Brazilian Research Foundations: FAPESP, CNPq, PROEX-
CAPES and FAEPAGrants.
p0498
PHARMACOLOGICAL CHARACTERIZATIONOF
HAMSTERGASH:SAL. CHRONIC EFFECTSOF
ANTIEPILEPTIC DRUGS IN THEGENETIC
AUDIOGENIC SEIZURE
C. Sancho*,†, B. Barrera*, J.A. Cortes de Oliveira‡,
M.J. Sanchez-Ledesma§, J. Goncalves†, S. Hernandez-
Noriega*,¶, N. Garcia-Cairasco‡, D.E. Lopez*,**
*Institute of Neuroscience of Castilla y Leon / Institute of
Biomedical Research of Salamanca, University of Salamanca,
Salamanca, Spain, †Faculty of Medicine, Department of
Physiology and Pharmacology, University of Salamanca,
Salamanca, Spain, ‡Neurophysiology and Experimental
Neuroethology Laboratory, Ribeir~ao Preto Medical School,
University of S~ao Paulo, S~ao Paulo, Brazil, §Department of
Surgery, University of Salamanca, Salamanca, Spain,
¶Department of Physiology and Pharmacology, University of
Salamanca, Salamanca, Spain, **Department of Cell Biology
and Pathology, University of Salamanca, Salamanca, Spain
Purpose: The study investigate the anticonvulsant, and potential
antiepileptic effects of different antiepileptic drugs (AED) in seizures of
the GASH:Sal hamster, an animal model of genetic audiogenic seizure
that is in the process of validation. The strain GASH:Sal is a rodent model
that exhibits generalized tonic-clonic seizures of genetic origin in
response to sound stimulation.
Method: We assess the anticonvulsant activity of five AED: Phenobar-
bital (PB), Valproic acid (VPA), Levetiracetam (LEV), Lamotrigine
(LTG) and Retigabine (RTG). The purpose of this study is also to charac-
terize the possible antiepileptic action of AEDs following chronic admin-
istration in the hamster.
We used male GASH:Sal hamsters two months old, 5 for each drug
and 6 animals untreated for the control group. The AEDs were adminis-
tered 30 days in the drinking water. The initial dose of the drugs was cal-
culated from the ED50 determined in our model, and was increased every
two weeks, according to the response of the animals (PB: 20–60 mg/kg/
day; VPA: 150–600 mg/kg/day; LEV: 50–150 mg/kg/day; LTG: 20–
25 mg/kg/day; RTG: 6–12 mg/kg/day).
Before starting pharmacological treatment, all animals were stimu-
lated once (0–18 kHz; 115–120 dB) to observe the crisis without influ-
ence of the AEDs; then, the audiogenic seizures were recorded every
week to see the effect of the AEDs.
Results: Drugs that have shown antiepileptic effect after chronic oral
administration have been PB and LTG.
Conclusion: We can conclude that GASH:Sal is a good model of epi-
lepsy, which will allow a pharmacological study closer to its use in
humans.
Acknowledgements: This study has been sponsored by USAL-USP,
Program for the Promotion of the Bilateral Cooperation in the Field of
Research (#2011–6; #2011.1.23386.1.3) and University of Salamanca
Support Grant for the GIRs 2017 (IP-D.Lopez)
p0499
PHOTOLYSIS OF RUBI-GABARAPIDLY TERMINATES
SEIZURES IN VIVO: DOSE- AND LIGHT INTENSITY-
DEPENDENCE
D. Wang*,†, Z. Yu*,†, J. Yan‡, F. Xu§, G. Ren*,†, C. Jiang*,†,
W. Wang*, Y. Piao*, X. Yang*,†
*Xuanwu Hospital, Capital Medical University, Beijing, China,
†Beijing Institute for Brain Disorders, Beijing, China, ‡North
China University of Technology, Beijing, China, §Core Facilities
Center, Capital Medical University, Beijing, China
Purpose: Our previous experimental results have demonstrated that the
use of blue light produced by light emitting diode (LED) to uncage ruthe-
nium-bipyridine-triphenylphosphine-c-aminobutyric acid (RuBi-GABA)
can rapidly terminate paroxysmal seizure activity both in vitro and
in vivo. However, the optimal concentration of RuBi-GABA, and the
intensity of illumination to abort seizures, remains unknown. This study
aimed to explore the optimal anti-epileptic effects of RuBi-GABA.
Method: Focal neocortical seizures of anesthetized rats were induced by
microinjection of 4-aminopyridine (4-AP) into the motor cortex.We then
investigated the effects of different combinations of RuBi-GABA con-
centrations and light intensity upon epilepsy by using implantable fibers
to introduce blue light into the neocortex of a 4-aminopyridine (4-AP)-
induced acute seizure rat model in rat.
Results: We first tested the combination of 0.1 mM RuBi-GABA with
15 mW and 20 mW of illumination (30 s). Under these conditions, sei-
zure duration was 61.56  3.57 s and 69.64  10.48 s respectively;
there was no significant difference when compared to the control group
(p = 0.905 and p = 0.585). However, when the concentration of RuBi-
GABA was increased to 0.2 mM with 10 mW and 15 mW of light inten-
sity, the seizure duration was significantly reduced to 25.31  6.05 s and
15.13  7.20 s, respectively. Compared with the control group, these
reductions were statistically significant.
Conclusion: Our results show that the anti-epileptic effect of RuBi-
GABA has obvious RuBi-GABA concentration and light intensity depen-
dence. These results provide important experimental data for future clini-
cal translational studies.
S92
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
p0502
DIFFERENTMOSSY FIBER SPROUTING PATTERNS IN
ILAEHIPPOCAMPAL SCLEROSIS TYPES
B. Schmeiser*, J. Li†, A. Brandt‡, J. Zentner*, S. Doostkam§,
T. Freiman¶
*Albert-Ludwigs-University/Medical Center, Neurosurgery,
Freiburg im Breisgau, Germany, †Friedrich-Alexander-
University, Neuropathology, Erlangen, Germany, ‡Albert-
Ludwigs-University/Medical Center, Epileptology, Freiburg im
Breisgau, Germany, §Albert-Ludwigs-University/Medical
Center, Neuropathology, Freiburg im Breisgau, Germany,
¶Goethe-University/University Hospital, Neurosurgery,
Frankfurt amMain, Germany
Purpose: Hippocampal sclerosis (HS) is the most prevalent pathology in
temporal lobe epilepsy (TLE) and characterized by segmental pyramidal
cell loss in the cornu ammonis (CA) 1–4. Migration of granule cells and
reorganization of their axons, is observed; known as granule cell disper-
sion (GCD) and the mossy fiber sprouting (MFS), respectively. The loss
of target cells in CA4 and CA3 was considered to be causative for MFS.
The ILAE (International League Against Epilepsy) classification of HS
identifies three subtypes with different cell loss patterns in CA1-4. We
studied the correlation of ILAE HS subtypes with GCD, MFS in a large
retrospective single-center series.
Method: Hippocampal specimen of 319 patients were screened, 214
could be analyzed. Immunohistochemistry for semi-quantitative analysis
of neuronal cell loss (NeuN) and mossy fiber sprouting (synaptoporin)
were used. Presurgical data and seizure outcome was studied and classi-
fied according to Engel score Ia-IV three, 12 and 24 months after sur-
gery.
Results: In 39 patients (18%) no neuronal cell loss (ILAE no-HS), no
GCD and no MFS was observed. In 154 patients (72%) severe neuronal
cell loss was seen in CA1, CA4 and CA3 (ILAE HS 1, typical HS); in
addition extensive GCD and MFS was observed. In 17 patients (8%). cell
loss, predominantly in CA1, was seen (ILAE HS 2), despite the different
cell loss pattern, these hippocampi showed also GCD and MFS. In 4
patients (2%) cell loss was seen predominately in CA3 and CA4 (ILAE
HS type 3), consecutively GCD and MFS were observed. However, there
was no significant correlation of ILAE HS subtypes, patterns of GCD or
MFS, with clinical histories; including age at seizure onset, duration of
epilepsy before surgery, nor with long-term post-surgical outcome.
Conclusion: Granule cell dispersion and mossy fiber sprouting might
develop independently from loss of neuronal target cells.
p0504
ANXIETYAND SLEEPDISTURBANCES ARE
ASSOCIATEDWITH SUBCLINICAL SEIZURES IN
ACUTE POSTTRAUMATIC PERIOD IN RATS
I. Komoltsev*, I. Kershner†, I. Levshina*, A. Manolova*,
M. Novikova*, M. Stepanichev*, Y. Obukhov†, N. Gulyaeva*
*Institute of Higher Nervous Activity and Neurophysiology,
Russian Academy of Sciences, Moscow, Russian Federation,
†Kotel’nikov Institute of Radio Engineering and Electronics,
Russian Academy of Sciences, Moscow, Russian Federation
Purpose: To evaluate behavioral and electrophysiological consequences
of traumatic brain injury (TBI) with its morphological substrates at the
early period of trauma, which may be involved in development of post-
traumatic epilepsy with its comorbidity.
Method: We used lateral fluid percussion model (3–4 atm) in adult male
Sprague-Dawley andWistar rats. Immediately after TBI tonic-clonic sei-
zures occurred. To estimate the time course of epileptiform discharges
during wake-sleep cycle and global brain function video-electrocortico-
grams (VECoG) were recorded prior TBI and during acute posttraumatic
period - first week after injury. To find epileptiform discharges we devel-
oped and used an automatic detection algorithm of EEG events with high
value of power spectral density based on wavelet transform. To evaluate
symptoms of depression and anxiety light-dark box and elevated plus-
maze tests were used. To assess brain damage morphological analysis
was performed one week after TBI.
Results: During acute posttraumatic period rats demonstrate symptoms
of anxiety and depression associated with reduced percentage of REM-
sleep, its decreased frequency and amplitude High voltage rhythmic
spikes (HVRS) were detected in background records and after TBI, par-
ticularly during the early stage of NREM sleep in several, but not all ani-
mals. After TBI, the number of HVRS increased particularly during
wakefulness. Histological studies revealed the presence of cortical dam-
age to the ipsilateral hemisphere and to the hippocampus.
Conclusion: So, we at the first time showed anxiety behavior, sleep dis-
turbances accompanying HVRS, which represents a subclinical epilepti-
form activity, with its morphological substrates in acute period after
TBI.Supported by RSF grant # 16-11-10258.
p0507
POLYSOMNOGRAPHIC SLEEP CHARACTERISTICS
OF THE PSYCHOGENIC NON-EPILEPTIC SEIZURES
H. Yilmaz, M. Batum, A. Kisabay Ak, M. Akgul
Celal Bayar University, School of Medicine, Neurology, Manisa,
Turkey
Purpose: Psychogenic non-epileptic seizures (PNES) are events resem-
bling an epileptic seizure, but without the characteristic electrical dis-
charges associated with epilepsy. They are one type of non-epileptic
seizures. They are a manifestation of psychological distress. Frequently,
patients with PNESmay look like they are experiencing generalized con-
vulsions similar to tonic clonic seizures with falling and shaking. Less
frequently, PNES may mimic absence seizures or complex partial sei-
zures with temporary loss of attention or staring. Little is known about
the sleep characteristics (macrostructure andmicrostructure) of the PNES
and we here aimed to describe the polysomnographic sleep characteris-
tics in PNES.
Method: We analyzed video EEG-polysomnographic recordings of 23
patients (9 male and 14 female; mean age: 25  8 years) with a diagno-
sis of PNES and 25 control cases. Conventional sleep measures (total
sleep time, sleep latency, non-rapid eye movement (NREM) and REM
sleep, light sleep (N1 + N2), slow wave sleep (N3), latancies of each
sleep cycle) were assessed and compared with control group.
Results: Compared to controls, patients with PNES showed that short-
ened REM onset latency, increased REM density, increased percentage
of REM sleep, reduced sleep efficiency, increased awakenings, and
decreased slowwave sleep.
Conclusion: The relationship between PNES and sleep is sparse in the
currently available literature. Patients with PNES may have a number of
psychiatric diagnoses. Our results are similar to sleep characteristics of
the maj€or depression. We believe that the detailed clinical and video
EEG PSG characteristics of the patients with PNES represents a better
understanding of the pathogenic mechanisms and different clinical out-
comes of the PNES.
p0508
ROLEOFQUANTITATIVE EEGTO IDENTIFY
NONEPILEPTIC EVENTS ATTHEBEDSIDE
A. Goenka, E. Yozawitz
Montefiore Medical Centre, Bronx, NY, United States
Purpose: To evaluate the sensitivity and specificity of quantitative EEG
(QEEG) seizure detection trend, and analyses of four spectrograms
(asymmetry relative spectrogram, FFT spectrogram, rhythmicity spectro-
gram, and amplitude EEG), for detecting nonepileptic events.
Method: Hypermotor events captured during EEG monitoring, for thirty
adult patients (ages 25–60 years) admitted to Montefiore Medical Centre
and associated hospitals from July 2016 to January 2017, were retrospec-
tively assessed using a QEEG seizure detection trend and specific spec-
trograms. Assessment of raw EEG was employed as the gold standard
against which to validate epileptic and nonepileptic events. All EEGs
were interpreted by an epileptologist trained in evaluation of QEEG.
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Seventeen patients with nonepileptic events were compared to a control
group of thirteen patients with epileptic seizures of similar semiology.
Results: Eighty two hypermotor events (46 nonepileptic, 36 epileptic)
were captured across a duration of 540 hours. QEEG analysis seizure
detection trend detected nonepileptic events with a sensitivity of 71%
(p = 0.01) and a specificity of 80%.The asymmetry relative spectrogram,
FFT spectrogram, rhythmicity spectrogram, and amplitude EEG yielded
detection sensitivities of 47% (p = 0.47), 65% (p = 0.09), 60%
(p = 0.10), and 58% (p = 0.14) for nonepileptic events. Their specifici-
ties were 69%, 69%, 75%, and 75% respectively.
Conclusion: High sensitivities and specificities for QEEG seizure detec-
tion analyses in detecting nonepileptic events suggest greater utility for
its clinical application. QEEG may be employed at bedside to facilitate
early identification of nonepileptic events in order to avoid unnecessary
administration of antiepileptic drugs (AEDs) and possible iatrogenic con-
sequences.
p0509
COMPARING SENSITIVITYOFQUANTITATIVE EEG
(QEEG) SPECTROGRAMS INVARIOUS SEIZURE
SUBTYPES
A. Goenka, E. Yozawitz
Montefiore Medical Centre, Bronx, NY, United States
Purpose: To compare the sensitivity of Quantitative EEG various spec-
trograms (Asymmetry relative spectrogram, FFT spectrogram, Rhyth-
micity spectrogram, amplitude EEG {aEEG} and seizure detection
trend) to detect various seizures subtypes (focal seizure, focal with sec-
ondary generalization, and generalized seizure).
Method: A total of 548 seizures, 348 hours of EEG, amongst a cohort of
58 patients were analyzed. The seizures were evaluated in 3 separate
groups (20 patients each in the focal seizure and focal with secondary
generalization group and 18 in the generalized seizure group). A seizure
pattern was identified in the QEEG based on the raw EEG, following
which seizures were identified using the QEEG spectrogram in a six hour
EEG epoch. The raw EEGs were reviewed by separate epileptologists
and were considered the gold standard for seizure identification. The sen-
sitivity of the analysis using each spectrogram was determined for each
seizure type.
Results: The overall sensitivity for seizure identification in QEEG var-
ied from 60- 73%, with highest sensitivity (73%) by the seizure detection
trend. However, in the focal seizure group, the asymmetry spectrogram
has significant higher sensitivity compared to the seizure detection trend,
93% vs. 69%, p value <0.0001, 95%confidence interval0.029 to 0.139.
Similarly, in the focal with secondary generalization group, FFT spectro-
gram sensitivity as compared to seizures detection trendwas 91% vs.
68%, p value < 0.0001, 95%confidence interval 0.332 to 0.647. In the
generalized seizure group, seizure detection trend has the highest sensi-
tivity of 78%.
Conclusion: Our study concludes that different seizures types have
specific patterns in the quantitative EEG, which can be diagnosed by
specific spectrograms. Identifying these patterns in the QEEG can signif-
icantly increase the sensitivity for seizure identification.
p0510
INTERICTALVERY FASTRIPPLES (500–1000 HZ) AND
ULTRA FAST RIPPLES (1–2 KHZ): NOVEL
BIOMARKERSOFTHEEPILEPTOGENIC ZONE
M. Brazdil*,†, M. Pail*, J. Halamek‡,§, F. Plesinger‡,
J. Cimbalnık¶, R. Roman†, P. Klimes‡, P. Daniel*,†,
J. Chrastina**, E. Brichtova††, I. Rektor*,†, G.A. Worrell‡‡,
P. Jurak‡,¶
*St. Anne’s University Hospital andMedical Faculty of Masaryk
University, Department of Neurology, Brno, Czech Republic,
†Masaryk University, Central European Institute of Technology,
Brno, Czech Republic, ‡Academy of Sciences of the Czech
Republic, Institute of Scientific Instruments, Brno, Czech
Republic, §St. Anne’s University Hospital, International Clinical
Research Center, Brno, Czech Republic, ¶St. Anne’s University
Hospital, Brno, International Clinical Research Center, Brno,
Czech Republic, **St. Anne’s University Hospital and Medical
Faculty of Masaryk University, Department of Neurosurgery,
Brno, Czech Republic, ††St. Anne’s University Hospital and
Medical Faculty of Masaryk University, Department of
Neurosurgery, Brno, Czech Republic, ‡‡Mayo Clinic, Rochester,
Mayo Systems Electrophysiology Laboratory, Departments of
Neurology and Physiology & Biomedical Engineering,
Rochester, MN, United States
Objective: In the present study, we aimed to investigate depth EEG
recordings in a large cohort of patients with drug resistant epilepsy and to
focus on interictal very high frequency oscillations (VHFOs) between
500 Hz and 2 kHz. We hypothesized that interictal VHFOs are more
specific biomarkers for epileptogenic zone compared to traditional
HFOs.
Methods: Forty patients with focal epilepsy who underwent presurgical
stereo-electroencephalography (SEEG) were included in the study.
SEEG data have been recorded with sampling rate of 25 kHz and
30 minutes of resting period was analyzed for each patient. Ten patients
met selected criteria for analyses of correlations with surgical outcome -
detection of interictal ripples (R), fast ripples (FR) and VHFOs, resective
surgery, and at least one-year post-operative follow-up. Using power
envelope computation and visual inspection of power distribution matri-
ces, electrode contacts with HFOs and VHFOs were detected and ana-
lyzed.
Results: Interictal very fast ripples (VFR; 500–1000 Hz) were detected
in 23 out of 40 patients and ultra fast ripples (UFR; 1000–2000 Hz) in
almost half of investigated subjects (N = 19). In our study, VFR and
UFR were recorded frommesiotemporal structures only. UFR were more
spatially restricted in the brain then lower frequency HFOs. When com-
pared to R oscillations, better outcomes were observed in patients with a
higher percentages of removed contacts containing FR, VFR, and UFR.
The percentage was highest for UFR (95%).
Conclusion: Interictal VHFOs are relatively frequent abnormal phenom-
ena in the epileptic brain, and appear to be more specific biomarkers for
epileptogenic zone when compared to traditional R and FR HFOs.
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p0513
DETECTIONOFRECURRENTACTIVATION
PATTERNS IN FOCAL SEIZURESANDAPPLICATION
TO SEIZURE-ONSET IDENTIFICATION
M. Vila Vidal*, A. Principe†, M. Ley‡, G. Deco§, A. Tauste
Campo‡, R. Rocamora‡
*Universitat Pompeu Fabra, Barcelona, Spain, †Epilepsy
Monitoring Unit, Hospital del Mar Medical Research Institute,
Department of Neurology, Barcelona, Spain, ‡Epilepsy
Monitoring Unit, Hospital del Mar Medical Research Institute,
Barcelona, Spain, §Univeristat Pompeu Fabra, Barcelona,
Spain
Purpose: We introduce a method that quantifies the consistent involve-
ment of intracranially monitored regions in recurrent focal seizures.
Method: We evaluated the consistency of two ictal spectral activation
patterns (mean power change and power change onset time) in intracra-
nial recordings across focal seizures from seven patients with well
mapped seizure onset zone (SOZ). We examined SOZ discrimination
using both patterns in different frequency bands and periods of interest.
Results: Activation patterns were proved to be consistent across more
than 80% of recurrent ictal epochs. In all patients, whole-seizure mean
activations were significantly higher for SOZ than non-SOZ regions
(p < 0.05) while activation onset times were significantly lower for SOZ
than for non-SOZ regions (p < 0.001) in six patients. Alpha-beta bands
(8  20 Hz) achieved the highest patient-average effect size on the
whole-seizure period, while gamma band (20  70 Hz) achieved the
highest average value near seizure onset (0 5s).
Conclusion: Consistent spectral activation patterns in focal epilepsies
help identify the SOZ with high levels of accuracy. The present method
may be used to improve epileptogenic identification as well as pinpoint
additional regions that are functionally altered during ictal events.
p0514
THE ELECTROENCEPHALOGRAPHIC AND
ELECTROCARDIOGRAPHIC EFFECTOF
INTRAVENOUS LACOSAMIDE INREFRACTORY
FOCALEPILEPSY
C.-W. Huang*,†, S. Brown*, N. Pillay‡, M. Del Campo§,
J. Tellez¶, R. McLachlan*
*Department of Clinical Neurological Sciences, Western
University, London, ON, Canada, †National Cheng Kung
University, Tainan, Taiwan, Republic of China, ‡Department of
Clinical Neuroscience, University of Calgary, Calgary, AB,
Canada, §Department of Medicine, University of Toronto,
Toronto, ON, Canada, ¶Department of Medicine, University of
Saskatchewan, Saskatoon, SK, Canada
Purpose: Lacosamide selectively enhances slow inactivation of voltage-
gated sodium channels to achieve seizure reduction. Its intravenous for-
mulation has been approved for treatment of acute seizures. We studied
the effect of 3 acute parenteral doses of lacosamide on the electroen-
cephalogram (EEG) and electrocardiogram (EKG) as well as its tolerabil-
ity in patients with refractory epilepsy.
Method: This Canadian, investigator-initiated, multicenter, double-
blind study recruited patients with refractory focal epilepsy admitted to a
seizure monitoring unit. Participants received a loading dose of either
100 mg, 200 mg or 400 mg over 30 minutes during continuous monitor-
ing by video-EEG and 12-lead EKG. The number of interictal spikes, fre-
quency and quantity of background rhythms, QT, PR interval, heart rate
(HR), blood pressure (BP) and respiration rate (RR) during 60 minutes
before the administration of lacosamide were compared to 60 minutes
starting 30 minutes after the administration.We documented any adverse
event during and after the infusion.
Results: 71 patients completed the study. There was a significant
decrease in interictal spikes (p = 0.04) and decreased frequency of the
alpha rhythm (p = 0.003). No significant difference in beta, theta, and
delta frequency or amount was noted. There were significant increases in
PR interval (153.4 to 155.8 ms, p = 0.03) and HR (73.4 to 75.5 bpm,
p = 0.02) but QT, BP and RR were not affected. 12 patients (16.9%)
experienced adverse events, all of them transient and mild, most com-
monly dizziness and leg tingling. Those who received 400 mg lacosa-
mide had significantly more adverse events (p = 0.048).
Conclusion: Intravenous lacosamide is effective in decreasing interictal
spikes. Despite a small dose related effect on normal EEG and EKG
rhythms, the drug is well tolerated when given parenterally with no seri-
ous adverse events documented.
p0515
CONSEQUENCEOF TBI –CHRONOTOPOLOGYOF
EPILEPTOGENESIS AND SURGICAL TREATMENT
FOR POSTTRAUMATIC TEMPORAL EPILEPSY
S. Kravtsova, T. Stepanova, A. Ulitin, V. Bersnev, V. Borovikova,
V. Kasumov
Russian A.L. Polenov Neurosurgical Institute (affiliated branch
of Federal Almazov Nort-West Medical Research Centre), St.
Petersburg, Russian Federation
Purpose: Traumatic epilepsy is a most severe complication of TBI. The
study was aimed at elaboration of diagnostic neurophysiologic biomark-
ers of postneurotrauma brain structure epileptization to solve principal
problems of optimization of epilepsy surgical treatment.
Method: Electroclinical examination and surgical treatment of 276
patients (19–50 aged) with drug-resistant posttraumatic temporal epi-
lepsy. An algorithm of presurgical epilepsy diagnostics comprising neu-
rophysiological (EEG-ECoG-SEEG) and neuroimaging (MRI, PET)
technologies was developed.
Results: Investigation into epileptic syndrome forming in post-neuro-
trauma patients based on critical chronotopology of electrographic trait-
markers particularities of preclinical (initial), early (temporal) and late
(extratemporal) epileptogenesis were established reflecting clinical-neu-
rophysiologic forms of focal and multifocal temporal epilepsy on differ-
ent stages of the disease.
Preclinical period revealed a number of critical electrographic EEG-
patterns denoting increasing spatial alpha-synchronization and reflecting
consecutive stages of brain epileptization before the clinical paroxysmal
signs appear. These neurophysiologic criteria help preclinical diagnosis
of epilepsy.
In the clinics of temporal epilepsy certain regularities of epileptogene-
sis were revealed at the levels of morphofunctional organization of tem-
poral epileptic foci and EEG-ECoG-SEEG-analysis. A major group of
our series (79%) comprised the patients with combined temporal neocor-
tical and deep limbic structure damage (hippocampus, amygdala), thus
optimizing the strategy of open surgical treatment (anterior temporal
lobectomy).
SEEG-analysis data demonstrated extratemporal structure routes of
epileptization: hippocampus and amygdala entered the Papez circles sys-
tem via anterior thalamic nuclei, which should be considered during
stereotaxic intervention.
Conclusion: Special studies of pathogenetic basis of the forming parox-
ysmal disorders carried out while examining the patients with the history
of craniocerebral trauma helped determine neurophysiologic regularities
of preclinical and clinical epileptogenesis. Neurophysiologic indicators
appear a reliable method to evaluate chronotopology of epileptic focus at
the cortical, limbic and brainstem structure levels. Neurophysiologic
peculiarities of early and late epileptogenesis found help determining
strategy of differentiated surgical treatment of resistant temporal lobe
epilepsy.
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p0516
EVALUATIONOFVISUALHABITUATION IN
JUVENILEMYOCLONIC EPILEPSY PATIENTS
D. Ilhan Algin*, O.O. Erdinc†
*Eskisehir Osmangazi University, Neurology, Eskisehir, Turkey,
†Eskisehir Osmangazi University, Eskisehir, Turkey
Purpose: Juvenile myoclonic epilepsy (JME) is one of the most common
age-related idiopathic generalised epilepsies and includes about
5%–10% of all of the epilepsies. The main purpose of the present study
was to investigate possible changes in visual habituation responses in
JME.
Methods: The patients comprised two groups: juvenile myoclonic epi-
lepsy (JME) (n = 15), and IGE with tonic-clonic seizures alone (GTCA)
(n = 20) in this study. Twenty-five healthy subjects were included in the
control group. The mean age was 28.5  4.04 years for JME group,
26.3  3.40 years for the GTCA and 31.7  5.30 years for the control
group. We measured the peak-to-peak amplitude of the N75-P100 and
P100-N75 complexes. Habituation was defined as the slope of the linear
regression line for the 6 blocks. All recordings were collected by the same
investigator, who did not meet the participants before the examination,
since they were not involved in recruitment and inclusion of subjects.
P100-N145 pattern-reversal visual evoked potential (PR-VEP) inter-peak
amplitudes and N75, P100, N145 latencies for the six blocks of 100
responses were measured. The slope of the linear regression line of the
N75-P100 and P100-N145 latencies was also analysed.
Results: There was no difference between the groups regarding gender
and age (p > 0.05). Statistical analysis revealed significant differences
between the three groups in the slope index of N75-P100 PR-VEP ampli-
tude, with increased in the JME group (p = 0.03).
Conclusion: These findings might be the expression of an abnormal sen-
sory pathway in JME patients that probably is the result of a neurotrans-
mitter disorder. We think that this study is important in terms of
supporting PR-VEP habituation as a method of distinguishing JME and
IGE patients.
p0519
NON-CONTACTVIDEODETECTIONOFTONIC-
CLONIC SEIZURES IN ARESIDENTIAL CARE
SETTING
E. Geertsema*, T. Gutter*, B. Vledder*, J. Arends†, F. Leijten‡,
R. Thijs*,§, G. Visser*, S. Kalitzin*,¶
*Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands, †Epilepsy Center Kempenhaeghe, Heeze,
Netherlands, ‡Brain Center Rudolf Magnus, University Medical
Center Utrecht, Utrecht, Netherlands, §Leiden University
Medical Centre, Neurology, Leiden, Netherlands, ¶Image
Sciences Institute, University Medical Center Utrecht, Utrecht,
Netherlands
Purpose: To investigate the detection performance of a non-contact
tonic-clonic seizure detection algorithm in a residential care setting.
Method: Our earlier described algorithm discerns tonic-clonic seizures
(TCs) from normal behavior in video registrations, by calculating relative
frequency content (2–6 Hz relative to 0–12 Hz) in the optical flow sig-
nal. A detection threshold was found using a learning set and detector
performance was studied using a test set. Experienced observers anno-
tated the clonic phase of all TCs, with five-second annotation margins on
both sides to allow for slightly earlier or later detections. The learning set
consisted of 50 video-EEG recordings of 50 patients with 72 TCs. The
detection threshold was set at the third percentile of detection output
maxima during clonic phases, obtaining 97% learning set sensitivity. The
test set consisted of 36 full night’s recordings (total duration ~362 hours)
of 12 patients in a residential care department, with 15 TCs. The algo-
rithm detects a seizure when its output exceeds the threshold during the
clonic phase. Remaining detections were categorized as: Other seizures,
detections with caregivers present, and false alarms. Detection
performance was measured in terms of sensitivity, latency and false
alarm rate per night (8 hours).
Results: Using the learning set, a detection threshold of 0.5 was found.
TCs were detected in the test set with 87% sensitivity and 4 second med-
ian latency. For all but one patient with TCs, all TCs were detected. The
median false alarm rate was 1.0 per night. Other detected seizures were
hyperkinetic and myoclonic seizures. False alarms were caused by
patient behavior (49%) and video disturbances (51%), such as moving
objects or framerate variations.
Conclusion: Our algorithmmay improve patient safety unobtrusively by
detecting TCs in video, with acceptable latency and false alarm rate.
Algorithm changes could be made to solve framerate variation problems.
p0520
TRANSIENT EPILEPTIC AMNESIA: A CHALLENGING
DIAGNOSIS, PITFALLS ANDKEY FEATURES
J. Lanzone, G. Assenza, M. Tombini
Campus Bio-Medico University of Rome, Neurology, Rome, Italy
Background and objectives: Differential diagnosis of transient amnesia
is challenging;in particular, differentiation between transient global
amnesia (TGA) and transient epileptic amnesia (TEA) may be difficult
on the basis of the clinical features of the episodes. Our aim was to
describe clinical and electroencephalographic features of patients
affected by TEA compared to patients with TGA, in order to highlight
major pitfalls and key features.
Materials and methods: Among 67 patients admitted to our department
because of one or more episodes of transient amnesia from 2008 to 2016,
14 patients (20.9%) were diagnosed as affected by TEA. We assessed
clinical features and performed neurophysiological and neuroimaging
assessment in all patients.
Results: Twelve out of 14 patients with TEA had temporal epilepsy with-
out mesial sclerosis, the remaining two patients showed symptomatic focal
epilepsy. The two groups differed significantly for the recurrence of epi-
sodes (higher in patients with TEA) and presence of other symptoms than
pure amnestic ones. Trigger factors were suggestive of TGA (25/53 cases),
while occurrence of amnestic episodes on waking was more frequent in
TEA (6/14 cases). EEG recording showed epileptiform abnormalities only
in 9 (64.3%) out of 14 patients, whereas the 24-hour ambulatory EEG
revealed these abnormalities in all patients studied.
Discussion: TEA is a neurological condition that typically affects older
people and mostly represented by cryptogenic temporal epilepsy. TEA
episodes are usually frequent, may have additional ictal manifestations,
tend to occur on waking and respond well to AEDs. The long duration of
the episodes observed in some patients could be due to postictal phenom-
ena. Interictal abnormalities may be absent in routine EEG studies, but
have always been detected during EEG sleep recordings.
Conclusions: The differential diagnosis of TEA from TGAmay be diffi-
cult inthe individual patient. Efforts should be made to obtain in these
patients an EEG sleep recording.
p0521
LEVETIRACETAM INDUCEDMURHYTHMSTATUS
ANDCYCLIC INSOMNIA
S. Abbas, S. Koussa, J. El Helou
Faculty of Medicine, Saint-Joseph University of Beirut,
Neurology Department, Beirut, Lebanon
Mu rhythm is a physiologic EEG finding of no clinical significance
mainly seen during resting wakefulness. There has been only two
described case where mu rhythm status was observed one being related to
levetiracetam (LEV).We report the second case.
We present the case of an 81 years old patient who had been followed
for tonic-clonic seizures of undetermined etiology for 9 months with
negative workup. Several antiepileptic drugs (valproate, carbamazepine,
lamotrigine, clonazepam) were tried unsuccessfully, leading to the addi-
tion of LEV. 45 days after introducing LEV and reaching a dosage of
2 g/day, the patient started experiencing, with constant periodicity, every
4 days, a state of insomnia during which he would present certain hours
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of cognitive impairment, lasting around 30 hours, followed by deep sleep
and return to basic state after awakening.
On day 3 after admission, EEG(d3), during a normal clinical state,
showed brief runs of diffuse theta slowing. On day 5, the patient got into
an episode of insomnia that lasted 30 hours and had the same characteris-
tics as the previous events. EEG(d5) showed a continuous mu rhythm, or
a mu status, intermixed with delta waves. Incrimination of LEV was sus-
pected and down tapering was started. On day 11, LEV at 500 mg/d, a
second similar clinical event was reported; EEG(d11) showed again a mu
status. At day 13, after complete withdrawal of LEV, EEG(d13) showed
a disappearance of the mu rhythm and of the delta waves with a well
organized background of 8 Hz. The patient did not present any new epi-
sode of insomnia after being discharged.
The time correlation between LEV administration and mu status leads
us to consider levetiracetam as a causal factor. The mu status was clini-
cally correlated with insomnia and cognitive impairment. The underlying
mechanisms of this triade remain to be clarified.
p0524
USEFULNESSOFVIDEO-EEG (VEEG)MONITORING
IN PATIENTSWITHEPILEPTIC ENCEFALOPATHY.
RETROSPECTIVEREVIEWOF 72 PATIENTS
N. Chamorro, V.L. Muro, M. Segalovich, G. Ugarnes,
J. Pociecha, C. D’Giano
FLENI, Epilepsy, Ciudad Autonoma de Buenos Aires, Argentina
Purpose: 1. To describe the electro-clinical aspects of patients admitted
for vEEG monitoring at FLENI Institute since June 2015 to December
2016.
2. To identify seizures and PNE (Paroxysmal Non epileptic Events)
frequency.
3. To determine if parent’s seizure frequency report and seizure type is
accurate compare with vEEG findings.
Method: Retrospective review of a cohort of 82/569 patients admitted to
vEEG unit, who met the electro-clinical criteria, during 18-month period.
Ten patients were excluded.
Results: 72 patients had Epileptic Encephalopathy (EE), from 1 month–
25 year old (6 adults). Associated etiologies were: structural n = 36
(49%), genetic-metabolic n = 10 (13%) unknown n = 26 (36%). All
patients received AED, ketogenic diet n = 11, VNS n = 5, surgery
n = 4, canabidiol n = 6. Neurological exam was abnormal in 77%
(n = 56) and 43% (n = 31) corresponded to cerebral palsy patients.
During vEEG a combination of PNE and epileptic seizures were seen
in 38.8%(n = 28), epileptic seizures only 58.3% (n = 42).
Seizure frequency parent0s report was not accurately in 59% (n = 39),
either in absolute numbers or range. 20/39 (51%) had >3 years of time
disease evolution.
Seizure frequency parent0s report could not be compare with seizure
frequency during the vEEG due to lack of information previous admis-
sion.
50%n = 37 of parents or caregivers did not recognized at least one sei-
zures type or more reported during the vEEG. The seizures type less rec-
ognized were: myoclonias 20/27 (74%), absence 11/17 (64%), focal 6/28
(21%), spasm 6/31 (19%), tonic seizures 9/43 (20%), atonic 2/11 (18%).
Conclusion: vEEG monitoring is a useful tool in EE, not only to recog-
nize PNE, either seizure frequency or detecting other seizures types for
treatment management. Finding a new seizure type during a vEEG not
always implies a progression of the disease and need to be carefully anal-
ysed.
p0525
A STUDYOFTUBEROUS SCLEROSISWITHNEW
HYBRID INTRACRANIALMICRO-
MACROELECTRODES
E. Despouy*,†, J. Curot*,‡, M. Deudon*, M. Denuelle‡, J.-
C. Sol‡, J.-A. Lotterie‡, L. Valton*,‡, E. Barbeau*
*Centre de Recherche Cerveau & Cognition, UMR 5549,
Toulouse, France, †DIXI Medical, Besancon, France, ‡CHU
Purpan, Toulouse, France
Purpose: Tuberous sclerosis complex (TSC) is a rare genetic disorder
associated with mutations in one of the two tumor suppressor genes
(TSC1/TSC2). TSC leads to multisystem hamartomas, including various
neuropathological brain lesions, such as tubers. Up to 90% patients suffer
from partial epilepsy, often drug-refractory. Seizures may remit after epi-
lepsy surgery in selected cases, but the exact location of the seizure onset
zone (SOZ) in TSC remains controversial. Some studies suggest that
tubers play a greater role in seizure genesis than perituberal cortex. But
increasing evidence exists for the epileptogenicity of MRI-normal peritu-
beral tissue. Fast-ripples (FR, 200–600 Hz) are supposed to be biomark-
ers of the SOZ. However, no FR were found in the tubers of a TSC
patient explored by stereo-electroencephalography (SEEG) macroelec-
trodes.
Method: We report the case of a patient who suffers from TSC compli-
cated by drug-refractory epilepsy. She underwent a SEEG pre-surgical
assessment using classical macroelectrodes but also 4 newly designed
hybrid micro-macroelectrodes (micro-macro): one micro-macro was
localized in the tuber and another one in the perituberal cortex. Micro-
electrodes have a higher sensitivity to FR than macroelectrodes.
Results: Our results show for the first time that FR are recorded both in
the tuberal and perituberal cortex using the microelectrodes whereas
none were recorded using the macroelectrodes. No FR was recorded in
the healthy cortex. Moreover single and multi-unit activities were differ-
ently modulated in the tuberal and perituberal cortices when interictal
spikes occured, with an interplay between both regions.
Conclusion: Our results imply that the perituberal cortex belongs to the
SOZ and suggest in fact neuronal interactions between the perituberal
and tuberal cortices.
p0527
IDENTIFICATIONOFHIGH-FREQUENCY
OSCILLATIONS (HFOS) IN PAEDIATRIC
INTRACRANIAL EEGBYMEANSOFKURTOSIS-
BASED TIME-FREQUENCYANALYSIS
L.R. Quitadamo*, R. Mai†, S. Seri*,‡
*Aston Brain Centre, School of Life and Health Sciences, Aston
University, Birmingham, United Kingdom, †Claudio Munari
Epilepsy Surgery Centre, Niguarda Hospital, Milan, Italy,
‡Epilepsy Surgery Programme, BirminghamWomen’s and
Children’s NHS FT, Birmingham, United Kingdom
Purpose: High-Frequency Oscillations (HFOs, >80 Hz) are biomarkers
of the seizure onset zone (SOZ) and their visual identification in multi-
electrode intracranial EEG (iEEG) is time-consuming. We implemented
a method for the automatic detection of HFOs with preliminary kurtosis-
based selection of the most informative channels. Channels with the
highest HFO rates (HFOs area) were compared with the post-operatively
confirmed SOZ for validation.
Method: IEEG data preceding seizure episodes in 6 representative pae-
diatric patients (mean age: 14y) with focal drug-resistant epilepsy and
who underwent presurgical assessment at the Birmingham Children’s
Hospital were band-pass filtered (80–250 Hz). Wavelet coefficient and
their mean kurtosis were computed on segmented signal. A threshold was
set on kurtosis distribution and channels were ranked according to the
total number of segments having kurtosis over that threshold. The first
third of channels was then retained. Candidate HFOs were detected
where the power of the wavelet coefficients exceeded the mean power by
5SD and for at least 20 ms. Channels with the highest HFO rates were
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marked as HFO area and compared to the SOZ, determining sensitivity
and specificity.
Results: Sensitivity of 100% was obtained in 3/6 patients together with
specificity of 100%, 95.08% and 93.11%, meaning that all the channels
in the HFO area were concordant with those in the SOZ. For 2/6 patients,
just one channel in the SOZ was not recognized (sensitivity 66.67%), still
with a low number of false positives (specificity 100% and 96.97%
respectively). Sensitivity of 60% and specificity of 85.19%were obtained
for 1/6 patient.
Conclusion: Preliminary findings show that the method allows identifi-
cation of the SOZ with high sensitivity (concordant with resected brain
area) and specificity (regions not included in the resection are not identi-
fied as HFOs area) in a totally blind and time-saving automatic way,
thanks to the kurtosis-based selection of the most informative channels.
p0528
A STUDYOF PRAXIS-INDUCED SEIZURES IN
JUVENILEMYOCLONIC EPILEPSY
B. Abarrategui*, L. Rodrigues De Marchi†, A.C. Zetehaku†,
J. Torres Corso†, N.S. Visona Figueiredo†, MS Guaranha†,
E.M. Yacubian†
*Hospital Clınico San Carlos, Neurology, Madrid, Spain,
†UNIFESP, Neurology and Neurosurgery, S~ao Paulo, Brazil
Purpose: Praxis induction (PI) is a reflex trait tightly linked to juvenile
myoclonic epilepsy (JME) whose high frequency allows recording of
myoclonia during a Video-EEG neuropsychological protocol (VNPP).
The purpose of this study is to characterize semiological and EEG fea-
tures of PI myoclonia describing subjective perception and impact on
patients.
Method: This study enrolled JME patients who presented myoclonia of
upper limbs induced by a VNPP. We analyzed semiological features of
myoclonia, ictal EEG patterns, and relations among them. A semi-struc-
tured interview assessed subjective description of PI myoclonia, tempo-
ral evolution of this reflex trait, and psychosocial aspects.
Results: 59 myoclonia in the arms were analyzed in 15 JME patients (8
women, mean age 23.4 years). Seven involved only hands, 24 distal
arms, 24 global arms, and 4 proximal arms. Jerks were more frequently
asymmetric or focal (32/59); a bilateral symmetric pattern of all myoclo-
nia was observed in only 5 patients. Hand executing movement was pre-
dominantly affected in 20 myoclonia. Jerks affecting only hands were
accompanied by spike-wave pattern, while polyspike-wave predomi-
nated in the remaining. A more extensive distribution of myoclonia
tended to show higher frequency (p = 0.100) and amplitude (p = 0.032)
of polyspike; two patients presented distal arms and global arms myoclo-
nia without any visible EEG change. Nine patients answered the semi-
structured interview. While 2 never perceived PI in daily life, 2 noted it
already in the first year of epilepsy and myoclonia were promptly con-
trolled with VPA. Five perceived PI for the first time more than 3 years
after epilepsy onset recognizing stress as aggravating factor. In 4 of them,
PI persisted despite different AEDs.Myoclonia provoked falls/other inju-
ries in 5/7, and job change/loss in 3/7.
Conclusion: PI myoclonia are valuable for JME diagnosis. Ictal EEG
patterns showed differences according to distribution of myoclonia. PI
influences negatively patients lives.
p0529
MODELINGOF INTRACEREBRAL INTERICTAL
EPILEPTIC DISCHARGES: EVIDENCE FOR
NETWORK INTERACTIONS
P. Ossenblok*,†, S. Meesters*,‡, A. Colon*, L. Wagner*,
O. Schijns§,¶, P. Boon*,**, L. Florack‡, A. Fuster‡
*Academic Centre for Epileptology Kempenhaeghe &
Maastricht UMC+, Heeze, Netherlands, †Eindhoven University
of Technology, Biomedical Image Analysis, Eindhoven,
Netherlands, ‡Eindhoven University of Technology,
Mathematics & Computer Science, Eindhoven, Netherlands,
§Academic Centre for Epileptology Kempenhaeghe &
Maastricht UMC+, Maastricht, Netherlands, ¶Maastricht
University Medical Center, Neurosurgery, Maastricht,
Netherlands, **University Hospital Gent, Neurology, Gent,
Belgium
Purpose: Stereotactic EEG (SEEG) recordings are considered to be the
best choice for preoperative invasive evaluation when the epilepsy of the
patient is suspected to originate in deep-sited anatomical structures and
standard electro-clinical examinations are not conclusive. The interictal
epileptic discharges (IEDs) occurring in these recordings in general are
abundant compared to ictal discharges, but difficult to interpret due to
complex underlying network interactions.
Method: A framework is developed to model the spatiotemporal net-
work interactions underlying the IEDs. To identify the highly synchro-
nized neural activity underlying these discharges, the variation in
correlation over time of the SEEG signals is related to the occurrence of
the IEDs using the general linear model [van Houdt et al., 2012]. Subse-
quently, it is assessed whether the brain regions that reflect highly syn-
chronized neural activity are either independent or interacting within an
epileptic network. Independent component analysis is applied followed
by clustering of the spatial distributions of the independent components.
The spatial distributions of the spike clusters are visualized together with
the estimated time delays against the patients’ brain anatomy [Meesters
et al., 2015].
Results: The analysis framework was evaluated for five patients who
underwent SEEG recordings prior to successful epilepsy surgery. The
spatial distribution of the spike cluster that was related to the MRI-visible
brain lesions coincided with the seizure onset zone of these patients.
Unraveling of the complex network interactions underlying the IEDs of
two more patients without satisfactory surgical outcome indicated that an
alternative and plausible resection strategy could have been considered.
Conclusion: The analysis framework applied to IEDs is considered a
valuable additional tool to the current seizure assessment approach,
which might lead to a more successful outcome of epilepsy surgery.
Acknowledgement: This study is part of the DeNeCor-project that has
received funding from the ENIAC Joint Undertaking (grant no. 324257).
p0530
TUNINGDECISION THRESHOLDS FORACTIVE/REST
PERIODS SIGNIFICANTLY IMPROVES SEIZURE
DETECTIONALGORITHMPERFORMANCE: AN
EVALUATIONUSINGEMBRACE SMARTWATCHON
OUTPATIENT SETTINGS
C. Caborni*, M. Migliorini*, F. Onorati*, G. Regalia*,
W.R. Picard*,†
*Empatica Inc, Milan, Italy, †MITMedia Lab, Massachusetts
Institute of Technology, Cambridge, MA, United States
Purpose: Embrace (Empatica, Inc., Boston, Massachusetts) is a wrist-
worn device coupled with a smartphone-based alert system using
accelerometer and electrodermal activity sensors. A machine learning
classifier trained on inpatient and outpatient convulsive seizure data pro-
vides real-time alarms; its performances in real life settings have been
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previously shown (Onorati et al., 2016), with Se (sensitivity) = 90% and
FAR (false alarm rate) = 1.05/24 hrs.
In this work, we show how applying different decision thresholds for
rest and active periods can improve performance in outpatient settings.
Method: The testing set consists of 27 patients who experienced 111
convulsive seizures (65 during rest, 46 during active periods) for a total
of 95 days of recordings in outpatient settings. Patients and caregivers
were instructed to accurately report seizures; these reports were used as
ground truth. We examined three different thresholds: TH1 for active
periods, to minimize false alarm rate (FAR); TH2 for rest periods, to
maximize Sensitivity (Se); and TH3 as a cut-off between minimizing the
FAR and maximizing the Se. Classifier I was tuned on TH3 only. Classi-
fiers II and III were tuned on TH2 for rest periods, and on TH1 and TH3,
respectively, for active periods. Rest periods were determined using a
proprietary rest-detection algorithm.
Results: Classifier I detected 99 seizures (Se = 89%) with 55 false
alarms (FAR = 0.58/24 hrs), all during active periods. Classifiers II
(Se = 92%) and III (Se = 93%) detected 4 more seizures during rest, but
Classifier II missed one seizure during an active period. While Classifier
III had the same FAR as Classifier I, Classifier II showed a 44% decrease
in the FAR, i.e. FAR = 0.33/24 hrs.
Conclusion: Using different decision thresholds for rest and active peri-
ods results in both increased sensitivity and decreased FAR. Thus, perfor-
mance improvements can be achieved by detecting rest and activity and
optimizing discrete decision thresholds for these periods.
p0532
INTRAOPERATIVEHIPPOCAMPAL SPIKES ANDHFO
INHIPPOCAMPAL SPARINGTEMPORAL LOBE
LESIONECTOMYFORDRUGRESISTANTEPILEPSY
H.-Y. Yu*, C.-F. Lin†, S.P. Hsu†, Y.-H. Shih†, C.-C. Chou*
*Taipei Veterans General Hospital and National YangMing
University, Neurology, Taipei, Taiwan, Republic of China,
†Taipei Veterans General Hospital and National YangMing
University, Neurosurgery, Taipei, Taiwan, Republic of China
Purpose: Temporal lobe epilepsy (TLE) with extrahippocampl lesion
could be benefit from hippocampal sparing lesionectomy (HPL). To
improve the seizure outcomes, some authors suggested extended resec-
tion if spikes in the hippocampus. High frequency oscillation (HFO) is
recently a popular biomarkers for epileptogenic tissue and used in tai-
lored resection during epilepsy surgery. We conducted this study to see if
residual spikes and HFO are associated with poor outcomes in this proce-
dure.
Method: Data were drawn from the database of epilepsy surgery in our
hospital between 2010 and 2015. Patients who had drug resistant TLE
with lesions in the temporal lobe were included. HSL was decided by
multidisciplinary conference after comprehensive presurgical evaluation.
The hippocampus was preserved when it looked normal on high resolu-
tion brain MRI, regardless of the location of the lesion or electroen-
cephalography (ECOG) findings. We only included patients who had
hippocampal recording by either depth electrodes or small strips. HFO
were analyzed only in recordings of appropriate sampling rate. Postoper-
ative seizure outcomes were followed for at least 2 years.
Results: 27 patients were included (14 male and 13 female, age 10–66,
left 16, right 11). Pathology included tumor (48.1%), vascular anomaly
(40.7%), focal cortical dysplasia (7.4%) and gliosis (3.7%). Among them,
26 (96.3%) patients had excellent outcomes (Engel’s classification I).
Hippocampal spikes were noted in the pre-resection and post-resecton
ECOG, 21/25 (84.0%), and 18/23 (78.3%) respectively. Fast ripples
(>250 Hz) were noted in 8/17 (47.1%) and 5/16 (31.3%) before and after
resection. Ripples (80~250 Hz) were noted in 13/18 (72.2%) and 12/16
(75.0%) before and after resection.
Conclusion: Hippocampal spikes and HFO were not uncommon in TLE
with extrahippocampal lesion. HSL in patients who had a grossly normal
hippocampus can achieve excellent seizure outcomes in spite of the pres-
ence of irritating features on intraoperative ECOG.
p0533
NONEVOLVING PERIODICDISCHARGES AND
EXTERNAL STIMULI REACTIVITYRELEVANCE
J. Miro*,†,‡, J. Pedro*, B. Garcıa*, S. Jaraba*,§, M. Santurino*,
D. Vi~nas*, M.P. Sanchez*, M. Veciana*, M. Falip*
*Hospital Universitari de Bellvitge, Barcelona, Spain,
†Universitat de Barcelona, Cognition and Brain Plasticity
Group, Barcelona, Spain, ‡IDIBELL, Barcelona, Spain,
§Hospital de Viladecans, Viladecans, Spain
Purpose: Nonconvulsive status epilepticus (NCSE) can have nonspeci-
fic ictal manifestations, like in confusional states or deeper stages of
coma. In these scenarios diagnosis cannot be made reliably without EEG.
When EEG presents periodic discharges (PDs), there is currently no con-
sensus about interpretation and need of antiepileptic drugs (AED). In
such situations, reactivity to external stimuli (RES) has been underesti-
mated. We reviewed electroclinical data of patients with PDs and RES
contributing to characterize EEG reactivity clinical relevance.
Method: This is a retrospective review of 33 consecutive patients from
our Unit Database with non evolving periodic discharges in the EEG. All
of them underwent video-EEG in the acute phase of CNS disturbances.
The revision was mainly focused in the reactivity to external stimuli with
discontinuation of periodic discharges (PDs) -lateralized periodic dis-
charges, bilateral independent periodic discharges and generalized peri-
odic discharges- when these are non time-locked to clinically apparent
symptoms and don’t have an ictal pattern. Patient charts and available
neuroimaging studies were also reviewed.
Results: Of the 33 patients included in our study, 20 were men, mean
age 66.52 (SD 11.54) years. The presence of PDs with RES was 63.6%
(21 of 33 patients). The aetiology of the CNS disturbance was classified
as: toxic metabolic -11 patients- (33.3%), vascular -9 patients- (27.3%),
multifactor -7 patients- (21.2%), tumour -4 patients- (12.1%) and infec-
tious -2 patients- (6.1%), with no significant RES association (p > 0.05).
The PDs with RES included a higher diagnosis rate of encephalopathy
(44.4%) vs lesion discharges (33.3%) or non convulsive status epilepticus
(11.1%). The association was only significant for the absence of RES in
NCSE (p 0.02).
Conclusion: This small series suggests that periodic discharges with
abscence of reactivity to external stimuli appear to be more frequently
associated with NCSE.The reactivity to external stimuli in periodic dis-
charges may contribute to diagnosis and treatment need decisions.
p0537
NON-INVASIVEDETECTIONOF FAST RIPPLES IN
LOW-NOISE EEGRECORDINGS
E. Boran*, G. Ramantani†, G. Curio‡, P. Hilfiker†,
T. Grunwald†, J. Sarnthein*, T. Fedele*
*University Hospital Zurich, Department of Neurosurgery,
Zurich, Switzerland, †Swiss Epilepsy Centre, Zurich,
Switzerland, ‡Campus Benjamin Franklin, Charite,
Neurophysics Group, Department of Neurology, Berlin,
Germany
Purpose: Ripples (80–250 Hz) and fast ripples (FR, 250–500 Hz) are
characterized by poor signal-to-noise ratio, which reduces their visibility
in non-invasive recordings. While ripples are observed in scalp EEG, FR
detection has been restricted to invasive recordings. We tested the
detectability of FR in the scalp EEG of epilepsy patients, recorded with
low-noise EEG, and quantified their specificity for the epileptogenic
zone (EZ).
Method: Scalp EEGwas recorded during one hour of slow wave sleep in
six patients with focal lateralized epilepsy. We used a custom-made low-
noise 8-channel amplifier (noise level 2.3 nV/√Hz). Electrodes were
placed symmetrically on the epileptogenic and non-epileptogenic hemi-
sphere (EZ-h, nEZ-h). Ripples and FR were detected by combining auto-
mated detection [1] and offline visual validation.
Results: For each patient, mean event rates were computed for EZ-h and
nEZ-h. Across patients, FR rates were 0.17  0.03 event/min in EZ-h
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and 0.11  0.05 event/min in nEZ-h (p = 0.031). Ripple rates were
0.19  0.34 event/min in EZ-h and 0.22/min  0.45 event/min in nEZ-
h (n.s.). Across all channels, mean peak-to-peak amplitude FR was
1.02  0.58 lV on a background noise level of 0.33  0.12 lV while
mean peak-to-peak ripple amplitude was 2.09  1.15 lV on a back-
ground noise level of 0.70  0.37 lV.
Conclusion: FR could be detected non-invasively on the scalp by using
an optimized low-noise EEG. FR were more specific than ripples for the
epileptogenic hemisphere. The opportunity to access FR non-invasively
represents a substantial advance in scalp EEG recording and could con-
tribute to therapy monitoring.
[1] Burnos S, Frauscher B, Zelmann R, Haegelen C, Sarnthein J, Got-
man J. The morphology of high frequency oscillations (HFO) does not
improve delineating the epileptogenic zone. Clin Neurophysiol (2016)
127 (4):2140-8.
p0538
SEIZUREONSET ZONECONNECTIVITYDURING
WAKEFULNESS AND SLEEP STUDIED THROUGH
SINGLE PULSE ELECTRICAL STIMULATIONDURING
SEEGRECORDINGS
A.A. Arbune*,†, I. Mindruta*,†, M. Mihai Dragos*, I. Popa*,†,
S. Ene‡, J. Ciurea§, A. Barborica‡
*University Emergency Hospital Bucharest, Neurology Clinic,
Bucharest, Romania, †Carol Davila’University of Medicine and
Pharmacy, Clinical Neurosciences, Bucharest, Romania,
‡University of Bucharest, Electricity and Magnetism, Solid-State
Physics, and Biophysics, Bucharest, Romania, §Bagdasar
Arseni’ Emergency Hospital, Neurosurgery, Bucharest,
Romania
Purpose: Invasive exploration of the epileptogenic network using depth
electrodes is usually indicated in refractory epilepsy patients for the accu-
rate delineation of the seizure onset zone (SOZ). Single pulse electrical
stimulation (SPES) protocol is oftenly used for obtaining additional
information during the presurgical invasive evaluation. Cortico-cortical
evoked potentials (CCEP) elicited by SPES during sleep in comparison
with wakefulness have been poorly studied.
Method: We performed SPES stimulation protocol in a slected group of
7 refractory epilepsy patients, explored by means of SEEG method with
intracerebral depth electrodes. All the patients were operated on and are
currently seizure-free. The seizure onset zone was located differently in
the studied patients
orbitofrontal (1), parietal operculum (1), middle cingulate and para-
central lobule (1), and mesial temporal (4). We selected the early
responses (ER) obtained from SPES stimulation of the electrode contacts
that were included in the siezure onset zone. Responses were analyzed by
means of amplitude during wakefulness and sleep.
Results: The ER amplitudes by SPES stimulation in the SOZ during
wakefulness and sleep showed statistically significant differences
(p < 0.001). We identified constant, stong connectivity within the SOZ,
but also with other brain areas, irrespective of patient status. The ERs
obtained by stimulating the SOZ in the areas adjacent to SOZ are signifi-
cantly inhibited during sleep in comparison with wakefulness. In 4
patients, by stimulating the SOZ (amygdala and hyppocampus), a signifi-
cant response in the temporal pole was observed during sleep, whereas
the response was much lower during wakefulness. The local connectivity
of the SOZ during sleep is enforced as opposed to a more widespread
connectivity with remote structures during wakefulness.
Conclusion: We described how sleep altered the connectivity of the
SOZ with various cerebral structures. More study is needed to complete
these novel observations on the influence of sleep on the epileptogenic
network.
p0540
IMPACTOFCANINE EPILEPSYONCOGNITIVE
DYSFUNCTION
R.M.A. Packer*, P.D. McGreevy†, H.E. Salvin†,
M.J. Valenzuela‡, H.A. Volk*
*Royal Veterinary College, Clinical Science and Services,
Hertfordshire, United Kingdom, †School of Veterinary Science,
University of Sydney, Sydney, NSW, Australia, ‡Brain and Mind
Centre, University of Sydney, Sydney, NSW, Australia
Purpose: There is extensive evidence from studies of both children and
adults with epilepsy that epilepsy can compromise cognition, ranging
from mild learning impairments to severe cognitive decline. A variety of
epilepsy-related factors affect cognitive function, including seizure type
and frequency, age of onset and anti-epileptic medication. Epilepsy is the
most common chronic neurological disorder in dogs, with parallels to
human epilepsy in presentation, diagnosis and treatment. This study
investigated whether, after accounting for age, dogs with epilepsy mani-
fest increased levels of cognitive dysfunction compared to control dogs.
Method: An online cross-sectional study of dogs aged over 3 years old
was conducted. Owners were recruited via veterinary practices and social
media and asked to complete the Canine Cognitive Dysfunction Rating
scale (CCDR), a validated tool measuring cognitive impairment in dogs
including deficits in learning, memory and spatial awareness. Owners
reported their dog’s seizure history and dogs were classified as being
affected by idiopathic epilepsy (with no structural cerebral pathology
suspected) if they met the International Veterinary Epilepsy Task Force
tier I diagnostic certainty criteria.
Results: Valid data were collected for 4051 dogs of 173 breeds, with a
median age of 98 months. Dogs with epilepsy (n = 286) had a signifi-
cantly higher CCDR score than control dogs (n = 3765) and were signifi-
cantly more likely to score above the CCDR threshold for diagnosis of
cognitive dysfunction (3.8% vs. 1.4%). In a linear model with CCDR
score as the outcome variable, the factors significantly associated with
CCDRwere idiopathic epilepsy diagnosis, age (months), weight and neu-
ter status.
Conclusion: These findings are the first to demonstrate the negative
effects of canine epilepsy on cognitive function. In addition, older dogs,
neutered dogs and lighter dogs were at more risk of impaired cognition.
Further studies detailing the nature of cognitive impairment in dogs
affected by epilepsy are required.
p0541
EXPRESSION PATTERNOFCALBINDIN
IMMUNOREACTIVE IN TEMPORALNEOCORTEXOF
PATIENTSWITHRESISTANT TEMPORALLOBE
EPILEPSYANDCOMORBID DEPRESSION
A. Acu~na*, P. Vazquez Borsetti†, H. Konopka‡, C. Nu~nez§,
P. Seoane¶, F. Loidl†, S. Kochen**, L. D’Alessio††
*Universidad de Buenos Aires, Instituto de Biologıa celular y
Neurociencias Profesor Eduardo De Robertis, Buenos Aires,
Argentina, †Universidad de Buenos Aires-CONICET,
Laboratorio de Neuropatologıa Experimental, Instituto de
Biologıa Celular y Neurociencia Profesor Eduardo De Robertis,
Buenos Aires, Argentina, ‡Hospital Moyano, Servicio de
Patologıa, Buenos Aires, Argentina, §Universidad de Buenos
Aires, Buenos Aires, Argentina, ¶Hospital Ramos Mejıa, Buenos
Aires, Argentina, **Unidad Ejecutora de Estudios de
Neurociencias y Sistemas Complejos (ENyS) - CONICET,
Universidad Nacional Arturo Jauretche, Hospital El Cruce,
Florencio Varela, Argentina, ††Universidad de Buenos Aires-
CONICET, Instituto de Biologıa Celular y Neurociencias
Profesor Eduardo De Robertis, Buenos Aires, Argentina
Purpose: Resistant temporal lobe epilepsy (RTLE) is associated with a
high prevalence of comorbid depression. Alterations in GABAergic
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system has been suggested to play an important role for development and
spread of seizures in patients with RTLE and there are evidence that is
also affected in depression. The aim of this study was to determine a sub-
group of GABAergic interneurons which express the calcium binding
protein calbindin (CB), in temporal 20 and 21 Brodmann neocortical
areas of patients with RTLE and hippocampal sclerosis (HE) with and
without comorbid depression, who underwent epilepsy surgery.
Method: Patient with RTLE and HE were included. Neurological, neu-
ropsychological, psychiatric (SCID I, DSMIV) and complementary eval-
uations (VIDEO EEG, RMN) were conducted before surgery (anterior
temporal lobectomy). The cortical sections from 20 and 21 Brodman
areas, were processed by histopathological routine techniques, and by
immunohistochemistry with anti- CB and anti- NeuN. Focal dyplasias
were excluded. Post mortem sections were processed simultaneously.
A quantitativemorphometric analysis was conducted (Image J).
ANOVA/Bonferroni test were used.
Results: Patients with RTLE and co-morbid depression n = 9 (age
30  10 years), and without depression n = 6 (age 36  9 years) and 5
matched postmortem controls were included. In patients with comorbid
depression the total number of CB interneurons and the reactive area in
layer II, were significantly reduced (ANOVA F (2.17) = 5.536,
p = 0.014). No significant differences in the groups in the number of
neuN cells were found in layer II (ANOVA F (2.14) = 0.550 p = 0.588).
Conclusion: Comorbid depression in RTLE patients was associated with
a reduction in the total number of CB interneurons in temporal areas,
which are involved in sensory integration and codification of affective
stimuli, suggesting alterations in inhibitory GABAergic system. Further
studies should been performed to confirm and extend this preliminary
findings.
p0543
BRAIN ACTIVITYCONTINUES DURING POSTICTAL
EEG SUPPRESSION IN INTRACRANIAL AND SCALP
RECORDINGS
L.M. Bateman*, A. Mendiratta*, J.-Y. Liou†, E.J. Smith‡,
C.W. Bazil*, H. Choi*, G.M. McKhann‡, A. Pack*, S.A. Sheth‡,
S. Srinivasan*, C.A. Schevon*
*Neurology, Columbia University, New York, NY, United States,
†Physiology and Cellular Biophysics, Columbia University, New
York, NY, United States, ‡Neurological Surgery, Columbia
University, New York, NY, United States
Purpose: Postictal generalized EEG suppression (PGES) has been pro-
posed to reflect profound electrical shutdown of the brain, which can be
used as a biomarker of SUDEP and potentially a predictor of individual
risk. PGES is typically seen only following generalized tonic-clonic sei-
zures, and while it has been associated with clinical and autonomic fea-
tures considered to be SUDEP precursors, the nature of the relationship
between PGES and SUDEP is controversial. We sought to characterise
postictal attenuation and evaluate its role as a potential SUDEP risk pre-
dictor.
Method: We performed a detailed electroclinical evaluation of an
intracranial EEG analogue of PGES, which we term postictal diffuse
attenuation (PDA), in a series of 31 secondarily generalized seizures
recorded from 16 patients. Scalp EEG recordings from the same patient
group were assessed separately for PGES.
Results: PDA was common, occurring in 84% of seizures from 94% of
patients in this study. PGES was seen in 50% of seizures from 44% of
patients who had seizures recorded with scalp electrodes. During the
PDA period, there was increased power in the infra-delta (<2 Hz) and
high frequency (68 +/- 41 Hz) ranges observed in intracranial recordings.
Clinical motor manifestations, including oral automatisms, unilateral or
bilateral limb posturing, lateralized head and/or eye deviation, non-pur-
poseful unilateral limb movements and focal or generalized myoclonic
jerks were observed during the period of EEG attenuation in 26% of sei-
zures.
Conclusion: Our clinical and electrographic findings indicate that brain
activity during postictal EEG attenuation is not universally suppressed.
Further, our study suggests that a phenomenon as common as postictal
EEG attenuation could not serve as a useful predictor of a rare event such
as SUDEP, although it does not preclude an association with SUDEP
mechanisms. We propose instead that PDA/PGES is a distinct phase of
generalized seizures.
p0546
PACES-V: ADAPTINGCONSUMER-DRIVEN EPILEPSY
SELF-MANAGEMENT FORUNITED STATES
MILITARYVETERANS
E.K. Johnson*, R. Fraser†, C. Ransom‡,§
*Health Services, University of Washington, Seattle, WA, United
States, †Rehabilitation Medicine, Neurology, and Neurosurgery,
University of Washington, Sea, WA, United States, ‡Neurology,
Veterans Affairs Puget Sound Healthcare System, Seattle, WA,
United States, §Neurology, University of Washington, Seattle,
WA, United States
Purpose: Self-management needs of adults with epilepsy are relevant to
addressing co-morbidity and adjustment to disability. The Program for
Active Consumer Engagement in Self-management (PACES) in Epi-
lepsy was developed in an adult civilian sample. RCT data showed imme-
diate and longer-term effects on depression, epilepsy self-management,
epilepsy self-efficacy, and quality of life. Minimal self-management
work to date has included U.S. Veterans.
Method: PACES developed in 3 phases:
(1) Mail survey to patients (n = 200) to identify medical and psy-
chosocial problems, and rank self-management intervention format pref-
erences (location, length, time of day, leadership model). Response rate
61%.
(2) Focus groups (4 groups; n = 24) validated survey content and
identified requisite changes to PACES, for extension of program beyond
academic epilepsy centers.
(3) RCT of PACES (n = 108). Based on data from (1) and (2), the 8-
week groups are co-lead by a psychologist and trained peer with epilepsy;
comprised of 6–8 patients, and meet weekly at hospital or by teleconfer-
ence for 75 minutes. Cognitive-behavioral psychoeducation and goal set-
ting/attainment scaling is used. Outcome measures: Epilepsy S-M Scale,
Epilepsy Self-Efficacy Scale, QOLIE-31, PHQ-9, and GAD-7; adminis-
tered at baseline, 8 weeks, and 6 months.
This presentation details the results of U.S. Veteran-specific focus
group research on program adaptations for this unique sub-population.
Additional content relevant to co-morbid traumatic brain injury, PTSD,
and PNES is hypothesized, along with location and composition of self-
management groups.
Results: Quantitative and qualitative Data collection occurs at a VA Epi-
lepsy Center of Excellence, with up 3 focus groups (n = 30) to reach con-
tent saturation. Data for PACES content changes and outcomes measures
is presented, along with an implementation model for a Veteran-specific
RCT.
Conclusion: PACES is a consumer-driven, psychoeducational interven-
tion for epilepsy self-management, and promising regarding disability
management. Top-down approaches have been less successful at partici-
pant engagement and lack longer-term follow-up relevant to sustained
cognitive-behavioral change.
p0547
PROGRAMFORACTIVECONSUMERENGAGEMENT
IN SELF-MANAGEMENT: FINDINGSANDNEW
DIRECTIONS
R.T. Fraser*, E.K. Johnson†, S. Lashley‡
*Rehabilitation Medicine, Neurology, Neurosurgery, University
of Washington, Seattle, WA, United States, †Health Services,
University of Washington, Seattle, WA, United States,
‡Rehabilitation Medicine, University of Washington, Seattle,
WA, United States
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The PACES in Epilepsy program is a partnership between patients and
providers, incorporating the patient’s preferences and goals. Initial litera-
ture review indicated issues in some existing self-management programs
relative to the derivation of program material and elevated dropout rates.
We developed a mail survey on desired content and program design and
sent it to 225 patients with epilepsy. The response rate was 61%, with
findings that responders wanted in-person individual or group sessions
co-led by an epilepsy professional and a person with epilepsy, eight ses-
sions of one hour each on a weekday or night, with a mixture of education
and coping strategies.
In Phase II of the study, PACES was modeled on survey findings and
delivered in RCT format. Subjects (n = 42) had significantly improve-
ments vs. controls (n = 42) on depression, epilepsy self-management,
epilepsy self-efficacy, and the QOLIE-31. At six months, significant dif-
ferences remained on a number of measures except depression and self-
efficacy. Results also showed high satisfaction with the material and
mode of delivery (all ratings >4/5). The highest three rated modules were
Epilepsy and Assertive Communication, Dealing with Cognitive Issues,
andManagingMy Epilepsy Care.
In the current third phase of the study, the sponsoring U.S. CDC has
encouraged a larger sample (n = 200), with patients from multiple sites
including Veterans Affairs, examination of a longer duration of impact,
and the use of multiple formats (on-site, telephone, and webinar). This
presentation will discuss the issues to be faced in the training and dissem-
ination (e.g., choice of personnel to be trained, a certification process,
and fidelity to the model) as well as PACES’ ultimate sustainability (e.g.,
partnering, financial reimbursement, and collaboration with members of
the U.S. Managing Epilepsy Well Provider Network). The above are
issues generally confronted by self-management program providers as
they seek stability of their programs.
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THE EFFICACYOF PERAMPANEL INREFRACTORY
STATUS EPILEPTICUS
T.W. Kjaer*,†, M. Atkins*, J. Friedrich*, J. Gyllenborg*
*Zealand University Hospital, Roskilde, Denmark, †University
of Copenhagen, Copenhagen, Denmark
Perampanel (PER) is a novel drug recently introduced as an add-on ther-
apy for the treatment and prevention of epileptic seizures in patients aged
12 years or over with partial-onset seizures, with or without secondary
generalization.
Purpose: To determine efficacy of PER as adjunctive treatment, we
report on 11 patients admitted to our hospital between 2013 and 2015
with refractory status epilepticus.
Methods: Patient records were investigated retrospectively to determine
treatment response to PER, measured as cessation of status epilepticus
and return to baseline consciousness.
Eleven patients were included, seven females, one child. Median age
of the adults 70 years (range 33–90 years). All patients had a symp-
tomatic etiology, and all but four patients had a pre-existing epilepsy.
PER was the terminating drug in all cases. However, two patient subse-
quently underwent propofol coma. All patients were receiving poly-ther-
apy. PER treatment was continued for eight weeks.
Results: During the maintenance period of eight weeks, we registered
cessation of SE in eight of the eleven patients (73%). Six patients
responded within two weeks and two patients within four weeks.
Conclusion: In terms of the efficacy criteria we have chosen, PER is
likely to be effective as an add-on treatment in difficult to treat status
epilepticus in the majority of patients. Early initiation with PER possibly
with a faster titration could be appropriate in patients with refractory sta-
tus epilepticus. The oral administration makes it unlikely that PER will
ever play a role in first line and early second line treatment.
p0552
REAL-WORLDDATAONANTIEPILEPTIC DRUGS
USED IN EPILEPSY TREATMENT IN 2010 AND 2014
G. Karakaya*,†, D.C.R. Van Woensel*, R. Van Tielen*,
W. Kestens*
*MLOZ - Mutualites Libres - Onafhankelijke Ziekenfondsen,
Representation and Studies, Brussels, Belgium, †ULB -
Universite Libre de Bruxelles, Department of Economics
(DULBEA), Solvay Brussels School of Economics and
Management, Brussels, Belgium
Purpose: Antiepileptic drugs (AEDs) are among the most commonly
prescribed centrally active agents. This study describes prescription and
utilization of AEDs among affiliates of the third Belgian health insurer
(MLOZ - Mutualites Libres - Onafhankelijke Ziekenfondsen) in 2010
and 2014.
Method: A detailed descriptive analysis was performed for pharmaco-
logical and behavioural features of about 20,000 patients using AEDs
during at least 3 months per year (ATC Class: N03) from a retrospec-
tively collected database.
Results: We identified 18,045 and 21,865 AED users for 2010 and 2014,
respectively. The prevalence of AED consumption increased from 9.2
(95% CI, 7.8–10.6) to 10.8 (9.5–12.2)/1000 persons during the study per-
iod. According to the age, the proportion of AED users in monotherapy
ranged from 58% (0–11 years) to 82% (>65 years) and the average num-
ber of different AEDs used varied between 1.6 (0–11 years) and 1.2
(>65 years). Valproic acid was the most common AED (35% of epileptic
patients in 2014 vs. 39% in 2010), followed by levetiracetam (19% vs.
14%), lamotrigine (18% vs. 16%) and carbamazepine (15% vs. 19%).
Two out of three AEDs were prescribed by GPs (67%), 15% by neurolo-
gists and 10% by psychiatrists. Prescription of AEDs by GPs increased
with aging (31% for 0–11 years and 82% for >65 years).
Conclusion: The use of administrative databases provides interesting
findings about the prescription of AEDs in real-world. This study identi-
fied prescribing trends in a cohort of patients with epilepsy in Belgium.
Results regarding demographic findings and selection of drug therapy are
comparable to findings from studies in other countries. The strong posi-
tive correlation between monotherapy, prescription by GPs and age of
patients seems to show that the elderly or long-time users are less likely
to have their treatment changed by the prescriber or more likely to have
just prescription renewals.
p0553
IMPACTOF EVEROLIMUS TREATMENTON
QUALITYOFLIFE (QOL) IN PATIENTSWITH
TUBEROUS SCLEROSIS COMPLEX (TSC)WHOHAVE
REFRACTORY PARTIAL-ONSET SEIZURES IN THE
CONTEXTOFAN INTERVENTIONALCLINICAL
TRIAL (EXIST-3)
R. Nabbout*, D.N. Franz†, J. Lawson‡, P. Curatolo§, M. Neary¶,
J. Fan¶, F. Herbst**, K. Sully††, E. Brohan††, P.J. de Vries‡‡
*Hospital Necker-Enfants Malades, Paris Descartes University,
Paris, France, †Cincinnati Children’s Hospital, Cincinnati, OH,
United States, ‡Sydney Children’s Hospital and UNSW
Medicine, Randwick, NSW, Australia, §Tor Vergata University
Hospital, Rome, Italy, ¶Novartis Pharmaceuticals Corporation,
East Hanover, NJ, United States, **Novartis Pharma AG, Basel,
Switzerland, ††Adelphi Values Ltd, Bollington, United Kingdom,
‡‡University of Cape Town, Cape Town, South Africa
Purpose: Three age-specific QoL measures were included as secondary
endpoints in EXIST-3 (NCT01713946), a three-arm, randomized, dou-
ble-blind, placebo-controlled phase III study to assess the efficacy/safety
of two trough exposure ranges of everolimus (Low exposure, LE: 3-7 ng/
mL and high exposure, HE: 9–15 ng/mL), as adjunctive therapy in
patients with TSC with partial-onset refractory seizures (N = 366). The
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aim of this work was to evaluate QoL alongside clinically relevant and
statistically significant reductions in seizure frequency in everolimus-
treated patients.
Method: QoL measures included QoL in Childhood Epilepsy (QOLCE;
caregiver-report for aged 2-<11), QoL in Epilepsy Inventory for Adoles-
cents (QOLIE-AD-48; self-report, aged ≥11-<18), and QoL in Epilepsy
Inventory-31-Problems (QOLIE-31-P; self-report, aged ≥18).
Results: Primary results showed statistically significant improvements
both in the response rate and percentage reduction of TSC-associated sei-
zures from baseline to end of Core phase (Week 18), for both exposure
ranges of everolimus, relative to placebo. At the end of Core phase, the
completion rate for the QOLCE was high across treatment arms (84%,
N = 197). The overall QoL score, as measured by the QOLCE, was asso-
ciated with minimal changes from baseline (LE, +3.1; HE, +4.0; Placebo,
+1.7). In everolimus HE arm, improvements were observed for selected
QOLCE subscales versus placebo: single QoL item (+11.1), physical
restrictions (+5.9) and self-esteem (+9.4). The end of core phase comple-
tion rates for the QOLIE-AD-48 (36%, N = 102) and QOLIE-31-P
(49%, N = 67) were low, limiting the conclusions that can be drawn. The
QOLIE-AD-48 overall QoL score marginally improved for all treatment
arms. The QOLIE-31-P overall QoL score was maintained in the LE
treatment arm and placebo, while minimal negative change from baseline
was observed in the HE arm.
Conclusion: Results provide evidence that efficacy gains with respect to
significant reduction in seizure frequency were achieved without detri-
ment to patients’QoLwhile receiving active treatment for 18 weeks.
p0555
THE EFFECTAFTERGOVERNMENT-GUIDING
INTRODUCTIONOFHLA-B*1502 SCREENINGTEST IN
TAIWAN
Y. Tseng, H.-L. Lin
Sijhih Cathay General Hospital, Neurology, New Taipei,
Taiwan, Republic of China
Purpose: To study the incidence rate of carbamazepine induced Ste-
vens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) after
government-guiding introduction of HLA-B*1502 screening test in Tai-
wan.
Method: Patients who received newly prescribed carbamazepine (ATC
code N03AF01) between January 1, 2007 and December 31, 2013
(n = 9,838) were identified from Taiwan National Health Insurance
Research Database. The dataset was divided into comparison and study
groups according to the prescription date, before or after June 1, 2010,
respectively. Each subject was traced for 60 days from carbamazepine
prescription to observe the occurrence of SJS (ICD-9-CM code 695.1). In
the study group, whether HLA-B*1502 test was ordered prior to carba-
mazepine prescription was examined. The demographic characteristics
of patients and specialty of prescribing physicians were recorded. The
amount of carbamazepine prescription was compared between study and
comparison groups. HLA-B*1502 test order rate was calculated in every
specialty.
Results: There were 2,494 subjects in the study group and 7,344 in the
comparison group. The incidence rate of SJS was 0.24% (6 of 2494) in
the study group and 0.27% (20 of 7344) in the comparison group. P-value
was 0.7896. In the study group, 204 (8.2%) patients received HLA-
B*1502 test and one SJS was observed. Five SJS (0.22%, 5 of 2290) were
identified in those without HLA-B*1502 test. The top three specialists
that reduced carbamazepine prescription were Orthopedics (80%), Reha-
bilitation (79%), Neurology and Neurosurgery (73%) physicians. Pedia-
tricians, Neurologists, and Psychiatrists were more willingly to test
HLA-B*1502 prior to prescribing carbamazepine. The rates of these 3
specialties were 33%, 27%, and 17%, respectively.
Conclusion: The government-guiding introduction of HLA-B*1502
screening test in Taiwan only decreased total number of carbamazepine-
induced SJS and TEN patients but not the incidence rate. Further investi-
gation is needed to find out why the incidence rate did not decrease as
expected.
p0557
COMPARISONOF SEIZUREOUTCOME IN PATIENTS
WITHWEST SYNDROMEAFTEREXTREMELYLOW-
DOSEADRENOCORTICOTROPICHORMONE
THERAPY
N. Matsushima*,†, S. Ito*, Y. Ohtani*, K. Eto*, H. Oguni*,
S. Nagata*
*Tokyo Women’s Medical University, Department of Pediatrics,
Tokyo, Japan, †Juntendo University School of Medicine,
Department of Pediatrics and Adolescent Medicine, Tokyo,
Japan
Purpose: The daily dose of synthesized adrenocorticotropic hormone
(ACTH) forWest syndrome varies widely among hospitals, and a dose of
0.005–0.025 mg/kg/day (equivalent to 0.2–1.0 IU/kg/day of natural
ACTH) is selected in Japan. We selected 0.005 mg/kg/day for patients
<1 year old and 0.025 mg/kg/day for patients >1 year old, with some
modifications based on the underlying condition. Here, we compare the
seizure outcome among 0.005 mg/kg/day, 0.025 mg/kg/day, and “step-
up”
(0.005 ->0.025 mg/kg/day) doses.
Method: We retrospectively reviewed the medical charts of patients
with West syndrome who underwent ACTH therapy at <3 years of age
and were admitted to our hospital between 2005 and 2016.
Results: Forty-three patients were included (20 with 0.005 mg/kg/day
[group A; median 8 months], 13 with 0.025 mg/kg/day [group B; median
19 months], and 10 with “step-up” [group C; median 8 months]. The sei-
zure-free rate among the 3 groups was not significantly different; it was
85% in A, 85% in B, and 80% in C at the end of ACTH therapy; and 65%
in A (median follow-up 42 months), 54% in B (median follow-up
68 months), and 50% in C (median follow-up 88 months) at the final fol-
low-up.
Conclusion: Based on our criteria, the short and long-term seizure out-
comes were not different among the 0.005 mg/kg/day, 0.025 mg/kg/day,
and “step-up” groups. This study indicates that 0.005 mg/kg/day of
ACTH therapy for West syndrome, especially in patients <1 year old,
might provide the same efficacy as that of 0.025 mg/kg/day.
p0558
BEHAVIORALEFFECTSOF LEVETIRACETAM IN
PATIENTSWITHEPILEPSY.WHO IS LIKELYTO
HAVETHEMANDHOWMUCH
P. Kharbanda*, G. Jain*, S. Grover†, M. Goyal*, V. Lal*
*Postgraduate Institute of Medical Education & Research,
Neurology, Chandigarh, India, †Postgraduate Institute of
Medical Education & Research, Psychiatry, Chandigarh, India
Purpose: Levetiracetam is a broad spectrum anti epileptic drug. There
have been concerns regarding its behavioral side effects, but the pattern
or risk factors are not yet clearly defined. This study was conducted to
assess these effects in our setting.
Method: This prospective observational study was undertaken on 157
epilepsy patients who were started on levetiracetam for the first time.
Patients having clear psychiatric syndrome were excluded. Behavior
symptoms were assessed at baseline; and 4, 8 and 12 weeks according to
neuropsychiatry inventory (NPI) which includes ten behavior symptoms.
They were rated according to frequency, severity and caregiver distress.
Results: Behavioral side effects attributable to levetiracetam were found
in 16/157 (10.2%) patients. New onset symptoms were noticed in 10/157
(6.3%) patients while 6/157 patients (3.8%) had exaggeration of baseline
symptoms. Agitation was the most common behavioral symptom. Symp-
toms were severe enough to stop levetiracetam in 9/16 (56.2%) of these
patients. After stopping levetiracetam, symptoms significantly decreased
in severity and frequency in 8/9 (88.8%) of these patients and completely
resolved in 1/9 (11.1%) patient. Suicidal thoughts were present in 2/157
(1.27%) patients. 37/157 (23.5%) patients had baseline behavioral symp-
toms, of which 19/37 (51.3%) had resolution of symptoms after starting
levetiracetam. All of these patients had fully controlled seizures. 12/37
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(32.4%) patients had persistence of symptoms and 6/37 (16.2%) patients
had exaggeration of symptoms. We found significant association of
behavioral side effects with three variables -abnormal MRI brain, higher
doses of levetiracetam at 4 weeks, and unmarried status.
Conclusion: These results show that behavioral side effects are not
uncommon in patients on levetiracetam, and may be dose dependent. The
incidence may be low if patients with clear psychiatric disorders are
excluded. Mild baseline behavioral symptoms may even improve on
levetiracetam; which may partly be due to good seizure control.
p0560
THE IMPACTOF PERAMPANELTREATMENTON
QUALITYOFLIFE AND PSYCHIATRIC SYMPTOMS IN
PATIENTSWITHDRUG-REFRACTORY FOCAL
EPILEPSY
F. Villani*, K. Turner†, G. Didato*, E. Zambrelli†, F. Deleo*,
A. Vignoli†,‡, I. Pappalardo*, V. Chiesa†, C. Pastori*, M. de
Curtis*, M.P. Canevini†,‡, R. Quintas*
*Clinical and Experimental Epileptology Unit, Foundation
Neurological Institute C. Besta, Milano, Italy, †San Paolo
Hospital, Epilepsy Center, Milan, Italy, ‡Universita degli Studi
di Milano, Department of Health Sciences, Milano, Italy
Purpose: Perampanel (PER) adverse effects (AE), such as depressive
symptoms and behavioural changes have been reported. The aim of the
study is to assess prospectively the effect of PER on psychological func-
tioning and Quality of Life (QoL) in a group of patients with drug-refrac-
tory focal epilepsy (DRE), before and during PER adjunctive treatment.
Method: Patients with DRE have been enrolled in this 18-months dura-
tion study. Socio-demographic and clinical information have been col-
lected. QoL levels, irritability, depressive symptoms and anxiety have
been assessed using the QoLIE-31, the Irritability Questionnaire, the
BDI-II, and the STAI Y-1 and Y-2 questionnaires, at three time points
(before PER, after 3 and 6 months).
Results: Data from 45 patients (females 40%, mean age 40.4 yrs SD
12.17) was collected. Before PER, QoL levels are slightly lower in our
sample compared to normative epilepsy data in overall QoLIE-31 score
(mean 61.14 SD 15.72), emotional well-being score (mean 65.53 SD
13.50) and social functioning score (mean 60.96 SD 23.54), depressive
symptoms were slightly higher than normative population (mean 15.36
SD 12.17), while anxiety and irritability scores were found not pathologi-
cal according to normative data. Comparing T0 and T2 assessments, a
slight increase in QoL scores were found for all scales (except for social
functioning: 56.71 SD 20.50), irritability scores become pathological
(mean 42.29 SD 17.76), while depressive symptoms decrease (mean
14.50 SD 10.43) and anxiety scores remain not pathological according to
normative data.
Conclusion: This longitudinal study allow us to conclude that QoL
levels increase after PER treatment together with a reduction in depres-
sive symptoms and anxiety levels. However, irritability symptoms seems
to worse in time as AE of PER treatment. Furthermore, the current instru-
ments proved to be accurate and able to provide reliable information on
the psychological functioning of patients with DRE submitted to PER
treatment.
p0562
OVERVIEWOFTHE SAFETYANDTOLERABILITYOF
ESLICARBAZEPINE ACETATE IN ELDERLYVERSUS
NON-ELDERLY PATIENTSWITH PARTIAL-ONSET
SEIZURES
L. Magalh~aes*, R. Costa*, J. Graca*, M. Vieira*, H. Gama*,
J. Moreira*, F. Rocha*, P. Soares-da-Silva*,†
*Bial - Portela & Ca. SA, S. Mamede do Coronado, Portugal,
†University of Porto, Porto, Portugal
Purpose: Limited safety data are available in the scientific community
concerning the use of eslicarbazepine acetate (ESL) in elderly popula-
tion. Therefore, a pooled analysis of seven clinical trials (CTs) was con-
ducted to assess the ESL safety/tolerability in elderly patients (≥65-
years-old) diagnosed with partial-onset seizures (POS). The incidence of
treatment-emergent adverse events (TEAEs) was used to assess this issue
and for comparison purposes with non-elderly patients (18 to 64-years-
old).
Methods: Data from double-blind, open-label phase II/III CTs in POS
(BIA-2093-201,-301 (Part I-IV),-302 (Part I-II),-303 (Part I-II),-304 (Part
I),-311, and -401) were pooled and analysed by age categories (18–64
and ≥65-years-old). For study -311, only data collected up to September
24th 2015 were included.
Results: The elderly patients treated with ESL (n = 120) showed a simi-
lar safety profile to non-elderly patients (n = 1863). At least one TEAE
occurred in 75.8% of elderly patients (vs.74.9% non-elderly), with 51.7%
reported as possibly-related TEAEs (vs.53.9% non-elderly). Overall,
20% of elderly patients discontinued treatment prematurely due to
TEAEs (vs.16.8% non-elderly). Serious TEAEs reported were higher in
elderly patients (21.7%) than in non-elderly (7.6%).
For both age categories, dizziness and somnolence were the most fre-
quently reported TEAEs representing 20.2% and 12.6% in the non-
elderly group and 10.8% and 9.2% in the elderly group, respectively.
However, the incidences of at least possibly-related individual TEAEs
differed in both categories: hyponatremia (6.7% vs.1.5%), fatigue (5.8%
vs.3.5%), ataxia (4.2% vs.3.7%) and increased gamma-glutamyltransfer-
ase (3.3% vs.0.6%) were more frequent in elderly population (vs.non-
elderly). In non-elderly patients (vs. elderly), besides dizziness and som-
nolence, headache (8.2% vs.5.8%), nausea (8.0% vs. 5.0%) and diplopia
(6.8% vs.2.5%) and vertigo (3.5% vs.2.5%) had higher incidence. Con-
cerning hyponatremia, 1.7% serious TEAEs were reported in elderly
patients (vs.0.2% non-elderly).
Conclusion: Overall TEAEs data collected indicate that no specific
safety issue was identified for the elderly compared with non-elderly
patients.
p0563
EFFICACYANDTOLERABILITYOFLACOSAMIDEAS
ADD-ONTREATMENT IN PATIENTSWITH
REFRACTORYEPILEPSYAND INTELLECTUAL
DISABILITY
T. Svendsen*, K.O. Nakken*, M.I. Lossius*, S.I. Johannessen*,†,
E. Brodtkorb‡, A. Baftiu§, C. Johannessen Landmark*,†,§
*National Center for Epilepsy, Oslo University Hospital,
Sandvika, Norway, †Department of Pharmacology, Oslo
University Hospital, Oslo, Norway, ‡Department of Neurology,
St Olavs Hospital, Trondheim, Norway, §Department of Life
Science and Health, Oslo and Akershus University College of
Applied Sciences, Oslo, Norway
Purpose: To assess the efficacy and tolerability of lacosamide (LCM) in
patients with difficult-to-treat epilepsy and learning disability.
Methods: In the TDM-registry at the Norwegian Center for Epilepsy in
the period 2013–16, 277 patients using LCM were identified. By going
through the patients’medical records, 74 (33%) patients appeared to have
refractory epilepsy and learning disability. The efficacy and tolerability
of LCM in these 74 patients were analysed.
Results: The study population consisted of 37 females and 37 males.
The average age was 31 years, and the median duration of epilepsy was
19 years. The average number of previously tried AEDs was 7.4. In addi-
tion to LCM, they used 1–4 other AEDs.
Improved seizure control (>50% reduction of seizure frequency) was
obtained in 51 patients (69%), of whom two (2.7%) became seizure free.
In 23 patients (31%), LCM had no seizure reducing effect. The drug had
been withdrawn in 21 patients, in 7 due to lack of efficacy, 6 due to
adverse effects and 6 due to a combination of these. The retention rate
after 1 year was 83%. 32 of the patients (43%) had used LCM for more
than 3 years.
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The mean daily dose of LCM was 321 mg (25 - 600 mg), and mean
serum concentration was 20 mmol/L (<10–50).
Adverse effects were reported in 27 patients (37%). There were no
serious adverse events. The most commonly reported side effects were
gastrointestinal discomfort, headache, dizziness, sedation, psychiatric
symptoms.
Conclusion: The present study shows that LCM given as add-on drug
appears to be favorable in treating patients with difficult-to-treat seizures
and learning disability. Improved seizure control was achieved in about
2/3 of patients, and in most cases the drug was well tolerated.
p0564
DENOVOMULTIFOCALMYOCLONUS INDUCEDBY
LAMOTRIGINE INATEMPORAL LOBEEPILEPSY
CASE
L. Ricci, M. Tombini, G. Assenza
University Campus Bio Medico of Rome, Rome, Italy
Introduction: Exacerbation or de novo LTG-induced myoclonus has
been reported in patients with various types of epilepsy. We report the
first case of de novo LTG-induced multifocal myoclonus in a patient
affected by temporal lobe epilepsy.
Description: A 34-year old man came to our attention because of fre-
quent complex partial seizures resistant to antiepileptic drugs. He was
treated with valproic acid (VPA) up to 1000 mg/day, with only partial
control of seizures; thus, at the age of 17, LTG was progressively titrated.
Clinical and electroencephalographic data were consistent with a diagno-
sis of TLE without mesial sclerosis. Afterwards the patient showed a
complex partial seizure with verbal automatisms, followed by confusion
and drowsiness. During the following video-EEG monitoring he showed
myoclonic jerks and frequent spikes and sharp waves in the left fron-
totemporal regions. The level of VPA was normal, while the level of
LTGwas slightly above the therapeutic range.
Discussion: We hypothesized that LTG induced a de novo myoclonus,
possibly in a dose-dependent manner. The myoclonus induced by LTG
has been usually reported in generalized epilepsies. In most of these
cases, LTGwas added to a pre-existing VPA therapy, leading to synergis-
tic pharmacodynamic interactions. The myoclonus onset or aggravation
induced by LTG can also depend on genetic susceptibility. To our knowl-
edge, this is the first report of a de novomultifocal myoclonus induced by
LTG toxicity in an adult with TLE.
Conclusion: Probably, different factors contribute to generation of the
myoclonic phenomenon, including type of epilepsy (focal/generalized),
etiology (symptomatic/idiopathic), genetic predisposition (i.e. SCN1A
mutations), as well as the LTG plasmatic concentration. Furthermore, on
the basis of the EEG NREM pattern of our patient we hypothesize a
potential role of the cyclic alternating pattern (CAP) during NREM sleep
as a facilitating factor in the development of myoclonus in our patient.
p0565
ADJUNCTIVE PERAMPANEL IN PATIENTSWITH
DRUG-RESISTANT PARTIAL SEIZURESWITHAND
WITHOUTCONCURRENTVNS THERAPY IN PHASE
III STUDIES
P. Klein*, A. Laurenza†, B. Williams†, A. Patten‡
*Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, United
States, †Eisai Inc, Woodcliff Lake, NJ, United States, ‡Eisai Ltd,
Hatfield, United Kingdom
Purpose: Perampanel is approved for adjunctive treatment of partial sei-
zures with or without secondarily generalized seizures and for primary
generalized tonic-clonic seizures in patients with epilepsy aged ≥12 yrs.
This post-hoc analysis reports efficacy and safety of perampanel in sub-
jects with drug-resistant partial seizures with and without concurrent
VNS therapy from Phase III clinical studies.
Method: Subjects with drug-resistant partial seizures were aged ≥12 yrs
and receiving 1–3 concomitant AEDs. VNS must have been implanted
≥5 mos before Visit 1; stimulator parameters were to remain stable. After
a 6-wk baseline, subjects were randomized to once-daily double-blind
treatment (6-wk titration, 13-wk maintenance) with placebo or peram-
panel 2, 4, 8, or 12 mg. Data were pooled for this post-hoc analysis, and
efficacy and safety were analyzed by concurrent VNS status.
Results: The full intent-to-treat population included: +VNS = 130 and -
VNS = 1348. Number of concomitant AEDs at baseline and baseline
characteristics were generally similar between VNS subgroups. Median
baseline seizure frequency was higher in +VNS subjects
(placebo = 18.1, perampanel 2 mg = 29.2, 4 mg = 28.0, 8 mg = 17.7,
12 mg = 27.3) vs -VNS (placebo = 10.2, perampanel 2 mg = 9.8,
4 mg = 9.8, 8 mg = 11.6, 12 mg = 12.1). During the double-blind
phase, reductions in seizure frequency/28 days and responder rates were
similar in +VNS and -VNS subjects. Higher total rates of TEAEs, SAEs,
and TEAEs leading to withdrawal were observed for perampanel- and
placebo-treated +VNS vs -VNS subjects. Most TEAEs in both VNS sub-
groups were considered mild or moderate; no deaths were reported. Limi-
tations are the small number of subjects with VNS in this post-hoc
analysis, which is not powered to show significance between VNS sub-
groups.
Conclusion: In subjects with drug-resistant epilepsy, adjunctive peram-
panel 4, 8, and 12 mg reduced the occurrence of seizures, regardless of
subjects’ use of concurrent VNS therapy. Safety data are consistent with
and without VNS, with somewhat higher event occurrences for both per-
ampanel and placebo with VNS.
p0566
ESLICARBAZEPINE ACETATE (ESL) IN TREATMENT
OFCHILDHOODFOCALEPILEPSY
M. Larsen*, K. Olofsson*, B. Jepsen*, P. Gellert*,
R. McMurray†, M. Nikanorova*
*Danish Epilepsy Center (Filadelfia), Dianalund, Denmark,
†Eisai IncEurope Ltd, European Knowledge Center, Hatfield,
United Kingdom
Purpose: To evaluate the clinical efficacy and tolerability of ESL in
children with focal epilepsies and to compare those of CBZ and OXC.
Method: 45 children (28 boys, 17 girls; age 4–17 years) with focal
epilepsies treated with ESL at the Danish Epilepsy Centre between
01.01.2012 and 31.12.2016 were included. Therapy duration varied from
six to 48 months. Thirty patients received ESL as add-on treatment and
15 as monotherapy. Treatment response was assessed as seizure-free,
>50% seizure reduction, <50% and non-responders. Fifteen patients were
earlier treated with CBZ, seven with OXC, 12 patients tried both drugs.
The clinical effect and tolerability of ESL, CBZ and OXC were evalu-
ated.
Results: ESL showed 50–100% seizure reduction in 61.4% of patients,
in 38.6% of cases its efficacy was lacking. ESL was well tolerated by all
but one patient (withdrawal due to skin rash). None of the children previ-
ously treated with CBZ and OXC were seizure-free. After ESL initiation
the complete seizure control was achieved in 6/27 patients in CBZ-group,
and 4/19 patients in OXB-group. ESL had much better side effect profile
compared with CBZ. CBZ was withdrawn in six patients while ESL only
in one.
Conclusion: ESL if effective and well tolerated drug in children with
refractory focal epilepsy. It was equally effective in focal hypomotor,
hypermotor and secondary generalized seizures. ESL showed higher effi-
cacy and better tolerability compared with CBZ and OXC.
p0570
EFFICACYANDTOLERABILITYOF PERAMPANEL IN
ADULTSWITHEPILEPSY FROMAMEDICALCENTER
IN TAIWAN: AN INITIAL REALWORLDEXPERIENCE
T. Wu, H.-I. Chiang, S.-N. Lim, W.-E.J. Tseng, M.-Y. Cheng, H.-
Y. Hsieh, H.-T. Li
Chang Gung Memorial Hospital Linkou Medical Center,
Epilepsy Section, Department of Neurology, Taoyuan, Taiwan,
Republic of China
S105
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Purpose: To evaluate the safety and efficacy of Perampanel in epilepsy
in adults in real life settings and understand the efficacy and safety of a
drug outside clinical trials. Here we report a data from a large series of
patients treated with perampanel in Taiwanese population over a period
of 6 months.
Method: Patients were retrospectively observed for 6 months. At the
end of 6 months, seizure freedom, median percentage seizure reduction,
responder rate, retention rate and patients with adverse events (AEs) were
evaluated.
Results: Of 232 patients on perampanel, 223 patients were as add on
therapy. 92 completed 6 months of evaluation, 57 were continuing and
74 patients discontinued because of lack of efficacy/AEs/lost to follow
up or subject choice.The mean age was 39 years and mean duration of
epilepsy was 20.8 years. 91.3% patients had focal epilepsy with or with-
out SGTC, 6.5% had PGTC. Number of cocomitant AEDs at baseline,
majority were on 2–4 AEDs. 82.6% patients were on enzyme inducers.
Responder rate at 6 months was 56.7% and seizure freedom was 24.4%.
Majority of the patients were on 4–6 mg of Perampanel. The seizure fre-
quency reduction with 2–4 mg was 66.7% and 82.1% with 6 mg. The
retention rate at end of 3 months and 6 months were 79.5 & 62.3%
respectively. 45.7% had TEAEs and 13% of patients discontinued medi-
cine. Most common TEAEs were diziness, somnolence, irritability,
malaise and weight gain.
Conclusion: Perampanel is effective and well tolerated in patients with
epilpesy. Seizure freedom was 24.4% at end of 6 months with a retention
rate of 62.3%. It is important to understand the efficacy and safety outside
the clinical trial setting and results are similar to other published real
world data on Perampanel.
p0571
ACOMMONREFERENCE-BASED INDIRECT
COMPARISONMETA-ANALYSIS OFNEW
GENERATIONANTIEPILEPTIC DRUGS AS
MONOTHERAPY TREATMENTS FORNEWLY-
DIAGNOSED FOCAL-ONSET SEIZURES
F. Brigo*,†, N.L. Bragazzi‡, N. Raffaele†,§, F. Tezzon†, E. Grillo¶
*Department of Neuroscience, Biomedicine and Movement
Science, University of Verona, Verona, Italy, †Department of
Neurology, Franz Tappeiner Hospital, Merano, Italy,
‡Department of Health Sciences (DISSAL), School of Public
Health, University of Genoa, Genoa, Italy, §Department of
Neurology, Christian Doppler Klinik, Paracelsus Medical
University, Salzburg, Austria, ¶Medical Department Eisai s.r.l.,
San Donato Milanese, Italy
Purpose: To indirectly estimate the efficacy and tolerability of novel
antiepileptic drugs (AEDs) used as monotherapy for adults with newly
diagnosed focal-onset seizures through a common-reference based indi-
rect comparison meta-analysis.
Method: We systematically searched RCTs double-blind randomized
controlled trials (RCTs) directly comparing gabapentin, pregabalin,
oxcarbazepine, perampanel, topiramate, lamotrigine, levetiracetam, zon-
isamide, lacosamide or eslicarbazepine acetate versus controlled-release
carbamazepine (CR-CBZ) as monotherapy treatments for adults (sub-
jects ≥ 16 years) with newly-diagnosed focal-onset seizures were
included in the meta-analysis. Following outcomes were collected: 1.
proportion of patients achieving at least 26-weeks seizure freedom during
the maintenance period (intention-to-treat population / full-analysis set
and per-protocol population/set); 2. proportion of patients seizure-free
for at least 52 consecutive weeks (intention-to-treat population / full-ana-
lysis set and per-protocol population/set); 3. proportion of patients with
treatment-emergent adverse events (TEAEs) during the treatment period
(safety population); 4. proportion of patients with TEAEs leading to dis-
continuation during the treatment period (safety population). Random-
effects Mantel-Haenszel meta-analyses were performed to obtain odds
ratios (ORs) for the efficacy/tolerability of each new generation AED
versus placebo. Adjusted indirect comparisons were then made between
each new generation AED using the obtained results.
Results: Only four monotherapy RCTs comparing new AEDs versus
CR-CBZ were identified and eventually included. Monotherapy AEDs
compared to CBR-CR were: levetiracetam, zonisamide, lacosamide, and
eslicarbazepine acetate. For other AEDs we did not find any monother-
apy RCT against CR-CBZ. Indirect comparisons showed no difference
between each new AED in any efficacy and safety/tolerability outcome
considered.
Conclusion: Indirect comparisons failed to find a significant difference
in efficacy and safety/tolerability between new AEDs used as monother-
apy treatments for newly-diagnosed focal-onset seizures. This finding
might partially be explained by type II statistical error. Apart from effi-
cacy and tolerability, other aspects should be considered when choosing
a new AED.
p0572
GENDERDIFFERENCES IN SAFETYOF
ANTIEPILEPTIC DRUGS
R. Shaimardanova*,†, F. Zaikova†,‡, R. Gamirova*,†,‡
*Department of Basic and Clinical Pharmacology, Kazan
Federal University, Kazan, Russian Federation, †Kazan
Municipal Children’s Hospital No. 8, Kazan, Russian
Federation, ‡Department of Pediatric Neurology, Kazan State
Medical Academy, Kazan, Russian Federation
Purpose: To assess the gender differences in safety of most commonly
used antiepileptic drugs (AED) in the treatment of epilepsy.
Method: We conducted a retrospective analysis of medical records of
392 epileptic outpatients (174 males - 44%, mean age = 11 years; 218
females - 56%, mean age = 14 years), who used monotherapy of val-
proates, or carbamazepine, or topiramate, or oxcarbazepine, or levetirac-
etam, or lamotrigine in 2015–2016. We calculated risk ratios (RR) and
95% confidence intervals (95% CI) for unfavorable outcome (assessment
of the safety): the number of patients with adverse effects using software
package RevMan 5.3. We compared the unfavorable outcome between
male and female patients. The results were considered significant when a
P-value was less than 0.05.
Results: Valproates were used in monotherapy in 58%, carbamazepine -
in 18%, topiramate - in 14%, oxcarbazepine - in 5%, levetiracetam - in
3%, lamotrigine - in 2% of cases. The risk ratio for the number of males
versus females, who had adverse reactions during monotherapy of val-
proates was as follows: RR = 0.85 95% CI [0.64 to 1.13], of carba-
mazepine - RR = 1.15 95% CI [0.68 to 1.93], of topiramate - RR = 1.17
95% CI [0.75 to 1.82], of oxcarbazepine - RR = 1.13 95% CI [0.34 to
3.74], of levetiracetam - RR = 0.50 95%CI [0.06 to 4.15], of lamotrigine
- RR = 1.33 95%CI [0.13 to 13.74], respectively.
Conclusion: No significant gender differences were found for the safety
of monotherapy of valproates, carbamazepine, topiramate, oxcar-
bazepine, levetiracetam and lamotrigine using as unfavorable outcome
the number of patients with adverse effects.
The authors report no conflicts of interest in this work.
p0573
SOCIALCOGNITIONOFCHILDREN EXPOSEDTO
ANTIEPILEPTIC DRUGS INUTERO
Y. Huber-Mollema*,†, H.R. Rodenburg*,†, D. Lindhout*,
F.J. Oort†, EURAP Development
*Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands, †University of Amsterdam, Amsterdam,
Netherlands
Purpose: Children exposed to antiepileptic drugs in utero are at higher
risk for congenital malformations. Long-term effects on child neurocog-
nitive and behavioral outcome are however hardly known. As a higher
risk for autistic spectrum disorders appears, the aim of this study is to
investigate emotion recognition ability and social perception of children
of mothers with epilepsy who were exposed to anti-epileptic drugs in
utero by measuring ‘Affect Recognition’ and ‘Theory of Mind’.
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Methods: Children exposed in utero to antiepileptic drugs (monother-
apy: VPA, CBZ, LTG, LEV), 6/7 years of age at testing, their mothers
and fathers were asked to participate in a longitudinal study by conduct-
ing neuropsychological tests (NEPSY-II-NL). Inclusion was on the basis
of an earlier inclusion of the mothers with epilepsy in the European Reg-
istry of Antiepileptic Drugs in Pregnancy (EURAP-NL) database. Analy-
ses MANOVA will be calculated to evaluate differences between
children exposed to the four types of antiepileptic drugs, and to compare
the children exposed to AEDs to children from te general population.
Results: Results of the approximately first 125 children will be presented
on the basis of the first wave assessment.
Conclusion: Social cognition will be discussed in relation to the risk for
autism in this group of children.
p0574
NEUROCOGNITIVE DEVELOPMENTOFCHILDREN
PRENATAL EXPOSEDTOANTIEPILEPTIC DRUGS:
PRELIMINARYRESULTSOF THEDUTCH
PROSPECTIVEOBSERVATIONAL STUDYEURAP&
DEVELOPMENT (NL)
Y. Huber-Mollema*,†, H.R. Rodenburg*,†, D. Lindhout*,
F.J. Oort†, EURAP Development
*Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands, †University of Amsterdam, Amsterdam,
Netherlands
Rationale: In the past years, there has been increasing attention for the
long-term effects of exposure to antiepileptic drugs during pregnancy.
For future mothers with epilepsy, it is important to further clarify the
effects of prenatal exposure to antiepileptic drugs on neurocognitive
development as to make a weighted choice between the risks for the
mother with epilepsy and for the unborn child.
Objective: EURAP & Development (NL) is a prospective longitudinal
study of children of mothers with epilepsy who were exposed to anti-
epileptic drugs in utero in which neurocognitive and behavioral develop-
ment, and parenting is investigated. The current study aims to examine
the neurocognitive abilities. The research question is: What are the long-
term effects of exposure to monotherapy VPA, CBZ, LTG or LEV during
pregnancy on neurocognitive development of children of 6/7 years of
age?
Methods: Children born between 2007–2010 and their mothers and
fathers were asked to participate by conducting neuropsychological tests
(e.g., WISC-III-NL, NEPSY-II-NL), and by completing questionnaires.
Inclusion was on the basis of an earlier inclusion of the mothers with epi-
lepsy in the European Registry of Antiepileptic Drugs in Pregnancy
(EURAP-NL) database.
Analyses: MANOVAwill be conducted to evaluate differences between
children exposed to the four types of antiepileptic drugs. Child IQ is the
primary outcome variable. Secondary outcomes are more specific cogni-
tive abilities.
Results: In anticipation of the upcoming report, preliminary results of
the approximately first 125 children will be presented.
Conclusion: On basis of the results neurocognitive effects of prenatal
exposure to antiepileptic drugs will be discussed.
p0575
EFFECTSOF ESLICARBAZEPINEACETATEONLIPID
METABOLISM PROFILEAND SODIUMVALUES: A
RETROSPECTIVE STUDY INOURPATIENTS
P. Pulitano*, M. Brienza†, C. Davassi†, E. Vicenzini*,
O. Mecarelli*
*Neurology and Psychiatry, Sapienza University of Rome,
Rome, Italy, †Medico-Surgical Science and Biotechnologies,
Sapienza University of Rome, Rome, Italy
Purpose: To characterize the association among eslicarbazepine acetate
(ESL), plasma lipid levels and sodium values and to compare it with pre-
vious effects of traditional dibenzazepine drugs.
Method: This is a retrospective cohort study. We considered 36 adult
patients suffered from focal onset epilepsy with and without tonic-clonic
bilateral evolution, in add-on treatment with ESL (800–1200 mg/die). In
8/36 patients, ESL was begun by switching from carbamazepine (CBZ)
or oxcarbazepine (OXC). The average time of treatment was
10.5 months (range 6–18). 7 patients (19.4%) were already affected by
dyslipidemia, nobody by hyponatremia. The lab values assessed prior
and after 6 and 12 months of treatment were natremia, total cholesterol,
low and high density lipoproteins (LDL and HDL), triglycerides (TGC).
Results: After 6 months of treatment with ESL, we compared the mean
total cholesterol and LDL values before and during ESL therapy (total
cholesterol values 191.3  29.6 vs 179.7  29.2 mg/dl, p < 0.0001;
LDL 114.58  22.7 vs 103.11  19.46 mg/dl, p < 0.0001). Further-
more, we evaluated HDL values before and during ESL (57.5  9.1 vs
63.9  8.3 mg/dl; p.0001). No statistically significant changes were
detected in TGC values. ESL was interrupted in 2 patients, after
6 months, because of serious hyponatremia whereas in the other patients,
we didn’t observe significant changes of sodium values.
Conclusion: Severe hyponatremia occurred in 6% of patients.The mean
total cholesterol and LDL values decreased significantly and HDL
increased during treatment with ESL: this suggests that ESL is possibly a
safe drug that doesn’t affect negatively the lipid metabolism profile. This
represents a difference from CBZ and OXC maybe because ESL binds
plasmatic proteins with lower affinity and it is a weaker inducer of liver
metabolism. However, a greater number of cases and a more prolonged
period of observation are necessary to confirm the results.
p0577
PERAMPANEL INROUTINECLINICALUSEACROSS
EUROPE: POOLEDOBSERVATIONAL STUDIES
A. Rohracher*, G. Zimmermann*, V. Villanueva†,
I. Garamendi‡, J. Sander§, R. Shankar¶, E. Ben-Menachem**,
M.J. Brodie††, M.C. Pensel‡‡, T. Wehner§§, G. Di Gennaro¶¶,
A. Maurousset***, A. Strzelczyk†††, S. Rheims‡‡‡, A. Racz§§§,
K. Menzler¶¶¶, V. Bertol-Alegre****, I. Garcıa-Morales††††,
F.J. Lopez-Gonzalez‡‡‡‡, M. Toledo§§§§, E. Trinka*
*Christian Doppler Klinik, Paracelcus Medical University,
Salzburg, Austria, †Hospital Universitario y Politecnico La Fe,
Valencia, Spain, ‡Hospital Universitario Cruces, Baracaldo,
Spain, §UCL Institute of Neurology, National Hospital for
Neurology and Neurosurgery, London, United Kingdom,
¶Cornwall Partnership NHS Foundation Trust, Exeter, United
Kingdom, **Sahlgrenska Academy, University of Gothenburg,
Gotheburg, Sweden, ††Epilepsy Unit, West Glasgow ACH -
Yorkhill, Glasgow, United Kingdom, ‡‡University Hospital of
Bonn, Department of Epileptology, Bonn, Germany, §§National
Hospital for Neurology and Neurosurgery, London, United
Kingdom, ¶¶IRCCS NEUROMED, Pozzilli, Italy, ***University
Hospital Bretonneau and INSERMU 930, Tours, France,
†††University Hospital Frankfurt, Frankfurt, Germany,
‡‡‡Hospices Civils de Lyon, Lyon, France, §§§Department of
Epileptology, University Hospital of Bonn, Bonn, Germany,
¶¶¶University Hospital Marburg, Marburg, Germany,
****Hospital Universitario Miguel Servet, Zaragoza, Spain,
††††Hospital Clinico San Carlos, Madrid, Spain, ‡‡‡‡Complejo
Hospitalario Universitario Santiago, Santiago de Compostela,
Spain, §§§§Hospital Universitario Vall d’Hebron, Barcelona,
Spain
Purpose: Data gathered during routine clinical use of a drug can provide
useful information in populations typically excluded from trials.
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Methods: Patient-level data from 46 centres across Europe were merged
into a single dataset. Pre-specified outcomes were: 1-year retention rate,
1-year seizure-freedom rate, incidence of adverse events (AEs). Relation-
ships were also explored with cumulative logistic regression analyses.
Results: We included 2332 people with epilepsy treated with peram-
panel. Median epilepsy duration was 27.0 years; 30.5% had previous
psychiatric history; median previously used AEDs was 6; and median
concomitant AEDs at baseline was 2 (including enzyme-inducers in
71%).Most had focal seizures (79%; 5% generalized; 16% focal and gen-
eralized). At 12 months, 49.5% were still taking perampanel, and 6.2%
discontinued due to intolerability. Median time on perampanel was
11.1 months and median dose was 8 mg. Seizure freedom (≥6 months)
was seen in 9.2% at 1 year (74/803 in whom data were available), and
≥50% reduction in seizure frequency in 45.6%. During the first year, AEs
were reported in 59.0% (1067/1808 in whom data were available), and
were more frequent in those titrated every 2 weeks or quicker than in
those in whom titration was slower. The most common AE categories
were somnolence/sleepiness (15.4%), dizziness/vertigo (13.4%), and
behavioural AEs (12.0%). Logistic regression found no factors to be
associated with AE rates. Six-month seizure freedom at 1 year was asso-
ciated with higher age at perampanel initiation, use of non-enzyme-indu-
cing AEDs, and lower number of previously failed AEDs.
Conclusion: Across a large European population, add-on perampanel
was retained for ≥1 year in about 50% of patients and 9.2% were seizure
free for ≥6 months. AEs were in line with previous reports.
Acknowledgements: Data analysis and writing were supported by an
Investigator-Initiated Study grant from Eisai Ltd, as was data collection
at some study sites.
p0578
USEOFESLICARBAZEPINE INCHILDRENAND
ADOLESCENTSWITHREFRACTORYEPILEPSYAT
TWONATIONALEPILEPSYCENTERS, DENMARK
ANDNORWAY
A. Baftiu*, M.L. Burns†, M. Nikaronova‡, A. Ramm-Pettersen§,
J.B. Rasmussen‡, S.I. Johannessen†,§, C.J. Landmark*,†,§
*Oslo and Akershus University College of Applied Sciences,
Oslo, Norway, †Oslo University Hospital, Department of
Pharmacology, Oslo, Norway, ‡Epilepsy Hospital Filadelfia,
Dianalund, Denmark, §The National Center for Epilepsy, Oslo
University Hospital, Sandvika, Norway
Purpose: Eslicarbazepine acetate (ESL) is a novel antiepileptic drug
(AED) approved for treatment of focal seizures as add-on in adults, ado-
lescents and children >6 years, but in the first years of marketing only for
use in adults. Data on use in children and adolescents are scarce. The pur-
pose of this study is to investigate the use of ESL in these two groups in
relation to age, comedication and duration of treatment.
Method: Retrospective anonymous data regarding children/adolescents
(<17 years) from the therapeutic drug monitoring (TDM)-databases at
the National Center for Epilepsy (SSE), Oslo University Hospital Oslo,
Norway, and The Danish Epilepsy Center, Filadelfia, Denmark, and clin-
ical data frommedical records during 2010–15 were collected.
Results: Data from 50 children and adolescents were included (in- and
out-patients), 21 girls/29 boys. Median age was 13 years (3–16), median
dose of ESL was 800 mg/day (400–1600) and serum concentration
58 lmol/L (10–100) (n = 17). TDM-data were lacking for the other
patients. Median concentration/dose-ratio was 0.07 (0.01–0.1). Only 4
children were <6 years. Polytherapy with eslicarbazepine was applied in
34 patients (combination with 1–2 other AEDs), most common combina-
tions: levetiracetam (14), topiramate (10) and clobazam (8). Thirteen dis-
continued the treatment, on average after 137 days (0–1155).
Conclusion: The present study shows that ESL was mostly used in ado-
lescents, although off-label use was observed. Combination with other
AEDs was common. 26% of the patients discontinued the treatment.
There should be increased focus on documentation of use and pharma-
cokinetic variability by use of TDM of new AEDs in children and adoles-
cents in a clinical setting.
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TREATMENTWITHANESTHETIC ANTICONVULSIVE
DRUGS IN STATUS EPILEPTICUS. BENEFICIALOR
HARMFUL?
J. Redecker*,†, M. Wittstock*, J. R€osche*,‡
*Universit€at Rostock, Klinik und Poliklinik f€ur Neurologie,
Rostock, Germany, †Klinikum Braunschweig, Neurologische
Klinik, Braunschweig, Germany, ‡Swiss Epilepsy Centre,
Z€urich, Switzerland
Purpose: Nowadays there is an ongoing discussion about the risks and
benefits of anesthetic treatment of status epilepticus (SE), especially con-
cerning the outcome. Therefore, we performed a retrospective database
analysis to examine the influence of treatment with anesthetic drugs and
narcosis in SE on mortality and disability.
Method: In a retrospective databank analysis all treatment episodes of a
NCSE between January 2010 and June 2013 in the department of Neurol-
ogy at Rostock University Hospital were identified and evaluated. SE
severity before treatment, mortality and disability at discharge were
taken into account.
Results: In 24 of 145 treatment episodes anesthesia was used. Although
the status epilepticus severity score (STESS) was higher in the anesthesia
group (3.5 SD 1.5 vs. 2.2 SD 1.4, U-test p < 0.0007), no patient treated
with anesthesia died while in the hospital. In the group not treated with
anesthesia 13 patients died (chi-square p = 0.09). For the majority of
these patients respiratory failure after pneumonia was the cause of death.
By the point of hospital-discharge, the patients who were treated with
anesthesia were more often diagnosed with a new neurological deficit
than the others (54.2% vs. 18.2%, chi-square p < 0.0002). Consequently,
excluding the patients who died, the patients who did not receive a treat-
ment with anesthesia had a smaller deterioration in the modified rankin
scale (mRS) at the date of their discharge compared to the estimated mRS
before occurrence of SE than the others (p = 0.03).
Conclusion: In this sample of patients there was a trend to lower mortal-
ity in the group of patients treated with anesthesia for SE. But preventing
death may result in new neurological deficits.
p0585
COMPARATIVE STUDYABOUTEFFECTSOF
DIBENZAZEPINESOVERLIPIDMETABOLISM
PROFILE, SODIUMVALUES, LIVER FUNCTIONTESTS
ANDBLOODCELLCOUNT
M. Ley Nacher*, P. Alessandro*, A. Tauste†, S. Alvaro*,
R. Rocamora‡
*Hospital del Mar, Epilepsy Monitoring Unit, Neurology
Department, Barcelona, Spain, †UPF, Computational
Neuroscience Group, Barcelona, Spain, ‡Hospital del Mar,
Neurology Department, Barcelona, Spain
Purpose: Older dibenzazepines with a carboxamide substitution had
been demonstrated to cause deleterious effects over lipid metabolism
profile, frequent hyponatremia as well as changes in liver function tests
and blood cell counts. However some of these adverse effects are more
evident with carbamazepine (CBZ) than with oxcarbazepine (OXC) or
eslicarbazepine acetate (ESL). The aim of this study was to compare the
effects of these 3 antiepileptic drugs over the previously mentioned vari-
ables.
Method: Retrospective study of consecutive patients attended in our
center between 1998 and 2016 and treated with CBZ, OXC or ESL. Vari-
abilty and evolution lipid metabolism profiles, sodium, blood cell count
and liver function tests was studied and compared between the 3 groups.
Patients whose treatment for dyslipidemia was modified during the study
period or with medical conditions that could modify the mentioned vari-
ables were withdrawn of the analysis.
Results: 303 patients were analyzed, 53% were males; average age was
44; 167 patients were under treatment with CBZ, 55 under treatment with
OXC and 81 under treatment with ESL. Average follow up of the entire
sample was 48 months. Patients under treatment with CBZ suffered a
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statistically significant greater impact over lipid metabolism profile when
compared with patients under treatment with OXC or ESL. Patients under
treatment with OXC showed a statistically significant higher frequency
of hyponatremia than patients under treatment with CBZ or ESL. No sta-
tistical differences were detected between groups related to liver function
tests or blood cell count.
Conclusion: In our sample CBZ showed a greater impact than OXC or
ESL over lipid metabolism profile, while OXC showed a higher fre-
quency of hyponatremia. No other clinically relevant or statistically
significant changes were detected.
p0586
OLIGOHYDROSIS AS ADVERSE EFFECTOF
ZONISAMIDE
J. Son
Bongseng Memorial Hospital, Neurology, Busan, Korea
Purpose: Zonisamide is classified as a sulfonamide and is characterized
having multiple antiepileptic action-mechanisms including inhibiting
carbonic anhydrase, which may lead to the oligohydrosis.The purpose of
this study is including the followings: (1) to determine the incidence and
(2) to reveal the risk factor of oligohydrosis-related symptoms in epilep-
tic patients treated with zonisamide
Method: I prospectively studied 153 patients under 20 ages who was
newly diagnosed with epilepsy or referred from other hospitals for con-
trolling a seizure. The patients were treated with zonisamide as a
monotherapy or adjuvant therapy. The data was collected by direct inter-
view at least 3 months after taking zonisamide. Facial flushing, lethargy,
itching sensation, irritability with hyperthermia, heat sensation and heat
intolerance were considered as a oligohydrosis-related symptom.
Results: 24.8% of patients were treated by zonisamide as a monother-
apy, and the other patients were treated by zonisamide as an adjuvant
therapy. The oligohydrosis-related symptoms were observed in 11.1% of
patients, and 2% of the patients have stopped taking zonisamide due to
the symptoms. The oligohydrosis-related symptoms were observed more
frequently in the patients between 15 and 20 years old than younger ages,
and more frequently in the patients who had taken topiramate.
Conclusion: The frequency was significantly higher than the results
from previous studies. Clinicians should monitor the patients who are
taking zonisamide regarding the oligohydrosis-related symptoms. Espe-
cially, the patients between 15 and 20 years old ages and the patients
who have a drug history of topiramate should be observed carefully.
p0590
EFFECTOFADJUNCTIVE PERAMPANELON
MYOCLONIC ANDABSENCE SEIZURES: A POSTHOC
ANALYSIS
C. Brandt*, R.T. Wechsler†, T.J. O’Brien‡, A. Laurenza§,
A. Patten¶, F. Bibbiani§, B. Williams§
*Bethel Epilepsy Centre, Bielefeld, Germany, †Idaho
Comprehensive Epilepsy Center, Boise, ID, United States,
‡Royal Melbourne Hospital, University of Melbourne,
Melbourne, VIC, Australia, §Eisai Inc., Woodcliff Lake, NJ,
United States, ¶Eisai Ltd, Hatfield, United Kingdom
Purpose: Perampanel is a selective, non-competitive AMPA receptor
antagonist, approved for adjunctive treatment of focal seizures, with or
without secondarily generalized seizures, and for primary generalized
tonic-clonic (PGTC) seizures in patients with epilepsy aged ≥12 years.
Approval for PGTC seizures was based on the placebo-controlled Phase
III Study 332 in patients with PGTC seizures and idiopathic generalized
epilepsy (IGE). Since some antiepileptic drugs can aggravate seizures in
IGE, this post hoc analysis assessed myoclonic and absence seizure out-
comes for patients receiving adjunctive perampanel in the Extension
Phase of Study 332.
Method: Study 332 methodology has been published (French et al. Neu-
rology 2015;85:950–957). Patients completing the Double-blind study
could receive perampanel during an Extension Phase: a 6-week blinded
Conversion Period (dose optimized to maximum of 12 mg/day) and up to
136 weeks’ unblinded Maintenance. For this post hoc analysis, the fol-
lowing endpoints were assessed for absence and myoclonic seizures
across the Extension Phase: median percent changes in seizure frequency
per 28 days, and proportions of patients achieving reductions in seizure
frequency of ≥50% (50% responder rate) or 100% (seizure-freedom
rate).
Results: Of 138 patients entering the Extension Phase, 76 experienced
myoclonic (n = 46) and/or absence (n = 52) seizures at Pre-perampanel
Baseline. At Weeks 40–52 of perampanel treatment, data were available
for 65 patients (myoclonic, n = 40; absence, n = 43). At this time win-
dow, median percent changes in seizure frequency were 100.0% for
both seizure types, 50% responder rates were 82.5% for myoclonic and
76.7% for absence seizures, and seizure-freedom rates were 57.5% for
myoclonic and 55.8% for absence seizures.
Conclusion: In this small, post hoc analysis, changes in seizure fre-
quency did not indicate any overall worsening of myoclonic or absence
seizures in patients with IGE who were receiving adjunctive perampanel.
Funding: Eisai Inc.
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ADJUNCTIVE PERAMPANEL IN PATIENTSWITH
PARTIAL SEIZURESOR PRIMARYGENERALIZED
TONIC-CLONIC SEIZURES (PGTCS): POSTHOC
ANALYSIS OF THEEFFECTOFAGEATDIAGNOSIS
L. Kramer*, A. Patten†, A. Laurenza*, J. French‡
*Eisai Inc., Woodcliff Lake, NJ, United States, †Eisai Ltd,
Hatfield, United Kingdom, ‡NYC Comprehensive Epilepsy
Center, New York, NY, United States
Purpose: Perampanel is approved for adjunctive treatment of partial sei-
zures, with or without secondarily generalized seizures, and for PGTCS
in patients with epilepsy aged ≥12 years. This post hoc analysis explores
whether age at epilepsy diagnosis impacts seizure outcomes with adjunc-
tive perampanel.
Method: In Phase III studies, patients with refractory partial seizures
were randomized to once-daily adjunctive placebo, perampanel 8 or
12 mg (Studies 304 [NCT00699972] and 305 [NCT00699582]), or per-
ampanel 2, 4, or 8 mg (Study 306 [NCT00700310]) during a 19-week
Double-blind Phase; patients with refractory PGTCS and idiopathic gen-
eralized epilepsy were randomized to placebo or perampanel 8 mg
(Study 332 [NCT01393743]) during a 17-week Double-blind Phase. Sei-
zure outcomes were assessed for partial seizures (pooled data from Stud-
ies 304, 305, 306) and PGTCS (Study 332) according to age at diagnosis
(<12 vs ≥12 years).
Results: Median percent changes in partial seizure frequency were simi-
lar for <12 vs ≥12 years with placebo (13.0% [n = 238] vs 12.7%
[n = 203]), perampanel 4 mg (26.2% [n = 91] vs 20.2% [n = 80]),
8 mg (30.9% [n = 233] vs 25.7% [n = 197]), and 12 mg (28.2%
[n = 138] vs26.5% [n = 115]). Median percent changes in PGTCS fre-
quency were also similar for <12 vs ≥12 years with placebo (39.5%
[n = 43] vs 25.7% [n = 38]) and perampanel 8 mg (78.3% [n = 40]
vs72.3% [n = 41]). Rank analysis of covariance and logistic regression
indicated no effect of age at diagnosis on median percent changes in sei-
zure frequency or 50% responder rates when treated as a categorical or
continuous variable, for partial seizures (categorical, p = 0.9999/0.6017;
continuous, p = 0.3624/0.3290) or PGTCS (categorical, p = 0.1933/
0.7219; continuous, p = 0.1837/0.2760). Models for partial seizures and
PGTCS studies included treatment, pre-randomization seizure frequency,
and age at diagnosis as covariates.
Conclusion: This post hoc analysis provides no evidence to suggest sub-
stantial variation in perampanel efficacy based on age at epilepsy diagno-
sis.
Funding: Eisai Inc.
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LONG-TERMEFFICACYAND SAFETYOF
ADJUNCTIVE PERAMPANEL INOPEN-LABEL
EXTENSION (OLEX) STUDIES: A POSTHOC
ANALYSIS
I. Rektor*, G.L. Krauss†, Y. Inoue‡, S. Kaneko§, B. Williams¶,
A. Patten**, F. Bibbiani¶, A. Laurenza¶, R.T. Wechsler††
*Epilepsy Center, Masaryk University, Brno, Czech Republic,
†Johns Hopkins Hospital, Baltimore, MD, United States,
‡National Epilepsy Center, NHO Shizuoka Institute of Epilepsy
and Neurological Disorders, Shizuoka, Japan, §North Tohoku
Epilepsy Center, Minato Hospital, Hachinohe, Japan, ¶Eisai
Inc., Woodcliff Lake, NJ, United States, **Eisai Ltd., Hatfield,
United Kingdom, ††Idaho Comprehensive Epilepsy Center,
Boise, ID, United States
Purpose: Perampanel is approved for adjunctive treatment of partial sei-
zures, with or without secondarily generalized (SG) seizures, and for pri-
mary generalized tonic-clonic (PGTC) seizures in patients with epilepsy
aged ≥12 years. Adjunctive perampanel was evaluated in Phase II-III
randomized, double-blind, placebo-controlled studies in patients with
partial seizures with or without SG seizures (Studies 206, 208, 304, 305,
306, 335), or PGTC seizures and idiopathic generalized epilepsy (Study
332). Here, we report post hoc analyses of efficacy and safety for patients
with SG or PGTC seizures across the OLEx Studies 207 (completers of
Studies 206 and 208; NCT00368472) and 307 (completers of Studies
304, 305, 306; NCT00735397), and the OLEx Phases of Studies 335
(NCT01618695) and 332 (NCT01393743).
Method: In the four OLEx studies, patients received perampanel (maxi-
mum 12 mg/day) during a blinded Conversion Period (6–16 weeks) and
aMaintenance Phase (32–424 weeks [≤1 to ≤8 years’ exposure]).
Results: Mean cumulative exposure to perampanel was 102.3 weeks for
patients with SG seizures (n = 720) and 83.9 weeks for patients with
PGTC seizures (n = 138); median percent reductions in seizure fre-
quency were 66.7% and 80.6%. Corresponding 50%, 75%, and 100%
responder rates were 59.5%, 45.3%, and 18.4% for SG seizures, and
72.5%, 51.5%, and 16.7% for PGTC seizures. For each seizure type, effi-
cacy was observed irrespective of prior treatment during the Double-
blind Phase. Treatment-emergent adverse events affected 90.3% and
87.0% of patients with SG and PGTC seizures, respectively.
Conclusion: Long-term adjunctive perampanel demonstrated efficacy
for SG or PGTC seizures. Safety outcomes were consistent with the
known safety profile of perampanel.
Funding: Eisai Inc.
p0593
BRIVARACETAM: THELEEDS EXPERIENCE
J. Geldard, M. Maguire, E. Wright, P. Goulding
Leeds Teaching Hospitals NHS Trust, Neurology, Leeds, United
Kingdom
Purpose: Brivaracetam (BVM) was approved in the EU in Jan 2016 as
an adjunctive treatment of focal-onset seizures with or without secondary
generalised seizures in patients with epilepsy aged 16 years and older.
The aim of the study was to assess the efficacy and tolerability of BVM
in clinical practice. BVM was also used off licence to treat those with
idiopathic generalised epilepsy (IGE).
Method: Preliminary data from 52 patients are presented. Data was col-
lected prospectively from patients experiencing focal and/or secondary
generalised tonic clonic seizures and primary generalised seizures.
Results: An overall ≥50% reduction in seizure frequency was achieved
in 28% of patients. In those with IGE 45% had a ≥50% reduction in sei-
zure frequency and one patient was rendered seizure free. In those with
focal onset epilepsy the overall ≥50% reduction in seizure frequency was
22%. 28% of those with secondary generalised tonic clonic seizures had
a ≥50% reduction in seizure frequency. 23% of those with focal seizures
had a ≥50% reduction in seizure frequency. The most common adverse
events were irritability 17% and sedation 15%.
Conclusion: Patients were taking a median of 2 antiepileptic drugs when
BVMwas commenced and had previously tried a median of 9 antiepilep-
tic drugs. This was therefore a very difficult to treat group of patients with
refractory epilepsy. The overall percentage of patients with a ˃50%
responder rate was slightly lower than clinical studies however this may
be reflected in the cohort of patients. Reported adverse events varied
from clinical trials with irritability being the most common. The evidence
suggests that BVM may be a useful adjunctive therapy for those with
refractory epilepsy. Interestingly those with IGE had a higher responder
rate than those with focal onset epilepsy which requires further investiga-
tion.
p0596
ESLIRA: A PROSPECTIVE STUDYTOASSESS THE
BEHAVIOR IN PATIENTSWITHEPILEPSY TREATED
WITHESLICARBAZEPINEACETATE
G. Mazuela*, M. Quintana*, J.A. Mauri†, X. Rodriguez-Osorio‡,
F.J. Lopez-Gonzalez‡, M. Gomez-Eguilaz§, M. Barcala¶,
J. Abril-Jaramillo**, J. Rodriguez-Uranga**, M.D. Castro††,
J.J. Octavio‡‡, P. Esteve-Belloch‡‡, L. Abraira*,
E. Santamarina*, X. Salas-Puig*, M. Toledo*
*Vall d’Hebron University Hospital, Barcelona, Spain, †Lozano
Blesa University Hospital, Zaragoza, Spain, ‡University
Hospital of Santiago de Compostela, Santiago de Compostela,
Spain, §San Pedro Hospital, Logro~no, Spain, ¶University
Hospital of Tarragona Joan XXIII, Tarragona, Spain,
**Advanced Neurology Center, Seville, Spain, ††Alvaro
Cunqueiro Hospital, Vigo, Spain, ‡‡Hospital de Tortosa Verge
de la Cinta, Tortosa, Spain
Purpose: This study aims to evaluate changes in the anger status in
patients with focal epilepsy who start treatment with Eslicarbazepine
acetate (ESL).
Methods: Prospective study of patients with focal epilepsy from 6 differ-
ent hospitals, who met the following criteria: ≥ 18 years old, certain diag-
nostic of focal epilepsy and ≤2 antiepileptic drugs at baseline visit. All
patients completed the State-Trait Anger with the Expression Inventory
2TM (Staxi-2™), hospital Anxiety and Depression Scale (HADS) and
Quality of Life in epilepsy inventory (QOLIE-10) at baseline before start-
ing ESL and in the final follow-up 3 months later.
Results: From 59 patients screened, 42 completed the study. Demo-
graphics: Mean age 50.6 years old (range 26–78); Females 45.2%. Half
of them were temporal lobe epilepsy and 45.2% cryptogenic. Mean
monthly seizure frequency was 3.1, which decreased to 0.7 in the follow-
up (p < 0.001). Main reason to start ESL was the presence of baseline
adverse events (47.6%) or lack of efficacy (40.5%). In the follow-up
59.5% were on ESL monotherapy and 40.5% bitherapy; levetiracetam
was the drug combined with ESL in 33.3%.
The anger expression index improved significantly in the whole group
(p = 0.036), the anger trait was more likely to improve in the bitherapy
patients (p = 0.029) and the state of anger showed better performances in
patients <50 years old (p = 0.005). A global improvement in anxiety
(p = 0.011) and QOLIE-10 (p = 0.023) was seen.
Conclusion: The treatment with ESL, alongside with a good seizure con-
trol and tolerability may improve the anger status in patients with
epilepsy.
p0597
EFFECTIVENESS ANDTOLERABILITYOF
PERAMPANEL IN PATIENTSWITH INTELLECTUAL
DISABILITYANDREFRACTORYEPILEPSY
P. Bonanni, S. Negrin, A. Danieli, E. Osanni
IRCCS Eugenio Medea, Epilepsy and Clinical Neurophysiology
Unit, Conegliano, Italy
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Purpose: Epilepsy is more prevalent in adults and children with intellec-
tual disabilities (ID). Many require life-long antiepileptic drugs for ade-
quate seizure control. Registration and ‘clinical’ studies confirmed
efficacy and safety of Perampanel (PER) in refractory epilepsy (RE).
Experience on the use of PER among patients with ID is still limited.
The purpose of this study is to extend our knowledge with respect to
the relevance of PER for patients with both ID and RE, and furthermore
to specify the behavioral adverse reactions (ADRs) of PER in this speci-
fic population.
Method: Retrospective, open label, single-center study. Inclusion crite-
ria: 1) follow up of at least 3 months; 2) presence of ID. Efficacy end-
points included responder rate and percentage of patients with some
reduction in seizure frequency. To assess tolerability, we evaluated the
incidence and severity of ADRs and the percentage of patients withdrawn
due to ADRs.
Results: 46 patients (23 female) were included (age range 8–55 years).
Follow-up range: 4–21 months, median: 13 months. Level of ID varied
from borderline to profound, and severe ID (moderate-severe-profound)
was most common (65%). The mean daily dosage of PER was 5.6 mg
(range 2–12 mg). Seizure reduction was achieved in 67% of patients.
Responders were 58% and seizure free 7%. 22 patients (48%) experi-
enced ADRs. Behavioral ADRs were present in 10 patients (22%, severe
in 4%). Most common were aggression, agitated behavior and mood
symptoms. In 13 patients PER was discontinued (lack of efficacy in 69%
and intolerable ADRs in 31%).
Conclusion: The use of PER might lead to an effective seizure reduction
without ADRs in 52% of patients with both RE and ID. Pre-existing
behavioral problems or polypharmacy do not predict the occurrence of
additional behavioral ADRs, implying that these patients need not be
excluded from the introduction of PERwhen clinically indicated.
p0598
PSYCHOGENIC NONEPILEPTIC SEIZURES IN
CANADA: A SURVEYDESCRIBINGCURRENT
PRACTICES
L.D. Ladino*,†, A. Voll†, J.F. Tellez-Zenteno†, L. Hernandez-
Ronquillo†, M. Reuber‡
*Hospital Pablo Tobon Uribe, Medellin, Colombia, †University
of Saskatchewan, Saskatoon, SK, Canada, ‡University of
Sheffield, Sheffield, United Kingdom
Purpose: Psychogenic Non-epileptic Seizures (PNES) is one of the com-
monest differential diagnoses of epilepsy, and have limited access to
management. An international task force (ILAE PNES project) has been
recently created to address this issue. Our objective is to describe current
management in Canada, identify styles of practice and service gaps.
Method: In 2016 a 35-question survey was sent, via email, to the 131
members of the Canadian League Against Epilepsy. The questions were
designed after literature review and discussion with Dr. Markus Reuber,
lead author of the ILAE PNES project. Questions were separated into 5
sections:
1) the role of the respondent and their exposure to PNES,
2) diagnostic methods,
3) management of PNES,
4) etiological factors, and
5) problems accessing health care.
This survey was validated in the UK and has been applied in different
international populations.
Results: Sixty-two questionnaires were analyzed (response rate: 47%).
Responses were received from seven provinces of Canada. Most respon-
dents were epileptologists (76%). 77% respondents diagnose between 1
to 20 new cases of PNES annually. The majority personally diagnoses
and communicates the diagnosis of PNES to the patient, but only 55%
provide follow-up within their practice and approximately 50% recom-
mend or arrange treatment. A large minority (35%) are either unfamiliar
with the diagnosis or treatment of PNES, or are inexperienced in arrang-
ing and offering treatment. Most (79%) provide follow-up to those
patients with concomitant epilepsy, but otherwise follow-up rates are
low. Although 84% of respondents feel that individualized psychological
therapy is the most effective treatment, 40% of patients are not referred
to psychotherapy.
Conclusion: Though Canadian Health epileptologists’ understanding of
PNES mostly reflected current international expert opinion, once the
diagnosis is made patients are discharged from the neurological service
without appropriate psychological referral in place. This may lead to
“bounce-back” and repeated ER visits.
p0600
THE EPIDEMIOLOGYOF FEBRILE SEIZURES IN
SOUTHKOREABASEDONTHENATIONALHEALTH
INSURANCE SERVICE-NATIONAL SAMPLECOHORT,
2002–2013
Y.J. Choi*, J.Y. Jung†, H. Kwon*, J. Kim*
*Seoul National University Bundang Hospital, Emergency
Medicine, Seongnam, Korea, †Seoul National University
Hospital, Emergency Medicine, Seoul, Korea
Purpose: Febrile seizures are the most common type of seizure in chil-
dren.We performed a large population-based epidemiologic study of feb-
rile seizures in South Korea.
Method: Data of 54,234 children, born in 2002–2007, was retrieved
from the Korean National Health Insurance Service - National Sample
Cohort covering 2002–2013 (representing 2% of the total population)
until their age five. The primary outcome was the prevalence and inci-
dence of febrile seizures in South Korea. The secondary outcomes were
the risk factors of febrile seizures and the probability of being diagnosed
epilepsy after the events. A mixed effects logistic regression model was
used to analyze the risk of having febrile seizures.
Results: The prevalence of febrile seizures in children under age five in
South Korea was 11.3%, and the incidence during the study period was
3.8%. There was no difference between genders and the highest inci-
dence was in the second year of life (p < 0.001). The risk of febrile sei-
zure was higher for those who had a history of preterm, cerebral birth
injury or cerebral palsy (p < 0.001). Children with febrile seizure has an
increasing risk of being diagnosed with epilepsy within a year up to 4.7%
in cumulative analysis compared to 0.3% in children without febrile sei-
zure (p < 0.001).
Conclusion: As the frequency of febrile seizure increased, the probabil-
ity of being diagnosed with epilepsy within a year after the events
increased in South Korea.
p0603
UTILISATIONOFVALPROATE INWOMENWITH
EPILEPSYANDOTHERDISORDERS IN NORWAY,
2004–2015
H.L. Linge*, I. Fløgstad*, A. Baftiu*, S.I. Johannessen†,‡,
P.G. Larsson§, C. Jonannessen Landmark*,†,‡
*Oslo and Akershus University College of Applied Sciences,
Oslo, Norway, †Oslo University Hospital, Department of
Pharmacology, Oslo, Norway, ‡The National Center for
Epilepsy, Oslo University Hospital, Sandvika, Norway, §Oslo
University Hospital, Department of Neurosurgery, Oslo, Norway
Purpose: The use of valproate in women of childbearing age is under
debate with regard to risk of teratogenicity, and also long-term effects on
the offspring. The purpose of this study was to document changes in use
of valproate in Norway the last decade.
Method: Anonymised data from the Norwegian Prescription Database
(2004–2015) were used, including data of antiepileptic drugs (AEDs)
from the whole population with detailed information of indication-
related reimbursement codes. The study was approved by the National
Institute of Public Health.
Results: In 2004, 49% of the total valproate users were women. In 2015
this number was reduced to 44% There was a total increase in the use of
valproate between 2004 and 2015 from 12662 to 18226 users (+44%),
and an increase in use of 2.6–3.2 DDDs/1000/day (+23%), which was
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mainly due to an increase in male users (68% of total) (6425 to 10222
men / 6237 to 8004 women). For women of child-bearing age
(15–45 years) there was a total decrease of 12.5% in the use of valproate
in Norway from 2010–15. In 2010 there were 4488 women who used val-
proate for epilepsy, while in 2015 there were 4216 (6%). The drug utili-
sation was more reduced, from 0.79 down to 0.72 DDDs/1000 women/
day (9%), which indicate a slight decrease in the daily prescribed dose.
Thus, recommendations of careful/restrictive use of valproate in women
in recent years have possibly been followed.
Conclusion: The present results demonstrate that the use of valproate in
women in Norway is decreasing for the indication epilepsy, but not to the
same degree in other indications. Recommendations of careful/restrictive
use of valproate in women, and especially of childbearing age, in recent
years are possibly followed. Documentation of changes in utilisation of
AEDs contributes to improved pharmacovigilance and safer treatment.
p0608
DELINEATIONOF THEGENETICCAUSESOF
EPILEPTIC ENCEPHALOPATHY IN SOUTHAFRICAN
PAEDIATRIC PATIENTS
A. Esterhuizen*, R. Ramesar†, H. Mefford‡, J. Wilmshurst§,
G. Carvill¶
*National Health Laboratory Service/University of Cape Town,
Human Genetics, Cape Town, South Africa, †Human Genetics,
University of Cape Town, Cape Town, South Africa, ‡University
of Washington, Seattle, WA, United States, §Red Cross War
Memorial Children’s Hospital/University of Cape Town,
Paediatric Neurology, Cape Town, South Africa, ¶Northwestern
University, Neurology, Chicago, IL, United States
Purpose: Sub-Saharan Africa bears the highest burden of epilepsy in the
world as a consequence of high incidence of CNS infections, perinatal
insults and traumatic brain injury. Genetic epilepsy is underdiagnosed
due to lack of awareness and unavailability of genetic testing for epi-
lepsy. In this study we aim to describe the genetic architecture of severe
infantile seizure disorders in South African patients and establish a
framework for genetic testing in South Africa and Africa more broadly.
Method: We recruited 92 South African children diagnosed with epilep-
tic encephalopathy (EE), on the basis of clinical semiology and neuro-
physiological studies: 46 Indigenous Black, 35 Mixed Ancestry and 11
Caucasian South African children. Of these, 21 were clinically suspected
to have Dravet Syndrome (DS). Targeted resequencing of 71 known EE
genes and chromosomal microarrays were deemed appropriate, was per-
formed. Patient recruitment is ongoing and we aim to recruit and test 200
patients.
Results: Pathogenic de novo mutations were identified in 35 patients.
SCN1A mutations were found in 9/21 (43%) of the Dravet group, which
was markedly less than the published frequency of SCN1A mutations in
DS. Clinical reassessment with the screening test by Hattori et al., (2008)
resulted in a changed working diagnosis of 5 SCN1A-negative patients in
the Dravet group. SCN1A variants were also found in 2 patients of the
remaining cohort, who are undergoing clinical reassessment emphasising
the value of a genetic diagnosis. In the larger cohort, likely pathogenic
changes were detected in 18 genes. A 16p13.11 deletion was detected in
1 patient, additional microarray analysis is ongoing.
Conclusion: These results carry implication for patient management and
present valuable insights into disease presentation, motivating translation
into diagnostic practice even in the resource-limited African setting. This
is the first genetic research study of epilepsy in South African patients.
p0609
INDIVIDUALRESILIENCEAS A STRATEGYTO
COUNTER EMPLOYMENTBARRIERS FOR PEOPLE
WITHEPILEPSY
J. Mugumbate
Bindura University, Social Work, Bindura, Zimbabwe
Purpose: Success in the labour market for people with epilepsy is diffi-
cult because of several barriers such as lack of employment support ser-
vices. People with epilepsy require support to overcome socioeconomic
disadvantage associated with their condition but in some cases that sup-
port is usually not available. This study looked at employment experi-
ences of people with epilepsy.
Method: Thirty (30) in-depth interviews were carried out in Harare,
Zimbabwe’s main urban and industrial area. Participants consisted of 13
males and 17 females whose ages ranged from 18–52 years. To supple-
ment data from interviews, a focus group discussion was done with seven
service providers working for the Epilepsy Support Foundation (ESF), a
welfare organisation providing epilepsy services such treatment, psy-
chosocial support, economic empowerment and awareness. Data were
analysed with the help of NVivo, a computer-assisted qualitative data
analysis application.
Results: The study found that people with epilepsy had extremely chal-
lenging experiences that affected skills attainment, job seeking and work-
ing. These challenging experiences were exacerbated by negative
attitudes and inaccessible public services. Unexpectedly, individual resi-
lience enhanced employment opportunities for some participants in a
context that was overwhelmingly pitted against them. Some participants
showed individual resilience in four domains: getting treatment, educa-
tion and training despite all odds; being their own advocates; achieving
high levels of workmanship; and adopting a positive attitude in the face
of negative social attitudes.
Conclusion: The study concluded that in situations where employment
support services are weak, individual resilience provides a coping mecha-
nism. In line with this conclusion, the study recommended strengthening
resilience-building factors, such as psychological services. However, this
should not undermine the need for public services.
p0610
TERTIARYEPILEPSY CENTRE IN RESOURCE
RESTRICTEDCOUNTRY – LUXURYORNECESSITY
N. Okujava*, A. Tsereteli†, N. Malashkhia†
*Tbilisi State Medical University, Tbilisi, Georgia, †S.
Khechinashvili University Hospital, SEIN-SKUH Epilepsy and
Sleep Centre, Tbilisi, Georgia
Purpose: Up to 40 000 people in Georgia have active epilepsy, 2/3 of
them being inappropriately treated or having wrong diagnosis, treatment
gap - 71% (G.Lomidze et al 2012). Aim of our study was to evaluate role
of tertiary epilepsy centre for improvement of diagnostic and treatment
possibilities and reducing treatment gap in country with restricted
resources and deficient health care system like Georgia.
Method: The study was carried out in SEIN-SKUH Epilepsy and Sleep
Centre Tbilisi. One hundred thirty two patients, who attended our Centre
in the period of 2014–2016 for reevaluation of diagnosis and treatment
possibilities were enrolled into the study. Inclusion criteria: complete
clinical workup, video EEG monitoring 12–48 hr, 1.5-3TL MRI with
epilepsy protocol, as well as sleep workup (diaries, actigraphy, PSG)
upon requirement.
Results: Final diagnosis was made in 98 cases out of 132 (75%). In 28
patients (21%) non- epileptic events were established, including dissocia-
tive seizures, syncope and migraine. Seven patients with dissociative sei-
zures previously have undergone treatment in the intensive care unit with
diagnosis “convulsive status epilepticus”. Seven patients appeared to
have combined clinical course with epileptic seizures together with dis-
sociative ones, this situation severely affecting their treatment outcome.
In 21 patients severe sleep disorders were established along with epilepsy
(insomnia, OSAS, PLM). In 78 cases epileptic syndrome was established
and seizure control, or significant improvement was reached due to elab-
oration of tailored therapy.
Conclusion: Our study showed that tertiary epilepsy centre with “state
of the art” special services significantly contributes to reduction of diag-
nostic and treatment failures, improves quality of life of the patients and
decreases social and financial burden of the disease.
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EPILEPSY IN PRIMARYCARE: A PILOT EXPERIENCE
OFONLINE EDUCATION IN LATIN AMERICA
J. Carrizosa Moog*, P. Braga Fernandez†
*Universidad de Antioquia, Medellın, Colombia, †Universidad
Nacional de Uruguay, Montevideo, Uruguay
Purpose: The aim was to decrease the diagnostic and therapeutic gap in
epilepsy, through a virtual course, language and costs-friendly, devoted
to primary care physicians in Latin America.
Method: The project was designed by the ILAE Education Commission
and submitted to evaluation by ILAE. It included 8 topic-specific mod-
ules of 1-week duration each, including epidemiology, clinics, diagnostic
procedures, drug treatment, social and legal aspects. A 16-members Latin
American teaching team developed the contents. Virtual platform and
formal accreditation were obtained through international University col-
laboration. Repositories and discussion forums were developed.
Approval required passing the final exam. Initially developed as a Span-
ish course, during 2016 all the platform and didactic material can be
accessed either in Spanish or Portuguese, and Brazilian tutors were
included in every module.
Results: Overall, 95 professionals from 15 countries registered and
started the course; 77 completed all modules and approved the final
examination. Approximately 20% (11–27%) felt confident on epilepsy
patients0 management before the course, increasing to a mean of 71%
(64–84%) after the course. Financial support from ILAE for the 3 courses
(2015–2016) was USD 13.000, with a total revenue from registrations of
USD 5700 (Net ILAE investment: USD 7300).
Conclusion: A cost effective and qualified online course on epilepsy is a
simple tool to educate primary care holders worldwide.
p0615
NATIONAL EPILEPSY PROGRAMOFTHEMINISTRY
OFHEALTHOFCHILE
L. Cuadra*,†, J. Foester‡, V. Venegas§, M. Carvajal¶
*Ministerio de Salud Chile, Enfermedades Cronicas no
Transmisibles, Santiago, Chile, †Instituto de Neurocirugıa
Asenjo, Pediatric Neurosurgery, Santiago, Chile, ‡Complejo
Hospitalario Sotero del Rıo, Pediatric Neurology, Santiago,
Chile, §Instituto de Neurocirugia Asenjo, Pediatric
Neurosurgery, Santiago, Chile, ¶Hospital Exequiel Gonzalez
Cortes, Neurologıa Infantil, Santiago, Chile
Purpose: In the last two years, in Chile a National Epilepsy Care Pro-
gram was designed, including processes, structure and results measure-
ment, with improvements at all levels of complexity, following theWHO
model in relation to the importance of the Health Network. The objective
is demonstrate that it is possible to work in Public Health with an Epi-
lepsy Program design for the whole country and in the three levels of
complexity of care.
Method: It was selected one Health Service as a pilot observatory, of the
29 existing in Chile. The strategies of the Program are applied: Design of
the Health Assistance Network with Regional Centers and Reference
Centers in epilepsy, design of “Model of chronic care in primary care”,
creation of special polyclinics at the secondary and tertiary levels in epi-
lepsy; On-line and presence-based courses training is provided to profes-
sionals, across the country and at the various levels of complexity.
Results: In Primary Care the attention was started based on the “Model
of care of chronic patients”. In primary care, the number of people diag-
nosed and treated as epilepsy in the Pilot Center is doubled.
It was perfomed non invasive surgery in a new center, in adition to one
existent. Invasive surgery is performed in a pre-existing single center.
Conclusion: It is possible to give better care to epilepsy patients based
on the implementation of a National Epilepsy Program, with an emphasis
on network care and the training of professionals in a Latin American
country such as Chile.
p0617
THEUSEANDABUSEOFEEG INTERPRETATION INA
DEVELOPINGMEDICAL SOCIETY
N. El Tantawi, B. Hasaneen, M. El Gamal, D. Abd Elmagid
Paediatric Department, Neurology Unit, Medical School,
Mansoura University, Mansoura, Egypt
Purpose: To study the effects of unnecessary EEG or miss interpreted
EEG on patient management.
Method: This was a part of an audit looking at why physicians ask for an
EEG. It took place in Mansoura University Children Hospital, Egypt, and
run between August 2016 to Feb 2017. We included here only the
patients referred to repeat an EEG, whether they were epileptic or non-
epileptic, on treatment or not, from 1 month to 17 years. We excluded
first time EEG patients.
We collected: demographic data (age, sex, residence), reason for
EEG, number of previous EEG done before, who asked for it (private
doctor, general hospital, or referred from our hospital), any diagnosis
given to the patient, current medication, imaging studies, and basic infor-
mation about socioeconomic level of parents. Two neurologist with expe-
rience in interpretation of EEG, reviewed the previous EEG (whenever
accepted or available)
Results: 509 patients were referred for EEG, 249 patients were included
in this study. Our preliminary results shows that EEG was performed for
unrecognized indications (behavior problems, cochlear implants, delayed
speech), treatment with AEDs was started in a significant number of
patients without having any clinical seizures and only based on EEG
results. There were a number of epileptic patients who were maintained
on AEDs for years because of presumed abnormal EEG, and patients
who received unsuitable AEDs for their condition.
Conclusion: There is no clear understanding of the indications and inter-
pretation of the EEG and its results in the practice of physicians, and this
adversely affect the management of epileptic and unfortunately non
epileptic patients as well.
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COMPREHENSIVE EPILEPSYCARE: EMPOWERING
HEALTHCARE PROFESSIONALSANDCAREGIVERS
IN RESOURCECONSTRAINED SETTINGS
S. Gulati*, V. Sondhi*, B. Chakrabarty*, P. Jauhari*, H. Patel*,
R. Dubey*, V.K. Paul†
*All India Institute of Medical Sciences, Child Neurology
Division, Department of Pediatrics, New Delhi, India, †All India
Institute of Medical Sciences, Department of Pediatrics, New
Delhi, India
Purpose: Around 10 million people are effected with epilepsy in India.
In resource constrained settings like India, there is skewed specialist-
patient ratio with further accentuation in rural compared to urban set-
tings. This is a description of initiatives by a tertiary care centre in north
India to empower health care providers and caregivers.
Method: To facilitate early diagnosis and management of epilepsy, a
diagnostic instrument has been developed, validated. and converted into
a mobile application. Studies have been conducted to evaluate telephonic
consultation against face to face evaluation in children with Neurocys-
ticercosis, West Syndrome and Lennox Gestaut syndrome. Currently, a
study is underway in which telephonic consultation by a specialty Nurse
is being compared to the same by a Pediatric Neurology resident doctor
against face to face evaluation. The longterm vision is to minimize
unnecessary hospital visits and decompress the healthcare system. A
web-based platform has been launched on epilepsy, along with an inter-
active platform for parents and physicians. Bilingual patient information
booklets on epilepsy, seizure card and seizure diary have been developed
to educate and assist care givers.
Results: The mobile application based on the diagnostic tool was
launched in December 2015, and has been downloaded on 854 mobile
phones. It is being used by nearly 800 physicians across the country. The
webpage that was launched in December 2014 gets an average of 20 hits
per week. On an average, 200 to 250 children and their families per week
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are getting benefitted by the patient information booklets, seizure card
and seizure diaries.
Conclusion: Conventional as well as technology aided, affordable and
innovative modes of health education can help empower care givers and
health care providers in a significant way, particularly in resource
constrained settings.
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IMPROVEMENTOF EXECUTIVE FUNCTIONAFTER
EPILEPSY SURGERY
R. Hanaya*,†, T. Otsubo‡, H. Hosoyama*,†, Y. Kashida*,†,
M. Tsumagari‡, S. Maruyama†,§, T. Fujimoto‡, K. Arita*
*Department of Neurosurgery, Graduate School of Medicine,
Kagoshima University, Kagoshima, Japan, †Epilepsy Center,
Kagoshima University Hospital, Kagoshima, Japan, ‡Fujimoto
General Hospital, Miyakonojo, Japan, §Kagoshima University,
Graduate School of Medicine, Department of Pediatrics,
Kagoshima, Japan
Purpose: Executive function means a series of cognitive activities to
effectively achieve a purpose, and the impairment is caused by frontal
lobe dysfunction. Epilepsy is also known to be associated with impaired
executive function. Changes of executive functions after epilepsy surgery
were examined using theWisconsin Card Sorting Test (WCST).
Method: Thirty-eight patients (16 male, 23 female; average age
30 years old) who underwent neuropsychological evaluation including
WCST before and 2 years after surgery among patients who underwent
surgical treatment since 2007. And the categories achieved (CA), total
errors (TE), and perseverative error of Milner/Nelson sustainability
(PEM/PEN) was evaluated.
Results: In the seizure type, there were 29 (18 right, 11 left) and 5 of tem-
poral lobe epilepsy (TLE) and temporal lobe neocortical epilepsy (NCE),
respectively who underwent resection. There were 4 suspected focal sei-
zures which underwent vagal nerve stimulation (VNS). CA and TE at
2 years after operation were improved at 58% (22/38) and 61% (23/38)
respectively, and decreased at 18% (9/34) and 32% (12/38) respectively.
PEM/PEN was improved or maintained, except for cases where CA and
TE both decreased. Improvement rate by seizure type is 73% (8/11) in left
TLE, 50% (9/18) in right TLE, 60% (3/5) in NCE, 25% (1/4). By out-
come, improvements in executive functions were obtained at 64% (16/
26) in Engel outcome scale class I, 67% (2/3) in class II, in class III at
75% (3/4), and 20% (1/5) in class III/IV of VNS. Correlation with
improvement ofWAIS-R / III andWMS-Rwas not strong.
Conclusion: In the cases of resection surgery, 64% of patients obtained
improvement of executive function after surgery. On the other hand, the
improvement rate was only 20% in the VNS cases. Seizure improvement
after resection surgery would contribute the improvement of executive
function.
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HIGH FREQUENCYOSCILLATIONS IN TUMOR
RELATEDEPILEPSY
N. van Klink*, W. Zweiphenning*, K. Miller†, E. Aronica‡,
K. Braun*, M. Zijlmans*,§
*UMCUtrecht, Neurology and Neurosurgery, Utrecht,
Netherlands, †Stanford University, Neurosurgery, San Diego,
CA, United States, ‡AMC Amsterdam, Pathology, Amsterdam,
Netherlands, §SEIN, Heemstede, Netherlands
Purpose: Epilepsy can be a first sign of a low-grade brain tumor. Gross
total resection is not always advised for tumor treatment, but surgery
might treat the epilepsy. The epileptic focus can be located around the
lesion, for which electrocorticography (ECoG) might help. High fre-
quency oscillations (HFOs) in ECoG are a better biomarker for epileptic
tissue than spikes. We investigated the relation between HFOs and low
grade brain tumors and their potential value for epilepsy surgery.
Method: We retrospectively analyzed pre- and postresection intra-
operative ECoG recorded at 2048 Hz in patients with refractory epilepsy
and a low grade brain tumor. We automatically detected ripples (R,
80–250 Hz) and fast ripples (FR, 250-–500 Hz), and checked them
visually with two reviewers. Presurgical and postsurgical MRIs were
coregistered, the tumor and resected volume were marked and locations
of the ECoG electrodes were matched. Electrodes on the tumor, in
resected tissue that was not tumor, and outside the resection area were
identified. Engel 1 was considered seizure freedom.
Results: We included 43 patients of whom 21 had mesiotemporal
tumors, and 22 neocortical tumors. Twenty-two patients had gangli-
ogliomas. Four patients were not seizure free (>1 year after surgery).
Mesiotemporal tumors showed more ripples and fast ripples than neocor-
tical tumors (R: p < 0.001. FR: p = 0.05). Tumor plus resected tissue
showed more ripples and fast ripples than tissue outside the resection (R:
18.1/min vs. 6.2/min, p = 0.05. FR: 3.8/min vs. 0.1/min, p < 0.001).
Three patients showed fast ripples after resection, who were all seizure
free and no tumor residual was reported. The rate of ripples and fast rip-
ples after surgery was not higher for patients with residual tumor tissue.
Conclusion: HFOs were a good indicator for the tumor and the surround-
ing epileptic tissue before surgery. HFOs after resection did not discrimi-
nate patients with recurrent seizures or patients with tumor residual.
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GROSS TOTALRESECTIONASA PREDICTOROF
SEIZURE-FREEOUTCOME INCHILDRENWITH
CORTICALMALFORMATIONS
S. Popovich, V. Solov`ev, A. Golovteev
Epilepsy Center, Moscow, Russian Federation
Purpose: To evaluate seizure outcome in children with cortical malfor-
mations included focal cortical dysplasia, polymycrogyria, hemimega-
lencephaly due to volume of resection (gross total or subtotal).
Method: We performed a retrospective analysis of MRI data of children
≤ 18 years who underwent the epilepsy surgery from October 19, 2010
through October 26, 2016 and had one-sided cortical malformations. Sur-
gical outcome was classified as seizure freedom (Engel class I) or seizure
recurrence (Engel class II-IV).
Results: Twenty five patients with cortical malformations included focal
cortical dysplasia (18), polymycrogyria (6), hemimegalencephaly (1)
were performed 33 operations (8 reoperations). Mean follow-up was
20 months (ranging from 3 to 64 months). Twenty patients (80%) were
seizure-free at last follow-up. Five patients (20%) had seizure recurrence
(Engel class II-IV). Sixteen patients with seizure-free outcome had gross
total resection and six of them patients had underwent reoperations.
Conclusions: Our study shows that gross total resection determine sei-
zure-free outcome in children with cortical malformations.
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EPILEPSY SURGERYOFTHETEMPORAL LOBE IN
ANEPILEPSYCENTER INVENEZUELA. SIX YEARS
OFEXPERIENCE
R. Gonzalez Zerpa*, A. Soto Reyes†, G. Contreras‡
*Medical Center La Trinidad, Neurology, Caracas, Venezuela,
†Medical Teaching Center La Trinidad, Neurology, Caracas,
Venezuela, ‡Medical Teaching Center La Trinidad, Child
Neurology, Caracas, Venezuela
Purpose: The surgical treatment of epilepsy is currently an effective and
safe therapeutic modality. The results depend on an adequate study algo-
rithm, a multidisciplinary approach of the patient, an appropriate selec-
tion of the surgical technique and the experience of the neurosurgeon.
We describe our experience of six years in surgery of temporal lobe epi-
lepsy in an Epilepsy Surgery Center in a developing country.
Method: This is a retrospective study. We evaluated medical records of
patients with drug-resistant temporal lobe epilepsy who underwent epi-
lepsy surgery in our center fromMay 2009 to Dec 2015.
S114
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Results: In our study 73 temporal lobectomies were performed. Patients
older than 20 years accounted for 82%. The most important personal
background in our patients was: history of febrile seizures in 11%, and
encephalocranial trauma with loss of consciousness in 9% of cases.
Regarding the delay time between the diagnosis of epilepsy and the per-
formance of surgery, similar percentages (30%) shared the patients oper-
ated in a range of 1 to 5 years, and those in a time greater than 20 years.
All patients were followed for at least one year. 84.5% of patients with
temporal lobe resection are in Engel class I, 12.3% in class II. One patient
was re-operated due to poor control of their seizures. Four patients pre-
sented postoperative complications (psychiatric illness). MRI 60% had
hippocampal sclerosis and 13.7% were normal, 12.3% were tumors,
6.9% double lesion, 4.1% high focal signal in the temporal lobe. Pathol-
ogy showed: 54.8% with hippocampal sclerosis, 13.7% with dual pathol-
ogy, 2.7%with dysplasia/heterotopias.
Conclusion: In this study epilepsy surgery in selected patients, has mini-
mal morbidity and offers high probability of significant reduction of the
seizures. Our results and our percentage of seizure free patients after per-
forming epilepsy surgery are comparable to those reported by other cen-
ters in the literature.
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INSULA IN THEDIAGNOSIS AND SURGICAL
TREATMENTOFTEMPORAL LOBEEPILEPSY IN
CHILDREN
R. Khachatryan, K. Lebedev, Y. Zabrodskaya, D. Ryzhkova,
G. Trufanov, W. Khachatryan
Russian Neurosurgery Research Institute in Honor of Professor
Polenov A.L., Branch of the Almazov Federal North-West
Medical Research Centre, Ministry of Healthcare, Saint
Petersburg, Russian Federation
Objectives: Study of the value of the insula in the diagnosis and treat-
ment of temporal epilepsy in children.
Method: 80 children aged 2–17 years with a drug-resistant TLE. Front
temporality resection was performed on 80 patients, partial resection of
insular cortex was performed in 11 cases. The researchers analyzed the
structures of seizures, their frequency, data of neuropsychological stud-
ies, EEG, invasive EEG and ECoG, 3D spiral CT, CT perfusion, MRI
(1.5–3 T) fMRI, MRS, FDG PET, SPECT, TCD, intraoperative EEG,
ECoG. Catamnesis: 1–3 years (average of 3.0 years). The involvement
of the cortex of insula was judged by the total assessment of structures of
seizures (laryngeal discomfort, somatosensory seizures, viscerosensory
seizures, etc), neuroimaging, electrophysiological data and histological
examination of biopsymaterial.
Results: In all children has been observed a progression of drug resistant
TLE with seizures within 1 to 13 years. Polymorphic (2–5) type of sei-
zures occured in⅔ cases. Involvement of the insula epileptogenic system
was established in 22 patients (27.1%). After surgery, Engel I results
were achieved in 82.2% of cases. With involvement of insula in epileptic
system the results of temporal resection are worse (16 out of 22–72.7%)
than in the whole group.
Conclusion: The question of the effectivenes and the algorithms of the
additional resection of the insula in the surgical treatment of temporal
lobe epilepsy in children is discussed.
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STEREOELECTROENCEPHALOGRAPHY-GUIDED
RADIOFREQUENCY THERMOCOAGULATION IN
DRUG-RESISTANT FOCALEPILEPSY: A NEW
PEDIATRIC TECHNIQUE TOGUIDETHE SURGERY
M. Chipaux, S. Ferrand-Sorbets, M. Fohlen, N. Dorison,
D. Taussig, G. Dorfmuller
Rothschild Foundation, Paediatric Neurosurgery, Paris, France
Purpose: In case of focal drug-resistant epilepsy, the presurgical evalua-
tion may include intracranial electroencephalogram (EEG), to delineate
cortical resection. Depth electrodes allow to realize radiofrequency ther-
mocoagulations, inside the epileptic focus, to reduce the seizure fre-
quency. The improvement is often transient, 2 to 4 months, and is a
diagnosis test confirming the limits of the cortical resection defined dur-
ing stereoEEG. This technique is well-known in adults, for the last
10 years, but unused in pediatrics.
Method: We report clinical data and outcome of 26 children eligible for
thermocoagulations during phase II invasive investigation by stereoEEG
since 2014. Thermocoagulations were performed with bipolar 100 mA
current during 10–50 seconds. The diameter of each lesion measure 5–
7 mm.
Results: 3 to 57 lesions were provoked, with a mean of 18 lesions. We
reported 65% of responders at 1 month, including 42% of seizure-free-
dom. The mean efficacy duration was 3 months. For one patient, we
decided to perform thermocoagulations inside the postcentral gyrus, he
experienced hemiparesthesia during few days. No side-effect was
reported in other patients. When surgery followed an SEEG-guided
RF-TC, the positive predictive value of being a responder and to be
Engel0s class I after surgery was 71%.
Conclusion: Stereo electroencephalography-guided radiofrequency
thermocoagulation is a safe technique in children, efficient in many
cases. The goal is to confirm the ictal onset zone and the limits of cortical
resection as defined after stereoEEG. They could also be used as pallia-
tive technique when ictal onset zone is within functional areas, which
cannot be operated on without sequellae.
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EVALUATING THEDIAGNOSTIC ACCURACYOF
HIGH-FREQUENCYOSCILLATIONS FOR
LOCALIZING EPILEPTOGENIC BRAIN USING INTRA-
OPERATIVERECORDINGS
S. Weiss*, B. Berry†, I. Chervoneva*, Z. Waldman*, M. Bower‡,
M. Kucewicz†, B. Brinkmann†, C. Nelson†, A. Sharan*, C. Wu*,
R. Staba§, J. Engel Jr§, M. Sperling¶, G. Worrell†
*Thomas Jefferson University, Philadelphia, PA, United States,
†Mayo Clinic, Rochester, Rochester, MN, United States, ‡Mayo
Clinic, Rochester, Neurology, Rochester, MN, United States,
§UCLA, Los Angeles, CA, United States, ¶Thomas Jefferson
University, Neurology, Philadelphia, PA, United States
Purpose: Determine the diagnostic accuracy of high-frequency oscilla-
tion (HFO) rates for localizing epileptogenic regions in the temporal
lobe.
Method: Intra-operative iEEG recordings, 2–10 minutes in duration,
from 45 patients with temporal lobe epilepsy (TLE) obtained at the time
of implantation, and 24 patients at the time of resection were analyzed
using a custom HFO detector. During the recording some subjects
received boluses of remifentanil, and 1% sevoflourane was stopped, to
increase epileptogenic activity. The identified HFO events were classi-
fied and characterized as true or false ripple/fast ripple on spikes, or rip-
ples/fast ripples on oscillations, and confirmed by visual inspection. The
accuracy of HFO rates for localizing the seizure onset zone was per-
formed using a ROC approach. The positive and negative predictive
value of resected and residual HFO rates on seizure outcome were calcu-
lated using a cutoff value for the threshold HFO rate used to calculate the
predictive values will be selected so as to maximize Youden’s J.
Results: Preliminary analysis demonstrates that in a cohort of seven
patients anesthetized using remifentanil with multiple subdural strips,
and a hippocampal depth electrode, undergoing a tailored temporal lobe
resection, the PPV of resected and residual ripple rates on seizure free
outcome was = 61.5% (56.5–67.3 95%CI), the NPV of resected and
residual ripple rates on seizure free outcome was = 63.0% (52.8–74.5
95%CI). In a smaller cohort of TLE patients (n = 3) undergoing depth
electrode implantation the area under the ROC curve for localizing the
seizure onset zone using HFO rates was 82%.
Conclusion: HFO rates measured in brief intra-operative recordings can
be helpful in localizing epileptogenic brain regions in the temporal lobe.
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PROGRESSIONOFMESIAL TEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS
J. Torres Corso*, A. Prada Jardim*, S.M. Comper*,
L. Rodrigues DeMarchi*, M. Salvadori Bittar Guaranha*,
A.C. Zetehaku*, M.T. Fernandes Castilho Garcia*, L. Botelho
Gaca*, H.J. Carrete†, G. Barbosa Sandim†, C.L. Penteado
Lancellotti‡, E. Abrao Cavalheiro*, I.B. Assunc~ao-Leme§,
A.P. Jackowski§, R. Silva Centeno*, E.M. Yacubian*
*UNIFESP, Neurology and Neurosurgery, Sao Paulo, Brazil,
†UNIFESP, Diagnostic Imaging, Sao Paulo, Brazil, ‡Faculdade
de Cie^ncias Medicas da Santa Casa de Sao Paulo, Pathological
Sciences, Sao Paulo, Brazil, §UNIFESP, Psychiatry, Sao Paulo,
Brazil
Purpose: To evaluate correlations between epilepsy duration and hip-
pocampal histopathology, electrophysiological findings and volumes of
temporal lobe structures in MRI in patients with mesial temporal lobe
epilepsy and hippocampal sclerosis (MTLE/HS).
Method: Seventy-seven patients with refractory MTLE/HS submitted to
surgery were included. Histopathological analysis:
(1) quantitative: hippocampal subfields and total estimated hippocam-
pal cell density (HCD), thickness of the dentate gyrus - normal, thin-
ning or dispersion;
(2) qualitative analyses: type of HS and granule cells pathology in the
dentate gyrus (normal, neuronal cell loss, dispersion and bilamina-
tion). Ictal and interictal EEGwere analysed:
1) Ictal EEG: number of localized, lateralized and non-lateralized sei-
zures, switch of lateralization, seizures evolving to tonic-clonic and
seizure onset contralateral to HS;
2) Interictal EEG: interictal epileptiform discharges (IEDs) were con-
sidered bilateral when ≥ 20% of independent IEDs were contralateral
to HS. Fifty-eight patients also had FreeSurfer volumetric analyses of
bilateral temporal structures (hippocampus, amygdala, parahip-
pocampal gyrus, temporal pole, entorrinal cortex). Histopathological
and imaging findings were compared to normal age-pared controls
and the data were adjusted to the age at epilepsy onset.
Results: Forty-two (54.5%) patients presented right HS. A longer epi-
lepsy duration was correlated to a smaller estimated HCD (r = 0.253,
p = 0.027). Patients with ≥ 20 years of epilepsy presented a lower proba-
bility of having a normal granule cells distribution (p = 0.035) and epi-
lepsy duration of patients with a normal thickness of granule cell layer
was shorter compared to the ones with dispersion (p = 0.025) and thin-
ning (p = 0.032). FreeSurfer processing showed that a longer epilepsy
duration was correlated to a lower ipsilateral hippocampal volume
(r = 0.321, p = 0.015).
Conclusion: MTLE/HS is a progressive disease in histopathological and
imaging aspects.
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SUCCESSFUL SEEG-INFORMEDLASERABLATIVE
THERAPYOFCINGULATE EPILEPSYWITHDEPDC5
MUTATION
S. Sattar*, D. Gonda†, M. Nespeca*
*San Diego/Rady Children’s Hospital, University of California,
Neurosciences, San Diego, CA, United States, †San Diego/Rady
Children’s Hospital, Neurosurgery, University of California,
San Diego, CA, United States
Purpose: In the past 10 years epilepsy surgery has increasingly been
recognized as a viable treatment for patients with medically refractory
seizures. Here we present a 17 years old right-handed Caucasian female
with MR-negative intractable frontal lobe epilepsy since the age of 8 who
had stereotactic electrode encephalogram (SEEG) in order to identify the
epileptogenic focus.
Method: Our patient0s seizures were characterized by a fearful aura with
arousal from sleep, sitting up in panic with nonspecific hypermotor
movements of the lower extremities followed by urinary urgency or
incontinence. Seizures were 3–6 per night with each lasting 10–45 sec-
onds. She had a positive family history of epilepsy. Scalp video elec-
troencephalogram had no localizing findings at seizure onset with
bifrontal slowing and recurrent epileptiform discharges. 1.5 & 3 tesla
MRI brain and interictal PET were normal. Functional MRI for language
showed bilateral activation. Magnetoencephalography (MEG) demon-
strated 2 spike clusters, 90% originating in the right superior frontal gyrus
and 10% originating from the left frontal operculum. Neuropsychological
testing did not reveal any cognitive deficits. Prior to surgery, an epilepsy
gene panel was done given the positive family history for epilepsy which
identified a mutation in DEPDC5, a gene associated with autosomal
dominant familial focal epilepsy with variable foci and cortical dyspla-
sia.
Results: SEEG implantation and recording, guided by clinical semiol-
ogy and MEG, identified the right anterior-mid cingulate gyrus as the
epileptogenic zone. Patient was counseled on lower chance of seizure
freedom given location and genetic findings. Stereotactic laser ablation
of the right anterior-mid cingulate gyrus was performed. She has been
seizure free for 8 months with no post op deficits.
Conclusion: DEPDC5 mutation should not be considered a contraindi-
cation to proceeding with SEEG implantation as it can identify the
epileptogenic focus. Laser cingulotomy is safe and should be considered
as an option.
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THEHIGH-FREQUENCYOUT-STRENGTHDIRECTS
THENEUROSURGEONTOTHEEPILEPTOGENIC
TISSUE
W. Zweiphenning*, E. van Diessen†, F. Leijten*, P. van Rijen*,
K. Braun†, M. Zijlmans*,‡
*UMCUtrecht, Neurology & Neurosurgery, Utrecht,
Netherlands, †UMCUtrecht, Pediatric Neurology, Utrecht,
Netherlands, ‡Stichting Epilepsie Instellingen Nederland
(SEIN), Heemstede, Netherlands
New insights in high frequency EEG activity and network analysis pro-
vide possible tools to improve delineation of epileptogenic tissue and
thereby increase the chance of postoperative seizure freedom. Based on
our observation of high frequency oscillations ‘spreading outward’ from
the epileptogenic source, we hypothesized that measures of directed con-
nectivity in the high frequency ranges might distinguish epileptogenic
from healthy brain tissue.
As a first step, we compared high-frequency (gamma: 30–80 Hz, rip-
ple: 80–250 Hz, fast ripple (FR): 250–500 Hz) directed network mea-
sures between the resected and non-resected tissue in 12 patients with
refractory epilepsy based on a lesion who had ioECoG-tailored resective
surgery. In these patients, the lesion and direct surroundings were fully
sampled and they became completely (Engel 1A) seizure free. The
resected area must thus have contained the actual epileptogenic tissue.
We found an increased out-strength (OS) and higher ratio (Rat)
between out/in-strength in the resected tissue, indicating more outgoing
than incoming connections in the high frequency ranges (gamma:
OSRes = 0.47, OSNonRes = 0.39, p = 0.02, RatRes = 1.97,
RatNonRes = 1.07, p < 0.01; ripple: OSRes = 0.59, OSNonRes = 0.52,
p = 0.01, RatRes = 3.26, RatNonRes = 1.16, p < 0.01; FR: OSRes = 0.72,
OSNonRes = 0.68, p < 0.01, RatRes = 4.01, RatNonRes = 1.38, p = 0.01).
The epileptogenic tissue has more outgoing than incoming connec-
tions in the high frequency bands, suggesting that it acts as an 0outward0
high frequency hub region.
We are currently repeating these analyses in a larger population, and
added patients that did not become seizure free after surgery as a control
group. Especially the latter comparison will be very informative as to
whether directed values of strength within the high frequency bands will
eventually be useful as a tool to delineate the epileptogenic tissue intra-
operatively.
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HIGH FREQUENCYOSCILLATIONS IN THE PRE-
OPERATIVE ECOGRECORDEDATMACRO- AND
MICRO-SCALE
T. Fedele*, P. Hilfiker†, T. Grunwald†, L. Stieglitz*,
J. Sarnthein*
*Neurosurgery Department, University Hospital Zurich, Zurich,
Switzerland, †Swiss Epilepsy Centre, Zurich, Switzerland
Purpose: High frequency oscillations (HFOs) in the pre-operative ECoG
are a promising biomarker of the epileptogenic zone (EZ). While HFOs
are recorded in epilepsy patients by implanted depth electrodes with
macro-contacts, little is known about the concomitant neural activity at
the micro-scale.
Method: We recorded ECoG during slow wave sleep from three mesial
temporal lobe epilepsy patients implanted with depth electrodes. Each
macro electrode (8 contacts of 1.3 mm diameter and 1.6 mm length) had
nine microwires protruding from its tip, including one low-impedance
wire with stripped insulation (1 kΩ). This wire was used as a reference
also for macro contacts in order to record from the same brain volume at
macro and micro scale. Macro HFO (mHFO) and micro HFO (lHFO) for
ripples (80–250 Hz) and fast ripples (FRs, 250–500 Hz) frequency
ranges were detected automatically [1]. For each electrode location, we
defined the co-occurrence Cl-m as the percentage lHFO occurring dur-
ing a mHFO, and Cm-l as the percentage mHFO occurring during a
lHFO.
Results: Across sampled sites, lFR rates were higher than mFR rates
(p < 1e-4). We observed a similar spatial distribution for lFR and mFRs
rates (Spearman, p < 0.05). The Cl-m was higher than Cm-l for FR
(p < 1e-4), while Cl-m was lower than Cm-l for ripples (p < 0.005).
For the two patients where the combined setup covered the EZ, mFR and
lFRwere higher in the EZ than outside.
Conclusion: Higher lFR rates and the higher co-occurrence with a FR at
macroscale is consistent with the more localized nature of FR generators.
While mFR confirmed to be a reliable biomarker of the EZ, lFR offer a
similar picture on a smaller spatial scale.
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POST-SURGICAL PROGNOSIS OF
HEMISPHERECTOMYANDHEMISPHEROTOMY
PROCEDURESONCHILDRENWITHREFRACTORY
EPILEPSY
L. Cuadra*, V. Venegas†, A. Zuleta‡, S. Valenzuela‡,§,
J.J. Marengo‡, O. Koller‡, C. Okuma¶, E. Garcia**,
N. Goycolea‡
*Instituto de Neurocirugia Asenjo, Santiago, Chile, †Instituto de
Neurocirugia Asenjo, Pediatric Neurosurgery, Las Condes,
Chile, ‡Instituto de Neurocirugia Asenjo, Pediatric
Neurosurgery, Santiago, Chile, §Universidad de Chile, Santiago,
Chile, ¶Instituto de Neurocirugia Asenjo, Neuroradiolgy
Service, Santiago, Chile, **Universidad del Desarrollo,
Santiago, Chile
Purpose: To evaluate the results of epileptic surgery on children oper-
ated with Functional Hemispherectomy (FH) and Hemispherotomy (H)
techniques at Instituto de Neurocirugıa Asenjo (INCA), Chilean public
hospital which has operated children with refractory epilepsy since 1990.
Method: A database of 400 children undergoing epileptic surgery at
INCAwas reviewed. 21 were operated with FH and 24 with H. 5 children
were removed for less than 1-year follow-up. We then analyzed the evo-
lution of 40 cases with controlled seizures using the Engel0s Scale, the
variation in the Antiepileptic Drugs (AEDs) intake, and the complica-
tions presented after surgery.
Results: From 40 children reviewed, an average age of 21 month at the
onset of seizure, (11 cases experienced onset at neonatal period). All
cases presented Epilepsy secondary to hemispheric structural anomalies.
The mean follow-up time was 55 month. 84% of patients (32/40) evolved
with Engel Ia at one-year follow-up. 28 cases (70%) evolved with Engel
Ia in the last control. Only 6 cases were in Engel III or IV, there were no
differences achieved at follow-up between the two surgical techniques.
28/40 children were able to reduce the number of AEDs post-surgery, 19
(67.8%) of which experienced H. In 5 cases AEDs were removed time
after surgery. In post-surgery complications, infections were equally
found using both techniques. Other complications were only seen in chil-
dren with FH: 3 hydrocephalus, 3 subdural collections and 1 transitory
endocrinological disorder.
Conclusion: Both surgical techniques were equally effective in reducing
epileptic seizures. More cases with H reduced the number of AEDs.
Infectious events were seen equally in both groups. Hydrocephalus, sub-
dural collections and transient endocrinological alteration were observed
only in cases with FH, thus it is a technique that presented a higher fre-
quency of complications.
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MILDMALFORMATIONOFCORTICAL
DEVELOPMENTAS A SUBSTRATE FORMRI-
NEGATIVE TEMPORAL EPILEPSY
S.M. Malyshev, V.G. Nezdorovina, Y.M. Zabrodskaya,
D.A. Sitovskaya, G.V. Odintsova, A.Y. Ulitin
Federal Almazov North-West Medical Research Centre, Russian
Neurosurgical Institute named after A.L. Polenov, St Petersburg,
Russian Federation
Purpose: To present the special features of diagnosis and treatment of
MRI-negative epilepsy caused by mild malformation of cortical develop-
ment (mMCD).
Method: A clinical observation of the patient with resistant temporal
epilepsy treated in Russian Neurosurgical Institute named after A.L.
Polenov. The evaluation included a diagnostic complex for neurosurgery
Results: A 32-years-old woman presented with a 13-years-old history of
medically refractory complex focal seizures with ambulatory automa-
tisms, often followed by secondary generalization. The seizures were
occurring at least 2–3 times a month, more frequently during menses.
According to video-EEG-recordings, epileptic activity was localized in
the left temporo-parietal region.MRI showed no structural abnormalities.
PET/CT revealed low glucose uptake in the left temporal lobe. Basing on
these findings, anterior temporal resection was performed, and the left
hippocampus and amygdala were removed. No seizures occurred in the
past three months, and patient0s quality of life has improved. The epilep-
tic activity on EEG is significantly reduced.
During the histological examination of the temporal pole, cortex dys-
plasia with ectopic neurons in the white matter was identified. Further-
more, there was a large number of heterotopic neurons located either in
the first layer of the neocortex that is the mMCD type I. Because this
abnormality can be detected only by microscopic examination, mMCD
may create a substrate for MRI-negative epilepsies.
Conclusion: In the given case, the epileptogenic lesion (mMCD) was
identified only by the histological examination of surgical specimens.
This observation demonstrates the need to develop new clinical and diag-
nostic approaches to identify cortical microdysgenesis during the presur-
gical evaluation of a patient with epilepsy.
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DETERMINANTSOF INTELLECTUALOUTCOME
AFTER FOCALEPILEPSY SURGERY INCHILDREN
C. Skirrow*,†, J.H. Cross*,†, R. Owens*, L. Weiss-Croft*,‡,
P. Martin-SanFilippo†, T. Banks†, W. Harkness†, F. Vargha-
Khadem*,†, T. Baldeweg*,†
*UCL Great Ormond Street Institute of Child Health, London,
United Kingdom, †Great Ormond Street Hospital for Children,
London, United Kingdom, ‡Kings College London, London,
United Kingdom
Purpose: Children often show disparate cognitive trajectories following
epilepsy surgery. The clinical and structural brain factors impacting on
IQ change post surgically are not yet known.
Method: 55 children who underwent presurgical evaluation were
reviewed; 41 had undergone focal resections (frontal 10, parietal 7, tem-
poral 18 and multilobar 6) and 14 had not proceeded to surgery. All
underwent IQ and structural MRI assessments as a part of routine pre-sur-
gical investigations (baseline), which were repeated at follow-up. Aver-
age age at surgery was 13.8 years, and mean duration from baseline to
follow-up was 7.5 years (range 3–16 years). Resection volumes were
measured by manual tracing and grey and white matter volumes were
extracted from segmentation analyses.
Results: At follow-up, 71% of the surgical group was seizure-free com-
pared to 14% in the non-surgical group; 47.5% and 93% remained on
antiepileptic drugs (AEDs), respectively. An overall increase in IQ was
seen in surgery patients at follow-up in comparison with non-surgical
controls (group x time effect: F1,49 = 7.1, p = 0.01). IQ improvement
was associated with cessation of AED use (T = 2.7, p = 0.01) but not
with seizure freedom (p = 0.2). There was neither a significant impact of
the resection location (e.g. frontal, temporal, parietal) nor volume of
resection (p > 0.15). However, improved IQ was seen after longer fol-
low-up (r = 0.4, p = 0.02) and was associated with more positive ipsi-
and contra-lesional hemispheric grey matter volume changes (ipsi:
r = 0.63, p < 0.001; contra: r = 0.55, p = 0.002).
Conclusion: We find positive cognitive outcomes for children who had
focal surgery for epilepsy, regardless of the extent or location of the
resection. Longer follow-up and cessation of anti-epileptic medication
were associated with positive IQ change. Improvements in intellectual
functioning were correlated with brain volume change in regions proxi-
mal and remote to the resection.
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ENDOSCOPIC DISCONNECTIONOFHYPOTHALAMIC
HAMARTOMA IN CHILDRENANDADULTSWITH
DRUGRESISTANTEPILEPSY: TECHNIQUEAND
RESULTS REGARDINGAPOPULATIONOF 126
PATIENTS
G. Dorfmuller, M. Fohlen, D. Taussig, M. Chipaux, N. Dorison,
C. Bulteau, O. Delalande, S. Ferrand-Sorbets
Fondation Rothschild, Paris, France
Purpose: Hypothalamic hamartomas (HH) may induce drug resistant
epilepsy (DRE) requiring surgical treatment. Disconnective procedures
have been shown to be safe and as effective as removal of the lesion. We
report on a large surgical series of 126 patients from our institution, with
emphasis on the surgical technique and seizures outcome.
Method: 126 patients with HH and DRE operated on between 1998 and
2015 were retrospectively reviewed. Hamartoma disconnection was per-
formed using either monopolar coagulation, thulium laser or ultrasonic
dissection throught a Robot-guided transventricular endoscopic route.
Few patients were operated throught an open pterional approach. Results
in term of safety and outcome of epilepsy were analysed.
Results: Mean age at surgery in all patients was 14.66 years. Mean age
at seizure onset was 31 months; 84% of the patients experienced gelastic
or dacrystic seizures as seizure type. Mental retardation was present in
41%. According to the Delalande’s classification, 3.2% of the patients
had a hamartoma of type 1, 59.5% of type 2, 27% of type 3 and 10.3% of
type 4.Endoscopic transventricular disconnection was performed in 96%
of the patients: in a single procedure in 60% and in more than one proce-
dure (2 to 5) in 40%. With a mean follow-up of 3.6 years, 72% of all the
patients and 81% of the patients with type 2 hamartoma had an excellent
seizure outcome (Engel 1 and 2) 0.28 patients presented post-operative
complications which consisted in recent memory deficit (6), hemiparesis
(4), hormonal dysfunction (12), third nerve palsy (5), meningitis (2), and
hydrocephalus (1).
Conclusion: Transventricular endoscopic HH disconnection is well tol-
erated, with an acceptable morbidity, and can easily be repeated in case
of large lesions or seizure persistence. Overall seizure outcome is excel-
lent, particularly for type 2 hamartomas.
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CANGENE PANEL TESTING IN EPILEPSY SAVE
MONEY?
S. Oates*, S. Tang*, R. Lear*, L. Larsen†, Q. Hao†, H.A. Dahl†,
R. Moller‡, D.K. Pal*
*King’s College London, London, United Kingdom, †Amplexa
Genetics, Odense, Denmark, ‡Danish Epilepsy Center,
Dianalund, Denmark
Purpose: next generation genetic testing is being introduced to epilepsy
practice in many industrialized countries, but few evaluations of its
implementation have been reported, especially in the area of cost-effec-
tiveness. We evaluated our epilepsy genetic diagnostic and counseling
services for a UK region of 3.5 million.
Methods: We set up a regional specialist outpatients clinic for suspected
genetic epilepsy staffed by an epilepsy geneticist, genetic counselor and
research fellow, in parallel with a gene panel diagnostic service using
gene panels ranging from 45–102 genes. We calculated diagnostic yield,
estimated clinical impact, surveyed referring clinicians and families who
used the outpatients service, and reconstructed investigational costs.
Results: 96 patients were referred for panel testing and 44 for outpatient
consultation. A genetic diagnosis was made in 40% when seizure onset
was <2 years, with average turnaround 21 days. Almost half the patho-
genic variants were in SCN2A, SCN8A, SCN1A and KCNQ2; half of the
results had implications for antiepileptic medication, including experi-
mental therapies. Clinical prediction was poor. Referrers rated the service
highly (83%) and 100% of families would recommend us to family and
friends. Among 15 tested neonates, the average investigation cost was >
£9500:£7,000 was spent on repeated MRI and EEG videotelemetry; and
£1,200 on zero yield array CGH, single gene and metabolic testing.
Conclusion: Diagnostic yield of gene panel in <2 year onset group is
excellent, and a specialist multidisciplinary clinic well received by refer-
rers and families. Clinical impact ranged from AED guidance to recur-
rence risk, prenatal and extended pedigree counseling, and will broaden
as new clinical trials open. The introduction of NGS technology man-
dates the revision of conventional clinical diagnostic pathways in an
effort to at least achieve cost neutrality; in the neonatal group, we show
possible savings of 12–54% by redesigning the content and sequence of
investigations.
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EXPRESSIONOF SERUMMIR-21 IN EPILEPSY: A
PRELIMINARY STUDY
R. Ferreira*, B. Leal*,†, C. Carvalho*,†, J. Chaves†,‡,
D. Rodrigues*, A. Bettencourt*,†, R. Chor~ao‡, J. Freitas‡,
D. Boleixa*, J. Lopes§, J. Ramalheira§, B. Martins da Silva*,†,
P. Pinho Costa†,¶, A. Martins da Silva†,§
*Instituto de Cie^ncias Biomedicas Abel Salazar (ICBAS),
Imunogenetica, Porto, Portugal, †UMIB - Instituto de Cie^ncias
Biomedicas Abel Salazar (ICBAS) - Universidade do Porto,
Porto, Portugal, ‡Centro Hospitalar do Porto, Hospital de Santo
Antonio, Servico de Neurologia, Porto, Portugal, §Centro
Hospitalar do Porto, Hospital de Santo Antonio, Servico de
Neurofisiologia, Porto, Portugal, ¶Instituto Nacional de Saude
Dr. Ricardo Jorge, Departamento de Genetica, Porto, Portugal
Purpose: MicroRNAs are short non-coding RNAs that regulate gene
expression post-transcriptionally, being able to modulate diverse biologi-
cal processes. The influence of MicroRNAs (miRs) in epileptogenesis
represents a growing field of research. MiR-21 is strongly associated to
immune cell differentiation and proliferation and has been shown to be
upregulated in epilepsy animal and human tissues (Peng, J. et al. 2012.;
Roncon, P. et al 0.2015). Knowing that miR expression is very stable in
biological fluids such as plasma or serum our aim was to analyse circulat-
ing serum miR-21 expression in Genetic Generalized Epilepsy (GGE)
andMesial Temporal Lobe Epilepsy (MTLE).
Method: Expression levels of miR-21 were quantified by Real-Time
PCR in sera from 48 GGE and 36 MTLE Patients. Forty-six healthy indi-
viduals were used as control. Relative expression values were calculated
by the 2-DDCt method.
Results: Serum expression levels of miR-21 were decreased in GGE
patients vs controls. However, no statistically significant differences
were observed. MTLE patients and controls had similar miR-21 expres-
sion levels.
Conclusion: Our study is the first to evaluate serum miR-21 expression
levels on GGE and MTLE patients. These results are not concordant with
the previously reported miR-21 up-regulation in epilepsy. This may
result from differences in clinical features and cohort size. This is a
preliminary study that requires further investigation on a larger cohort.
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THE IDENTIFICATION FOR PHARMACOGENETIC
BIOMARKERS IN THETREATMENTOF EPILEPSY
S. Wolking*, C. Stapleton†, H. Schulz‡, A. Nies§,
M. McCormack†, J. Schubert*, M. Schwab§, T. Sander‡,
G. Cavalleri†, H. Lerche*, EpiPGX Consortium
*University Hosptial T€ubingen, Hertie Institute for Clinical
Brain Research, Neurology and Epileptology, T€ubingen,
Germany, †Royal College of Surgeons in Ireland, Molecular and
Cellular Therapeutics, Dublin, Ireland, ‡University of Cologne,
Cologne Center for Genomics, Cologne, Germany, §Institute for
Clinical Pharmacology, Stuttgart, Germany
Purpose: Pharmacoresistance is a major burden in the treatment of epi-
lepsy. The search for an effective and well-tolerated antiepileptic drug
(AED) is achieved by trial and error. Responders to the first AED account
for only 50% of all treated epilepsy patients. The second drug accounts
for another 15%, whereas all the following AEDs deliver <5% response -
with lessening chance of success with increasing number of drug trials.
Genetic biomarkers can help to individualize the treatment. Drug trans-
porter genes and more generally genes involved in the absorption, deliv-
ery, metabolization and excretion of drugs (ADME) present likely targets
in the search for biomarkers for pharmacoresponse.
Method: In the framework of the EpiPGX consortium, a European
research project on epilepsy pharmacogenomics, about 5000 patients
were recruited and meticulously phenotyped between 2011 and 2015.
Our primary interest within the consortium was the pharmacoresponse of
specific AEDs or groups of AEDs. For idiopathic generalized epilepsy
(IGE) we included 850 subjects, for focal epilepsies we included 3650
subjects. We performed genome wide association studies (GWAS) for 9
different AEDs or groups of AEDs. In the next step, we conceived a list
of 406 ADME genes that were likely involved in pharmacoresponse and
performed a gene set analysis based on the GWAS analyses.
Results and outlook: We could not observe any significant genetic asso-
ciations (p < 5*10-8) in the 17 GWAS subsets. Although, we detected
some promising association signals, the total number of cases might have
been too low to retrieve significant results. The gene set analysis for
ADME genes revealed no significant results. For 4 AEDs (levetiracetam,
valproate, lamotrigine and lacosamide) exome sequencing data has been
obtained to extend this study to include rare coding variants. Results are
still pending.
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MALE PATIENTS AFFECTEDBYMOSAIC PCDH19
MUTATIONS: 5 NEWCASES
I. de Lange*, P. Rump†, R. Neuteboom‡, P. Augustijn§,
K. Hodges¶, A. Kistemaker**, O. Brouwer††, G. Mancini‡‡,
H. Newman§§, Y. Vos†, K. Helbig§§, C. Peeters-Scholte¶¶,
M. Kriek***, N. Knoers*, D. Lindhout*, B. Koeleman*, M. van
Kempen*, E. Brilstra*
*UMCUtrecht, Genetics, Utrecht, Netherlands, †University of
Groningen, Genetics, Groningen, Netherlands, ‡Erasmus MC,
Neurology, Rotterdam, Netherlands, §S.E.I.N., Child
Epileptology, Heemstede, Netherlands, ¶Miller Children’s
Hospital, Adult & Child Neurology, Long Beach, CA, United
States, **Tjongerschans Hospital, Neurology, Heereveen,
Netherlands, ††University of Groningen, Neurology, Groningen,
Netherlands, ‡‡Erasmus University, Clinical Genetics,
Rotterdam, Netherlands, §§Ambry Genetics, Clinical
Diagnostics, Aliso Viejo, CA, United States, ¶¶Leiden University,
Neurology, Leiden, Netherlands, ***Leiden University, Clinical
Genetics, Leiden, Netherlands
Purpose: Mutations in the PCDH19 gene are associated with epilepsy,
intellectual disability (ID) and behavioral disturbances. Only heterozy-
gous females andmosaic males are affected, likely due to a disease mech-
anism named cellular interference. Until now, only four affected mosaic
male patients have been described in literature. Here, we report five addi-
tional male patients, of which four are older than the oldest patient
reported so far.
Method: All reported patients were selected for genetic testing because
of developmental delay and/or epilepsy. Custom targeted next generation
sequencing gene panels for epilepsy genes were used. Clinical data were
collected frommedical records.
Results: All patients were mosaic for mutations in the PCDH19 gene. In
most, clinical features were very similar to the female phenotype, with
normal development before seizure onset, which occurred between 5 and
10 months of age, clustering of seizures and sensitivity to fever. Four out
of five patients had mild to severe ID and behavioral problems.
Conclusion: In five male patients, mosaic PCHD19 mutations were
identified by Next Generation Sequencing. We reaffirm the similarity
between male and female PCDH19-related phenotypes, now also for
male patients of ages 10–14 years. The fact that mosaic males and
heterozygous females for a PCDH19 mutation show identical clinical
phenotypes weakens the hypothesis of a compensating effect by a
non-paralogous gene in hemizygous males.
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PCDH19MOSAICMUTATION INAMALE PATIENT
WITHLENNOX-GASTAUT SYNDROME
Z.-R. Chen, L.-M. Yan, Y.-H. Yi, W.-P. Liao
Institute of Neuroscience and Department of Neurology of the
Second Affiliated Hospital of Guangzhou Medical University,
Guangzhou, China
Purpose: Variants in the gene encoding protocadherin-19 (PCDH19),
which are associated with epilepsy and mental retardation limited to
females (EFMR) and epileptic encephalopathies resembling Dravet syn-
drome. This study aimed to supplement the phenotypic spectrum associ-
ated with PCDH19mutations in epilepsy patients.
Method: We selected 90 patients with epilepsy, and collected their clini-
cal data on age at seizure onset, seizure types, seizure frequency, seizure
offset, results of EEG, psychomotor development, and behavioral fea-
tures. Mutations were detected by targeted next generation sequencing
(NGS) approach, and all the pathogenic mutations were confirmed by
Sanger sequencing. Functional impact of all variants was inspected by
three different in silico tools (sift http://sift.jcvi.org/; polyphen
http://genetics.bwh.harvard.edu/pph2/; mutation taster http://www.mu
tationtaster.org/). Meanwhile, SNP Array test was used to check
PCDH19 for gene number.
Results:
1 Sequencing analysis showed a de novo heterozygous mutation in the
PCDH19 gene (NM_001184880) c.1091delC and no mutation in the
SCN1A gene.
2 One male patient was diagnosed as LGS based on his typical clinical
features, and the PCDH19mosaic mutation (p.P364 fs) was identified
in this patient by de novo pattern.
3 The mutation, p.P364 fs, is predicted to result in functional distur-
bance of EC4 of PCDH19.
Conclusion: In this study, we report the first PCDH19-related Lennox-
Gastaut syndrome in a mosaic male patient. This finding suggests a possi-
ble role for PCDH19 in the etiology of Lennox-Gastaut syndrome. The
molecular genetic screening for PCDH19 gene should be addressed to
male patients with early onset epilepsy and mental retardation.
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USEOFEPILEPSYGENE PANELS FOREARLY
DIAGNOSIS OF EPILEPSY INCHILDREN 2–4 YEARS
OFAGE: EXPERTCONSIDERATIONSONCURRENT
AND FUTURE PRACTICES IN EUROPE
H. Lerche*, M. Bailey†, E. Barroso‡, S. Griesbach§, E. Izzo†,
L. Jenkins¶, E. Le Guern**, D. Mei††, S. Mikhailova‡‡,
F. Santorelli§§, N. Miller†
*Department of Neurology and Epileptology, University of
Tubingen, Tubingen, Germany, †BioMarin Pharmaceutical Inc.,
Novato, CA, United States, ‡University La Paz Hospital, Madrid,
Spain, §Center for Genomic and Transcriptomic (CeGaT),
T€ubingen, Germany, ¶NE Thames Regional Genetics Service,
Great Ormond Street Hospital for Children NHS Foundation
Trust, London, United Kingdom, **Neurogenetics Laboratory,
Pitie-Salpe^triere Hospital, Pierre and Marie Curie University,
Faculty of Medicine, Paris, France, ††Neurogenetics Lab –
Pediatric Neurology, Children’s Hospital A. Meyer –University
of Florence, Florence, Italy, ‡‡Metabolic and Genetic
Departments, Republic Pediatric Hospital, Moscow, Russian
Federation, §§Molecular Medicine for Neurodegenerative and
Neurogenetic Diseases, IRCCS Stella Maris, Pisa, Italy
Purpose: The epilepsy gene panel is a molecular test increasingly used
in clinical practice for the genetic diagnosis of epilepsy. A delay from
clinical onset to molecular diagnosis may occur due to variability in
referral criteria, regional variability in gene panel content, test availabil-
ity/awareness and cost.
Methods: In December 2016, eight European experts in the genetic diag-
nosis of epilepsy completed a survey and met to discuss current and
future application of epilepsy gene panels in the diagnosis of children
aged 2–4 years. The meeting was sponsored by BioMarin Pharmaceuti-
cal Inc.
Results: Upon first presentation of unprovoked seizures in children aged
2–4 years, molecular testing is usually ordered only after several clinical
examinations (e.g. metabolic investigations, EEG,MRI), seizure worsen-
ing, manifestation of additional symptoms, and/or resistance to anti-epi-
leptic drugs (AEDs).
Key considerations offered::
i To shorten the time to genetic diagnosis of epilepsy, a gene panel test
performed during initiation of AEDs may be warranted before worsening
of symptoms, when an additional symptom is present;
ii all epilepsy gene panels should include a core set of genes linked to
epilepsy syndromes/diseases presenting with epilepsy and with clinically
actionable potential;
iii a gene panel is the first-tier choice in contrast to whole-exome/gen-
ome, due to higher gene coverage and lower cost.
Conclusions: Early use of an epilepsy gene panel provides a cost-effec-
tive diagnostic approach for timely identification of genetic causes of
pediatric epilepsy which informs: clinical management, genetic counsel-
ing, prognosis and, when available, targeted therapy.
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ANOVELCENTROMERE PROTEIN FMUTATION INA
PEDIATRIC PATIENTWITH PRESENTATIONOF
MOTORANDMENTALRETARDATION,
MICROCEPHALYANDDRUG-RESISTANT EPILEPSY
A. Kacar Bayram*, H. Per*, H. G€um€us*, M. G€unel†,
A.O. Caglayan†,‡
*School of Medicine, Erciyes University, Kayseri, Turkey,
†Departments of Neurosurgery, Neurobiology and Genetics,
School of Medicine, Yale University, New Haven, CT, United
States, ‡School of Medicine, Istanbul Bilim University, Istanbul,
Turkey
Purpose: Centrioles are microtubule derived cylindrical structures that
play an important role in the formation of centrosomes, cilia and flagella.
Mutations in centrosomal and microtubule-regulating genes can lead to
disorders of neuronal migration and microcephaly. Centriole length regu-
lation has recently been described in the pathogenesis of the ciliopathy
disorders. Mutations in centromere protein F (CENPF) gene are associ-
ated with disorders of severe ciliopathy and microcephaly. Herein, we
report a novel CENPF mutation in a 3-year-old female with presentation
of motor and mental retardation, microcephaly, and drug-resistant epi-
lepsy.
Method: A 3-year-old girl presented with motor and mental retardation,
microcephaly, and drug-resistant epilepsy. In family history of patient, it
was learned that her sister had lost with diagnosis of Lennox-gastaut syn-
drome. The eye examination revealed bilateral chorioretinal atrophy. All
laboratory findings, including cerebrospinal fluid neurotransmitter analy-
sis and metabolic tests, were within normal limits. Electroencephalogra-
phy was compatible with epileptic encephalopathy. Brain magnetic
resonance imaging demonstrated generalized cerebral atrophy.
Results: Molecular analysis revealed a novel homozygous nonsense
mutation (R3063X) in CENPF gene.
Conclusion: CENPF gene mutations should be considered in patients
with neuronal migration disorders and microcephaly. CENPF gene muta-
tions could also be implicated in drug-resistant epilepsy related pheno-
types. Further studies will provide knowledge regarding the development
of heterogeneity of phenotypic characteristics of CENPF gene mutations.
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ANOVELMUTATIONOF THE INOSITOL 1,4,5-
TRIPHOSPHATERECEPTORTYPE 1GENE IN
DIZYGOTIC TWIN BROTHERSWITHREFRACTORY
EPILEPSY
M. Erdogan*, A. Kiraz*, A. Kacar Bayram†, B. Balta*,
N. Bayram*, H. G€um€us†, S. Saracoglu†, H. Per†
*Kayseri Education and Research Hospital, Kayseri, Turkey,
†Erciyes University, Faculty of Medicine, Kayseri, Turkey
Purpose: The inositol 1,4,5-triphosphate receptor type 1 (ITPR1) is a
gene that encodes the inositol 1,4,5-triphosphate (IP3) receptor. This
receptor modulates intracellular calcium signaling over an intracellular
IP3-gated calcium channel. IP-3 is one of the intracellular secondary
messengers, causing Ca2+ release from the endoplasmic reticulum that
are involved in various cellular processes. ITPR1 is the most plentiful in
the central nervous system, highly enriched in the cerebellum, particu-
larly in Purkinje cells. Herein, we report a novel mutation of the ITPR1
gene in dizygotic twin brothers with refractory epilepsy.
Method: Both siblings were born to consanguineous, unaffected Turkish
parents. The first patient s a 16-year-old girl who presented with motor
and mental retardation, microcephaly, and intractable epilepsy. The preg-
nancy and neonatal periods were unremarkable. The physical examina-
tion revealed microcephaly, muscle hypotonia, joint hypermobility, skin
hyperextensibility, osteoporosis, and scoliosis. Nystagmus and bilateral
optic atrophy were detected on ophthalmic examination. Brain MRI
demonstrated brainstem and cerebellar atrophy. MR spectroscopy
demonstrated an increase in brain myo-inositol. Phenotypic features,
radiologic findings and clinical course of the second patient are similar to
first patient except for the male gender.
Results: Whole-exome sequencing revealed a novel homozygous muta-
tion c.5309 G>T (p.Gly1770Val) in ITPR1 gene on chromosome 3p26.
Conclusion: ITPR1-dependent pathways have been implicated in the
development and maintenance of the normal functions of cerebellum.
ITPR1 mutations should be considered in patients with cerebellar ataxia
and cerebellar atrophy. Our study showed that ITPR1 gene mutations
could also be implicated in refractory epilepsy related phenotypes. More
investigation will be necessary for the development of heterogeneity of
phenotypic characteristics.
p0666
DEPDC5AS A SUSCEPTIBILITYGENEOF FOCAL
EPILEPSIES
L. Liu*, H. Xu†, L. Yan*, S. Lin*, W. Liao*
*Institute of Neuroscience and Department of Neurology of the
Second Affiliated Hospital of Guangzhou Medical University
and Key Laboratory of Neurogenetics and Channelopathies of
Guangdong Province and the Ministry of Education of China,
Guangzhou, China, †Xuzhou Central Hospital, Affiliated
Hospital of Southeast University, Department of Neurology,
Xuzhou, China
Purpose: DEPDC5 (disheveled, Egl-10, and pleckstrin domain-contain-
ing protein 5) has recently been reported to be the causal gene for familial
focal epilepsy with variable foci as well as other syndromes of familial
focal epilepsies. This study is aimed to extend knowledge of DEPDC5-
related epilepsies, and highlight the susceptibility of DEPDC5 in focal
epilepsies.
Method: We performed targeted next-generation sequencing on 56 spo-
radic patients and 6 pedigrees of focal epilepsy with a panel of 480 epi-
lepsy-related genes. According to the International League against
Epilepsy criteria, patients were diagnosed as epilepsy with febrile sei-
zures plus (EFS+), epileptic encephalopathy, neurodevelopment-asso-
ciated epilepsy, or unclassified idiopathic focal epilepsy (IFE).
Results: We identified one frameshift (c.450delG, p.V151SfsTer27) and
two missense (c.2507A > G, p.Y836C; c.3092C > A, p.P1031H)
heterozygous DEPDC5 vatiants in three probands, respectively, among
which two novel variants (p.V151SfsTer27 and p.Y836C) were related to
febrile seizure (FS). The patient carried frameshift variant was experi-
enced single FS, while Y836C was identified in a pedigree of EFS+. The
variant P1031H was associated with IFE, probably one of the digenic
causes in focal epilepsy with CACNA1A. All of these three variants
showed incomplete penetrance.
Conclusion: Our findings expanded the DEPDC5-related phenotypic
spectrum to EFS+, and suggested thatDEPDC5was a susceptibility gene
of focal epilepsies.
p0667
ME2GENE INFLUENCES SUSCEPTIBILITY TO
GENETICGENERALIZEDEPILEPSY: EVIDENCE
FROMCOSEGREGATION, GENETIC ASSOCIATION
ANDGENEEXPRESSION STUDIES IS COMPELLING
W. Stewart*,†, M. Wang*, A. Malhotra*, D. Greenberg*,†
*Nationwide Children’s Hospital, Columbus, OH, United States,
†Ohio State University, Columbus, OH, United States
Purpose: Based on previous cosegregation (HLOD 4.50; Durner et al.
2001) and genetic association (p < 4x105; Greenberg et al. 2005) analy-
ses, we showed that malic enzyme 2 (ME2) is one of several major sus-
ceptibility genes for GGE (genetic generalized epilepsy).
Method: Now, we have replicated the original cosegregation result
(HLOD = 3.1), and the original association result (p < 2x104) using an
entirely new sample. Our most recent work points directly and unambigu-
ously toME2, and it continues to support a recessive mode of inheritance,
which is the most common form of inheritance for enzymatic disorders.
Results: In the original genetic association analysis, we identified a 9-
SNP-risk haplotype of ME2 (OR = 6.1) that is present homozygously in
35% of GGE cases and only 8% of controls (p < 0.025). This led us to
hypothesize that reducedME2 expression may play a causal role in GGE
susceptibility. By testing lymphocytes, we found thatME2 expression in
homozygous carriers of the 9-SNP-risk haplotype is 11% lower than
expression in heterozygous controls (p < 0.031). In a concurrent analysis
of 20 healthy postmortem brains, we also showed that 75% of the varia-
tion in ME2 expression is explained by 3 SNPs in the ME2 gene
(p < 0.005). Using the genotypes at these 3 SNPs, we predicted ME2
expression levels in 125 GGE cases and 81 controls. We found that pre-
dicted ME2expression was significantly lower in cases than controls
(p < 7x104).
Conclusion: Thus there is very strong evidence for ME2’s role in GGE;
and the accumulation of evidence from the original findings, our replica-
tion results, and preliminary expression studies, continues to support
ME2 as a major susceptibility gene for GGE.
p0668
PET-ANALYSIS: A NEWUSER-FRIENDLY TOOLBOX
FOREPILEPTIC SEIZUREONSET ZONE
LOCALIZATION. VALIDATIONANDCOMPARISON
WITH STATISTICAL PARAMETRICMAPPING
M.Mayoral*, A. Ni~nerola-Baizan†, B. Marti-Fuster†, A. Martın-
Pero†, A. Calvo†, D. Ros†, J. Pavıa†, M. Carre~no*, A. Donaire*,
J. Rumia*, F. Pons*, F. Lome~na*, X. Setoain*
*Hospital Clınic, Barcelona, Spain, †University of Barcelona -
CIBER-BBN, Barcelona, Spain
Purpose: To validate PET-Analysis, a new user-friendly application for
seizure onset zone (SOZ) localization from 18F-FDG PET in refractory
epilepsy and compare the results with visual assessment and Statistical
ParametricMapping (SPM).
Method: Thirty patients with treatment-refractory epilepsy who under-
went presurgical 18F-FDG PET and had a good postoperative outcome
(Engel I-II) were included. Two observers evaluated the studies by visual
assessment, with SPM8 and PET-Analysis. In statistical methods, a
voxel-based two-sample T-test was performed between each patient and
a control database. In SPM, T-maps were thresholded at p < 0.05 and
cluster size k > 50, when FWE correction for multiple comparisons was
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performed, and at p < 0.001 and k > 100. In PET-Analysis, studies were
spatially normalized, smoothed and intensity normalized using in-house
algorithms. Afterwards, T-maps were thresholded with multiple standard
deviations andminimum clusters sizes combinations, as this new applica-
tion rapidly processes different threshold combinations in the same ses-
sion. The visually-, SPM- and PET-Analysis-identified potential seizure
zone was compared to the SOZ, which was determined as the resected
area. The percentages of correctly localizing studies were compared by
McNemar test and concordance was assessed using the kappa index (к).
Results: PET-Analysis obtained 66.7% (20/30) of correctly localizing
studies, comparable to the percentage achieved by visual assessment
which was 70.0% (21/30), and statistically significantly higher
(p < 0.02) than the rate obtained with SPM threshold p < 0.001/
k > 100, which was 36.7% (11/30). SPM FWE threshold p < 0.05/
k > 50 was too restrictive and the SOZ was correctly localized in only
one study. The concordance was substantial for PET-Analysis
(к = 0.643) and visual interpretation (к = 0.622) while fair for SPM
(к = 0.242).
Conclusion: PET-Analysis is a robust application for SOZ localization
which could be superior to SPM because it easily and rapidly processes
different threshold combinations. Thus, PET-Analysis can be useful in
clinical practice as an objective complementary tool to visual assess-
ment.
p0670
ICTAL BRAIN PERFUSION SPECT SUBSTRACTED
WITH INTERICTAL FDG-PET FOR SEIZUREONSET
FOCUS LOCALIZATION
A. Perissinotti*, A. Ni~nerola-Baizan†,‡, S. Rubı§, M. Carre~no¶,
A. Donaire¶, N. Bargallo**, J. Rumia††, B. Martı-Fuster†,‡,
J. Pavıa*,†, D. Ros†,‡, F. Lome~na*, X. Setoain*
*Hospital Clınic Barcelona, Nuclear Medicine, Barcelona,
Spain, †Grupo de Imagen Biomedica, Centro de Investigacion
Biomedica en Red en Bioingenierıa, Biomateriales y
Nanomedicina (CIBER-BBN), Barcelona, Spain, ‡Facultat de
Medicina, Universitat de Barcelona, Unitat de Biofısica i
Bioenginyeria, Barcelona, Spain, §Hospital Universitari Son
Espases, Nuclear Medicine, Palma, Spain, ¶Hospital Clınic
Barcelona, Neurology, Barcelona, Spain, **Hospital Clınic
Barcelona, Radiology, Barcelona, Spain, ††Hospital Clınic
Barcelona, Neurosurgery, Barcelona, Spain
Purpose: To develop and validate a new processing nuclear imaging
procedure consisting of ictal perfusion SPECT studies subtracted with
interictal FDG-PET images coregistered to MRI (PISCOM) for seizure
onset focus (SOF) localization in patients with intractable complex par-
tial seizures.
Method: A retrospective selection from our clinical practice included 23
patients (11 male and 12 female, from 4 to 61 years - mean age: 31 years)
who had been diagnosed of medically refractory epilepsy, studied with
MRI, ictal SPECT, interictal SPECT, interictal FDG-PET and also that
remained seizure free for at least two years after surgical resection of the
SOF. To perform PISCOM analysis, interictal FDG-PET images were
resampled and filtered to obtain a same matrix, voxel size and a similar
degradation to that of 99mTc-interictal perfusion SPECT. PISCOM and
SISCOM images coregistered with MRI were obtained using Focus-DET
software and SOF localization in both techniques was determined blinded
for clinical data by two nuclear medicine experts. Results of both studies
were compared with each other and with the known surgical site of resec-
tion (15 temporal and 8 extratemporal).
Results: PISCOM and SISCOM showed equivalent results in 17/23
cases with a good concordance among them (global agreement of 74% -
CI: 56–87%). The SF was correctly identified as compared to surgical
resection brain area and post-surgical outcome in 15/23 (65%) patients
by both PISCOM and SISCOM. PISCOM successfully identified SF in
19/23 (83%) subjects and SISCOM in 17/23 (74%). In two cases both
modalities failed to correctly identify SOF.
Conclusion: Preliminary findings of this new procedure are promising
as a high rate of PISCOM/SISCOM concordance and correct seizure
onset focus localization has been found. Possibly, with further develop-
ment of the PISCOM technique, the need to obtain interictal SPECT
images could be minimized or even be avoided and replaced by interictal
FDG-PET images.
p0671
MAPPINGOFTEMPORAL LOBELANGUAGE
REGIONS USINGVISUALANDAUDITORYNAMING
STIMULI: A LANGUAGE FMRI STUDY IN TEMPORAL
LOBEEPILEPSY
K. Trimmel*,†, L.A. van Graan*,†, A. Haag*,†, M. Koepp*,†,
P. Thompson*,†, J. Duncan*,†
*Department of Clinical and Experimental Epilepsy, University
College London, London, United Kingdom, †Epilepsy Society
Chalfont St Peter, Buckinghamshire, United Kingdom
Purpose: Verbal fluency functional MRI (fMRI) is used for predicting
language deficits after anterior temporal lobe resection (ATLR) for tem-
poral lobe epilepsy (TLE), but primarily engages frontal lobe areas. In
this observational study, we investigated fMRI paradigms using visual
and auditory stimuli, which predominately involve language areas
resected during ATLR.
Method: Thirty-three controls and 60 patients (36 left (LTLE), 24 right
(RTLE)) were assessed using three fMRI paradigms: verbal fluency,
auditory naming with a contrast of auditory reversed speech, and picture
naming with a contrast of scrambled pictures and blurred faces.
Results: Auditory naming and picture naming showed bilateral temporal
lobe activations. Correcting for auditory and visual input (by subtracting
activations resulting from auditory reversed speech and blurred pictures/
scrambled faces respectively) resulted in left-lateralised activations in
posterior temporal lobe regions for patients and controls. These activa-
tions were correlated with clinical naming performance outside of the
scanner (McKenna Graded Naming Test Score). Verbal fluency primar-
ily activated frontal lobe areas.
Conclusion: While verbal fluency primarily activated frontal lobe lan-
guage regions, auditory and picture naming activated temporal lobe
structures, which are resected during ATLR. Controlling for auditory and
visual input resulted in more left-lateralised activations. Temporal lobe
activations correlated with clinical naming performance. We hypothesise
that these paradigmsmay be more predictive of naming decline following
ATLR than verbal fluency fMRI.
p0672
SEMANTIC VERBALMEMORYOUTCOMEAFTER
SURGERY IN DRUGREFRACTORYEPILEPSY: AN
FMRI BASED STUDY
K. Chaudhary*, B. Ramanujam†, S. Kumaran†, P.S. Chandra†,
A. Nehra†, M. Tripathi†
*All India Institute of Medical Sciences, Neurology, New Delhi,
India, †All India Institute of Medical Sciences, New Delhi, India
Purpose: The surgical planning in DRE patients is usually associated
memory deficit. The aim of study was to measure BOLD activation dur-
ing semantic verbal memory task and correlation with clinical parameters
(age of seizure onset, duration and PGI memory evaluation) in cases (pre
and 6 month of post-surgery) and controls.
Method: After obtaining the institute ethics approval, 20 TLE (mean
age: 25.1  5.60; Seizure onset: 7.65  4.76; Seizure duration:
17.9  5.2; M/F: 13/7) and 10 ETLE (mean age: 20.1  4.6; Seizure
onset: 4.2  1.9; Seizure duration: 15.9  5.7; M/F: 5/5) and 24 (mean
age: 27  6.7; M/F: 18/6) healthy controls were recruited in this study.
Auditory cue of a standardized story in Hindi, using Super Lab presenta-
tion software was provided to the subjects using MR compatible auditory
interface system (NordicNeuroLab, Norway). After the story, patients
were instructed to speak the answers in this story based questions during
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fMRI scan.The fMRI sessions were carried out using 1.5T MR scanner
(Avanto, Siemens, Germany).
Results: The intra group comparison analysis (pre-surgery with respect
to post-surgery group) of BOLD activation in TLE subjects during the
memory task, using paired t-test (p≤0.001, cluster threshold 10) elicited
significant BOLD activation in left MTG. Whereas post-surgery com-
pared to pre-surgery group revealed, greater activation in right MTG
along with hippocampal gyrus. In ETLE group significant BOLD activa-
tion was observed in bilateral MTG along with hippocampal gyrus in pre-
surgical than post-surgical group. Clinical memory assessment was
declined in TLE compared ETLE after 6 months of surgery. Negative
correlation was found in LMTG (r = 0.5*; p < 0.05) in patients with
higher seizure duration. Greater activation in hippocampus and LMTG
correlated (r = 0.6*; p < 0.05) with lower seizure duration.
Conclusion: Decreased PGI memory rating and changes of BOLD acti-
vation in MTL region suggest memory (mild to moderate) impairment in
TLE subjects post ATLR.
p0673
SPECIFICMR-IMAGING PATTERNSOFNEURONAL-
GLIAL TUMORSASSOCIATEDWITHFOCAL
EPILEPSY INCHILDREN
V. Khalilov*, A. Kholin*, B. Bakaeva†, K. Gazdieva†
*Department of Child Neurology, Neurosurgery and Medical
Genetics, Russian National Research Medical University,
Moscow, Russian Federation, †Russian National Research
Medical University, Moscow, Russian Federation
Purpose: To analyze the specificity of MRI patterns encountered during
visualization of neuronal-glial tumors associated with epilepsy in chil-
dren.
Method: Were analyzed MR-images of 33 epileptic children with neu-
ronal-glial tumors who underwent examination and treatment at the
RCCH at 2007–2016 years with 1–8 years catamnesis. High resolution
MRI scans was done before and after surgery on the GE Signa infinity 1.5
Tesla device.
Results: Dysembryoplastic neuroepithelial tumor (DNET) was observed
in 18 patients and ganglioglioma (GG) in 15 cases. A combination with
FCD IIIb revealed in 4 patients and the presence of histological signs of
DNET and GG in one tumor substrate in two patients. Verification of the
neoplastic process on the MRI was difficult in 12 patients. Predominantly
temporal localization of the tumor substrate was observed in 16 cases,
rarely parietal - 7, frontal - 5 and 5 cases of multilobar localization. In
one case of DNET in mass effect perifocal edema was not detected. In 12
patients with DNET and 7 with GG were revealed the specific character-
istics of neuronal-glial tumors such as cortical localization, triangular
configuration, “comet tail” symptom and “soap bubble” pattern. The
presence of 3 or more specific patterns were present in 7 patients with
DNET and in 5 with GG. Hyperintensity of the peritumoral signal, the
violation of gray-white matter differentiation and cortical organization
suggested FCD-associates in 9 patients which was confirmed by histol-
ogy in 6 cases. Contrast-positive effect was seen in 1 DNET cases and in
4 GG.
Conclusion: MRI-patterns described in the literature as specific for
DNET could also occur with high probability in GG and some other
tumors. We were able to assume neuronal-glial tumors in 21 patients
according to MRI, however, conclusively differentiation between
DNET/GG/FCD IIb type on the results of standardMRI is not possible.
p0674
NETWORKCHANGES IN PATIENTSWITH
TEMPORAL LOBEEPILEPSY BASEDON
HIPPOCAMPAL SCLEROSIS
H. Urbach*, K. Egger*, K. Rutkowski*, J. Nakagawa†,
B. Schmeiser†, M. Reisert‡, A. Brandt§, S. Bernhard¶, A. Schulze-
Bonhage§, T. Hammen**
*Department of Neuroradiology, University Medical Center
Freiburg, Freiburg, Germany, †Department of Neurosurgery,
University Medical Center Freiburg, Freiburg, Germany,
‡Department of Medical Physics, Medical Center Freiburg,
Freiburg, Germany, §Department of Epileptology, University
Medical Center Freiburg, Freiburg, Germany, ¶Kork Epilepsy
Center, Kehl-Kork, Germany, **Department of Epileptology,
University Medical Center Freiburg, Freiburg, Germany
Purpose: Temporal lobe epilepsy (TLE) as most common focal epilepsy
is frequently caused by hippocampal sclerosis (HS).
As the hippocampal formation is an essential part of the Papez circuit,
our intention was to evaluate whether HS is associated with alterations of
mentioned circuit by applying a new Diffusion-weighted MRI (DTI)
method called “Global Tracking”.
Method: Twenty consecutive patients with mesial TLE due to unilateral
HS and twenty corresponding controls concerning age, handedness and
gender were included in our study.
DTI data processing was performed using a recently introduced
MATLAB-based in-house algorithm for global fiber tracking (http://
www.uniklinik-freiburg.de/mr-en/research groups/diffperf/fiber-
tools.html).
Statistics: Hippocampal volumes (HV), numbers of streamlines (SC)
and Fractional Anisotropy (FA) values of cingulum, fornix, and mam-
millo-thalamic tract ipsilateral and contralateral to HS were compared
between patients and healthy age-matched controls, using a two-sided
Wilcoxon signed rank tests.
Results: Cingulum streamline counts were significantly lower in
patients than in age-matched controls both ipsilateral (258  81.0 vs.
417  138, p = 0.0017) and contralateral (271  85.6 vs. 478  135,
p = 0.000082) to HS.
Cingulum FA on HS side was significantly lower (0.400  0.0289)
compared to contralateral (0.415  0.0405, p = 0.030). Intergroup anal-
ysis comparing cingulum FA ipsilateral or contralateral to HS in patients
to corresponding data in healthy controls did not demonstrate significant
differences.
SC of the mamillo-thalamic tracts did neither differ between the scle-
rotic and contralateral side in patients, nor between patients and controls.
FA of the mamillo-thalamical tract ipsilateral to HS (0.316  0.0273)
was significantly smaller than contralateral to HS (0.329  0.0203,
p = 0.021), while no statistical significance was verified in intergroup
analysis comparing FA values of patients, ipsi- or contralateral to HS, to
corresponding data of healthy controls.
Conclusion: Our data support HS as network disease demonstrating
bilateral alterations of cingulum association fibers projecting from the
cingulate gyrus to the entorhinal cortex.
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BRAIN FUNCTIONALCONNECTIVITY IN SLEEP-
RELATEDHYPERMOTOREPILEPSY
L. Ferri*, S. Evangelisti†, G. Rizzo*,‡, L.L. Gramegna†,
C. Testa†, L. Licchetta*,‡, L. Rossi Magi§, D. Remondini§,
G. Castellani§, C. Tonon†, F. Bisulli*,‡, R. Lodi†, P. Tinuper*,‡
*Department of Biomedical and NeuroMotor Sciences
(DiBiNeM), University of Bologna, Bologna, Italy, †Functional
MR Unit, Policlinico S. Orsola-Malpighi, Department of
Biomedical and NeuroMotor Sciences (DiBiNeM), University of
Bologna, Bologna, Italy, ‡IRCCS Istituto delle Scienze
Neurologiche Bologna, Bologna, Italy, §Department of Physics
and Astronomy, University of Bologna, Bologna, Italy
Purpose: Sleep-related hypermotor epilepsy (SHE) is a form of focal
epilepsy in which hypermotor seizures appear almost exclusively during
sleep. Orbito-frontal and mesial involvement is necessary for ictal motor
manifestation, however a wider network involving thalamus, basal gan-
glia and extra-frontal areas participate in SHE pathophysiology.
We evaluated the resting state functional connectivity (FC) in a group
of SHE patients compared to healthy controls, in order to detect any rest-
ing state network (RSN) abnormalities and to assess a possible topo-
graphical organization.
Method: Resting-state fMRI was acquired in 13 SHE patients
(age = 38.3  11.8 years, 6M) and 13 matched healthy controls
(age = 38.5  10.8 y, 6M). Independent component analysis (ICA) and
graph theoretical approach were applied. We evaluated node degree
(ND), betweenness centrality (BC), clustering coefficient (CC), local
efficiency (LE) and global efficiency (GE).
Results: ICA. At the group level, we distinguished 16 RSNs. SHE
patients showed mainly significantly increased FC in a sensorimotor-tha-
lami network. Graph. Compared to controls, SHE patients showed no
significant differences in network global efficiency, while ND and BC
were increased in the limbic system regions and decreased in the occipital
cortex, while CC and LE were increased in basal ganglia regions and
decreased in the same limbic zones.
Conclusion: The increased FC of the sensorimotor-thalami network
may be in agreement with the hypothesis of altered excitability of the
arousal regulatory system in SHE patients. An altered topology has been
found in structures like basal ganglia and the limbic system, which have
been hypothesized to be responsible for the hypermotor manifestations
observed during the seizures. These data support the idea that it is an
oversimplification to consider SHE as just a focal epilepsy.
p0676
PARTIAL VOLUMECORRECTED PET SHOWS
PROGRESSIVE FOCALHYPOMETABOLISM
ASSOCIATEDWITHTEMPORAL LOBECTOMY
OUTCOME
S. Agrawal, I. Dustin, J. Heiss, W. Theodore
NIH, Bethesda, MD, United States
Rationale: It is unclear if progressive Fluorine 18-2 deoxyglucose posi-
tron emission tomography (FDG-PET) mesial temporal hypometabolism
in temporal lobe epilepsy (TLE) is independent of hippocampal volume
loss, and has independent clinical significance.
Method: We used FDG PET and MRI to study patients with TLE con-
firmed on ictal video electroencephalography. An automated MRI-core-
gistered partial volume correction (PVC) algorithm was applied.
Metabolic activity in congruent regions of interest was used to calculate
asymmetry indices (AI): 2*(C-I)/C+I). We used ANOVA and Mann-
Whitney test to compare onset age, epilepsy duration, and post surgical
outcome on PVC hippocampal asymmetry index (HAI), and AI between
patients seizure-free (SF) or not seizure-free (NSF) after surgery.
Results: 38 patients (17 females) had minimum 1 year anterior temporal
lobectomy follow up.. Mean onset age was 14.3 years (range 1–43) and
epilepsy duration prior to imaging 19.7 years (range 2–45). MRI was
normal in 13 patients. 23 had mesial temporal sclerosis, one a lateral
temporal lesion and one callosal dysgenesis. PVC PET showed gradually
increasing asymmetry index with increased epilepsy duration of for
patients seizure free after surgery (R2 0.32; F 10.9: p < 0.005), but not in
patients who continued to have seizures after surgery. Parahippocampal
gyrus and amygdala asymmetry were significantly correlated with HAI;
increasing asymmetry was not seen in amygdala. For all patients, PVC-
PET HAI showed significant correlation with epilepsy duration and post
surgical outcome but not MRI findings or epilepsy onset age. Seizure-
free patients had significantly higher HAI (p < 0.005).
Conclusion: This study shows progressive hippocampal hypometabo-
lism with increasing epilepsy duration, after correction for volume loss,
suggesting independent progressive cellular dysfunction in TLE, particu-
larly in patients seizure-free after temporal lobectomy. NSF Patients had
lower AI than SF patients, which could be due to an incorrect presurgical
hypothesis or more diffuse pathology.
p0677
‘IMAGING’MEMORY IN TEMPORAL LOBE
EPILEPSY-VALIDATIONOF ‘WITHIN-SCANNER’
MATERIAL SPECIFIC ENCODING-RECALL
PARADIGMSDURINGMEMORYTASK-BASED
FUNCTIONALMAGNETIC RESONANCE IMAGING
(FMRI)
R.N. Menon*, P.G.R. Pillai*, B. Thomas*,
K. Chandrashekaran*, A. Radhakrishnan*, S. Justus*, D. Sasi*,
C. Pammi†
*Sree Chithra Tirunal Institute for Medical Sciences and
Technology, Trivandrum, India, †Centre of Behavioural and
Cognitive Sciences, University of Allahabad, Allahabad, India
Purpose: To establish efficiency of within-scanner encoding and recog-
nition-memory paradigms for task-based memory fMRI as an objective
measure of pre-operative hippocampal reserve (HR) in mesial temporal
lobe epilepsy due to hippocampal sclerosis (MTLE-HS).
Method: Memory paradigms were designed for three stimuli types -
faces, word-pairs and abstract designs. The deep-encoding task was
designed as a block design paradigm comprising of a total of 9 cycles run
within a 1.5T MRI scanner. The recall session was performed after
1 hour within the scanner using an event related paradigm; the pre-
encoded stimuli were randomly combined with distracters following a
ratio 10:15. Group analysis was done following post-processing of recog-
nition memory performances, with ‘correct-incorrect’ responses denoted
‘1-0’ applied as parametric modulators on the design specification in Sta-
tistical Parametric Mapping version 8 using boot-strap method to enable
estimation of laterality indices (LI) with a p-value < 0.05 considered sig-
nificant.
Results: Fifteen subjects with drug-resistant MTLE-HS [10 patients of
left MTLE-HS (verbal memory impairment in 6) and 5 patients of right
MTLE-HS (1 with verbal memory deficits)] and 15 age-matched healthy
controls (right handed; age range: 18–45 years) were recruited. Encoding
paradigms in both the patient and control groups revealed robust bilateral
BOLD activations over the regions of interest. Analysis of delayed-
recognition memory BOLD signals in the left MTLE-HS group demon-
strated moderate to strong right laterality for faces (LI 0.49  0.16),
word-pairs (LI0.54  0.13) and designs
(LI0.21  0.07). The right MTLE-HS group demonstrated moder-
ate-strong left laterality for word-pairs
(LI +0.52  0.19) as well as faces (+0.24  0.13) but not for designs
(LI0.033  0.16).
Conclusion: This is the first study validating intra-mural recall effi-
ciency of material-specific memory paradigms equivalent to the widely-
practised out-of scanner recall score based post-processing of encoded
BOLD signals. Our results provide objective proof of HR for predomi-
nantly word-pair and face stimuli in MTLE-HS.
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ASYMMETRICALVOLUMEREDUCTIONOFTHE
HIPPOCAMPAL SUBFIELDS IN DRUG-RESISTANT
PATIENTSWITHGENERALIZED TONIC-CLONIC
SEIZURES
Z. Wang, Z. Wang, L. Cao, X. Wang, Y. Xu
Nanjing Drum Tower Hospital, Nanjing, China
Purpose: It has been recognized that the hippocampus participates in the
pathophysiology of genetic generalized epilepsy (GGE). Meanwhile,
repeated seizures induce neuronal loss in the hippocampus. However,
hippocampal atrophy is not entirely understood in GGE patients with
drug-resistant epilepsy (DRE). Since the hippocampus is heterogeneous
with distinct functions in subfields, we investigated the alteration of sub-
field volume in drug-resistant patients with GGE characterized by gener-
alized tonic-clonic seizure (GTCS).
Method: A total of 23 patients with GGE-GTCS aged between 14 and
50 were enrolled retrospectively. The subjects having cognitive or psy-
chological impairment were excluded. According to DRE definition of
ILAE 2010, 12 individuals were regarded as drug-resistant, and 11 were
drug-responsive. MRI data were obtained on a 3T scanner from patients
and 17 healthy controls. The volumes of the bilateral hippocampal subre-
gions were measured with the FreeSurfer 5.3 subfield segmentation pack-
age employed. Moreover, abnormal volumes were correlated with
seizure duration in linear models.
Results: The entire volume of the left hippocampus was significantly
smaller in drug-resistant patients than in the healthy controls. The major
atrophy was located in the CA2-3, CA4-DG (the dentate gyrus), pre-
subiculum, and subiculum. The drug-responsive individuals showed dra-
matic atrophy only in the left presubiculum without change in the whole
structure when compared to the controls. There were no significant dif-
ferences in right hippocampal volumes of the whole or all subfields
among the controls, the drug-responsive patients, and the subjects with
DRE. In addition, the volumes of the whole hippocampus, presubiculum
and subiculuma in the left side showed strong negative correlation with
seizure duration respectively among the drug-resistant group.
Conclusion: Our findings found significantly asymmetrical atrophy
among hippocampal subfields in drug-resistant patients, which was more
severe than drug-responsive group. Hippocampal subfield volumes may
be helpful for identification of DRE, and indicate potential cognitive def-
icit at a preclinical stage.
p0679
EPIJET: FIRST COMMERCIALLYAVAILABLE
AUTOMATED INJECTOR FOR ICTAL SPECT
X. Setoain*, A. Donaire†, O. Vernet‡, F. Gil§, M. Mayoral*,
J. Rumia¶, F. Campos*, N. Bargallo**, A. Tapias*, M. Carre~no§
*Hospital Clınic Barcelona, Nuclear Medicine, Barcelona,
Spain, †Hospital Clınic Barcelona, Barcelona, Spain, ‡Hospital
Clınic Barcelona, EEG Operator, Barcelona, Spain, §Hospital
Clınic Barcelona, Neurology, Barcelona, Spain, ¶Hospital
Clınic Barcelona, Neurosurgery, Barcelona, Spain, **Hospital
Clınic Barcelona, Radiology, Barcelona, Spain
Purpose: To present the main features of the first remotely controlled
automated injector system for ictal SPECT (epiJET, LemerPax, Nantes,
France) used in patients with refractory epilepsy. We report the results of
injection time (Ti) and seizure focus (SF) localization with ictal SPECT
using epiJET.
Method: Ti and SF localization using epiJET in 23 patients were com-
pared with Ti (t-test) and SF localization (X2) of the retrospective data-
base of the historic pool of 126 patients injected manually during 2011–
2015. Injection dose error and radiation dosimetry were also compared.
Results: EpiJET injects the full volume of the perfusion radiotracer
(3–8 ml) in 3,5s on average (2–6s) and all injections were performed
without any problem. Ti with epiJET, using the remote control system
and doing the injection from the control-EEG roomwas 12  7.2s. Man-
ual Ti was 17  11.7s on average (p < 0.001). Otherwise, when the
manual injection took place with the operator waiting the seizure from
the control room (same conditions used in epiJET), the Ti in these group
of 54 patients was 24  12s (p < 0.001). When the manual injection
took place with the operator waiting the seizure inside the patient room
(bedside and worse conditions compared with epiJET), the average Ti in
these 72 patients were 13  9.7s (p = 0.6). Ictal SPECT with epiJET
localized SF in 18/21 (85%) patients and with manual injection in 89/117
(76%) of patients (p > 0.05). Radiation exposure with epiJET was very
low and injection dose error decreased from <12% with manual injection
to <5%with epiJET.
Conclusion: EpiJET, the first commercially available dedicated auto-
mated injector for ictal SPECT simplify the methodology for injecting
radioactive doses during seizure, making ictal SPECT more accessible.
First results using epiJET are promising in reducing injection time and
improving SPECT accuracy.
p0682
MULTI-MODAL BRAIN IMAGING SOFTWAREFOR
GUIDING INVASIVE TREATMENTOFEPILEPSY
P. Ossenblok*,†, S. Mari€en*,‡, S. Meesters*,‡, L. Florack‡,
P. Hofman*,§, O. Schijns¶,**, A. Colon*
*Academic Centre for Epileptology Kempenhaeghe &
Maastricht UMC+, Heeze, Netherlands, †Eindhoven University
of Technology, Biomedical Image Analysis, Eindhoven,
Netherlands, ‡Eindhoven University of Technology,
Mathematics & Computer Science, Eindhoven, Netherlands,
§Maastricht University Medical Center, Radiology, Maastricht,
Netherlands, ¶Academic Centre for Epileptology Kempenhaeghe
&Maastricht UMC+, Maastricht, Netherlands, **Maastricht
University Medical Center, Neurosurgery, Maastricht,
Netherlands
Purpose: The surgical treatment of patients with complex epilepsies is
changing more and more from open, invasive surgery towards minimally
invasive, image guided treatment. Multi-modal brain imaging procedures
are developed to delineate preoperatively the region of the brain which is
responsible for the epilepsy of a patient and delimit the functional areas
relative to this region. The ultimate aim is to provide the neurosurgeon
with a clear and intuitive image of the targeted epileptogenic region in
order to render the patient seizure free, while avoiding damage to elo-
quent cortex.
Method: A software product (SP) is developed for multi-modality map-
ping of the analysis results of non-invasive and invasive epilepsy record-
ings and visualization of these results against brain anatomy. The SP
contains several pre-programmed sequences for creating the most com-
monly used multi-modality brain images that can be used to delineate the
epileptic tissue versus functional areas, like visualization of inverse solu-
tions of high density EEG and MEG, EEG informed functional MRI
(fMRI) visualizations and functional Near-Infrared Spectroscopy
(fNIRS) projections.
Results: The SP is optimized for intuitive and clinical usage to interac-
tively explore the different modalities in relation to the available anatom-
ical and structural MRI data. The distinct modalities can be combined by
3D-fusion of the images and visualized in 2D- and 3D-MRI viewports
against the implanted depth electrodes and the brain mapping results of
the invasive EEG recordings.
Conclusion: Multi-modal functional and structural brain imaging
applied on data of the individual patient can be used for guiding surgical
resections with minimal disruption of brain anatomy, while rendering a
patient seizure free.
Acknowledgement: This study is part of the project “Advancing Smart
Optical Imaging and Sensing for Health (ASTONISH)” that has received
funding from ECSEL Joint Undertaking (grant no. 692470).
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INTERACTIONS BETWEENDEFAULTMODE
NETWORKANDMEMORYPERFORMANCE IN
PATIENTSWITHTEMPORAL LOBEEPILEPSY AND
CONTROLS
T. Zan~ao, T. Martins Lopes, R. Mariano Junior, B. Machado
Campos, C. Yasuda, F. Cendes
UNICAMP - School of Medical Sciences, Campinas, Brazil
Purpose: We investigated the Default Mode Network (DMN) during
resting-state functional MRI (rs-fMRI) and its relation to cognitive
impairment in patients with temporal lobe epilepsy (TLE). It is expected
that patients with TLE present cognitive impairments secondary to dam-
aged structures directly involved in memory, such as hippocampus; how-
ever, it still essential to better understand the extension and causes of
these damages. DMN is known to be active during introspective thoughts
that might be related with cognitive processes. Studies suggest that DMN
has an altered activation in patients with TLE. Our purpose is to investi-
gate the relationship between DMN and neuropsychological performance
in TLE patients and controls.
Method: We scanned (3T-MRI) 69 controls, 42 right-TLE, 49 left-TLE,
31MRI-Negative TLE patients. We performed seed-based analysis using
posterior cingulate cortex to identify the DMN. Images were pre-pro-
cessed/analyzed on SPM12. Significance was determined at p < 0.01.
We analyzed IQ, verbal, visual and delayed memory in all patients and
41 controls.We used SPSS22 for statistical analysis, including chi-square
test and GLM.
Results: A MANOVA with Bonferroni correction confirmed that con-
trols had a significant better performance in all tests, while MRI-Nega-
tive performed better than right-TLE. Left-TLE performed worst, except
on visual memory tests. On rs-fMRI, right-TLE and left-TLE presented
similar patterns of increased connectivity, considering the hemispheres
ipsilateral and contralateral to the seizure focus. In the ipsilateral hemi-
sphere, frontal lobe was more connected, while temporal lobe, caudate
and hippocampus presented reduced connectivity.
Conclusion: Our data suggest that there is a disruption of the normal pat-
tern of DMN in TLE, with reduction of temporal lobe connectivity. Per
neuropsychological examination, both right-TLE and left-TLE had a
worse performance in verbal memory compared to controls and
MR-Neg. The absence of hippocampal atrophy (MRI-Negative) seems to
yield a less prominent disruption in both functional connectivity and neu-
ropsychological performance.
p0685
ANTIEPILEPTICMEDICATIONSMODULATE
FUNCTIONALCONNECTIVITY INMESIAL
TEMPORAL LOBEEPILEPSY
K.F. Alves*, T.O.P. Rezende*, D.B. Figueiredo*,
F.F. Bellentani*, S. Yamashita†, L.E. Betting*
*Department of Neurology, Psychology and Psychiatry,
Botucatu Medical School, S~ao Paulo State University, UNESP,
Botucatu, Brazil, †Department of Tropical Diseases and
Diagnostic Imaging, Botucatu Medical School, S~ao Paulo State
University, UNESP, Botucatu, Brazil
Purpose: Mesial temporal lobe epilepsy (MTLE) is the most common
refractory epilepsy of adulthood and high doses of antiepileptic medica-
tions (AEDs) or politherapy is often required. Functional connectivity is
disrupted in MTLE and AEDs affect these networks. The objetive of this
study was to investigate this interaction between AEDs and the resting
state functional connectivity.
Method: 31 patients with MTLE (16 right and 15 left) and 36 controls
were included. Patients were grouped into high and low doses according
to the drug load calculated as the sum of prescribed daily dose and
defined daily dose ratios for each coprescribed AED. T1 volumetric and
resting state EPI images were acquired in a 3T scanner. The software
CONN was used for the analysis. Structural images were registered into
standard space and automatically segmented. Functional images were
realigned, normalized, smoothed and corrected for artifactual effects (de-
noising). General linear model (GLM) was used to obtain the correlation
maps between BOLD timeseries. Statistical analysis was performed
using GLM (p < 0.05 FDR corrected). Seed (amygdala and hyppocam-
pus ipsilateral to the atrophy) to voxel analysis was performed. Compar-
isons were made between patients with MTLE (right or left) using high
or low doses of AEDs and controls.
Results: Areas of reduced connectivity were observed. For left MTLE
with high doses, abnormalities were disclosed in the mesial temporal
regions. For low doses, a more extensive involvement was observed
encompassing the medial frontal cortex, posterior cingulate and pre-
cuneus. For right MTLE with high doses abnormal areas were disclosed
in the medial frontal cortex, whereas for low doses in the medial frontal
cortex and posterior cingulate region. Positive correlation was observed
between the connectivity and AEDs load.
Conclusion: Areas of impaired functional connectivity were observed in
patients with MTLE. AEDs doses influenced these observations. Patients
receiving higher doses showed less abnormalities.
p0686
CHARACTERISTICSOF SEIZURE-INDUCED SIGNAL
CHANGESONMRI IN PATIENTSWITH FIRST
SEIZURES
S.E. Kim, K.M. Park, B.I. Lee
Haeundae Paik Hospital, Inje University College of Medicine,
Neurology, Busan, Korea
Purpose: The aim of this study was to investigate the predictive factors
and identify the characteristics of the seizure-induced signal changes on
MRI (SCM) in patients with first seizures.
Method: We conducted a retrospective study of patients with first sei-
zures from March 2010 to August 2014. The inclusion criteria for this
study were patients with 1) first seizures, and 2) MRI and EEG performed
within 24 hours of the first seizures. The definition of SCM was hyper-
intensities in the brain not applying to cerebral arterial territories. Multi-
variate logistic regression was performed with or without SCM as a
dependent variable.
Results: Of 431 patients with seizures visiting the ER, 69 patients met
the inclusion criteria. Of 69 patients, 11 patients (15.9%) had SCM.
Epileptiform discharge on EEG (OR 29.7, 95% CI 1.79–493.37,
p = 0.018) was a independently significant variable predicting the pres-
ence of SCM in patients with first seizures. In addition, the topography of
SCM was as follows; i) ipsilateral hippocampus, thalamus and cerebral
cortex (5/11), ii) unilateral cortex (4/11), iii) ipsilateral thalamus and
cerebral cortex (1/11), iv) bilateral hippocampus (1/11). Moreover, 6 out
of 7 patients who underwent both perfusion CT andMRI exhibited unilat-
eral cortical hyperperfusion with ipsilateral thalamic involvement
reflecting unrestricted vascular territories.
Conclusion: Epileptiform activities may contribute to the possible
mechanism of SCM in patients with first seizures. Additionally, the
involvement of the unilateral cortex and ipsilateral thalamus in SCM and
its hyperperfusion state could be helpful in differentiating the conse-
quences of epileptic seizures from other pathologies.
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PERICTALMAGNETIC RESONANCE IN STATUS
EPILEPTICUS
M. Requena*, S. Sarria†, M. Toledo‡, M. Gonzalez‡,
E. Santamarina‡, L. Guzman§, M. Sueiras§, M. Quintana‡,
X. Salas‡, A. Rovira†
*Department of Neurology, Vall d’Hebron University Hospital,
Barcelona, Spain, †Department of Radiology, Vall d’Hebron
University Hospital, MRI Unit and Neuroradiology Section,
Barcelona, Spain, ‡Department of Neurology, Vall d’Hebron
University Hospital, Epilepsy Unit, Barcelona, Spain,
§Department of Neurophysiology, Vall d’Hebron University
Hospital, Barcelona, Spain
Purpose: Detect acute changes in magnetic resonance imaging (MRI)
related to status epilepticus (SE), and study an association with patients
outcome.
Method: Retrospective study of five years including consecutive
patients with the electroclinical diagnostic of SE, who received a MRI
within 96 hours from the start of the SE. Main data recorded was the SE
type and duration and the changes observed in the T2-weighted (TWI)
and diffusion imaging (DWI). The outcome was assessed by mortality
and increase of Rankin-modified scale (mRS) during the hospital admis-
sion.
Results: From 47 patients included, 59.6% were male and mean age was
59.2 years. Types of SE were generalized 12.8% and partial 87.2% (tem-
poral 48.9%; frontal 31.9%). Of them, 93.6% were symptomatic (acute
59.6% and remote 34%). The most frequent etiologies were tumor
(29.8%) and infectious (27.7%). Median duration were 24 hours (range
1–720 hours). The mRS increased at hospitalization discharge in 25.1%.
Global mortality after discharge at one year follow-up was 34.4%. Areas
of edema seen in 66%of the TWI, showed DWI restrictions in 44.7%.
DWI restrictions were more likely seen in acute symptomatic SE
(p = 0.020) and related to the structural lesions in all but three cases. The
time from SE onset to MR acquisition was not relevant; in those SE that
showed DWI restriction were likely to last more than 12 hours
(p = 0.043). DWI restrictions were associated with the epileptic source
in the EEG. The presence of DWI restrictions was significantly associ-
ated with an impairment in the short-term functional status (p = 0.003).
Conclusion: The presence of edema in the MRI acquired early after the
onset of SE, are commonly seen in acute symptomatic cases in closed
relation with the epileptogenic source. The presence of DWI restriction
may predict a longer duration of the SE and impairment in the functional
status of the patients.
p0688
PREDICTIVE VALUEOF FMRI, SELECTIVE / SUPER-
SELECTIVEWADA-TEST,MEGAND FTCD FOR
MEMORYANDLANGUAGEOUTCOMEAFTER
EPILEPSY SURGERY: A SYSTEMATIC REVIEW
E. Schmid*,†,‡, A. Thomschewski*,†,‡,§, A. Taylor*,†,
G. Zimmermann*,‡,¶, T. Kobulashvili*, F. Brigo**,††,
E. Trinka*,‡,§
*Paracelsus Medical University, Department of Neurology,
Christian-Doppler-Klinik, Salzburg, Austria, †Paris-Lodron
University of Salzburg, Department of Psychology, Salzburg,
Austria, ‡Spinal Cord Injury and Tissue Regeneration Centre
Salzburg, Salzburg, Austria, §Centre for Cognitive
Neuroscience, Salzburg, Austria, ¶Paris-Lodron University of
Salzburg, Department of Mathematics, Salzburg, Austria,
**University of Verona, Department of Neuroscience,
Biomedicine andMovement Science, Section of Clinical
Neurology, Verona, Italy, ††Franz Tappeiner Hospital,
Department of Neurology, Merano, Italy
Purpose: The European Union funded E-PILEPSY project was launched
to develop guidelines and recommendations for epilepsy surgery across
Europe. In this systematic review we aimed to assess the predictive value
of fMRI, selective / super-selective WADA-Test, MEG and fTCD for
memory and language outcome after surgery.
Method: An extensive literature search was conducted using PubMed,
Embase and CENTRAL. The predicted value was expressed in terms of
sensitivity and specificity for postoperative language or memory decline,
as determined by pre- and postoperative neuropsychological assess-
ments.
Results: 29 papers met the inclusion criteria and data was extracted for
further analysis. All tests for heterogeneity were highly significant indi-
cating large between-study variability (p < 0.001). For memory out-
comes, meta-analyses were conducted for WADA-Tests (n = 17) using
both, memory and language Laterality Quotients (LQs). If two or more
estimates of sensitivity or specificity were extracted from a study, two
meta-analyses were conducted indicating the maximum (“best case”) and
the minimum (“worst case”) of all estimates. In the “best case”, meta-
analyses yielded a sensitivity estimate of 0.79 (95% CI: 0.67–0.92) and a
specificity estimate of 0.65 (95% CI: 0.47–0.83). Though, in the “worst
case”, meta-analyses yielded a sensitivity estimate of 0.65 (95% CI:
0.48–0.82) and a specificity estimate of 0.46 (95% CI: 0.28–0.65). Meta-
analyses concerning the diagnostic accuracy of fMRI and fTCD for mem-
ory changes were not feasible due to small numbers of studies (fMRI:
n = 4; fTCD: n = 1). For language outcomes, meta-analyses were again
not possible due to small numbers of studies eligible for respective analy-
ses (WADA-Test: n = 6; fMRI: n = 2; fTCD: n = 1).
Conclusion: Only in a few subgroups, meta-analyses could be con-
ducted. This underscores the necessity for more evidence for certain
methods regarding our research question. Moreover, the large between-
study heterogeneity also indicates the need for more homogeneous and
thus more comparable studies in future research.
p0690
AN EMERGINGNEUROPSYCHOLOGICAL ISSUEOF
TEMPORAL LOBEEPILEPSY: SOCIALCOGNITION
A.R. Giovagnoli*, A. Parente†, R. Ciuffini‡, K. Turner§,
B. Pucci¶, C. Scalera**, A. Maialetti††, R. Sapone‡‡,
G. Strigaro§§, F. Villani†, M. Maschio††, A. Magaudda**,
A. Marrelli¶¶
*C. Besta National Neurological Institute, Neuropsychology
Unit, Department Clinical Neurosciences, Milan, Italy,
†Fondazione I.R.C.C.S Istituto Neurologica ‘C Besta’, Milan,
Italy, ‡Universita degli Studi del l’Aquila, L’Aquila, Italy,
§Ospedale San Paolo, Milan, Italy, ¶Azienda Ospedaliera
Universitaria Senese, Siena, Italy, **Azienda Ospedaliera
Universitaria Policlinico ‘G. Martino’, Messina, Italy, ††Istituto
Nazionale Tumori Regina Elena, Roma, Italy, ‡‡Azienda
Ospedaliera ‘Bianchi-Melacrino-Morelli’, Reggio Calabria,
Italy, §§Universita degli Studi del Piemonte Orientale Amedeo
Avogadro, Novara, Italy, ¶¶Ospedale San Salvatore, L’Aquila,
Italy
Purpose: Patients with epilepsy may experience communication inter-
personal difficulties, with poor social adjustment. Social cognition
includes theory of mind (ToM), perception of social situations, empathy,
and sensitivity to conventional and moral rules, allowing to predict
others0 behaviour and to interact with social environments and relation-
ships. This study characterized social cognition and its relationship to
psychopathological symptoms in patients with temporal lobe epilepsy
(TLE).
Method: Fifty TLE patients enrolled in eight Italian credited epilepsy
centres and 50 healthy controls were evaluated using standardized neu-
ropsychological tests for ToM, empathy, recognition of behaviour appro-
priateness in social situations, and sensitivity to moral and conventional
rules. The Symptoms Check List 90R (SCL 90R) assessed the psy-
chopathological aspects.
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Results: The groups were similar in type of occupation, income, age,
sex, marital status and number of family members, suggesting similar
sociocultural contexts. Multivariate analysis of variance with schooling,
age and attention as the covariates, showed that, in comparison with the
controls, the patients were impaired in comprehension of others’ mental
states appreciation of social situations. By contrast, there were no differ-
ences in empathy or sensitivity to conventional and moral rules tests. In
comparison with the controls, the patients also revealed higher levels of
obsessive-compulsive and paranoia symptoms. The paranoia scores
related to ToM, while the total SCL90R score related to ToM and appre-
ciation of social situations.
Conclusion: This is the first study analyzing the components of social
cognition in TLE patients. These patients showed a multifaceted pattern,
with selective deficits of ToM and appreciation of social situations. Such
impairments related to psychopathological symptoms, highlighting their
clinical impact. On the other side, preserved empathy and sensitivity to
moral and conventional rules may be a resource for dealing with the
social environment and establishing satisfactory interpersonal relation-
ships. Comprehensive assessment of social cognition can have clinical
implications.
p0695
LONG-TERMFORGETTING INCHILDRENWITH
GENETICGENERALISED EPILEPSY: THE
TEMPORAL TRAJECTORYANDCONTRIBUTIONOF
EXECUTIVE SKILLS
S. Joplin*,†, M. Gascoigne*,†, R. Webster‡, D. Gill‡, B. Barton§,
S. Lah*,†
*The University of Sydney, The School of Psychology,
Camperdown, NSW, Australia, †ARC Centre of Excellence in
Cognition and its Disorders, Sydney, NSW, Australia, ‡T.Y.
Nelson Department of Neurology and Neurosurgery, Neurology
Department, The Children’s Hospital at Westmead, Westmead,
NSW, Australia, §The Children’s Hospital at Westmead,
Children’s Hospital Education Research Institute, Westmead,
NSW, Australia
Purpose: Long-term memory, which is critical for day to day life, social
interaction, and academic learning, is impaired in children with genetic
generalised epilepsy (GGE). In this study, we examined the relationship
between the temporal pattern of long-term forgetting and executive skills
of children with GGE, which has not been previously reported.
Method: Ten children with GGE and 47 typically developing control
children, completed standardised tests of executive skills and two experi-
mental long-term memory tasks (one verbal and visual). The verbal task
involved the recall of words after short (2- and 30-min) and long (1-day,
2-weeks) delays. The visual task involved the selection and placement of
objects into a previously shown scene at two long delays (1 day,
2 weeks).
Results: On the visual task, analyses revealed that children with GGE
obtained lower object placement accuracy score (p = 0.029) and selected
fewer correct objects (p = 0.021) at 2 weeks, but not at 1 day relative to
typically developing control children. On the verbal task, the between
group difference was not significant at any delay. In the GGE group,
visual working memory (WM) was correlated with lower object place-
ment accuracy (r = 0.648, p = 0.043), but not with the number of cor-
rectly selected objects at the 2 weeks delay.
Conclusion: This study provided several novel findings. For the first
time, deficits were found in long-term visual memory in children with
GGE. The study revealed that deficits in long-term visual memory
emerge gradually and relate to reduced executive skills. Our findings can
be used to inform the development of interventions for remediation of
long-term forgetting of visual information.
p0696
LANGUAGEOUTCOMEFOLLOWINGDOMINANT
HEMISPHERE LASERABLATION SURGERY FORTHE
TREATMENTOFMEDICALLYREFRACTORY
EPILEPSY
M. Pinjala*, C. Bermudez*, W. Jermakowicz†, C. Milan*,
R. Ribot*, E. Serrano*, N. Velez*, M. Lowe*, L. Tornes*,
A. Kanner*, J. Jagid†, M. Palomeque*, G. Rey*
*Neurology, University of Miami School of Medicine, Miami,
FL, United States, †Neurosurgery, University of Miami School of
Medicine, Miami, FL, United States
Purpose: To examine post-surgical language outcome in a consecutive
series of adult patients undergoing dominant hemisphere mesio-temporal
laser ablation for the treatment of pharmaco-resistant epilepsy.
Method: 10 consecutive patients with documented hemispheric lan-
guage dominance (confirmed with fMR and/or WADA) that underwent
laser ablation surgery for the treatment of intractable seizures were
included in the study. Comprehensive neuropsychological examination
was conducted 6–12 months pre- and post-procedure. Evaluation of lan-
guage skills included measures of confrontation naming, and semantic
and phonemic fluency. Eight of the subjects were male and the group had
a mean age of 41.70 (SD = 16.37), 13.33 (SD = 3.61) years of educa-
tion, and a mean duration of seizure disorder of 29.60 (SD = 15.58)
years. Correlation analysis was performed to examine the relation
between language scores and demographic and clinical variables.
Repeated measures analysis was conducted to assess changes in language
post-surgically.
Results: Demographic and clinical variables were not correlated with
scores of the three measures of language examined. Repeated measures
analysis did not reveal significant differences between pre- and post-sur-
gical language performance. However, two patients exhibited clinically
significant decline (>1 SD) in naming and phonemic fluency, while one
subject deteriorated significantly in the measure of semantic fluency.
Conclusion: Preliminary analysis suggests that, as a group, no signifi-
cant language morbidity occurs following dominant hemisphere laser
ablation for the treatment of medically refractory temporal lobe epilepsy.
However, individual differences may exist and further studies with a lar-
ger sample size are necessary to understand clinical and/or demographic
factors mediating potential changes in language capacities.
p0700
SAFETYANDEFFICACYOFVNS THERAPY IN A
POPULATION BASED STUDY IN FRANCE
E. Landre*, F. Bartolomei†, R. Nabbout‡, W. Szurhaj§,
B. Godet¶, C. Gordon**, W. Van Grunderbeek††, E 104 Study
Group
*Sainte Anne Hospital, Neurosurgery, Paris, France, †CHU
Marseille, Marseille, France, ‡Necker Hospital, Paris, France,
§CHU Lille, Lille, France, ¶CHU Limoges, Limoges, France,
**LivaNova PLC, Huston, TX, United States, ††LivaNova PLC,
Bruxelles, Belgium
Purpose: In order to assess long-term safety and effectiveness of VNS
Therapy in patients with drug resistant epilepsy in France, consecutive
patients from 15 out of 32 implanting centers were followed. This post-
market evaluation, requested by the French Health Authorities (HAS:
Haute Autorite de Sante), provides a comprehensive evaluation of
patients treated with VNS Therapy in France.
Method: (ISRCTN #72921325) 15 sites were selected for participation
based on geographic location and experience with VNS Therapy. 174 of
the 181 enrolled patients were implanted for the first time with a VNS
Therapy system between February 2013 and March 2015. Long-term
data through 2 years post-implant were collected on seizure frequency,
seizure severity (NHS3), quality of life (QOLIE-31P / QOLIE-48-AD),
general health status (EQ-5D-3L/EQ-5D-Y), and safety.
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Results: [Based on an interim analysis of ~100 patients. Data on all
patients will be available at the time of the conference.] Of the 181
enrolled patients, 53% were female with an average age of 35.6 years
(range 6–59 years). 53.3% of all patients had focal epilepsy, while 43.3%
had generalized epilepsy. Patients failed an average of 7 anti-epileptic
drugs (range 0–18) prior to treatment with VNS Therapy. Following
24 months of VNS Therapy, 47.3% (n = 44/93) of patients were respon-
ders (≥50% reduction in seizure frequency). Statistical significant
improvements in seizure severity and quality of life were also observed.
The most common adverse events were cough (n = 10; 10%) and
dysphonia (n = 9; 9%).
Conclusions: Treatment with VNS Therapy was well tolerated. In this
refractory epilepsy population, nearly half of all patients had ≥50%
reduction in seizure frequency following 2 years of treatment. Improve-
ment in quality of life and seizure severity were reported in the long-
term.
p0701
HIGH-FREQUENCY BURSTVAGALNERVE
SIMULATION THERAPY INANATURAL PRIMATE
MODELOFGENETICGENERALIZEDEPILEPSY
C.A. Szabo*, F. Salinas†, A. Papanastassiou‡, J. Begnaud§,
M. Ravan§, K. Eggleston§, R. Shade¶, M. De La Garza**
*UT Health San Antonio, Neurology, San Antonio, TX, United
States, †UT Health San Antonio, Research Imaging Institute, San
Antonio, TX, United States, ‡UTHealth San Antonio,
Department of Neurosurgery, San Antonio, TX, United States,
§LivaNova PLC, Houston, TX, United States, ¶Southwest
National Primate Research Institute, Sann Antonio, TX, United
States, **Southwest National Primate Research Institute, San
Antonio, TX, United States
Purpose: Since the approval of Vagal Nerve Stimulation (VNS) Therapy
for medically refractory focal epilepsies, it has been also reported to be
effective in idiopathic generalized epilepsies. Instead of conventional
VNS Therapy delivered at 20–30 Hz signal frequencies, this study evalu-
ates efficacy and tolerability of high-frequency burst stimulation
(300 Hz) with varying interburst intervals in the epileptic baboons, repre-
senting a natural animal model for genetic generalized epilepsy (GGE).
Method: Two female baboons had at least weekly generalized tonic-clo-
nic seizures (GTCS) prior to VNS implantation. VNS Therapy was initi-
ated after 4–5 weeks, and different VNS settings (0.25, 2 or 2.5 mA,
300 Hz, 4 vs 7 pulses, 0.5–2.5 sec interburst interval, stimulation inter-
mittently for 1–2 hours/day vs continuously) were tested over the subse-
quent fifteen weeks, including a 4–6 week wash-out period. GTCS
frequencies were quantified for each setting, while seizure duration and
postictal recovery times were compared to baseline. Scalp EEG studies
were performed at most settings, including intermittent light stimulation
(ILS) to evaluate photosensitivity. interictal discharge (IED) rates and
ILS responses were compared between trials. Finally, treatment-related
behavioral effects were also evaluated.
Results: High-frequency burst VNS therapy successfully reduced GTCS
frequencies at most treatment settings, except when output currents were
reduced (0.25 mA) or intermittent stimulation was restricted to 1–
2 hours/day. Scalp EEG studies did not demonstrate treatment-related
decrease of IED rates or photosensitivity, but continuous treatment dur-
ing ILS did reduce photoparoxysmal responses. VNS Therapy was well-
tolerated, without cardiac or behavioral changes. Repetitive muscle con-
tractions involving the neck and left shoulder girdle were observed inter-
mittently in both baboons, most commonly at 0.5 interburst intervals.
Conclusion: This study demonstrates efficacy and tolerability of high-
frequency VNS therapy in the baboon model of GGE. The twitching arti-
fact may be due to aberrant propagation of the stimulus along the vagal
nerve or ansa cervicalis.
p0704
CLINICALOUTCOMESOFVNS THERAPYWITH
ASPIRESRATA LARGEUKCOMPLEXEPILEPSYAND
SURGERYCENTRE
P. Hamilton*, P.A. Dhahri*, A. Leat*, D. Hughes†, N. Toghill*,
M. Bagary†, D. McCorry*, I. Soryal*, R. Chelvarajah*
*Queen Elizabeth Hospital, Complex Epilepsy and Surgery
Service, Birmingham, United Kingdom, †Barberry, Epilepsy
Service, Birmingham, United Kingdom
Purpose: Vagal nerve stimulation (VNS) emerged in 1988 as a treatment
alternative for medically refractory epilepsy which is not amenable to
resective surgery. Device models have evolved over time with the latest
being the AspireSR (model #106). This latest generation model has been
shown to have the ability to detect a rapid-onset tachycardia as a proxy to
an epileptic seizure and deliver on-demand closed-loop electrical stimu-
lation. The traditionally held view is that one-third of the implanted
patients will have significant benefit of ≥50% seizure burden reduction,
one-third of patients will have less meaningful benefit, and the final third
will have little benefit. More recent large series have suggested about
two-thirds of patient will have a significant benefit. The aim of this study
is to compare the seizure control effect of the AspireSR at a large com-
plex epilepsy and surgery centre in the UK with preceding VNS battery
models.
Method: We retrospectively analysed the records for 55 patients who
had battery change to the AspireSR implants over a period of 3 years
using our electronic patient database. Supplemental telephone interviews
were used to trace patients whose follow-up details were not available
electronically. Seizure frequency and severity pre and post AspireSR
were compared to pre-VNS therapy. Results are presented aligned to the
McHugh classification of VNS outcomes.
Results: Pre-Aspire follow-up was for a mean of 7.6 years and post-
Aspire added a further 1 year of mean follow-up. The ≥50%-responder
cohort increased from 53% to 80% with AspireSR. Within this cohort,
the >80% group increased from 22% to 38%. In contrast, the <50%-
responder cohort decreased from 47% to 20%with AspireSR.
Conclusion: With four-fifths of the patients having more than 50%
reduction in seizure frequency, the AspireSR has shown promising
outcomes, which often translates into better quality of life.
p0705
CATHODALTRANSCRANIAL DIRECTCURRENT
STIMULATIONREDUCES SEIZURE FREQUENCYAND
MODULATES BRAIN FUNCTIONALCONNECTIVITY
INDRUG-RESISTANT TEMPORAL LOBEEPILEPSY: A
SHAMCONTROLLED STUDY
G. Assenza*, C. Cottone†, F. Tecchio†, G. Pellegrino‡,
C. Campana§, C. Porcaro†, A. Cancelli†, F. Assenza*, G. Di
Pino*, M. Tombini*, V.Di. Lazzaro*
*Campus Bio-Medico University of Rome, Neurology, Rome,
Italy, †ISTC - CNR, Department of Neuroscience, Laboratory of
Electrophysiology for Translational Neuroscience (LET’S),
Rome, Italy, ‡IRCCS San Camillo, Venice, Italy, §Universita di
Milano, Department of Biomedical and Clinical Sciences
‘L.Sacco’, Milan, Italy
Purpose: One-third of epilepsy patients develop drug resistance epilepsy
(DRE), and half of them can benefit from the surgical removal of epilep-
tic focus (EF). Neuromodulation represents the only hope to ameliorate
the quality of life of the remaining patients. Cathodal transcranial direct
current stimulation (ctDCS) is a techniques able to non-invasively inhibit
cortical excitability, which is abnormally increased in epilepsy, but its
efficacy in reducing seizures and in modulating epileptic network is still
under debate.
We evaluated the efficacy of 20-minutes 1 mA ctDCS vs sham-tDCS
in reducing seizure frequency and in modulating the functional
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connectivity (FC) between EF and the other cortical areas, in temporal
DRE patients.
Methods: After 7 days of seizure diary, patients were randomized to
either first-ctDCS or first-sham-ctDCS treatment. On day 8, patients
underwent the assigned stimulation. On day 38, patients underwent the
single-session opposite stimulation. 7 days after the second session, the
study was concluded.
The ctDCS cathode was placed over the EF and the anode over the
contralateral homologous region. Immediately before and after stimula-
tions, a one-hour resting state closed-eyes 19-electrodes video-EEG
recording was acquired.
We enrolled ten patients affected by temporal lobe DRE (4 males;
42  15.7 years old; 4 symptomatic and 6 cryptogenic;5 right EF).
Results: ctDCS reduced the percent weekly SF more than sham stimula-
tion (71  33% ctDCS vs 25  125% sham; Z = 2.201, p = 0.028).
EA changes did not differ between ctDCS respect to sham-ctDCS
(p > 0.200 consistently). No patients reported worsening of SF or of sei-
zure intensity.
FC changed after real stimulation in all patients and involved the focus
in 71% of the new connections. No FC change was found after sham.
Conclusions: we demonstrated that an individualized ctDCS reduced
seizure frequency in temporal DRE without any safety concern. FC
changes may help to explain ctDCS effects on DRE patients.
p0706
A SINGLECENTRE STUDYCOMPARING THE
EFFECTIVENESS OF THEASPIRESR 106 VAGUS
NERVE STIMULATORMODELTOOLDERMODELS IN
DRUGRESISTANTEPILEPSY
L. Mecia*, S. Sheikh†, M. Maguire‡, E. Wright‡, J. Sivakumar‡
*University of Leeds, Leeds, United Kingdom, †Leeds Teaching
Hospitals NHS Trust, School of Medicine, Leeds, United
Kingdom, ‡Leeds Teaching Hospitals NHS Trust, Leeds, United
Kingdom
Purpose: One third of patients with epilepsy are drug resistant. A vagus
nerve stimulator (VNS) demonstrates sustained efficacy with around 50–
60% achieving a 50% seizure reduction after two years of treatment in
patients not suitable for resective surgery. The Livanova Aspir-
eSRVNS106 is the newest model with an additional auto-activation
upon detection of tachycardia. The effectiveness of this additional feature
in clinical practice requires further evaluation.
Method: We retrospectively compared the seizure efficacy for the new
Livanova AspireSR model 106 device to previous models in patients
who had undergone VNS replacement or de novo insertions for drug
resistant epilepsy at Leeds Teaching Hospitals NHS Trust (LTHT). We
also examined the adverse effect profile and tolerance of the new
AspireSRmodel 106.
Results: We examined 19 patients who had AspireSR model 106
device inserted at LTHT. Nine patients had a replacement VNS106 and
ten patients underwent a de novo VNS106 insertion. At a mean follow-up
of 6 months (3–12 months), there was an 68%mean reduction in seizure
frequency with AspireSR VNS 106. This compared to a 33% mean sei-
zure frequency reduction over a similar period of follow-up prior to indi-
cation of battery depletion with previous models. Over half the sample
reported improvement in seizure severity and 90% reported an improve-
ment in quality of life with AspireSR VNS 106 device. 80% of partici-
pants subjectively reported an improvement in mood with the 106 model.
Further analyses will report on long-term efficacy and tolerability for
both treatment groups.
Conclusion: Preliminary results suggest that AspireSRVNS 106 may
exhibit greater efficacy in seizure control when compared to older mod-
els. Whilst further data is to be reported on this cohort, the results are
encouraging with high percentage seizure reductions and improvement
in mood/quality of life outcomes. Available data would also suggest that
the VNS106 is well tolerated.
p0707
AN EVALUATIONOF SEIZURES REDUCTION
OUTCOMES INVARIOUS DUTYCYCLES IN VAGAL
NERVE STIMULATION (VNS) THERAPY IN LEEDS
GENERAL INFIRMARY
E. Wright, J. Geldard
Leeds Teaching Hospitals NHS Trust, Neurology, Leeds, United
Kingdom
Purpose: VNS is an adjunctive treatment for people with intractable
generalised or focal epilepsy where resective surgery is not suitable or
desired (NICE Guidelines 2016). This study aims to evaluate seizure
reduction in patients with a VNS in Leeds and establish any features of
the patient group that may influence effectiveness of the VNS.
Method: Data was collected retrospectively from 68 patients with
intractable epilepsy and VNS therapy at therapeutic range (1.0 mA to
2.25 mA). Overall seizure reduction rates and effect of VNS were anal-
ysed at varying duty cycles (on/off times of the VNS).
Results: An overall reduction in seizure frequency from baseline was
achieved in 53% of patients throughout all seizure types, Patients with
generalised seizures achieved an overall seizure reduction of 57% (19
patients), patients with focal seizures achieved an overall seizure reduc-
tion of 52%. 75% of patients had an improvement in mood and 78%
noted an effect on seizures (aborted a seizure, reduced seizure severity,
shortened a seizure and/or improved recovery time) when using the VNS
magnet. 27 patients on 8–19% duty cycles achieved 61% seizure reduc-
tion (range 0%–100%), 13 patients on 20–29% duty cycles achieved 58%
seizure reduction (range 0–100%). 18 patients on 30–39% duty cycles
achieved a 45% seizure reduction (range 0–100%) and 9 patients on 40–
49% duty cycle achieved a 59% seizure reduction (range 0- 92%).
Conclusion: These were a very refractory group of patients having tried
a median of 7 anti-epileptic drugs (AEDs) (range 4–13) and taking a med-
ian of 3 AEDs (range 1–5) concomitantly with VNS therapy. The respon-
der rates were similar to other studies, however, there are few studies that
examine the effect of VNS duty cycles on seizure frequency. This study
demonstrates that VNS therapy is effective at multiple VNS duty cycles
in both focal and generalised epilepsy.
p0708
LOCATION, SIZEOF FOCALCORTICALDYSPLASIA,
ANDAGEOF SEIZUREONSET INCHILDRENWHO
UNDERWENTEPILEPSY SURGERY
N. Wiwattanadittakul*,†, S. Suwannachote†,‡, X. You†,
T. Tsuchida†, D.-D. Cabacar†, T. Zelleke†, J. Schrieber†,
A. Kao†, J. Conry†, L. Bartolini†, C. Oluigbo†, C.-Y. Ho†,
K. Havens†, M. Whitehead†, W.D. Gaillard†
*Chiang Mai University, Pediatrics, Maung, Thailand, †George
Washington University, Center for Neuroscience, Washington,
DC, United States, ‡Queen Sirikit National Institute of Child
Health, Rungsit University, Department of Pediatrics, Bangkok,
Thailand
Background: Focal cortical dysplasia (FCD) is the most frequent cause
of refractory epilepsy in children; age of onset varies from infancy to ado-
lescence.
Purpose: To determine relationships between age of seizure onset, loca-
tion and size of FCD in children.
Method: We retrospectively reviewed medical records and magnetic
MRI in patients who underwent epilepsy surgery between May 2009 to
July 2016 at Children’s National Medical Center. All had pathology to
confirm diagnosis and categorization of FCD. Volumes were calculated
by ROI approach from T2 and SPGR images; location identified from
ROI center of mass co-registered in common space.
Results: Forty nine patients were identified: 24 girls; 25 boys. Mean age
of seizure onset was 2.9 years (range 1 month - 16 years). Age at seizure
onset was similar in temporal, extratemporal and multilobar FCD. Most
had complex partial seizures as a first seizure type (28), the remaining
had generalized tonic/tonic clonic seizures (9), infantile spasms (4), focal
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motor seizures (4) and others (4). Location of FCD; frontal (18), temporal
(13), parietal (11), multilobar (5) and occipital (2). MRI abnormalities
were identified at mean age 7.14 years (range 0–19.7 years) using epi-
lepsy protocol at 1.5T (19 patients) or 3T (30 patients). The mean volume
of focal cortical dysplasia was 22.5 cm3 (range 0.87–167.4 cm‡). Mean
age at surgery was 9.5 years (range 2 months-21 years old). There was
no significant correlation between age of seizure onset and location of
FCD (p = 0.433). Age of seizure onset before one month was found in
patients with large lesions (r = 0.24). There was a trend for temporal tip
abnormalities to have later seizure onset (p < 0.06).
Conclusion: Larger FCD is associated with earlier age of seizure onset.
The trend for location of FCD and age of onset may reflect myelin matu-
ration and capacity for seizure propagation.
p0712
BLOODLEVELSOFKYNURENINE DERIVATIVES IN
CHILDREN FEDKETOGENIC DIET
I. Zarnowska*, T. Kocki†, K. Mitosek-Szewczyk*, M. Gasior‡,
W.A. Turski†
*Medical University, Department of Child Neurology, Lublin,
Poland, †Medical University, Department of Experimental and
Clinical Pharmacology, Lublin, Poland, ‡Drexel University of
Pensylvania, Department of Pharmacology and Physiology,
Philadelphia, PA, United States
Purpose: The aim of the present study was to measure blood levels of
tryptophan (TRP) and its kynurenine derivatives and to correlate them
with clinical efficacy of the KD used therapeutically in children suffering
from refractory epilepsy and autism.
Material and methods: 16 children (9 F, 7 M), with refractory epilepsy
(12) or autism (4) were enrolled into the study in the Department of Child
Neurology, Medical University, Lublin, Poland. Patients were fed the
classical ketogenic diet or modified Atkins diet. After reaching ketosis of
>2 mM of b-hydroxybutyrate, patients’ blood levels of TRP, kynurenine
(KYN), KYNA, and 3-OH-kynurenine (3-OH-KYN) were measured
chromatographically after 3 months, 6 months, and 12 months on the
diet; pre-KD levels served as base-line controls.
Results: TRP levels remained unchanged at 3, 6, and 12 months on the
diet (95%, 107%, 87%, respectively; p > 0.05). KYNA blood levels
increased 152% at 3 months (p < 0.001), 206% at 6 months
(p < 0.001), and 273% at 12 months (p < 0.05) compared to the pre-KD
controls levels. Of 16 patients, 8 attained high level of compliance and
consequently had the best clinical outcome. In those patients, KYNA
levels increases were also the least variable and the highest in magnitude,
ranging from 314 to 327% at 6 months and 12 months compared to the
pre-KD control levels, respectively. KYN levels decreased compared to
the pre-KD control levels (83%, 79%, and 77%, at 3, 6, and 12 months,
respectively; p > 0.05) while 3-OH-KYN levels increased 126%, 171%,
and 130%, respectively; p > 0.05).
Conclusions: Blood levels of KYNA were significantly elevated in KD-
fed patients. These elevations appeared even more pronounced in patients
with better compliance to the diet regimen, which was also associated
with a better clinical outcome.
p0716
ACQUIRED EPILEPTIFORMOPERCULAR
SYNDROMEWITHOUTROLANDIC EPILEPSY? A
VARIANTOF LKS
K. Ballaban-Gil, R. Jehle
Montefiore Medical Center, Neurology, Bronx, NY, United
States
Landau-Kleffner syndrome (LKS) is a rare epilepsy syndrome character-
ized by regression in speech and language in association with frequent
sleep-activated epileptiform discharges +/- seizures. The most common
associated language disorder is verbal auditory agnosia, with severe defi-
cits in language comprehension and expression. There are rare reports of
oromotor and speech disturbances in children with rolandic epilepsy,
labeled acquired epileptiform opercular syndrome. Most have sleep acti-
vated EEG abnormalities, typically CSWS. We report a case of severe
speech impairment without deficits in expressive language or compre-
hension, who does not have rolandic epilepsy, centro-temporal spikes or
CSWS.
R.F. is a 3 year old female with previously normal development, who
awoke from a nap with slurred speech, followed by progressive deteriora-
tion in her articulation and increasing difficulty producing words over the
ensuing 3 weeks. There was deterioration in language comprehension.
About 2 weeks into the course of her illness she developed gagging while
eating. Three weeks after the onset of symptoms her exam was remark-
able for a youngster with severe verbal dyspraxia, which worsened as
mean length of utterance increased and fluctuated during the exam. Lan-
guage comprehension was intact, and the rest of her neurologic examina-
tion was normal. Non-contrast brain MRI was normal. Video-EEG
monitoring at this time was remarkable for rare paroxysmal bursts of high
amplitude delta activity, with intermixed spikes in the left frontal-central
region. She was started on a course of high dose steroids.
This case is unique because prior cases of oral apraxia without struc-
tural lesion have been associated with frequent seizures or, often with
continuous or near continuous epileptiform discharges, usually activated
by non-REM sleep (CSWS). Our patient has a marked verbal dyspraxia,
but relatively infrequent discharges. We postulate that this may be due to
performing vEEG assessment so early in the course of her illness.
p0717
KETOGENIC DIET IN PYRUVATEDEHYDROGENASE
COMPLEXDEFICIENCY
M. Furujo*, M. Kinoshita†, T. Inoue*, T. Kubo*
*OkayamaMedical Center, Pediatrics, Okayama, Japan,
†Utano National Hospital, Neurology, Kyoto, Japan
Purpose: To assess the clinical characteristics and efficacy of ketogenic
diet therapy in a case of pyruvate dehydrogenase complex (PDHC) defi-
ciency, which is a major inborn error of oxidative metabolism of pyruvate
in the mitochondria causing congenital lactic acidosis and brain dysgene-
sis. PDHC provides the link between glycolysis and the tricarboxylic acid
cycle by catalyzing the conversion of pyruvate into acetyl-CoA.
Method: A 9-year-old female patient with PDHC deficiency was evalu-
ated. At 24 weeks of gestation a fetal ultrasonography revealed enlarge-
ment of the lateral ventricles and hypoplasia of the cerebellum.
Immediately after birth the patient developed fatal lactic acidosis and
hypoglycemia. The patient was diagnosed as having PDHC deficiency
based on normal ratio of lactate/pyruvate and improvement of lactic aci-
dosis by ketogenic diet. Currently she is bed-ridden and treated with keto-
genic diet (ketone ratio 1:1), vitamin B1, and L-carnitine. We evaluated
the seizure semiology and EEG findings.
Results: Her seizures comprised of abrupt breath holding and brief hic-
cup-like movement of mouth and upper trunk, once in several minutes.
EEG showed continuous fluctuating periodic epileptiform discharges,
generalized and multifocal, bilaterally independently.
Conclusion: Ketogenic diet can be effective to PDHC deficiency not
only to provide an alternate source of acetyl-CoA derived from ketone
bodies to the developing brain but also to suppress seizures.
p0721
AGGRAVATIONOF EPILEPSY INA PATIENTWITH
ATYPICAL BENIGN PARTIAL EPILEPSYOF
CHILDHOODAFTERADMINISTRATIONOF
SULTHIAME
I. Zaitsau, S. Likhachev, S. Kulikova, I. Kozireva
Republican Scientific and Practical Centre of Neurology and
Neurosurgery, Minsk, Belarus
Purpose: To describe our own experience of treatment with sultiame
that led to worsening of epilepsy.
S131
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Method: A 6 years old patient, male, with atypical benign partial epi-
lepsy of childhood debuted at 4 years and 6 months. The diagnosis was
proved by typical seizures and changes in EEG. The Patient was suffered
from several types of seizures: focal motor seizures with Todd paralysis,
atypical absences, atonic seizures, jerks, secondarily generalised tonic-
clonic seizures. EEG changes: awake EEG showed bilateral centrotem-
poral spikes and there was CSWS during sleep. After the start of seizures,
ADHD and speech disorders were developed. Administration of VPA,
levetiracetam, ethosuximide gained a few therapeutic effect.
Results: Sulthiame is one of the most effective drug used for the treat-
ment of benign childhood focal epilepsies with regard to its effect in sup-
pressing seizures and EEG abnormalities. After administration of
sulthiame in a dose of 5 mg/kg there was improvement in behavioral and
mental sphere, decrease of seizures and improvement of EEG changes.
Further treatment with sulthiame in a 10 mg/kg dose resulted in severe
aggravation of all types of seizures, even absence status epilepticus was
developed. This negative clinical changes were proved by EEG.
Conclusion: In rare cases, in the treatment of children with atypical
benign partial epilepsy it’s important to keep in mind the possibility that
the treatment with sulthiamemay make themworse.
p0722
INTRATHECAL INFUSIONOFAUTOLOGICADIPOSE
DERIVEDREGENERATIVECELLS (ADRC) IN AN
AUTOIMMUNEDETERMINEDREFRACTORY
EPILEPSY INCHILDREN
E. Szczepanik*, H. Mierzewska*, D. Antczak-Marach*,
A. Figiel-Dazbrowska†, Z. Zalewska Miszkurka*, M. Kruk*,
I. Terczynska*, J. Tryfon*, N. Krzesniak‡, E. Sawicka§,
D. Mydlak§, A. Sarnowska†
*Institute of Mother and Child, Clinic of Children and
Adolescents Neurology, Warsaw, Poland, †Polish Academy of
Sciences, NeuroRepair Department, Mossakowski Medical
Research Centre, Warsaw, Poland, ‡Centre of Postraduate
Medical Education, Department of Plastic Surgery, Warsaw,
Poland, §Institute of Mother and Child, Paediatric Surgery
Clinic, Warsaw, Poland
Purpose: Taking into account that ADRC isolated from lipid tissue are
supposed to have immunomodulatory, neuroprotective, trophic and anti-
apoptotic qualities an evaluation of safety and efficacy of ADRC in
autoimmune determined refractory epilepsies was undertaken.
Method: After bioethic commission agreement, 6 patients with mean
age of 10 years, and with proven or probable autoimmune refractory epi-
lepsy (2 with Rasmussen encephalitis, 2 with neuronal autoantibodies, 2
with possible FIRES) were included into the project. A procedure of
intrathecal infusion of ADRC acquired through liposuction followed by
isolation by Cytori machine were performed. Procedure was repeated 3
times every 3 months in each patient. Neurological status, cognitive
function and antiepileptic effect were supervised during 12 months of
follow-up.
Results: Immediately after procedure all patients were in good condi-
tion. In individual cases transient mildly elevated body temperature, pain
in regions of liposuction or slight increasing of number of seizures during
24 hours were noted.
During next months, cognitive functioning and manual performance
improved in all patients. One patient has been seizure free up today. In
other patients frequency of seizures was different: from reduction of their
number to lack of improvement.
Conclusion: Autologous ADRC therapy may constitute a new option for
some patients with autoimmune determined refractory epilepsy. Based
on our trial and other clinical data the autologic ADRC therapy appears
to be safe. Antiepileptic efficacy proved to be various, however cognitive
abilities improved in all children.
p0725
TOLERABILITYOFADJUNCTIVE LACOSAMIDE IN
PAEDIATRIC PATIENTS AGED 4 TO <16 YEARSWITH
FOCAL SEIZURES: AN INTERIM POOLEDANALYSIS
OFDATA FROMOPEN-LABEL TRIALS
N. Yuen*, C. Taeter†, C. Beller*, T. Daniels*, A. Bozorg*
*UCB Pharma, Raleigh, NC, United States, †UCB Pharma,
Braine l’Alleud, Belgium
Purpose: To assess long-term tolerability of adjunctive lacosamide in
children (4 to <16 years) with focal seizures.
Method: Interim data (cut-off: 02 May 2016) were pooled from three
open-label trials (SP0847/NCT00938431, SP848/NCT00938912,
EP0034/NCT01964560) investigating adjunctive lacosamide in children
with focal seizures. Weight-based dosing regimens of 2–12 mg/kg/day
were used (oral solution/tablets; maximum dose: 600 mg/day). Safety
data are presented for patients aged 4 to <16 years.
Results: Data from 294 patients were analysed (45.9% female;
mean  SD age: 10.25  3.34 years; mean epilepsy duration:
6.46  3.64 years). 109 (37.1%) had 1–3 previous antiepileptic drugs
(AEDs) and 93 (31.6%) had ≥4. At cut-off date, 174 (59.2%) had ongoing
lacosamide, 45 (15.3%) had completed, and 75 (25.5%) had discontinued
prematurely. Most common primary reasons for discontinuation were
lack of efficacy (33 [11.2%]) and adverse events (AEs) (17 [5.8%]).
Mean duration of lacosamide exposure was 355.1  236.7 days; 216
(73.5%) patients received treatment for >6 months, 135 (45.9%) for
>12 months, and 55 (18.7%) for >24 months. Mean modal daily lacosa-
mide dose was 7.79  2.83 mg/kg/day. Most patients had 2 (50.7%) or 3
(31.6%) concomitant AEDs at lacosamide initiation. Levetiracetam, val-
proate, and lamotrigine were most common concomitant AEDs during
exposure period. Treatment-emergent AEs occurred in 240 (81.6%)
patients, most commonly nasopharyngitis (19.4%), vomiting (17.0%),
dizziness (16.3%), pyrexia (14.6%), upper respiratory tract infection
(12.2%), somnolence (11.9%) and headache (11.6%). 128 (43.5%)
patients had drug-related TEAEs (most common: dizziness [12.2%];
somnolence [10.2%]) and 7 (2.4%) had drug-related serious TEAEs.
TEAEs leading to discontinuation in ≥1% patients were dizziness (1.7%)
and convulsion (1.4%). One patient died due to unknown causes (not con-
sidered lacosamide-related).
Conclusion: Long-term adjunctive lacosamide was generally well toler-
ated in children (4 to <16 years) with focal seizures. Tolerability of
adjunctive lacosamide in children was consistent with well-established
tolerability profile in adults. No new safety concerns were identified.
Funding: UCB-Pharma-sponsored.
p0730
HYPSARRHYTHMIAMAY INDICATES THE
PATIENT’S NONCOMPLIANCE –OBSERVATION IN
TWOTSC PATIENTS FROMEPISTOP PROJECT
D. Domanska-Pakieła, J. Borkowska, K. Sadowski,
D. Chmielewski, K. Kotulska-Jozwiak
The Children’s Memorial Health Institute, Child Neurology and
Epileptology Department, Warszawa, Poland
Purpose: EPISTOP project is a large, 7th FP EU multicenter study
aimed to identify the risk factors and biomarkers of epileptogenesis in a
genetic model of focal epilepsy - tuberous sclerosis complex. The clinical
part of the project is based on prospective study on infants with the diag-
nosis of TSC prior to epileptic seizures. The children are followed with
video EEG, brain MRI and blood samples analysis (genetic protein,
immunological and other studies) up to the age of 2 years. At the point of
epileptic discharges seen on EEG patients are randomized to early treat-
ment group (before the clinical seizures) or standard group (after clinical
seizures) group in order to establish the clinical benefit of early interven-
tion in TSC children.
Method: We present 2 children -a girl and a boy, participating in a ran-
domized part of the study. Video EEG was being registered in 6 weeks
intervals and analyzed according to EPISTOP EEG score form. Both
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infants were randomized to early treatment group based on video EEG
results at the age of 5 and 3 months, respectively
Results: In both children, follow-up EEG after treatment initiation
revealed hypsarrhythmia pattern. They still present no clinical seizures.
Detailed review with the family showed that both children didn’t get the
recommended treatment. After treatment re-start, in both children EEG
improved, hypsarrhythmia disappeared.
Conclusion: Currently hypsarrhythmia is a very rare pattern observed in
TSC patients before clinical seizures. Its presence in patients on
antiepileptic medication may results from noncompliance.
p0731
DEMOGRAPHICANDCLINICAL PROFILEOF
CHILDRENWITHEPILEPSY IN DEVELOPING
ECONOMY
L. Tiwari*, C. Anand†, S.H. Warsi†, R. Kumar†
*All India Institute of Medical Sciences, Paediatrics, Patna,
India, †All India Institute of Medical Sciencs, Patna,
Paediatrics, Patna, India
Purpose: All India Institute of Medical Sciences (AIIMS) Patna is one
of the newly established institutes of national importance in India. Analy-
sis of clinical and demographic profile of newly established Pediatric epi-
lepsy Clinic is likely to help in making health policies for similar
economies.
Method: Retrospective analysis of demographic and clinical profile of
the children registered at Pediatric Seizure Clinic. Children having sei-
zures with developmental issues are part of Neurodevelopment clinic and
they are not included in this analysis.
Results: Out of 243 registrations, 148 files with sufficient information
were analyzed. The most common type of seizure is GTCS noted in 92
(62.2%), and focal in 41 (27.7%) children. Neuroimaging was found
abnormal in 48 (38.7%) out of 124 children screened so far. Inflamma-
tory granuloma is most common CT finding noted in 26 (21%) children.
NCC was detected in 19 children (46.3%) out of 41 presenting with focal
epilepsy. Thyroid function was found abnormal in 7 out of 29 children
screened for it. First line AEDs for GTCS and focal seizures are valproate
and carbamazepine respectively. Common add-on drugs include leveter-
acetam, clobazam, clonazepam and vigabatrin. 101 (68.2%) children
have well controlled seizures while 47 (31.7%) have partial control.
Myoclonic seizures are the most difficult to treat needing multiple AEDs.
80.4% children are regular in follow up with good drug compliance.
Conclusion: Inflammatory granuloma is most common CT finding in
children with focal seizures. Incidence of thyroid dysfunction in these
children was found more than the background incidence in the popula-
tion. Most of the cases had good control on first line AEDs.
p0732
REVIEWOFDRUGRESISTANT EPILEPSYCHILDREN:
FOCUSONTHEDISCLOSUREOFUNNOTICED
EPILEPSY-SURGERYCANDIDATES
O. Horak, P. Hanakova, M. Ryzı, H. Oslejskova
University Hospital of Brno, Clinic of Paediatric Neurology,
Epilepsy Center Brno, Brno, Czech Republic
Purpose: To reveal the unnoticed non-pharmacological therapy (espe-
cially epilepsy-surgery) candidates among the children with epilepsy,
beeing in the long-term care of the Clinic of Paediatric Neurology of
University Hospital and Epilepsy Center of Brno, The Czech Republic.
Method: A single-center retrospective, outpatient trial, realized in fol-
lowing methodological steps: In the first step, 1032 patients, ranging age
0–19 years, with diagnosis epilepsy and/or epileptic status
(acc. International Statistical Classification of Diseases and Realated
Health Problems), at least once examined in our center during the year
2014, were detected. In the second step, 141 drug resistant epilepsy chil-
dren (excluding patients with benign age-dependent epilepsies and
patients, who have been seizure-free more than 6 months since the last
visit) were selected. In the third step, 12 patients with low seizure
frequency were excluded. In the fourth step, in October 2016, remaining
129 patients were re-examined by two independent paediatric epileptolo-
gists, who made an effort to select eligible candidates for non-pharmaco-
logical treatment. Finally, descriptive statistics was used for complete
assessment.
Results: From a total of 1032 patients, only 141 (13.67%) were classified
as drug resistant and 129 of them were subsequently enrolled into the
next evaluation - 39 (30.2%) patients were assessed as potential eligible
candidates for non-pharmacology therapy by both of epileptologists. In
33 cases the vagal nerve stimulation was recommended as a choice of
option by both epileptologists. From 82 (63.6%) patients, considered to
be unsuitable for non-pharmacological treatment, 51 (39.5%) became
seizure-free and 10 (7.8%) were already clearly targeted to epilepsy-sur-
gery or ketogenic diet treatment.
Conclusion: Revaluation of patients as a form of self-control in the
scope of one epilepsy center can be helpful in registration unnoticed epi-
lepsy-surgery candidates. In our experience, in majority of 39 detected
candidates, the parent0s refusal of non-pharmacological therapy was the
main reason of its providing failure.
p0735
CLINICAL, ELECTROENCEPHALOGRAFICAL AND
FAMILIARCHARACTERIZATIONOFROLANDIC
EPILEPSY IN PEDIATRIC POPULATIONOF TWO
CENTERS FROMMEDELLIN, COLOMBIA, FROM 2011
TO 2016
Y.M. Bayona Ovalles*, R. Solarte Mila†, W. Cornejo Ochoa*,
I. Camacho Ordo~nez†, D.M. Cornejo-Sanchez*
*Universidad de Antioquia, Medellın, Colombia, †CEC-LAB
electrophysiology laboratory, Medellın, Colombia
Purpose: Rolandic epilepsy is the commonest epileptic syndrome in
pediatric population. We don0t have any data of this epilepsy in our coun-
try. The aim of this study was to describe clinical, electroencephalo-
graphic and familiar characteristic in our population and with this data
orientate future investigations.
Mehod: Descriptive, retrospective, cross-sectional study.
Results: We enrolled 39 patients, 53% male, 47% female. The fisrt sei-
zure was at 6.5 years old (2.28 SD). Most crisis presented in the awake
state (46%) and the most frequent symptom was sialorrhea in 5.1%.
There was clonic generalization in 66.6% of patients.
In the EEG we had left irritative activity in 38.4% and bilateral irrita-
tive activity in 23%. All patients had spike wave complexes. The maxi-
mal irritative activity presented in N2 sleep stage in 82%. There was
extra centro-temporal irritative activity in 23%.
Patients had family history of epilepsy in 33.3% and personal history
of academic difficulties in 38.5%. This was the more frequent comorbil-
ity in the group, follow by attention deficit hyperactivity disorder in 23%.
Conclusion: We found an important familiar history of epilepsy in this
group of patients wich makes this an important area of investigation to
try to find the specific genes involved.
Of notice the big prevalence of academic difficulties in this popula-
tion. This is an important issue to be aware of in the following of this
patients.
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THEROLEOFANAGEAPPROPRIATE FDG-PET
DATABASE IN PAEDIATRIC CLINICAL PATHWAYS
OF PRE-SURGICAL PLANNING FORTHE
TREATMENTOFEPILEPSY
B. De Blasi*, A. Barnes†, I. Boscolo Galazzo‡, C.-H. Hua§,
B. Shulkin¶, M. Koepp**, M. Tisdall††
*University College London, Medical Physics, London, United
Kingdom, †UCL Hospitals NHS Foundation, London, United
Kingdom, ‡University of Verona, Computer Science, Verona,
Italy, §St. Jude Children’s Research Hospital, Radiation
Oncology, Memphis, TN, United States, ¶St. Jude Children’s
Research Hospital, Diagnostic Imaging, Memphis, TN, United
States, **UCL Institute of Neurology, London, United Kingdom,
††Great Ormond Street Hospital, London, United Kingdom
Purpose: Evaluation of paediatric F-18-deoxyglucose positron emission
tomography (FDG-PET) images as part of pre-surgical planning is cur-
rently a subjective procedure, based on visual assessment only. Con-
versely, voxel-wise statistics is an objective and user independent
analysis to automatically identify areas of significant hypometabolism,
associated to the epileptogenic zone. This analysis is implemented in
commercially available software packages like Scenium (Siemens). The
main limitation of this software is the use of an in-built adult control data-
set which differs from children in both brain size and metabolism. In this
work, we present a semi-quantitative processing pipeline to improve the
accuracy in localising the epileptic focus on FDG-PET data and aid clini-
cal diagnosis.
Methods: We developed a flexible pipeline based on SPM8, allowing
the use of in-house FDG-PET templates in paediatric standard space and
age-matched control dataset (6–20y). We retrospectively collated the
FDG-PET scans of 20 patients (6–17y) with focal and generalised epi-
lepsy, which reflects what is normally found in the clinical setting. We
compared their clinical diagnosis, established on the basis of clinical
information and imaging findings, with the results of the semi-quantita-
tive analysis from Scenium (an automated FDA-approved software
which relies only on adult dataset, 19–44y) and our pipeline.
Results: We report agreement with clinical diagnosis in 90% of cases for
younger patients (6–9y) and 80% for older ones (10–17y), compared to
60% in both cases, with Scenium. In the younger (older) patient group,
we report a sensitivity of 90% (89%), while Scenium achieves 80%
(67%). The average percentage of false positives is found to be 33%
(17% for the older patients) with our pipeline as compared to 58% (33%)
of Scenium.
Conclusions: Our initial results show that the use of a more appropri-
ately matched image database can lead to a more accurate detection of
the epileptogenic zone on paediatric FDG-PET scans.
p0738
IRON SUPPLEMENTATIONON PAROXYSMALNON-
EPILEPTIC EVENTS
J.W. Kang*,†, J.S. Lee†
*School of Medicine, Chungnam National University,
Pediatrics, Daejeon, Korea, †Chungnam National University
Hospital, Pediatrics, Daejeon, Korea
Purpose: Paroxysmal nonepileptic event (PNE) is a common seizure-
like symptom in children, resulting in sudden changes in behavior or con-
sciousness. In contrast to the common incidence, there are few known
therapies. It is important that the PNE be separated from the epileptic sei-
zures as well as being careful not to be misdiagnosed so that the anticon-
vulsant is not used improperly. In relation to therapy, a reduction in iron
was reported in breath-holding spells, but not in other PNEs. We investi-
gated the effects of iron supplementation on various PNEs.
Method: We retrospectively reviewed the medical records of patients
who visited the Chungnam National University Hospital between Jan-
uary, 2013 and February, 2016.
Results: A total of 46 patients were analyzed. Seventeen patients were
male and 29 patients were female. The mean gestational age was
39.3 weeks, and birth weight was 3,000 g. The mean age at the time of
visit was 3.6 years. Among 11 cases of brain MRI, 10 cases were normal
and 1 case was subdural hemorrhage. All 2 cases underwent brain ultra-
sound were normal. EEG was performed in 33 patients, 24 patients were
normal (72.7%), slow background waves were 4 (12.1%), and spikes
were observed in 5 patients. 31 patients (67.4%) had less than 80 ug/dL
iron. Except for 2 patients who were not followed for 3 months or more,
24 of the 44 patients had iron supplementation, and 91.7% of them
showed improvement. In 20 patients without iron supplementation,
65.0% showed improvement in symptoms, it was statistically significant
(p = 0.035).
Conclusion: PNE improved near 80%, and the rate of symptom
improvement can be expected through iron administration.
p0742
SCN8AMUTATION-RELATED EPILEPSY
RESPONSIVE TOLOWDOSE PHENYTOIN
C. Cukiert*, A. Cukiert†, J. Burattini†, P. Mariani†
*Clinica de Epilepsia de Sao Paulo, Neurology, S~ao Paulo,
Brazil, †Clinica de Epilepsia de Sao Paulo, Neurosurgery, S~ao
Paulo, Brazil
Purpose: Some SCN8Amutation patients were recently reported to have
a paradoxical good response to sodium channel blocker drugs. We report
a kid with SCN8A mutation who became seizure free under low-dose
phenytoin therapy.
Method: A 3 years-old boy presented with seizures since the age of
8 months; neurological and developmental milestones were normal until
that age. By the age of 8 months he developed infantile spasms associ-
ated to an hypssarhytmic EEG partially treated with ACTH, vigabatrin,
multiple anti-epileptic drugs and immunoglobulin. Developmental delay
was noted after seizure onset. By the age of 2 years he presented with
refractory unaccountable daily atypical absences, generalized tonic-clo-
nic, tonic, and myoclonic seizures. Exome evaluation disclosed SCN8A
mutations. He was unable to sit or speak, presented with sequential upper
respiratory tract infections, and underwent gastrostomy. EEG showed
multifocal epileptic discharges and frequent secondary bilateral syn-
chrony. MRI was normal. At admission, he was taking valproate, lacosa-
mide and steroids.
Results: Oxcarbazepine led to a marked reduction in tonic, myoclonic
and generalized tonic-clonic seizures. He was submitted to VNS which
led to additional seizure frequency reduction (especially atypical
absences) and cognitive improvement; there were still frequent daily sei-
zures. He was started on phenytoin 7 mg/kg daily (50 mg bid); phenytoin
plasma level under this regimen was 3 μg/ml. Seizures disappeared
almost immediately after phenytoin was started; cognitive, motor and
behavior improvement were also noted. EEG showed independent bitem-
poral spiking; no generalized activity or secondary bilateral synchrony
was noted. He remained seizure-free for the last 6 months.
Conclusion: Contrary to SCN1A mutations` patients, SCN8A patients
might benefit from the use of sodium channel blocker drugs. The dosage
and plasma levels needed to ensure seizure control might be lower than
the traditionally accepted ones in this patient population.
p0743
THREECASESOFRASMUSSEN´S ENCEPHALITIS
WITHOUTBRAIN ATROPHYONMR IMAGING
J.P. Princich*,†, R. Caraballo‡, G. Reyes Valenzuela‡,
J. Pociecha‡, F. Maldonado†, P. Alonso†, C. Rugilo†
*Hospital El Cruce, Nestor Carlos Kirchner, ENyS Estudios en
Neurociencias y Sistemas Complejos., Florencio Varela,
Argentina, †Hospital de Pediatrıa J.P Garrahan, Imagenes,
Buenos Aires, Argentina, ‡Hospital de Pediatrıa J.P Garrahan,
Neurologıa, Buenos Aires, Argentina
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Purpose: To retrospectively evaluate atypical MR images in three cases
of Rasmussen´s encephalitis (RE) with clinical and histopathology find-
ings fulfilling Part B diagnostic criteria of the disease as proposed by the
European consensus (2005). We present MR findings that may assist
radiologist to consider RE in the differential diagnosis of epilepsy
patients and eventually aid in the early recognitions of this condition.
Method: All patients underwent at least one contrast enhanced brain
MRI at 1.5T including T1, T2, FLAIR and DWI sequences. Diagnosis
was established based on clinical features and histology findings after
brain biopsy or surgery samples.
Results: Age at onset was 9 years (7-13y), all patients showed ictal
semiology of focal origin before the development of epilepsia partial con-
tinua (EPC). Two patients presented with unilateral, transitory and iso-
lated clonic movement of limbs and absent gaze. One patient evidenced
ictal hypersalivation, absent gaze, ocular and head version with further
development of behavior disturbances and hallucinations. EEG during
clinical episodes was characterized by unilateral fast activity spikes,
acute waves or spike-waves without hemispheric slowing in all cases.
Average time to EPC was 9 months in all patients (3-12 m). All patients
had histo-pathology findings compatible with active RE. During the
acute stage all patient had subcortical FLAIR/T2 hyper-intensities with
partial collapse of subarachnoid spaces. Lesions were initially unilateral
in all cases (one or two lobes affected) with further involvement of the
contralateral hemisphere in one patient. Two patients had five follow-up
MRI during 18 and 7 months respectively. Lesions progressed in both
cases after brain biopsy involving previously unaffected regions (within
3 months). Patient showed no evidence of brain atrophy.
Conclusion: MRI evidence of brain atrophy is not required for the
definitive diagnosis of RE. Non typical initial neuro-imaging or unusual
progression are not sufficient to exclude the diagnosis.
p0744
PAROXYSMALNONEPILEPTIC EVENTS IN
PEDIATRIC EPILEPSYCLINIC: A DESCRIPTIVE
STUDYOF ETIOLOGY, PROPORTIONAND
THERAPEUTIC IMPLICATIONS ATA TERTIARY
HEALTHCARECENTRE
A. Mandli*, N. Desai*, R. Badheka*, V. Udani*, D. Mhatre*
*P. D. Hinduja National Hospital &Medical Research Centre,
Pediatric Neurology, Mumbai, India
Purpose: To study the proportion of paroxysmal non-epileptic events in
pediatric patients presenting with history of paroxysmal events in epi-
lepsy clinic.
Objectives:
1 To determine the age (< 5 years, 5 to < 12 years, ≥12 years) and gen-
der distribution of different paroxysmal non-epileptic events in pedi-
atric patients.
2 To evaluate the therapeutic implications of correct diagnosis (modifi-
cation/ withdrawal of drugs).
3 To determine the co-existence of true epilepsy in this population.
4 To evaluate for psychological co-morbidities in patients with psy-
chogenic non-epileptic seizures.
Method: All new patients of 1-month to 18-year of age attending the
Pediatric epilepsy clinic were included if they presented with history of
paroxysmal events.Patients were assessed by history and clinical evalua-
tion by pediatric neurologists.Sometimes aided by recorded videos of
these events.If the diagnosis was not confirmed by this preliminary evalu-
ation, further investigations like EEG/videoEEG, ECG and neuroimag-
ing were advised.
Results: In this study of 200 new patients presenting with paroxysmal
events in the pediatric epilepsy clinic, 19%had nonepileptic events,80%
had epileptic events, and 1%remained undiagnosed. Physiological or
organic non-epileptic events were more common in patients less than
5 years of age and psychogenic non-epileptic events were more common
in more than 5 years of age. Syncope was more common in adolescents.
There was no statistically significant gender predilection for different
paroxysmal non-epileptic events. 34.2% of patients with non-epileptic
events were on AEDs. After confirming non epileptic attacks, only 2.6%
patients needed AEDs for coexisting true epilepsy. 31.6% of patients had
received unnecessary AEDs. The change in treatment with correct diag-
nosis was statistically significant (p = 0.0001).
Conclusion: Mimickers of epilepsy are common in pediatric practice
and are often a cause of drug refractoriness and side effects of antiepilep-
tic drugs (AEDs) and mental and financial burden to entire family.Cor-
rect diagnosis leads to correct management, commencing new treatment
for the specific diagnosis if needed and appropriate referrals to other
health care providers as indicated.
p0749
EEGCAN PREDICTNEUROLOGICOUTCOME IN
CHILDRENRESUSCITATED FROMCARDIACARREST
H.J. Kim*, D.H. Yang*
*Gachon University Gil Medical Center, Incheon, Korea
Purpose: Early prediction of prognosis of children resuscitated from car-
diac arrest is a major challenge. We investigated the utility of EEG for
predicting of neurologic outcome in children resuscitated from cardiac
arrest.
Method: We retrospectively analyzed medical records of patients who
were resuscitated from cardiac arrest from 2006 to 2015 at the Gil Medi-
cal Center. Patients aged one month to 18 years were included. EEG
analysis included background scoring, reactivity and seizure burden.
EEG background scoring classified 0(nomal/organized), 1(slow and dis-
organized), 2(discontinuous or burst suppression), 3(attenuated). Neuro-
logic outcome was evaluated by Pediatric Cerebral Performance
Category(PCPC) at least 6 months after cardiac arrest.
Results: Among 166 patients who had cardiac arrest, 109 death of arrival
patients were excluded. Among resuscitated 57 patients, 26 patients who
had performed EEG were evaluated. The mean age was 5.0  5.5 years.
Nine patients showed good neurologic outcome(PCPC 1,2,3) and 17
patients showed poor neurologic outcome(PCPC 4,5,6). Good neurologic
outcome group patients’ mean arrest duration was 10.4  8.3 minutes,
percent of treated with hypothermia was 44.4. Poor neurologic outcome
group patients’ mean arrest duration was 17.5  11.1 minutes, percent
of treated with hypothermia was 29.4. EEG background scores in good
neurologic outcome group were consist of 1(11.1%) in score 0, 2(22.2%)
in score 1, 1(11.1%) in score 2, 5(55.6%) in score 3. Four patients
(44.4%) of good neurologic outcome group showed reactivity and seizure
burden. EEG background scores in poor neurologic outcome group were
consist of 0(0%) in score 0, 1(5.9%) in score 1, 1(5.9%) in score 2, 15
(78.9%) in score 3. Five patients(29.4%) and 4 patients(23.5%) of good
neurologic outcome group showed reactivity and seizure burden each.
Conclusion: EEG background patterns may be used to support prognos-
tic decision in children resuscitated from cardiac arrest.
p0751
EARLYELECTROCLINICAL FEATURES AND
OUTCOMEAT 6 YEARSOFAGEOF 61 SUBJECTS
WITHDRAVET SYNDROMEBORNBETWEEN 1972
AND 2010
F. Darra*, V. Beozzo*, E. Fontana*, F. Offredi*, R. Opri*,
E. Fiorini*, E. Boni*, B. Dalla Bernardina*, G. Cantalupo*
*University of Verona, Life and Riproduction Sciences, Verona,
Italy
Purpose: The correlations in DS between type of mutation and pheno-
type are unknown and the definition of the early electroclinical features
having a prognostic meaning remains debated. In order to evaluate which
findings can be predicting and/or conditioning the outcome and if it has
modified during the years we analyzed comparatively the electroclinical
features of 61 DS cases (aged 7 to 45 years) born between 1972-1990
(Group 1: 20), 1991-2000 (group 2: 22), 2001-2010 (Group 3: 19).
Method: They have been analyzed demographic and electroclinical
findings at onset and during the evolution, age at diagnosis, kind of
genetic disorder, treatment and the epilepsy, neurological and cognitive
outcome at the age of 6 years. According to the cognitive outcome the
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subjects have been divided un two groups: Normal/Mild ID (18), Moder-
ate/Severe ID (43).
Results: The incidence of cases showing a moderate/severe ID is greater
(80%)in group 3 than in group 1, 2 (53%). The findings statistically
related with a worse neurological and cognitive outcome are: age at onset
< 6 months, significant and persistent myoclonic manifestations (ab-
sences with myoclonias and massive myoclonias), photosensitivity, self-
induction. No correlations have been found according to type of genetic
disorder, first seizure semiology, partial or generalized seizures occur-
rence and frequency. Diagnosis in the first year is more frequent in group
3 and long-lasting treatment with phenobarbital and phenytoin more fre-
quent in groups 1,2 without reaching statistical significance.
Conclusion: The electroclinical features observing during the first years
constitute the only significant prognostic factors, having myoclonic man-
ifestations, photosensitivity and self-induction a poorer significance. The
relatively lower incidence of subjects with a poorer outcome in group 3 is
only related to the expanded phenotypic spectrum of DS. Only future
long-term studies concerning cases born in the last years can evidence if
earlier diagnosis and different treatments can modify the prognosis.
p0754
INTERICTALDYSPHORIC DISORDERANDQUALITY
OFLIFE IN PATIENTSWITHEPILEPSY
G.M. Tedrus*, R. Lima Silva*
*Pontificia Universidade Catolica de Campinas, Faculdade de
Medicina, Campinas, Brazil
Purpose: Interictal dysphoric disorder (IDD) is described in patients
with epilepsy (PWE), but the associated factors remain controversial.
Objective: To analyze the occurrence of IDD in PWE and its relation-
ships with the clinical and cognitive aspects of epilepsy and quality of life
(QoL).
Method: The study included 117 consecutive PWE from the neurology
outpatient clinic of PUC-Campinas. Possible associations of Interic-
talDysphoric Disorder Inventory (IDDI) data with the clinical aspects of
epilepsy and QOLIE-31 were investigated at a significance level of 5%
(p < 0.05).
Results: The patients had a mean age of 42.9 (16.2) years; mean educa-
tion level of 6.4 years; mean age at first seizure (ES) of 19.5 (14.5)
years; 45.7% of the patients were female; and 40.2% of the PWE had psy-
chiatric disorders. Twenty-five (21.4%) patients had idiopathic general-
ized epilepsy, 29 (24.8%) had symptomatic focal epilepsy, and 63
(53.8%) had probably symptomatic focal epilepsy. IDD was found in 25
(21.4%) PWE. IDD was significantly more common in patients with psy-
chiatric disorders (a2; p = 0.021) and those with Neurological Disorders
Depression Inventory forEpilepsy (NDDI-E) scores >15 (a2; p = 0.039).
The presence of IDD did not vary significantly by epileptic syndrome,
hemispheric lateralization, seizure frequency, and type of seizure. PWE
with IDD had significantly lower QOLIE-31 scores (dimensions and total
score). The total QOLIE-31 score was negatively correlated (Spearman’s
correlation; p < 0.05) with total symptomatology, labile depressive
symptoms, labile affective symptoms, and specific IDDI symptoms.
Conclusion: IDDwas found in 21.4% of the cases and occurred in differ-
ent epileptic syndromes. Worse QoL (dimensions and total score) was
associated with the presence of IDD.
p0755
EMOTIONRECOGNITIONOFAUDITORYAND
VISUAL STIMULI IN PATIENTSWITHRESISTANT
TEMPORAL LOBEEPILEPSY
M. Fernandez Lima*,†,‡, S. Oddo*,‡, N. Pereira de Silva*,‡,
B. Giagante*, P. Solis*,‡, J.P. Princich*, B. Gori*, C. Munera*,
S. Kochen*,†,‡, L. D’Alessio*,†,‡, N. Campora*
*Studies of Neurosciences and Complex Systems ENyS, National
Scientific and Technical Research Council CONICET,
Neurosciences, Florencio Varela, Argentina, †Buenos Aires
University, Institute of Cellular Biology and Neurosciences E de
Robertis IBCN-CONICET, Buenos Aires, Argentina, ‡Ramos Mejia
Hospital, Epilepsy Center, Buenos Aires, Argentina
Purpose: Temporal lobe epilepsy (TLE) is the most common form of
epilepsy. The hippocampus-amygdala complex, along with others struc-
tures of the limbic system, plays a central role in emotional recognition
(ER) and this function plays an essential role in social cognition and
behavior. The aim of this study was to determine the performance in ER
in patients with drug-resistant TLE (RTLE) using visual and auditory
stimuli.
Methods: Patients with RTLE were diagnosed according to the follow-
ing protocol: neurological, neuropsychological, and psychiatric evalua-
tions; EEG, VEEG and MRI studies. Healthy controls were matched
according to age and gender. The ER was determined using visual stimuli
from the Set “Pictures of facial affect” (POFA) - (Ekman and Friesen,
1976) and auditory stimuli from the Set “Montreal Affective Voices”
(Belin, Fillon-Bilodeau and Gosselin, 2008). In both cases, the emotional
categories of the stimuli sets were seven: Happiness, Anger, Sadness,
Fear, Disgust, Surprise and Neutral. Statistical analysis performed: nor-
mality test, Student´s test and Mann-Whitney test were applied for the
statistical analysis.
Results: We included 53 subjects: 29 patients with RTLE (13 women,
16 men, mean age: 32.09 + /- 13 years) and 24 healthy controls (13
women, 11 men, mean age: 37.21 + /- 13 years). The RTLE patients pre-
sented a lower performance in the ER with both, auditory (a-) and visual
(v-) stimuli in the general performance (p < 0.01) and in the following
stimuli categories: v-Happiness, a & v-Anger, a- Fear, a & v-Surprise, a
& v-Neutral (p < 0.01) and in a-Happiness, v-Fear, a-Asco, a & v-Sad-
ness (p < 0.05).
Conclusion: Patients with RTLE presented a marked alteration in ER for
both visual and auditory stimuli, which may explain at least partially the
behavioral and social cognition alterations observed in these patients.
p0756
DIAGNOSTIC ANDTREATMENT SERVICES FOR
PATIENTSWITHPSYCHOGENIC NONEPILEPTIC
SEIZURES (PNES): A SURVEYOFHEALTH
PROFESSIONALS IN URBANCHINA
X. Tong*, D. An*, M. Reuber†, D. Zhou*
*West China Hospital, Sichuan University, Neurology
Department, Chengdu, China, †University of Sheffield, Royal
Hallamshire Hospital, Academic Neurology Unit, Sheffield,
United Kingdom
Purpose: The Psychogenic Nonepileptic Seizures (PNES) Task Force of
International League Against Epilepsy (ILAE) neuropsychiatric commit-
tee devised a questionnaire for health professionals to investigate how
they diagnose and treat PNES. Using this questionnaire, we conducted a
survey among Chinese health professionals to gain an overview of diag-
nostic and treatment services for PNES.
Method: The survey was conducted at the Sixth Advanced International
Course: Clinical Epileptology. We distributed the questionnaires to the
health professionals attending the course. Descriptive analysis was per-
formed upon the reclaimed questionnaires.
Results: One hundred and two eligible questionnaires were analysed.
Responses were received from urban areas in 20 provinces /
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municipalities all around China. Most respondents were neurologists.
The results showed that hospitals in urban China were mostly well-
equipped to diagnose patients with PNES, and that health professionals’
understanding of PNES mostly reflected current international expert
opinion. However, although more than half of the participants knew how
to diagnose PNES, many of them would not actually make the diagnosis,
and most provided neither follow-up nor treatment (especially psy-
chotherapy) for patients with PNES. Only about one third of the patients
diagnosed with PNES were estimated to have at least one appointment
for psychological treatment. In the opinion of the respondents, tacit
trauma (neglect and stress) play a particularly important role in the devel-
opment of PNES. The main obstacles to patients with PNES accessing
health services for their condition were considered to be lack of knowl-
edge or awareness among health professionals, patients and society at
large.
Conclusion: Despite good access to equipment, diagnostic and treatment
service for patients with PNES in China are currently deficient. Educa-
tion programmes about PNES with different target groups, a more effec-
tive referral and social security system, and more qualified psychological
practitioners emerge from the survey as particular development needs.
p0760
CLINICAL FEATURESOF POST-ICTAL PSYCHOSIS:
ANOBSERVATIONALDESCRIPTIVE STUDY
V. Braatz*, S. Balestrini*, J.W. Sander*, S. Sisodiya*
*University College London, Department of Clinical and
Experimental Epilepsy, London, United Kingdom
Purpose: Post-ictal psychosis (PIP) comprises approximately 25% of
the psychosis of epilepsy. Better understanding clinical features helps
proper recognition, which is imperative for adequate treatment and
understanding causation.
Method: Clinical, electroencephalographic and neuroimaging data of
tertiary referral-centre patients with PIP were retrospectively collected.
Patients with epilepsy-related psychosis other than PIP were excluded.
Results: Of 43 patients, 28 (65%) were men, mean age at epilepsy onset
was 16.5 years (S.D. 12.1), mean age at PIP onset was 36.4 years (S.D.
12.6). The mean duration of epilepsy until the first PIP episode was
20 years (S.D. 12.9). Focal epilepsy predominated (39; 90%) over
generalized epilepsy (4; 10%), particularly those with temporal lobe
involvement (23; 53%). There were no clear lateralization findings (17
were left-sided, 15 right-sided). 40 (93%) had a history of bilateral con-
vulsive seizures, 28 (65%) had two types of seizures, which occured in
clusters in 27 patients (62%). All of them had pharmacoresistant epi-
lepsy. Neuroimaging study was lesional for epilepsy in 29 patients
(67%), with hippocampal sclerosis in 15 patients (34%). Electroen-
cephalographic data showed epileptiform discharges in 27 (62%), with
temporal lobe predominance (15, 34%). Previous personal history of psy-
chiatric disease was found in 24 patients, with a predominance of mood
disorder (n = 15) and five had a family history of psychiatric disease.
Documented clusters in seizure-PIP related occurred in 28 patients
(65%), with predominance of bilateral convulsive seizures (18). Most
episodes (31; 72%) required treatment adjustments. The middle-term
outcome showed a single episode occurred in 12 patients; 28 experienced
recurrent episodes, while three developed chronic interictal psychosis.
Conclusion: Male gender, focal epilepsy, pharmacoresistance, long-
term disease and clusters of seizures were the main clinical features
among patients with PIP. Treatment was usually required and most
patients experienced recurrent episodes. Further studies are required to
better understand this entity.
p0763
ASSOCIATIONOFRELIGIOSITYWITHANXIETY,
DEPRESSIVE SYMPTOMSANDQUALITYOFLIFE IN
PATIENTSWITHEPILEPSY
M.A. Ko*, H.U. Ryu†, G.-H. Lee‡, S.-H. Han§, K.D. Cho¶,
M.K. Lee¶, J.Y. Jeon*, E.-J. Choi*, S.-A. Lee*
*Asan Medical Center, Neurology, Seoul, Korea, †Chonbuk
National University, Neurology, Jeonju, Korea, ‡Pusan National
University, Neurology, Busan, Korea, §Chungang University,
Neurology, Seoul, Korea, ¶GangNeung Asan Hospital,
Neurology, Gangneung, Korea
Purpose: Little is known about the impact of religiosity and spirituality
on quality of life in epilepsy patients. This study was designed to analyze
the association of religiosity and spirituality with anxiety, depression and
quality of life (QoL) in epilepsy patients.
Method: We investigated 227 patients with epilepsy (41.9%male, mean
age 40.9 years, range 19-70). Anxiety and depressive symptoms were
assessed with the Hospital Anxiety and Depression Scale (HADS) and
QoL with the WHO Well-being Index. The Duke University Religion
Index and the Spirituality Self-Rating Scale were administered to assess
religiosity and spirituality of the individuals, respectively. The Duke
University Religion Index is a multidimensional measurement of reli-
giosity assessing organizational religiosity, non-organizational religios-
ity (NOR), and intrinsic religiosity (IR), which were categorized into 2 or
3 subgroups (no-religiosity, low-religiosity, and high-religiosity). The
confounding variables included in the multiple linear regression analyses
were age, sex, and composite seizure severity.
Results: In univariate analyses, the degree of anxiety, depressive symp-
toms, and QoL were significantly different among NOR and IR sub-
groups (p < 0.05). After adjusting confounding variables, yes-religiosity
NOR subgroup and no- and high-religiosity IR subgroups were still sig-
nificantly related to the higher QoL and lower HADS than the other sub-
groups (p < 0.05). After further adjusting HADS for QoL, yes-religiosity
NOR and high-religiosity IR subgroups significantly had the higher QoL
comparing to the other subgroups. There was no significant association
with organizational religiosity and spirituality with anxiety, depressive
symptoms, and QoL in patient with epilepsy.
Conclusion: Our data suggest that there are significant associations
between religiosity and anxiety, depressive symptoms, and QoL in epi-
lepsy patients. Therefore, having religiosity could be a supportive strat-
egy to improve QoL in patients with epilepsy.
p0764
CURATED EPILEPSYCONTENTTO FOSTER SELF-
MANAGEMENT:MYEPILEPSYKEY
L. Todd*, J. Burford†, C. Ireland*
*Epilepsy Action Australia, Sydney, NSW, Australia,
†Epilepsy Action Australia, Adelaide, SA, Australia
Purpose: In a digitally connected world 70% of Australians own either a
smartphone, tablet device or both(1) with approximately 98.5% having
network coverage(2). Pew reports 72% of people sought health informa-
tion online in the previous year(3). A Google search on ´epilepsy´ returns
more than twenty million results. The need for reliable, curated epilepsy
content was identified. The aim was to test the feasibility of an exclusive
service via USB key or QR code accessible micro-site with curated evi-
dence-based epilepsy content to increase client and their family´s under-
standing of the condition through offerings such as self-management
tools, resources and courses to optimise life outcomes.
Methodology: Consumer and stakeholder consultation, analysis of sup-
port service requests and review of QOL and self-management literature
was undertaken. A small reference group was consulted during the devel-
opment phase. Content was gathered, tailored to the needs of three
streams: Adults; Youth; and Parents of children with epilepsy. Content
was divided into four sections ´About Epilepsy´, ´What´s Available´, ´
Get Connected´ and ´Your Say´. A cohort of 62 clients piloted and evalu-
ated the concept.
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Results: Pilot cohort n = 62, 53% adults, 13% youth and 34% parents of
children with epilepsy. 65% reported ´About Epilepsy´ was the most use-
ful with 34% finding ´What´s Available´ most useful. 78% intended to
share the information within the next month while 69% found the site
very easy or easy to navigate. 65% reported they now had a better under-
standing of their or their family member´s epilepsy.
Conclusion: This self-management tool, MyEpilepsyKey, has proven to
meet the intended purpose of curated, reliable, evidence-based informa-
tion for people living with epilepsy. It has emerged through evaluation of
general comments that the greatest benefit is gained by those newly diag-
nosed with epilepsy whilst those with greater life experience of epilepsy
requested the addition of specialised information.
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THE EXPERIENCEOFTRANSITION FORYOUNG
PEOPLEWITHEPILEPSY: DEVELOPINGAN
ANIMATION
J. Winterbottom*, J. Lynch†, J. Vinten‡
*The Walton Centre NHS Foundation Trust, Epilepsy
Department, Liverpool, United Kingdom, †The Walton Centre
NHS Foundation Trust, Neurology Department, Liverpool,
United Kingdom, ‡TheWalton Centre NHS Foundation Trust,
Neuropsychology Department, Liverpool, United Kingdom
Purpose: Epilepsy affects around one in 240 children in the United
Kingdom; the majority will transition to adult care. When approaching
adulthood, young people with epilepsy (YPWE) experience challenges to
successful transition, including knowledge deficits and negative attitudes
towards their condition. Our aim was to explore the experience of transi-
tion for YPWE to produce accessible resources, increase knowledge and
engagement in adult epilepsy services.
Method: A longitudinal mixed-methods study followed 22 YPWE
(16-21 years old) and 18 parents/carers through transition to the Walton
Centre, Liverpool UK. Each participant attended up to four focus groups;
with semi-structured interviews gathering longitudinal data. Quantitative
self-reported questionnaires were completed at recruitment and at study
completion to assess knowledge, mood, seizure impact, and quality of
life. Descriptive statistics and thematic analysis generated key themes to
explore the contextual data from interviews and focus groups.
Results: Young people told us they lacked social support during transi-
tion, and struggled to locate and access appropriate information at the
required times when needed, such as prior to first appointment in adult
services or when they experienced changes in their condition. Of interest,
participants revealed misconceptions about pregnancy and topics includ-
ing inheritance, antiepileptic drug risk, and actions to take if experiencing
accidental pregnancy. They valued meeting other young people, and felt
it should form part of their routine epilepsy care. The opportunity to
develop and improve their social and coping skills was achieved through
development of an animation for future YPWE first attending adult epi-
lepsy services.
Conclusion: This project builds on previous studies identifying barriers
to transition.Working with YPWEwe identified key themes about transi-
tional worries, utilized to develop accessible resources: leaflets, anima-
tion and group interventions. These resources focus on psycho-social
education and coping strategies in order to increase knowledge and resili-
ence and facilitate engagement with adult epilepsy services.
p0766
DRIVING INNEWLYDIAGNOSED EPILEPSY
PATIENTS: RESULTS FROMTHE SEISMIC STUDY
Y. Xu*, M. Hackett*, J. Muhunthan*, N. Glozier†, A. Nikpour‡,
E. Somerville§, A. Bleasel¶, C. Ireland**, C. Anderson††
*The George Institute for Global Health, The University of
Sydney, Sydney, NSW, Australia, †Brain and Mind Centre, The
University of Sydney, Sydney, NSW, Australia, ‡Central Clinical
School, The University of Sydney, Sydney, NSW, Australia,
§Prince of Wales Clinical School, University of New South
Wales, Sydney, NSW, Australia, ¶Westmead Hospital, Sydney,
NSW, Australia, **Epilepsy Action Australia, Sydney, NSW,
Australia, ††The George Institute for Global Health at Peking
University Health Science Centre, Beijing, China
Purpose: To determine the frequency and factors associated with driving
before and within 1 year after a diagnosis of epilepsy in adults.
Method: The Sydney Epilepsy Incidence Study to Measure Illness Con-
sequences (SEISMIC) was a prospective, multicenter, community-wide
study of people of all ages with newly diagnosed epilepsy in Sydney,
Australia. Socioeconomic, clinical, epilepsy-related and demographic
characteristics including driving status were obtained. Multivariate logis-
tic regression was used to determine variables associated with driving
before the diagnosis of epilepsy and at 12-months assessments.
Results: Before the diagnosis of epilepsy, 181 (76%) adult participants
(≥ 18 years) drove. Being in a relationship, in paid employment, owning
accommodation, having better family function and no family history of
epilepsy were associated with driving before the diagnosis of epilepsy (C
statistics 0.81). Driving status at 12 months was available for 152 partici-
pants who drove before the diagnosis of epilepsy, of whom 34 (22%)
stopped driving. Driving for reasons other than getting to work or place
of education (odds ratio [OR] 4.70, 95% confidence intervals [CI] 1.87 to
11.86), seizure recurrence since diagnosis (OR 5.15, 95% CI 2.07 to
12.82) and being on antiepileptic drug polytherapy (OR 4.54, 95% CI
1.45 to 14.22) were associated with stopping driving (C statistics 0.79).
Over half of the participants with recurrent seizures did drive in the same
time frame.
Conclusion: SEISMIC project identified variables associated with driv-
ing before and after the diagnosis of epilepsy. Accessible public trans-
portation or home-based employment opportunities should be available
for people with epilepsy who have been told they are unwell to drive.
Individuals with newly diagnosed epilepsy, especially those being sei-
zure free or on fewer AEDs, should be advised about when they are eligi-
ble for returning to driving.
p0768
ANEWWIRELESS ACCELEROMETRYDEVICE FOR
MOTOREPILEPSYDETECTION: AWAYTO
DECREASE ECONOMIC BURDENOFEPILEPTIC
POPULATION
L. Chen*, X. Qiu*, X. Zhu*, A. Peng*, S. He*, D. Zhou*
*West China Hospital of Sichuan University, Neurology,
Chengdu, China
Purpose: Epilepsy is a serious neurological condition with different
types of manifestations which sometimes are difficult to diagnose accu-
rately. Epileptic status is the failure of seizure termination, which seri-
ously threaten the patients´ life, especially for those suffer generalized
tonic clonic seizure when they are alone. Difficulties in diagnosis, espe-
cially when no one witnessed the emergence of seizures, and hospitaliza-
tion due to epileptic status increase the economic burden of epileptic
population. In order to monitor the seizures for sake of seeking help from
family members timely and help diagnosis, portable epilepsy monitory
device is necessary to be invented and widely used in areas where medi-
cal resources are limited. The objective of this study was to quantitatively
analyze the movement trajectories of temporal lobe seizure and
psychogenic non-epileptic seizure.
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Method: From movement trajectories obtained from patients, ampli-
tude, frequency, proximal/distal limb amplitude ratios, and shoulder/ab-
dominal amplitude ratios measurements were calculated. One-way
ANOVAwere used to analyze all the data.
Results: The results revealed statistically significant differences in aver-
age amplitude, as well as proximal/distal limb amplitude ratios in supple-
mentary motor area(SMA) seizures when compared with those of
temporal lobe seizures and psychogenic non-epileptic seizures. This
study proved the feasibility of quantitative analysis of SMA seizures and
suggested that it should be further evaluated for its capability to distin-
guish different seizure manifestations for the diagnosis of epilepsy.
Conclusion: The wireless monitory device we developed shows a
promising perspective for timely recognizing seizures and help to pro-
vide information about seizures to the physicians. The use of this device
could decrease the economic burden due to hospitalization and ease the
patients and family members from the fear of seizures when the patients
are alone.
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FROMTHE PATIENTS’ PERSPECTIVE. LIFE IMPACT
OF ILLNESS IN DRUG-RESISTANT EPILEPSY
PATIENTS FROMBUENOSAIRES, ARGENTINA
M. Sarudiansky*, L. Scevola†, S. Oddo‡, S. Kochen‡,
L. D’Alessio‡
*CAEA/CONICET, CABA, Argentina, †Hospital Ramos Mejıa,
CABA, Argentina, ‡ENYS - CONICET, Buenos Aires, Argentina
Purpose: To identify categories concerning the life impact of illness in
patients with drug-resistant epilepsy, taking into account the patient’s
narratives.
Method: A qualitative method using semistructured interviews -McGill
Illness Narrative Interview Schedule- was chosen to gain an in-depth
understanding of the perspectives of epilepsy life impact. 32 patients
were interviewed. All of them were admitted in the VEEG-Units at two
general hospitals in Buenos Aires (Argentina). The interviews were tran-
scribed Verbatim. Analysis involved open coding of the data using a pro-
cess of constant comparison. The data were organized into themes by
sorting codes according to relationships between them.
Results: Several domains emerged from the data: Social commandment,
affective reactions, autonomy, prejudice, limitations, epilepsy meanings,
explanatory models, seizure unpredictability, doctor-patient communica-
tion, among others. These categories were organized into 6 broad themes:
Self-perception; External perception; Performance; Illness attributions;
Illness characteristics; Healh-system features.
Conclusion: Qualitative methods make it possible to identify idiosyn-
cratic meanings about the disease, which are difficult to achieve through
self-administered questionnaires. They give access to gaining knowledge
on how patients understand their illness, and how they feel like living
with epilepsy. The domains presented in this work serve as a basis to
develop conceptual models about the impact of drug-resistant epilepsy in
the patients’ different life areas -social, cognitive, affective, economic,
among others-. They also allow focusing on local features of the disease.
In fact, some of the domains relate specifically to characteristics of the
context of inquiry -i.e., Health system features-, and cultural variables -
i.e., Explanatory models, Social commandments. Taking into account the
patients’ points of view give place to a better understanding of the
patients’ experience and the life impact of the disease. It could also be
useful to generate more comprehensive forms of patient care in chronic
conditions.
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“INVOLVED –ANDYET FEELINGOUTSIDE”:
A NURSING PERSPECTIVE FROMPEDIATRIC
EPILEPSY SURGERY
H. Grønvold*
*The Danish Epilepsy Hospital, Out - Patient Clinic, Pediatric,
Dianalund, Denmark
Purpose: At the Danish Epilepsy Center, we have well documented
patient courses for our brain surgery patients. This also includes a big
awareness of the time-consuming stress and worry it can cause to take
part in the complex process towards epilepsy surgery. However, it
appears that siblings to the children waiting for epilepsy surgery seem to
feel outside when the rest of the family debate all the surgery’s pros and
cons. We therefore wanted to pay more attention towards this part of the
family in order to prevent feelings of loneliness and worries.
Methods: In a professional framework, we offered, as a pilot project, an
individual nurse consultation that was adressed to the individual sister/
brother. The consultation had focus on informing and answering ques-
tions regarding the surgery field, but perhaps the most important thing
was to pay attention to the feelings and worries described from the sib-
ling.
Results: The consultation proved very beneficial for the child as she
could address all her deepest worries and feelings.The consultation high-
lighted particually the siblings feeling of loneliness as the parents were
occupied with their own worries about the coming surgery.
Conclusion: The outcome from the consultation highlighted the impor-
tance of adding more focus and attention to this field. Particularly the sib-
lings seem to have many considerations for the parents as they can feel
their worries. The nurses could possibly contribute with more focused
psychosocial approaches to these healthy children, as the process is very
vulnerable for the whole family. Hence, healthy siblings are described in
the literature as an important group to have in mind, it should be high-
lighted that siblings within this very stressful period needs extra atten-
tion.
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THERESULTSOFDIFFERENCES BETWEEN
MOTHERS SELFANDRESEARCHERREADING FOR
“IMPACTOF PEDIATRIC EPILEPSY SCALE”
M. Tanrıverdi*, F. Mutluay†
*Bezmialem Vakıf University, Istanbul, Turkey, †Istanbul
Medipol University, Istanbul, Turkey
Purpose: The psychosocial impact of pediatric epilepsy on the family
have that 11-item scale was created for parents’ use to evaluate the influ-
ence of epilepsy on the major aspects of their family and child’s life by
Carol Camfield et all. We investigated interrater reliability (mothers self
and researcher reading) of overall assessment of Impact of Pediatric Epi-
lepsy Scale (IPES) in children with epilepsy in Turkey.
Method: Mothers rated their child’s quality of life on a visual analogue
scale (1-6) and completed the Impact of Pediatric Epilepsy Scale (IPES),
which assesses the impact on academic achievement, participation in
activities, health, relationships with family and with peers and siblings,
social activities, self-esteem, and the caregiver’s hopes for their child’s
future adapted. Simple percentage agreement, the Cohen kappa statistic
representing interrater reliability for each item, and overall kappa
between examiners were evaluated.
Results: Twenty-eight female (35%), 52 male (65%) 80 patients were
included. The mean mothers education level was found 58 (72.5%) pri-
mary school, 5 (6.3%) secondary school, 11 (13.8%) high school, 6
(7.5%) college level. The intraclass correlation coefficient for interrater
reliability of the IPES was (95% ICC= 0.453-0.735). A highly significant
correlation was found between the responses of the mothers self and
physiotherapist reading to the IPES (r = 0.942, p < 0.01).Interrater relia-
bilities were substantial to almost perfect for each. Considering overall
interrater reliability was substantial (Kappa 0.76).
Conclusion: The IPES can be used by the physiotherapists to determine
the functional-social changes in children with epilepsy and can help clini-
cians derive important information from the families about functional of
their children. And we think that education level is important to fill in the
scales in our country.
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EFFICACYOFCONTINUOUSMIDAZOLAM INFUSION
FORHYPERTHERMIA-INDUCED SEIZURES IN
DRAVET SYNDROME
S. Ito*, N. Matsushima*,†, Y. Ohtani*, K. Eto*, H. Oguni*,
S. Nagata*
*Tokyo Women’s Medical University, Department of Pediatrics,
Tokyo, Japan, †Juntendo University School of Medicine,
Department of Pediatrics and Adolescent Medicine, Tokyo,
Japan
Purpose: We investigated the efficacy of continuous intravenous mida-
zolam (cIV-MDL) infusion in patients with Dravet syndrome and hyper-
thermia-induced seizures.
Method: We retrospectively reviewed the medical charts of patients
with Dravet syndrome who were admitted to our hospital and underwent
cIV-MDL due to hyperthermia-induced seizures from 2005-2016.
Results: A total of 11 patients, 24 cIV-MDL administration were
included. The median age was 4 years 10 months (1 year 2 months-
12 years 7 months). Eleven (46%) presented with seizures in clusters
and 3 (13%) with status epilepticus immediately before administration.
The median dose of initial cIV-MDL was 0.2 mg/kg/h (0.05-0.2 mg/kg/
h), and 10/24 (42%) patients had recurring seizures. The median dose of
second (increased) cIV-MDL was 0.3 mg/kg/h (0.1-0.3 mg/kg/h), and 1/
9 (11%) patients had recurring seizures. The median dose of the recur-
rence group was 0.15 mg/kg/h (0.05-0.2 mg/kg/h), and of the control
group was 0.2 mg/kg/h (0.1-0.3 mg/kg/h) (p = 0.003). In the 0.1 mg/kg/
h, 0.2 mg/kg/h, and 0.3 mg/kg/h groups, 2/7 (29%), 15/21 (71%), and 5/
5 (100%) patients had the seizures under control, respectively
(p = 0.004); however, 1/7 (14%), 3/21 (14%), and 2/5 (40%) patients
needed oxygen supplementation.
Conclusion: For hyperthermia-induced seizures, especially in clusters,
in Dravet syndrome, cIV-MDL exhibits a dose-dependent efficacy of sei-
zure control; however, caution is needed for the emergence of respiratory
suppression.
p0782
LACOSAMIDE IN STATUS EPILEPTICUS
TREATMENT: EXPERIENCE INANHOSPITALIZED
ADULT POPULATION
G. Giovannini*, G. Monti*, L. Mirandola*, S. Meletti*
*University of Modena and Reggio Emilia, Department of
Biomedical, Metabolic and Neural Sciences, Modena, Italy
Purpose: To evaluate the efficacy and safety of Lacosamide in Status
Epilepticus (SE) treatment.
Method: Adults patients with SE were prospectively collected (period:
2013 - 2017) at the OCSAE hospital in Modena, Italy. Among them,
patients treated with Lacosamide were extracted and separately ana-
lyzed.
Results: we collected 306 SE patients. Among them, 32 (10.5%) were
treated with Lacosamide either as a first line antiepileptic drug (AED)
after benzodiazepine administration or as an add on treatment after other
AEDs. 20 patients were female (62.5%), the mean age was 63 (ranging
from 18 to 98). The most common etiologies were: cerebrovascular dis-
ease (28%), cerebral tumor (19%) and sepsis (15%); overall 41% pre-
sented an acute symptomatic etiology. Lacosamide was mainly chosen as
a treatment in clearly focal SE manifesting as Non-convulsive SE
(NCSE, 28%), Focal motor SE (FMSE, 28%) or FMSE evolving into
NCSE (25%). Lacosamide was used as a second choice drug for the treat-
ment of Established SE, after benzodiazepines and after another AED
administration in 18 patients (56%); while in 6 patients (19%) was used
as first choice immediately after benzodiazepines and in another 3
patients even before the benzodiazepines administration. Lacosamide
was administered as an iv bolus in 25 patients (78%) and the dose most
frequently used was 200 mg. The SE was interrupted after Lacosamide
administration in 17 patients (53%). Among these lacosamide was effec-
tive in 2 out of 5 cases of refractory/super-refractory SE. None
immediately major complication was seen after Lacosamide infusion,
and the drug was well tolerated even in the chronic phase.
Conclusion: These results, even if derived from a single center and a
small cohort of patients, confirm the effectiveness and safety of Lacosa-
mide and encourage its used in the treatment of established Status Epilep-
ticus or as an adjunctive therapy in the treatment of Refractory SE.
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NOGROWTH-RELATED LONG-TERMEFFECTSOF
PRENATAL EXPOSURETOTOPIRAMATE
J.S. Matzen*, A. Sabers*
*Epilepsy Clinic, University State Hospital, Rigshospitalet-
Blegdamsvej, Dept. Neurology, Copenhagen, Denmark
Purpose: Treatment with topiramate (TPM) during pregnancy has been
associated with foetal growth retardation. We aimed to evaluate the post-
partum growth in TPM exposed infants up to one year of age.
Method: Pregnancies with use of TPM during pregnancy between 2004
and 2014 in Denmark were identified from the International Registry of
Antiepileptic Drug and Pregnancy Registry (EURAP). Data on birth
weight, length, and head circumference at delivery were collected from
EURAP. The weight, length, and head circumference at five weeks, five
months and one year of age were obtained by contacting the children’s
general practitioners. All data were compared with an ideal birth weight
in relation to the gestational age calculated with a fourth-degree polyno-
mial equation based on Scandinavians birth weights. Growth patterns
data were plotted on standardized growth charts based on Danish boys
and girls.
Results: 43 pregnancies with TPM exposure were identified. Data from
GPs were available in 18 women giving birth to 24 infants (13 boys/11
girls). In the majority of pregnancies (66.7% (16/24)) TPM was pre-
scribed as polytherapy. Four infants (16.6%) were found to be small for
gestational age. Two of these showed a spurt in weight gain ending up
following a higher growth curve at one year of age, one showed a spurt in
weight gain too but data were only available until the 5th month, and one
had a spurt in weight gain too but was underneath -2SD at one year. In
total, three of 21 children showed a weight-restricted growth pattern at
one year. The heights and head circumference at one year were within +/-
10% from the mean in all children.
Conclusion: In our small study, infants born to mothers treated with
TPM during pregnancy had normal growth patterns regarding to weight,
height and head circumference during their first year of life.
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ANOBSERVATIONAL STUDYOFCHILDRENOF
MOTHERSWITHGENETICGENERALIZEDEPILEPSY
EXPOSED TOANTIEPILEPTICMEDICATIONS
DURING PREGNANCY
A.C. Zetehaku*, J. Torres Corso*, L. Botelho Gaca*,
L. Rodrigues DeMarchi*, N.S. Visona Figueiredo*,
R.H. Almeida Barbosa†, R. Fock†, E. Perrone†, A.B. Alvarez
Perez†, MS Guaranha*, E.M. Yacubian*
*UNIFESP, Neurology and Neurosurgery, S~ao Paulo, Brazil,
†UNIFESP, Morfology and Genetics Department, S~ao Paulo,
Brazil
Purpose: To analyze pregnancies of mothers with genetic generalized
epilepsy (M-GGE) regarding seizure control, treatment, and outcome;
cognitive impairment, dysmorphic features (DF), and major congenital
malformations (MCMs) in offspring, concerning prenatal exposure to
antiepileptic drugs (AEDs), especially valproate (VPA).
Method: Data of 65 pregnancies of 41 M-GGE from a Brazilian clinic.
Groups:
(1) pregnancies under VPAmonotherapy;
(2) polytherapy including VPA;
(3) mono/polytherapy without VPA; and
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(4) without AED. Fifty-three living births were examined for DF/
MCMs.
Standard photographs from 49 children were analyzed by geneticists
to identify DF according to gestalt, determining the presence of fetal val-
proate syndrome (FVS).Thirty-four children were evaluated with neu-
rodevelopmental tests, 37 with behavioral tests, and 36 using autistic
traits screening (AST) tests; 38 M-GGEwere submitted toWAIS-R.
Results: Group (1) had 19 pregnancies; (2), 16; (3), 15; and (4), 3. Dur-
ing pregnancy, more M-GGE were free from tonic-clonic seizures than
previously, especially in the first trimester (p = 0.023). Eleven (22.4%)
children fulfilled the criteria for FVS (9 exposed to VPA). MCMs
occurred in 17.1% of fetuses exposed to VPA (at least 6 DFs each, mini-
mum dose of 750 mg/day, 4 in polytherapy). Children with FVS had
moreMCMs (p = 0.019). Vineland score was normal in no-FVS children
(p = 0.033). Two children (18.2%) with FVS showed AST. Neurodevel-
opmental and behavior tests were not influenced by folic acid supplemen-
tation (IQ/mental maturity: p = 1.000; CARS: p = 0.293; Vineland:
p = 0.631). Higher maternal IQ (p < 0.001) and PHT dose (p = 0.006)
were associated with AST.
Conclusion: FVS prevalence was 11 times that of DF (2%) in Brazilian
general population and MCMs 7 times (2-3%). AST was 30 times more
frequent than WHO (0.6%). FVS, MCMs, and AST may not depend on
VPA dose.
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SPONTANEOUS ABORTIONS AMONGWOMENWITH
EPILEPSY
G. Kiteva-Trenchevska*
*University Clinic of Neurology, Clinical Neurophysiology,
Skopje, the Former Yugoslav Republic of Macedonia
Purpose: There are reports of increased frequency of spontaneous abor-
tions among women with epilepsy (WWE). The aim is to evaluate the
spontaneous abortions, especially repetitive spontaneous abortions
among pregnantWWE.
Method: 114 pregnancies of WWE on AEDs were followed prospec-
tively by obstetricians and neurologists. We analyzed those pregnancies
that were interrupted with spontaneous abortions unexpectedly.
Results: Ten pregnancies out of 114 ended with spontaneous abortions.
Spontaneous abortions happened in WWE taking AED monotherapy
(CBZ) except in two WWE who were on politherapy (VPA + TPM and
CBZ + Pb). Seizure control was not achieved during pregnancy in 3 cases
and folic acid supplementation was not used in one pregnancy during first
trimester. Three out of ten pregnancies were twin pregnancies and two
ended with only one healthy newborn each. Five spontaneous abortions
in two WWE were repetitive. Six spontaneous abortions happened in 3
WWE with GGE. These three WWE were diagnosed before pregnancy
erroneously as having focal epilepsy of unknown etiology. Two of them
with rare GTCS at seizure onset were treated with CBZ. One of them
without seizure control was gradually switched from CBZ and TPM to
VPA monotherapy. In this WWE 2 repetitive spontaneous abortions hap-
pened while she was on polytherapy VPA and TPM, but she had 3 con-
secutive pregnancies with healthy newborns with VPAmonotherapy.
Conclusion: There are reports that spontaneous abortions in WWE are
genetically provoked. There are reports about the greatest teratogenic
potential of VPA. There are reports of best seizure control of GGE in
WWEwith VPA. Proper epilepsy classification, AED selection and man-
agement according the EBM guidelines are essential for WWE to have
healthy pregnancy and healthy newborn. Personalized approach is rec-
ommended to WWE planning pregnancy having in mind not only epige-
netic (AED) but also genetic factors involved in pregnancy outcome.
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PREGNANCYANDFETALOUTCOMES INWOMEN
AFTER SURGERY FORDRUGREFRACTORY
EPILEPSY
S. Satish*, S. Thomas*, J. Samuel*, R. Menon*,
A. Radhakrishnan*, A. Cherian*, M. Abraham†,
G.C. Vilanilam†, M. Jose*
*Sree Chithra Tirunal Institute for Medical Sciences and
Technology, Neurology, Trivandrum, India, †Sree Chithra
Tirunal Institute for Medical Sciences and Technology,
Neurosurgery, Trivandrum, India
Purpose: To determine pregnancy and fetal outcomes in women with
epilepsy, after surgery for drug refractory epilepsy.
Method: Study population was selected from Kerala Registry of Epi-
lepsy in Pregnancy. Women with focal epilepsy who underwent epilepsy
surgery were included in the “Surgical group”, while who didn’t undergo
surgery but managed medically were included in the “Medical group”.
Women who underwent surgery prior to the index pregnancy and later
were included in the “Surgery first group” and “Pregnancy first group”
respectively. Epilepsy course during pregnancy (seizure freedom during
pregnancy, increase in AED dosage or number), Pregnancy and fetal out-
comes [complications during pregnancy, fetal loss (abortions/intrauterine
death/neonatal death), major congenital malformations and development
at 1 year of age) were compared. Sub group analysis of surgical first
group was done comparing women in whom AEDs could be withdrawn
before conceiving (Withdrawal Group) and in whom AEDs had to be
continued (Non-withdrawal group).
Results: Among the epilepsy outcomes, surgery first group (n = 76) had
prolonged seizure freedom prior to pregnancy (31.8 vs 13.6 months <
0.05) and decreased seizure aggravation during pregnancy (13.2 vs 34.8
%, p < 0.05) as compared to medical group (n = 158). There were no
differences in the pregnancy outcomes. Among fetal outcomes, there was
no difference in birth weight, APGAR scores, malformations (8.5% vs
11.1%, p 0.79) and normal development at 1 year of age (59% vs 57.1%,
p 0.07). All women in the withdrawal group remained seizure free
throughout pregnancy without any need for reintroduction of AEDs.
There were no complications during pregnancy, fetal loss or malforma-
tions as compared to non-withdrawal group (0% vs 9.8%, p 0.355).
Conclusion: Epilepsy surgery before pregnancy is associated with less
seizure aggravation during pregnancy. There was trend towards less
AED fetal exposure, Major congenital malformations and better develop-
ment at one year of age.
p0793
PREVALENCEOFCESAREAN SECTION IN
PREGNANTCHINESEWOMENWITHEPILEPSYAND
ITS POTENTIAL CORRELATIONS
N. Hao*, M. Wu*, B. Yan*, Y. Xiao*, J. Li*, D. Zhou*
*Sichuan University, Department of Neurology, Chengdu, China
Purpose: To investigate the prevalence of cesarean section in Chinese
women with epilepsy (WWE) and identify its potential correlations with
selected sociodemographic and clinical factors.
Method: A semi-structured questionnaire was administered to 258
WWE in South-West China from December 2013 to July 2015. Data
about sociodemographic, obstetric, and epileptic variables were col-
lected. Univariate and multivariate logistic regression analyses were uti-
lized to examine associations between selected factors and delivery
mode.
Results: The cesarean section rate in participants was 70.5% (182/258).
Epilepsy was involved as a reason in 77(42.3%) participants who chose
to have cesarean section. Of whom, 20.8% (16/77) were of increased sei-
zure frequency (11/16) or status epilepticus (5/16) during the last trime-
ster. The rest of them (61/77) chose cesarean section because they were
afraid of seizure onset during delivery although some of them (20/61)
had no seizure in their whole pregnant period. About one quarter of the
participants had cesarean section because of perinatal obstetric
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complications. The most common perinatal indications for C-section
were failure to progress and fetal distress in the current study. Enrolled
WWEwho lived in rural areas or had term delivery were more inclined to
have vaginal delivery. Seizure onset during pregnancy and AED poly-
therapy were positively associated with cesarean section.
Conclusion: Chinese WWE in our study have high prevalence of cesar-
ean section. Good seizure control and optimal therapy during gestation
were associated with a higher rate of natural delivery.
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VALPROATEUSAGEAND PREGNANCYRELATED
KNOWLEDGE INWOMENWITHEPILEPSYOF
CHILDBEARINGAGE IN CROATIA
L. Friedrich*, A. Pirsic*, I. Bielen*
*University Hospital ‘Sveti Duh’, University Department of
Neurology, Zagreb, Croatia
Purpose: After the FDA and EMA warnings on valproate in 2013 and
2014, the role of this drug in the population of women with epilepsy is
being redefined. We made a study among women with epilepsy in Croa-
tia about their knowledge and sources of information regarding preg-
nancy related issues in epilepsy (PRIE), with special interest in those
receiving valproate.
Method: An online anonymous questionnaire was offered during August
and September 2016 to women with epilepsy aged 15-45 years.
Results: Respondents were 225 women aged 29  7.9 years, and in
46% they stated that they have previously discussed PRIE with their neu-
rologist. There were 52 women (25% of total) currently taking valproate,
among which 26 (50%) as monotherapy. Valproate therapy was signifi-
cantly related with earlier epilepsy onset. In the group of women taking
valproate, only 41% have previously discussed PRIE with their neurolo-
gist. They were planning to have children in 51% of cases, and further
18% were unsure. Fourty-nine percent thought that the risk for fetal
malformations is similar among all the antiepileptics.
Conclusion: In Croatia a quarter of all women with epilepsy of child-
bearing age are taking valproate, but they have not received proper
counceling in the majority of cases, and are largely unaware of the poten-
tial harmful consequences.
Posters
Tuesday 5th September, 2017
p0797
QUALITATIVEANALYSIS OFDIRECTANDDELAYED
REPRODUCTION INNARRATIVEVERBALMEMORY
IN PATIENTSWITHTEMPORAL LOBE EPILEPSYAND
CONTROLS
D.M. Hartgerink*, J.M. Oosterman†, Z. Bouman†,
M.P.H. Hendriks†,‡
*Radboud University, Behavioural Science Institute, Nijmegen,
Netherlands, †Radboud University, Donders Institute for Brain,
Cognition and Behaviour, Nijmegen, Netherlands, ‡Academic
Centre for Epileptology Kempenhaeghe, Heeze, Netherlands
Purpose: The WMS-IV is capable of detecting memory deficits in
patients with TLE, although it may have limited value in identifying
material-specific memory problems in lateralized epileptic activity.
However, these results are only based on quantitative analysis of test
scores, and not on qualitative scoring indicators. The aim of this study
was to find indicators in the subtests Logical Memory I and II of the
Dutch version of the Wechsler Memory Scale-IV (WMS-IV), for the
immediate and delayed recall of narrative verbal memory.
Method: Patients with TLE (22 left-TLE and 18 right-TLE) and 44 nor-
mal matched controls completed three stories of the subtests Logical
Memory I (LM I) and II (LM II) from the Dutch WMS-IV. Seven
different mistakes were defined: intrusion (semantic and non-semantic),
confabulation, incorrect detail, conceptual mistake, holistic mistake, and
interference.
Results: When comparing quantitative test scores, controls scored sig-
nificantly better than TLE-patients on LM I and LM II (p = 0.012). All
groups reproduced significantly more items in LM I compared to LM II
(p < 0.001). Controls reproduced significantly more non-essential infor-
mation compared to patients with TLE (p < 0.001). However, patients
with right-TLE made significantly more mistakes in order reproduction
than patients with left-TLE. Patients with left-TLE made marginally sig-
nificantly more confabulations (p = 0.056) and marginally significantly
more interferences (p = 0.054) than patients with TLE-right and controls
on LM I.
Conclusion: Qualitative analyses show that reproduction patterns differ
for TLE-patients and controls. TLE-patients reproduce less correct infor-
mation and show a weaker primacy effect than controls. Specifically,
patients with right-TLE have significantly more deficits with the order of
reproduction, while patients with left-TLE make marginally more con-
fabulations. We conclude that besides a quantitative analysis of test
scores, clinicians should also include qualitative indications in the inter-
pretation.
p0798
MEASURINGCOGNITIONANDCOGNITIVE RESERVE
IN PATIENTSWITHFIRST SEIZUREORNEWONSET
EPILEPSY
B.P. Whatley*, A. Omisade†, K. Legg‡, R.M. Sadler*,
B. Pohlmann-Eden*
*Dalhousie University, Division of Neurology, Halifax, NS,
Canada, †Nova Scotia Health Authority, Clinical Psychology,
Halifax, NS, Canada, ‡Nova Scotia Health Authority, Division of
Neurology, Halifax, NS, Canada
Purpose: Up to 80% of people with epilepsy will develop some degree
of cognitive impairment. Subtle cognitive dysfunction may be present
even before a first seizure (FS), suggesting very early, diffuse changes in
brain function. The relationship between cognitive dysfunction and epi-
lepsy progression is poorly understood. Cognitive reserve (CR) is a con-
cept that has been validated as a mediating factor between
neuropathology and cognition in several chronic conditions. The concept
may be helpful in predicting cognitive changes in FS and new onset epi-
lepsy (NOE), as well as risk of disease progression. This study seeks to
elucidate the relationship between early cognitive dysfunction, CR, and
indicators of neuropathology in patients with FS and NOE, in a well-con-
trolled prospective cohort.
Method: 60 patients with unprovoked FS or NOE are being recruited
from the Halifax First Seizure Clinic. We are collecting clinical variables
(demographic details, seizure semiology and frequency, family history,
medications), neurophysiological and neuroimaging data, and a cognitive
screening assessment at the time of initial presentation. We are also
deriving composite scores for CR, based on IQ, occupational attainment,
and engagement in leisure activities. Patients will be followed for one
year, with monitoring for conversion to NOE and for indicators of refrac-
tory epilepsy.
Results: We present two illustrative cases from ongoing data collection,
which demonstrate the interplay between cognitive reserve, cognition,
and indicators of neuropathology at the time of the initial clinic visit.
Conclusion: We describe a comprehensive system for the evaluation of
cognition in FS or NOE. The illustrative cases suggest that CRmaymedi-
ate between markers of brain pathology and cognitive dysfunction in epi-
lepsy. If this hypothesis is confirmed, then CR and early cognitive
dysfunction can be further explored as possible biomarkers for disease
trajectory with respect to cognitive decline or even the development of
medically refractory seizures.
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FALLS ASANEWCLINICALMANIFESTATIONOF
TEMPORAL LOBEEPILEPSY
I. Dolezalova*, J. Chladek†, M. Pail*, M. Brazdil*
*St. Anne´s University Hospital andMedical Faculty of Masaryk
University, Brno, Czech Republic, †Institute of Scientific
Instruments of the CAS, v. v. i., Brno, Czech Republic
Purpose: Sudden falls are not supposed to be the typical sign of temporal
lobe epilepsy (TLE). Despite of this claim, we sometimes meet a patient
who report brief fall as a typical seizure type. The main aim of this study
was to retrospectively evaluate the presence of a sudden fall as a clinical
manifestation of TLE. We suppose that some type of vegetative instabil-
ity must be responsible for this seizure manifestation, that´s why we ana-
lyzed interictal ECG in these patient.
Method: We have retrospectively reviewed the data of all patients inves-
tigated in Brno Epilepsy Center since 2000. We included into our study
only patients (1) who reported sudden unexpected falls as a typical sei-
zure manifestation; (2) who underwent comprehensive evaluation includ-
ing long-term ECG monitoring and tilt-table test; (3) who were operated
and in whom the seizure, including falls, completely disappeared since
surgery. Subsequently the age- and gender-matched control group of
operated patients for TLE without falls was created, these two groups
were compared in term of 20 minutes long interictal ECG.
Results: We identified 13 patients (7 females, 6 males) who reported
sudden falls which completely disappeared after surgery. The median
age of epilepsy onset was 13 (minimum-maximum 1-30 years), the med-
ian duration of epilepsy was 15 (minimum-maximum 3-20 years), the
median age at the surgery was 25 (minimum-maximum 20 - 47 years).
When comparison of interictal ECG between patients with falls and
patients without falls was made, patients with falls tend to have signifi-
cantly higher cardiac frequency (p = 0.006).
Conclusion: It seems that sudden unexpected falls could be associated
with TLE as a new clinical sign of this epilepsy.
p0801
EVALUATIONOFVENTRICULARREPOLARIZATION
PARAMETERS IN EPILEPSY PATIENTS
A. Akyol G€urses*, K.M. G€urses†, B.O. Genc*, E. Genc*
*N.E.U. MeramMedical School, Neurology, Konya, Turkey,
†Health Sciences University of Turkey-Konya Training and
Resarch Hospital, Cardiology Clinic, Konya, Turkey
Purpose: Cardiac rhythm abnormalities and autonomic dysfunction are
generally associated with TLE. The role of amygdala in cardiovascular
autonomic control and insular propagation of the seizure activity are
among the possible pathologic mechanisms. In this study, we aimed to
evaluate whether vulnerability to ventricular arrhythmias differ between
subgroups of epileptic patients and also patients with pure non-epileptic
psychogenic seizures (NEPS).
Method: Records of 74 patients followed in the outpatient clinic of NEU
Meram Faculty of Medicine-Neurology Department between Oct 15th
2015- Sept 16th 2016 were retrospectively reviewed. A 12-lead electro-
cardiogram of each patient was examined by a cardiologist and heart rate
(HR), PR, QRS, QTc intervals, QTdispersion were calculated. The
patients who had a seizure within the last 48 hours were not included so
the evaluation was performed in the interictal state.
Results: Fifty four patients (%73) were diagnosed with epilepsy accord-
ing to ILAE criteria. The remaining twenty patients (%27) had pure
NEPS and were medication free. Twenty seven patients had primary gen-
eralized epilepsy (PGE) and another 27were diagnosed with focal epi-
lepsy (FE). Median age was similar between epileptic and non-epileptic
subjects (p > 0.05). HR, PR-QRS intervals and QTc were also similar
between these groups (p > 0.05); however QTdispersion was signifi-
cantly longer in the epilepsy group [46.5  6.2 vs 36.9  4, p < 0.001].
In a further step, cardiac parameters were compared between PGE and
FE patients. HR, PR-QRS intervals, QTc and QTc dispersion did not dif-
fer between PGE and FE patients (p > 0.05).
Conclusion: Our results suggest that; QTdispersion is longer in epilepsy
patients when compared to patients with pure NEPS. Since there was no
difference among epilepsy subgroups; QTdispersion, as well as vulnera-
bility to ventricular arrhythmias could be a consequence of epilepsy
regardless of origin. Further studies are needed to clarify the underlying
mechanism of increased QTdispersion in the epileptic patients and its
prognostic value.
p0802
QUALITYOFLIFE IN ADULT PATIENTSWITH
EPILEPSYANDTHEIR FAMILYMEMBERS IN
TASHKENT
S. Gazieva*, D. Akramova*, U. Shamsieva*
*Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan
Purpose: Epilepsy is not only a neurological disorder but may also have
negative psychosocial consequences on people with epilepsy (PWE) and
their relatives. Epilepsy has a major impact on quality of life (QoL) in
PWE and family members. Therefore, the study aimed to investigate fac-
tors that influence QoL in hospitalized adult patients with epilepsy and
their relatives.
Method: An explorative cross-sectional study has been conducted in a
clinic in Uzbekistan. Hospitalized adult patients with epilepsy and their
relatives were enrolled in the study. Subjective QoL as well as family
support and family functioning were measured with patients and family
members. Patients and their relatives assessed the patients’ support need
and their satisfaction with the care provided. In addition, patients were
administered a disease-related HRQoL measure . Backward stepwise
multivariate linear regression analysis was used to explain variances in
patients and relatives’ subjective QoL.
Results: One hundred and four dyads of patient and family member par-
ticipated. Subjective QoL in patients and family members differed signif-
icantly, as did satisfaction with care delivery. In both groups family
support contributed significantly to QoL. In the models 38% of the vari-
ance in QoL in patients and relatives could be explained. While the qual-
ity of life of the family members was affected by the patients’ knowledge
about the disease and the reason for their current hospitalization, patient
QoL scores had no influence on the QoL of family members. The
patients’ QoL, however, depended significantly on the QoL of the family
members.
Conclusion: Affected by the patients’ knowledge about the disease and
the reason for their current hospitalization, patient QoL scores had no
influence on the QoL of family members. The patients’ QoL, however,
depended significantly on the QoL of the family members.
p0804
EPILEPTIC SEIZURES ASA PREDICTOROF IN-
HOSPITALMORTALITY IN PATIENTSWITHACUTE
ISCHEMIC STROKE
L. Vojvodic*, M. Vukicevic*, T. Jaramaz-Ducic*,
A. Mihailovic*, M. Savic*
*Special Hospital for Cerebrovascular Diseases St. Sava,
Belgrade, Serbia
Purpose: Aim of this study was to evaluate incidence of epileptic sei-
zures as the first manifestation of acute ischemic stroke (AIS) and in-hos-
pital mortality rate in those patients.
Method: During the six month period we conducted prospectively anal-
ysis of 2198 patients (1132 women and 1066 men, aged 20-102 y,
mean=71.11) with AIS admitted to our hospital. The diagnosis of AIS
was based upon the clinical picture, physical finding and neuroradiologi-
cal brain examination. Epileptic seizure as the first manifestation of
stroke preceding hospital admission were diagnosed according to the
clear heteroanamnestic data obtained by the qualified neurologists from
eye-witnesses or emergency physicians upon arrival. We compared mor-
tality rate of patients who had epileptic seizures as the initial symptom of
AIS with mortality rate of patients without epileptic seizures preceding
hospital admission.
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Results: In total, 22 (1%) patients (11 women, 11 men; aged 34-87 y,
mean=70.27) had epileptic seizures as the first manifestation of AIS.
Among them, 10 (45.5 %) had one isolated generalized tonic-clonic
(GTC) seizure, 8 patients (36.3%) had partial motor seizures, 2 patients
(9.1%) had GTC status and 2 patients (9.1%) had complex partial sei-
zures. Inhospital mortality rate was 9 out of 22 (40.9 %) in the seizure
group and 435 out of 2176 (19.8%) in nonseizure group (p = 0.0277;
OR=2.7708, 95%CI=1.1769-6.5242).
Conclusion: Epileptic seizures are rare initial symptom of AIS. Patients
with epileptic seizures as the first manifestation of AIS compared to those
without, were almost 3 times more likely to have in-hospital mortality
outcome.
p0805
LOWCARDIOVASCULAR FITNESS IN PATIENTS
WITH PHARMACORESISTANT TEMPORAL LOBE
EPILEPSY
G.L. Fialho*, A.G. Pagani*, R. Walz*, P. Wolf*,†, K. Lin*
*Federal University of Santa Catarina, Florianopolis, Brazil,
†Danish Epilepsy Center, Dianalund, Denmark
Purpose: To study autonomic variables and cardiovascular response to
exercise of patients with epilepsy (PWE), with no known cardiovascular
disease, submitted to maximal treadmill test, comparing them with
matched controls.
Method: Thirty consecutive PWE [mean age 37.4  standard deviation
(SD) 11.2, 18 (60%) males] and sex, age and body mass index (BMI)
matched controls were submitted to clinical assessment, 12-lead electro-
cardiogram (ECG) and echocardiogram to exclude cardiovascular dis-
ease. Maximal/exhaustive treadmill test using the Bruce protocol was
then performed.
Results: Clinical-epidemiological features were similar in both groups,
regarding known cardiovascular risk factors, such as diabetes, dyslipi-
demia, hypertension, family history for premature cardiac disease or
sedentary lifestyle. Patients with epilepsy achieved a lower peak heart
rate (163.8  21.28 bpm x 180.9  12.52 bpm; p = 0.002), which was
associated to a lower Bruce protocol stage (4.0  0.91 x 4.7  0.91;
p = 0.004), lower duration of exercise (673.6  148.27 seconds x
784.4  155.72 seconds; p = 0.004), lower Duke Score (11.8  2.48 x
13.4  2.28; p = 0.02) and lower achieved metabolic equivalent of task
(MET) (12.8  2.49 x 14.5  2.46; p = 0.006). Chronotropic incompe-
tence (measured as peak heart rate ≤ 85% of maximal age predicted heart
rate or ≤ 80% of the chronotropic index) was more frequent in PWE.
Female gender, age of epilepsy onset, number of secondarily generalized
seizures and polytherapy were associated to lower cardiovascular fitness
in multiple linear regression.
Conclusion: PWE have a 20 to 40-fold increased risk for sudden unex-
pected death (SUDEP) compared to the general population. Possible
mechanistic explanations include seizure-related autonomic abnormali-
ties associated with respiratory and cardiac dysfunction. This increased
risk for SUDEP in PWE may be associated with autonomic disturbances
of the cardiovascular system secondary to low cardiovascular fitness.
p0806
ROLEOFEMERGENCYDEPARTMENT (ED)
PHYSICIANS IN IDENTIFYINGANDMANAGING
PATIENTSWHOMAYMEET THE “PRACTICAL
CLINICAL”DEFINITIONOFEPILEPSY
B. Smith*,†
*Spectrum Health Medical Group, Clinical Neurosciences,
Grand Rapids, MI, United States, †Michigan State University
College of HumanMedicine, Division, Clinical Neurosciences,
Grand Rapids, MI, United States
Purpose: In 2014, the ILAE re-defined epilepsy as a disease of the brain
causing at least two unprovoked or reflex seizures occurring more than
24 hours apart or after one seizure if risk of recurrence are “high”
(>60%). Although most patients with a single unprovoked seizure have
low to intermediate risks for recurrence (20-50%), some patients such as
those with remote symptomatic etiologies, epileptiform discharges on
EEG, or an epileptogenic lesion identified on neuroimaging may be at
high risk for multiple seizure recurrences. This retrospective study
attempts to determine if current practice in a busy emergency department
properly addresses the diagnosis of epilepsy based on the new “practical
clinical” definition.
Method: All patients seen in a six month period (10/01/2015-03/31/16)
at the Spectrum Health Butterworth Hospital ED with a principle diag-
nostic code of seizure, epilepsy, or status epilepticus were reviewed.
Chart review included ED documentation, completed testing (CT brain,
EEG), patient disposition (admission, Observation Unit, or discharge
home), neurological consultation and evaluation / treatment plan.
Results: 285 patients were identified by primary diagnostic codes (in-
cluding seizure or epilepsy), and subsequent chart review was completed
on 210 patients. Forty-four patients were identified with a clinical presen-
tation consistent with new onset seizure, while 166 patients were
excluded with a history of confirmed epilepsy or psychogenic nonepilep-
tic seizures (PNES). No specific evaluation protocol was identified, and
disposition included direct admissions (n = 20), admission after initial
evaluation in Observation Unit (n = 3), discharge after ED evaluation
(n = 19), and discharge after evaluation in Observation Unit (n = 2).
Diagnostic studies performed included CT brain (n = 42), EEG
(n = 22), and neurology consultation (n = 24).
Conclusion: Current practice in the ED may fall short of identifying
patients with a diagnosis of epilepsy as risk factors for seizure recurrence
are not fully assessed after presentation with a new onset seizure.
p0808
EFFECTSOFCHRONICANTI-EPILEPTIC USEON
SERUM 25OH-VITAMIND LEVELS ANDCALCIUM
METABOLISM
A. Akyol G€urses*, B. Genc*, A. Akyol†, E. Genc*
*N.E.U. MeramMedical Faculty, Neurology, Konya, Turkey,
†AdnanMenderes University, Medical Faculty, Neurology,
Aydın, Turkey
Purpose: Chronic antiepileptic use may lead to Ca metabolism derange-
ments and is a well-known cause for secondary osteoporosis. Hepatic
microsomal enzyme inducers such as carbamazepine and phenytoin,
increase vitamin-D metabolism and cause Vitamin-D deficiency. In this
study, we aimed to evaluate Ca metabolism in epilepsy patients and the
effects of enzyme inducers on serum Ca, P and 25OH-Vitamin D levels
in these patients.
Method: Records of 147 epilepsy patients, who were admitted to outpa-
tient clinics of NEU Meram and Adnan Menderes Faculty of Medicine
between December 2015-December 2016 were retrospectively evaluated
and 106 patients were enrolled in the study. Age, disease duration, sei-
zure types/frequency, medication history, serum Ca, P and 25OH-Vita-
min D levels were recorded. Described parameters were compared
between the users and non-users of enzyme inducers with appropriate sta-
tistical methods.
Results: Enzyme inducer users consisted of 29.2% of patients. Polyther-
apy was more common among enzyme inducer users when compared to
non-users (64.5% vs. 25.3%, p < 0.001); however serum 25OH-Vitamin
D levels did not differ between mono and polytherapy groups
(p = 0.365). Likewise, serum 25OH-Vitamin D levels did not differ sig-
nificantly between enzyme inducer users and non-users
(11.27  8.5 ng/mL vs. 11.47  10.5 ng/mL, p: 0.947). Serum Ca and
P levels were also similar between two groups (p = 0.135 and p = 0.824,
respectively).
Conclusion: Our results indicate that there is no difference between
25OH-Vitamin D levels of enzyme inducer users and non-users. These
results may be related to high prevelance of Vitamin-D deficiency in the
Turkish population. On the other, it should be noted that Ca and bone
metabolism derangements related to conventional antiepileptic use is not
always associated with hepatic microsomal enzyme induction and
Vitamin D dependent mechanisms.
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AUTOMATICMEGDATACLASSIFICATION TO
EPILEPTIC ANDHEALTHY SUBJECTUSING
STATISTICAL FEATURES
T.N. Alotaiby*, S. Alrshoud*, S.A. Alshebeili†, M. AlHameed‡
*King Abdulaziz City for Sceience & Technology KACST,
Riyadh, Saudi Arabia, †King Saud University, Collegae of
Enginerring, Riyadh, Saudi Arabia, ‡King FahadMedical City,
Riyadh, Saudi Arabia
Purpose: To have independent predictors of which subject is likely to be
Epileptic or not. The diagnosis of Epilepsy up until present day is a clini-
cal diagnosis with supplementary evidence of Electroencephalogram
(EEG). In this study we use magnatoencephalogram (MEG) data which
is an artifacts free & rich of signals variation to identify a certain features
to easily differentiate epileptic from non-epileptic individuals, a process
which can help as screening tools for hiring/recruitment or in the future
to assert the diagnosis.
Method: These data were collected from real Patients who were seen,
assessed & diagnosed with Epilepsy in multiple visits & investigated
thoroughly. the Control were just normal person matching age without
significant past medical History. signal classification method based on
statistical features for classifying multi-channel MEG signals into epilep-
tic and health subjects is proposed. The method is composed of two
phases: statistical feature extraction and classification. After segmenting
the multi-channel signal into 30-second non-overlapping segments, four
statistical features are extracted from each segment to form the feature
vector. The features are skewness, mean, median, and interquartile range.
The feature vectors are used for training a k-nearest neighbor classifier
which is then employed in the testing phase.
Results: 4-fold cross validation strategy is adopted in the experiment.
The proposed method is evaluated using real MEG data obtained from 32
healthy subjects and 32 epileptic patients and achieved a sensitivity of
96.59%, a specificity of 93.25%, and an accuracy of 94.9%.
Conclusion: These results is largely showing how excellent the test as
positive Predictive test. the high detection rate of epileptic Patients.
p0811
EPILEPSYMIMICKING STROKE: CANWEMANAGE
IT BETTER? A PREVALENCEANDCLINICAL
FEATURES STUDY
J.D. Herrera-Garcıa*, V. Guillen-Martınez*, R. Gutierrez-
Zu~niga*, M.D. Fernandez-Perez†, I. Villegas-Rodrıguez†,
J.A. Ruiz-Gimenez‡, M.T. Escobar-Delgado‡
*Complejo Hospitalario Universitario de Granada, Neurology
Department, Granada, Spain, †Complejo Hospitalario
Universitario de Granada, Stroke Unit, Neurology Department,
Granada, Spain, ‡Complejo Hospitalario Universitario de
Granada, Epilepsy Unit, Neurology Department, Granada,
Spain
Purpose: Patients presenting with transient neurological deficit (TND)
of epileptic etiology are often misdiagnosed with transient ischemic
attack (TIA) even with a normal neurovascular assesment. This fre-
quently implies repeated emergency consultations and tests, as the TND
normally reappears. Our aim is to review the prevalence of “epileptic
stroke mimics” in our stroke unit and try to identify special electroclinical
features that could help prevent misdiagnoses.
Method: We reviewed the clinical records of all patients admitted to our
stroke unit between April 2013 and December 2016 with a TIA diagnosis
(TND, normal or inespecificMRI features) and analyzed those of patients
diagnosed with epilepsy after repeated TND.
Results: We found 301 patients diagnosed with TIA, seven of wich (2´
3%, mean age 73.5 years old) were finally diagnosed with epilepsy.
100% presented language impairment as part of the TND (median
duration of 60 minutes) and suffered 4 episodes on average (range 2-8)
before the diagnosis of epilepsy was established (5.5 months on average
after the first event). Six patients (85,7%) had stereotypical episodes.
Paroxismal auricular fibrilation was found in one patient, being the neu-
rovascular assessment normal in the rest. Interictal EEG showed epileptic
features in 28,57% (n = 2). Six patients (85%) were seizure free after
starting an antiepileptic drug (AED) treatment.
Conclusion: Seizures presenting with TND are frequently misdiagnosed
with TIA, leading to unnecessary repeated neurovascular assessment and
treatment delay which could be prevented with a better characterization
of common clinical features in this group of patients. Our results suggest
that repeated TND involving language impairment could be strongly
related to an epileptic etiology when initial neurovascular assesment is
normal (even without interictal epileptic activity). Further and prospec-
tive studies should be done in order to better identify a clear and reliable
electroclinical constellation with consequent earlier diagnosis and man-
agement improvement.
p0812
USEOFCOMPLEMENTARYANDALTERNATIVE
MEDICINEAMONGADULT PATIENTSWITH
EPILEPSY IN SINGAPORE
P.S. Wong*, Q. Chen†, S.J. See*, J. Ng*, G.E. Sklar†, S. Wang*,
S.-H. Lim*
*Singapore General Hospital, Singapore, Singapore, †National
University of Singapore, Singapore, Singapore
Purpose: Complementary and alternative medicine (CAM) use is preva-
lent in Asian patients with chronic diseases. Previous studies have
reported that healthcare providers were often not informed about CAM
use in patients on chronic medications. This study aims to characterize
CAM usage and identify predictors of CAM usage in adult patients with
epilepsy (PwE) in a multiracial community.
Method: A prospective cross-sectional study was conducted at a tertiary
adult neurology clinic in Singapore from September 2016 to January
2017. Patients with epilepsy were recruited to complete an interviewer-
administered survey. Those who declined participation, unable to provide
informed consent independently or lacked understanding of English or
Chinese were excluded.
Results: Out of the 113 adult PwEs surveyed (mean age: 43.9  12.6),
46.9% were male and almost 80% were Chinese. Overall CAM use was
80.5%, with the most frequently reported being vitamins and supple-
ments (60.4%), traditional herbs (31.9%) and prayers (31.9%). The main
reasons cited for CAM use were for general health (46.4%), seizure con-
trol (14.3%), improve mood and relaxation (12.7%), and management of
side effects of antiepileptic drugs (12.2%). Among those who indicated
CAM use for seizure control, prayers (50%), meditation (18.2%) and tra-
ditional herbs (13.2%) were commonly used. Majority (70%) of the oral
CAM users did not disclose CAM usage to their healthcare providers and
only 16% considered the risk of interactions with antiepileptic drugs.
Multivariate analysis showed that patients with tertiary education
(OR=4.83, 95% CI 1.43-16.33) and non-Chinese (OR=7.32, 95% CI
1.25-43.01) were more likely to use CAM.
Conclusion: CAM use is prevalent among our adult PwE. There is lim-
ited disclosure of CAM usage to healthcare providers and lack of aware-
ness of potential antiepileptic drug interactions risk with oral CAM use.
Active enquiry by healthcare providers on CAM use may provide oppor-
tunities to discuss safe modalities for unmet needs.
p0814
TREATMENTOF STATUS EPILEPTICUS/SEIZURE
CLUSTERS IN TWOPATIENTSWITHMELAS
SYNDROME
M.J. Kjeldsen*, C.P. Beier*
*Odense University Hospital, Department of Neurology, Odense
C, Denmark
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Purpose: MELAS syndrome is a hereditary mitochondrial disorder char-
acterized by myopathy, encephalopathy, lactic acidosis and stroke-like
episodes. Stroke-like episodes are often triggered by epileptic seizures.
Treatment of epileptic seizures may be complicating because anti-epilep-
tic drugs (AED) may interfere with mitochondrial function and thereby
provoke life-threatening lactic acidosis. Our knowledge about the feasi-
bility of the modern third and fourth generation AED in these cases is
very sparse.
Method: We report two adult patients with genetically confirmed
MELAS and refractory seizures, treated for acute seizure clusters with
various newer anti-epileptic drugs under monitoring of serum lactate
levels, EEG and clinical response.
Results: After the first stroke-like episode, the first patient was treated
with levetiracetam and L-argenin with good response. After a severe gen-
eralised tonic-clonic seizure, lacosamide was added. No signs of lactic
acidosis but she developed a psychosis. Swithing from levetiracetam/la-
cosamide to perampanel/brivaracetam only slightly improved the psy-
chosis. The other patient suffered from status epilepsy (SE) due to a
stroke-like episode. EEG confirmed SE and treatment with levetirac-
etam, lacosamide and phenytoin was without clinical or EEG improve-
ment. Diazepam improved the EEG but not the clinical symptoms.
Lactate levels remained stable. L-argenin was started with rapid improve-
ment of the EEG and almost completely recovered. A new SE due to
stroke-like episode despite treatment with levetiracetam and L-argenin
was treated with phenytoin with improvement in the EEG but not clini-
cally.
Conclusion: These two patients with MELAS and seizures been treated
with a large panel of newer and older anti-epileptic drugs. None of the
drugs used induced lactic acidosis or caused other MELAS-related com-
plications. If required, newer and older AEDmay be used with caution in
patients with MELAS and clinical need for rapid AED treatment.
p0815
THEMODIFIEDATKINS DIET IN PATIENTSWITH
REFRACTORYEPILEPSYAND INTELLECTUAL
DISABILITY: A RANDOMIZEDCONTROLLED TRIAL
H. Hulshof*, F. Jansen*, K.P.J. Braun*, H. Carpay†
*University Medical Center Utrecht, Pediatric Neurology,
Utrecht, Netherlands, †Tergooi Hospital, Neurology, Blaricum,
Netherlands
Purpose: The modified Atkins diet (MAD) is an effective dietary treat-
ment for children with epilepsy, and fewer trials have also shown a posi-
tive effect on seizure control in adults. However, trials including adult
patients with intellectual disability (ID) are lacking. We aimed to estab-
lish efficacy, safety and feasibility of the MAD in adult patients with ID
and pharmacoresistant epilepsy.
Method: We performed a prospective open-label randomized controlled
trial in institutionalized adult epilepsy patients with moderate to severe
ID. Antiepileptic drugs were continued during the trial-period. Patients
were randomized to receive the MAD or no dietary intervention. Primary
outcome was the number of responders (>50% reduction in seizure fre-
quency) at 4 months. Secondary outcome parameters were adverse
events and effect on daily functioning. An intention to treat analysis was
performed. To obtain a difference with a=5% and a power of 80%, an
estimated sample size of 27 per group was computed.
Results: After randomization of 23 patients (11 in the MAD group, 12 in
the control group) an interim safety and feasibility analysis was per-
formed. One of the patients randomized for MAD did not start the diet
because of withdrawal of support from caregivers, and 5 patients on
MAD discontinued before the study end point was reached, because of
inefficacy or side effects. At 4 months, the number of responders in the
MAD group was 0/11 (0%), and in the control group 1/12(8%). One
patient on MAD was reported to recover sooner from seizures and thus
have an increased quality of life. Most common reported side effects
were fatigue and apathy. The results from the interim analysis led to pre-
mature termination of the trial for reasons of non-feasibility.
Conclusion: We could not demonstrate a beneficial effect of the MAD
in adult patients with refractory epilepsy and moderate to severe intellec-
tual disability.
p0817
OLFACTORYANDGUSTATORYDYSFUNCTION IN
EPILEPSY
B.G. Turk*, Z. Ates*, C. Kes*, E.B. Calıskan*, C. Ozkara*
*Istanbul University, Cerrahpasa Medical Faculty, Istanbul,
Turkey
Purpose: Neurosensory dysfunction in temporal lobe epilepsy (TLE)
usually involve either hallucinations prior to seizures or chronic impair-
ments in odor and taste discrimination and identification. We aim to eval-
uate the olfactory and gustatory function in TLE patients, but also in the
generalized epilepsy and extra-temporal epilepsy patients. We compare
the results with age and sex-matched healthy controls.
Method: 165 individuals with epilepsy who had applied to our epilepsy
outpatient clinic for last 6 months and 76 healthy volunteers were stud-
ied. A questionnaire was applied which included 30 questions, question-
ing whether the patients were experiencing problems with smell and
taste. We correlate chemosensory function with the duration of seizure
and the number of drugs used.
Results: Patients showed significantly lower (p < 0,001) olfactory and
gustatory scores than the healthy controls. Chemosensory dysfunction
was detected mostly in TLE patients, generalized epilepsy and extra-tem-
poral epilepsy patients, respectively.
Conclusion: This study shows the presence of the olfactory and gusta-
tory dysfunction not only in TLE patients but also in generalized epilepsy
and extra-temporal epilepsy patients.
p0818
EFFECTIVENESS AND SAFITYOF
ESLICARBAZEPINAACETATEAS ADJUNCTIVE
TREATMENT FORREFRACTORYEPILEPSY: A LONG
TERMRETROSPECTIVE STUDY
E. Osanni*, A. Danieli*, P. Bonanni*
*IRCCS Eugenio Medea, Conegliano, Italy
Purpose: In refractory epilepsy (RE) newer drugs have improved out-
comes mainly due to improved tolerability profile rather than increased
seizure freedom rates. The purpose of this study is to assess the long-term
efficacy and tolerability of eslicarbazepine acetate (ESL) as an adjunctive
treatment in adult patients with refractory epilepsy.
Method: Retrospective, open label, single-center study. Inclusion crite-
ria:
(1) refractory epilepsy with focal seizures
(2) minimum 12 months of clinical follow-up.The percentage of
patients with ≥ 50% seizures reduction (responders) was estimated.
Tolerability was evaluated in relation to incidence and severity of
adverse reactions and drop-out due to ADRs.
Results: 27 patients were included (average age 37.7 years). 6 (22%)
patients had more than 20 seizures/month, 18 (66%) patients had 2-20
seizures/month. At baseline 22 patients (81%) were taking more than 2
AEDs (range 2-6). None of the patients were treated with concomitant
carbamazepine. 8 (30%) patients were on VNS therapy. At 12 months a
percentage of responders of 33% (9/27) was observed. 15% (4/27) of
patients had a reduction of seizures < 50%. None were seizure free (com-
pare with 15% at 6 months follow up). 7/27 (26%) experienced side
effects: 1 irritability, 1 drowsiness, 1 recurrent falls, 1 peptic ulcer, 3
(11%) severe hyponatremia. There was no evidence of a correlation
between the appearance of adverse effects and the number of concomi-
tant AEDs (1 to 5). 8/27 (30%) patients dropped-out between 9 and
12 months: 3 due to inefficacy, 5 because of side effects.
Conclusion: The use of ESL was associated with significant seizure
reduction without ADRs in approximately 1/3 of our RE sample at
12 months. In contrast to open label extension studies, no long-term sei-
zure-free patients were observed. Considering the severity of epilepsy in
our sample,responders rates are still high. Hyponatremia was the most
common side effect.
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CO-OCCURRENCEOFANTI-NMDARANTIBODIES IN
PATIENTSWITHTLEANDHIPPOCAMPAL
SCLEROSIS
N. Watanabe*, A. Lizcano†, R. Barbosa†, M.K.M. Alvim†,
N. Paschoal Divino†, M.E. Morita*, C.L. Yasuda†, F. Cendes†
*University of Campinas - UNICAMP, Neurology, Campinas,
Brazil, †University of Campinas - UNICAMP, Campinas, Brazil
Purpose: Autoantibodies to specific neurologic proteins are associated
with subacute onset encephalopathies, which often present with refrac-
tory seizures. Previous studies have found specific neurologic antibodies
in a small proportion of people with epilepsy. Positive antibody titers
appear to be more frequent in patients with focal epilepsies of unknown
cause. Studies also suggested a potential role of autoimmunity in the pre-
cipitation of adult-onset temporal lobe epilepsy with hippocampal sclero-
sis (TLE-HS). TLE-HS is considered to be the most frequent of all
epileptic syndromes. The prevalence of autoantibodies to neuronal sur-
face proteins in this population is uncertain. We aim to investigate the
frequency of neurological autoantibodies in a group of patients with
TLE-HS.
Method: We screened neuronal autoantibodies in 47 patients with previ-
ous established diagnosis of TLE-HS. Forty-five patients were enrolled
randomly and two were included because the symptomatology suggested
limbic encephalitis.
Results: The two patients with suggestive symptoms of limbic
encephalitis had diagnosis of refractory TLE-HS several years before,
with fluctuating psychiatry symptoms. They had acute and severe exacer-
bation of psychiatric symptoms. No significant change in previous sei-
zure frequency was noted. These two patients tested positive for
antibodies against NMDAR. In the group of 45 patients who were tested
randomly, two were positive for anti-NMDAR Abs. Age at seizure onset
was similar in those with or without positive Abs, initiating in infancy or
early childhood. In the group of patients who randomly tested positive
for anti-NMDAR, one patient had refractory epilepsy with frequent sei-
zures and mild depression, and the other had familial mesial TLE with
infrequent seizures and no psychiatric symptoms.
Conclusion: Among patients with TLE-HS, a significant minority
(4.4%) had detectable serum Abs suggesting an autoimmune etiology.
Certain clinical features, such as striking psychiatry symptoms, could be
used to identify patients with the highest probability of harboring neuro-
logical Abs.
p0820
PERI-ICTAL PRONE POSITION IS ASSOCIATEDWITH
INDEPENDENTRISK FACTORS FOR SUDDEN
UNEXPECTEDDEATH IN EPILEPSY: A CONTROLLED
VIDEO-EEGMONITORINGUNIT STUDY
E. Oguz Akarsu*, E. Sahin*, S. Ozel Yıldız†, N. Bebek*,
C. G€urses*, E. Altindag*, B. Baykan*
*Istanbul University, Istanbul Faculty of Medicine, Departments
of Neurology and Clinical Neurophysiology, Istanbul, Turkey,
†Istanbul University, Istanbul Faculty of Medicine, Department
of Biostatistics, Istanbul, Turkey
Purpose: Sudden unexpected death in epilepsy (SUDEP) is the major
cause of death in patients with chronic drug-resistant epilepsy and peri-
ictal prone position has been proposed as a risk factor for SUDEP. We
aimed to investigate the patients with peri-ictal prone position in our
video epilepsy monitoring (VEM) unit and compare the patients with and
without peri-ictal prone position to emphasize its relationship with other
independent risk factors for SUDEP.
Method: We retrospectively screened all patients with peri-ictal prone
position who underwent VEM in our epilepsy monitoring unit for a 10-
year period and these patients constituted the Prone (+) group. All
patients without peri-ictal prone position who underwent VEM in the last
two years constituted Prone (-) group. Peri-ictal positions were evaluated
in detail in Prone (+) group. Clinical and laboratory features and SUDEP
7 scores were compared between groups.
Results: A total of 21 seizures were identified in peri-ictal prone position
from 16 patients. SUDEP 7 scores were significantly higher in Prone (+)
group. Longer duration of epilepsy, early age at seizure onset, mental
retardation and frequency of seizures of any type (>50 seizures per month
for last year) were found significantly different between Prone (+) and
Prone (-) groups. A binary logistic regression analysis showed that men-
tal retardation was the differentiating variable between groups.
Conclusion: Peri-ictal prone position in VEM unit may relate with other
independent risk factors of SUDEP, especially with mental retardation.
Nocturnal supervision becomes important to reduce SUDEP risk espe-
cially in patients with mental retardation.
p0821
LONG-TERMFOLLOW-UPOF ICTALASYSTOLE IN
TEMPORAL LOBEEPILEPSY: IS PERMANENT
PACEMAKERTHERAPYNEEDED?
N. Akamatsu*,†, S. Tsuji†, R. Kohno‡, H. Abe‡
*International University of Health and Welfare School of
Medicine, Neurology, Narita, Japan, †International University
of Health and Welfare, School of Health Sciences at Fukuoka,
Okawa, Japan, ‡University of Occupational and Environmental
Health School of Medicine, Cardiology, Kitakyushu, Japan
Background: Ictal asystole (IA) is an infrequent complication of tempo-
ral lobe epilepsy (TLE), but one that may cause transient loss of con-
sciousness (T-LOC) similar to reflex syncope (particularly the vasovagal
faint). Although IA-triggered T-LOC is relatively rare, its recognition is
therapeutically important. However, while the need for anti-epileptic
drugs (AEDs) is broadly accepted, cardiac pacing in IA is controversial.
This study aimed to evaluate the need for cardiac pacing in the follow-up
of IA patients being treated with AEDs.
Methods and results: Six patients (2 men, mean age of 66  16 years),
with documented prolonged asystole on electrocardiogram (ECG) in
association with TLE, were followed for an average of 19.7 (range, 2-37)
years; a pacemaker had been implanted in 4 of 6 patients, whereas 2
patients underwent long-term ECG monitoring with an implantable loop
recorder (ILR). The longest documented IA pause lasted 12.6  6.2
(range: 3.5-20) seconds. All patients were treated with AEDs. During fol-
low-up, after optimization of AED dosing, none of the patients had
T-LOC spells or detected epileptic seizure episodes. During regular
device interrogation, there was no evidence of pacing interventions (cu-
mulative ventricular pacing, 0%) in the 4 pacemaker patients, and no
symptomatic bradyarrhythmias in the 2 ILR patients.
Conclusions: AED therapy was effective to prevent IA in this cohort of
TLE patients with prior IA. Consequently, pacemaker implantation is not
immediately indicated for IA prevention, but should be reserved for those
cases in which there is documented failure of AED therapy.
p0824
LEVETIRACETAMMODIFIES QUANTITATIVE EEG
IN THEANTERIORCORTICALREGIONS IN
EPILEPTIC PATIENTS SHOWINGPSYCHIATRIC
MANIFESTATIONS
A. D’Elia*, L. Bianchi†, F. Placidi*, F. Izzi*, N. Manfredi*,
L. Mari*, N.B. Mercuri*, A. Pisani*, C. Liguori*
*University of Rome “Tor Vergata”, Department of Systems
Medicine, Rome, Italy, †University of Rome “Tor Vergata”,
Rome, Italy
Purpose: Levetiracetam (LEV) is a widely used second generation
antiepileptic drug. It was documented that LEV may induce psychotic
disorders, depression, and paroxysmal non-epileptic seizures (PNES).
Forced normalization has been hypothesized at the basis of psychiatric
symptoms occurring after LEV use. Moreover, LEV significantly
reduces epileptiform discharges in epileptic patients and increases the
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frontal theta bands in healthy volunteers. This study aimed at evaluating
the quantitative EEG changes in a group of epileptic patients who discon-
tinued LEV due to the appearance of psychiatric adverse events, although
the significant seizure reduction.
Method: We retrospectively evaluated a group of seven epileptic
patients visited at our centre from October 2015, who started LEV as
monotherapy. We considered for the quantitative analysis the EEG per-
formed before starting treatment in the diagnostic workup and the EEG
performed at the follow-up visit, when psychiatric events were reported.
Results: Seven patients under LEV monotherapy (range 1000-2000 mg/
day) were evaluated (1M6F, aged 18-57). At follow-up, 4 patients
(1M2F) showed depressive symptoms, 2 patients (2F) reported aggres-
siveness, and 1 patient presented PNES (1F). All patients were seizure
free. Comparing the quantitative EEG analysis we observed the reduction
in the beta1 band in the anterior cortical regions in all patients (Fp1, Fp2,
F3, F4, F7, F8, Fz, C3, C4, Cz). No other significant quantitative EEG
changes were observed in the other bands and/or cortical regions.
Conclusions: This report suggested that forced normalization may be
the cause of psychiatric symptoms in epileptic patients treated by LEV.
We documented in all patients the pathological slowing of quantitative
EEG in the anterior cortical regions, which may underlie the dysfunction
of the frontal cortex in patients showing psychiatric adverse events due to
LEV. Hence, we supposed that LEVmay induce psychiatric symptoms in
epileptic patients by altering the frontal networks.
p0825
EVALUATIONOFCOGNITIVE FUNCTIONS AND
DIFFUSION TENSORMRI IN PATIENTSWITH
JUVENILEMYOCLONIC EPILEPSY
N. Kishk*, I. El Banhawya*, A. Nawito†, K. Hammouda*,
R. Edward‡, A. Hassan*, L. Elghonamy*
*Cairo University School of Medicine, Neurology, Cairo, Egypt,
†Cairo University School of Medicine, Clinical
Neurophysiology, Cairo, Egypt, ‡Cairo University School of
Medicine, Radiodiagnosis, Cairo, Egypt
Background: Frontal lobe dysfunction in juvenile myoclonic epilepsy
(JME) patients has been reported with significant impairment on tests of
frontal functioning.
Purpose: To study the cognitive performance and its relation with the
clinical and neuroanatomical/neurophysiological abnormalities in JME
patients.
Methods: Fifty patients with JME and a sample of healthy controls were
assessed using a series of neuropsychological tests as well as diffusion
tensor imaging MRI (DTI), tractography and electroencephalography.
DTI measures assessed fractional anisotropy within the white matter.
Results: Cognitive testing showed subtle dysfunction in verbal learning
and memory, phonemic and semantic fluency, attention, speed and men-
tal flexibility in JME patients as compared to healthy controls. We also
found significant reductions in fractional anisotropy in the left anterior
corpus callosum, right supplementary motor area and left anterior cingu-
late in JME patients.
Conclusion: Patients with JME had poorer cognitive performance in
verbal learning and memory, attention, speed and mental flexibility,
which was associated with white matter cortical/subcortical microstruc-
tural alterations.
p0829
RNA-EDITEDGLYCINERECEPTORS AREA
POTENTIAL TARGET FORANTI-EPILEPTIC DRUGS
IN TEMPORAL LOBEEPILEPSY
L. Kraus*,†, S. Kankowskic‡, F. Hetsch‡, M. Holtkamp*,
J.C. Meier‡, P. Fidzinski*
*Charite Universitaetsmedizin Berlin, Clinical and
Experimental Epileptology, Berlin, Germany, †Berlin Institute of
Health, Berlin, Germany, ‡Technical University Braunschweig,
Zoological Institute, Cell Physiology, Braunschweig, Germany
Purpose: Temporal lobe epilepsy (TLE) is one of the most common
forms of focal epilepsy. Unfortunately, 70% of TLE patients develop
pharmacoresistance and continue to suffer from seizures despite poly-
therapy with antiepileptic drugs. For these cases, resection of the affected
brain region remains the sole therapy option. In resected brain tissue from
pharmacoresistent TLE patients with a severe course of disease, expres-
sion of RNA-edited glycine receptors was shown to be elevated. C-to-U
RNA editing in GlyRmRNA leads to a gain of function due to amino acid
recoding, resulting in an increased affinity for glycine.
Method: In a corresponding knock-in animal model, these RNA-edited
GlyRs facilitate glutamate release of principal neurons, leading to faster
onset of epileptiform activity and possible pro-epileptic effects. In con-
trast, expression of these receptors in parvalbumin-positive interneurons
facilitates persistence of contextual fear memory.
Results: We recently identified two substances that specifically block
the possibly pathogenic RNA-edited GlyRs. We are currently assessing
their potential antiepileptic efficacy on RNA-edited GlyR associated
changes in human TLE specimen.
Conclusion: We propose that our research on TLE-associated modifica-
tion of GlyR-coding gene transcripts can be useful for the identification
of affected neuron types in intractable TLE and possibly provide new
treatment options against maladaptive neuronal plasticity in TLE.
p0830
SPATIAL – TEMPORALCHARACTERISTICSOF
THALAMO-CORTICALOSCILLATIONS AFTER
UNILATERALCORTICAL SPREADINGDEPRESSION
IN THERECOVERY PERIOD INWAG/RIJ RATS
K. Abbasova*, A. Zybina*, G. van Luijtelaar†
*Moscow State University, Human and Animal Physiology,
Moscow, Russian Federation, †Radboud University, Donders
Institute for Brain Cognition and Behaviour, Nijmegen,
Netherlands
Purpose: To investigate cortical pattern and incidence of thalamo-corti-
cal oscillations after transient unilateral physiological cortical inactiva-
tion inWAG/Rij rats.
Method: A single unilateral cortical spreading depression (SD) was used
as a temporal functional inactivation of the cortex by injection of 5%KCl
in the occipital cortex of awake WAG/Rij rats (n = 12), control rats
received sham microinjections. Rats were equipped with six recording
stainless-steel electrodes placed bilaterally over the frontal, somatosen-
sory and parietal cortex. EEG was recorded for one hour before, immedi-
ately after, and 24 hours after SD initiation. The successful induction of
SD in cortex was verified by spectral analysis of EEG based on a brief
slump of gamma-activity.
Results: A significant (p < 0.01) increase in number and mean duration
of sleep spindles (SS), spike-wave spindles (SW spindles) and decrease
in SWDs in both hemispheres was found in the hour after unilateral single
cortical SD. Unilateral SS, SW spindles and SWDs reappeared first in the
contralateral somatosensory cortex. SS and SW spindles were also
quicker to return than SWDs in the contralateral hemisphere. Bilateral
SWDs, SS and SW spindles reappeared later than unilateral SWDs, SS
and SW spindle in the same chronological order as in the contralateral
hemisphere. Next day all oscillations returned to baseline except SW
spindles.
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Conclusion: Transient changes of functional state even in one hemi-
sphere lead to a suppression of non-convulsive epileptic activity in both
hemispheres. This suggests that a ffunctional integrity of interhemi-
spheric cortico-cortical and cortico-thalamo-cortical network for genera-
tion of bilateral occurring SWDs is necessary. The appearance of first
SWDs in the somatosensory cortex confirms the crucial role of the
somatosensory cortex in generation of SWDs. The fast return of sleep
spindles might be due to their thalamic origin and that in contrast to
SWDs, a complete intact cortex is not a requirement for their presence.
p0831
PERIVASCULAR PDGFRCELLS PARTICIPATE TO
INFLAMMATIONDURING IN VIVO
EPILEPTOGENESIS AND IN VITRO ICTOGENESIS
W. Klement*, L. Runtz*, B. Girard*, A. Fayd’herbe*, N. Smith*,
M. Morin-Brureau†, F. Bertaso*, F. De Bock*, N. Marchi*
*INSERM, U 1191, Institut de Genomique Fonctionnelle,
Neuroscience, Montpellier, France, †ICM, Institut du Cerveau et
de la Moelle Epiniere, Plateforme d’Electrophysiologie, Paris,
France
Purpose: Changes in platelet-derived growth factor receptor beta
expression have been associated to pathophysiological cerebrovascular
functions, with a link to pericyte modifications. Perivascular PDGFRb+
pericyte reactivity was observed in human temporal lobe epilepsy. We
asked whether changes in PDGFR+ cells spatially and temporally match
the archetypal parenchymal and perivascular inflammatory response
occurring during seizures.
Method: We used intra-peritoneal (i.p.) or intra-hippocampal (i.h.) kai-
nic acid (KA) injections in mice to induce status epilepticus (SE) and
epileptogenesis, as monitored by video-EEG. Animals were processed at
24 h, 72 h, 1 week after SE (i.p KA) or focal hippocampal seizures (i.h
KA), and during spontaneous EEG activity (i.h. KA; 6-8 weeks).
PDGFRb, PDGFRa, GFAP, isoletinB4, IBA1 and collagen-IV expres-
sion was evaluated. We used organotypic hippocampal slices where
epileptiform activity was elicited using bicuculline or kainic acid, associ-
ated or not to inflammatory changes. The effect of PDGFR activation
(PDGF-BB) and inhibition (Imatinib) on perivascular cell remodeling
was determined.
Results: Perivascular PDGFRb reactivity was increased in the hip-
pocampi 72 hours and 1 week after seizures induction. The latter topo-
graphically coincided with pockets of IsoB4/IBA1/GFAP inflammation.
Z-plane morphological reconstruction indicated PDGFRb vascular reac-
tivity at the pericyte level. PDGFRa+ cells were increased, suggesting an
oligodendrocyte response concerted with PDGFRb+ cells. We identified
perivascular and parenchymal PDGFRb/a double positive cells, paral-
leled by two discrete cell populations in the parenchyma. Accordingly,
in vitro epileptiform activity induced PDGFRb reactivity proximal to
RECA-1 + vessels, with KA exerting greater changes linked to inflam-
mation in this model. PDGF-BB treatment activated PDGFRb cells at the
vasculature while the PDGFRb blocker Imatinib (1 to 10uM) only par-
tially impacted RECA/PDGFRb remodeling consequent to ictal activity
in vitro.
Conclusion: Our results support PDGFRa/b pericytes and oligodendro-
cytes as participants to the inflammatory and vascular remodeling during
seizure progression. The possibility of modulating PDGFR signaling to
modify these changes is offered.
p0832
CEREBELLAR PURKINJECELLCOUNTS IN A
KNOCK-INMOUSEMODELOFALTERNATING
HEMIPLEGIAOFCHILDHOOD
M. Szabo*, E. Abdelnour*, M. Sachdev*, A. Hunanyan*,
M. Mikati*
*Duke University Medical Center, Division of Pediatric
Neurology, Durham, NC, United States
Purpose: Dystonia is closely tied to dysfunction in both the basal ganglia
and cerebellum. Recent work has shown that perfusion of ouabain, a
selective blocker of the alpha-3 isoform of the Na/K-ATPase, into the
cerebellar cortex is sufficient to induce dystonia in mice. Cerebellar
Purkinje cells (PCs) exclusively express the alpha-3 isoform of the Na/K-
ATPase, making them particularly sensitive to mutations in the ATP1A3
gene. While not considered sufficient to be the major cause of dystonia,
cell death in the cerebellar cortex has been found in one alpha-3 knock-
down model of dystonia. This study investigated whether dystonia in a
knock-in (E815K) mouse model of Alternating Hemiplegia of Childhood
(AHC), which manifests prominent dystonia and is associated with
ATP1A3 dysfunction, could result from cerebellar PC loss.
Method: Mouse brains were extracted, sectioned, and immunostained
using GAD67 to identify GABAergic cells. PCs were identified by stain
quality, morphology, and location. Cell numbers were quantified using
stereological analysis in the cerebellar vermis and each of the cerebellar
hemispheres. Mean cell counts were then compared using Student’s t-
test.
Results: Vermis PC counts did not show a significant difference between
heterozygous E815K mice (HET, N = 4) and wild type littermate con-
trols (WT, N = 4), (123797  38553 vs 112119  18722,
p = 0.60543). Similarly, the cerebellar hemispheres, when considered
together, showed no significant difference in PC numbers between HET
and WT (132886  32817 vs 117716  20214, p = 0.46116). Compar-
ing the hemispheres separately as well as total PC number between HET
andWT also yielded no significant results.
Conclusion: These results indicate that the pathophysiology in dystonia
in the model does not involve reduction in cells in the cerebellar cortex.
This is reason to investigate PC physiology as well as other cell types as
explanations for dystonia in the E815Kmodel.
p0835
IMPACTOF EPILEPTOGENESIS ONHEPATIC AND
BRAIN NUCLEARRECEPTORSANDMETABOLIC CYP
ENZYMES EXPRESSION
L. Runtz*, B. Girard*, B. Boussadia*, C. Ghosh†, F. De-Bock*,
F. Bertaso*, J.-M. Pascussi‡, N. Marchi*
*INSERM, U 1191, Institut de Genomique Fonctionnelle,
Neuroscience, Montpellier, France, †Cleveland Clinic,
Biomedical Engineering, Cleveland, OH, United States,
‡INSERM, U 1191, Institut de Genomique Fonctionnelle, Cancer
Biology, Montpellier, France
Purpose: Seizure control remains a clinical issue in 1/3 of the epileptic
patients. Variations between anti-epileptic drug plasma levels and effi-
cacy can be observed. We propose the hypothesis that epileptogenesis is
sufficient to install changes in brain and hepatic metabolic enzymes
(Cyp) expression.We propose the corollary hypothesis that seizure activ-
ity impacts the expression of specific nuclear receptors (NR) known to be
master controllers of Cyp levels.
Method: Cyp and NR expression was determined in two experimental
models of seizures, i.e., intra-peritoneal (i.p.) and intra-hippocampal
(i.h.) kainic acid (KA) injections in mice inducing status epilepticus and
spontaneous chornic seizures monitored using video-EEG. Mice were
obtained at 24 h, 72 h and 1 week after i.p or i.h KA, while chronic
epileptic animals were obtained 6-8 weeks after i.h. KA. Hepatic and
brain areas were snap frozen for qPCR and Western blot analysis, while
additional animals were processed for immunohistochemistry.
Results: We found increased hepatic and brain expression of Cyp3a11,
Cyp3a13 and Cyp2e1 in chronic epileptic animals. These enzymes are
known to metabolize a number of anti-epileptic drugs. Interestingly,
acute SE or partial seizures were associated with a decreased Cyp and
NR1I2 or NR1I3 expression in the liver.
Conclusion: Our results indicate dynamic changes of key metabolic
enzymes during epileptogenesis in the liver and brain. The functional rel-
evance to drug bio-distribution and resistance is under examination.
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CHANGES INMICROSEIZURE PROPERTIES
ANTICIPATE SEIZURECLUSTERS IN TETANUS
TOXINMODELOF TEMPORALLOBE EPILEPSY
J. Kudlacek*,†, P. Vlk*,†, L. Kovacova*, R. Janca†, V. Kumpost*,
A. Posusta*, J. Otahal*, P. Jiruska*
*Institute of Physiology of Czech Academy of Sciences,
Developmental Epileptology, Prague, Czech Republic, †Faculty
of Electrical Engineering, Czech Technical University,
Department of Circuit Theory, Prague, Czech Republic
Purpose: The long-term fluctuations in seizure probability are well doc-
umented in both patients and various models of epilepsy. The most fre-
quently observed type of the fluctuation is a seizure clustering. In this
study, we show that specific changes in parameters of short seizure-like
EEG events (microseizures) anticipate the onset of the clusters.
Method: TLE was induced in six adult rats by injection of 10 ng of teta-
nus toxin into the right dorsal hippocampus. Then, the animals were
implanted with recording electrodes in the hippocampi and motor cor-
tices. The animals were video-EEG monitored for three weeks. Micro-
seizures were detected using custom made detector, and the detections
were visually verified. Inter-cluster periods were equally divided into 5
time segments in which the following parameters of microseizures were
analyzed: rate, duration, signal power and cross-correlation between
channels.
Results: In total 6560 microseizures from 6 inter-cluster periods were
analyzed. Microseizure rate gradually increased from 99  42 events in
the first segment to 305  37 in the fifth segment. Signal power
increased from 5.7  0.6 to 6.9  0.9 mV2/s and mean cross-correla-
tion coefficient between channels increased from 0.48  0.02 to
0.62  0.02. Average duration initially decreased, and from the third to
the fifth segment it increased from 0.53  0.05 to 1.01  0.09 s. Each
parameter in each rat was fitted by a straight line. Slopes of the lines were
significantly positive (Wilcoxon signed rank test, p < 0.05).
Conclusion: This study demonstrates that changes in the brain dynamics
precede seizure clusters. Initiation of the cluster is not a sudden process
but is preceded by an increase in several parameters of microseizures.
These results may have implications for understanding of long-term sei-
zure dynamics and mechanisms responsible for seizure clustering.
Supported by grants from the Ministry of Health of the Czech Repub-
lic (AZV CR 15-29835A) and Czech Science Foundation (GA CR 15-
08565S).
p0837
EFFECTOF SODIUMBROMIDEONGABAERGIC
TRANSMISSION, SYNAPTIC PLASTICITY AND
PILOCARPINE-INDUCED SEIZURES
H. Kolb*, J. Hackert*, J. Freise*, C. Unger*, M. Rohde*,
T. Kirschstein*, R. K€ohling*
*Rostock University Medical Center, Oscar-Langendorff-
Institute of Physiology, Rostock, Germany
Purpose: Bromide, even though it has been supplanted by more recent
drug developments, is an effective drug for the treatment of refractory
epilepsy in pediatric patients, often used as last-line drug. Its mechanism
of action is still under debate and our study aims to clarify this issue.
Method: We tested the effect of sodium bromide in chronically epileptic
rats following a pilocarpine-induced status epilepticus using field and
intracellular recordings in hippocampal slices to gauge synaptic plasticity
(long-term-potentiation; LTP), GABAergic responses and membrane
propertis, as well as behavioural analyses (video monitoring) to quantify
seizures.
Results: Acute application of sodium bromide to hippocampal slices
from control and epileptic animals evoked no effect on long-term potenti-
ation (LTP). Moreover, intracellular recordings with sharp microelec-
trodes from CA1-neurons failed to detect changes in active and passive
membrane properties. Furthermore, GABA-A receptor mediated inhibi-
tory postsynaptic potentials and GABA-A receptor reversal potential
were equally unaffected by acute application of sodium bromide. We
next tested chronic sodium bromide treatment using osmotic pumps
inserted subcutaneously during the late phase of epileptogenesis. In
marked contrast to the acute bromide application, chronic sodium bro-
mide treatment significantly reduced generalised seizures in epileptic
rats. Intriguingly, chronic sodium bromide application was accompanied
by a decreased LTP level in slices from pilocarpine treated rats, while this
therapy had no effect on LTP in saline treated animals.
Conclusion: These results indicate that chronic treatment with bromide
is an effective anticonvulsant therapy in the pilocarpine model of epi-
lepsy. However, the therapeutic effect of sodium bromide cannot be
explained by acute effects on GABAergic transmission or synaptic plas-
ticity. Rather, chronic effects seem to be required for antiseizure efficacy,
but the underlying mechanisms during chronic treatment await further
investigation.
p0838
CX3CR1MODULATIONALTERS SYNAPTIC
INTEGRATIONOFADULTBORNHIPPOCAMPAL
NEURONS FOLLOWINGANEPILEPTOGENIC INSULT
U. Avdic*, I. Ali*, D. Chugh*, T.C. Ekdahl*
*Lund University, Department of Clinical Sciences, Lund,
Sweden
The fractalkine-CX3CR1 pathway has been shown to regulate neurogen-
esis in the dentate gyrus (DG). In temporal lobe epilepsy neuronal prolif-
eration in the hippocampus is frequently described and microglia
activation is associated with a reduced survival of new adult born neu-
rons. If a reduced inflammatory environment, by CX3CR1 modulation,
will alter the synaptic integration of these neurons remains to be studied.
These mechanisms might be important in driving hippocampal hyperex-
citability after epileptogenic injury and may be targeted for therapeutic
intervention. Thus, we investigated the expression of synaptic proteins in
neurons born in an acute epileptic environment with an altered neuroin-
flammatory milieu.
Adult male rats were implanted with electrodes in the right hippocam-
pus and a brain infusion cannula in the lateral ventricles. Following 1w of
recovery temporal status epilepticus (SE) was electrically induced in the
hippocampus. Seven days following SE, rats were injected with retroviral
vector expressing GFP. Immediately after, brain infusion cannulas were
connected with osmotic pumps carrying either anti-CX3CR1 antibody
(ab) or vehicle.
7w following SE, morphological evaluations revealed changes in den-
dritic morphology with reduced medial dendrites in SE-CX3CR1 rats.
Seizure-induced microglia activation was also reduced in the hilus in SE-
CX3CR1 animals. Although no changes in the expression of scaffolding
proteins (gephyrin) and adhesion molecules (NL-2) were detected at inhi-
bitory synapses, there was a strong reduction of scaffolding proteins at
excitatory synapses in treated rats. PSD-95 cluster density was decreased
in the molecular layer of the DG. No changes were observed in the excita-
tory adhesion molecule NL-1.
Here we show a role of fractalkine-CX3CR1 pathway in mediating
neuroinflammation on synaptic integration of neurons born in an epilep-
tic environment, confirmed by altered morphological profiles and altered
expression of synaptic scaffolding proteins. Future studies need to inves-
tigate whether an altered neuroinflammatory environment leads to differ-
ences in chronic seizure burden in these animals.
p0839
SELECTIVE, UNILATERALABLATIONOF
HIPPOCAMPAL INTERNEURONS CAUSES ACUTE
SEIZURES
J. Spampanato*, F.E. Dudek*
*University of Utah, Neurosurgery, Salt Lake City, UT, United
States
Purpose: The death of GABAergic interneurons has long been hypothe-
sized to contribute importantly to acquired epilepsy. Pharmacological
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treatments that block GABA-mediated inhibition produce seizures in
normal brain, and evidence from animal models and humans suggests
interneuron death often occurs in acquired epilepsy. However, relatively
little is known about whether interneuron lesions alone can cause sponta-
neous recurrent seizures (SRSs, i.e., epilepsy). These experiments aimed
to test the hypothesis that focal death of interneurons can cause chronic
epilepsy.
Method: Gad2-ires-Cremice were injected unilaterally in the CA1 area
of the dorsal hippocampus with an adeno-associated virus (AAV) con-
taining the diphtheria toxin receptor (DTR) to selectively ablate interneu-
rons. Simultaneously, an electrode, connected to a miniature telemetry
device, was positioned at the injection site for chronic recordings.
Results: Two weeks after virus transfection, intraperitoneal injection of
diphtheria toxin (DT) caused focal ablation of interneurons (confirmed
with immunohistochemistry). Whole cell recordings from CA1 pyrami-
dal cells in ex vivo slices showed that the frequency of miniature inhibi-
tory post-synaptic currents was reduced. Long-term, continuous
monitoring revealed that all mice with focal, DT-induced interneuron
lesions had SRSs after DT treatment. Sham-control animals had no
detectable seizures. The onset of the SRSs was 3-5 days after DT treat-
ment, and for 5 of 6 mice the seizures stopped within several days (in one
animal the seizures persisted for at least 34 days post-DT).
Conclusion: These data show that selective interneuron ablation can
cause SRSs (and not status epilepticus), which appear to have no latent
period and generally undergo remission.
p0840
KCNQ1GENEEXPRESSION IN EPILEPTIC RATS
A. Gkiaka*, V. Maltabe†, N. Voulgari*, E. Siarava‡,
I. Georgiou*, S. Markoula‡
*University of Ioannina, Laboratory of Human Genetics,
Medical School, Ioannina, Greece, †University of Ioannina,
Laboratory of Biology, Medical School, Ioannina, Greece,
‡University of Ioannina, Department of Neurology, Medical
School, Ioannina, Greece
Purpose: KCNQ1 gene exhibits expression in heart as well as in brain, in
multiple regions including the hippocampus. The aim of our study is to
investigate changes in KCNQ1 gene expression both in brain and heart of
rats, at different stages of epileptogenesis (latent period, early chronic
and late chronic periods), following Status Epilpepticus (SE).
Method:
Lithium-pilocarpine model was used in order to provoke SE in Spra-
gue-Dawley rats. : To determine whether expression of KCNQ1 gene is
modified at critical stages of epileptogenesis, our study was developed as
follows:
(1) five latent period rats (10 days following SE)and 2 controls,
(2) five early chronic epileptogenesis period rats (1 month following
SE)and 2 controls),
(3) five late chronic epileptogenesis period rats (2 months following
SE) and 2 controls. Total RNA was isolated from hippocampus and
heart. Relative changes in gene expression were assessed by quanti-
tative RT-PCR analysis by delta-delta CTmethod.
Results: No differences in the gene expression levels in the heart was
found at the different stages of epileptogenesis. In the hippocampus, our
analysis revealed a significant change in gene expression at the different
stages of epileptogenesis. A significant down-regulation was detected at
10 days following SE. Gene expression was up-regulated at 1 month fol-
lowing SE; the epileptic rats, at that stage, were compared to control
levels and the epileptic animals at the latent period. Gene expression
2 months following SE had a significant difference compared to controls
and compared to the epileptic animals at the latent period and the early
chronic epileptogenesis stage.
Conclusion: Our data indicate that pilocarpine-induced SE provokes an
epileptogenesis-related dysregulation of KCNQ1 gene in the rat hip-
pocampus. These findings suggest that the seizure-related changes in
gene expression exhibit different patterns that may indicate dynamic
reorganization of molecular machinery accompanying structural and
functional modifications in epilepsy.
p0841
DOES EARLY-LIFEKINDLINGAFFECT THE
CHARACTERISTICSOF SWDS INADULTHOOD IN
RATSWITHGENETIC ABSENCE EPILEPSY?
O. Akman*, S. Ince†, N. Carcak‡, T. Karamahmutoglu§,
M. Gulcebi Idrizoglu§, O. Cokar†, F. Onat§
*Istanbul Bilim University Faculty of Medicine, Department of
Physiology, Istanbul, Turkey, †Haseki Research and Training
Hospital, Department of Neurology, Istanbul, Turkey, ‡Istanbul
University Faculty of Pharmacy, Department of Pharmacology,
Istanbul, Turkey, §Marmara University Faculty of Medicine,
Department of Pharmacology and Clinical Pharmacology,
Istanbul, Turkey
Purpose: Genetic Absence Epilepsy Rats from Strasbourg (GAERS)
show a resistance to secondary generalization of focal limbic seizures
evoked by kindling. These findings indicate a mutual interaction between
the limbic seizure circuits and the networks involved in absence epilepsy.
In present study, we investigated whether early-life kindling may alter
the characteristics and occurrence of spike-and-wave discharges (SWDs)
of GAERS in adulthood.
Method: Stimulation electrodes were stereotaxically implanted into
basolateral amygdala and recording electrodes were implanted on the
cortices of male GAERS at PN20. After a short recovery period, rat pups
in kindling-GAERS group were stimulated until they achieved three
stage 5 seizures using fast kindling protocol. Sham-GAERS group did
not receive any stimulation. The rats in both groups were allowed to grow
until PN75 then the EEGwas recorded to analyze SWDs.
Results: The mean duration of the SWDs was calculated as the ratio of
the cumulative total duration to the number of SWDs over 3-hours per-
iod. The cumulative total duration of SWDs decreased in the kindling-
GAERS group compared to sham-GAERS group (p < 0.05). The spec-
tral characteristics of first 2-seconds of SWDs were analyzed by comput-
ing the power spectra using the Fast Fourier Transform. The peak
frequency of SWDs were faster in kindling-GAERS rats than the sham-
GAERS group (7.75  0,25 vs. 7.5  0,158 Hz).
Conclusion: These findings support the evidence that indicate a mutual
interaction between the limbic circuits and the cortico-thalamo-cortical
networks involved in absence epilepsy.
p0843
RESVERATROLATTENUATESOXIDATIVE STRESS
ANDMITOCHONDRIALDYSFUNCTION IN
IMMATURE BRAIN DURINGEPILEPTOGENESIS
J. Folbergrova*, P. Jesina*, H. Kubova*, J. Otahal*
*Institute of Physiology of the Czech Academy of Sciences,
Prague, Czech Republic
Purpose: We have demonstrated recently existence of oxidative stress
and mitochondrial dysfuntion in immature brain during the period of
epileptogenesis. The aim of the present study was to evaluate potential
protective effect of natural polyphenol resveratrol.
Method: Status epilepticus (SE) was induced in immature 12-day-old
rats by Li-pilocarpine and at selected periods of early epileptogenesis (up
to 5 weeks) rat pups were subjected to examinations. Dihydroethidium
(Het) method was used for detection of superoxide anion production in
brain in situ. Mitochondrial function was evaluated by measuring activity
of respiratory chain complex I in isolated mitochondria. Oxidative dam-
age of mitochondrial proteins was assessed by immunoblot analyses of 3-
nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE). Resveratrol was
given i.p. at selected time points both before and after the induction of
SE.
Results: Increased levels of superoxide anion in all the studied structures
(CA1,CA3, dentate gyrus, cerebral cortex and thalamus), a marked
decrease of complex I activity and the increased levels of 3-NT and
4-HNE persisted during the whole period of epileptogenesis studied.
Resveratrol either completely prevented or significantly reduced markers
both of oxidative stress and mitochondrial dysfunction.
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Conclusion: The present findings suggest that compounds with antioxi-
dant properties or ability to promote endogenous antioxidant defence,
combined with conventional therapies, could provide a beneficial effect
in the treatment of epilepsy.
Supported by the Czech Science Foundation (grant No. 15-08565S).
p0846
CHARACTERISING EEGCORTICALDYNAMICS AND
CONNECTIVITYWITHRESPONSES TO SINGLE
PULSE ELECTRICAL STIMULATION (SPES)
G. Alarcon*,†,‡,§, D. Jimenez-Jimenez*,†, A. Valentin*,†,
D. Martın-Lopez*,‡,¶,**
*King’s College London, Institute of Psychiatry, Psychology and
Neuroscience, London, United Kingdom, †King’s College
Hospital, London, United Kingdom, ‡Universidad Complutense,
Madrid, Spain, §HamadMedical Corporation, Doha, Qatar,
¶Kingston Hospital, London, United Kingdom, **St George’s
University Hospitals, London, United Kingdom
Purpose: To model cortical connections as control systems in order to
characterize their oscillatory behavior and role in the generation of spon-
taneous electroencephalogram (EEG).
Method: We studied averaged responses to single pulse electrical stimu-
lation (SPES) from the non-epileptogenic hemisphere of five patients
assessed with intracranial EEG who became seizure free after contralat-
eral temporal lobectomy. Second order control system equations were
modified to characterize the systems generating a given response. SPES
responses were modelled as responses to a unit step input. EEG power
spectrumwas calculated on the 20 seconds preceding SPES.
Results: 121 channels showed responses to thirty-two stimulation sites.
A single control system could model the response in 41.3% and two sys-
tems were required in 58.7%. Peaks in the frequency response of the
models tended to occur within the frequency range of most activity on the
spontaneous EEG. Discrepancies were noted between activity predicted
by models and activity recorded in the spontaneous EEG. These discrep-
ancies could be explained by the existence of alpha rhythm or interictal
epileptiform discharges.
Conclusion: Cortical interactions shown by SPES can be described as
control systems which can predict cortical oscillatory behaviour. The
method is unique as it describes connectivity as well as dynamic interac-
tions.
p0850
ABERRANTCONNECTIVITYOFHIPPOCAMPAL
MOSSY FIBERS IN TEMPORAL LOBEEPILEPSY
T. Freiman*, K. Leicht†, M. Gierthmuehlen†, J. Zentner†,
C. Haas‡
*Goethe-University/University Hospital, Neurosurgery,
Frankfurt amMain, Germany, †Albert-Ludwigs-University/
Medical Center, Neurosurgery, Freiburg im Breisgau, Germany,
‡Albert-Ludwigs-University/Medical Center, Neurosurgery/
Epilepsy Research Group, Freiburg im Breisgau, Germany
Purpose: The pathoanatomical correlate of temporal lobe epilepsy is
hippocampal sclerosis, characterized by a selective neuronal death of
mossy cells in the hilus and of pyramidal cells in CA1. Granule cells sur-
vive, but loose mossy cell as targets and redirect their axons, the mossy
fibers, backwards into the granule cell layer. It has been assumed that this
leads to excitatory circuits. Therefore we examined, whether sprouted
mossy fibers impinge only excitatory granule cells or also inhibitory
interneurons, such as basket cells, which might have survived the neu-
ronal death.
Method: Resected hippocampal specimens of patients with hippocampal
sclerosis were compared with controls of patients with extrahippocampal
lesions with only mild sclerosis. Mossy fibers were traced with neurobi-
otin or labeled against synaptoporin, inhibitory interneurons against
parvalbumin. Synapses were examined with electron microscopy,
labeled in addition with post-embedding GABA-immunogold.
Results: Sprouted mossy fibers of epileptic hippocampi innervate not
only excitatory granule cells but also inhibitory parvalbuminergic
interneurons. The axonal plexus of inhibitory interneurons, which sur-
rounds the granule cells, is still preserved despite neuronal death in hip-
pocampal sclerosis. Connections of sprouted mossy fibers and inhibitory
axon terminals were quantified, showing that the number of inhibitory
axon terminals exceeds significantly the number of sprouted excitatory
mossy fiber terminals.
Conclusion: This aberrant connectivity might lead to an increased inhi-
bition and synchronization of granule cells because the preserved inhibi-
tory interneurons show an additional innervation through sprouted mossy
fibers. This results in instability of a previously balanced network.
p0852
HIGH FREQUENCYOSCILLATIONS DETECTED BY
AUTOMATICKURTOSIS-BASED TIME-FREQUENCY
ANALYSIS INMEGAND INTRACRANIAL EEG IN
PAEDIATRIC EPILEPSY
E. Foley*, L. Quitadamo*, A. Hillebrand†, P. Bill‡, S. Seri*,‡
*Aston Brain Centre, School of Life and Health Sciences, Aston
University, Birmingham, United Kingdom, †VUUniversity
Medical Center, Department of Clinical Neurophysiology and
Magnetoencephalography Center, Amsterdam, Netherlands,
‡Birmingham Children’s Hospital NHS Foundation Trust,
Neurophysiology Department, Birmingham, United Kingdom
Purpose: High frequency oscillations (HFOs) in epilepsy have been pro-
posed as electrophysiological biomarkers for localising the seizure onset
zone (SOZ). We present an automated approach to detecting HFOs non-
invasively in MEG recordings in a group of paediatric patients with
refractory epilepsy. HFO detection was validated against intracranial
EEG recordings in the same group of patients.
Method: MEG and intracranial EEG data were acquired on six paedi-
atric patients (4 male; mean age 16 years) from Birmingham Children’s
Hospital during presurgical evaluation. Atlas-guided beamformer source
reconstruction was performed on the filtered (80-250 Hz) MEG data
using the automatic anatomical labelling atlas (AAL) to produce time
series (virtual electrodes) for 90 regions of interest across the entire brain.
An automatic HFO detection algorithm based on the preliminary selec-
tion of informative channels by means of kurtosis and time-frequency
analysis was applied to the data.
Results: HFOs were detected in the intracranial EEG (iEEG) data of all
6 patients. The source locations of the HFOs identified in iEEG data cor-
responded with the SOZ with 66% sensitivity and 91% specificity across
the 6 patients. HFOs were identified in the MEG virtual electrodes in 5/6
patients, which represents 83% concordance between modalities, and the
sources of HFOs coincided with the SOZ at the sub-lobar level.
Conclusion: These results show good concordance between the source
locations of HFOs detected in non-invasive MEG data and those identi-
fied in intracranial recordings, which were in close proximity to the SOZ.
The non-invasive localisation of HFOs using MEG could prove a useful
addition to surgical planning in paediatric patients with epilepsy.
p0853
EXPLORINGCARDIACAUTONOMIC FUNCTIONS IN
EATINGEPILEPSY
T. Sathyaprabha*, A. Meghana†, S. Jaideep‡, V. Prathyusha§,
S. Sinha¶, P. Satishchandra¶
*National Institute of Mental Health & Neurosciences,
Neurophysiology, Bangalore, India, †NIMHANS,
Neurophysiology, Bangalore, India, ‡MS Ramaiah Center for
Ayurveda and Integrative Medicine, Kayachikitsa, Bangalore,
India, §NIMHANS, Biostatistics, Bangalore, India, ¶NIMHANS,
Neurology, Bangalore, India
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Purpose: Reflex epilepsies are known to be associated with autonomic
dysfunction. While this has been characterized in few reflex epilepsies,
currently there does not seem to be information of cardiac autonomic
function in eating epilepsy. The current study explored possible alteration
in cardiac autonomic function parameters in patients of eating epilepsy.
Methods: The study protocol was approved by the Institute Ethics Com-
mittee and informed consent was obtained from the participants. Drug
na€ıve eating epilepsy patients (n = 10, mean age 24.9  4.51 yrs, male:
female 6:4) were recruited from the Neurology Out-patient Department,
NIMHANS, India. Age and gender matched healthy volunteers are
recruited as controls (n = 20, mean age 20.08  6.04 yrs, male:female
14:6). Resting Heart rate was obtained from continuous Lead II ECG
recording for 15 min using Power Lab (AD Instruments, Australia) and
Blood pressure was recorded using Finometer (Finapres Medical Sys-
tems, The Netherlands). Data was analysed offline to obtain time and fre-
quency domain parameters of Heart Rate variability(HRV) and Blood
Pressure Variabilty (BPV). Baroreflex sensitivity (BRS) was determined
by spectral and sequence methods. Mann Whitney U test was used for
comparing between the groups; significance was set at p < 0.05.
Results: Significant dysfunction was evidenced in most of the auto-
nomic function parameters in the eating epilepsy patients when compared
with controls. In the HRV parameters, parasympathetic activity was sta-
tistically reduced (RMSSDU = 40, NN50 U = 43) and sympathetic over
activity (LFnu U = 49, LF/HF U = 53,) was observed. Significant
impairment of short-term fluctuation of blood pressure was also evident
(SP U = 34, MP U = 34, p < 0.01, DP U = 46, p < 0.05 Alpha LF
U = 27, p < 0.01, Alpha HF U = 41, p < 0.05) and the BRS was statisti-
cally altered (Up BRS U = 35,Total BRSU = 28).
Conclusion: The overt cardiovascular autonomic dysfunction observed
here may be evidence for other pathways for triggering seizures while
eating in these patients in addition to just gastrointestinal activity.
p0857
CONNECTIVITY BETWEENBILATERALTEMPORAL
LOBEBYCORTICO-CORTICAL EVOKED POTENTIAL
IN TEMPORAL LOBEEPILEPSY –BASEDONTWO
CASEWITHTEMPORAL LOBEEPILEPSY
S. Chen*,†
*Capital Institute of Pediatrics Children Hospital, Neurology
Department, Beijing, China, †Capital Medical University SanBo
Brain Hospital, Beijing, China
Purpose: To study the Connectivity between bilateral temporal lobe by
cortico-cortical evoked potential (CCEP) in temporal lobe epilepsy based
on two cases with temporal lobe epilepsy.
Method: Two patients with temporal lobe epilepsy and were performed
by intracranial subdural stripe electrodes in bialteral temporal lobes, then
were examined by CCEP.
Results: Firstly, there was bidirectional connectivity between bilateral
hippocampus in both patients with temporal lobe epilepsy. Secondly,
there were different connectivities between the ipsilateral neocortical and
bilateral lateral and basal temporal regions in the two patients. Thirdly,
both hippocampus connected with its contralateral neocortical temporal
region.
Conclusion: This study probably can further explain why the mesial
temporal lobe discharges prefer to propagate to contralateral mesial tem-
poral structures and bilateral neocortical temporal regions.
p0858
EEG FINDINGS IN ATTENTIONDEFICIT
HYPERACTIVITYDISORDERDISEASE
G. Akdag*, M. Cetiner†, S. Canbaz Kabay†
*Dumlupinar University Evliya Celebi Research and Training
Hospital, Department of Neurology, K€utahya, Turkey,
†Dumlupinar University Faculty of Medicine, Department of
Neurology, K€utahya, Turkey
Purpose: Attention deficit hyperactivity disorder (ADHD) is one of the
most common psychiatric disorder in childhood and adolescence. The
incidence of epilepsy in ADHD is 5-6% and it is seen more common than
normal populations. Epileptiform abnormalities on electroencephalogra-
phy (EEG) were detected in 5-60% of cases.We aimed to investigate the
EEG findings in patients with ADHD in this study.
Method: We investigated the EEG reports of the patients whom diag-
nosed with ADHD during January-December 2016,retrospectively.
Results: We detected 13 patients with ADHD whom underwent EEG
examination, of them 5 were female and 8 were male. The mean age of
the patients was 11.8 (minimum: 7, maximum: 18). EEG findings; Focal
epileptiform foci were found in 4 (30.7%) patients, focal organisation
disorder in 3 (23.0%) patients, generalized organisational disorder in 2
(15.3%) patients and generalized epileptiform abnormality were in 1
patient (7.6%). Epileptiform disorder was detected in 30.7% of the
patients and 38.4% of the patients had organisation disorder on EEG
without clinical symptom. One (8.3%) patient was diagnosed as absence
epilepsy because of clinical episodes accompanied by EEG findings.
Conclusion: Epileptic disorders may be the underliying cause in atten-
tion disorders. Our findings in ADHDwere similar to the literature. How-
ever, extensive series of studies are needed.
p0859
MULTILOBAR EPILEPTTOGENIC ZONES BUT
MOTORAREA:MOSES´SMOTORAREA SKIPPING
PATHOLOGICALHFO
Y. Iimura*, K. Jones†, H. Otsubo*
*The Hospital for Sick Children, Toronto, ON, Canada,
†McMaster Children’s Hospital, Hamilton, ON, Canada
Purpose: Subtotal hemispherectomy is characterized by resection of
multiple-lobes skipping motor area (MA). We determined the epilepto-
genicity using occurrence rate (OR) of high frequency oscillations (HFO)
and modulation index (MI) demonstrating strength of coupling between
HFO and slow wave. We hypothesized that epileptogenicity increased
over the multiple-lobes but skippingMA.
Method: We analyzed 23 children(subtotal hemispherectomy,14; multi-
lobar resections, 9). Scalp video-EEG and magnetoencephalography
were performed before surgery. We analyzed OR(HFO) and MI(5 phases=0.5-
8 Hz) on electrodes of total, resection areas and MA. We divided good
(ILAE I) vs. poor (II-VI) seizure outcome groups.
Results: ILAE Class Ia outcome was achieved in 18 children. Among
MI(5-phase slow waves) in the resection areas, MI(HFO & 3-4 Hz) was the high-
est. OR(HFO) and MI(HFO & 3-4 Hz) in both total area and resection areas
were significantly higher of good seizure outcome group than those of
poor group. OR(HFO) and MI(HFO & 3-4 Hz) in resection areas were signifi-
cantly higher than those of MA.
Conclusion: Our patient cohort with subtotal hemispherectomy showed
evidence of multifocal epileptogenicity specifically skipping MA, as if
Moses parted the sea of pathological HFO. This is the first study demon-
strating the electrophysiological phenotype of multifocal epilepsy specif-
ically skippingMA, using OR(HFO) andMI(HFO & 3-4 Hz).
p0861
EVENT-RELATED POTENTIALS IN TEMPORAL LOBE
EPILEPSYWITHANDWITHOUTHIPPOCAMPAL
SCLEROSIS
J. Kim*
*Korea University College of Medicine Ansan Hospital,
Department of Neurology, Ansan, Korea
Purpose: To investigate the role of event-related potentials in patients
suffering from temporal lobe epilepsy with and without hippocampal
sclerosis.
Methods: Fourteen patients (6 men and 8 women; mean age: 35.5 years
old) suffering from temporal lobe epilepsy with hippocampal sclerosis
(TLE-HS) and eleven non-lesional temporal lobe epilepsy (TLE-NL)
patients (6 men and 5 women; mean age: 37.1 years old) enrolled in the
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study. P300 was elicited using an auditory two-stimulus oddball para-
digm and MMN was elicited using a passive oddball paradigm. The peak
latency and amplitude of P300 measured at Pz and the latency and ampli-
tude ofMMNmeasured at Fz.
Results: These two groups did not differ significantly in mean age and
sex. TLE-HS had a significantly longer duration of epilepsy
(14.8  11.1 vs 4.5  4.2 years, p < 0.01), and frequent seizure attacks
(29.5/year vs 3.4/year, p < 0.01). The average number of AED was sig-
nificantly larger in TLE-HS (2.6  1.0) than that of TLE-NL
(1.5  0.6, p < 0.01). Among ERP variables, the amplitude of P300
were significantly lower in TLE-HS patients (11.4  5.4 uV) than in
TLE-NL patients (16.1  3.5 uV, p < 0.01). Subsequent ANCOVA
showed significant P300 amplitude differences even after adjusting for
age, duration of epilepsy and seizure frequencies. There was no additive
meaningful difference between two groups in the other variables.
Conclusion: The scalp-recorded auditory ERPs of patients with TLE
varied among studies due to different selective criteria of the methods. A
previous study, using intracranial EEG, demonstrated that limbic P300
potentials were selectively reduced by HS compared to other epilepto-
genic lesions of the temporal lobe. From our results, we might infer that
the presence of HS is a major independent precipitate factor for abnormal
amplitude of P300 in the TLE patients. Future studies should focus on the
association of these P300 with cognition in such patients.
p0862
ALTERNATIVE SEIZURE PROVOKINGTECHNIQUES
AT THEEPILEPSYMONITORINGUNIT
J. Palm Eriksen*, L. Dunkan*, C.M. Olsen†, I.V. Mæhl†,
O. Lundgren Hansen†, S. Beniczky*, E. Gardella*
*Danish Epilepsy Centre, Dept. of Clinical Neurophysiology,
Dianalund, Denmark, †Danish Epilepsy Centre, Dept. of Ergo-
Fysiotherapy, Dianalund, Denmark
Purpose: Provocation may be of particular value in patients who have
infrequent seizures and would otherwise be unsuitable for telemetry.
Routine photic and hyperventilation stimuli are the most common acti-
vating procedures. Stress in general and in some cases simple suggestion
are very important provoking factor for both epileptic seizures (ES) and
psychogenic non epileptic seizures (PNES), as well. In patients with
reflex epilepsies, seizure can be elicited by simple or complex triggers.
Little is known so far about the evaluability of cognitive stimulation tech-
niques as a seizure provoking technique.
Methods: We reviewed the long term video-EEG-recordings at the
EMU of the Danish Epilepsy Centre in 2016, selecting patient who
underwent a tailored protocol of intensive cognitive and motor stimula-
tion (CMs) as a seizure provoking technique. We evaluated whether CMs
(1) was time related with the appearance of a clinical event (ES or PNES)
(2) the time latency between CMs the clinical event.
Results: 235 patients have been monitored and 45 (31 females, 14 males)
of them underwent CMs during the recordings. Patient’s age ranged from
10 - 68 years. Twenty-one patients did not present clinical manifestation
in relation to CMs, whilst 24/45 subjects (53%) had one or more typical
clinical event
(9 had PNES, 15 ES) during or short after stimulation. PNES were typ-
ically recorded during (5/9) or short after CMs. Patients with ES in rela-
tion to CMs had often a focus involving the temporal region
(9/15 patients); the seizure in most cases came (12/15 patients) a few
hours after CMs.
Conclusion: Cognitive and motor stimulation during intensive video-
EEG-monitoring seems to be a valuable non-invasive instrument for the
provocation of both epileptic and non-epileptic seizures. On the base of
our preliminary data, we estimate we were likely able to reduce the need
for prolonged recordings in about one-half of patients.
p0864
INVASIVE AND SCALP EEG IN PRESURGICAL
EVALUATIONOFMRNEGATIVEDRUGRESISTANT
EPILEPSY
I. Trifonov*, M. Sinkin†, I. Kaĭmovskiĭ‡
*Moscow State University of Medicine and Dentistry, Moscow,
Russian Federation, †Sklifosovsky Research Institute of
Emergency Medicine, Neurosurgery Department, Moscow,
Russian Federation, ‡Buyanov City Clinical Hospital, Moscow,
Russian Federation
Purpose: To evaluate seizure outcomes in surgically treated patients
with magnetic resonance (MR) negative drug-resistant epilepsy who
underwent invasive and noninvasive presurgical EEG.
Method: Study includes 47 patients with drug-resistant epilepsy without
any abnormalities on brain MRI. Patient population was divided to 2
groups. In 17 patients (31%) localization of epileptogenic zone was con-
firmed by ictal scalp EEG. Invasive EEG (iEEG) monitoring was per-
formed in 30 patients (69%). Both subdural strips and depth electrodes
was used. In cases of equivocal ictal epileptiform activity and bilateral
electrographic seizure onset iEEG was performed. The patients under-
went resective surgery between 01.01.2014 and 01.02.2017. 32 patients
were followed up at 12 months after surgery: 9 and 23 patients from scalp
and iEEG group respectively. Surgical outcomes, complication rate, MRI
results were analyzed in booth groups.
Results: Temporal lobe epilepsy was diagnosed in 32 (68%) patients,
generalized forms - 2 (6%) patients, temporal plus - 11 (23%) patients,
parietal form - 2 (6%) patient. Average duration of EEG monitoring was
100,42  40,7 hours. In iEEG group 14 patients (61%) became seizure
free: 9 patients (39%) - Engel Ia, 5 (22%) - Engel Ib. 7 patients (30%) had
Engel II. The unsatisfactory results of treatment were noted at 2 patients
(9%) - Engel IVa. Burr hole liquorrhea and hemorrhagic impregnation
after depth electrode implantation was noted in 5 patients (16%).
In scalp EEG group 6 patients (66%) became seizure free (Engel Ia). 2
patients (11%) had Engel IIb. The unsatisfactory results of treatment
were noted at 2 patients (22%) - Engel IIIb and IVa respectively.
Conclusion: Scalp EEG in presurgical evaluation of MR negative drug
resistant epilepsy showed comparative results with invasive EEG in
selected patients with clear clinical and electrographic seizure onset.
Invasive EEGmonitoring showed low complication rate with good surgi-
cal outcome.
p0868
DIFFERENTIAL REACTIVITYOFHFOS TO
COGNITIVE STIMULATIONWITHIN EPILEPTIC AND
NON-EPILEPTICHIPPOCAMPUS
M. Pail*, J. Cimbalnık†, R. Roman‡, J. Chrastina§, P. Daniel*,‡,
M. Brazdil*,‡
*St. Anne’s University Hospital andMedical Faculty of Masaryk
University, Brno Epilepsy Center, Department of Neurology,
Brno, Czech Republic, †International Clinical Research Center,
St. Anne’s University Hospital, Brno, Czech Republic, ‡CEITEC
- Central European Institute of Technology, Masaryk University,
Brno, Czech Republic, §St. Anne’s University Hospital and
Medical Faculty of Masaryk University, Brno Epilepsy Center,
Department of Neurosurgery, Brno, Czech Republic
Purpose: In the present study, we aimed to investigate depth EEG
recordings and to focus on the effect of cognitive stimulation on interictal
high frequency oscillations (HFOs) within epileptic (EH) and non-epilep-
tic (NH) hippocampi. We hypothesized differential reactivity of ripples
and fast ripples (including their characteristics) to cognitive stimulation
within EH and NH.
Method: We analyzed stereo-electroencephalography (SEEG) data from
13 patients with drug resistant focal epilepsy, in whom hippocampal
activity was recorded during quiet wakefulness and subsequently during
a simple cognitive task. Automated detection was used to detect HFOs.
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The characteristics (especially rate, relative amplitude, spectral entropy
and duration) of HFOs were statistically compared separately in ripple
(R; 80-250 Hz) and fast ripple (FR; 250-600 Hz) range.
Results: HFOs were significantly more frequent, shorter with higher rel-
ative amplitude and spectral entropy in EH than in the NH. Compared to
quiet wakefulness we observed a significant reduction of R and FR rate
during cognitive stimulation in EH, moreover, R rate was lower also in
NH. During cognitive stimulation the relative amplitude and entropy of
HFOs were lower and higher respectively in both EH and NH in compar-
ison with wakefulness period.
Conclusion: Various HFO parameters differ in epileptic and non-epilep-
tic hippocampi. Our results thus point to differential reactivity especially
of fast ripples to cognitive stimulation within EH and NH.
p0869
PREDICTINGOUTCOME IN POSTANOXIC
ENCEPHALOPATHY: AQUANTITATIVEMODEL-
BASEDAPPROACH (EEG STATE SPACEANALYSIS)
E. Efthymiou*, R. Renzel*, R. Poryazova*, L. Imbach*
*University Hospital Zurich, Zurich, Switzerland
Purpose: The majority of comatose patients after cardiac arrest do not
regain consciousness due to severe postanoxic encephalopathy. Early
and accurate outcome prediction is therefore essential in determining fur-
ther therapeutic interventions. The electroencephalogram (EEG) pro-
vides a standardized and commonly available tool for measuring brain
activity and has been used to determine prognosis in postanoxic patients.
The identification of pathological EEG patterns with poor prognosis
relies however primarily on visual EEG scoring. We introduced a model
based approach of EEG analysis (state space model), that allows for a
quantitative description of temporal EEG variability.
Method: We retrospectively analyzed standard EEG recordings in 83
comatose patients after cardiac arrest between 2005 and 2013 in the
intensive care unit of the University Hospital Z€urich. Neurological out-
come was assessed one month after cardiac arrest using the Cerebral Per-
formance Category. For a dynamic and quantitative EEG analysis, we
implemented a model-based approach (state space analysis) to quantify
EEG background variability independent from visual scoring of EEG
epochs. We then compared state space velocity (i.e. a measure for spec-
tral variability) between groups and correlated mean velocity with clini-
cal outcome parameters and EEG patterns.
Results: Quantitative assessment of spectral variability (state space
velocity) revealed a significant difference between patients with poor
and good outcome after cardiac arrest: Lower mean velocity of temporal
electrodes (T4 and T5) was significantly associated with poor prognostic
outcome (p < 0.005) and correlated with visual EEG markers such as
generalized periodic discharges (p < 0.02) or burst suppression pattern
(p < 0.03). Receiver operating characteristic (ROC) analysis confirmed
the predictive value of lower state space velocity for poor clinical out-
come after cardiac arrest (AUC 80.8, 70% sensitivity, 15% false positive
rate).
Conclusion: Model-based quantitative EEG analysis (state space analy-
sis) provides a novel, complementary marker for prognosis in postanoxic
encephalopathy.
p0870
DURATIONOFTACHYCARDIA IN THE POST-ICTAL
PERIOD
C. Scott*,†,‡, L. Allen†,‡, I. Valente‡, A. Cuarentas‡, B. Diehl*,†,‡
*National Hospital for Neurology & Neurosurgery, Dept of
Clinical Neurophysiology, London, United Kingdom, †National
Hospital for Neurology & Neurosurgery, Dept of Clinical and
Experimental Epilepsy, London, United Kingdom, ‡National
Hospital for Neurology & Neurosurgery, Sir Jules Thorn
Telemetry Unit, London, United Kingdom
Purpose: Continuous recording of electrocardiogram (ECG) during
EEG Video Telemetry is common practice in epilepsy monitoring units
(EMU). Ictal tachycardia (IT) frequently accompanies and outlasts con-
vulsive seizures which have been identified as a risk factor for sudden
unexpected death in epilepsy (SUDEP) however there is little informa-
tion on the duration of heart rate changes.
The aim of this study was to determine the duration of the heart rate
changes following convulsive seizures.
Method: We reviewed the ECG of patients recruited into a study on
autonomic markers for SUDEP and who had generalised tonic-clonic sei-
zures (GTCS). Recordings were carried out between June 2015 and Jan-
uary 2017 and the majority of these were Phase I or II presurgical
investigations. 27 GTCS recorded in 24 patients (18 males, mean age
30.2 years). GTCS were only included if the heart rate (HR) returned to
baseline before any subsequent seizure. Heart rate was counted over 30 s
epochs. Baseline heart rate was counted 1 minute before the first change
in either EEG or ECG and IT was defined as a HR >100 bpm. Onset of IT
was marked, time when HR< 100 bpm and time taken to return to within
10% of baseline.
Results: HR was >100 bpm (ictal and postictal) for an average of
52.75 minutes (1.5 mins - 4.5 hrs); peak HR was 134 + 15.3 bpm
(mean+SD). Average time to return to baseline was 153 minutes (2mins
- 6 hrs). There was no clear correlation between duration of GTCS (aver-
age 116s), the clonic phase (average 38 s), pre-ictal or peak HR to explain
the variation in heart rate recovery.
Conclusion: This study highlights the prolonged autonomic changes
caused by GTCS evidenced by increased heart rate that outlast the ictal
and immediate postictal period thus emphasising the importance of main-
taining adequate ECG recording at all times in the EMU.
p0871
DYNAMIC PROPAGATIONOF INTERICTAL
EPILEPTIC SPIKEOFMEDIAL TEMPORAL LOBE
EPILEPSY PREDICT SEIZURENETWORK: AMEG
COMBINEDWITH SEEG STUDY
J. Du*, Y. Shan†, L. Li*, X. Fan†, Y. An†, X. Zhang*, J. Xiang‡,
L. Ren*, Y. Wang*
*Xuanwu Hospital of Capital Medical University, Department of
Neurology, Beijing, China, †Xuanwu Hospital of Capital
Medical University, Department of Neurosurgery, Beijing,
China, ‡Cincinnati Children’s Hospital Medical Center, MEG
Center, Division of Neurology, Cincinnati, OH, United States
Background: Medial temporal lobe epilepsy (MTLE) is stereotype of
focal epilepsy, especially in adults. Interictal spikes (IISs) were recog-
nized as the signatures of epileptogencity, reflecting brief pathologically
synchronous discharges of neuronal populations that are large enough to
be manifest as voltage transients. Even IISs occur much more frequently
than seizures, the propagation of IISs in MTLE through neural networks
is not yet defined well.
Purpose: The purpose of current study is to map the epileptic network of
interical status by probing the propagation pattern of IISs in patients with
MTLE using magnetoencephalography (MEG)
, and to investigate the correlation between interical and ictal epileptic
network.
Method: Three patients with refractory MTLE and unilateral hippocam-
pal sclerosis who underwent presurgical evaluation were studied. All the
patients were performedMEGwith a 306-Channel MEG system. Typical
IISs of 15 min continued MEG epoch of each patient were identified by
visual inspection. IISs will be further classified if there is more than one
pattern based on electrographic waveforms. The initiation, propagation
of representative IIS and averaged IISs (the peak of IISs were considered
as zero) were tracked by using
dynamic magnetic source imaging (dMSI). Since all the patients were
implanted SEEG, the magnetoencephalographic pathway of IISs was fur-
ther compared with intracranial recordings.
Results: Significantly, reproduced pathway of MEG IISs along rostral-
dorsal axis of hippocampus were identified among all the patients, which
is parallel with the spread of ictal discharges recorded by SEEG.
S155
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
Conclusion: IISs propagation patterns are indicative of the hierarchical
structure of epileptic network . Our study demonstrated the dynamic
propagation of IISs could predict seizure network.
p0874
SPIKEANDWAVEDYNAMICSOF TYPICAL
ABSENCES INWAKEANDNONREM-REMSLEEP
K. Tsatsou*, A. Bonakis†, A. Dinopoulos‡, M. Tsirouda‡,
S. Sklavos§, P. Polychronopoulos*
*University of Patras Medical School, Department of
Neurology, Rion-Patras, Greece, †National and Kapodistrian
University of Athens, Athens, Greece, ‡National and
Kapodistrian University of Athens, Department of Child
Neurology, 3rd Pediatrics Clinic, Athens, Greece, §University of
Athens, Department of Physiology and Clinical
Neurophysiology, School of Nursing, Athens, Greece
Purpose: Investigate time- frequency dynamics of spike-wave dis-
charges in patients with typical absences (TA) in wake condition and in
sleep stages.
Method: Spatiotemporal and frequency analysis were applied separately
for spikes and waves using a novel algorithm developed in Matlab. 50
TA seizures were analyzed in different vigilance states obtained from
overnight-recordings in 10 treatment naive children (ages 4-10 yrs mean
7.65). Spikes and waves were marked independently as time events in
different electrodes. Range of frequencies was measured for the two com-
ponents of the spike Wave complex, in Wake and Sleep-Non Rem and
Rem.
Results: Spike-event frequency frontally ranged from 2-45 Hz (mean
11.8 Hz wake, 15 Hz N1, 10.9 Hz N2, 10.2 Hz N3 and 11.7 Hz REM).
Wave-event frequency ranged from 1.5-9 Hz (3.5 Hz wake, 2.5 Hz N1,
2.3 Hz N2, 2.3 Hz N3 and 2.5 Hz REM). AtWake spikes and waves tend
to manifest themselves as complex while at Rem Sleep at least one spike
precedes the wave appearance and terminate themselves one second
before the end of the seizure. Time Series of Spike events are different in
Wake and in Rem; their distribution is right and left skewed respectively.
The more prolonged discharges were observed at N1 and wake and had
two phases: during the initial part of the seizure the frequency decreased
quickly from 4 to 3 Hz and slower frequency decrease with periodical
fluctuations, during the second part of the seizure and a final frequency
quick decrease at the end of the discharge.
Conclusion: Studies demonstrated substantially reduced connectivity in
REM sleep when compared to wakefulness and rare TA. This investiga-
tion could elucidate possible parameters involved in the periodical fre-
quency fluctuations of TA in different states of vigilance - and the
cortico-thalamo-cortical oscillatory system involved.
p0875
INTRACRANIAL INFRASLOWACTIVITY IDENTIFIED
WITHDEPTHELECTRODERECORDINGSHELPS TO
DETERMINE LATERALIZING THEEPILEPTOGENIC
ZONE
L. Bello-Espinosa*
*University of Calgary, Paediatrics and Neurosciences,
Calgary, AB, Canada
Purpose: Analysis of infraslow EEG activity (ISA) has shown potential
in the evaluation of patients with epilepsy. Infraslow EEG activity analy-
sis may also provide insights in determining the origin of focal epilepto-
genic focus.
The purpose of this report is to present our experience of eight children
with drug-resistant epilepsy, who underwent robotic-guided intracranial
depth electrodes placement whose intracranial recording demonstrated
lateralized infraslow ictal pattern changes that preceded the onset of the
recorded clinical seizures.
Methods: The continuous prolonged intracranial depth EEG recording
of eight children with severe drug-resistant epilepsy were obtained as part
of the intracranial evaluation to determine the epileptogenic zone. During
the recording multiple habitual seizures were captured. In addition to the
conventional settings, analysis of the EEG infraslow (ISA) activity was
undertaken using LFF 0.01 AND HFF of 0.1 Hz respectively to deter-
mine the presence of infraslow activity.
Results: Focal unilateral infraslow activity was identified in all the case .
The recorded lateralized/focal infraslow activity preceded the onset of
the clinical seizures in all the recorded habitual seizures. The identified
infraslow activity was concordant with the conventionally identified
epileptogenic zone.
Conclusion: Ictal infraslow activity can be detected prior to the onset of
clinical seizures in children with drug-resistant epilepsy. Identification of
focal infraslow activity (ISA) can help in determining and localizing the
epileptogenic zone in patient with drug-resistant epilepsy.
p0877
DEJA-RE^VE (ALREADYDREAMED) INDUCED BY
ELECTRICAL BRAIN STIMULATION
J. Curot*, L. Valton†,‡, M. Denuelle*, T. Busigny†, J.P. Vignal§,
L. Maillard§,¶, J. Pariente†,**, A. Trebuchon††,‡‡,
F. Bartolomei††,‡‡, E.J. Barbeau‡, E. Despouy‡
*University Hospital of Toulouse, Neurology, Toulouse, France,
†University Hospital of Toulouse, Toulouse, France, ‡Centre de
Recherche Cerveau & Cognition, UMR 5549, Toulouse, France,
§University Hospital of Nancy, Nancy, France, ¶University of
Nancy, Nancy, France, **INSERM, U1214, TONIC, Toulouse,
France, ††University Hospital of Marseille, Marseille, France,
‡‡INSERM, U751, Marseille, France
Purpose: Epileptic patients sometimes report experiential phenomena
related to a previous dream during seizures or cortical stimulations. This
has been alluded to as “deja-re^ve” (“already dreamed”) in the literature,
but no neuroscientific evidence supports its existence.
Method: We collected all experiential phenomena related to dreams
induced by electrical brain stimulations (EBS) in our epileptic patients
(2003-2015) explored during stereoelectroencephalography and in a
review of the literature. The content of these deja-re^ve and the localisa-
tion of EBS were analysed.
Results: We collected 7 deja-re^ve in our database and 37 from the litera-
ture. Deja-re^ve is a generic term for distinct entities: it can be recollection
of a specific dream similar to an episodic memory (“episodic-like”), rem-
iniscences of a vague dream (“familiarity-like”) or experiences in which
the subject feels like dreaming (literally “a dreamy-state”). Localisation
of the EBS inducing “episodic-like” and “familiarity-like” deja-re^ve
were mostly medial temporal. “Dreamy-states” were more diffuse in the
temporal lobes.
Conclusion: Our study is the first to demonstrate the existence of deja-
re^ve as an experiential phenomenon that can be reported after EBS. It
demonstrates that deja-re^ve is a heterogeneous entity that is different
from deja-vu and “dreamy-state”. It may be relevant for clinical practice
and a guide to temporal lobe dysfunction, in some instances even more
precisely to dysfunction of the medial temporal lobes.
p0878
EPILEPSY SURGERYOUTCOME IN THEGENEVA-
LAUSANNECENTER: IMPROVING SURGICAL
RESULTS DESPITEMORECOMPLEX SURGERIES
S. Baldini*, F. Pittau†, M.-I. Vargas†, V. Garibotto†, L. Spinelli†,
A. Rossetti†, P. Ryvlin†, J. Novy†, M. Baud†, S. Momjian†,
A. Bartoli†, F. Picard†, K. Schaller†, S. Vulliemoz†, M. Seeck†
*University of Geneva - Faculty of Medicine, Geneva,
Switzerland, †Geneva University Hospitals, Geneva, Switzerland
Introduction: Two recent single-center retrospective studies1,2 indi-
cated a trend to more complex surgeries, but with stable surgical results.
However, an US study reported that their patients were referred only after
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long and even increasing years of epilepsy duration, despite published
guidelines on early referral for epilepsy surgery. Here we analyze the
database of our center, draining approximately 2/3 of the Swiss epileptic
population, in order to determine if these trends are also observed.
Method: We reviewed our database between 1.4.1995 and 31.12.2016.
Patients investigated for other reasons (e.g. differential diagnosis) were
excluded from the study. All patients received video-EEG monitoring
and structural MRI. Whenever possible, imaging included also PET,
SPECT, electrical source imaging and, less frequently, EEG-fMRI. We
considered only patients with at least 2 years of follow-up.
Results: A total of 826 patients underwent evaluation, 410 (56%) were
operated and 99/410 (24%) were < 16 years. The duration of epilepsy
decreased from 1995 to 2016 in adults (on average by 16 to 20 years), but
remained stable in children (mean: 5.3 y). Patients with hippocampal
sclerosis and benign tumors as epilepsy origin decreased compared to
non-lesional and dysplasia cases. Complete seizure control was obtained
in 71% undergoing surgery with a curative goal (47% with temporal
resection). No major changes of outcome were observed over time,
despite an increased number of non-temporal surgeries.
Conclusions: Our retrospective analysis confirmed stable favorable sur-
gical outcome despite an increase in complex surgeries, similar to previ-
ous studies. There is now a strong trend to refer adult patients earlier,
compared to earlier years, as a result of continuous education. It shows
the benefit of national meetings in creating a strong national network and
close collaboration within the neurologist community.
References1Cloppenborg et al, JNNP 2016, 87 :1322-1329 ; 2Bien et al,
JNNP 2013 ; 84 :54-61
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AN INTERIMANALYSIS FROMTHEMULTI-SITE
HOBSCOTCHREPLICATION TRIAL
B. Jobst*, N. Streltzov*, W. Zhao*, R. Roth*, K. Secore*,
L. Schommer*, K. Birney*, F. Chu†, H. Henninger‡, K. Nagle§,
P. Jarvis§, S. Schmidt*
*Dartmouth-Hitchcock Medical Center, Lebanon, NH, United
States, †Univerisity of Massachusetts Medical School,
Worcester, MA, United States, ‡Maine Medical Center,
Portland, ME, United States, §University of Vermont Medical
Center, Burlington, VT, United States
Purpose: This study aims to compare results from the initial randomized
controlled trial of the epilepsy self-management intervention, HOme
Based Self-management and COgnitive Training CHanges lives (HOBS-
COTCH) to an ongoing pragmatic replication trial of HOBSCOTCH per-
formed at four New England medical centers. An interim analysis was
performed to assure fidelity of the program and to compare in-person
with virtual delivery.
Method: This analysis (n = 44) compared waitlisted controls (n = 25)
against two delivery methods of the intervention: in-person (H-IP,
n = 11) and virtual (H-V, n = 8). Quality of life (QOLIE-31), depression
(PHQ-9) and self-reported cognitive function (Neuro-QOL - Cognitive
Function) were assessed at baseline and after 3 month follow up.
Results: Patients who received H-IP had statistically significant
improvements in QOLIE-31 (p < 0.001), Neuro-QOL (p = 0.03), and
PHQ-9 (p = 0.02) scores compared to waitlisted controls. For controls,
the mean change in score worsened on both the QOLIE-31 (-1.4), and
PHQ-9 (+0.6), whereas the mean scores improved for the H-IP group on
both measures (QOLIE: +13.7 PHQ-9: -3.5). The treatment effect was
greater for H-IP than H-V, as the virtual group did not report significant
differences from waitlisted controls on any outcome measures. Differ-
ences in total scores between H-IP and H-V were not statistically signifi-
cant.
Conclusion: Compared with waitlisted controls, patients who received
HOBSCOTCH in person reported improved quality of life and subjective
cognitive function scores, in addition to decreased depression scores
3 months after treatment. This analysis replicated the findings of the ini-
tial HOBSCOTCH trial and supports the generalizability of the program
across multiple sites and trials. Our findings indicate that the program
can enhance patients’ self-reported executive functioning and has fidelity
at other health care institutions. Despite a small sample size, it appears
that H-IP may be a more effective delivery method than H-V. The trial is
ongoing with inclusion of more patients.
p0886
COMORBIDITYOFEPILEPSYANDHEADACHES
M.Milovanovic*, V. Radivojevic*, M. Jovanovic*, N. Buder*
*Institute of Mental Health, Epilepsy and Clinical
Neurophysiology, Belgrade, Serbia
Association of headache and epilepsy can be presented as independent
coexistence, headache can be part of seizures or the post-ictal state, and
both disorders sometimes share a common underlying etiology. Purpose
was To present the types of coexistence of epilepsy and headaches and
migraine-epilepsy syndromes characterized by a close temporal relation-
ship between seizure and migraine attack.
Method: We included consecutive adult patients (age range 18-
65 years) with epilepsy without any progressive neurological disease.
Patients underwent detailed clinical examination and interview regarding
occurrence and characteristics of headaches.
Results: Of 203 patients with epilepsy 14.3% suffered from migraine
headaches (29/203), and 30% from tension type headaches (61/203).
Headaches occurred interictally in 39% (79/203) and periictally in 19,7%
(40/203). Headaches are preictal in 5% (10/203) patients. Postical head-
aches are reported in 14,8% (30/203): migraine type in 27%, tension type
in 60%, other type in 3%. Two patients with idiopathic partial occipital
epilepsy (Gastatut) reported migraine headaches during their partial sei-
zures or during postictal period. Three female subjects with primary gen-
eralized epilepsy were classified as catamenial migralepsy since the
onset of the menstruation activated both migraine attacks and seizures.
Symptomatic etiology was proven in three patients in whom the clinical
picture of migraine associated with epileptic seizures was imitated by
arteriovenous malformation, aneurysm and occipital lobe astrocytoma.
Migraine associated with epilepsy in 15 of 29 patients required a prophy-
lactic therapy, postictal migrainous headache was relieved with sumatrip-
tan, and postictal tension-type headache are treated by analgesics.
Conclusion: Classification of seizure types in their temporal relation
with migraine and their etiologic diagnosis are mainstay for the treatment
and prognosis of migraine-epilepsy syndrome.
p0891
DESIGNANDMETHODSOF STUDY 338: A
MULTICENTER, DOUBLE-BLIND, RANDOMIZED,
PLACEBO-CONTROLLED TRIALOF PERAMPANEL
AS ADJUNCTIVE TREATMENT IN SUBJECTS ≥2
YEARSOFAGEWITH INADEQUATELY
CONTROLLED SEIZURES ASSOCIATEDWITH
LENNOX-GASTAUT SYNDROME
R.T. Wechsler*, G. Popli†, J. Dimos†, J. Ferreira‡, F. Bibbiani§,
A. Laurenza§, A. Patten¶, B. Rege§
*Idaho Comprehensive Epilepsy Center, Boise, ID, United
States, †Wake Forest Baptist Health, Winston-Salem, NC, United
States, ‡University of South Florida; St. Joseph’s Children’s
Hospital; Pediatric Epilepsy and Neurology Specialists, School
of Medicine, Tampa, FL, United States, §Eisai Inc, Woodcliff
Lake, NJ, United States, ¶Eisai Ltd, Hatfield, United Kingdom
Purpose: Lennox-Gastaut syndrome (LGS) is a severe form of child-
hood-onset epilepsy associated with multiple seizure types.* Polytherapy
is often required, complicated by pharmacoresistant seizures.* Study 338
explores whether adjunctive perampanel (PER) is superior to placebo in
reducing drop seizures during 18-weeks of treatment in subjects with
inadequately controlled seizures associated with LGS.
Method: This multicenter, double-blind, randomized, parallel-group
study consists of a Core Phase [Prerandomization Screening and Baseline
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(4-8 weeks); Randomization (6-week Titration, 12-week Maintenance,
4-week Follow-up)] and open-label Extension (52-week Conversion/
Maintenance, 4-week Follow-up). Approximately 142 subjects will be
randomized 1:1 to receive adjunctive PER or placebo at ~70 global sites.
Inclusion criteria: LGS diagnosis; ≥2-years-old and aged < 11 years at
LGS onset; experienced ≥2 drop seizures during Baseline; and currently
treated with stable doses of 1-3 antiepileptic drugs. Exclusion criteria:
progressive neurological disease, drop seizure clusters where individual
seizures cannot be counted, prior PER discontinuation due to safety, con-
comitant vigabatrin, and concomitant felbamate for < 1-year. Subjects
will receive PER 2-8 mg/day in a single daily dose. The primary end-
point, change in drop seizure (tonic, atonic, myoclonic) frequency, is
used for the second time in a Phase 3 study, and the first time in a global
development program including patients as young as 2 years. Secondary
endpoints include reductions in total and non-drop seizures, safety, and
PER pharmacokinetics. Quality-of-life, long-term efficacy, and resource
utilization are exploratory.
Conclusion: Study 338 will provide clinical data on use of adjunctive
PER in patients with LGS, which is of interest in this difficult-to-treat
population, and provide the first Phase III data for PER in chil-
dren2- < 4-years old at initial filing.
1LancetNeurol.2009;8:82-93.
p0893
IMPROVEMENTS IN SEIZURE FREQUENCY
PARALLEL IMPROVEMENTS IN SEIZURE SEVERITY
INANOPEN LABEL STUDYOFCANNABIDIOL
J.P. Szaflarski*, E.M. Bebin*, T. Gaston*, L. Grayson*, Y. Liu*,
G. Cutter*, J. DeWolfe*, L. Dure*, B. Hansen*, K. Hirsanyi*,
J.T. Houston*, P. Kankirawatana*, T. McGrath*, R. Singh*,
A. Thomas*, L. Ver Hoef*
*University of Alabama at Birmingham, Birmingham, AL,
United States
Purpose: To assess the response to pharmaceutical formulation of CBD
(Epidiolex) in patients with treatment-refractory epilepsy enrolled in an
open-label safety study.
Method: Patients who failed ≥4 different AEDs were enrolled. Pre-CBD
seizure frequency was averaged over 3 months prior to initiating CBD at
5 mg/kg/day for seizure control.Adjustments were allowed as tolerated
every two weeks by 5 mg/kg/day up to a maximum of 50 mg/kg/day.
Baseline and bi-weekly seizure frequency (SF) was monitored via diary
and seizure severity was assessed at every visit with the Chalfont Seizure
Severity Scale (CSSS). Other AEDs were adjusted as needed. Mixed
model analysis allowing fixed (dose) and random (patient) effects with
an autoregressive covariance structure was utilized.
Results: Seizure severity (N = 115; 59 children): the outcome is the per-
centage of total CSSS score at baseline. For all patients, the estimated
coefficient of CBD dose is significant (t value=-9.51, p < 0.0001); this is
significant for adults (t value=-8.15, p < 0.0001) and children (t value=-
3.97, p < 0.0001). SF (N = 105; 56 children): the outcome is the percent-
age of total seizure frequency at baseline. For all patients, the estimated
coefficient of CBD dose is significant (t value=-2.44, p < 0.05); this was
not significant for adults (t value=-1.82, p > 0.05) or children (t value=-
1.68, p > 0.05), separately. Seizure severity and frequency combined:
the outcome is the product of the percentage of SF and CSSS at baseline.
For all patients, the estimate of the coefficient of CBD dose is significant
(t value=-7.05, p < 0.0001); this is also significant for adults (t value=-
6.04, p < 0.0001) and children (t value=-3.87, p < 0.001).
Conclusion: For every unit increase in CBD dose there is a decrease of
seizure severity and frequency. There is consistency in subgroups though
seizure frequency decreases are significant only when data from children
and adults are combined. Decreases in seizure frequency and severity
occur in parallel.
p0894
ANTIEPILEPTIC DRUGSANDANTIRETROVIRAL
THERAPYUSE INHIV POSITIVE PATIENTS
A.M. Magnerou*, H.F.S. Ngoungoure*, L. Belarabi*,
M.M. Ndiaye*
*Cheikh Anta Diop University / Fann National Teaching
Hospital, Neurology, Dakar, Senegal
Introduction: Antiepileptic drugs (AED) are commonly used in HIV-
patients. There are few studies which report the concomitant use of AED
in patients on antiretroviral therapy (ART), in Senegal there are no formal
AED treatment guidelines currently exist for HIV-patients.
Purpose: Identify different indications of AED in the HIV-patients and
the virological interactions that may exist between AED and ART.
Methods: We conducted a retrospective study from 2013 to 2016 and
we’ve collected epidemiological data of patients who are both under
ART and AED. We have identified the indications for putting under
AED and evaluate the immuno-virological interaction of Enzyme-Indu-
cing Antiepileptic Drugs (EI-AED) and Non Enzyme-Inducing
Antiepileptic Drugs (NEI-AED) by assay of viral load and CD4 count.
Results: Record of 28 patients were analyzed, indications for AED were
central nervous system opportunistic infections associated with seizure
(n = 16),stroke associated with seizure (n = 2), painful peripheral neu-
ropathy (n = 4), mood disorders (n = 5) and migraine (n = 1). All
patients were taking ART for at least 6 months, with episodes of AED
and ART overlap by at least 28 days, 12 patients were under EI-AED,
and16 under NEI-AED. The viral load suppression during ART treatment
was inferior in patients who were co-administered EI-AED (5/12) com-
pared to NEI-AED (2/16). The EI-AED and NEI-AED did not differ in
CD4 count at ART initiation. We did not take into account the interac-
tions with trimethoprim/sulfamethoxazole (used in 18/28 patients for
prophylaxis against opportunistic infections) which commonly compete
with AED.
Conclusion: There are many indications of AED in HIV patients; our
study has found virological impact between AED and ART. The mea-
surement of serum levels of both treatment is important to better assess
these interactions in order to provide specific recommendations for better
management of this drugs-drugs interactions.
p0896
PHYSIOLOGICALLY BASED PHARMACOKINETIC
(PBPK)MODELINGOFDISPOSITIONANDDRUG-
DRUG INTERACTIONS FORVALPROICACID/
DIVALPROEX
R. Reed*, T. Conner*, T. Zhang*
*Husson University, School of Pharmacy, Bangor, ME, United
States
Purpose: Valproic acid (VPA; Divalproex) is a first-line antiepileptic
drug used for treating seizures. This study presents a new physiologically
based pharmacokinetic (PBPK) model considering UGT enzyme kinetics
and an Advanced Dissolution, Absorption and Metabolism (ADAM)
model for extended-release (ER) formulations. Our objective was to pre-
dict VPA disposition within adults, and evaluate the model´s predictive
performance through drug-drug interactions (DDIs).
Method: Our PBPK models for VPA IR+ER formulations were con-
structed using Simcyp Simulator (Version 15), utilizing the ADAM
model for ER. We applied simulation to observed data from 19 peer-
reviewed, published clinical studies. Concentration-time profiles were
simulated for IR single-dose (SD) and steady-state (SS) doses (range:
250 to 1000 mg). Similarly, profiles were simulated for ER SD and SS
doses of 500 mg and 1000 mg, respectively. Co-administration of VPA
as an enzyme-inhibitor of phenytoin and lorazepam was simulated for
DDI prediction.
Results: Our VPA PBPK model predicted serum concentration-time
profiles for IR and ER formulations within 95th and 5th percentile confi-
dence intervals. AUC and Cmax results for IR SD were within 40% and
25% of observed data, respectively; IR SS dosing was within 40% and
30% of observed data, respectively. The ADAM model included a
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controlled-release profile for ER where simulated profiles were in good
agreement with observed data. AUC and Cmax values for ER SD was
within 20% and 30% of observed data, respectively; ER SS dosing was
within 40% and 25% of observed data, respectively (see Figures 1 & 2).
The ratio of AUC inhibited:AUC control for VPA inhibition of phenytoin
metabolism was within 1% of observed data; likewise, the AUC ratio for
VPA inhibition of lorazepamwas within 1% of observed.
Conclusion: Our novel PBPK model predicted serum VPA concentra-
tion-time disposition for ER and IR formulation profiles reasonably well
and had substantial accuracy for DDI prediction.
p0899
IMPROVEMENT INQUALITYOF LIFERATINGS
AFTERONEYEAROF TREATMENTWITH
PHARMACEUTICAL FORMULATIONOF
CANNABIDIOL (CBD)
T. Gaston*, M. Szaflarski†, B. Hansen†, L. Grayson*,
E.M. Bebin*, J. Szaflarski*
*University of Alabama at Birmingham, Neurology,
Birmingham, AL, United States, †University of Alabama at
Birmingham, Sociology, Birmingham, AL, United States
Purpose: Refractory epilepsy has negative effects on quality of life
(QOL). Previously presented data revealed that 6 refractory epilepsy
patients enrolled in an open label expanded access CBD program who
withdrew from the study due to inefficacy had a clinically significant
change in QOLIE-89 scores between enrollment and withdrawal from
the study. The aim of this study was to compare QOLIE-89 scores at
baseline and after one year of treatment with CBD. We hypothesized that
QOLIE-89 scores would improve in patients at one year follow up.
Method: The AL state CBD program is an open-label safety study in the
use of CBD (pharmaceutical grade; Epidiolex) for treatment-refractory
epilepsy, defined here as failing at least 4 anti-epileptic drugs (AEDs),
including a trial of 2 concomitant AEDs. We collected QOLIE-89 scores
from adult patients with refractory epilepsy on two occasions: at study
enrollment (baseline) and after one year of CBD treatment (follow-up). If
a patient withdrew from the study before one year, a follow-up QOLIE-
89 was completed at study termination visit (at which time CBD had been
stopped). Two-tailed paired samples T-test was used for analysis. A clini-
cally significant change in QOLIE-89 score has been previously defined
as ≥ 10 points.
Results: At the time of this analysis, 31 patients had completed baseline
and follow-up QOLIE-89 (15 female, ages 19-62). Six of these patients’
follow-up QOLIE-89 were completed at study withdrawal secondary to
drug inefficacy. Mean baseline QOLIE-89 score was 48.4  17 points,
while mean follow-up score was 58.3  21 points (mean difference +9.9
points). This difference was statistically significant at P = 0.027.
Conclusion: A significant improvement in QOL was seen on average in
adult epilepsy patients after 1 year of treatment with CBD. Future data
will need to be collected to determine if this improvement is sustained
over time.
p0907
LACOSAMIDE/LEVETIRACETAMCOMBINATION
TREATMENT IN EPILEPSY PATIENTS –
PERSPECTIVE FROMTHEASIANREGION
H. Leung*, H. Yip*, K.S. Wong*, C. Lui†
*Chinese University of Hong Kong, NT, Hong Kong, †Queen
Elizabeth Hospital, Kowloon, Hong Kong
Purpose: Lacosamide(LCS) is an antiepileptic agent with a unique
mechanism of action (slow inactivation of sodium channels). Levetirac-
etam(LEV) is one of the most widely used AEDs with binding to the
synaptic vesicle protein SV2a. The aim of this study is to evaluate the
clinical use of LCS/LEV combination in partial-onset seizure patients as
compared with patients who are only offered LCS-only treatment.
Method: This is a prospective, observational, open-label study to assess
the efficacy and tolerability of LCS/LEV combination in Chinese sub-
jects aged 18 years or above. Patients on LEV are screened for a low and
slow titration schedule of LCS over 8 weeks. A maintenance phase of
8 weeks will be given. The treatment phase refers to the entire period of
treatment beyond 16 weeks. The primary efficacy endpoint was the
50%-responder rate and percentage change from baseline in 28-day total
seizure frequency from baseline to maintenance phase or treatment
phase. The safety profile is based on the incidence and severity of trea-
ment-emergent adverse events (TEAE).
Results: 92 patients were included in this study with 40 patients for the
LCS/LEV cohort in whom 9 screening failures occurred. 69 patients were
recruited for the LCS-only group in whom 8 were screening failures. The
baseline demographics of the two groups did not differ. The 50% respon-
der rate for the LCS/LEV group was 67.7%(21/31) and for the LCS-only
group 50.8% (p < 0.05). The percentage reduction of seizure was -
57.44 + /- 42.32 for the LCS/LEV group and -30.78 + /-81.56 for the
LCS-only group. Seizure freedom was achieved in 32.3% (LCS/LEV)
and 14.8%(LCS only) respectively. TEAE was reported in 19.4%(LCS/
LEV) and 24.4%(LCS only). The withdrawal rates due to TEAE was
9.7%(LCS/LEV) and 13.1%(LCS-only).
Conclusion: The LCS/LEV combination offers a higher 50%-responder
rate and fewer TEAEs/withdrawals compared with the LCS-only combi-
nation for partial epilepsy.
p0909
THE INVESTIGATIONOFTHEADVERSE EVENTS
DURING INTRA-GROUPREPLACEMENTOFANTI-
EPILEPTIC DRUGS
O. Rakhmanina*, E. Levitina*, A. Balabanova†
*FSBEE PE Tyumen State Medical University of Ministry of
Health, Tyumen, Russian Federation, †SBAEHC TR Regional
Center of Rehabilitation and Treatment, Tyumen, Russian
Federation
Purpose: To describe the clinical types of adverse events at changing the
original anti-epileptic drugs to generic drugs in patients with various
forms of epilepsy.
Method: There were studied 61 cases of unsuccessful transfer of the
patients (24 men and 37 women) with epilepsy from an original
antiepileptic drug to generic drug. Changing the trade name of prescribed
drug was carried out in the following groups: valproate, levetiracetam,
topiramate, lamotrigine.
The statement of the fact of the transfer and the development of an
adverse event was conducted retrospectively, since the change was car-
ried out due to the changes in the provision of concessional supplementa-
tion of patients without participation of treating epileptologist.
Results: In 45 of 61 patients at changing of the original drug to a generic
appeared failure of remission or marked more frequent attacks. Of these,
from group of topiramate there were 16 patients, levetiracetam group had
14, in valproate group there were 10, lamotrigine group had 5. At the time
of replace of a drug 16 of 61 patients developed side effects that did not
exist before during long-term use of the original form. Of these, a group
of lamotrigine had 6 (1 - urticaria, 1 - headache, 4 - dermatitis); levetirac-
etam had 6
(2 - dermatitis, 2 - angioedema, 1 - urticaria, 1 - depression), valproate
had 3 (1 - urticaria, daytime sleepiness, 1 - dyspepsia), topiramate had 1
(dizziness).
Conclusion: The presented clinical experience demonstrates the unde-
sirability of intra-group replacement of anti-epileptic drugs. Transfer of
patients from the original form to the generics led to the disruption of
remission or worsening at the course of epilepsy, or to the development
of side effects (mainly allergic reactions) that were not defined previ-
ously.
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IMPACTOF TREATMENTREFRACTORINESS ONTHE
EFFECTIVENESS, SAFETYANDTOLERABILITYOF
ESLICARBAZEPINE ACETATE INCLINICAL
PRACTICE
M. Holtkamp*, S. Rheims†, M. Zivansky‡, V. Villanueva§
*Charite-Universit€atsmedizin Berlin, Berlin, Germany,
†Hospices Civils de Lyon, Lyon, France, ‡Eisai Ltd, Prague,
Czech Republic, §Hospital Universitario y Politecnico La Fe,
Valencia, Spain
Purpose: Eslicarbazepine acetate (ESL) is approved in Europe as
adjunctive therapy for adults, adolescents and children aged >6 years
with partial-onset seizures, with or without secondary generalisation.
Patients encountered in clinical practice are often less refractory to
antiepileptic drug (AED) treatment than those in clinical trials. We inves-
tigated the effectiveness, safety and tolerability of ESL in terms of treat-
ment refractoriness (number of concomitant AEDs) using data from a
large audit of real-world studies.
Method: Data from the Euro-Esli study (pooled analysis of 14 European
clinical practice studies) were analysed by the number of baseline AEDs
patients were receiving when ESL was initiated (0,1,2 or ≥3 AEDs).
Effectiveness assessments included responder rate (≥50% seizure fre-
quency reduction) and seizure freedom rate (seizure freedom at least
since prior visit), assessed after 3, 6 and 12 months of ESL treatment.
Safety and tolerability were assessed by evaluating adverse events (AEs)
and ESL discontinuations.
Results: At baseline, the numbers of patients treated with 0,1,2 and ≥3
concomitant AEDs were 88 (4.3%), 969 (47.4%), 567 (27.7%) and 421
(20.6%), respectively. At 12 months, responder rates for patients receiv-
ing 0,1,2 and ≥3 concomitant AEDs were 94.1% (48/51), 87.6% (429/
490), 69.5% (198/285) and 53.8% (121/225), respectively. Correspond-
ing values for seizure freedom rates were 88.2% (45/51), 59.2% (290/
490), 24.2% (69/285) and 13.8% (31/225), respectively. At all time-
points, responder and seizure freedom rates were significantly greater in
patients treated with lower versus higher numbers of concomitant AEDs
(p < 0.001 for all comparisons). Overall, for patients treated with higher
versus lower numbers of concomitant AEDs, there were significantly
higher rates of reported AEs (p = 0.004) and AEs leading to ESL discon-
tinuation (p < 0.001).
Conclusion: ESL’s effectiveness, safety and tolerability were signifi-
cantly superior in patients who were less - versus more - refractory to
treatment at baseline.
Study supported by Eisai.
p0914
EFFECTIVENESS AND SAFETYOF
ESLICARBAZEPINE ACETATE FORTREATMENTOF
PARTIAL-ONSET SEIZURES IN CLINICAL PRACTICE
ACCORDING TOAGEDECADEOF PATIENTS
R. Rocamora*, M. Holtkamp†, C. Karlsson‡, V. Villanueva§
*Hospital del Mar, Barcelona, Spain, †Charite-
Universit€atsmedizin Berlin, Berlin, Germany, ‡Eisai AB,
Stockholm, Sweden, §Hospital Universitario y Politecnico La Fe,
Valencia, Spain
Purpose: Eslicarbazepine acetate (ESL) is approved in Europe as
adjunctive therapy for adults, adolescents and children aged >6 years
with partial-onset seizures, with or without secondary generalisation. We
investigated the effectiveness and safety profile of ESL by age decade,
using real-world data from the Euro-Esli study.
Method: Euro-Esli was an exploratory pooled analysis of real-world
data from 14 European clinical practice studies. Assessments of effec-
tiveness included responder rate (≥50% seizure frequency reduction) and
seizure freedom rate (seizure freedom at least since prior visit), assessed
after 3, 6 and
12 months of ESL treatment. Adverse events (AEs) were evaluated.
Data were analysed for cohorts aged < 18, 18-29, 30-39, 40-49, 50-59,
60-69 and ≥70 years.
Results: Euro-Esli included 2057 patients aged < 18 (n = 12), 18-29
(n = 404), 30-39 (n = 479), 40-49 (n = 444), 50-59 (n = 360), 60-69
(n = 225) and ≥70 (n = 133) years. After 12 months, responder rates
were 100.0%, 71.8%, 77.8%, 67.9%, 76.8%, 80.5% and 90.3% in patients
aged < 18, 18-29, 30-39, 40-49, 50-59, 60-69 and ≥70 years, respec-
tively, and corresponding seizure freedom rates were 77.8%, 40.5%,
32.6%, 35.3%, 39.0%, 58.6% and 58.3%, respectively. At 12 months,
responder and seizure freedom rates were significantly greater in earlier
and more advanced ages versus intermediate ages (responder rate,
p = 0.001; seizure freedom rate, p < 0.001). Overall, AEs were reported
by 33.3%, 30.5%, 27.9%, 33.6%, 39.4%, 39.5% and 44.4% of patients
aged < 18, 18-29, 30-39, 40-49, 50-59, 60-69 and ≥70 years, respec-
tively. Incidence of AEs was significantly greater in more advanced ages
than in less advanced ages (p = 0.001).
Conclusion: ESL was effective with a generally acceptable safety pro-
file regardless of the age decade of patients. As expected, incidence of
AEs was greatest in patients of more advanced age.
Study supported by Eisai.
p0915
POSTMARKETING EXPERIENCEWITH
BRIVARACETAM IN THETREATMENTOF
EPILEPSIES: AMULTICENTRECOHORT STUDY
FROMGERMANY
A. Strzelczyk*, I. Steinig*, F. von Podewils†, G. M€oddel‡,
S. Bauer*, K.M. Klein*, E. Paule*, P.S. Reif*, L.M. Willems*,
J.P. Z€ollner*, R. Kunz†, U. Runge†, G. Kurlemann‡, S. Schubert-
Bast*, F. Rosenow*
*Epilepsy Center Frankfurt Rhine-Main, Goethe-University,
Frankfurt amMain, Germany, †University of Greifswald,
Greifswald, Germany, ‡University of M€unster, M€unster,
Germany
Purpose: To evaluate factors predicting efficacy, retention and tolerabil-
ity of add-on brivaracetam (BRV) in clinical practice.
Method: A multicentre, cohort study recruiting all patients that started
BRV between February and November 2016 with observation time
between three and 12 months.
Results: Of a total of 262 patients (mean age 40, range 5-81 years, 129
male) treated with BRV, 227(87%) were diagnosed to have focal, 19(7%)
idiopathic generalised and eight (3%) symptomatic generalised epilepsy,
while eight (3%) were unclassified. The length of exposure to BRV ran-
ged from one day to 12 months with a median retention time of
6.1 months, resulting in a total exposure time to BRV of 1504 months.
The retention rate was 79.4% at three months and 75.8% at six months.
Efficacy at three months was 41.2%(50% responder rate) with 14.9% sei-
zure free and, at six months, 40.5% with 15.3% seizure free. Treatment-
emergent adverse events were observed in 37.8% of the patients with the
most common being somnolence, dizziness and behavioural adverse
events (BAE). BAE presenting under previous LEV-treatment improved
upon switch to BRV in 57.1%(20/35) and LEV-induced somnolence
improved in 70.8%(17/24). Patients with BAE on LEV were more likely
to develop BAE on BRV, OR 3.48(95%CI 1.53-7.95).
Conclusion: BRV in broad clinical postmarketing use is a well-tolerated
anticonvulsant drug with 50% responder rates, similar to those observed
in the regulatory trials, despite the fact that 90% of the patients included
had previously been exposed to LEV. An immediate switch from LEV to
BRV at a ratio of 10:1 to 15:1 is feasible. The only independent signifi-
cant predictor of efficacy was the start of BRV in patients not currently
taking LEV. The occurrence of BAE during previous LEV exposure pre-
dicted poor psychobehavioural tolerability of BRV-treatment. A switch
to BRV can be considered in patients with LEV-induced BAE.
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RUFIPRAT: ARETROSPECTIVE STUDYONTHE
EVERYDAYCLINICALUSEOFRUFINAMIDE IN
CHILDRENWITHREFRACTORYEPILEPSY
C. Milleret*, E. Losito†, S. Auvin‡, C. Di Meglio§, C. Cances¶,
F. Dubois**, H. Doudoux**, R. Nabbout†, M. Milh§,
L. Verceuil**, Z. Gokce-Samar††, E. Panagiotakaki††,
A. Arzimanoglou††
*University Hospitals of Lyon, Department of Clinical
Epileptology, Sleep Disorders and Functional Neurology in
Children, Lyon, France, †University Hospital Necker-Enfants
Malades, Paris, France, ‡University Hospital Robert Debre,
Paris, France, §University Hospital La Timone, Marseille,
France, ¶University Hospital of Toulouse, Toulouse, France,
**University Hospital of Grenoble, Grenoble, France
††University Hospitals of Lyon, Lyon, France:
Purpose: Evaluate efficacy and tolerability of Rufinamide as used in
everyday clinical practice by French child Neurologists.
Method: The files of children aged 4 years and above, treated with Rufi-
namide between January 2010 and December 2015 at 6 University
Hospitals (Grenoble, Lyon, Marseille, Paris-Robert Debre, Paris-Necker,
Toulouse) were collected by a per centre principal investigator and
pooled for analysis. Data related to the global epilepsy profile (age at
onset; underlying aetiology; type(s) of seizures and predominant type of
seizures; syndromic diagnosis; concomitant medication and titration atti-
tudes have been recorded.
Results: We analyzed the data from 136 patients (85 males, age range
3 -56). Most the patients presented with multiple seizure types (drop
attacks; dialeptic; tonic; generalized tonic-clonic seizures) and suffered
from drug-resistant epilepsy of early onset (usually before the age of 12-
18 months). Intellectual disability and behavioral or psychotic troubles
were often present. SodiumValproate and Levetiracetamwere frequently
associated.
Investigators estimated that seizure frequency reduction was recorded
in nearly 50% of the children treated. No major adverse event was
reported. Weight loss, vomiting, asthenia and somnolence were the most
frequent, rarely leading to a discontinuation for adverse event.
Conclusion: Rufinamide can be safely tried for the treatment of a large
spectrum of seizure types. The clinical profile of the patients as well as
efficacy and tolerability results will be presented in detail.
p0917
IMPACTOF INTELLECTUALDISABILITYONTHE
EFFECTIVENESS, SAFETYANDTOLERABILITYOF
ESLICARBAZEPINE ACETATEAS ATREATMENT
FOR PARTIAL-ONSET SEIZURES
M. Bagary*, N. Delanty†, R. McMurray‡, V. Villanueva§
*Barberry National Centre for Mental Health, Birmingham,
United Kingdom, †Beaumont Hospital, Dublin, Ireland, ‡Eisai
Europe Ltd, Hatfield, United Kingdom, §Hospital Universitario
y Politecnico La Fe, Valencia, Spain
Purpose: Epilepsy in people with intellectual disability is common and
difficult to manage. Eslicarbazepine acetate (ESL) is approved in Europe
as an adjunctive therapy for adults, adolescents and children aged
>6 years with partial-onset seizures, with or without secondary generali-
sation. We investigated the effectiveness, safety and tolerability of ESL
in patients with intellectual disability, compared with those without such
disability, using data from a large audit of European real-world studies.
Method: Euro-Esli study was an exploratory pooled analysis of 14 Euro-
pean clinical practice studies. Data from patients with and without intel-
lectual disability who were included in the study were extracted and
analysed. Assessments of effectiveness included responder rate (defined
as ≥50% seizure frequency reduction) and seizure freedom rate (defined
as seizure freedom at least since prior visit), assessed after 3, 6 and
12 months of ESL treatment. Safety and tolerability were assessed by
evaluating adverse events (AEs) and ESL discontinuations.
Results: At baseline, 11.3% (108/952) of patients included in Euro-Esli
had intellectual disability. At 12 months, responder rates for patients
with versus without intellectual disability were 60.3% (35/58) versus
76.6% (222/290) (p = 0.010), and seizure freedom rates were 22.4%
(13/58) versus 43.1% (125/290) (p = 0.003). In addition, responder and
seizure freedom rates at 3 and 6 months were significantly lower in
patients with versus without intellectual disability. Overall, for patients
with versus without intellectual disability, 45.8% (49/107) versus 32.6%
(275/844) reported AEs (p = 0.007), and 44.7% (46/103) versus 26.8%
(222/827) discontinued ESL due to AEs (p < 0.001).
Conclusion: This large audit of real-world data demonstrated that the
effectiveness and safety and tolerability profiles of ESL were signifi-
cantly impaired in patients with intellectual disability, compared to those
without intellectual disability, highlighting the challenges associated
with treating epilepsy in those with such disability.
Study supported by Eisai.
p0918
A EUROPEANAUDITOFREAL-WORLDUSEOF
ESLICARBAZEPINE ACETATEAS ATREATMENT
FOR PARTIAL-ONSET SEIZURES: THE EURO-ESLI
STUDY
V. Villanueva*, M. Holtkamp†, P. Santagueda*, R. McMurray‡
*Hospital Universitario y Politecnico La Fe, Valencia, Spain,
†Charite-Universit€atsmedizin Berlin, Berlin, Germany, ‡Eisai
Europe Ltd, Hatfield, United Kingdom
Purpose: Eslicarbazepine acetate (ESL) is approved in Europe as
adjunctive therapy for adults, adolescents and children aged >6 years
with partial-onset seizures, with or without secondary generalisation.
Real-world clinical practice data complement evidence from clinical tri-
als by providing information on patients who are more diverse in terms of
clinical characteristics than those recruited for clinical trials. The purpose
of Euro-Esli was to audit the real-world effectiveness, safety and tolera-
bility of ESL when used in everyday clinical practice.
Method: An exploratory pooled analysis of real-world data from 14
European clinical practice studies was conducted. Retention and effec-
tiveness were assessed after 3,6 and 12 months of ESL treatment. Effec-
tiveness assessments comprised percentage reduction from baseline in
monthly seizure frequency, responder rate (≥50% seizure frequency
reduction) and seizure freedom rate (seizure freedom at least since prior
visit). Safety and tolerability were assessed by evaluating adverse events
(AEs) and ESL discontinuations.
Results: Data from 2058 patients (52.1% male; mean age 44 years;
mean epilepsy duration 20.9 years) were included. All patients were
assessed for safety and 1975 were assessed for effectiveness. At 3,6 and
12 months, retention rates were 95.4%, 86.6% and 73.4%, responder
rates were 60.9%, 70.5% and 75.6%, and seizure freedom rates were
30.6%, 38.3% and 41.3%, respectively. There were significant reductions
from baseline to final visit in monthly frequencies of total (mean reduc-
tion 44.1%), simple partial (78.8%), complex partial (53.1%) and secon-
darily generalised (80.0%) seizures (p < 0.001 for all). AEs were
reported for 34.0% patients and led to discontinuation of 13.6% patients.
The most frequently reported AEs were dizziness (6.7% patients), fatigue
(5.4%) and somnolence (5.1%).
Conclusion: This large audit demonstrated that ESL was effective and
generally well tolerated when used in everyday clinical practice, with
approximately three-quarters of patients retained on treatment at
12 months.
Study supported by Eisai.
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ESLICARBAZEPINE ACETATEAS ATREATMENT
FOR PARTIAL-ONSET SEIZURES IN PATIENTSWITH
PSYCHIATRIC COMORBIDITIES, INCLUDING
DEPRESSION
G. Assenza*, C. Doherty†, R. McMurray‡, V. Villanueva§
*Universita Campus Bio-Medico di Roma, Rome, Italy, †St
James’s Hospital, Dublin, Ireland, ‡Eisai Europe Ltd, Hatfield,
United Kingdom, §Hospital Universitario y Politecnico La Fe,
Valencia, Spain
Purpose: Psychiatric comorbidities, including depression, are common
in epilepsy patients and can influence the effectiveness of antiepileptic
treatment. We investigated the effectiveness, safety and tolerability of
eslicarbazepine acetate (ESL) in patients with psychiatric comorbidities
and those specifically with comorbid depression, using data from a large
audit of European real-world studies.
Method: Data from patients with psychiatric comorbidities and depres-
sion included in the Euro-Esli study (a pooled analysis of 14 European
clinical practice studies) were extracted and compared with data from
patients without these comorbidities. Effectiveness assessments included
responder rate (≥50% seizure frequency reduction) and seizure freedom
rate (seizure freedom at least since prior visit), assessed after 3, 6 and
12 months of ESL treatment. Safety and tolerability were assessed by
evaluating adverse events (AEs) and ESL discontinuations.
Results: At baseline, psychiatric comorbidities and depression were pre-
sent in 283/1138 (24.9%) and 141/1134 (12.4%) patients, respectively.
At 12 months, responder rates for patients with versus without psychi-
atric comorbidities were 83.1% (128/154) versus 82.5% (326/395)
(p=not significant), and seizure freedom rates were 51.3% (79/154) ver-
sus 51.4% (203/395) (p=not significant). Corresponding values for
patients with versus without depression were 81.0% (51/63) versus
82.9% (402/485) (p=not significant), and 46.0% (29/63) versus 52.0%
(252/485) (p=not significant), respectively. Overall, for patients with ver-
sus without psychiatric comorbidities, 43.1% (122/283) versus 30.5%
(261/855) reported AEs (p < 0.001), and 31.9% (88/276) versus 21.2%
(178/840) had AEs leading to ESL discontinuation (p < 0.001). Corre-
sponding values for patients with versus without depression were 42.6%
(60/141) versus 32.4% (322/993) (p = 0.017), and 34.8% (48/138) versus
22.2% (216/974) (p = 0.001), respectively.
Conclusion: ESL’s effectiveness was generally similar in patients with
versus without psychiatric comorbidities, and in those with versus with-
out comorbid depression. ESL’s safety and tolerability were less favour-
able in patients with psychiatric comorbidities and depression, compared
with those without these comorbidities.
Study supported by Eisai.
p0920
REAL-WORLDEFFECTIVENESS ANDTOLERABILITY
OFESLICARBAZEPINE ACETATE IN PATIENTS
RECEIVINGVERSUS NOTRECEIVINGOTHER
SODIUM-CHANNEL BLOCKERS
C. Lawthom*, F. Sales†, R. McMurray‡, V. Villanueva§
*Royal Gwent Hospital, Newport, United Kingdom, †Centro
Hospitalar e Universitario de Coimbra, Coimbra, Portugal,
‡Eisai Europe Ltd, Hatfield, United Kingdom, §Hospital
Universitario y Politecnico La Fe, Valencia, Spain
Purpose: Eslicarbazepine acetate (ESL) differs from other sodium chan-
nel blockers (SCBs) in being selective for slow inactivated sodium chan-
nels. It may have efficacy in patients who have not achieved sufficient
seizure control with other SCBs. We investigated the effectiveness,
safety and tolerability of ESL in patients treated either with or without
concomitant SCBs by analysing real-world data from the Euro-Esli
study.
Method: Euro-Esli was an exploratory pooled analysis of data from 14
European clinical practice studies. Effectiveness assessments included
responder rate (≥50% seizure frequency reduction) and seizure freedom
rate (seizure freedom at least since prior visit), assessed after 3, 6 and
12 months of ESL treatment. Safety and tolerability were assessed by
evaluating adverse events (AEs) and ESL discontinuations. Data were
analysed for patients receiving concomitant antiepileptic drug treatment
that included/did not include other SCBs.
Results: Euro-Esli included 1852 patients for whom the mode of action
of concomitant antiepileptic drug treatment was known, 993 (53.6%) of
whom were treated with SCBs when ESL was initiated. At 12 months,
responder rates were 70.2% (363/517) and 81.5% (352/432) in patients
receiving and not receiving other SCBs, respectively (p < 0.001). Corre-
sponding values for seizure freedom rates were 28.6% (148/517) and
52.1% (225/432), respectively (p < 0.001). At all timepoints, responder
and seizure freedom rates were significantly greater for patients not
receiving versus receiving other SCBs (p < 0.001 for all). Overall, AEs
were reported for 35.3% (349/989) patients receiving SCBs versus 33.1%
(284/859) patients not receiving SCBs (not significant), and led to dis-
continuation of 30.7% (301/981) versus 22.0% (186/846) patients,
respectively (p < 0.001).
Conclusion: Adjunctive ESL was effective in patients already receiving
other SCBs, with approximately one third achieving seizure freedom
after 12 months. AEs leading to ESL discontinuation were reported more
frequently in patients receiving, versus not receiving, other SCBs.
Study supported by Eisai.
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BRAIN LESIONS IN ELOQUENTAREAS:
INTRAOPERATIVEMAPPING, SEIZURES
OCCURRENCEANDANTIEPILEPTIC DRUG
PROPHYLAXIS. COMPARISONOF PHENYTOINVS
LEVETIRACETAMVS LACOSAMIDEUSE: EFFICACY
AND SAFETY
A. Mascia*, V. Esposito†, G. Di Gennaro‡, G. De Benedictis§,
E. Aglialoro§, A. D’Elia¶, R. Morace¶, L. Chiacchieri**,
C. Liguori††, F. Aloj§
*IRCCS NEUROMED, Epilepsy Surgery, Pozzilli, Italy,
†University ‘La Sapienza’ of Rome, Neurosurgery, Rome, Italy,
‡IRCCS NEUROMED, Epilpsy Surgery, Pozzilli, Italy, §IRCCS
NEUROMED, Anesthesiology, Pozzilli, Italy, ¶IRCCS
NEUROMED, Neurosurgery, Pozzilli, Italy, **IRCCS
NEUROMED, Neurophysiology, Pozzilli, Italy
††University Hospital of Rome Tor Vergata, Neurophysiophatology,
Rome, Italy:
Purpose: Intraoperative mapping and monitoring techniques for elo-
quent area brain lesions surgery are routinely used word wide. Very few
data are available regarding intraoperative seizures (IS) occurrence and
intraoperative antiepiletptic drug prophylaxis use. The IS incidence as
reported, in literature, ranges from 0% to 24% and seems to be related
several variables: parameters of stimulation, anesthetic regimen, the
intrinsic epileptogenicity of the tumor. The IS prevention is fundamental
to avoid premature interruption of functional mapping as well as prema-
ture interruption of tumor resection and consequent postoperative neuro-
logical deficits.
Methods: 107 patients undergoing elective craniotomy for brain lesions
in eloquent area with intraoperative mapping, received antiepileptic
drugs (27 pts levetiracetam, 24 pts phenytoin and 56 pts lacosamide) as
intraoperative seizures prophylaxis. The drug was administred intra-
venously after induction of anaesthesia and approximately two hours
before start of surgery. Levetiracetam was administred at dosage of
20 mg/Kg and lacosamide in a single dose of 200 mg, both given as slow
infusion (20 min.); phenytoin was administred at dosages of 15 mg/kg a
slower infusion rate (40 min.) as raccommended to prevent cardiovascu-
lar adverse effects. Cortical mapping was performed using short train
direct electrostimulation technique (250 Hz, monophasic current,
500 μs, train of 4-5) with motor evoked potentials (MEP) monitoring.
The seizure occurrence was evaluated clinically and was reported by
neurosurgeon, anesthesiologist or neurophysiologist.
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Results: Seizures were observed in five patients of 27 who received
levetiracetam, one seizure was reported in 24 patients who received
phenytoin and one seizure in 56 patients who received lacosamide. Cate-
gorial ANOVA was used to compare the three groups LCS vs LEV
p = 0.03; PHT vs LEV p = 0.03; LCS vs PHT p=ns.
Conclusions: Lacosamide is effective and safe as well as phenytoin in
preventing intraoperative seizures without any special precaution.
p0926
PHARMACOKINETIC VARIABILITYOF PHENYTOIN
–ANOLDDRUGUSED INNEWCOMBINATIONS
A. Gottas*, M.L. Burns*, A. Baftiu†, S.I. Johannessen*,‡,
C. Johannessen Landmark*,†,‡
*Oslo University Hospital, Department of Pharmacology, Oslo,
Norway, †Oslo and Akershus University College of Applied
Sciences, Programme for Pharmacy, Oslo, Norway, ‡Oslo
University Hospital, The National Center for Epilepsy,
Sandvika, Norway
Purpose: Phenytoin is an old antiepileptic drug (AED) with challenging
pharmacokinetic properties, mainly prescribed to patients with refractory
epilepsy. The purpose of this study was to investigate the impact of age,
gender and comedication with a selection of newer AEDs thought to have
interaction potential on the pharmacokinetic variability of phenytoin.
Method: Anonymous data from the therapeutic drug monitoring
(TDM)-database at the National Center for Epilepsy in Norway were col-
lected for patients who used phenytoin during 2010-15. Variables
included age, gender, dose, drug-fasting steady-state serum concentra-
tions and concomitantly prescribed AEDs. The study was approved by
the Regional Ethics Committee.
Results: 280 patients were included: Median age 53 years (range 1-96),
gender distribution 40/60% women/men, 29% were elderly above
65 years and 7% were under 18 years. Mean dose and serum concentra-
tion were 288 mg/day (range 25-900) and 53 μmol/L (observed range
2-170, reference range 40-80), respectively. Mean concentration/dose
(C/D)-ratio was 0.19 (SD=0.13) μmol/L/mg, with a 180-fold variability.
There were no gender differences in C/D ratio or significant differences
between adults and elderly, 0.16 (0.11) and 0.17 (0.12) respectively.
Polytherapy (2-4 AEDs) was noted in 182 patients (65%). 108 patients
(59%) used at least one newer AED. No significant changes in C/D-ratio
were found when phenytoin was combined with newer AEDs, such as the
possible inducer topiramate (> 200 mg/day) or the inhibitor oxcar-
bazepine, compared to monotherapy or combinations with AEDs with no
expected interactions (C/D-ratio 0.16 (0.08), 0.20 (0.18) and 0.21 (0.18)
(n = 7,14,98) respectively).
Conclusion: The pharmacokinetic variability of phenytoin was exten-
sive and could not be explained by single factors such as age, gender or
comedication. One third of the patients were elderly. Polytherapy was
common, with combinations with newer AEDs stated in two thirds of the
population. Careful monitoring of phenytoin therapy is still important for
improved safety.
p0927
CARDIOVASCULARAUTONOMIC FUNCTIONS IN
PATIENTS AFFECTEDBYPARTIAL EPILEPSYON
LACOSAMIDEMONOTHERAPY
F. Izzi*, F. Placidi*, C. Liguori*, I. Posca†, A. Pisani*,
N.B. Mercuri†, C. Rocchi†
*Neurophysiopathology Unit, Epilepsy Center, University of
Rome ‘Tor Vergata’, Department of Systems Medicine, Rome,
Italy, †Neurology Unit, University of Rome ‘Tor Vergata’,
Department of Systems Medicine, Rome, Italy
Purpose: Several studies indicate that some AEDs like sodium channel
blockers are significantly associated with autonomic dysfunction in
epileptic subjects (Isojarvi et al., 1998; Persson et al., 2003). This study
was designed to find any alteration of cardiovascular autonomic function
in patients affected by partial epilepsy on lacosamide monotherapy.
Methods: Patients affected by partial epilepsy on lacosamide monother-
apy underwent automic function tests including head up tilt test (HUTT),
Valsalva maneuver, deep breathing, hand grip, and cold face. HRV anal-
ysis was performed in the frequency domain using both autoregressive
(AR) and fast Fourier transform algorithms in rest supine condition and
during HUTT. Subjects taking any medication other than AEDs known
to affect the autonomic nervous system were excluded. All data were
compared with age and sex matched controls. Statistical significance was
set at p < 0.05.
Results: Eight patients (53  25.52 years) affected by partial epilepsy
on lacosamide monotherapy (mean daily dose 187.5  25 mg/die) and
10 healthy controls (51.5  15.17 years) were included in the study.
Cardiovascular responses to autonomic function tests and HRV analysis
did not differ between patients on lacosamide monotherapy and controls.
Conclusion: Unlike other sodium channel-blocking antiepileptic drugs,
lacosamide selectively enhances sodium channel slow inactivation and
its cardiac toxicity has been described in the literature. Interestingly, we
found no abnormalities of autonomic cardiovascular functions in partial
epileptic patients on lacosamide monotherapy.
ReferencesIsojarvi JIT, Ansakorpi H, Suominen K, Tolonen U, Repo M,
Myllyla VV. Interictal cardiovascular responses in patients with epilepsy.
Epilepsia 1998;39:420-6 Persson H, Ericson M, Tomson T. Carba-
mazepine affects autonomic cardiac control in patients with newly diag-
nosed epilepsy. Epilepsy Res. 2003;57(1):69-75.
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GANAXOLONE IN CHILDRENWITHCDKL5GENE-
RELATEDEPILEPTIC ENCEPHALOPATHY:
PRELIMINARYANALYSIS FROMANOPEN-LABEL
TRIAL
N. Specchio*, M. Chez†, D. Tarquinio‡, O. Devinsky§,
J. Lappalainen¶, B. Dettore¶, A. Patroneva¶, E. Carrazana¶
*Bambino Gesu Children’s Hospital, IRCCS, Department of
Neuroscience, Rome, Italy, †Sutter Neuroscience Institute,
Sacramento, CA, United States, ‡Emory University School of
Medicine, Atlanta, GA, United States, §New York University,
Epilepsy Center, New York City, NY, United States, ¶Marinus
Pharmaceuticals, Radnor, PA, United States
Purpose: The X-linked CDKL5 gene, which encodes cyclin-dependent
kinase-like 5 protein, has been implicated in early-onset encephalopathy
and atypical Rett syndrome with early-onset difficult-to-control seizures.
An open-label study is being conducted to explore safety, tolerability and
possible efficacy of ganaxolone in children with CDKL5 epileptic
encephalopathy.
Method: NCT02358538 is an open-label flexible-dose study at 10 Ital-
ian and US centers with exploratory objectives of safety, tolerability and
efficacy in various epileptic encephalopathy syndromes. Following
screening and baseline visit, the patients enroll into a 26-week study
during which the investigators can flexibly dose ganaxolone up to
1,800 mg/day (> 30 kg) or 63 mg/kg/day (< 30 kg). Following the 26-
week study period eligible patients may enroll into a 52-week extension.
The primary efficacy measure is % change from baseline in the 28-day
seizure frequency (total seizure count).
Results: Preliminary data were analyzed for the first 4 enrolled subjects
with CDKL5 epilepsy (4 girls; average age of 7.5 years; average ganax-
olone exposure of 5 months at time of analysis). Three of the 4 patients
experienced a seizure reduction ranging from 52% to 88%. CGI-I scores
administered by the caregiver or investigator generally correlated with
seizure reduction. One subject was discontinued after four months of
treatment due to lack of efficacy. All three responders continue to receive
treatment. Two patients who completed the 26-week study period have
enrolled into the study extension. There have been no SAEs or drug-
related AEs reported in this small cohort of patients.
Conclusion: These preliminary results suggest that ganaxolone is safe
and well-tolerated, and could have potential in the treatment of CDKL5
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epilepsy. An updated analysis from an expanded CDKL5 cohort will be
presented.
p0930
LACOSAMIDE –ANEWTREATMENTOPTION FOR
CHILDRENWITHELECTRICAL STATUS
EPILEPTICUS IN SLEEP (ESES)
M. Feucht*
*Medical University Vienna, Department of Pediatrics, Wien,
Austria
Purpose: ‘Electrical status epilepticus in sleep’ (ESES) is a childhood-
onset self-limited sleep-induced EEG pattern characterized by (nearly)
continuous focal or generalized spike and waves during non-rapid eye
movement sleep. Most patients develop epileptic seizures and they pre-
sent with variable degrees of regression in different aspects of develop-
ment related to no other factor than ESES. Treatment has therefore to
extend beyond the control of epileptic seizures and should aim to sup-
press the nocturnal interictal EEG discharges as early as possible. ESES
often remains pharmacoresistant, and complete resolution is primarily
achieved using steroids, whereas the application of standard antiepileptic
drugs (AEDs) is often ineffective. In addition, some AEDs - especially
sodium channel blocking agents may aggravate the disorder.
Lacosamide (LCM) - despite the fact that it selectively enhances slow
inactivation of voltage-gated sodium channels- has been reported to be
effective in 75% of eight children with ESES (1). We evaluated the effi-
cacy and safety of LCM on EEG and language development in children
with ESES.
Method: Children with a confirmed diagnosis of ESES and drug-resis-
tant to standard treatment with steroids were included. 24-h EEG record-
ings and neuropsychological testing were performed before and
12 months after initiation of LCM. The spike-wave index (SWI) and.
Language quotients (LQs) were calculated.
Results: 20 children (11 boys) were included. 80% of patients responded
to treatment (SWI < 25%). In 40% of them the EEG completely normal-
ized. Seizure and/or EEG aggravation was not observed. In addition,
marked improvement in LQs was noticed
Conclusion: LCM seems to be an effective and safe treatment option for
children with ESES.
p0932
DYNAMICSOFQUALITYOF LIFE IN EPILEPSY
PATIENTSWITHCOMPARATIVE ANALYSIS OF
EFFICACYANTIEPILEPTIC DRUGSMONOTHERAPY
Z. Akbarkhodjaeva*, K. Mirzaeva*
*Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan
Purpose: Evaluate the quality of life (QOL) of epilepsy patients with
estimating its dynamics on the background of monotherapy with some
AEDs.
Method: The study included 52 patients (aged 18-44 years), underwent
standard clinical-neurological, electroencephalographic studies. In addi-
tion, all patients filled questionnaire QOLIE-31 before beginning AEDs
or its correction and after optimization of antiepileptic therapy (4 month
later).
Results: Clinical picture of disease was represented by the following
types of seizures: simple partial- 25% of all patients, complex partial (au-
tomatisms) - 19%, secondary generalized seizures - 56%. From all cases
31% of epilepsy was idiopathic, 54% - symptomatic, 15% - cryptogenic.
All patients with epilepsy were on monotherapy with following AEDs:
Carbamazepine - 37% of patients, Valproate - 37%, Topiramate - 15,
Lamotrigine- 11%.
A comparative analysis of the efficiency of AEDs on QOL of patients
with epilepsy showed higher rates for patients receiving Valproate and
Lamotrigine, which correlate with higher efficiency and tolerability of
therapy. The most significant anti seizure efficiency among all groups of
drugs demonstrated Topiramate, frequency of clinically significant side
effects and negative impact on QOL weren’t observed, which doesn’t
distinguish it from Valproate. Change by subscales “Emotional well-
being”, “Cognitive functioning” in course of treatment was significantly
higher in Carbamazepine, than in Lamotrigine and Valproate groups.
This confirms existing data in the literature about greater negative impact
of Topiramate on cognitive function than other AEDs.
Conclusion: Optimized pharmacotherapy reduces incidence of side
effects, increases efficiency and improves the emotional, psychological
and physical condition of patients. To achieve high QOL remission of
seizures is not enough, because QOL is affected by presence or absence
of side effects, psycho-emotional disorders, social adaptation. Assessing
QOL of epilepsy patients using QOLIE-31 along with clinical, instru-
mental methods of examination is a reliable criterion for evaluating the
additional efficacy and tolerability of therapy.
p0933
PHARMACISTS’ PERCEIVEDCONFIDENCEAND
KNOWLEDGEONANTIEPILEPTIC DRUGS IN
ALBANIA
S. Grabova*, I. Alimehmeti†, E. Kurmaku*, A. Tela*,
O. C ibuku*, L. Lala*, E. Rraklli*, J. Kruja‡
*University Hospital Centre ‘Mother Theresa’, Service of
Neurology, Tirana, Albania, †University of Medicine,
Department of Family and Occupational Health, Tirana,
Albania, ‡University of Medicine, Department of Neurosciences,
Tirana, Albania
Purpose: Antiepileptic drugs (AEDs) are pivotal in epilepsy treatment
and pharmacists play a key role in supporting and advising people with
epilepsy (PWE). Therefore our aim was to assess pharmacists’ knowl-
edge and attitude about AEDs use in Albania.
Method: Random pharmacists from four different cities were invited to
answer to a self-administered questionnaire on demographics, years of
practice, distance from the nearest health-care center, and average num-
ber of PWE seen per month. Before the test, pharmacists were asked to
state their level of confidence and need for training on AEDs. Moreover,
a 10-item evidence-based knowledge test created by expert neurologists
was administered. These 10 vignettes included real-life situations as
emergency situations, drug-drug interactions, valproic acid blood levels
and start of lamotrigine therapy, to which pharmacists were asked to act.
Each correct action was given 1 point creating a scale of 0-10 points.
Results: Seventy-eight pharmacists, 52 females (66.7%), with a mean
age of 35.6 (10.2) years, were included in our analysis. The level of
confidence in AEDs was very high in 19.2%, average in 65.4% and low
in 15.4%. Nevertheless, 78.2% admitted that training and update were
needed. Knowledge level was impressively low, mean 2.77  1.55. The
score was not affected by gender, age, years of practice and number of
PWE per month in either t-test, correlation or regression analysis. Impor-
tantly, likewise higher confidence level did not statistically predict better
knowledge.
Conclusion: Pharmacists’ knowledge on antiepileptic drugs in Albania
is very low (2.77 out of 10) warranting their immediate training, regard-
less their perceived competence or confidence.
p0934
PERAMPANEL IN 359 REFRACTORY FOCAL
EPILEPSIES: A FRENCHCOHORT
P. Gelisse*, P.L. Tang*, P. Genton†, A. Crespel*
*Gui de Chauliac Hospital, Epileptology, Montpellier, France,
†Centre Saint Paul-H. Gastaut, Marseille, France
Purpose: Perampanel (PER) was introduced in France in May, 2014 as
add-on in drug-resistant focal epilepsies. As of June 28, 2016, all patients
newly treated with PER have been prospectively added to an ad hoc data-
base in two tertiary epilepsy clinics (Montpellier and Marseille), in order
to assess efficacy and tolerability in a practical setting.
Method: Patients were reviewed at 3 months intervals at least and were
encouraged to manifest at shorter intervals in case of problems with their
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treatment. We recorded all personal and epilepsy data, and actively
looked for side effects and all parameters of clinical efficacy at each con-
tact.
Results: A total of 359 patients were included in this study (53.5%
women; mean age 44.5 years (range 11-83); epilepsy duration
28  15.26 years; symptomatic epilepsy 62% vs cryptogenic 38%).
Patients had seizure at least one per day (11%), at least one per week
(33%) and at least one per month (47%). They were on two antiepileptic
drugs (15%), three (28%), four (41%), more than four (16%). Mean daily
dose of PER was 6.3 mg +/- 2.6 mg (range 1-14 mg). Mean exposition
to PER was 13.41 + /- 4 (range 1-25 months). PER was stopped in 23%
of the cases mainly for side effects (75%) and also for lack of efficacy
(25%). The percentage of patients with a > 50% reduction in seizure fre-
quency was 53% and 15% became seizure free. Side effects were
reported by 31% of the patients: drowsiness 21%, dizziness 12%, asthe-
nia 10%, psychiatric disorders 10%, irritability 5%.
Conclusion: In this population, PER appears to be an effective
antiepileptic drug and should thus be tried in patients who are not satis-
factorily controlled by the usual drugs. Its use can be limited by the
occurrence of psychiatric disorders or irritability. We recommend a dose
around 6 mg/day.
p0935
PERAMPANEL IN 65 ADULTSWITHTHELENNOX-
GASTAUT SYNDROMEANDRELATED
ENCEPHALOPATHIES
P. Genton*, A. Crespel†, N.P.L. Tang‡, P. Gelisse‡
*Centre Saint Paul-H. Gastaut, Marseille, France, †Gui de
Chauliac Hospital, Montpellier, France, ‡Gui de Chauliac
Hospital, Epileptology, Montpellier, France
Purpose: Perampanel (PER) was introduced in France in May, 2014 as
add-on in drug-resistant focal epilepsy. The Lennox-Gastaut syndrome
(LGS) is a rare, severe epileptic encephalopathy, in which bilateral syn-
chrony plays a major role, and the same consideration applies to related
epileptic encephalopathies with diffuse EEG changes that do not fulfill
the strict criteria of LGS. All LGS patients newly treated with PER have
been prospectively added to a database in two tertiary epilepsy clinics
(Montpellier andMarseille) in order to assess efficacy and tolerability.
Method: Patients were reviewed at 3-month intervals at least and were
encouraged to manifest at shorter intervals in case of problems with their
treatment. We recorded all personal and epilepsy data from patient dia-
ries, and actively looked for side-effects and all parameters of clinical
efficacy at each contact. We asked carers to quantify visible seizures,
including falls, motor seizures and absences.
Results: As of June 28, 2016, we have treated 43 patients with LGS and
22 with related epileptic encephalopathies (M 51%, F 49%, mean age
37 years, range 18-68). All patients had a history of mixed seizures, mod-
erate to severe mental handicap, and drug resistance. They were receiving
an average of 4.5 antiepileptic drugs, 28% also had vagus nerve stimula-
tion. Usual daily dose of PER was 6 mg. The percentage of patients with
a > 50% reduction in seizure frequency was 53% including 17%
a > 90% reduction. Side effects were reported by 27% of the patients:
psychiatric disorders 20%, drowsiness and asthenia 5%, dizziness 2.5%
and seizures aggravation 5%.
Conclusion: PER is a new treatment option. More than 50% had worth-
while improvement with a mean daily dose of 6 mg. Its use can be lim-
ited by the occurrence of psychiatric disorders or behavioural side
effects.
p0936
EFFECTIVENESS ANDTOLERABILITYOF
PERAMPANEL INCHILDRENANDADOLESCENTS
WITHREFRACTORYEPILEPSIES –AN ITALIAN
MULTICENTER STUDY
P. De Liso*,†, F. Vigevano*, N. Specchio*, L. De Palma*,
P. Bonanni‡, E. Osanni‡, G. Coppola§, P. Parisi¶, S. Grosso**,
A. Verrotti††, A. Spalice‡‡, F. Nicita‡‡, N. Zamponi§§,
S. Siliquini§§, L. Giordano¶¶, P. Martelli¶¶, R. Guerrini***,
A. Rosati***, L. Ilvento***, V. Belcastro†††, P. Striano‡‡‡, MS
Vari‡‡‡, M. Spano’§§§, F. Cucinotta§§§, G. Capovilla¶¶¶,
F. Beccaria¶¶¶, A. D’Aniello****, G. Di Gennaro****,
O. Bruni††††, A. Luchetti††††, G. Gobbi‡‡‡‡, A. Russo‡‡‡‡,
D. Pruna§§§§, G. Assenza¶¶¶¶, R. Cusmai*
*Bambino Gesu Children’s Hospital, IRCCS, Department of
Neuroscience, Neurology Unit, Rome, Italy, †Sapienza
University of Rome, Department of Pediatrics and Child
Neuropsychiatry, Rome, Italy, ‡Epilepsy and Clinical
Neurophysiology Unit, Scientific Institute, IRCCS Eugenio
Medea, Conegliano, Treviso, Italy, §Child and Adolescent
Neuropsychiatry, Medical School, University of Salerno,
Salerno, Italy, ¶NESMOS Department, Faculty of Medicine and
Psychology, Sant’Andrea Hospital, Sapienza University, Rome,
Italy, **Paediatric Neurology-Immunology and Endocrinology
Unit, University of Siena, Siena, Italy, ††Department of
Paediatrics, University of L’Aquila, L’Aquila, Italy,
‡‡Department of Paediatrics and Child Neuropsychiatry,
Sapienza University of Rome, Rome, Italy, §§Child
Neuropsychiatry Unit, Polytechnic University of the Marche,
Ancona, Italy, ¶¶Paediatric Neuropsychiatric Division, Spedali
Civili, Brescia, Italy, ***Paediatric Neurology Unit, Children’s
Hospital A. Meyer, University of Firenze, Florence, Italy,
†††Neurology Unit, Department of Neuroscience, Sant’Anna
Hospital, Como, Italy, ‡‡‡Paediatric Neurology and Muscular
Diseases Unit, Department of Neurosciences, Rehabilitation,
Ophthalmology, Genetics, Maternal and Child Health,
University of Genoa, G. Gaslini Institute, Genoa, Italy, §§§Unit
of Child Neurology and Psychiatry-University Hospital of
Messina, Messina, Italy, ¶¶¶Department of Child
Neuropsychiatry, Epilepsy Centre, C. Poma Hospital, Mantova,
Italy, ****Centro per la Chirurgia dell’epilessia IRCCS
Neuromed, Pozzilli, Isernia, Italy, ††††Child Neuropsychiatry
Unit, S. Andrea Hospital, Rome, Italy, ‡‡‡‡Child Neurology Unit,
IRCCS Institute of Neurological Sciences, Bologna, Italy,
§§§§Epilepsy Unit, Child Neuropsychiatry Department,
University Hospital, Cagliari, Italy, ¶¶¶¶Clinical Neurology,
Campus Biomedico University of Rome, Rome, Italy
Purpose: To evaluate the efficacy and tolerability of Perampanel (PER)
in children and adolescents with refractory epilepsies in daily clinical
practice conditions.
Patients and methods: This Italian multicenter retrospective observa-
tional study was performed in 19 pediatric epilepsy centers. Children and
adolescents ≤18 years of age were included. Pilot data from patients with
≥12-months follow-up were also analyzed. Age, gender, cognitive
impairment, age at onset of epilepsy, seizure and epilepsy types, aetiol-
ogy, monthly seizure frequency, number of previous anti-epileptic drugs
(AEDs), adverse events and concomitant AEDs were collected. Response
was defined as a ≥ 50% reduction in monthly seizure frequency com-
pared with the baseline.
Results: 76 patients were included in this study, 56% males with a mean
age of 14 years  2,44 (6-18 years), 75% with intellectual disability.
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Mean age at epilepsy onset was 43 months  43,26 and 10.7 years 
3,95 (range 0-17) of epilepsy duration with at least three seizure per-
month (up to several per-day). 67% (n = 51) had symptomatic focal epi-
lepsy. Mean number of AEDs used in the past was 7.08 and mean number
of concomitant AEDs was 2.48. Mean PER dose was 6,96  2,4 (2-
12 mg). After an average of 14-months of follow-up (12-21 months), 48
patients (77%) continued on PER. The response rate was 54%, 17% with
≥75% seizure frequency reduction and 5% (n = 3) becoming completely
seizure free. Seizure aggravation was observed in 10,5% (n = 8).
Adverse events were experienced in 16/76 (21%) and resulted in with-
drawal in 23 (30.3%). The most common adverse events were behavior
disturbance (irritability and aggression), dizziness and sedation.
Conclusion: Perampanel is effective in children and adolescents with
refractory epilepsy but is associated with a relatively high rate of beha-
vioural adverse events mainly in older.
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OROMUCOSALMIDAZOLAM IN PATIENTSWITH
PROLONGEDACUTECONVULSIVE SEIZURES: AN
ITALIAN EXPERIENCE
P. De Liso*,†, M. Trivisano*, N. Pietrafusa*, L. De Palma*,
R. Cusmai*, F. Antonucci*, N. Specchio*, F. Vigevano*
*Bambino Gesu Children’s Hospital, IRCCS, Department of
Neuroscience, Neurology Unit, Rome, Italy, †Department of
Pediatrics and Child Neuropsychiatry, Sapienza University of
Rome, Rome, Italy
Purpose: In pediatric age, convulsive seizures lasting more than 5 min-
utes represent a life- threatening condition. Oromucosal midazolam is a
promising first-line treatment option, which is approved in the EU for the
treatment of prolonged, acute, convulsive seizures (PACS), in patients
aged between 6 months and 18 years. The aim of this study is to evaluate
the effectiveness of oromucosal midazolam and, to compare with rectal
diazepam efficacy.
Methods: We included all consecutive patients followed-up at Bambino
Gesu Children´s Hospital in Rome who received oromucosal midazolam
treatment between January 2015 and July 2016. A telephone survey was
carried out to evaluate effectiveness, tolerability and convenience of the
administration route of oromucosal midazolam in terminating PACS.
Moreover, when rectal diazepam was previously used, has been asked a
comparative effectiveness between the two benzodiazepines.
Results: We enrolled 293 patients (149 males), aged between 6 months
and 18 years (9  4,61 years old; median: 9 years) at the time of pre-
scription, with a 16-month follow-up in average (16  5,24 months).
Most of them (98/203, 48%) had a symptomatic epilepsy and 90% (268/
273) received oromucosal midazolam care plan for the first time. We will
present the results of the telephone survey.
Conclusion: In the previous reported clinical trials, oromucosal midazo-
lam was at least as effective as rectal diazepam in the treatment of PACS
in children and was generally well tolerated. The results of this survey
showed that oromucosal midazolam has several advantages if compared
with rectal diazepam, the previous gold standard of treatment, such as
having a more convenient and socially acceptable administration route.
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LAFORABODYDEGRADATIONBYATHERAPEUTIC
ENZYMEFORTHETREATMENTOFLAFORA
DISEASE
M.K. Brewer*, J. McCarthy†, J. Pauly‡, T. McKnight§,
D. Armstrong§, MS Gentry*
*University of Kentucky, Department of Molecular and Cellular
Biochemistry, Lexington, KY, United States, †University of
Kentucky, Department of Physiology, Lexington, KY, United
States, ‡University of Kentucky, College of Pharmacy,
Lexington, KY, United States, §Valerion Therapeutics, Concord,
MA, United States
Lafora disease (LD) is the most common form of progressive myoclonus
epilepsy. LD manifests in adolescence with an initial seizure, followed
by rapid development of epilepsy, neurodegeneration and dementia, lead-
ing to a vegetative state. Treatments for LD are only palliative; death
ensues ten years after initial onset. Insoluble carbohydrate deposits
known as Lafora bodies (LBs) are present in all tissues of LD patients
and contain an aberrant form of glycogen, a carbohydrate storage mole-
cule normally found in most cells. LD is caused by mutations in EPM2A
and EPM2B, genes that respectively encode laforin, the glycogen phos-
phatase, and malin, an E3 ubiquitin ligase. EPM2A- and EPM2B-defi-
cient mice have LBs, neurodegeneration, and seizures, and multiple
groups have shown that the reduction or ablation of glycogen synthesis
eliminates LB formation and rescues LD in mice, demonstrating that LBs
drive disease progression.
Enzyme therapy is becoming increasingly popular in the treatment of
genetic diseases, but delivery to the cytoplasm is problematic. By fusing
an enzyme to an anti-DNA autoantibody fragment that penetrate cells via
a nucleoside transporter, Valerion Therapeutics successfully designed
cytosol-deliverable enzymes that are efficacious for the treatment of
Pompe disease and myotubular myopathy. We explored this approach to
deliver an amylase that would degrade LBs. We isolated LBs from
EPM2A-deficient mice and showed that amylase 2A conjugated to an
Fab fragment of human IgG1 (Fab-AMY) degrades LBs in vitro, and
injected Fab-AMY is active in vivo.We are now testing whether LBs iso-
lated from EPM2B-deficient tissues can be degraded by Fab-AMY, and
if Fab-AMY injection reduces LB load in LD mice. Fab-AMY is a
promising therapeutic for Lafora epilepsy, potentially the first drug to
provide a significant clinical benefit.
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FEBRILE SEIZURES ANDRISKOF PSYCHIATRIC
DISEASE IN ADULTHOOD
J. Werenberg Dreier*, C. Boecker Pedersen*, J. Christensen†
*Aarhus University, National Centre for Register-Based
Research, Aarhus, Denmark, †Aarhus University Hospital,
Department of Neurology, Aarhus, Denmark
Purpose: To examine the relationship between febrile seizures and sub-
sequent risk of psychiatric disease in adulthood.
Method: This is a population-based cohort, including all children born
in Denmark between 1977 and 2002. We assessed the risks of psychiatric
disease associated with a history of febrile seizures. We followed the
children from their 10th birthday, and assessed the risk of substance abuse
disorders, schizophrenia, mood disorders, anxiety and personality disor-
ders. Cox regression was used to estimate hazard ratios (HRs) and corre-
sponding 95% confidence intervals (95% CI) for each disorder, adjusted
for relevant confounders.
Results: We followed 1,556,959 children, of which 54,614 (3.5%) had
febrile seizures for a total of ~19 million person-years of follow up and
identified 101,515 persons who subsequently developed a psychiatric
disease. A history of febrile seizures was associated with slightly elevated
rates of psychiatric diseases in later life, with the associations being
strongest for schizophrenia (HR: 1.25, 95% CI: 1.13-1.37). Recurrent
admissions to the hospital for febrile seizures were generally associated
with more pronounced effects. Age of onset of febrile seizures (3-
14 months/ ≥15 months) did not seem to affect the strength of the associ-
ations.
Conclusion: Febrile seizures were associated with a mild to moderate
increased risk of psychiatric disease in adulthood. The findings suggest
that in some children, febrile seizures may affect the developing brain,
resulting in an increased vulnerability to develop psychiatric disease.
However, the associations may also be explained by a common underly-
ing genetic susceptibility or by unmeasured or residual confounding.
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INFECTIONS INCREASE THERISKOFEPILEPSY: A
NATIONWIDEREGISTER BASEDCOHORT STUDY
F.S. Ahlers*, M.E. Benros†, J. Christensen*
*Aarhus University Hospital, Neurological Department F,
Aarhus, Denmark, †Copenhagen University Hospital, Mental
Health Centre Copenhagen, Copenhagen, Denmark
Purpose: The causes of epilepsy are not fully understood. But epilepsy
has a high degree of psychiatric comorbidity, and infections increase the
risk of psychiatric disorders, while certain infectious diseases also
increase the risk of epilepsy. This study investigates whether infectious
diseases increase the risk of subsequent epilepsy.
Methods: This is a nationwide, prospective cohort study including all
2,235,490 persons born in Denmark from 1977 to 2012. Patients with
infections and epilepsy were identified from the National Patient Regis-
ter. Vital status was determined from the Danish Civil Registration Sys-
tem and the Danish Medical Birth Register. Persons were individually
followed from the day of birth until one of the following endpoints: epi-
lepsy diagnosis, death, emigration, disappearance, or December 31st
2012, whichever came first.
Adjusting for age, sex, calendar year, Apgar score, gestational age and
birthweight, the following exposure variables were studied: number of
admissions with infections, time since last infection, total number of days
hospitalized with infection, organ of infection, number of different infec-
tions, and microbiological type. Data was analyzed using Cox regression
in STATA.
Results: During 36 years of follow up, 721,460 persons had hospital
contacts with infection and 35,112 with epilepsy. The overall risk of epi-
lepsy after a hospital contact with infection was approximately twice that
of persons without hospital contacts for infection (aHR=2.05, 95% CI:
2.00-2.10). The risk of epilepsy increased with the number of contacts
with infection: one contact: 1.72 (1.67-1.77), two: 2.18 (2.09-2.28), three:
2.57 (2.41-2.74), four: 3.40 (3.13-3.68), five: 3.70 (3.31-4.12), six: 4.56
(3.99-5.21), seven: 4.62 (3.88-5.50), eight or more: 6.24 (5.61-6.93).
Conclusion: Hospital contact with infection was associated with an
increased risk of developing epilepsy later. The risk of epilepsy was
highly associated with the number of admissions with infections. The
findings are compatible with an inflammatory hypothesis in subgroups of
persons with epilepsy.
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PREMATUREMORTALITY IN PERSONSWITH
EPILEPSYAND SCHIZOPHRENIA: A NATIONWIDE
COHORT STUDY
K. Maul Andersen*, L. Petersen†, M. Vestergaard‡, C. Bøcker
Pedersen†, J. Christensen*
*Aarhus University Hospital, Neurology, Aarhus C, Denmark,
†Aarhus University, National Centre for Register-Based
Research, Aarhus C, Denmark, ‡Aarhus University, Research
Unit and Section for General Practice, Institute of Public
Health, Aarhus C, Denmark
Purpose: Both epilepsy and schizophrenia are associated with premature
mortality. However, it is uncertain how comorbidity between the two dis-
orders affects the mortality. We assessed the mortality for persons with
epilepsy and schizophrenia in absolute and relative measures.
Method: We included all persons born in Denmark 1960-87, who were
alive and residing in Denmark by their 25th birthday. From national
health registries we identified persons diagnosed with epilepsy and
schizophrenia prior to their 25th birthday. Participants were followed
from their 25th birthday to death, emigration, or December 31st 2012. The
primary outcome was overall mortality. In sub-analyses estimates were
stratified by sex, epilepsy sub-types, and a stricter definition of
schizophrenia. Furthermore, in sensitivity analyses we estimated the
mortality in participants followed from their 20th and 30th birthday. Data
was analysed using Cox regressions.
Results: We followed 1,620,376 persons for 24,167,573 person years of
follow up; median 15 years. The mortality rate ratio (MRR) was 44
(95% CI; 41-47) for persons with epilepsy, 66 (95% CI; 61-71) for
persons with schizophrenia, and 128 (95%CI; 91-181) for persons with
both disorders compared to persons without these disorders. Estimated
cumulative mortality at the age of 50 was 31 % (95% CI; 30-31 %) for
persons without epilepsy and schizophrenia, 107 % (95% CI; 97-118
%) for persons with epilepsy, 174% (95% CI; 160-188 %) for persons
with schizophrenia, and 272 % (95% CI; 157-401 %) for persons with
both disorders.
Conclusion: Persons with both epilepsy and schizophrenia have a very
high mortality; the absolute risk of dying before the age of 50 was nine
times higher compared to persons without epilepsy and schizophrenia,
indicating that these patients constitute a vulnerable group that needs
special clinical attention.
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THE IMPACTOFGEOGRAPHYONEPILEPSY
MORTALITY: A RETROSPECTIVECASE SERIES
FROM 4U.S.MEDICAL EXAMINEROFFICES
E. Cihan*, D. Hesdorffer†, M. Brandsoy‡, J. Lucas‡, L. Li§,
J. Graham¶,**, O. Devinsky*, D. Friedman*
*NYU Langone School of Medicine, Neurology, New York, NY,
United States, †Columbia University College of Physicians and
Surgeons, New York, NY, United States, ‡San Diego Department
of the Medical Examiner, San Diego, CA, United States,
§Maryland Office of the Chief Medical Examiner, Baltimore,
MD, United States, ¶New York City Office of the Chief Medical
Examiner, New York, NY, United States, **NYU Langone School
of Medicine, Department of Forensic Pathology, New York, NY,
United States
Purpose: We examined the impact of correlates of socio-economic sta-
tus (SES) on decedents with epilepsy presenting for medico-legal investi-
gation (MLI) in four medical examiner (ME) offices in the United States.
We hypothesize that there is excess epilepsy mortality in neighborhoods
with the lowest median income.
Methods: We queried all decedents for MLI at four ME offices (NYC,
Maryland, San Diego Co. and Monmouth Co.) between 1/1/2009-12/31/
2010, and identified all decedents where epilepsy or seizure was a cause
or contributor to death on the death certificate. We reviewed the available
autopsy reports, investigation notes and ME records. We independently
adjudicated which deaths were due to SUDEP.We used postal (ZIP) code
of residence as a SES surrogate. ZIP code regions were ranked by median
household income (American Community Survey, 2009-2013) and
divided into quartiles based on total regional population (US Census
Bureau, 2010). Region-, age- and income-level adjusted epilepsy preva-
lence in each ZIP code was estimated using 2010 CDC National Health
Interview Survey data. Rates and adjusted rate ratios were calculated
using OpenEpi.com.
Results: We identified 317 decedents (168 NYC, 76 Maryland, 62 San
Diego, 11 Monmouth) with epilepsy as cause/contributor to death over
the 2-year period. The rate of epilepsy-related deaths (per 1000 pt-yrs)
undergoing MLI was 0.5 (95% CI: 0.4-0.8) in highest income quartile
and 1.3 (95% CI: 1.1-1.6) in the lowest income quartile. ME office-
adjusted rate ratio between lowest and highest income quartile was 2.3
(95% CI: 1.6-3.3; p < 0.0001). Considering only SUDEP deaths, the dif-
ference between lowest and highest income quartiles remained signifi-
cant (adjusted RR:2.6 95% CI: 1.8-3.9).
Conclusion: The rate of all epilepsy-related deaths and SUDEPs under-
going MLI was significantly greater among resident of the poorest ZIP
codes compared to the wealthiest ZIP codes. Further studies are needed
to understand the causes of these disparities.
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PATERNALAGEANDRISKOFEPILEPSY IN THE
OFFSPRING
J. Christensen*, J.W. Dreier†
*Aarhus University Hospital, Department of Neurology, Aarhus,
Denmark, †Aarhus University, National Centre for Register-
Based Research, Aarhus, Denmark
Purpose: Advanced paternal age is associated with a range of adverse
neuropsychiatric outcomes possible due to an age associated increase in
de novo mutations in the mal germ cells. We examined the relationship
between paternal age and risk of epilepsy in the offspring.
Methods: The study was designed as a population-based cohort, includ-
ing all children born in Denmark between 1977 and 2012. The children
were followed from birth, and we assessed the risks of epilepsy stratified
on paternal age. Cox regressions were used to estimate hazard ratios
(HR) and corresponding 95% confidence intervals for epilepsy adjusted
for gestational age at birth, birth weight, Apgar scores (5 min), and
maternal age.
Results: We followed 2,246,886 children for 38,139,744 years of follow
up, of which 31,406 were diagnosed with epilepsy. Compared to off-
spring of fathers aged 25-29, the risk of epilepsy was increased - both off-
spring of younger and older fathers (fathers age: < 20 years (aHR: 1.09
(95% CI: 0.96-1.23)), 20-14 years (aHR: 1.07 (95% CI: 1.02-1.11)); 30-
34 years (aHR: 1.00 (95% CI: 0.97-1.03)), 35-39 years (aHR: 1.02 (95%
CI: 0.98-1.07)), 40-44 years (aHR: 1.09 (95% CI: 1.02-1.21), and
≥45 years (aHR: 1.12 (95%CI: 1.03-1.21))
Conclusions: For offspring of fathers older than 25-29 years of age, the
risk of epilepsy increased with increasing age. However, the results
suggest only a modest effect of paternal age on the etiology of epilepsy.
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EXPERIENCESOF ELDERLYEPILEPSY PATIENTS IN
EMERGENCYCARE
T. Porschen*, F.C. Schmitt†, B.J. Steinhoff‡, W. Graf§, C. Tilz¶,
H. Stefan**
*Association for People with Epilepsy, Epilepsy Self-Help,
Koeln, Germany, †University of Magdeburg, Department of
Neurology, Magdeburg, Germany, ‡Epilepsy Center Kork, Kehl-
Kork, Germany, §University Hospital Erlangen, Department of
Neurology, Erlangen, Germany, ¶Krankenhaus Barmherzige
Br€uder Regensburg, Department of Neurology, Regensburg,
Germany, **University Hospital Erlangen, Department of
Neurology-Biomagnetism, Erlangen, Germany
Purpose: There is little knowledge about emergency care in elderly epi-
lepsy patients. A multicenter survey was performed to get more informa-
tion about this relevant topic.
Method: In this retrospective survey a structured questionnaire was
developed to explore patient experiences during their emergency situa-
tions. Epilepsy patients older than 50 years or their family members were
included. The multicenter study was accompanied by physicians in dif-
ferent parts of Germany, patients self-help groups and by using an inter-
net platform. The project started in October 2015 and finished in
November 2016.
Results: Complete information about 83 epilepsy patients was collected
via internet platform (n = 36) or a handwritten form (n = 47). The med-
ian age was 61 years (range 50-79 years). 94 % of the patients knew their
epilepsy diagnosis. 33 % of the patients lived alone. 59% of all patients
reported about seizure-related-injuries in the past, 70% of all patients
were treated in a hospital, although they did not want to go in a hospital.
36% of the respondents took epilepsy emergency medications. 52% of
the epilepsy patients felt not adequately informed about measures and
behavior in case of epilepsy emergency. Only 15% of all participants
used an epilepsy emergency card.
Conclusion: The emergency care experiences of elderly epilepsy
patients were collected using a structured patient questionnaire. The
results show a great need for more information and education of elderly
epilepsy patients about management of emergency situations. From the
patient´s point of view, it is particularly important for elderly patients to
avoid unnecessary emergencies.
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ASSOCIATIONOFALPHA SUBUNITOFGABAA
RECEPTOR SUBTYPEGENE POLYMORPHISMWITH
EPILEPSY SYNDROMES IN INDIAN POPULATION
S.A. Guru*, M.A. Bhat*, R. Mir*, M. Zuberi*, M. Sumi*,
S. Bodeliwala*, V. Puri†, A. Saxena*
*Maulana Azad Medical College, New Delhi, India, †G B Pant
Hospital, New Delhi, India
Aims: To evaluate GABAA (c-amino butyric acid) receptor gene as can-
didates for epilepsy susceptibility, we screened coding single-nucleotide
polymorphism of GABRA1 15 A>G in Indian epilepsy syndrome
patients.
Methods: The genotyping was performed in 100 control subjects and
100 patients with epilepsy syndromes, of whom 50 were Juvenile Myo-
clonic Epilepsy (JME) patients and 50 were Lennox-Gastaut syndrome
(LGS) patients by RFLP-PCR.
Results: We determined the genotypic and allelic frequencies in 100 epi-
lepsy syndrome patients (50 JME and 50 LGS) and 100 normal healthy
controls by PCR-RFLP assay. In Juvenile Myoclonic Epilepsy, no statis-
tical difference was observes among the patients and control subjects
(p = 0.06) and in Lennox-Gastaut syndrome, no statistical difference
was observes among the patients and control subjects (p = 1.78). How-
ever, a statistical difference was observed among the patients with
respect to drug response with a p value of 0.04.
Conclusion: GABRA1 15 A>G polymorphism of GABA receptor gene
may play a significant role in LGS with respect to drug response.
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EFFICACYAND SAFETYOF INTRAVENOUS
LACOSAMIDE IN FOCAL STATUS EPILEPTICUS IN
ELDERLYANDCRITICALLY ILL PATIENTS
E. Venturelli*, S. Quadri*, B. Frigeni*, M.C. Servalli*,
C. Foresti*, M. Viscardi*, MR Rottoli*
*ASST Hospital Papa Giovanni XXIII Bergamo, Bergamo, Italy
Introduction: Non convulsive status epilepticus (NCSE) is a commonly
underrecognized condition in clinical practice. In elderly and critically ill
patients, NCSE treatment presents pharmacological management chal-
lenges and potential serious side effects. Lacosamide (LCM) is an anti-
convulsant with a good safety profile.
Purpose: To evaluate the efficacy of lacosamide in a prospective obser-
vational study enrolling patients with NCSE in focal epilepsy.
Methods: Patients were included according to the following inclusion
criteria: 1. Diagnosis of NCSE 2. No PLEDS or BPLEDS in EEG moni-
toring or diagnosis of postanoxic encephalopathy.
Primary outcome measure was incidence and time to seizure EEG and
clinical cessation. We enrolled 25 consecutive subjects with NCSE in
whom LCM at a loading dose of 300 mg over 15 minutes, was added
during continuos EEG monitoring for inefficacy of benzodiazepine and
levetiracetam (LEV).
Results: Twenty five patients (17 men, 8 women) were included, with a
median age of 65 (range 19-87) years. The most common etiology of
NCSE was intracranial hemorrhage and brain tumor. LCM was intro-
duced as third agent after benzodiazepine and LEV (2000-3000 mg/die).
Most (20/25) NCSE was terminated within 8-20 hours after LCM. The
time to improvement in the EEG and in clinical observation varied
between 6-48 hours. There were no side effects directly attributable to
LCM.
Conclusions: Both LEV and LCM share some characteristics (rapid act-
ing, little drug-drug interaction) that make them ideal AED in NCSE.
Although the lack of randomized clinical trials assessing efficacy, LEV
has been shown to be safe and effective in critically ill patients as well in
status epilepticus. Our data suggest that LCM is well tolerated and
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effective in the treatment of refractory NCSE. Waiting for trials evaluat-
ing effectiveness of LCM in comparison to LEV, we suggest to try LCM
in NCSE in focal epilepsy before and not after LEV.
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PERAMPANELUSE INOLDER PEOPLEWITH
EPILEPSY: POOLEDDATA FROMEUROPEAN
OBSERVATIONAL STUDIES
C. Neuray*, G. Zimmermann*, V. Villanueva†, I. Garamendi‡,
J. Sander§, R. Shankar¶, E. Ben-Menachem**, M.J. Brodie††,
M.C. Pensel‡‡, T. Wehner§§, G. Di Gennaro¶¶,
A. Maurousset***, A. Strzelczyk†††, S. Rheims‡‡‡, A. Racz‡‡,
S. Knake§§§, V. Bertol-Alegre¶¶¶, I. Garcıa-Morales****,
F.J. Lopez-Gonzalez††††, M. Toledo‡‡‡‡, E. Trinka*
*Christian Doppler Klinik, Paracelsus Medical University,
Salzburg, Austria, †Hospital Universitario y Politecnico La Fe,
Valencia, Spain, ‡Hospital Universitario Cruces, Baracaldo,
Spain, §UCL Institute of Neurology, National Hospital for
Neurology and Neurosurgery, London, United Kingdom,
¶Cornwall Partnership NHS Foundation Trust, Exeter, United
Kingdom, **Sahlgrenska Academy, University of Gothenburg,
Gotheburg, Sweden, ††Epilepsy Unit, West Glasgow ACH -
Yorkhill, Glasgow, United Kingdom, ‡‡University Hospital of
Bonn, Department of Epileptology, Bonn, Germany, §§National
Hospital for Neurology and Neurosurgery, London, United
Kingdom, ¶¶IRCCS NEUROMED, Pozzilli, Italy, ***University
Hospital Bretonneau and INSERMU 930, Tour, France,
†††University Hospital Frankfurt, Frankfurt, Germany,
‡‡‡Hospices Civils de Lyon, Lyon, France, §§§University
Hospital Marburg, Marburg, Germany, ¶¶¶Hospital
Universitario Miguel Servet, Zaragoza, Spain, ****Hospital
Clinico San Carlos, Madrid, Spain, ††††Complejo Hospitalario
Universitario Santiago, Santiago de Compostela, Spain,
‡‡‡‡Hospital Universitario Vall d’Hebron, Barcelona, Spain
Purpose: Phase III clinical trials of antiepileptic drugs include few peo-
ple aged ≥65 years. To supplement data from randomized controlled
studies, real-world evidence with perampanel in older people with epi-
lepsy is therefore essential, when considering treatment choices for this
population.
Method: Data from clinical records of patients treated with perampanel
at 46 European centres were pooled. One-year retention rate, seizure-
freedom (for ≥6 months), and adverse events (AEs) were recorded and
are reported here for patients aged ≥65 years. Cumulative logistic regres-
sion analyses were performed.
Results: Logistic regression in the full dataset (N = 2332) showed the
probability of seizure freedom increased with age (regression coefficient
range: 0.032-0.067). There were 135 patients aged ≥65 years (range 65-
96 years). Median epilepsy duration in this population of older patients
was 45 years, aetiology was mostly cryptogenic (35/128) or symptomatic
(92/128), and focal seizures were the most common type. Patients had
previously used a median of 5 AEDs, and were taking a median of 2 con-
comitant AEDs before perampanel. One-year retention rate was 50%; 67
patients discontinued (intolerability in 10, lack of efficacy in 3, not speci-
fied in 54). Among the 46 patients for whom full seizure data were avail-
able, 13 (28.3%) were seizure free (95% confidence interval 15.2-41.3).
AEs were reported in 71% (69 of 97) during 12 months, most commonly
dizziness/vertigo (18.0%), somnolence/sleepiness (14.6%), behavioural
AEs (11.2%), and mental confusion/slowing (9.0%).
Conclusion: In patients aged ≥65 with predominantly focal epilepsy, sei-
zure freedom with add-on perampanel was seen in 28%, higher than
achieved in Phase III trials. Perampanel was well tolerated, with half of
the treated patients remaining on perampanel at 1 year, and AEs were in
line with previous reports.
Acknowledgements: Data Analysis and writing were supported by an
Investigator-Initiated Study grant from Eisai Ltd, as was data collection
at some study sites.
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THEROLEOFVASCULARIZATIONOFTHECORPUS
CALLOSUMDURINGMICROSURGICAL
CALLOSOTOMY IN PATIENTSWITH SEVERE
SYMPTOMATIC EPILEPSY
V. Cheburakhin*, K. Kostiuk*
*Romodanov Neurosurgery Institute, Functional Neurosurgery,
Kiev, Ukraine
Purpose: Evaluate of the efficacy and safety of microsurgical calloso-
tomy in the early postoperative period, taking into account the features of
the vascularization of the corpus callosum in the surgical treatment of
severe symptomatic epilepsy.
Method: In this study were enrolled 13 children with drug-resistant epi-
lepsy aged from 2 t 16 years (mean 7.3  2.8 years) who underwent cal-
losotomy. At the time of the surgery frequency of seizures was
20.3  9.8 per day, 11 from 13 (84.6%) had repeated status epilepticus.
Six (46.2%) had one-stage total callosotomy and 7 (53.8%) underwent
anterior callosotomy. Postoperative follow-up was from 8 to 30 moths
(mean - 16.7  3.6 months).
Results: After surgery 4 (30.8%) were seizure-free (Engel scale - 1), 5
(38.5%) had rare short auras (Engel scale - 2), in 3 (23.0%) cases the sei-
zure frequency significantly reduced - over 80%. In 1 (7.7) child who had
Rasmussen encephalitis secondary generalised seizures were stopped but
partial motor fits persist (Engel scale - 4).
Conclusion: Callosotomy is effective and safe methods of treatment sev-
ere epilepsy. Positive outcome is caused by establishing the correct indi-
cations for surgery and application of modern microsurgical equipment,
taking into account topographic and anatomic features of the blood sup-
ply of the corpus callosum.
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OUREXPERIENCEOF SURGICALTREATMENTOF
MULTIFOCALEPILEPSY
K. Kostiuk*, Y. Medvedev*, M. Shevelov*, V. Cheburakhin*,
A. Popov*, N. Vasulyv*, O. Kanajkin†, S. Dichko*
*Romodanov Neurosurgery Institute, Functional Neurosurgery
and Neuromodulation, Kyiv, Ukraine, †Romodanov
Neurosurgery Institute, Functional Diagnostic, Kyiv, Ukraine
Purpose: A characteristic feature of multifocal epilepsy is a high inci-
dence of intractable, severe and traumatic seizures. Patients with multifo-
cal epilepsy are often considered unsuitable for epilepsy surgery. The
purpose of the report is to demonstrate our initial experience of surgical
treatment of multifocal epilepsy.
Method: 18 patients with multifocal epilepsy were enrolled in study,
among them there were 16 (89%) children and 2 (11%) adults. Patient’s
age ranged from 4 to 42 years (mean - 12.5 years). Mean duration of epi-
lepsy before surgery was 7.5 years; mean seizure frequency was 21.6 sei-
zures per day. Epileptic encephalopathy observed in 12 cases (67%).
Patients underwent the following surgical interventions: topectomy - 4
(22.2%), callosotomy - 7 (38.9%); multilobar resections - 4 (22.2%), cal-
losotomy in combination with resective interventions - 3 (16.7%). Fol-
low-up ranged from 1 to 3.5 years (mean - 2.3 months).
Results: In 10 (55.6%) cases seizure foci were found independently in
multiple lobes of the same hemisphere or included a single wide field
within several lobes of one hemisphere. In 8 (44.4%) cases seizure foci
were found in both hemispheres. After treatment 7 (38.9%) patients
became seizure-free (Engel 1), 5 (27.8%) patients had rare short auras
(Engel 2), in 4 (22.2%) cases seizure frequency reduced over 75%, in 2
(11.1%) cases seizure frequency reduced less then 75% or did not change.
Best results were achieved after multilobar resections and combined
resective intervention and callosotomy. There were no postoperative
morbidity and mortality.
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Conclusion: Our preliminary results may to conclude that multilobar
resections and combined resective surgery with callosotomy can be the
valuable treatment approach for multifocal epilepsy because of their
effectiveness and safeness. Functional disconnecting interventions (cal-
losotomy) aimed to blocking epileptogenic activity and are reserved for
patients, suffering from severe epilepsy who are not good candidates for
resective surgery.
p0965
ATYPICAL PRESENTATIONOFRASMUSSEN’S
ENCEPHALITIS: A CASE SERIES
G. Reyes Valenzuela*, J. Princich†, R. Gutierrez*, R. Lizama*,
L. Beltran*, M. Massaro Sanchez*, M. Bartuluchi‡,
F. Lubieniecki§, R.H. Caraballo*, J. Pocciecha*
*Hospital de Pediatria J. P Garrahan, Neurology, Buenos Aires,
Argentina, †Hospital de Pediatria J. P Garrahan, Buenos Aires,
Argentina, ‡Hospital de Pediatria J. P Garrahan, Neurosurgery,
Buenos Aires, Argentina, §Hospital de Pediatria J. P Garrahan,
Pathological Anatomy, Buenos Aires, Argentina
Purpose: To analyse the unusual clinical, electroclinical, and neu-
roimaging features in a group of patients diagnosed with Rasmussen’sen-
cephalitis (RE).
Method: Forty patients with RE seen between 1990 and 2016 meeting
the inclusion criteria of the 2014 European Consensus were retrospec-
tively evaluated. Only those with atypical presentations were included in
the study.
Results: Of 40 patients, seven presented with atypical forms: Pure motor
deficit 3/7 (hemiparesis 2, monoparesisand steppage gait 1); hemichorea
and hemidystonia 1/7; isolated focal seizures 3/7. All patients developed
epilepsy partialis continua (EPC) 2.8 years after symptom onset (range,
1-6 years). In all patients, EEG recordings at onset showed focal dis-
charges, with unilateral deterioration of the background activity in three.
In five patients, the initial MRI did not show signs of atrophy, but in three
of them extensive abnormal areas with hyper-intense T2/FLAIR signal in
the subcortical white matter compatible with edema and mild mass effect
were observed. In another patient, images were suggestive of focal corti-
cal dysplasia and in the remaining one a posterior lesion compatible with
sequelae of ischemic injury was seen. A control MRI was available in
five showing local atrophy in only three of them. Lesions in both hemi-
spheres were observed in two, seen since onset in one. In four patients
with refractory seizures hemispherectomy was performed, with a biopsy
in two. Histopathology showed signs of inflammation compatible with
RE.
Conclusion: RE should be considered in patients with focal motor signs,
hemichorea, orhemidystonia previous to seizure onset. The presence of
epileptic spasms in bursts does not rule out the diagnosis. Radiological
signs of pseudotumorcerebri or bilateral involvement may be manifesta-
tions of RE.
p0967
MILDMALFORMATIONOFCORTICAL
DEVELOPMENTWITHOLIGODENDROGLIAL
HYPERPLASIA IN FRONTAL LOBEEPILEPSY:
CLINICALANDMANAGEMENTAPPROACHOFA
NEWENTITY
A. Aledo-Serrano*, R. Toledano*, I. Garcıa-Morales*,
J. Alvarez-Linera†, A. Gil-Nagel*
*Hospital Ruber Internacional, Neurology, Madrid, Spain,
†Hospital Ruber Internacional, Radiology, Madrid, Spain
Purpose: Mild Malformation of Cortical Development with Oligoden-
droglial Hyperplasia in Frontal Lobe Epilepsy (MOGHE) is a recently
described clinico-pathological entity associated with a drug-resistant epi-
lepsy. In this communication we report the clinical and prognostic
features of patients withMOGHE in our clinic.
Method: Out of 33 patients with focal cortical dysplasia surgically trea-
ted between 2008 and 2016, we identifed 5 patients (2 women, range 3-
10 years) with pathological diagnosis of MOGUE. The presurgical eval-
uation included VEEG,MR/PET and neuropsychological assessment.
Results: All patients had a frontal lobe epilepsy with early onset (me-
dian=18 months), daily focal seizures and cognitive impairment. MRI
showed white-gray matter blurring and hypersignal in T2. PET/MRI
showed a wide frontal hypometabolism. EEG demonstrated frontal sei-
zures, with bilateral synchrony during interictal registry. In 3 patients,
stereo-EEG showed a wide epileptogenic area at frontal lobe, with more
involvement of the medial aspect. After surgery, 2 patients were seizure
free, 2 without tonic seizures.
Conclusions: In our serie, patients with MOGHE presented a frontal
medial epilepsy with tonic seizures and cognitive impairment of early
onset. Although radiological findings are not circumscribed, epilepsy
surgery can be effective in a subgroup of patients.
p0968
TUBERCENTRE-ONLYRESECTIONS FOR SEIZURE
CONTROL IN TUBEROUS SCLEROSIS
A.S. Harvey*, C. Bailey*, J. Freeman*, S. Barton*,
S. Mandelstam†, R. Leventer*, D. Macgregor‡, W. Maixner§
*Royal Children’s Hospital, Melbourne, Neurology, Melbourne,
VIC, Australia, †Royal Children’s Hospital, Melbourne, Medical
Imaging, Melbourne, VIC, Australia, ‡Royal Children’s
Hospital, Melbourne, Pathology, Melbourne, VIC, Australia,
§Royal Children’s Hospital, Melbourne, Neurosurgery,
Melbourne, VIC, Australia
Purpose: Intracranial EEG monitoring studies reveal seizures in tuber-
ous sclerosis (TS) arise from tubers not peri-tuberal cortex (Mohamed,
Neurology 2012), and specifically from the dysplastic centre of tubers
(Kannan, Brain 2017). We report 6 epilepsy surgeries in 5 children with
TS in whom resection was limited to the tuber centre, leaving the tuber
rim and surrounding cortex.
Method: The 5 children, aged 0.8-4.2 years at surgery, had epilepto-
genic tubers in the precentral or postcentral gyri. In 5/6 surgeries, seizures
were focal clonic, scalp EEG showed interictal epileptiform discharges
(IEDs) and ictal rhythms in the central region, and surgery was performed
in 1-stage with intraoperative ECoG. One child had complex seizure pat-
terns and underwent 2-stage surgery with prior intracranial EEGmonitor-
ing.
Results: In all 6 surgeries, rhythmic IEDs were recorded from the tuber
centre with depth electrodes. To minimize the risk of postoperative motor
deficit, surgery was limited to the cortex in the centre of the tubers. Post-
resection ECoG revealed no rhythmic IEDs in the tuber rim or surround-
ing cortex. Histopathology revealed a concentration of dysmorphic neu-
rons, compared to tuber rim biopsies. There were no transient or
permanent motor deficits following surgery. Focal motor seizures and
central IEDs ceased in 5/6 surgeries (follow-up 4 m, 2.1y, 2.2y, 4.7,
4.9y). Seizures continue in the child with complex seizure patterns.
Conclusion: The seizure free outcomes following limited resection of
the centre of tubers add to the EEG, MRI and histological evidence of
epileptogenicity in TS being localised to dysplastic cortex in the tuber
centre.
S170
Abstracts
Epilepsia, 58(Suppl. 5):S5–S199, 2017
doi: 10.1111/epi.13944
p0969
MAPPINGHYPEREXCITABLENEURALNETWORK
CONNECTIONS IN EXTRA-TEMPORAL LOBES IN THE
HUMANBRAIN IN PATIENTSWITHEPILEPSY
R. Warraich*, C. Pimenta-Reis*, R.P. Selway†, G. Alarcon*,‡,§,
D. Jimenez-Jimenez*,¶, A. Valentin*,¶
*Kings College London, Department of Basic and Clinical
Neuroscience, Institute of Psychiatry, Psychology and
Neuroscience. King’s College London, UK, London, United
Kingdom, †Department of Neurosurgery, King’s College
Hospital, NHS Trust, London, United Kingdom, ‡Comprehensive
Epilepsy Center Neuroscience Institute, Academic Health
Systems, HamadMedical Corporation, Doha, Qatar,
§Universidad Complutense, Departamento de Fisiologıa,
Facultad de Medicina, Madrid, Spain, ¶Department of Clinical
Neurophysiology, King’s College Hospital NHS Trust, London,
United Kingdom
Purpose: Understanding seizure connectivity is of paramount impor-
tance if aiming for extensive disconnection of epileptogenic neural net-
works. The aim of this study is to identify seizure spreading across the
extra-temporal lobes of epilepsy patients and to test whether spreading
channels are hyperexcitable regions.
Method: 66 seizures were visually analysed by two independent obser-
vers and grouped into 14 different types of unilateral onset seizures from
10 patients with intracranial electrodes implanted at KCH. Patients had
the following electrode coverage: Frontal, parietal and temporal (FPT),
(FP), (TF), (TP) and occipital and temporal (OT). Seizures were classi-
fied as: seizure onset (SO), seizure spreading (SS). Single pulse electrical
stimulation (SPES) delivered electrical stimuli (1 msec, 4-8mAs every 5
secs) to two adjacent channels at a time to identify hyperexcitable regions
(delayed responses).
Results: 10 out of 14 seizures had spreading to different lobes. Patients
with FPT and SO in the temporal lobe had SS to frontal and parietal and
those with SO in the parietal lobe had SS to frontal and temporal. In
patients with FP, 4 had frontal SO with 3 SS to the parietal lobe. In
patients with TF, 2 had temporal SO with 1 SS to the frontal lobe. In TP,
1 patient had temporal SO with SS to the parietal. In OT, 1 patient had
occipital SO with SS to the temporal.
From 10 spreading seizures analysed, one set of spreading channels
were hyperexcitable in the OT patient, who has had resective surgery.
This may explain the poor post-surgical outcome (Engel III), after
14 months follow up. The remaining spreading channels were not hyper-
excitable and therefore the hyperexcitable regions remained in the SO
zone.
Conclusion: SS channels are not usually hyperexcitable. However, in
patients with hyperexcitable SS channels, resective surgery should
include these channels or consider subacute cortical stimulation of them.
p0970
PROLONGEDREVERSIBLE NEUROLOGICAL
DYSFUNCTION INNEUROSURGICAL PATIENTS
S.-Y. Lee*, W.-S. Cho†, S.J. Lee‡, J.-H. Phi§
*Kangwon National University School of Medicine, Neurology,
Chuncheon, Korea, †Seoul National University College of
Medicine, Neurosurgery, Seoul, Korea, ‡Kangwon National
University School of Medicine, Neurosurgery, Chuncheon,
Korea, §Seoul National University Children’s Hospital,
Pediatric Neurosurgery, Seoul, Korea
Purpose: In neurosurgical patients, unexplainable neurological deterio-
ration is often observed. We report a new category of transient focal neu-
rologic dysfunction with electroencephalography (EEG) suppression of
neither ischemic nor epileptic cause.Methods
We describe prolonged but fully reversible focal neurologic dysfunc-
tions without the evidence of ischemia and seizures in 8 patients who
received indirect revascularization surgery for moyamoya disease. We
performed brain imaging including diffusion weighted MR and perfusion
MR or SPECT, and EEG during the episodes and after the resolution of
the symptoms.
Results: The symptoms were dysarthria with or without hemiparesis,
hemiparesthesia of limbs contralateral to the operation side. A patient
had a focal motor seizure in paretic arm for 3 minutes in the middle of
the episode. The symptoms developed from 12 hours to 8 days after sur-
gery and lasted for 2 days to 17 days. Brain imaging showed only mini-
mal subdural hemorrhage associated with surgery without interval
change. Perfusion imaging showed subtle elevation of cerebral blood
flow in the operated hemisphere. EEG revealed low amplitude arrhyth-
mic slowing in corresponding hemisphere. Follow-up imaging and EEG
after recovery showed no abnormality.
Conclusion: Sudden neurologic deterioration after surgery embarrasses
neurosurgeons but it resolves spontaneously if not accompanied by struc-
tural abnormality or ischemia. Hypofunction and EEG suppression char-
acterize this phenomenon whereas hyperactivity and EEG hyper-
synchrony characterize seizure.We hypothesize that the pathophysiology
of this condition is transient cortical depression triggered by surgical pro-
cedure, like Leao’s “cortical spreading depression”.
p0972
MODIFIED SUBPIAL “ENBLOC”RESECTION FOR
AMYGDALO- HIPPOCAMPECTOMYTOAVOID
COMPLICATIONS IN TEMPORALLOBE SURGERY
K. Roessler*, B. Kasper†, R. Coras‡, B. Sommer*, I. Blumcke‡,
H. Hamer†, M. Buchfelder*
*Erlangen University Clinic, Neurosurgery, Erlangen,
Germany, †Erlangen University Clinic, Neurology, Erlangen,
Germany, ‡Erlangen University Clinic, Neuropathology,
Erlangen, Germany
Purpose: Temporal lobe surgery including amygdalo- hippocampec-
tomy (AHE) is the most frequent performed procedure in epilepsy sur-
gery. Due to the anatomical relationship of the mesial temporal structures
to the midbrain and choroidal fissure, the risk of severe complications
like postoperative stroke is up to 1-2%.
Methods: Thus, we developed a modified subpial en bloc resection tech-
nique for removing the mesial structures (hippocampus, parahippocam-
pus, uncus and amygdala,) with early identification of the pes
mesencephaly and the posterior cerebri arteri through the anterior part of
the fronto- mesial temporal horn cleft. Uncus and amygdala were
removed as a second step after visualization of the cleavage plane
between midbrain and middle cerebral artery.
Results: Altogether, 81 patients had temporal lobe epilepsy surgery
including amygdalo-hippocampectomy for various pathologies using this
surgical technique (42 hippocampal sclerosis,14 epilepsy associated
tumors- gangliogliomas, DNET, 25 other pathologies- cavernomas, scar
tissue, mild cortical dysplasia). All patients had anterior temporal resec-
tion including amygdalo-hippocampectomy. Seizure outcome was favor-
able after one year: 64% (35/55) were completely seizure free (Engel1A)
and 75% had Engel Class 1 outcome. Surgical complication rate was
3.7% (reoperation for 1 empyema and 2 subdural hematomas), severe
neurological complication rate was 1.2% temporarily (1 transient hemi-
paresis due to postoperative vasospasm) and 0% permanently.
Conclusion: The described subpial modified en bloc resection technique
for temporo- mesial structures demonstrated low complication rates in
surgery of medically refractory temporal lobe epilepsy. Its attention espe-
cially contributes to avoid permanent hemiparesis.
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SEIZUREOUTCOMEOF PATIENTSWITHMAGNETIC
RESONANCE IMAGING-NEGATIVE EPILEPSIES:
STILL ANONGOINGDEBATE
C. Isler*, C. Ozkara†, MS Delil‡, A. Kayhan*, K. Deniz§,
S. Akkol§, B. Kucukyuruk*, T. Tanriverdi*, B. Oz¶,
N. Comunoglu¶, M. Uzan*
*Istanbul University Cerrahpasa Medical Faculty,
Neurosurgery, Istanbul, Turkey, †Istanbul University
Cerrahpasa Medical Faculty, Neurology, Istanbul, Turkey,
‡Istanbul Batı Bahat Hospital, Neurology, Istanbul, Turkey,
§Istanbul University Cerrahpasa Medical Faculty, Istanbul,
Turkey, ¶Istanbul University Cerrahpasa Medical Faculty,
Pathology, Istanbul, Turkey
Purpose: The aim of our study is to present our surgical results and dis-
cuss clinical and histopathological parameters related to outcome in
patients with MRI-negative epilepsy
Method: 36 MRI-negative epilepsy patients (19 females / 17 males )
who had been evaluated for surgery at our institution between 2004 and
2016 were retrospectively analyzed. Histopathological specimens were
re-rewieved by two blind neuropathologists and re-classified based on
the current classifications. Seizure outcome of the patients were assessed
on the basis of Engel´s classification.
Results: The mean age at surgery was 24.5 years (9-51 years) and the
mean seizure onset was 9.3 years (1 - 30 years). Eight patients were
younger than 18 years. The Mean duration of seizures was 15.3 years (2-
41 years). All but two underwent invasive monitorisation. A total of 33
patients out of 36 were finally operated on. Eighteen patients had hypo-
metabolism on FDG-PET with temporal lobe involvement in majority
(66.7%). Hypometabolism was found in all patients with hippocampal
sclerosis(HS), however it was 50 % and 66.7% in Focal Cortical Dys-
plasia (FCD) type I and II patients, respectively. The frontal lobe resec-
tion was the most frequent followed by temporal, parietal and occipital
lobes. In 7 patients multilobar resection was necessitated. Histopatholog-
ical diagnosis was FCD type I, II, III, HS, and gliosis in 14, 12, 2, 3 and 2
patients, respectively. The mean follow-up was 5.8 years (1-12 years).
Seventeen patients were seizure free and favorable outcome (Engel´s I
and II) was found in 69.7%. FCD type I tend to have more favorable sei-
zure outcome. Duration of epilepsy and hypometabolism on FDG-PET
was significantly related to outcome, whereas involved lobe was not.
Conclusion: Results from our own experience like others, suggest that,
it is worth pursuing resective surgery in adults as well as in children with
drug-resistant epilepsy with normal MRI.
p0976
ROBOTIC STEREOELECTROENCEPHALOGRAPHY
WITHOUTHEAD-FRAMEANDCOMPUTED
TOMOGRAPHY –ANALYSIS OFACCURACY
A. Spyrantis*, A. Cattani*, J. Quick-Weller*, A. Strzelcyk†,
F. Rosenow‡, V. Seifert*, T. Freiman*
*Goethe-University/University Hospital, Neurosurgery,
Frankfurt amMain, Germany, †Goethe-University/University
Hospital, Epileptology, Frankfurt amMain, Germany, ‡Goethe-
University, Epileptology, Frankfurt amMain, Germany
Purpose: Recent studies with classical frame-based stereotaxy but also
robot-guided stereotaxy use computed tomography (CT) scans for refer-
encing the system to the patients´ head. Thereafter the CT dataset is fused
with the preoperative magnetic resonance imaging (MRI), which usually
was used for trajectory planning. In order to reduce CT radiation, in par-
ticular for children, we have performed robot guided stereotactic proce-
dures using preoperative MRI datasets, only. We will provide evidence
that using only preoperative MRI datasets referenced with a laser scan of
the patients` face is sufficient for sEEG implantations.
Method: Forty sEEG electrodes for recording of a potential epilepto-
genic zone due to pharmacoresistant epilepsy in five patients (three male,
mean age 31 years) by the robotic surgery assistant (ROSA, Zimmer
Biomet Robotics, Montpellier, France) were evaluated. Trajectories were
planned on preoperativeMRI with a safty margin of 5 mm, where no ves-
sels or sulci were accepted. Postoperative CT identifying electrode posi-
tions were fused with the preoperative MRI-based planned and the
accuracy was determined by the target point error (TPE) and the entry
point error (EPE) applying the Euclidian distance.
Results: In 3 Tesla (T) MRI mean TPE amounted to 2.96 mm (min.
2.04 mm, max. 4.4 mm), mean EPE to 2.53 mm. The TPE was larger in
temporal implantations, where it amounted to 3.02 mm, the mean tempo-
ral EPE was 2.39 mm. The accuracy was improved 1.5 T MRI, mean
TPE amounted to 1.72 mm. The mean time of diagnostic recording
amounted to 8.8 days (minimum five days, maximum 11 days), No com-
plications, hemorrhages, infections, etc., were observed.
Conclusion: Robot-guided sEEG based on three Tesla MRI safes radia-
tion for patient and can be still safely performed.
p0977
TESTINGQUALITY INDICATORS FORADULT
EPILEPSYMONITORINGUNIT IN THECENTER FOR
TREATMENTOFREFRACTORYEPILEPSY (CETER),
A NEWEPILEPSYMONITORINGUNIT IN BRAZIL
M.M. Bianchin*,†, C.M. Torres‡, K.C. Martin*, J.A. Bragatti*,
C. Guzinsk*, J.U. Castan*, S.V. Schonwald*, J.A. Duarte*,
G.R. Isolan*
*Hospital de Clınicas de Porto Alegre, Neurology Division,
CETER - Center for Treatment of Refractory Epilepsy, Porto
Alegre, Brazil, †Universidade Federal do Rio Grande do Sul,
Internal Medicine, Porto Alegre, Brazil, ‡Hospital de Clınicas
de Porto Alegre, Porto Alegre, Brazil
Purpose: An evidence-based consensus of quality indicators for epilepsy
monitoring units (EMUs) was developed by Sauro and colleges, on
behalf of the EMU Quality Improvement Team (Epilepsia, https://doi.
org/10.1111/epi.13563, 2016). The purpose of our study was to test these
indicators in our EMU.
Methods: We implemented and evaluated the 25 evidenced-based indi-
cators selected by Sauro and colleges in our EMU, The Center for Treat-
ment of Refractory Epilepsy (CETER). CETER is a new two bed EMU
that has been used for evaluating patients with epilepsy during the last
twelve months in our hospital. CETER is in Hospital de Clinicas de Porto
Alegre (HCPA), Brazil.
Results: During one year, 52 patients were admitted in CETER and some
of suggested indicators are reported here. Summarizing, thirty-three
patients (63.5%) were female, with mean age of 41.9 years. Mean time
of hospitalization was 10.3 days. Twenty-three patients (44.2%) were
referred for diagnostic evaluation, three (5.8%) for optimizing medical
treatment and 26 (50.0%) patients were referred for epilepsy surgical
work-up. Forty (76.9%) patients had confirmed diagnosis of epilepsy, 8
(15.4%) had only psychogenic non-epileptic seizures and 4 (7.7%)
patients had inconclusive video-EEG results. Video-EEG monitoring
was considered extremely useful or very useful in 27 (51.9%) and 14
(28.9%) patients respectively, leading to change in treatment in 35
(67.3%) patients. Four (7.7%) patients had adverse events during video-
EEG monitoring. Ten temporal and 2 extra-temporal lobe surgeries were
done, with 8 patients (66%) showing Engel I outcome.
Conclusion: In our experience, the indicators suggested by Sauro and
colleges were very useful for assessing objectively the quality and safety
in our EMU. We approve it and will use these indicators for our practice.
We highly recommend implementation of these indicators in any EMU
as a simple and effective way to improve medical care in epilepsy. Study
funded by CNPq.
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GOODOUTCOMEOFRESECTIVE EPILEPSY
SURGERY IN PATIENTSWITHNON-LESIONAL
FOCALEPILEPSYAFTER INVASIVE EVALUATION
WITH STEREOTACTICALLY IMPLANTEDDEPTH
ELECTRODES
C. Vollmar*, J. Thorsteinsdottir†, F. Kreth†, A. Peraud†,
S. Noachtar*
*University of Munich, Dept. of Neurology, Epilepsy Center,
Munich, Germany, †University of Munich, Dept. of
Neurosurgery, Munich, Germany
Purpose: To evaluate the outcome of resective surgery after intracranial
EEG recording from depth electrodes and identify risk factors for unfa-
vorable outcome.
Method: All patients had noninvasive Video-EEG-monitoring and MRI
scans, some had additional SPECT, PETT or DTI scans. Implantation of
electrodes was planned individually, based on the conclusive interpreta-
tion of all available clinical and imaging data. Tailored resections were
planned individually and were aided by a MRI-guided navigation system
where labelled electrode localizations were available for reference. Clini-
cal characteristics, details of electrode implantation, resection volume
and postsurgical outcome were determined. Chi-square/ Fisher’s exact
test for categorical variables and Student’s t-test / Mann-Whitney U test
for continuous variables were used for statistical analysis to identify
prognostic factors for postsurgical outcome.
Results: 70 patients were included (median age: 34.9 years). Structural
MRI was non-lesional in 29 patients (41%) and showed a structural lesion
in 41 (59%). 26 patients (37%) had temporal lobe seizure onset, 44 (63%)
were extratemporal. Between 3 and 16 (median 9) depth electrodes were
implanted. After a median follow up of 13.1 months 79% of the patients
were free of all seizures (Engel IA). Another 17% were free or almost
free of disabling seizures (Engel IB, IC and II). There was no significant
difference between lesional (81%Engel IA) and non-lesional (77%Engel
IA) patients (p = 0.73), between temporal or extratemporal (p = 0.81)
and left- or right-sided (p = 0.69) resection, nor between first resection
and re-operation (p = 0.78) or an effect of proximity to eloquent cortex
(p = 0.59). There was no difference in the average resection volume
between lesional (28 cm³) and non-lesional (26 cm³) patients (p = 0.64).
Conclusion: Resective epilepsy surgery after invasive EEG with depth
electrodes can achieve as good an outcome in non-lesional as in lesional
focal epilepsy with temporal and extra-temporal seizure onset.
p0981
POST-OPERATIVE INFECTIONS SECONDARYTO
INVASIVE ELECTRODEMONITORINGAND
EPILEPSY SURGERY IN PEDIATRIC POPULATION
Y. Meng*, Z. Merali*, A. Moghaddamjou*, S. Suppiah*,
A. Manicat-Emo†, J. Rutka†
*University of Toronto, Toronto, ON, Canada, †Hospital for Sick
Children, Toronto, ON, Canada
Many children with medically refractory epilepsy, who are candidates
for epilepsy surgery, require placement of intracranial electrodes to fur-
ther lateralize or localize their seizures. The variety of electrodes include
subdural grid and strips as well as depth electrodes. These electrodes are
left in situ over a week period, after which a decision about resective sur-
gery is made. The factors influencing rate of postoperative infections
associated with the procedure is unclear. This retrospective study reports
the rate and nature of post operative infection in our pediatric neuro-
surgery centre in relation to various patient factors. We reviewed 198
consecutive patients who underwent insertion of intracranial electrodes
between the 2001 and 2015. The protocol for prophylaxis antibiotics con-
sists of intravenous Vancomycin & Cefotaxime while the electrodes are
in situ, intravenous Cloxacillin for 5 days after removal with a final
switch to oral Cephalexin for an additional 5-7 days. There were two
cases of intracranial infections with six superficial wound infections. We
then examined factors that may correlate with infection including number
and type of electrode implants, length of operation, number of personnels
in the operating room, number of anti-epileptic medication, and preoper-
ative bloodwork. Preliminary analysis did not show a significant correla-
tion between infection and age, length of procedure or number of
monitoring days. Quantifying our infection rate and treatment can inform
future prospective studies to reduce postoperative infections in children
undergoing this procedure.
p0982
DIFFERENTGAIN-OF-FUNCTION EFFECTS IN SCN2A-
MUTATIONS
S. Lauxmann*,†, N. Verbeek‡, Y. Liu†, M. Zaichuk†, S. M€uller†,
J. Lemke§, H. Lerche*,†, M. van Kempen‡, U.B.S. Hedrich-
Klimosch†
*University of T€ubingen, Neurological Department, T€ubingen,
Germany, †Hertie Institute for Clinical Brain Research,
T€ubingen, Germany, ‡University Medical Center Utrecht,
Utrecht, Netherlands, §University of Leipzig, Institute of Human
Genetics, Leipzig, Germany
Purpose: Mutations in the SCN2A gene cause a broad spectrum of epi-
lepsy syndromes of variable severity including neonatal-infantile sei-
zures and epileptic encephalopathies, but also neuropsychiatric disorders
such as autism spectrum disorders and schizophrenia. Here, we describe
four different mutations in the SCN2A gene causing three distinct pheno-
types: benign familial neonatal-infantile seizures (BFNIS), myoclonic
atonic epilepsy (MAE) and one patient with intractable neonatal seizures.
Although phenotypes were quite diverse, our electrophysiological studies
revealed gain-of-function defects for all of them.
Method: We evaluated the clinical and genetic characteristics of the four
families, identified four SCN2A mutations - three of them novel - and
characterized their functional consequences.
Results: Patient 1 and 2 with BFNIS showed typical clusters of cognitive
and bilateral tonic-clonic seizures up to status epilepticus between 3 and
13 months. There were four, respectively two, affected family members.
Also in Patient 3 (MAE) the mother was a carrier but without a clinical
manifestation. Only Patient 4 carries a de novo mutation. Sequencing of
SCN2A revealed 3 novel missense mutations: R28C, T773I, K908E. The
V208E mutation was described earlier, but without electrophysiological
characterization.
Functional studies using heterologous expression in tsA201 cells and
whole cell patch clamping disclosed an increased window current for the
K908E, V208E and T773I mutations, as well as an increased persistent
current (T773I). By reproducing the physiological dynamic conditions of
a firing neuron through the application of action potentials as voltage
stimuli, we were able to show that during these stimuli all mutations
exhibited an increased sodium inward current, which occured in the criti-
cal subthreshold depolarizing phase. Interestingly, one of the mutations
(R28C) disclosed this subthreshold Na+ current as sole finding, which we
consider as the pathophysiological hallmark for this mutation.
Conclusion: Such alterations indicate a gain-of-function, which can
plausibly explain a neuronal hyperexcitability and epileptic seizures.
p0983
DEVELOPMENTALREGRESSION PRECEDING
SEIZUREONSET: AGUIDE FOR SLC6A1MUTATION
TESTING IN CHILDRENWITHATYPICAL
MYOCLONIC ASTATIC EPILEPSY
M. Taylor*, F. Stewart†, D. Peake*
*Belfast Health and Social Care Trust, Paediatric Neurology,
Belfast, United Kingdom, †Belfast Health and Social Care Trust,
Genetics, Belfast, United Kingdom
Purpose: We have identified 3 patients with SCL6A1 mutations in
Northern Ireland through the Deciphering Developmental Disorders
(DDD) study. The purpose of the review was to identify if these subgroup
of patients with atypical myoclonic astatic epilepsy (MAE) have any
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common specific phenotypical or investigative findings that would
prompt SCL6A1 testing.
Method: Retrospective chart review.
Results: Two of the patients were monozygotic twins and one was an
unrelated female.
The monozygotic twins were referred jointly at 23 months and were
subsequently diagnosed with atypical myoclonic astatic epilepsy. Both
have responded to the initial anti-epileptic drug trialled (sodium val-
proate). They both had global developmental delay with marked social
communication difficulties evident prior to the onset of seizures.
In the third case anti-epileptic therapy is rufinamide and clobazam.
Previous AEDs include levetiracetam, sodium valproate and topiramate.
This patient also has severe learning difficulties and global developmen-
tal delay prior to the onset of seizures.
Phenotypically all 3 cases were similar with blonde hair, profound
speech delay, global developmental delay preceding the onset of epilepsy
and ASD traits. In all cases the diagnosis of Angelmans Syndrome was
suggested from the EEG reports indicating high amplitude rhythmic 4-
6 Hz activity, prominent in the occipital regions, with spikes, which can
be facilitated by eye closure on at least one occasion. Subsequent EEGs
were more in keeping withMAE.
Conclusion: Cognition and development are generally normal at the
onset of seizure development (ILAE definition). In these cases, develop-
mental delay was found prior to the onset of seizures. This is not a unique
finding and Carville et al. (2015) found that similar across the cohort of
patients identified with this mutation. The EEG findings and the common
phenotypical blonde hair with profound speech delay may be a common
feature that could prompt testing for SLC6A1.
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EPILEPSYAND SLEEPDISORDERS IMPROVE IN
ADOLESCENTS ANDADULTSWITHANGELMAN
SYNDROME: AMULTICENTER STUDYOF 46
PATIENTS
C. Sueri*, E. Ferlazzo*,†, M. Elia‡, P. Bonanni§, G. Randazzo§,
S. Gasparini*,†, T. D’Agostino*, A.R. Sapone*, M. Ascoli*,
M.A. Bellavia†, V. Cianci*, A. Gambardella†, A. Labate†,
U. Aguglia*,†
*Regional Epilepsy Center, Bianchi-Melacrino-Morelli
Hospital, Reggio Calabria, Italy, †Magna Græcia University,
Department of Medical and Surgical Sciences, Catanzaro, Italy,
‡Oasi Institute for Research on Mental Retardation and Brain
Aging IRCCS, Troina, Italy, §Epilepsy and Clinical
Neurophysiology Unit, Scientific Institute IRCCS Eugenio
Medea, Conegliano, Italy
Purpose: Angelman syndrome (AS) is caused by deficient expression of
the maternal copy of the ubiquitin protein ligase E3A gene. Actual
knowledge on evolution of AS relies on questionnaire-based cohort stud-
ies, phone interviews or small retrospective cohort studies focused on
specific clinical-genetic features, providing conflicting results. This
study aims to assess long-term outcome of epilepsy, sleep disorders and
EEG in a vast series AS subjects.
Method: We collected patients with genetically confirmed AS,
aged≥14 years, followed in three tertiary epilepsy Centers or attending
the meetings of the Italian Organization for AS(OrSA). Retrospective
clinical and EEG data were retrieved from hospital archives or family
documents. At index evaluation (IE) (last visit at tertiary Centers or sin-
gle visit during OrSA meetings), caregivers were interviewed about
anamnestic data and filled questionnaires on sleep disorders and daily-
living skills; patients underwent general and neurologic evaluation,
video-EEG recordings. All available EEGs were analyzed to compare
evolution of spike-wave index(SWI) over the years.
Results: Forty-six subjects aged 14-45 years were included: 24 from ter-
tiary Centers, 22 from OrSA meetings. Forty-two/46 (91.3 %) had sei-
zures during childhood, which improved over the years in all subjects.
Among epileptic patients, 27(64%) became seizure-free at a median age
of 10 years and 4 remained seizure-free even after antiepileptic
withdrawal. Thirty-nine/46 (84.8%) had sleep disorders in childhood,
which improved in 27/39 (69%) over the years. At IE, daily-living skills
corresponded to age ≤1.6 years in 29/46 (63%). EEG showed typical AS
patterns in 35/46 (76.1%). SWI was not significantly different between
infancy/childhood and adolescence/adulthood in EEGs recorded from 10
patients.
Conclusion: Improvement of epilepsy or sleep disorders should not dis-
regard clinical suspicion of AS in adolescent or adult patients with sug-
gestive features. Drug withdrawal might be considered in the
management of epilepsy during adolescence or adulthood, despite the
persistence of epileptiform abnormalities.
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DISCOVERYAND PATHOGENICITYASSESSMENTOF
NEUROPATHOLOGY-ASSOCIATEDGENEVARIANTS
L.-M. Neupert*, P. May†, K. Kobow‡, M. Nothnagel*,
P. N€urnberg*, T. Freiman§, P. Harter§, K.M. Klein§, Y. Weber¶,
I. Bl€umcke‡, D. Lal**
*Cologne Center for Genomics, Cologne, Germany,
†Luxembourg Centre for Systems Biomedicine, Belvaux,
Luxembourg, ‡University Hospital Erlangen, Erlangen,
Germany, §Epilepsy Center Frankfurt Rhine-Main, Frankfurt
amMain, Germany, ¶Hertie Institute for Clinical Brain
Research, T€ubingen, Germany, **Stanley Center for Psychiatric
Research, Broad Institute of Harvard and M.I.T., Cambridge,
MA, United States
Germline and brain-specific somatic variants have been reported as an
underlying cause in patients with epilepsy-associated neuropathologies,
including focal cortical dysplasias (FCDs) and long-term epilepsy associ-
ated tumors (LEAT). However, evaluation of identified neuropathology-
associated variants in genetic screens is complex since not all observed
variants contribute to the etiology of neuropathologies not even in gen-
uinely disease-associated genes. Here, we critically reevaluated the
pathogenicity of 12 previously published disease-related genes and of 79
neuropathology-associated missense variants listed in the PubMed and
ClinVar databases. We
(1) assessed the evolutionary gene constraint using the pLI and the mis-
sense z score,
(2) used the latest American College of Medical Genetics and Genomics
(ACMG) guidelines, and
(3) performed bioinformatic variant pathogenicity prediction analyses
using PolyPhen-2, CADD and GERP
Constraint analysis classified only seven out of 12 genes to be likely
disease-associated. Furthermore, 78 (89%) of 88 neuropathology-asso-
ciated missense variants were classified as being of unknown signifi-
cance (VUS) and only 10 (11%) as being likely pathogenic (LPII).
Pathogenicity prediction yielded a discrimination between LPII variants
and a discrimination for VUS compared with rare variant scores from
individuals present in the Genome Aggregation Database (gnomAD). In
summary, our results demonstrate that interpretation of variants associ-
ated with neuropathologies is complex while the application of current
ACMG guidelines including bioinformatic pathogenicity prediction can
help improving variant evaluation. Furthermore, we will augment this set
of literature-identified variants at the conference by results from our vari-
ant screen using self-generated deep sequencing data in >150 candidate
genes in >50 patients not yet analyzed.
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NOVELMUTATIONS IN SLC2A1GENE: PHENOTYPE
VARIABILITYOFGLUT1 DEFICIENCY SYNDROME IN
A SMALLCASE SERIES
L. Di Vito*, L. Licchetta*,†, C. Stipa†, L. Alvisi*,†, B. Mostacci*,
I. Naldi†, S. Baldassari*, T. Pippucci‡, C. Marini§, F. Bisulli*,†,
P. Tinuper*,†
*IRCCS Institute of Neurological Sciences, Bologna, Italy,
†University of Bologna, Department of Biomedical and
Neuromotor Sciences, Bologna, Italy, ‡U.O. Medical Genetics,
Polyclinic Sant’Orsola-Malpighi - Department of Medical and
Surgical Sciences, University of Bologna, Bologna, Italy,
§Pediatric Neurology Unit and Laboratories, Children’s
Hospital Meyer, University of Florence, Firenze, Italy
Purpose: Glucose transporter type 1 (GLUT1) deficiency due to
SLC2A1 gene mutation has been recognised to cause a wide spectrum of
neurologic disorders ranging from severe encephalopathy with develop-
mental delay, epilepsy, ataxia and acquired microcephaly of the “classi-
cal” phenotype, to atypical variants with less severe manifestations.
Early diagnosis is crucial because it allows the start of the ketogenic diet.
However, recognizing GLUT1 deficiency syndrome (GLUT1DS) may
represent a challenge for the clinician, leading to a late diagnosis. Hereby
we present the clinical and genetic features of a small case series of both
sporadic and familial cases confirming the wide spectrum of clinical phe-
notype of GLUT1DS.
Method: Patients with a clinical history suggestive for GLUT1DS have
been screened for SLC2A1 mutations. Blood samples were collected
from proband and first degree relatives. All patients underwent a full clin-
ical, neuroradiologic (MRI), neurophysiologic examination (EEG
recording) and neuropsychological assessment. A lumbar puncture was
performed in two patients in fasting state and both cerebrospinal fluid
and blood glucose measurement were undertaken at the same time.
Results: Since 2010, 19 patients with a clinical history suggestive for
GLUT1DS have been screened for SLC2A1 mutations. We identified 4
different SLC2A1 pathogenic variants in 3 sporadic cases and one pedi-
gree. In 2 patients the GLUT1DS was related to novel SLC2A1 muta-
tions. Two patients presented mutations already reported in literature but
associated with different phenotypes.
Conclusion: Here we describe a small case series of patients with spo-
radic (3 cases) and familial (1 pedigree) GLUT1DS presenting with a
wide phenotypic heterogeneity, leading us to a considerable delay in the
diagnosis. In 2 of our patients the GLUT1DS was related to novel
SLC2A1mutations.
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DOWN-REGULATIONOF ADGRV1GENEEXPRESSION
IN THE INFERIORCOLLICULUSOFTHEGENETIC
AUDIOGENIC SEIZURE-PRONEHAMSTERGASH:SAL
D. Alvarez-Morujo de Sande*, D. Lopez-Lopez†, M.J. Herrero-
Turrion*, D. Sanchez-Benito†,‡, S. Hernandez-Noriega†,§,
R. Gomez-Nieto†,‡, A.J. Alvarez-Morujo*,¶, D.E. Lopez†,‡,
audiomotor diseases and reflex epilepsies
*Institute of Neuroscience of Castilla y Leon, University of
Salamanca, Salamanca, Spain, †Institute of Neuroscience of
Castilla y Leon / Institute of Biomedical Research of Salamanca,
University of Salamanca, Salamanca, Spain, ‡Department of
Cell Biology and Pathology, University of Salamanca,
Salamanca, Spain, §Department of Physiology and
Pharmacology, University of Salamanca, Salamanca, Spain,
¶Department of Anatomy and Histology, University of
Salamanca, Salamanca, Spain
Purpose: The ADGRV1 gene, also known asGPR98, VLGR1b orMass1,
encodes a member of the G-protein coupled receptor superfamily. The
encoded protein is expressed in the central nervous system and contains a
7-transmembrane receptor domain that binds calcium. Diseases associ-
ated with this gene include Usher syndrome 2 and familial febrile sei-
zures. We study the expression of this gene in the Mesocricetus auratus
strain GASH:Sal, a genetic audiogenic seizure hamster, inbred at the
University of Salamanca.
Method: Ictal events in strains susceptible to audiogenic seizures cause
gene deregulation in the inferior colliculus, an auditory nucleus involved
in epileptogenesis. Thus, we study the expression of ADGRV1 gene with
real-time RT-PCR, comparing controls and GASH:Sal under stimulated
and basal conditions. Since ADGRV1 gene is required for proper stere-
ocilia maturation of cochlear hair cells, we also study the cochlear recep-
tor of the control and GASH:Sal using scanning electron microscopy.
Results: Compared to controls, ADGRV1 expression was found to be
very reduced in the inferior colliculus of the GASH:Sal under stimulated
and basal conditions. At electron microscopy level, the GASH:Sal
showed cochlear damage characterized bymarked distortions in the orga-
nization and number of the stereocilia.
Conclusion: The GASH:Sal exhibits down-regulation of ADGRV1 gene
in the inferior colliculus and alterations in the stereocilliary organization
of the cochlear hair cells. This might impair the auditory sensitivity of the
GASH:Sal, making this strain particularly susceptible to audiogenic sei-
zures.
Acknowledgements: This study has been sponsored by the USAL sup-
port Grant for the GIRs 2017 (IP-DE Lopez).
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AUDIOGENIC SEIZURES INDUCECHANGES IN THE
GENE EXPRESSION IN THE INFERIORCOLLICULUS
OFTWOANIMALMODELSOFEPILEPSY, THEWAR
ANDGASH:SAL STRAINS
D.E. Lopez*,†, M.J. Herrero-Turrion*, D. Lopez-Lopez*,
D. Sanchez-Benito*,†, C. Sancho*,‡, S. Hernandez-Noriega*,‡,
O. Castellano*,†, L.J. Mu~noz§, N. Garcıa-Cairasco¶, R. Gomez-
Nieto*,†
*Institute of Neuroscience of Castilla y Leon / Institute of
Biomedical Research of Salamanca, University of Salamanca,
Salamanca, Spain, †Department of Cell Biology and Pathology,
University of Salamanca, Salamanca, Spain, ‡Department of
Phisiology and Pharmacology, University of Salamanca,
Salamanca, Spain, §Animal Resources, University of Salamanca,
Salamanca, Spain, ¶University of S~ao Paulo, Neurophysiology
and Experimental Neuroethology Laboratory LNNE of the
Ribeir~ao Preto School of Medicine, Ribeir~ao Preto, Brazil
Purpose: Genetic animal models of epilepsy are important tools for
understanding the cellular mechanisms underlying epileptogenesis and
for developing novel antiepileptic drugs. We conducted a comparative
study of gene expression in the inferior colliculus (IC), a nucleus that trig-
gers audiogenic seizures, using two animal models of reflex epilepsy, the
Wistar audiogenic rat (WAR) and the genetic audiogenic seizure hamster
(GASH:Sal).
Method: WAR and GASH:Sal animals were exposed to high intensity
auditory stimulation, collecting the IC 60 min later. RNA was isolated,
and microarray analysis was performed using the rat (Gene 1.0 ST Array)
or mouse (GeneChipMouse Gene ST Array) microarrays. We also car-
ried out RT-qPCR analyses to validate some genes in the microarrays of
the IC. In the case of the hamster study, we employed Chinese hamster
probes (Cricetulus griseus) via transcriptomic analysis for results verifi-
cation. For comparison, controls animals were subjected to the same
stimulation, tissue preparations, protocols and gene expression analysis
than those carried out in the epileptic models.
Results: Among the common genes differentially expressed in both
models, we identified the zinc finger immediate-early growth response
gene (Egr3), the ATP- transport protein gene (Abcb1), the gene encoding
neuropeptide Y (Npy), the Regulator of G protein signaling (Rgs2) and
the gene encoding the carrier protein Transthyretin (Ttr). These genes are
associated with stress responses (Egr3 and Npy), with epilepsy
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phenotypes (Npy and Abcb1a) and one of them (Rgs2) is the target of the
antiepileptic drug Levetiracetam.
Conclusion: Ictal events in strains susceptible to audiogenic seizures
cause gene deregulation in the IC. These data may contribute to the
knowledge of new targets on which antiepileptic drugs act.
Acknowledgements: Sponsored by USAL-USP, Program for Promotion
of the Bilateral Cooperation in Research (#2011-6; #2011.1.23386.1.3),
FAPESP (07/50261-4) to Garcia-Cairasco, and University of Salamanca
Support Grant for the GIRs 2017 (IP- DE.Lopez).
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DNAMETHYLATIONOFTHE BRD2 PROMOTER IS
ASSOCIATEDWITH JUVENILEMYOCLONIC
EPILEPSY ETIOLOGY
S. Pathak*, J. Miller*, E. Morris*, D. Greenberg*
*Natiowide Children’s Hospital, Battelle Center for
Mathematical Medicine and Department of Neurology,
Columbus, OH, United States
Juvenile Myoclonic Epilepsy (JME) is one of the most common of the
adolescent onset generalized epilepsy syndromes. BRD2 has consistently
been found to be involved in the expression of JME and the BRD2-JME
link in humans is further corroborated by our murine model (Brd2 + /-),
which demonstrated that Brd2 insufficiency leads, in mice, to clinical
hallmarks seen in JME. Yet no JME-related exonic mutations were ever
found in human BRD2, so we have focused on testing putative non-cod-
ing regions for influence on JME susceptibility. The BRD2 promoter har-
bors a JME associated SNP (rs3918149) and a CpG island (CpG75)
making it a potential “hotspot” for JME-associated epigenetic variants.
Methylation of the promoter CpG sites in BRD2 has been shown to lead
to gene silencing. We tested whether DNAmethylation of the BRD2 pro-
moter (and therefore lead to a deficit of BRD2 transcription) is tied to the
JME phenotype. We did bisulfite sequencing, pyrosequencing, and glo-
bal methylation estimation on lymphoblastoid cell lines from JME pro-
bands and family members. We found that CpG75 is highly methylated
in JME patients but unmethylated in the unaffected family members in
Caucasian JME families. Furthermore, we found that JME itself segre-
gates together with BRD2 promoter methylation but families with non-
JME idiopathic generalized epilepsy do not show such segregation, mak-
ing the BRD2 promoter a JME-specific, differentially methylated region.
We also found, using lymphoblastoid cell lines, that in the cells showing
high methylation, there is reduction in BRD2 levels. DNA methylation
variation at the BRD2 promoter in JME patients and family members
show the specificity of methylation as a possible seizure susceptibility
motif important for JME risk assessment and perhaps JME therapeutics
targeting BRD2.
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GENETICHETEROGENEITYOF SLEEPRELATED
HYPERMOTOREPILEPSY (SHE)
F. Bisulli*,†, L. Licchetta*,†, S. Baldassari*,‡, F. Provini*,†,
G. Plazzi*,†, M. Santucci*,†, L. Vignatelli*, C. Zenisi*,
I. Scheffer§, S. Berkovic§, T. Pippucci‡, P. Tinuper*,†, LICE
(Italian League against Epilepsy) Genetic Study Group
*IRCCS Institute of Neurological Sciences, Bologna, Italy,
†University of Bologna, Department of Biomedical and
Neuromotor Sciences, Bologna, Italy, ‡University of Bologna,
Sant’Orsola-Malpighi Hospital, Medical Genetic Unit,
Department of Medical and Surgical Sciences, Bologna, Italy,
§Epilepsy Research Centre, Department of Medicine, The
University of Melbourne, Melbourne, VIC, Australia
Purpose: To identify the genetic cause underlying SHE (also known as
Nocturnal Frontal Lobe Epilepsy) in a large cohort of patients.
Methods: We performed genetic analysis using different approaches
(screening, NGS epilepsy gene panel, MIPs targeted sequencing and
WES), in patients with clinical/confirmed SHE, according to predefined
diagnostic criteria. Both familial and sporadic cases were enrolled.
Results: From a pool of 191 SHE probands, 128 underwent at least one
genetic test.
Findings::
(i) three variants were found 126 patients where CHRNA4 was
sequenced (2.4%). A novel missense change with incomplete penetrance
(p.G307V) in the proband of an ADSHE pedigree; two mutations (de
novo p.S284L; p.S284W) in two sporadic patients with refractory SHE;
(ii) two mutations in KCNT1 were found in 2/112 pts (1.8%): a de novo
p.A889T in a sporadic case with intellectual disability (ID) and an inher-
ited p.Tyr796His in a proband with (ID) and psychiatric disorders of an
ADSHE pedigree;
(iii) six mutations in DEPDC5 were found in 6/107 pts (5.6%). Five
loss-of-function mutations (p.T329Lfs*7; p.R165Yfs*13;
c.279 + 1G>A; p.R389Pfs*2; p.R422*) in the probands of three families
and in two sporadic cases, and one pathogenic missense variant
(p.Y281F) in a sporadic case;
(iv) a missense mutation (p.L105P) of NPRL2 (1/87) was found in the
proband of a FFEVF pedigree with prevalent SHE phenotype;
(v) no mutations were identified in the other genes coding for neuronal
acetylcholine receptor subunits (nAChRs) CHRNB2 (0/119) and
CHRNA2 (0/123), nor in PRIMA1 (0/64), nor inNPRL3 (0/87).
Conclusion: Mutations in GATOR1 genes account for 6.5% of our
cases, with DEPDC5 showing the highest frequency. KCNT1 accounts
for a low proportion of our cohort and is confirmed to be involved in SHE
associated with ID. nAChRs genes and PRIMA1 appear to have a minor
role in this disorder.
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TARGETEDNEXTGENERATION SEQUENCINGAS A
DIAGNOSTIC TOOL IN 644 CHILDHOODEPILEPSY
PATIENTS ANDTRANSMISSIONOFVARIANTS FROM
MOSAIC PARENTS
L.H.G. Larsen*, Q. Hao*, N. Kako†, K. Olofsson‡, M. Miranda§,
M. Kinali¶, I. Borggr€afe**, D. Svaneby††, J.E.K. Nielsen‡‡,
L. Lavard§§, P. Uldall‡,¶¶, T. Talvik***, I. Talvik***,
C. Fusco†††, C. Spagnoli†††, M. Frangu‡‡‡, P.A. Born§§§,
P. Striano¶¶¶, D.K. Pal****, S. Oates****, P. Gellert‡,
M. Nikanorova‡,††††, M.B. Petersen‡‡‡‡, C.K. Lautrup‡‡‡‡,
K. Brusgaard*, U. Dunkhase-Heinl§§§§, M. Rokkjær§§§§,
A. Bayat§§, Y. Petkov¶¶¶¶, M.L. Børresen§§§, B. Jepsen‡,
D. Marjanovic‡, H. Hjalgrim‡,††††, H.A. Dahl†, R.S. Møller‡,††††
*Amplexa Genetics, Odense, Denmark, †Amplexa Genetics,
Odense C, Denmark, ‡Danish Epilepsy Centre, Dianalund,
Denmark, §Herlev University Hospital, Department of
Pediatrics, Herlev, Denmark, ¶Imperial College London,
Department of Paediatric Neurology, London, United Kingdom,
**Dr von Haunersche Kinderspital,Haunersches Children`s
Hospital and Epilepsy Center, University of Munich, M€unchen,
Germany, ††Vejle Hospital, Department of Genetics, Vejle,
Denmark, ‡‡Roskilde Hospital, Department of Clinical
Medicine, Section of Gynaecology, Obstetrics and Paediatrics,
Roskilde, Denmark, §§Hvidovre Hospital, Department of
Paediatrics, Hvidovre, Denmark, ¶¶Copenhagen University
Hospital, Paediatric Clinic, Copenhagen, Denmark, ***Tartu
University Hospital, Children’s Clinic, Tartu, Estonia,
†††Arcispedale Santa Maria Nuova, Department of Pediatrics,
Reggio Emilia, Italy, ‡‡‡Holbæk Hospital, Department of
Paediatrics, Holbæk, Denmark, §§§Copenhagen University
Hospital, Paediatric clinic, Copenhagen, Denmark,
¶¶¶University of Genova, DINOGMI-Department of
Neurosciences, Rehabilitation, Ophthalmology, Genetics,
Maternal and Child Health, Genova, Italy, ****King’s College
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London, Department of Basic and Clinical Neuroscience,
Institute of Psychiatry, Psychology and Neuroscience, London,
United Kingdom, ††††University of Southern Denmark, Institute
for Regional Health Services, Odense, Denmark, ‡‡‡‡Aalborg
University Hospital, Department of Clinical Genetics, Aalborg,
Denmark, §§§§Lillebaelt Hospital, Department of Paediatrics,
Kolding, Denmark, ¶¶¶¶Sydvestjysk Hospital, Department of
Paediatrics, Esbjerg, Denmark
Purpose: Epilepsy is one of the most common neurological disorders,
and is known to have a very heterogeneous background with a strong
genetic contribution. However, making a genetic diagnosis can be chal-
lenging as there is both genetic heterogeneity for a given epilepsy syn-
drome and phenotypic heterogeneity for a specific gene. The most severe
epilepsy phenotypes are often caused by de novo variants, however, some
of these might be inherited from mosaic parents, which will influence
genetic counselling. The aim of this study was to develop a diagnostic
screening method to analyze the genetic basis of childhood epilepsies,
and to investigate the ratio of variants inherited frommosaic parents.
Method: A cohort of 644 patients were analyzed on evolving NGS gene
panels targeting from 31 to 97 known epilepsy genes. Epileptic
encephalopathy or childhood epilepsy were the predominant phenotypes
amongst the cohort. Potentially causative variants were evaluated by lit-
erature and database searches and submitted to bioinformatic prediction
algorithms. All variants were confirmed by conventional Sanger
sequencing and, when possible, validated by parental testing and segrega-
tion analysis. Parents of 42 patients carrying an apparent de novo variant
were screened by NGS deep sequencing to analyze for parental mosai-
cism.
Results: We identified a presumed disease-causing variant in 131 of 644
patients (20%). The aberrations encompassed known and unknown vari-
ants in 39 different genes. In 3/42 cases (7%), parental DNA showed
mosaicism of the causative variant.
Conclusion: We have developed a rapid and cost-efficient screening
panel for the analysis of the genetic basis of childhood epilepsies. With
this panel we were able to find a disease-causing genetic variant in 20%
of the analyzed patients. Seven% of the parents tested negative by Sanger
sequencing could be showed to be mosaic.
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HOMOZYGOUSMUTATION IDENTIFIED IN
GLUTAMATEACIDCHANNELGENEGRIN3A INA
PEDIGREEWITHMYOCLONIC EPILEPSY
J. Ye*, H. Sun*, C. Wang*, M. Li*, X. Zhao*, Y. Wang*
*Xuanwu Hospital, Capital Medical University, Neurology,
Beijing, China
Purpose: To identify the causative mutations in a pedigree with myoclo-
nic epilepsy.
Method: Inheritance pattern and clinical data were collected from a Chi-
nese family with myoclonic epilepsy. Qualified genomic DNA was
extracted from the all the 3 affected and 7 unaffected members of the
family. DNA of the proband was submitted for whole-exome sequencing
(WES) on the HiSeqX10 platform. Candidate mutations were validated
by Sanger sequencing in all other affected and unaffected members of the
family, and analyzed for co-segregation with the disease.
Results: The inheritance pattern of the pedigree was autosomal reces-
sive, with all three siblings including the proband in the 3rd generation
affected by myoclonic epilepsy. The proband was a 30-year-old female,
who suffered from the first myoclonic attack at 15 years old. One year
later, the patient began to experience tonic-clonic seizure. EEG showed
sharp waves and spike-and-slow activity in the bilateral frontal pole, tem-
poral and middle temporal regions. Her younger sister, a 24-year-old
female, presented with episodic absence. EEG showed spike-and-slow
waves and episodic slow waves. Their younger brother, a 22-year-old
male, suffered from tonic-clonic seizure 1-2 times per year since 16 years
old. EEG showed generalized spike-and-slow waves. MRI scan did
showed no abnormality in all patients. WES identified a homozygous
missense mutation on glutamate acid channel gene GRIN3A
(NM_133445), c.2620G>A (p.Gly874Ser) in the proband. Sanger
sequencing suggested that the other two affected siblings were homozy-
gous, while her unaffected mother and grandfather-in-law was heterozy-
gous, for this mutation. The proband’s elder father’s brother and his son
were also heterozygous for this mutation, indicating that her father might
also be heterozygote.
Conclusion: The results demonstrated that GRIN3A is a novel causative
gene for familial myoclonic epilepsy.
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RECESSIVEVARIANTS INVARSCAUSE ACLINICAL
SYNDROMEWITH SEVEREDEVELOPMENTAL
DELAY, EPILEPSYANDMICROCEPHALY
A. Siekierska*, H. Stamberger†,‡, J. Sourbron*, T. Deconinck‡,
A. Kecskes*, S. Oprescu§, Q. Waisfisz¶, K. Helbig**,
K. Hardies‡, D. Shinde**, J. J€ahn††, H. Muhle††,
M. Pendziwiat††, I. Helbig††,‡‡, J. Hersh§§, P. Lakeman¶¶,
E. Schmitt§§, S. Von Spiczak††, M. Weiss¶, S. Weckhuysen†,‡,
P. May***, R. Balling***, A. Antonellis§, P. De Jonghe†,‡, P. de
Witte*, EuroEPINOMICS-RES Consortium ARWorking Group
*KU Leuven, Leuven, Belgium, †Antwerp University Hospital,
Antwerp, Belgium, ‡CMN and Institute Born Bunge, Antwerp,
Belgium, §University of Michigan, Ann Arbor, MI, United States,
¶VUUniversity Medical Center, Amsterdam, Netherlands,
**Ambry Genetics, Aliso Viejo, CA, United States, ††Christian-
Albrechts-University Kiel & University Hospital Schleswig-
Holstein, Kiel, Germany, ‡‡Children’s Hospital of Philadelphia,
Philadelphia, PA, United States, §§University of Louisville
School of Medicine, Louisville, KY, United States, ¶¶Academic
Medical Center, University of Amsterdam, Antwerp,
Netherlands, ***Luxembourg Centre for Systems Biomedicine,
Belvaux, Luxembourg
Purpose: Recessive variants in tRNA synthetases, likeQARS, AARS and
KARS, have been previously linked to epilepsy and developmental delay.
In this study, we focus on recessive variants in VARS, encoding a valyl
tRNA synthetase, which might play an important role in development
and epilepsy.
Method: All variants were identified with whole exome or whole gen-
ome sequencing and validated with conventional Sanger sequencing. A
zebrafish knockout (KO) varsmodel was developed using CRISPR-Cas9
to study the zebrafish phenotype.
Results: Through international collaborations we identified three fami-
lies with compound heterozygous (p.Gly822Ser/p.Leu434Val and
p.Gln400Pro/p.Arg442Gln) or homozygous missense variants
(p.Arg173Leu) in VARS. The three patients with compound heterozygous
variants had severe developmental delay (DD), early onset epilepsy and
microcephaly, whereas the homozygous variant was identified in a con-
sanguineous family, in which five out of six pregnancies ended prema-
turely due to intra-uterine fetal death. Yeast complementation assays
showed a loss of function effect for the Gly822Ser variant. Results from a
KO zebrafish model showed that vars HO larvae died prematurely, had
smaller head and eyes and their locomotor activity was decreased in com-
parison to heterozygote and wild type larvae. Moreover, investigation of
abnormal brain activity demonstrated that recurrent spontaneous epilepti-
form events occurred in ~55% of all HO larvae.
Conclusion: We identified three families with novel recessive variants
in VARS. All patients had a complex developmental disorder including
severe DD, early onset epilepsy and microcephaly except for one family
where intra-uterine lethality repeatedly occurred. The results from a zeb-
rafish KO model provided a functional proof that vars KO in a vertebrate
in vivo system caused abnormal seizure-like behaviour.
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GENETIC CAUSESOF PEDIATRIC EPILEPTIC
ENCEPHALOPATHY: ARETROSPECTIVE
CHARTREVIEW
S. Gulati*, B. Chakrabarty*, P. Jauhari*, V. Sondhi*, A. Gupta*
*All India Institute of Medical Sciences, Child Neurology
Division, Department of Pediatrics, New Delhi, India
Purpose: Advances in genetic diagnostics has led to the identification of
etiology in upto 30% previously labeled ‘Idiopathic’ epilepsies. The
Genetic counseling should be available to all epilepsy patients. The can-
didate genes span the entire neuronal structure with widespread func-
tional implications. A retrospective review of genetic causes of pediatric
epileptic encephalopathy (EE) is being presented from a tertiary care cen-
ter in north India.
Method: Between January 2015 to December 2016, 218 children pre-
sented with EE, of which, in72, an etiology was not identified. The
detailed etiological evaluation included MRI brain/ EEG/metabolic test-
ing (arterial lactate/pH, blood sugar, urine ketones, blood tandem mass
spectrometry and urine gas chromatography mass spectrometry) and
cerebrospinal fluid (CSF) analysis (CSF: serum glycine, CSF: blood glu-
cose and lactate) and enzyme analysis for neuronal ceroid lipofuscinosis
1 and 2.
Results: Of these 72 children, 29 underwent gene panel testing by next
generation sequencing (NGS). Eight neonates presented with EE, of
which five had additional extrapyramidal features. The neonates with iso-
lated EE demonstrated KCNT-1 mutations(N = 3), while the five with
additional extrapyramidal features demonstrated mutations in PNPO,
KCNQ2, GRIN2B, ATP7A, and GPR98 genes. Three patients presenting
with early infantile EE showed SCN2A, SCN8A, and NUBPLmutations.
Seven patients(aged 6 to 24 months) presented with Genetic Epilepsy
Febrile Seizures Plus phenotype and were detected to have SCN1A
(N = 5), SCN2A (N = 1) and PRODH (N = 1) mutations. Five children
presenting as west syndrome were noted to have PRRT2, ALG13,
SCN8A, CHRNA2 and DEPDC5 mutations. One child presenting at four
years with myoclonic-astatic phenotype demonstrated CLCN5 mutation,
while another presenting at 8 years with focal seizures, neuroregression
and dystonias showed POLG mutation. Two children with myoclonia-
astasia did not reveal any mutation.
Conclusion: It is advisable to obtain a genetic diagnosis wherever feasi-
ble in children with EE as it has important diagnostic, therapeutic and
prognostic implications.
p1001
DEPENDENCEOFTHE INDICATORSOFCOGNITIVE
POTENTIALOF P300 TOTHE FORMSOF EPILEPSY
M. Salokhiddinov*, R. Aziziova*, J. Toshnazarov*
*Tashkent Medical Academy, Tashkent, Uzbekistan
Purpose: To study the indicators of cognitive potentials P300 in various
forms of epilepsy (idiopathic and symptomatic).
Method: The research is based on data from a survey of 72 patients with
epilepsy. Patients depending on the forms of the disease are distributed in
two groups: I group - 38 patients with symptomatic epilepsy (SE) and
group II - 34 patients with idiopathic epilepsy (IE). The control group
consisted of 10 healthy individuals matched by age. Acoustic cognitive
evoked potential ( ACEP) test or P300 were performed by standard meth-
ods «odd-ball paradigm.” Four-channel electromyograph by MEDELEC
company «Sapphire premier»was used to conduct this.
Results: In order to detect cognitive impairment we applied to neuro-
physiological study of P300 cognitive evoked potential. With the results
obtained we were able to identify non-uniform by the severity and char-
acteristics of qualitative changes. As a result, light emotional disorders,
disregulatory reflecting dysfunction of cortical and subcortical structures
were detected in patients with SE. This is manifested in the absence of a
distinct hemispheric asymmetry of the amplitude of P300. More signifi-
cant disorders characterized by the absence of asymmetry P300 ampli-
tude and a significant increase in latency of P 300 were found in patients
with IE.
Conclusion: In patients with epilepsy, neurophysiological indicators of
cognitive evoked potentials objectively reflect the status of higher cere-
bral functions in epilepsy. The absence of inter-hemispheric asymmetry
of the P300 wave amplitude was revealed in the forms of idiopathic and
symptomatic, which indicates that dysfunctional disorders. Indicators of
latent period of P300 in symptomatic epilepsy increased unlike idiopathic
and reflected slowing of cognitive processes.
p1002
DISTRIBUTIONOFGENETIC EPILEPSIES AND
ACCORDINGLYADJUSTEDMEDICAL TREATMENT
AT THEDANISH EPILEPSYCENTRE: A SYSTEMATIC
ANALYSIS OF CHILDRENBORNBETWEEN 2006 AND
2011
C.D. Fenger*, K.M. Johannesen*, E. Gardella*, G. Rubboli*,
D.B. Kjelgaard*, H. Hjalgrim*, R.S. Møller*
*The Danish Epilepsy Centre Filadelfia, Institute for Regional
Health Services, Research Unit, Dianalund, Denmark
Purpose: We aimed to assess the distribution of genetic epilepsies and
accordingly adjustedMedical treatment at a tertiary epilepsy centre.
Method: The records of all children born between 2006 and 2011 and
followed at the Danish Epilepsy Centre in 2015 were systematically anal-
ysed regarding: diagnosis, epilepsy syndrome, age of seizure onset, cog-
nitive skills, MRI findings, co-morbidities, genetic diagnosis, and
medical treatment adjustments due to the genetic diagnosis.
Results: A total of 357 patients were included, however 27 (7.5%) of
them turned out not to have epilepsy, and 40 children (11%) had epilepsy
due to an acquired damage. These two groups of patients were excluded
from further analysis. The remaining 290 children were mainly diag-
nosed with epileptic encephalopathies or intractable focal or multifocal
epilepsies. Only 177/290 cases (61%) underwent genetic testing and a
genetic cause for their epilepsy was found in 87 of them (49%). The most
common genetic syndromes were Dravet syndrome and tuberous sclero-
sis followed by the PCDH19 and SCN2A related disorders. The medical
treatment was subsequently adjusted as a result of the genetic diagnosis
in 29/87 of the cases (33%), meaning that the genetic diagnosis ensured
the best possible medical treatment of these children. The adjustments
included more specific treatment for patients with Dravet syndrome,
SCN2A, SCN8A, SLC2A1, andKCNQ2 related disorders.
Conclusion: In the present study, we found that 49% of the genetically
tested children at the Danish Epilepsy Centre had a proved genetic cause
of their epilepsy and that 33% of the children with a genetic diagnosis
were ensured the best possible medical treatment due to their genetic
diagnosis. This study supports that a genetic diagnosis leads the way
toward more personalized medical treatment.
p1003
WIDESPREADWHITEMATTERALTERATIONS
PREDICT REFRACTORINESS INMILDTEMPORAL
LOBEEPILEPTIC PATIENTS
M.E. Caligiuri*, L. Mumoli†, A. Sarica*, M. Trimboli†,
A. Cherubini*, A. Gambardella†, A. Labate†
*Institute of Molecular Bioimaging and Physiology IBFM-CNR,
Neuroimaging Research Unit, Catanzaro, Italy, †Institute of
Neurology, University Magna Graecia, Catanzaro, Italy
Purpose: Mild mesial temporal lobe epilepsy (mMTLE) is characterized
by adult-onset, long-term seizure freedom (> 24 months) and drug-
responsiveness. About a quarter of patients with mMTLE develop refrac-
toriness after a decade. We aim to identify potential early imaging
biomarkers of refractoriness already at baseline.
Method: Fifty-five participants were drawn from a larger cohort of pre-
viously described mMTLE patients. At baseline, all 55 patients had
mMTLE and underwent structural MRI at 1.5T, including a 3D
T1-weighted spoiled gradient echo sequence. Based on the long-term
outcome after a mean follow-up of 12  3 years, we divided the baseline
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cohort into two groups for statistical analyses: true mMTLE patients
(N = 39) and “shifted” (sMTLE) patients (N = 16). All T1 images were
processed using FSL and FreeSurfer. We performed voxel-based mor-
phometry, cortical thickness and local gyrification index analyses, in
order to compare grey and white matter density (GM,WM), cortical GM
thickness and cortical folding abnormalities, respectively. Statistical
analyses were carried out accounting for age, age at onset, gender, pres-
ence of HS, left and right hippocampal volumes, correcting for multiple
comparisons across space using Threshold-Free Cluster Enhancement (in
FSL) or False Discovery Rate (in FreeSurfer) methods.
Results: All analyses concerning GM structure revealed no significant
difference at baseline between mMTLE and sMTLE. On the contrary,
VBM highlighted a widespread bilateral region in which temporal, fron-
tal and parietal WM density was significantly reduced in sMTLE vs
mMTLE already at baseline, i.e., when all patients were drug-responsive.
Conclusion: Due to its clinical and radiological features, mMTLE repre-
sents a superb resource to better delineate the biological substrates under-
lying the epileptic syndrome itself. In this work, we found further
evidence that WM alterations may play a crucial role in the processes that
lead to the development of refractoriness inMTLE later on.
p1005
MRI T2-HYPERINTENSIVE LESIONS IN TSC
CHILDREN TREATEDWITHVIGABATRIN
K. Sadowski*, J. Dezbska†, P. Pawliszak†, J. Borkowska*,
D. Domanska-Pakieła*, E. Jurkiewicz†, K. Kotulska*
*Children’s Memorial Health Institute, Department of
Neurology and Epileptology, Warsaw, Poland, †Children’s
Memorial Health Institute, Department of Radiology, Warsaw,
Poland
Purpose: To assess T2- and DWI- MRI changes in the basal ganglia
observed in pediatric patients with epilepsy associated with tuberous
sclerosis treated with vigabatrin. It has been uncertain whether these
lesions should be regarded as pathological and are ADC values of any
clinical importance.
Method: MRI brain examinations of 54 TSC patients were analyzed. 32
were male (59 %) and 22 female (41 %). Their age varied from 7 weeks
to 11 years, median 15 months. All children were treated with vigaba-
trin. The control group consisted of 10 age-matched children with no
known history of neurological disorder or brain MRI pathology. The
ADC was measured with a manual placement of regions of interest
(ROIs) in the thalami. The signal intensities of the thalami, basal ganglia,
midbrain, dorsal brainstem, and dentate nuclei were analyzed visually.
ADC values of the thalami were measured and compared with control.
Results: 9 patients (17 %) demonstrated at least one focus of abnormal
MRI signal, 4 were female and 5 male. In 88 % of patients the lesions
were observed in thalami, in 66% in midbrain in 88 % in tegmentum, in
66 % in globi pallidi and 22 % had abnormal signal in dentate nuclei. 2
patients out of 9 (22 %) had lesions in all analyzed regions. We detected
no correlation between these lesions and sex, TSC type, VGB dosage,
treatment duration or clinical state of patients. ADC values were notably
lower in children with DWI/T2WI signal abnormalities therefore seem
unlikely to be a variant of physiological development.
Conclusion: MRI abnormalities in infants with TSC treated with VGB
are relatively common, benign findings. Lesions are most frequently
found in the thalami. ADC has proven to be a useful and objective param-
eter in evaluating these lesions when they are not clearly visible on DWI/
T2WI.
p1006
RELIABILITYOF PRESURGICAL BRAINMRI
PROTOCOLS IN EPILEPTOGENIC LESION
DETECTION: THE TERTIARY EPILEPSYCENTER
EXPERIENCE
N. Vojvodic*, A. Djuranovic*, A.J. Ristic*, D. Damjanovic†,
I. Nikolic†, V. Bascarevic‡, T. Djukic*, L. Brajkovic§, D. Sokic*
*Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia,
†MRI Center, Clinical Center of Serbia, Belgrade, Serbia,
‡Neurosurgery Clinic, Clinical Center of Serbia, Belgrade,
Serbia, §Institute for Nuclear Medicine, Clinical Center of
Serbia, Belgrade, Serbia
Purpose: To assess the reliability of presurgical brain MRI examination
in detection of epileptogenic lesions in patients with focal farmacoresis-
tant epilepsies.
Method: We conducted two year prospective study in 222 consecutive
patients (110 men and 111 women) with focal farmacoresistant epilep-
sies. We compared the standard prehospital brain MRI findings with the
findings of MRI reivestigation performed according to the protocol based
on electroclinical diagnosis of an epileptic syndrome. The patients with
temporal lobe epilepsy (91/222; 41%) were undergone bran MRI proto-
col with axial planes aligned with the longitudinal axis of hippocampus.
In patients with extratemporal epilepsies MRI axial planes were aligned
with anterior-posterior commissure line. The starting point for coronal
planes was frontal pole in frontal and periroladic epilepsies (37/222;
16%) or occipital pole in posterior epilepsies (26/222; 12%). All other
patients (68/222; 31%) diagnosed as nonlocalised epilepsies were
excluded from the analysis. MRI structural images were acquired using
1.5T MRI Scanner with all preferred sequences in sagital, axial and coro-
nal orientation. MRI findings were analyzed by the experienced neurora-
diologists.
Results: Epileptogenic lesion was detected in 59.9% of all prehospital
MRI scans and 72.4% of all presurgical MRI scans (p = 0.0064). Presur-
gical MRI scans comparing to prehospital MRI scans were much more
valuable in discovering epileptgenic lesion among temporal (84.4% vs.
70.1%; p = 0.032) then extratemporal epilepsy patients (50.1% vs.
65.1%; p = 0.1452). Regarding the type of epileptogenic lesion, presur-
gical MRI was the most reliable in detecting hippocampal sclerosis
(29.4% vs. 19.35%; p = 0.0148) and malformations of cortical develop-
ment (10.41% vs. 4.15%; p = 0.0159).
Conclusion: Comparing prehospital and presurgical MRI findings in the
same cohort of patients with focal farmacoresistant epilepsies, we found
the latter much more valuable in revealing epileptogenic lesions espe-
cially among the patients with temporal lobe epilepsy and hippocampal
sclerosis.
p1008
EPILEPTIC NETWORK INACTION: SYNCHRONYOF
INTRACRANIAL SPIKINGACTIVITY INDISTANT
INTERICTALDISCHARGE-RELATED
HEMODYNAMICRESPONSES REVEALED BYEEG/
FMRI
H.M. Khoo*,†, N. von Ellenrieder*, N. Zazubovits*, F. Dubeau*,
J. Gotman*
*McGill University, Montreal Neurological Institute, Montreal,
QC, Canada, †Osaka University, Department of Neurosurgery,
Suita, Japan
Purpose: Structural and functional imaging studies in focal epilepsy
often reveal distributed regions of abnormality. These are interpreted as
representing the existence of epileptic networks but the presence of actual
neuronal interactions between these regions has not been demonstrated.
We sought to determine if the distributed hemodynamic responses often
seen in functional MRI (fMRI) studies of scalp interictal epileptic dis-
charges (IEDs) actually correspond to synchronized neuronal activities
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when examining the intracerebral EEG (iEEG) at distant nodes of the net-
work.
Method: We studied 28 patients who underwent first EEG-fMRI study
showing significant hemodynamic responses in the cerebral cortex, and
then iEEG. We co-registered the hemodynamic responses to the iEEG
electrode contact positions and analyzed synchrony, measured by corre-
lation, between IEDs recorded by iEEG in regions with and without
hemodynamic responses.
Results: The synchrony of intracerebral IED activity between pairs of
regions showing a hemodynamic response was higher compared to that
between pairs of regions without hemodynamic response (p < 0.0001)
and between pairs of regions, one with and one without hemodynamic
response (p < 0.0001). These differences were found during the interictal
periods with IEDs but were absent during the interictal periods without
IEDs. Higher synchrony was also observed between regions involved at
seizure-onset (p < 0.0001).
Conclusion: EEG-fMRI studies are unique in their ability to reveal
hemodynamic concomitants of IEDs anywhere in the brain with equal
sensitivity, and they often showmultiple regions of activation. This study
proves that iEEG activity is synchronized between these regions of
hemodynamic response, thus demonstrating the existence of an actual
neuronally-based epileptic network, during interictal period with IEDs.
This also validates EEG-fMRI as a non-invasive approach to reveal this
network.
p1009
SPATIALCONGRUENCEOF INTEGRATEDEEG/FMRI
NETWORKS IN TEMPORAL LOBE EPILEPSY
P. Satishchandra*, G. Chaitanya*, S. Sinha*, R.D. Bharath†,
K. Raghavendra*, R. Panda†, M. Anupam‡, A. Pathak‡,
K.K. Majumdar‡, R. Mundlamuri*
*National Institute of Mental Health & Neuro Sciences
(NIMHANS), Department of Neurology, Bangalore, India,
†National Institute of Mental Health & Neuro Sciences
(NIMHANS), Department of Neuroimaging and Interventional
Radiology, Bangalore, India, ‡Indian Statistical Institute,
Bangalore, India
Purpose: Integrating EEG-fMRI (fusion/time-series regression) helps
understand neurovascular coupling.We studied interictal discharge (IED)
network synchronization in EEG with Granger’s Causality (GC) and
Phase Lag Index (PLI) and compared it with the fMRI spatial extent in
temporal lobe epilepsy (TLE).
Method: Thirty two EEG-fMRI (R:20, L:12)sessions from 17 patients
with TLE (M:F = 10:7, Age=25.9  9.2 years) with BrainAmpMR and
3T Siemens MAGNETOM Skyra(Germany) were analyzed. EEG syn-
chronization was tested using GC and PLI across central brand frequen-
cies at 6 (theta), 10 (alpha), 14 (beta1), 18 Hz (beta2)[sampling
rate:500 Hz, window length:200 ms, overlap:50%).Synchronization
peaking at 300 - 500 ms window at a network threshold value of 0.8,
FDR corrected p < 0.05 was compared with spike timed fMRI activation
network.
Results: Beta1 synchronization networks in EEG had good spatial con-
cordance with fMRI.Synchronization pattern of smEEG during the IED
phase in left temporal lobe epilepsy (LTLE)usingGC showed sparsely
networking but widely distributed connections in left (L)>right (R)tem-
poro-frontal leads along with involvement of parieto-occipital leads ipsi-
laterally. PLI didn’t show a concordant network. GC network was
concordant with the fMRI activation pattern involving widespread areas
of the frontotemporal cortices and left parietal regions. In right temporal
lobe epilepsy (R TLE) - GC showed R temporal frontal networking along
with involvement of parieto-occipital leads ipsilaterally. PLI did not
show any above threshold activations. FMRI showed above threshold
epileptic network pattern in right fronto-temporal and bilateral posterior
temporal, and dorsal frontal cortex, anterior cingulate and inferior pari-
etal regions.
Conclusion: Network analysis of EEG in beta frequency band width and
fMRI provide good spatial concordance of the IED derived networks and
the fMRI BOLD changes in TLE.
p1010
INTERICTALGRANGER’S CAUSALITY
SYNCHRONIZATION IN EEG,MAPSCONGRUENT
BOLDCHANGES IN POSTERIORQUADRANT
EPILEPSY: A SIMULTANEOUS EEG-FMRI STUDY
P. Satishchandra*, G. Chaitanya*, S. Sinha*, R.D. Bharath†,
K. Raghavendra*, R. Panda†, M. Anupam‡, A. Pathak‡,
K.K. Majumdar‡, C.M. Ravindranadh*
*National Institute of Mental Health & Neuro Sciences
(NIMHANS), Department of Neurology, Bangalore, India,
†National Institute of Mental Health & Neuro Sciences
(NIMHANS), Department of Neuroimaging and Interventional
Radiology, Bangalore, India, ‡Indian Statistical Institute,
Bangalore, India
Purpose: Lesional parietal (PLE) and occipital lobe epilepsy (OLE)pre-
sent with prominent interictal discharges (IEDs). We propose a method
of a spatialmapping of temporally locked neuro-vascular coupling syn-
chrony between IED related neuronal activity and the hemodynamic
changes in patients with Posterior Quadrant Epilepsy (PQE).
Method: Twenty one EEG-fMRI sessions were available from PLE: [6
(Right-R:3, Left-L:3)] and OLE: [Bilateral-BL:15] of 9 patients (M:
F = 6:3, Age=18.25  7.2 years) with BrainAmpMR and 3T Siemens
MAGNETOM Skyra (Erlangen, Germany) were analyzed. IED timed
EEG synchronization was tested using GC estimated between 1 - 20 Hz
[sampling rate:500 Hz, window length:200 ms, overlap:50%, surro-
gates: 50). Synchronization peaking at 300 - 500 ms window at a network
threshold value of 0.8, FDR corrected p < 0.05 was compared with spike
timed fMRI activation network determined using time and dispersion
derivatives of the hemodynamic response function.
Results: GC networks in EEG had good spatial concordance with fMRI.
In RPLE, GC showed mainly a paramedian pareitooccipital networking.
fMRImainly showed involvement of the DMN areas mainly the precuens
and posterior cingulate cortex.In LPLE, GC showed increased connectiv-
ity in BL parieto-temporo-occipital leads. GC was spatially more concor-
dant with the fMRI map which showed mainly regions of precuneus and
inferiorerior parietal lobule. In BLOLE, GC showed BL parieto-occipital
connectivity pattern concordant with the fMRI activation patterns involv-
ing the left cerebellum, BL occipital, and parietal cortices. Network
abnormality tended to be more widespread in PLE compared to OLE
groups particularly involving posterior DMN.
Conclusion: Granger’s Causality can spatially map the IED related EEG
networks that spatially mapped to the fMRI IED related BOLD activa-
tions. This method demonstrates that short term neural behaviours such
as IEDs and large-scale cortical activations involved in spontaneous
epileptic brain activity can be mapped with good spatial congruence.
p1011
SV2A PROTEIN LEVELS IN THEKAINIC ACID
EPILEPSYRATMODELDURINGTHEACUTE PHASE
M.E. Serrano Navacerrada*, G. Becker*, M.A. Bahri*,
C. Warnier*, J. Aerts*, F. Mievis*, F. Giacomelli*, C. Lemaire*,
E. Salmon*, A. Luxen*, A. Plenevaux*
*Universite de Liege, GIGA-CRC In vivo Imaging, Liege,
Belgium
Purpose: The Ka€ınic Acid model (KA) is one of the most validated mod-
els of temporal lobe epilepsy (TLE) (Levesque et al.,2016). Its adminis-
tration induces status epilepticus (SE), characterized by an extensive
neuronal damage in limbic structures (Sperk et al.,1983). Post-mortem
studies, such as the epilepsy model presented in (Wang et al., 2014),
show a reduction of SV2A protein levels during the chronic phase, how-
ever, no data have been reported during the acute phase (0-48 h after KA
injection).. The present pilot study is undertaken to evaluate in vivo, with
the specific radiotracer [18F]UCB-H (Bretin et al., 2015; Warnock et al.,
2014), the SV2A expression 24 h after a SE produced by KA administra-
tion.
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Method: Two Sprague-Dawley rats were scanned at two different times:
baseline, and 24 h after three systemic injections of 5 mg/kg KA. The
scanning process consisted of a first scan with microPET (Focus 120),
during 1 hour, using [18F]UCB-H (41  5 MBq IV tail vein). This is fol-
lowed by MRI (9.4T Agilent, anatomical T2). A coregistration was per-
formed with PMOD 3.6 software. Data were expressed as SUV and AUC
were calculated for the different brain regions.
Results: [18F]UCB-H microPET images exhibited a small reduction
(around 10%) in SV2A brain levels after KA injections compared to the
baseline, marked in thalamus, hippocampus and amygdale. MRI images
obtained 24 h after KA injections are in accordance with previous histo-
logical studies, revealing inflammatory edema, tissue necrosis and
increased ventricle volume (Sperk et al.,1983).
Conclusion: These preliminary results obtained in KA treated rats show
that [18F]UCB-H is able to detect alterations in SV2A levels in relevant
regions for epilepsy. This radiotracer emerges as a valuable tool to follow
in vivo SV2A through longitudinal studies. KA model in rats deserves as
a tool for the study of epilepsy, exhibiting the same features than the
human disease.
p1012
NEUROPSYCHOLOGICANDMETABOLIC CHANGES
IN PATIENTSWITHLEFTMESIAL TEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS AFTER
EPILEPSY SURGERY
C. G€uvenc*, P. Dupont†, J. Van den Stock‡, L. Seynaeve*,
K. Porke§, E. Dries§, K. Van Bouwel§, K. Goffin¶, W. Van
Paesschen*
*University Hospitals & KU Leuven, Department of Neurology,
Laboratory for Epilepsy Research, Leuven, Belgium, †KU
Leuven, Laboratory for Cognitive Neurology, Leuven, Belgium,
‡KU Leuven, Laboratory for Translational Neuropsychiatry,
Leuven, Belgium, §UZ Gasthuisberg, Department of Neurology,
Laboratory for Epilepsy Research, Leuven, Belgium, ¶UZ
Gasthuisberg, Nuclear Medicine and Molecular Imaging,
Department of Imaging & Pathology, Leuven, Belgium
Purpose: Epilepsy surgery may cause changes in cognition and cerebral
glucose metabolism. Our aim was to explore relationships between pre-
and postoperative cerebral FDG-PET metabolism and neuropsychologic
performance in patients with left mesial temporal lobe epilepsy with hip-
pocampal sclerosis (MTLE-HS), who were rendered seizure free after
epilepsy surgery.
Method: Thirteen patients were included. All had neuropsychologic
testing and an interictal FDG-PET scan of the brain pre-and postopera-
tively. Correlations between changes in neuropsychologic test scores and
metabolism were examined using Statistical Parametric Mapping (SPM
12).
Results: Postoperative neuropsychologic test scores were not signifi-
cantly different from pre-operative scores at the group level. Metabolism
decreased postoperatively in ipsilateral mesial temporal regions and
increased in frontal and occipital lobes, as well as cerebellum.In these
regions, we did not find a correlation between changes in metabolism and
in neuropsychologic test scores. A significant negative correlation, how-
ever, was found between metabolic changes in the precuneus and in
Boston Naming Test (BNT) scores.
Conclusion: There are significant metabolic decreases in ipsilateral
mesial temporal regions, and increases in frontal and occipital lobes, and
cerebellum post- compared to preoperatively in patients with MTLE-HS
who were rendered seizure free after epilepsy surgery. We could not con-
firm that these changes translate into significant cognitive changes. A
negative correlation between metabolic changes in the precuneus and
changes in BNT scores was unsuspected.We speculate that the precuneus
may play a compensatory role in patients with postoperative naming dif-
ficulties after left TLE surgery. Understanding of these neural mecha-
nisms may aid in designing cognitive rehabilitation strategies.
p1015
AUTOMATEDEPILEPSYDIAGNOSIS AND SEIZURE
FOCUS LATERALIZATION BASEDONDEEP
LEARNING
B. Bernhardt*, R. Gill*, R. Vos de Wael*, S.-J. Hong*,
F. Fadaie*, A. Bernasconi*, N. Bernasconi*
*Montreal Neurological Institute and Hospital, Montreal, QC,
Canada
Purpose: Randomized controlled trials indicate that resective surgery
may be the currently most effective treatment to control the seizures in
patients with drug-resistant temporal lobe epilepsy (TLE). The lateraliza-
tion of the seizure focus is one of the core determinants for surgical target
identification and, thus, successful surgery. Deep learning techniques
have recently made a tremendous impact on a variety of automated visual
recognition tasks but the translation of these tools to epilepsy diagnostics
has remained absent. Here, we present a novel analytical framework to
harness the power of deep learning algorithms for the analysis of MRI-
derived shape information of the hippocampus in patients with drug-
resistant temporal lobe epilepsy (TLE).
Method: Our approach parameterizes shape information in individual
subjects using spherical harmonics with a point-distribution model
(SPHARM-PDM). This model represents thousands of surface points on
a triangular mesh along the outer hippocampal boundary using a grid of
spherical coordinates and offers shape-inherent point-correspondence to
assess local deformations. Correspondence across individuals allows
interpolating shape-derived volume change measures to 2D images, on
which deep convolutional networks can be readily applied. We evaluated
our framework in a consecutive cohort of 40 patients with drug-resistant
temporal lobe epilepsy and pathologically validated hippocampal sclero-
sis, and 46 healthy controls. Manually segmented hippocampi were con-
verted into SPHARM-PDM representations for every participant.
Deformation fields describing inward/outward displacements in a given
subject relative to a template were then interpolated onto a 2D grid.
Results: Our deep convolutional network algorithm achieved excellent
(>95%) performance for both patient vs. control discrimination and sei-
zure focus lateralization in patients using 5-fold cross-validation.Our
approach outperformed seizure focus lateralization and patient-vs-con-
trol classification algorithms operating on global volumetry alone.
Conclusion: The proposed analytical framework enables efficient
deployment of deep learning techniques for hippocampal shape metrics,
with suggested benefits for individualized diagnostics in disease.
p1016
WHOLE-BRAIN STRUCTURALCONNECTOME
DISRUPTIONS IN TEMPORAL LOBEEPILEPSY:
RELATIONTOHIPPOCAMPAL PATHOLOGY
B. Bernhardt*, M. Liu*, S.-J. Hong*, S. Gu*, D. Bassett*,
A. Bernasconi*, N. Bernasconi*
*Montreal Neurological Institute and Hospital, Montreal, QC,
Canada
Purpose: The hallmark of temporal lobe epilepsy (TLE) is hippocampal
sclerosis (HS) characterized by variable degrees of cell loss and gliosis in
the hippocampal formation. Increasing evidence suggests that anomalies
in this condition are rarely confined to the hippocampus alone, but that
the disease impacts large-scale networks. We assessed whether the sever-
ity of HS pathology is mirrored in whole-brain network phenotypes.
Method: We studied 44 TLE patients and 25 healthy controls. All
patients had been operated at the time of study, and histological exam
revealed marked hippocampal cell loss and gliosis in 24 (TLE-HS) and
isolated gliosis in 20 (TLE-G). Subfield segmentation was based on high-
resolution MRI. We applied surface-based techniques that measure atro-
phy (a proxy for cell loss) and T2 hyperintensity (indexing gliosis) along
individual subfields. Connectomes were derived from diffusion MRI
tractography, and parameterized using graph theoretical analysis. We
also calculated average controllability, a measure that captures whether a
given area could steer the network into a wide range of (simulated)
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functional dynamics. Multivariate analysis evaluated the modulation of
network markers by degrees of hippocampal subfield pathology.
Results: We observed a gradual pattern of topological changes in TLE
cohorts compared to controls, with marked increases in path length and
decreases in clustering and controllability in TLE-HS and trends for these
changes in TLE-G . Notably, controllability reductions in TLE-HS were
largely confined to posterior default mode regions known to be densely
integrated with the mesiotemporal lobe. Last, multivariate correlation
analysis indicated a significant relationship between hippocampal and
network-level anomalies in patients.
Conclusion: Combining hippocampal subfield phenotyping with whole-
brain network analysis indicates that the histological make-up and
severity of the hippocampal pathology ultimately relates to the extent of
large-scale connectome anomalies. Hippocampal cell loss may exert a
cascading impact on large-scale networks, likely via processes related to
secondary degeneration.
p1017
DIRECTED FUNCTIONALCONNECTIVITY IN
PATIENTSWITHFOCALEPILEPSYUSINGLOW-
DENSITY EEG
A. Coito*,†, P. van Mierlo*, J. Tepperberg†, U. Roelcke†,
M. Seeck‡, K. Nedeltchev†, S. Biethahn†, S. Vulliemoz‡
*Functional Brain Mapping Lab, Department of Fundamental
Neurosciences, University of Geneva, Geneva, Switzerland,
†Cantonal Hospital of Aarau, Neurology Department, Aarau,
Switzerland, ‡Epilepsy Unit, University Hospital of Geneva,
Geneva, Switzerland
Purpose: Several high-density EEG studies have shown that directed
functional connectivity can be useful for depicting the main drivers of
epileptic activity, which could ultimately help in the diagnosis and prog-
nosis of patients with focal epilepsy. However, the utility of these mea-
sures in the clinical environment is limited by the availability of high-
density EEG in clinical settings worlwide. Therefore, we investigated the
reliability of directed functional connectivity and Electrical Source Imag-
ing (ESI) using low-density EEG (19-32 channels) to estimate the epilep-
togenic zone (EZ).
Method: We searched in the databases of the Cantonal Hospital of Aarau
and the University Hospital of Geneva for patients with focal epilepsy
who had a focal lesion and a presumably well-localized EZ. We report
here the results for the first 14 (10 temporal and 4 extra-temporal epi-
lepsy) patients of our study. Interictal spikes were visually marked and
ESI was performed for source activity estimation in 82 regions of interest
(ROIs) using a distributed inverse solution and the Finite Different
Method (FDM) for the head model. A time-varying and frequency-
resolved Granger-causality measure was applied to all ROIs source sig-
nals in order to investigate whole-brain dynamic and directed functional
connectivity for the frequency of maximal spectral power. The summed
outflow from each ROI and the connectivity in between the regions with
the highest summed outflowwere computed.
Results: In all patients analysed, the ROIs with the strongest source
activity and also summed outflow were coincident with the presumed EZ
and the strongest connections originated from ROIs inside the presumed
EZ, as confirmed by EEG experts.
Conclusion: Our preliminary results suggest that directed functional
connectivity could be applied to low-density EEG to help clinicians in
the diagnosis and management of patients with focal epilepsy.
p1018
MAPPING THEVERBAL SEMANTICMEMORY
NETWORKBEFOREANTERIOR TEMPORAL
LOBECTOMYUSINGACOMBINATIONOFRTMSAND
FMRI
M. Sethi*,†,‡, P. Carney*,†,‡,§, M. Kowalczyk*, M. Pedersen*,‡,
C. Tailby*,†,‡, G. Jackson*,†,‡
*The Florey Institute of Neuroscience and Mental Health,
Heidelberg, VIC, Australia, †Austin Health, Heidelberg, VIC,
Australia, ‡University of Melbourne, Parkville, VIC, Australia,
§Eastern Health, Box Hill, VIC, Australia
Purpose: The left lateral anterior temporal lobe is posited as a hub within
a distributed left lateralised verbal semantic memory network. We used
fMRI to image a verbal semantic task-related network and resting state
functional connectivity before and after and offline inhibitory rTMS
induced ´virtual lesion´ of the left lateral anterior temporal lobe. Data
from an initial subject forming a part of an ongoing larger cohort is pre-
sented.
Method: Ethical permission was obtained from the Austin Health
Human Research Ethics Committee. T1 weighted images from a pre-sur-
gical right-handed patient with left temporal lobe epilepsy were obtained.
Fiducial landmarks were co-registered to structural images using a
frameless stereotaxic neuro-navigation system (Brainsight, Rogue
Research Inc, Canada ). Resting motor threshold (rMT) was obtained
from the ipsilateral hemispheres using standard protocols. 11 min (660
stimuli, 120% of rMT) of 1 Hz rTMSwas applied to the left anterior tem-
poral lobe 2 cm posterior to the pole along the middle temporal gyrus. A
figure-of-eight coil and Magstim Rapid2 stimulator (Magstim Whitland,
UK) were used. fMRI (semantic task and rest) was before and after
rTMS.
Results: Time between rTMS and fMRI was 3.5 minutes. There was
increased task related activation in the contralateral anterior temporal
and frontal regions post rTMSwithout a significant change in task perfor-
mance (reaction time and number of correct responses). Resting state
connectivity was altered among multiple brain regions post rTMS.
Conclusion: The results suggest the presence of a bilaterally distributed,
partially redundant, verbal semantic memory network that in this subject
reorganises post rTMS to maintain task performance in this subject.
Future studies will determine if characterising networks using rTMS-
fMRI predicts network reorganisation and memory outcomes after ante-
rior temporal lobectomy.
p1021
BRAIN SURFACEMAPPINGOFOBJECTIVELY
DEFINEDGLUCOSEMETABOLIC ABNORMALITIES
BEFORETWO-STAGE EPILEPSY SURGERY IN
CHILDRENABOVE 1 YEAROFAGE
C. Juhasz*,†, V. Pilli*,†, E. Asano*, A. Kumar*,†, S. Sood‡,§,
A. Luat*,§, H. Chugani†,¶, J.-W. Jeong*,†
*Wayne State University, Pediatrics and Neurology, Detroit, MI,
United States, †Children’s Hospital of Michigan, PET Center
and Translational Imaging Laboratory, Detroit, MI, United
States, ‡Wayne State University State University, Pediatrics and
Neurosurgery, Detroit, MI, United States, §Children’s Hospital
of Michigan, Detroit Medical Center, Detroit, MI, United States,
¶Nemours A.I. DuPont Hospital for Children, Pediatric
Neurology, Wilmington, DE, United States
Purpose: Interictal 2-deoxy-2(18F)-fluoro-D-glucose (FDG)-PET
abnormalities can assist presurgical localization of epileptic foci, particu-
larly when MRI is non-focal or discordant with electro-clinical findings.
However, objective, accurate delineation of hypo- and hypermetabolic
cortical regions is difficult in young children. In this study we used a
quantitative 3D brain surface mapping approach with statistical paramet-
ric mapping (SPM) to evaluate the accuracy of FDG-PET in lobar and
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sublobar localization of epileptic cortex defined by intracranial EEG in
children 1-18 years of age.
Method: Preoperative FDG-PET scans of 37 children with intractable
epilepsy (mean age: 9.7 years) were compared to age-matched pseudo-
normal pediatric control PET data (N = 64; mean age: 9.3 years). SPM-
defined hypo- and hypermetabolic maps were transformed to native 3D-
MRI brain surface where subdural grid electrodes were also mapped.
Accuracy of intracranial seizure onset zone (SOZ)-detection by these
metabolic abnormalities was determined both on the lobar level as well
by comparing the surface locations of metabolic changes with brain-sur-
face electrode coordinates.
Results: MRI showed focal cortical abnormality in 6 children (16%). At
least one cluster of metabolic abnormality was found in 34 (92%) patients
for hypometabolism and in 25 (67%) for hypermetabolism. Hypometa-
bolic clusters had a sensitivity of 75% and specificity of 64% to detect
the lobe(s) of SOZ. Hypermetabolic clusters had a slightly higher lobar
specificity (69%) but lower sensitivity (34%). Detailed surface-based dis-
tance analysis showed that the SOZ often extended ≥ 3 cm beyond meta-
bolic abnormalities.
Conclusion: Objective PET analysis utilizing age-matched pseudocon-
trols can reliably detect hypo- and hypermetabolic cortex on the lobar
level even in young children (above 1 year of age), providing a lobar
accuracy similar to accuracy reported in previous studies in older groups
for SOZ detection. However, seizure onset electrodes are often found at
least 3 cm away from cortical metabolic abnormalities.
p1022
THEUSEOF FMRI FOR PREDICTING POST-
OPERATIVEMEMORYDECLINE IN TEMPORAL
LOBEEPILEPSY
B. Metin*, C. Ozkara†, S. Ibrahimoglu†, S. Yagci Kurtish†,
M. Uzan†
*Uskudar University, Istanbul, Turkey, †Istanbul University,
Istanbul, Turkey
Purpose: Postoperative amnesia is a serious consequence of temporal
lobe epilepsy surgery. The gold standard procedure to anticipate the risk
of amnesia is WADA test. However due to practical difficulties, WADA
test is not frequently used. An alternative method is functional magnetic
resonance imaging (fmri), which can allow calculation of a lateralization
index for memory functions.
Method: Seven patients with left temporal lobe epilepsy were scanned
preoperatively using a memory paradigm. The paradigm consisted of
blocks that include verbal (words) and non-verbal (houses) memory
items. Lateralization indices were calculated separately for verbal and
non-verbal memory activations. Patients were also examined with verbal
and non-verbal memory tests both preoperatively and post-operatively.
Results: Preoperative lateralization index for verbal and non-verbal
memory predicted significantly postoperative decline in both verbal and
non-verbal memory. The patients with verbal memory lateralized to left
medial temporal lobe suffered from more post-operative verbal memory
loss. Likewise patients with non-verbal memory lateralized to right side
had lower post-operative decline.
Conclusion: The results indicate that fmri may be an effective and non-
invasive alternative to WADA test in predicting post-operative memory
decline after temporal lobe surgery.
p1023
POORLYCONTROLLED SEIZURESDISRUPT
RESTING STATENETWORKS IN PATIENTSWITH
GENERALIZED EPILEPSIES
D. Garcia*, M. Alvim*, M. Polydoro*, A. Ishikawa†,
L. Montanher*, B. Campos*, M. Morita*, F. Cendes*,
C. Yasuda*
*University of Campinas - UNICAMP, Neurology, Campinas,
Brazil, †University of Campinas - UNICAMP, Institute of
Computing, Campinas, Brazil
Purpose: Although generalized epilepsies are considered “easy to con-
trol”, some individuals present persistent seizures despite optimized
polytherapy. The impact of refractory seizures on large-scale resting state
networks (RSNs) in generalized epilepsies (GE) has not been entirely
explored; therefore here, we compared interactions among RSNs
between refractory and seizure-free subjects to evaluate disruptions in
normal pattern of brain connectivity.
Materials and methods: Resting-state fMRI was acquired on 3T-PHI-
LIPS from two groups of patients [23 SEIZURE-FREE (free of seizures
for at least one year before MRI acquisition; SZ-free, 15 women,
36.6  12 years years) and 37 REFRACTORY (persistent seizures, 22
women, 34.2  12 years)] and 60 CONTROLS matched by age
(p = 0.7) and gender (p = 0.9). To compare interactions of 12 RSNs
(from resting-state functional-MRIs, parcellated in 70 regions of interest
(ROIs)), images were processed with UF2C-toolbox (running on
MATLAB2014/SPM12), for ROI parcellation, matrix construction and
statistical analysis (with intranetwork and internetwork connectivity).
Each group of patients was compared with matched controls. Reported
results have a 0.001 alpha.
Results: Compared to controls, there were intranetwork and internet-
work dysfunctions. Both groups presented abnormal correlations in the
posterior salience network, default mode network (dorsal and ventral por-
tions) and auditory network. Despite some similarities between groups,
Refractory group displayed a more widespread array of abnormalities,
including reduced correlations mainly involving the visuospatial network
and an intriguing opposite correlation between basal ganglia and sensori-
motor networks. Although more restricted alterations occurred in the SZ-
free group, we identified specific alterations involving left executive con-
trol and visual networks.
Conclusion: These results suggest that both SZ-free and refractory
patients present abnormal interactions of large-scale brain network; how-
ever, Refractory patients displayed a more extensive network dysfunc-
tion, mainly in the left hemisphere. Further investigation is necessary to
evaluate the impact of such dysfunctional networks on both cognition,
behavior and mood alterations.
p1024
AUTOMATEDHIPPOCAMPALVOLUMETRY
PROFILES ALONGTHEANTERIOR-POSTERIORAXIS
FORHIPPOCAMPAL SCLEROSIS DETECTION
S.B. Vos*,†, G.P. Winston†,‡, N. Toussaint*, J. Burdett†,
M.J. Cardoso*, J.S. Duncan†,‡, S. Ourselin*,‡
*University College London, Translational Imaging Group,
London, United Kingdom, †Epilepsy Society Chalfont St Peter,
MRI Unit, Chalfont St Peter, United Kingdom, ‡University
College London, Department of Clinical and Experimental
Epilepsy, London, United Kingdom
Purpose: Hippocampal sclerosis (HS) is the most common cause of
refractory temporal lobe epilepsy (TLE). It is radiologically recognized
by hippocampal atrophy and increased T2-weighted signal, with quanti-
tative imaging such as hippocampal volumetry improving sensitivity.
Following our automation of hippocampal volumetry (HippoSeg, https://
hipposeg.cs.ucl.ac.uk) we present an automated method to evaluate volu-
metric profiles along the anterior-posterior (AP) axis, to improve our sen-
sitivity to detect localised atrophy.
Methods: 50 TLE-patients with radiologically-confirmed HS (mean age
42.9 years, 23 male) and 50 age- and gender-matched healthy controls
underwent imaging on a 3T GE MR750 scanner with a 1 mm isotropic
3D T1-weighted MPRAGE. Hippocampi were automatically segmented
using HippoSeg†.
Subject scans were reoriented to have their hippocampi along the AP
axis (found using principal component analysis) and cross-sectional area
was obtained at each slice. MNI-152 template and Harvard-Oxford hip-
pocampal delineations were similarly reoriented (template named MNI-
HC). To compare across subjects, all scans were then registered to the
MNI-HC atlas with an initial affine alignment followed by a b-spline reg-
istration, with the matching between template and subject scan excluding
the hippocampi, to ensure no influence of pathology on outcome. Cross-
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sectional areas were transformed according to this registration and sam-
pled along the centre of the Harvard-Oxford hippocampal segmentations,
using the 50 control subjects to generate a normative range (median-
2*IQR to median+2*IQR).
Results: Global volumetric values from HippoSeg showed significant
atrophy in 83.6% of radiologically-confirmed sclerotic, and 2% of con-
trol subjects’, hippocampi. Including hippocampal volume profiling
along the AP axis, while keeping the control rate detection at 2%,
increased automated detection of atrophy to 87.7%.
Conclusion: Manual hippocampal volume profiling has previously
shown potential to improve the distinction between healthy and sclerotic
hippocampi but is very labour-intensive. Our work demonstrates the fea-
sibility of automating this process to increase atrophy detection rates in a
time- and cost-effective way.
p1025
ABERRANT FUNCTIONALCONNECTIVITY
PATTERNSOF THEDEFAULTMODENETWORK IN
TLE-HS PATIENTSWITHANTI-NMDARANTIBODIES
N. Watanabe*, B.M. de Campos†, A. Lizcano†, N.P. Divino*,
R. Barbosa‡, M.K.M. Alvim‡, C.L. Yasuda‡, M.E. Morita‡,
F. Cendes‡
*UNICAMP - University of Campinas, Neurology, Campinas,
Brazil, †University of Campinas - UNICAMP, Campinas, Brazil,
‡UNICAMP - University of Campinas, Campinas, Brazil
Purpose: Previous studies have found specific neurologic antibodies in a
small proportion of people with epilepsy, mostly of unknown cause.
Studies also suggested a potential role of autoimmunity in the precipita-
tion of adult-onset temporal lobe epilepsy with hippocampal sclerosis
(TLE-HS). Structural MRI reveals abnormalities in up to 50% of patients
with anti-NMDAR encephalitis, without relationship with severity of
symptoms. Functional MRI (fMRI) connectivity patterns of the default
mode network (DMN) using resting state fMRI (RS-fMRI) may correlate
better with clinical presentation. We aim to describe connectivity pat-
terns of DMN in anti-NMDAR positive TLE-HS patients.
Method: We acquired RS-fMRI in 3 anti-NMDAR positive TLE-HS
patients: two were tested for autoantibodies because of severe exacerba-
tion of psychiatric symptoms; and one patient was randomly tested.
Images were acquired in a 3T scanner. We performed images preprocess-
ing and analysis with UF²C toolbox: realignment, normalization, smooth-
ing, and tissue segmentation. We regressed the fMRIs for head motion,
white-matter and CSF global signals and band-pass filtered (0.008-
0.1 Hz). We used 18 ROIs (regions-of-interest) of the DMN for individ-
ual cross-correlations. Sequentially the individual’s adjacency matrices
were taken to the second level analysis: results from each patient were
compared separately to 20 subjects with TLE-HS who tested negative for
anti-NMDAR, using Z-test (p < 0.001 FDR corrected for multiple ROI-
wise comparisons).
Results: The two patients with exacerbation of psychiatric symptoms
had widespread abnormalities in DMN connectivity, including frontal,
parietal, medial and lateral temporal lobes, and insula. The patient who
tested positive for anti-NMDAR Abs and presented mild psychiatry
symptoms had less alterations in DMN connectivity involving insula and
medial parietal lobe.
Conclusion: These preliminary findings suggest that aberrant patterns of
connectivity in RS-fMRI occur in anti-NMDAR positive TLE-HS
patients, and its abnormalities may correlate to clinical presentation. Fur-
ther longitudinal studies with more patients are necessary to confirm
these findings.
p1027
SPATIO-TEMPORALCHARACTERIZATIONOF
NEURONALACTIVITY INA ZEBRAFISHMODELOF
EPILEPTIC SEIZURES
T.G. Martins*, M. Moein*, N. Norlin†,‡, S. Komoto†,
L. Salamanca*, N. Komin*,§, S. Hachi*, A.F. d’Herouel*,
J. Martens*, A. Skupin*,§, F. Peri†, A.D. Crawford*
*Luxembourg Centre for Systems Biomedicine LCSB, University
of Luxembourg, Belvaux, Luxembourg, †European Molecular
Biology Laboratory EMBL, Developmental Biology Unit,
Heidelberg, Germany, ‡Karolinska Institute, Department of
Medical Biochemistry and Biophysics MBB, Stockholm, Sweden,
§National Centre for Microscopy and Imaging Research,
University of California, San Diego, CA, United States
Purpose: Epilepsy is a chronic brain disorder of unprovoked and recur-
rent seizures. Cellular and molecular mechanisms of seizures and epi-
lepsy have been proposed, such as genetic mutations that affect neuronal
activity. However, epilepsy is ultimately a disease of functionally and/or
structurally aberrant neuronal networks and the mechanisms that link cel-
lular/molecular alterations into dysfunctional neuronal circuits are poorly
understood. Recent advances in neuroimaging and electrophysiology
opened the possibility to characterize local neuronal networks of in vitro
and in vivo seizure models. However, brain volume limits a detailed anal-
ysis of larger neuronal circuits using the available recent techniques. The
zebrafish larvae model offers the possibility of a whole network-level
functional imaging due to their small size and optically transparent brain.
Therefore, this project aims to investigate the spatio-temporal profile of
neuronal activity in the epileptic zebrafish brain using both electroen-
cephalography and calcium imaging.
Method: Seizure-like behavioural activity of zebrafish larvae exposed to
picrotoxin, a pro-convulsant and GABAA receptor antagonist, was char-
acterized by visual observation and quantification of locomotor activity.
Afterwards, zebrafish larvae expressing a genetically encoded calcium
indicator were incubated with picrotoxin, the brain imaged with a confo-
cal microscope, and calcium levels analysed with imaging softwares.
Results: Picrotoxin induces increased hyperactivity, followed by jerky
movements, body stiffening and loss of posture. This behaviour is con-
centration-dependent, shown by an increased locomotor activity. Picro-
toxin induces a time-dependent increase in the amplitude and duration of
low-frequency calcium peaks in a focal plane of the optic tectum and
hindbrain.
Conclusion: The calcium dynamics in the zebrafish brain after exposure
to picrotoxin suggests an increased neuronal hyperactivity and/or syn-
chronization. Ongoing work will address a correlation between calcium
peaks and electrical brain activity, and in response to anti-epileptic drugs.
Additionally, the whole brain activity will be analysed using microscopy
techniques that offer high spatial and temporal resolution.
p1028
DIFFUSION-WEIGHTED IMAGING IN THEBABOON
MODELOFGENETICGENERALIZEDEPILEPSY
F. Salinas*, C.A. Szabo†
*University of Texas Health Science Center at San Antonio,
Research Imaging Institute, San Antonio, TX, United States,
†University of Texas Health Science Center at San Antonio,
Dept. of Neurology, San Antonio, TX, United States
Purpose: The baboon provides a natural model of genetic generalized
epilepsy (GGE) that closely resembles juvenile myoclonic epilepsy. This
study uses diffusion-weighted imaging (DWI) to determine any
microstructural brain abnormalities between a cohort of epileptic (EPI)
and healthy control (CTL) baboons.
Method: Twenty-seven baboons, matched for age and weight, were clas-
sified into two groups (13 EPI, 14 CTL) on the basis of scalp EEG find-
ings. All 3T MRI images were pre-processed using FSL’s FDT pipeline
and DWI maps were created for each animal’s fractional anisotropy (FA)
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and mean diffusivity (MD) values. Voxel-wise analysis of group-wise
differences were compared using FSL’s TBSS program after correcting
for gender and age distributions within each group. Region-specific dif-
ferences in each group’s DWI indices were also assessed using FSL’s
probabilistic tractography program (Probtrackx) in the primary motor
(M1), posterior limb of the internal capsule (PLIC), parietal and the
anteromedial thalamus - all of which have been implicated in previous
human GGEMRI studies.
Results: Similar to human studies of GGE, the epileptic baboons demon-
strated significant (p < 0.05, family-wise error (FWE) corrected)
decreases in the FA of the left M1, right M1, and left anteromedial thala-
mus. We also found increases (p < 0.10, FWE corrected) in the MD of
each of these regions. The parietal and PLIC regions did not have any sig-
nificant differences between groups.
Conclusion: This is the first study (using DWI) to demonstrate
microstructural differences between EPI and CTL baboons that resemble
the network differences observed in human GGE patients. Additionally,
these regions have also been implicated in the functional connectivity
differences found in our previous resting-state fMRI studies of the
baboon model of GGE. With DWI of the baboon model of GGE, we also
have more investigative options available when assessing the effects of
neuromodulatory and/or anti-epileptic medications on a na€ıve patient
population.
p1029
TEMPORAL LOBEEPILEPSY: QUALITATIVE
READINGOF 1HMR SPECTROSCOPIC IMAGES FOR
PRESURGICAL EVALUATION IN UZBEKISTAN
J. Fokhirov*, K. Daminova*
*Tashkent Medical Academy, Department of Neurology,
Tashkent, Uzbekistan
Purpose: To study the feasibility and clinical potential of visual inspec-
tion of hydrogen 1 magnetic resonance (MR) spectroscopic metabolite
images for the lateralization of unilateral nonlesional temporal lobe epi-
lepsy (TLE).
Method: MR imaging and 1H MR spectroscopic imaging were per-
formed of the temporal lobes in 50 patients with TLE and 23 age-matched
healthy volunteers. N-acetylaspartate (NAA) and creatine plus choline
metabolite images were read by two neuroradiologists who determined
lateralization according to the side of lower NAA signal intensity. Quan-
titative estimates of NAA were calculated by using an automated fitting
program.
Results: Agreement in lateralization between readers was significant
with a kappa score of 0.53 for all patients with TLE and 0.63 for patients
displaying mild or marked NAA asymmetry. Among the 50 patients with
TLE, lateralization was determined correctly by reader 1 in 38 (76%)
patients and by reader 2 in 31 (62%) patients. If limited to patients with
mild or marked NAA asymmetry, correct lateralization improved to 30
(77%) of 39 and 16 (80%) of 20 patients, respectively. Combined qualita-
tive reading and quantitative spectral fitting enabled lateralization in 34
(85%) of 40 patients with TLE for reader 1 and 30 (77%) of 39 for reader
2, including nine of 14 patients with TLEwith negativeMR images.
Conclusion: Reading of metabolite images is a feasible and fast means
for noninvasive evaluation of patients with TLE who are candidates for
surgery and enables lateralization in some patients with negative MR
images.
p1030
RELIABILITYOF THEDIAGNOSIS OFHETEROTOPIA
IN PATIENTSWITHPHARMACORESISTANT
EPILEPSIES
D. Sokic*,†, V. Bascarevic†,‡, S. Raicevic§, T. Djukic*,
A. Ristic*,†, N. Vojvodic*,†, A. Parojicic*, L. Brajkovic¶,
I. Nikolic**
*Clinic of Neurology CCS, Department of Epileptology,
Belgrade, Serbia, †Medical Faculty University of Belgrade,
Belgrade, Serbia, ‡Clinic of Neurosurgery CCS, Belgrade,
Serbia, §Center for Pathology CCS, Belgrade, Serbia, ¶Center
for Pathology CCSNuclear Medicine CCS, Belgrade, Serbia,
**Center for MRI CCS, Belgrade, Serbia
Purpose: Periventicular nodular, subcortical focal and band hetero-
topias, are rare causes of neuronal migration disorders in which a group
of neurons fail to migrate from the inner lining of ventricles to cortical
plate, leaving tracks or nodules of normal neurons in abnormal locations,
usually adjacent to the ependymal lining. Interaction of the nodular tissue
and the overlying cortex in the generation of seizures can be variable, so
the surgical resection of heterotopias may not be sufficient for rendering
patients seizure free. Visibility of heterotopias depends on size, location
and MRI quality. Based on the high number of MRI scans performed
before the final diagnosis is reached, we hypothesize that heterotopias are
more frequent than usually perceived.
Method: We conducted retrospective study of the frequency of hetero-
topias among patients with pharmacoresistant epilepsy subjected to non-
invasive presurgical evaluation comprising 5-15 days of noninvasive
video-EEG telemetry, 1,5T MRI, extensive neuropsychologic testing,
and FDG PET-CT scan (in ~one third of patients). MRI was performed
on Philips Achieva 1.5T DS MR system with paracoronal or coronal
angulation according to hypothesis reached after video-EEG telemetry.
Results: Between 01.07.2010 and 30.06.2016 we performed presurgical
evaluation in 872 patients with uncontrolled seizures. Heterotopia was
diagnosed in 25 patients (2.8%). In 7 patients (28%) the diagnosis was
established after the first MRI. The median number of previous nondiag-
nostic MRI scans was 4 (range 2-7) in 16 patients (64%) although subse-
quent MRI reevaluation showed signs of heterotopia in 7 of them. In 2
patients MRI showed unilateral hippocampal sclerosis (HS) and temporal
lobectomy on appropriate side was performed. Histology showed nodular
heterotopia adjacent to HS in both of them and only one patient remained
seizure free.
Conclusion: We conclude that heterotopias are probably underdiag-
nosed and that proper analysis of high quality MRI scans could improve
the diagnostic yield.
p1034
RISK FACTORS FORNEUROPSYCHOLOGICAL
IMPAIRMENT IN BENIGN EPILEPSYWITH
CENTROTEMPORAL SPIKES
I. Almashmoom*, O. Al-Shuker*, D. Macdonald*,
H. Aldhalaan*, M. Nester*
*King Faisal Specialist Hospital and Research Center,
Neuroscience, Riyadh, Saudi Arabia
Purpose: This study evaluates risk factors for neuropsychological
impairment in benign epilepsy with centrotemporal spikes (BECTS).
Method: In a retrospective cohort of 36 children with BECTS, we com-
pared the electroclinical features of 25 who were neuropsychologically
normal (Group1) and 11 who developed impairments (Group2) consist-
ing of hyperactivity and attention deficit disorder in all 11 with additional
language disturbances in 6.
Results: Median onset age was younger in Group2 than Group1 (4 vs.
8 years), and median epilepsy duration was longer (6.5 vs. 2 years)
(p < 0.001). Most patients with onset age < 5 years and especially those
with >5-year duration were in Group2, while most patients with onset
age >5 years and < 5-year duration fell into Group1 (p < 0.001). A
greater proportion of Group2 took >1 anticonvulsant (36% vs. 4%,
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p < 0.05). Classical or atypical benign epileptiform discharges of child-
hood (BEDC) were frequent in both groups, but were the only EEG
abnormality in half of Group1 vs. none of Group2 (p < 0.01). A greater
proportion of Group2 had multiregional epileptiform abnormalities (73%
vs. 8%), regional intermittent slow activity (91% vs. 16%), or both (73%
vs. none) (p < 0.001).
Conclusion: Possible risk factors for neuropsychological impairments in
BECTS include onset age < 5 years, >5-year epilepsy duration, taking >1
anticonvulsant, multiregional epileptiform abnormalities, and regional
intermittent slow activity. Features against these complications may
include onset age >5 years and EEG disclosing only BEDC. Risk factor
identification might guide potentially beneficial cognitive and educa-
tional intervention.
p1035
DEVELOPMENTANDVALIDATIONOF ICTAL
COGNITIVE TESTINGANDLOCALIZATION (ICTAL):
AN INDIVIDUALISEDHYPOTHESIS-TESTING
TABLET BASEDNEUROPSYCHOLOGICAL TEST
PROGRAMTOEVALUATECOGNITIVE DEFICITS
DURING ICTALEEGABNORMALITIES,WADA-
TESTING, INTRACRANIAL EEGRECORDINGS AND
AWAKE SURGERY
M. Hendriks*,†, S. Flachs†, F. Bremm†, A. Colon‡, S. Tousseyn‡,
L. Wagner‡, B. Vaessen§
*Academic Centre for Epileptology Kempenhaeghe, Department
of Behavioural Sciences, Heeze, Netherlands, †Donders Institute
for Brain, Cognition and Behaviour, Radboud University,
Nijmegen, Netherlands, ‡Academic Centre for Epileptology
Kempenhaeghe, Department of Clinical Neurophysiology,
Heeze, Netherlands, §Metrisquare, Sittard, Netherlands
Purpose: Evaluation of cognitive deficits during epileptic seizures,
Wada-testing, or intracranial stimulation depth-EEG and awake surgery
is critical for decision making in epilepsy surgery. In clinical practice
these diagnostic procedures are considered as independent. We devel-
oped ICTAL: a cognitive testing procedure that can be used for all four
diagnostic applications. ICTAL is an individualised hypothesis-testing
neuropsychological test program that runs on a tablet-based computer.
The program presents cognitive stimuli to assess multiple cognitive
domains depending on the clinical hypotheses formulated by the neu-
ropsychologist and neurophysiologist. In this study we validated the clin-
ical applicability of ICTAL for the use at the video-EEGmonitoring unit.
Method: 41 Epilepsy patients undergoing prolonged video-EEG-moni-
toring, and 41 healthy controls took part in the study. All participants
recieved a testbattery during 30 seconds 4 times. Patients were radomly
assigned to a hypothesized right temporal lobe battery or a left temporal
lobe battery.
Results: A chi-square test of independence indicate that epilepsy
patients made significantly more errors (p < 0.001). Crosstabs displayed
15 patients made one error compared to 4 controls, and 5 patients making
1 error compared to 0 controls. Errors were rare except for one item, that
was excluded from the test battery.
Conclusion: We concluded that ICTAL is a feasible neurocognitive
assessment battery that is presented on a tablet pc to be used during ictal
anomalies at the video-EEG-monitoring. Stimuli from all different cogni-
tive domains are generated at random depending on patient based
hypotheses. All patients and controls show 100 percent correct responses
on all stimuli. ICTAL is also applicable for Wada-testing, intracranial
EEG and awake surgery.
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BILATERAL TEMPORALLOBE EPILEPSYVERSUS
UNILATERALTEMPORAL LOBE EPILEPSY: DOTHEY
HAVEDISTINCTNEUROPSYCHOLOGICAL
PROFILES?
M. Baggio*, M. Da Rold*, E. Osanni*, F. Fabbro†, P. Bonanni*
*Epilepsy and Clinical Neurophysiology Unit, Scientific
Institute IRCCS “Eugenio Medea”, Conegliano, Italy,
†University of Udine, Department of Medicine, Udine, Italy
Purpose: Anatomo-electro-clinical characteristics in temporal lobe epi-
lepsy (TLE) with bilateral ictal involvement (bitemporal epilepsy
BTLE), are different from the pattern found in unilateral temporal lobe
epilepsy (UTLE). As only in UTLE is surgery good clinical practise, the
type of epilepsy needs to be early identified. Electro-clinical and neu-
roimaging information should be integrated with a wider cognitive
assessment. The purpose of this work was to define specific neuropsy-
chological differences between TLE and BTLE, in order to understand
the type of epilepsy and the patients suitable for surgical intervention.
Method: Neuropsychological data from eighteen BTLE patients (6
males, mean age 39,89 years) and Seventeen UTLE patients (6 males,
mean age 33,80 years) were retrospectively compared. The assessment
included the WAIS-R scale with measures of the Verbal Intelligence
Quotient (VIQ), the Performance Intelligence Quotient (PIQ) and the
Full Scale Intelligence Quotient (FSIQ). Moreover, other cognitive func-
tions like verbal and visuospatial short-term memory, verbal and visu-
ospatial long-termmemory, and attention were assessed.
Results: BTLE showed a wider impairment of neuropsychological func-
tions, and a lower IQ. Significant differences were found in two verbal
and one performance subtest of WAIS-R, as well as in VIQ (mean
BTLE-VIQ 75,94 (21,27); mean UTLE-VIQ 85,47 (19,34)), PIQ (mean
BTLE-PIQ 81,72 (20,25); mean UTLE-PIQ 89,12 (22,71)), and FSIQ
(mean BTLE-FSIQ 80,31 (18,69); mean UTLE-FSIQ 85,60 (18,14)).
Considering the clinical cut-off, verbal long-term memory was found
compromised in more BTLE (45,5%) than UTLE (10%) patients. More-
over, in visuospatial long-term memory, the average performance of
UTLE reached the 10th percentile, whereas in BTLE it was below the
clinical cut-off.
Conclusion: BTLE shows a wider impairment of neuropsychological
functions and lower IQ. BTLE and UTLE patients probably have distinct
neuropsychological profiles, thus neuropsychological assessment could
be used like a marker of bilateral temporal lobe epilepsy.
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COGNITIVEOUTCOMES FOLLOWING
RADIOFREQUENCY-THERMOCOAGULATION IN
TEMPORAL LOBEEPILEPSY (TLE): PRELIMINARY
DATA
C. Perez-Enrıquez*,†, R.M. Manero*,†, J. Pe~na-Casanova†,
A. Principe*, M. Ley-Nacher*, I. Delgado-Martinez‡,
G. Conesa‡, R. Rocamora*
*Epilepsy Monitoring Unit, Department of Neurology. Hospital
del Mar-IMIM, Barcelona, Spain, †Behavioral Neurology. Mar
Institute Medical Research-Foundation FIMIM, Barcelona, Spain,
‡Mar Institute Medical Research-Foundation FIMIM, SYLVIUS
Project, Neurofuncitonaly of Brain and Language, Barcelona,
Spain
Purpose: Radiofrequency-thermocoagulation (RF-TC) is a treatment
option for pharmacoresistant focal epilepsy when resective surgery is not
feasible. However, RF-TC can be performed in the SEEG-evaluation
frame. Despite the increasing use of neuro-ablative procedures in epi-
lepsy surgery, there is a lack of evidence whether this treatment can cause
alterations in the cognitive sphere. This work aims to the characterization
of the neuropsychological profile before and after RF-TC in a group of
patients with non-lesional TLE.
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Method: 10 non-lesional TLE patients (70% males; age range 21-
44 years, IQ 102.6  18.5) under SEEG monitoring were selected. The
main thermocoagulated regions were basal temporal (2.5  2.9 contacts
pairs), amygdala (2.4  1.7), temporal pole (2.0  1.9) hippocampus
(1.9  2.0) and entorhinal cortex (1.0  1.15). All underwent a neu-
ropsychological protocol, before unilateral RF-TC (70% left and 30%
right) and a follow-up 5 months later. Epileptic seizure frequency and
cognitive status were used to evaluate the outcome.
Results: After RF-TC, 20% of the patients were seizure free and the
remaining had a significant reduction of seizure frequency, decreasing
from 10.6  10.0 before, RF-TC to 3.8  8.5 after. Significant
improvements were found in some cognitive fields between pre- and
post-RF-TC assessments, mainly those in which processing speed and
executive function were involved (Tower of London p = 0.018 and Trail
Making Test scores p = 0.027). In non-case cognitive tests performance
was worse after RF-TC. Interestingly, there was an improvement of
depressive symptoms only when RF-TC was applied to the amygdala
(p = 0.029).
Conclusion: Our study shows an improvement after RF-TC in cognitive
fields such as processing speed and executive function and no-significant
differences in other cognitive/affective outcomes. These preliminary
results indicate that RF-TC generated lesions can lead to a significant sei-
zure frequency reduction without concerns an impairment in neuropsy-
chological function.
p1042
INTRATHALAMICHIGH-FREQUENCY EEGCAN
PREDICT DEEP BRAIN STIMULATIONEFFICACY IN
EPILEPSY
P. Klimes*,†, P. Jurak*,†, J. Halamek*,†, M. Bockova‡,
A. Damborska‡, I. Dolezalova§, K. Stillova‡, M. Balaz‡,
P. Daniel§, M. Brazdil§,¶, I. Rektor‡
*Institute of Scientific Instruments of the CAS, v. v. i., Brno,
Czech Republic, †International Clinical Research Center, St.
Anne’s University Hospital Brno, Brno, Czech Republic, ‡Multi-
Modal and Functional Neuroimaging Research Group, CEITEC
- Central European Institute of Technology, Masaryk University,
Brno, Czech Republic, §Brno Epilepsy Center, Department of
Neurology, St. Anne’s University Hospital and the Faculty of
Medicine at Masaryk University, Brno, Czech Republic,
¶Behavioral and Social Neuroscience Research Group, CEITEC
- Central European Institute of Technology, Masaryk University,
Brno, Czech Republic
Purpose: Deep brain stimulation (DBS) is a promising therapeutic
approach in pharmacoresistant epilepsy.
Method: We analyzed intracranial EEG recordings from depth elec-
trodes placed bilaterally in ncl. thalami anterior, sampled at 5 kHz
(15 minutes resting condition, recorded before DBS therapy, medication
on), in 7 epileptic patients with > 1-year follow-up (4 patients with posi-
tive response - at least 50 % reduction of seizures, 3 with negative
response). We analyzed relative power (normalized to power in Ripple
Band, 80-200 Hz) in the Fast Ripples (FR, 200-500 Hz), Very Fast Rip-
ples (VFR, 500-1000 Hz) and Ultra Fast Ripples (UFR, 1000-2000 Hz)
bands.
Results: Our results show significantly increased relative power
(p < 0.01) in patients with a positive response to DBS (relative power in
FR: 2.37  0.52, 1.73  0.39, VFR: 2.89  1.53, 0.87  0.33, and
UFR: 1.92  1.45, 0.06  0.03 for positive and negative response,
respectively).
Conclusion: We hypothesize that high-frequency EEG recordings can
predict the DBS outcome in epilepsy treatment. Our preliminary results
must be verified on a larger group of DBS-epilepsy patients.
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DIURNALVARIATIONOF POTENTIAL ICTAL
ONSETS DETECTED BYARESPONSIVE
NEUROSTIMULATIONDEVICE
P. Van Ness*, D.K. Chen*, Z. Haneef*, D. Yoshor†
*Baylor College of Medicine, Neurology, Houston, TX, United
States, †Baylor College of Medicine, Neurosurgery, Houston,
TX, United States
Purpose: To describe the diurnal variation of brief ictal rhythmic dis-
charges (BIRDs) with intracranial electrodes that are programmed to
detect potential intracranial onsets of subclinical or clinical seizures.
Method: 9 Patients had intracranial electrodes implanted with a respon-
sive neurostimulation system (RNS) (NeuroPace) at our center. All had
up to 8 electrodes recorded. These cases had seizure detection program-
ming to identify potential ictal onsets or BIRDs, based on comparisons to
actual clinical seizures recorded. Ictal onsets could include repetitive
spike wave epochs, or high or low voltage fast activity most commonly.
Due to responsive neurostimulation, the BIRDs may have been termi-
nated and this may have prevented conversion to a clinical seizure. Inter-
ictal spikes were ignored. The data was downloaded for 3-6 days of EEG
where the detection was functional and where the detected EEG segments
were logged for date and time.
Results: 4 cases had bitemporal depths from a posterior approach; 4
cases had unilateral temporal strips, depths or both, and 1 case had
extratemporal neocortical strips. 6/9 had increased sleep detections only.
2/9 had increased awake detections and 1/9 had awake or sleep detections
varying from day to day. Naps generally showed the same increase in
BIRDs seen during night time sleep in cases with naps. Interesting, one
case with 11 seizures had 9/11 when awake, while the BIRDs were pre-
dominant in sleep.
Conclusion: BIRDs showed a nocturnal or daytime predominance in all
9 of our RNS cases with most showing a nighttime (sleep) pattern. While
these findings are similar to reports of interictal spiking, this study is
looking at BIRDs, possibly for the first time. Studies are ongoing to deter-
mine if the BIRDs are predictive of seizures occurring with the same
diurnal pattern.
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CLINICALOUTCOMESOFVNS- ASPIRESR IN
PATIENTSWITHREFRACTORYEPILEPSY IN SHEBA
MEDICALCENTER, ISRAEL
M. Tzadok*, M. Boxer†, A. Nissenkorn*, O. Bar Yosef*,
Z. Feldman‡, Y. Zauberman‡, I. Blatt†, B. Ben Zeev*
*Chaim Sheba Medical Center, Pediatric Neurology, Ramat
Gan, Israel, †Chaim Sheba Medical Center, Neurology, Ramat
Gan, Israel, ‡Chaim Sheba Medical Center, Neurosurgery,
Ramat Gan, Israel
Objectives: The Vagus Nerve Stimulation (VNS) Therapy System has
been shown to be effective in reducing the number of seizures in people
with partial and secondarily generalized seizures. The Automatic Stimu-
lation Mode (AutoStim) feature of the Aspire SR Therapy System stimu-
lates the left vagus nerve on detecting tachycardia which may precede
seizures in addition to normal and magnet mode. This “upgraded” device
was approved for use in epilepsy by the Israeli ministry of health in Jan-
uary 2015. This study evaluates long- term clinical outcomes in patients
using the device in the epilepsy clinics in ShebaMedical Centre.
Methods: A retrospective follow up of the effect of AspireSR in patients
with drug-resistant epilepsy treated in both pediatric and adult epilepsy
clinics in Sheba Medical Centres. Outpatient visits tracked seizure fre-
quency, severity, quality of life, and adverse events from the device inser-
tion to now.
Results: 61 patients (ages 4-66) were implanted with the Aspire device
between March 2015 to November 2016. 12(20%) of them were reim-
planted replacing the 103 model VNS and for the rest of them it was the
first VNS implantation.
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35(57%) of the patients are followed in the pediatric neurology unit
and 26(43%) patients are being treated in the neurology department.
Aim of presentation: We will present the effect on seizure frequency,
severity, quality of life, and adverse events with Aspire SR in comparison
to pre implantation and in comparison to treatment with the previous
model of VNS.
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VENTRALANTERIORCINGULATEGYRUS:
INTEGRATIONOF BODY POSITIONANDCOMPLEX
MOTORRESPONSES
M. Centeno*, A. Jha†, P. Nachev†,‡, B. Diehl†,‡
*National Hospital for Neurology and Neurosurgery,
Videotelemetry Unit, Epilepsy Department, London, United
Kingdom, †Institute of Neurology, UCL, London, United
Kingdom, ‡National Hospital for Neurology and Neurosurgery,
London, United Kingdom
Purpose: Although the voluntariness of an action and its complexity
often go hand-in-hand, rapid, highly automatic movements must some-
times be remarkably complex. Falling, for example, requires an instant
response to the potential consequences of unopposed gravity that neces-
sarily integrates a multiplicity of facts about the state of the body and its
environment.
The anterior cingulum (AC) is a potential node where motor control,
emotional, and vegetative responses may integrate. It has been involved
in the production of stereotypical complex motor responses limited to
small body areas (Talariach 1972). AC is also involved in the generation
the sensation of body movement being part of the so called part of “the
human vestibular cortex” (Kahane 2003).
Here we report two cases of complex, rapid, stereotyped motor actions
associated with sensations of body position change triggered by stimula-
tion of the ventral aspect AC.
Method: Patients were implanted with depth EEG electrodes for epi-
lepsy presurgical investigations. Bipolar stimulation to 50 Hz with inten-
sities of 1-7 mA was performed in each patient. Their motor, sensory,
emotional, and vegetative responses were recorded, including, in one
patient, head and eye position sampled at 1 kHz.
Results: Stimulation induced a stereotypical complex motor response
involving the trunk and all four limbs (contralateral>ipsilateral) in both
patients. This complex action was adapted to the environment, naturally
interacting with surrounding elements. Patients reported a contemporane-
ous sensation of falling/sliding down.Motor response could not be volun-
tarily suppressed and was experienced as externally induced.
Conclusion: This case study reveals complex, yet highly automatic,
motor patterns activated in response situations such as a falling where a
rapid but stereotyped response is required. That they are reliably elicited
from ventral AC suggests it is key in integrating body position informa-
tion and retrieving rapid, adaptive motor patterns in response.
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CEREBELLAR TRANSCRANIAL DIRECTCURRENT
STIMULATION (TDCS) IN DRUG-RESISTANT
EPILEPSY: PRELIMINARYRESULTS FROM 10
PATIENTS
A. Mingarelli*, F. Furia*, V. Chiesa*, G. Oggioni*, A. Vignoli†,
A. Priori‡, M.P. Canevini†
*Epilepsy and Sleep Medicine Center, San Paolo Hospital, ASST
Santi Paolo e Carlo, Milan, Italy, †Epilepsy and Sleep Medicine
Center, San Paolo Hospital, ASST Santi Paolo e Carlo,
Neuroscience Department - University of Milan, Milan, Italy,
‡Neurology Unit, San Paolo Hospital, ASST Santi Paolo e Carlo,
Neuroscience Department - University of Milan, Milan, Italy
Purpose: Transcranial direct current stimulation (tDCS) is an emerging
non-invasive neuromodulation therapy, preliminary studies support its
safety and efficacy on seizures and EEG modulation in epilepsy but tar-
get and stimulation parameters have not been yet established. Cerebellum
has been proposed as a safe and efficient target for neuromodulation tech-
niques and could be a good target for patients with multifocal or general-
ized epilepsy.
Method: Ten patients (4 males- 6 females, aged 22-55) with drug resis-
tant multifocal or generalized epilepsy of unknown origin or associated
with diffuse MRI abnormalities, with seizure frequency >4 per month,
underwent to 5 consecutive daily session of cerebellar anodic tDCS
(2 mA, 20 min). Five patients presented intellectual disability. Seizure
frequency was recorded during the 30 days before and after stimulation’s
week, adverse events were assessed before, during and at the end of every
session. Standard EEG was recorded before stimulation on day 1, on day
5 at the end of the last session and after 30 days. Interictal epileptic activ-
ities was manually detected and quantified.
Resultsall patients completed the study period, no major adverse
events were recorded. Frequent complaints were hitching and redness on
the stimulation site vanishing within few minutes after stimulation.Four
patients referred increased sleepiness during the treatment week. At 7
and 30 days from last stimulation session no statistically differences
were observed in seizure frequency and interictal EEG abnormalities.
Despite this, 5/10 patients reported subjective benefit on seizure control
(particularly on seizure intensity).
Conclusionwe confirmed safety and good tolerability of cerebellar
tDCS in epilepsy patients, also in presence of intellectual disability. No
major effects on seizure frequency and EEG abnormalities were detected,
but half of our patients reported subjective benefit on seizure control.
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SLEEPDISORDERS IN CHILDRENAND
ADOLESCENTSWITHEPILEPSY: AN
OBSERVATIONAL STUDY
F. Furia*, E. Zambrelli*, K. Turner*, S. Malanchini†,
A. Vignoli†, F. La Briola*, A. Mingarelli*, M.P. Canevini†
*Epilepsy and Sleep Medicine Center, Pediatric
Neuropsychiatric Unit, ASST Santi Paolo e Carlo, Milan, Italy,
†Epilepsy and Sleep Medicine Center, Pediatric
Neuropsychiatric Unit, ASST Santi Paolo e Carlo, University of
Milan, Italy, Neuroscience Department, Milan, Italy
Purpose: This research studies children and adolescents suffering from
epilepsy, to assess the presence and prevalence of sleep disorders and to
investigate the reciprocal interactions between epilepsy, sleep disorders
and behavioral problems.
Method: We enrolled 60 children (34 M, aged 3-17 years, mean BMI
19), suffering from epilepsy, diagnosed according to the ILAE classifica-
tion of 2010, compared with a homogeneous group of healthy controls
for age, sex and BMI. We used the SDSC (Sleep Disturbance Scale for
Children) to assess the presence of sleep disorders and the CBCL (Child
Behavior Checklist) to describe the behavior and to identify any psy-
chopathological problems.
Results: Patients with epilepsy have obtained high scores both at SDSC
(p < 0.05 at DIMS and DES, 13% and 20% vs 0% and 2% in controls)
that the CBCL (p < 0.05 for almost all categories). 66.7% of patients
with pathological SDSC presented seizures in sleep. Pathological scores
at CBCL were related to the frequency of seizures (57% with multidaily
seizures), the presence of seizures in sleep (42.8%), multiple antiepileptic
therapy (57.2%) and the presence of autism or intellectual disabilities
(43%).
Conclusion: A pathological score at SDSC should always address the
clinician to investigate the presence of seizures in sleep, through noctur-
nal laboratory polysomnography. A pathological score at CBCL should
lead to reconsider anti-epileptic treatment and to look for the presence of
sleep disorders. The treatment of children with epilepsy should consider
a co-morbidity with a sleep disorder.
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DIETARYTREATMENTOFCHILDRENWITH
EPILEPSY: SIMPLE INTERVENTIONS LEADTOA
NEARTHREEFOLD INCREASE INRETENTIONRATE
K.C. Haavardsholm*,†, M.L. Hem*, S. Pedersen*,†,
M.I. Lossius*, A. Ramm-Pettersen*, K.K. Selmer†,‡
*Oslo University Hospital, National Centre for Epilepsy,
Sandvika, Norway, †Oslo University Hospital, National Centre
for Rare Epilepsy-Related Disorders, Oslo, Norway, ‡Oslo
University Hospital, Department of Medical Genetics, Oslo,
Norway
Purpose: Recent reports suggest that the modified Atkins diet (MAD)
may be as efficient as the established classical ketogenic diet (KD), at
least in children >2 years of age. Even if MAD is considered less strict
and requires less stringent weighing and planning of meals, poor reten-
tion rates remain a major challenge for both the KD and the MAD treat-
ments. The goal of our study was to test whether simple interventions
could increase the retention rate in children with epilepsy treated with
MAD.
Method: We studied two cohorts of children with refractory epilepsy
where MAD was initiated as treatment. In the first cohort, treatment with
MAD was initiated using our regular follow-up protocol. The second
cohort was followed applying a protocol where several measures had
been added, including pre-treatment and motivational consultations and
education of patients and parents/guardians.
Results: A total of 40 patients were included, 21 adhering to the regular
protocol (62% female, age 5-18 years, median 12 years) and 19 in the
intervention group (74% female, age 5-15 years, median 11 years). The
two groups were similar; no significant difference in age, gender nor
number of previous antiepileptic drugs (median 7). After 1 month, there
was a trend towards higher retention rate in the intervention group (71%
vs. 95%, p = 0,09), and after 3 and 6 months, this was significant (52%
vs. 95%, p = 0,004 and 33% vs. 90%, p < 0,001, respectively).
Conclusion: Ensuring the patients try the diet properly is important for
the success rate. Our results show that retention rate of dietary treatment
can be significantly increased with simple measures added to the follow-
up protocol. Motivational consultations, education of the patients and
their parents/guardians, and tight follow-up during the initiation of diet-
ary treatment seem to be key features.
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RELIABILITYANDVALIDITY ‘IMPACTOF
PEDIATRIC EPILEPSY SCALE’OF TURKISHVERSION
INCHILDRENWITHEPILEPSY
M. Tanrıverdi*, F. Mutluay†
*Bezmialem Vakıf University, _Istanbul, Turkey, †_Istanbul
Medipol University, _Istanbul, Turkey
Purpose: “Impact Of Pediatric Epilepsy Scale (IPES)” was developed
by Carol Camfield, containing 11 items. The assessment scored with the
overall health, family, social environment, activity number of schools
and the academic status of self-care situation, the question of family
activities. At the end of assesment there is a visual scale for measure the
quality of life that ask the verbal score between 1-6. Our aim in this study,
IPES scale by translate the Turkish ensure the validity and reliability of
our language, is used to make clinical trial in patients with epilepsy.
Method: The scale was translated into Turkish by following the appro-
priate translation step. The demographic datas of patients were recorded.
Internal structure consistency and test-retest reliability for reliability
analysis were measured. Cronbach´s alpha coefficients for all subscales
for each item separately and the scale and item-total correlations were
calculated. Test-retest reliability, including baseline and 2 week after the
scale was applied twice by physiotherapist. Test-retest reliability was
assessed statistically using Pearson correlation test for validity ´with
validity´was investigated.
Results: 28 female (35%), 52 male (65%) 80 patients were included.
Mean age was 6.94  1.453 year, the mothers education level was found
58 (72.5%) primary school, 5 (6.3%) secondary school, 11 (13.8%) high
school, 6 (7.5%) college level. In the 95% confidence interval assessors
from 0,851- 0,922 found that Cronbach´s alpha; Intraclass Correlation
Coefficient (ICC) 0,890 (r = 0,971; p = 0,000), respectively.
Conclusion: The IPES is a valid and reliable measurement for assessing
functions in children with epilepsy in Turkey.
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ELECTROCLINICAL FEATURESOFEPILEPSY IN
THREE FEMALE PATIENTSWITH KIAA2022
MUTATION
H. Ikeda*, K. Imai*, H. Ikeda*, S. Yoshitomi*, A. Horino*,
H. Omatsu*, T. Koike*, T. Yamaguchi*, H. Otani*,
H. Shigematsu*, Y. Takahashi*, Y. Inoue*, M. Kato†,
M. Nakashima‡, N. Matsumoto‡
*NHO Shizuoka Institute of Epilepsy and Neurological
Disorders, Shizuoka City, Japan, †Showa University School of
Medicine Medicine, Department of Pediatrics, Shinagawa,
Japan, ‡Yokohama City University Graduate School of
Medicine, Yokohama, Japan
Purpose: KIAA2022 is located on Xq13.3 and known to be an X-linked
intellectual disability gene in males. Recently, female patients who carry
de novo KIAA2022mutations have been reported. These female individu-
als share the same phenotypes of intellectual disability, facial dysmor-
phisms and epilepsy as males, with similar severity. Although there are
some reports of seizures, detailed characterization of seizure manifesta-
tion and EEG abnormality based on video-EEG recording are still lim-
ited. We evaluated three patients with KIAA2022mutation in our hospital
to elucidate the electro-clinical features of epilepsy in those patients.
Results: Patient 1 was a 19 year-old female with a de novo nonsense
mutation (p.(K560*)) in KIAA2022. Since the age of 2 years, she had
generalized epilepsy with eyelid myoclonia or myoclonic seizures
induced by closing eyes, with concomitant generalized spike and waves
(GSW) on EEG. Her interictal EEG showed GSW at 2.5-3.5 Hz. The sei-
zures persisted despite treatment with several drugs. Patient 2 was a
9 year-old female with a de novo frameshift mutation (p.(D600)) in
KIAA2022. She had epilepsy with myoclonic absence at the age of three
years. Her interictal and ictal EEG showed GSW burst at 2-3 Hz. Epi-
lepsy was controlled by valproic acid (VPA) and ethosuximide. Patient 3
was a 42 year-old female with a de novo nonsense mutation (p.(R481*))
in KIAA2022. She has had epilepsy with tonic seizures and nonconvul-
sive status epilepticus since the age of four years. Her interictal and ictal
EEG showed bilateral diffuse sharp waves in the alpha range. Her sei-
zures responded partially to VPA, clobazam, topiramate, lamotrigine and
clonazepam, but seizures remained refractory.
Conclusion: Three patients with KIAA2022 mutation in our hospital
manifest various types of epilepsy, and tend to have generalized seizures
including myoclonic seizure and absence.
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CHARACTERISTICSOF POLYMICROGYRIA-
RELATEDEPILEPSY
A. Ko*, S.E. Youn*, H.-C. Kang*, J.S. Lee*, S.H. Kim*,
H.D. Kim*
*Yonsei University College of Medicine, Severance Children’s
Hospital, Department of Pediatrics, Seoul, Korea
Purpose: This study aims to investigate characteristics of polymicro-
gyria (PMG)-related epilepsy in pediatric population.
Method: A retrospective study was conducted for all patients whose
who visited Department of Pediatric Neurology in Severance Children’s
Hospital between 2006 and 2016 and whose brain MRI revealed polymi-
crogyria of any extent, by review of clinical data.
Results: Sixty one patients were reviewed. The median age of the diag-
nosis of PMG - the age of initial brain MRI taken for any reasons - was 8
(2-32) months, and 37 (60.7%) were boys. Of 61, 9 patients (14.8%)
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showed unilateral unilobar involvements of PMG, 14 (23.0%) showed
unilateral multilobar involvements, and 38 (62.3%) showed involve-
ments of bilateral hemispheres. 14 (23.0%) patients showed other cortical
malformations: 8 (13.1%) showed gray matter heterotopia, 3 (4.9%) par-
tial or complete agenesis of corpus callosum, 2 (3.3%) schizencephaly,
and 2 (3.3%) focal cortical dysplasia of other natures (1 patient had both
heterotopia and partial agenesis of corpus callsum). 52 patients (85.2%)
showed seizures. 56 patients (91.8%) showed developmental delay, and
among them, 38 patients (67.9%) showed developmental delay before
onset of seizures. The median age of onset of seizures was 10.5 (2-48)
months. Among 52 patients who had seizures, 26 (50.0%) showed focal
seizures, 19 (36.5%) showed spasms, 3 (5.8%) showed myoclonic sei-
zures, 3 (5.8%) showed tonic seizures, and 1 (1.9%) showed head nod-
dings. By syndromic classification, 19 (36.5%) patients were diagnosed
with infantile spasms, and 7 (13.5%) with Lennox-Gastaut syndrome. 29
(55.8%) patients were intractable to more than 2 antiepileptic drugs.
Conclusion: The incidence of epilepsy in patients with PMG is as high
as 85.2%, and among them, 55.8% are intractable to medical therapy.
p1066
EFFICACY, ACCEPTABILITY ANDTOLERABILITY
OFLOWGLYCEMIC INDEXDIET IN SOUTH INDIAN
CHILDRENWITHREFRACTORYEPILEPSY
N. Pavithran*
*Amrita Institute of Medical Sciences, Amrita University,
Clinical Nutrition, Ernakulam, India
Purpose: This study was conducted to determine the efficacy, accept-
ability and tolerability of Low Glycemic Index Treatment (LGIT) in
South Indian children with pharmacoresistant epilepsy.
Method: We identified children with refractory epilepsy from the diet
clinic of a tertiary care university hospital for LGIT initiation over a per-
iod of 2 yrs. Demographic and clinical informations were collected. Initi-
ation of the LGIT was done in an outpatient setting as per the institutional
protocol . LGIT was classified as Step 1- only sugar restriction and Step 2
- restriction of sugar, rice, roots and tubers. Change in seizure frequency
was assessed at 1-, 3-, 6-, 9-, 12-, and 24 month follow-up intervals.
Results: 60 children were enrolled for LGIT during the study period.
Male:female ratio:34:28. Age ranged from 1 year to 19 years with mean
age 5.54 + _ 4.41 years. 80% of children were on 3 or more AED. 63%
of patients were categorized as having more than one seizure per day at
study entry, with the remaining children as experiencing over one seizure
per week. 33 patients were started on Step 1 LGIT and 44 patients were
on Step 2 LGIT. 33.3% of patients were seizure free at the end of the first
month. At the last follow up 42.80% of children had >80% seizure reduc-
tion and 14.2% had 50-80% reduction in seizures. Complete withdrawal
of current medications was possible in 2 patients at the end of 3 months.
Diet was discontinued in 14 patients due to poor compliance and no
response in seizure control. In 3 patients due to seizure freedom diet was
changed to normal. Otherwise no significant complications were
observed during the administration of the diet.
Conclusion: LGIT is a safe and effective adjuvant antiepileptic therapy
and may be used as an alternative to the ketogenic diet.
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SIGNIFICANCEOF FUNCTIONALCONNECTIVITY
BEFOREANDAFTERCORPUSCALLOSOTMYOR
HEMISPHEROTOMY IN PEDIATRIC EPILEPSY
PATIENTS
A. Ko*, C.W. Pae†, M.K. Oh†, S. Eom*, S.H. Kim*, H.-C. Kang*,
D.-S. Kim‡, H.D. Kim*, H.-J. Park†, J.S. Lee*
*Yonsei University College of Medicine, Severance Children’s
Hospital, Department of Pediatrics, Seoul, Korea, †Yonsei
University College of Medicine, Department of Nuclear
Medicine, Seoul, Korea, ‡Yonsei University College of Medicine,
Severance Children’s Hospital, Department of Pediatric
Neurosurgery, Seoul, Korea
Purpose: Assessing functional connectomes before and after epileptic
surgeries has proven its usefulness in selecting surgical candidates and
predicting outcome after surgery in epileptic patients in several studies.
This study was conducted to investigate functional connectivity using
resting state fMRI (rs-fMRI) before and after corpus callosotomy and
hemispherotomy in pediatric epileptic patients.
Method: This is a prospective study that has been carried out since 2009.
A total of 33 patients were enrolled in this study, with inclusion criteria
of patients less than 19 years old with intractable epilepsy with daily sei-
zure who received corpus callosotomy or hemispherotomy. Six patients
were excluded later as functional imaging after the surgery could not be
obtained. Analysis was conducted for 26 patients. Patients were dichoto-
mized into favorable (Engel scale 1-2) vs unfavorable (Engel scale) 3-4
based on their seizure profile at 6 months after the surgery.We evaluated
network properties of the functional network with respect to - node
degree, global efficiency, pathlength, and strength - to assess alteration of
the functional network after callostomy.
Results: The node degree (p = 0.037429), global efficiency
(p = 0.023312), and strength (p = 0.028665) were significantly lower,
and path length (p = 0.013516) was significantly higher in the favorable
group than in the unfavorable group before callosotomy.
Conclusion: Functional connectivity still remains after corpus calloso-
tomy or functional hemispherotomy. Graph characteristics - node degree,
global efficiency, path length, and strength - of rs-fMRI may predict out-
come of corpus callosotomy or functional hemispherotomy.
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EPILEPSY INCHILDRENWITHTUBEROUS
SCLEROSIS COMPLEX: LJUBLJANAUNIVERSITY
CHILDREN´S HOSPITAL EXPERIENCE
J. OrazemMrak*, D. Neubauer*, M. Perkovic Benedik*
*University Children’s Hospital Ljubljana, Dept. of Child,
Adolescent and Developmental Neurology, Ljubljana, Slovenia
Background: Tuberous sclerosis complex (TSC) is a multisystem
genetic disorder characterised by growth of hamartomas in several
organs, including the brain. Epilepsy is reported in 70-90% of patients. In
Ljubljana University Children´s hospital, Center for TSC was formally
established in 2012.
Objective: Analysis of epilepsy characteristics of TSC patients followed
by our Center.
Methodsdata regarding types of epilepsy, age at onset (AO), forms
and effectiveness of treatment was abstracted frommedical records.
Results: Of 18 included patients (5M, 13F), 3/18 (17%) did not have epi-
lepsy. 8/18 (44%) had infantile spasms (IS) - 1 child had IS only, 1 later
developed Lennox-Gastaut syndrome, 6 later developed focal epilepsy
(FE). Average AO of IS was 5.1 months. In 6/8 vigabatrin (VGB) was
the first antiepileptic drug (AED) used, in 3 (50%) it effectively stopped
the seizures. After unsuccessful therapy with VGB only and in combina-
tion, 2 patients were effectively treated with hydrocortisone. In 2/8
patients IS were resistant to all forms of treatment. 13/18 (72%) patients
had FE (7/13 FE only, 6/13 had previous IS). 6/13 patients had pharma-
coresistant FE, one of them had successful epilepsy surgery. In 7/13
(54%) epilepsy was controlled with AEDs, in 5 with one AED, in 2 with
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two AEDs. 2 patients achieved seizure remission after discontinuation of
all AEDs. 4 patients with FE were treated with everolimus - 1 for SEGA,
2 for AML, 1 for epilepsy. Two reported improvement of epilepsy.
Conclusions: 83% patients in our cohort had epilepsy. 44% had IS, VGB
was the first AED used in 75%, with 50% success in controlling the
spasms. 72% of patients had FE, in 46% epilepsy was pharmacoresistant.
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ANEWCOMPUTERBASEDALGORITHMFOR
CALCULATINGKETOGENIC PARENTERAL
NUTRITION IN CHILDHOODEPILEPTIC
ENCEPHALOPATHIES
A. Dressler*, N. Haiden*, P. Trimmel-Schwahofer†,
F. Benninger*, G. Gr€oppel*, S. Pelzmann†, A. M€uhlebner*,
K. Abraham‡, M. Feucht*
*Medical University Vienna, Vienna, Austria, †General Hospital
Vienna, Vienna, Austria, ‡Hospital Oberwart, Oberwart, Austria
Purpose: Ketogenic parenteral nutrition (KPN) is indicated when enteral
intake is temporarily limited or not possible. Evidence-based prescrip-
tions are lacking.
Objective was to evaluate the efficacy and safety of a KPN in children
with epileptic encephalopathies using a new computer based algorithm
for accurate component calculating.
Method: Children with epilepsy receiving a KPN were included. A new
computer based algorithm for calculating the ketogenic ratio and daily
energy requirements was established based on the ESPGHAN guidelines
, fat-intake not exceeding 4 g/kg/d, age-adequate supply of protein, elec-
trolytes, vitamins and trace elements and reduced of carbohydrate.
Primary outcome was the success to achieve/maintain relevant ketosis
defined as beta-hydroxybutyrate plasma evel of ≥ 2 mmol/l. Efficacy
was defined as the reduction of seizures ≥ 50% in de novo kPN and as
maintenance of seizure reduction in children already on KD. Safety was
assessed by adverse effects, laboratory findings and the appropriateness
of nutritional intake.
Results: 17 children (median age of 1.84 years) were studied. Indica-
tions for kPN were surgery, Status epilepticus, vomiting, food refusal,
and introduction of enteral feeding in neonatal age. The parenteral fat/
non-fat ratio was mean 0.9 ( 0.3; range 0.6 - 1.5). Relevant ketosis was
achieved/maintained in ten children (median 2.9 mml/l), target levels
were not reached in 7 (median =1.4 mmol/l). In de novo kPN signifcant
response was observed in 50% (2/4), in the remaining patients previously
on KD 77% (10/13) maintained response and 23% (3/13) were still within
the evaluation period. The correlation between the degree of ketosis and
seizure reduction was significant (correlation coefficient = 0.691;
p = 0.002). No adverse events were observed.
Conclusion: KPN not exceeding a fat intake of 3.5-4.0 g/kg/d is effec-
tive and safe. The computer based algorithm helped to tailor the kPN
according to guidelines and to both age and individual nutritional needs.
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LONG-TERM SEIZUREANDDEVELOPMENTAL
OUTCOME IN SURGICALCASESOF INFANTILE
EPILEPTIC ENCEPHALOPATHIES
K. Sugai*, T. Otsuki†, A. Takahashi†, T. Saito*, E. Nakagawa*,
M. Sasaki*, N. Ikegaya†, Y. Kaneko†, M. Iwasaki†
*National Center of Neurology and Psychiatry, Child
Neurology, Kodaira, Tokyo, Japan, †National Center of
Neurology and Psychiatry, Neurosurgery, Kodaira, Tokyo,
Japan
Purpose: Infantile epileptic encephalopathies (IEE) are severe disorders.
Long-term seizure and developmental outcome of surgical cases of IEE
were evaluated.
Method: Surgical cases of IEE followed up for one to 15 years after sur-
gery were studied.
Results: The subjects included Ohtahara syndrome (OS), 26 cases
[hemimegalencephaly (HME) 21, multilobar dysplasia (MCD) 3, no cor-
tical dysplasia (CD) 2], West syndrome (WS), 30 [HME 5, MCD 7, focal
cortical dysplasia (FCD) 6, no CD 11], early myoclonic encephalopathy
(EME), 1 [MCD 1], and Aicardi syndrome (AS), 1 [MCD 1]. All the
cases underwent surgery after non-invasive evaluations. Surgical proce-
dures included hemispherotomy (Hemi) in 28, multilobar resection/dis-
connection (M/D) in10, focal resection (FR) in 6, and callosotomy (Cal)
in 14 cases. Surgery was done at 58 days and under 12 months in 41
cases, and 1 and 3 years in 17 cases. At the last evaluation aged 1-year-1-
month and 15-year-9-month, seizure outcome of Engel Class I was 36,
Class II 1, Class III 13, and Class IV 8 cases. IQ/DQ > 80 was in 7 (OS 1,
WS 6/Engel Class I 7/Hemi 1, M/D 2, FR 4), 79-70 in 1 (OS/Class I/
Hemi), 69-50 in 9 (OS 3, WS 6/Class I 8, Class II 1/Hemi 4, M/D 2, FR 1,
Cal 2), 49-35 in 8 (OS 4, WS 4/Class I 4, Class III 4/Hemi 4, FR 1, Cal 3),
34-20 in 11 (OS 9, WS 2/Class I 10, Class III 1/Hemi 8, M/D 3), and < 20
in 22 cases (OS 8, WS 12, EME 1, AS 1/Class I 3, Class II 1, Class III 11,
Class IV 7/Hemi 9, M/D 2, FR 2, Cal 9).
Conclusion: In view of the severity and pathology of the present IEE
cases, early surgery for IEE is encouraging for long-term seizure and
developmental outcome.
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AUTOIMMUNEEPILEPSY IN CHILDREN:
IDENTIFICATIONANDMANAGEMENT STRATEGIES
S. Gulati*, V. Sondhi*, B. Chakrabarty*, P. Jauhari*,
P. Madaan*, R. Dubey†
*All India Institute of Medical Sciences, Child Neurology
Division, Department of Pediatrics, New Delhi, India, †All India
Institute of Medical Science, Child Neurology Division,
Department of Pediatrics, New Delhi, India
Purpose: Autoimmune epilepsy (AIE) is defined as epilepsy with defini-
tive or presumptive evidence of immune mediated neuroinflammation. A
retrospective chart review of children with AIE is being presented from a
tertiary care center in northern India.
Method: The records of 1408 children presenting with epilepsy between
2014 to 2016 were analyzed; 49children with suspected AIE were
included. AIE was suspected in following settings:
(1) recognizable syndromes such as surface or anti-neuronal anti-
body positive-/ limbic-encephalitis,:
(2) evidence of neuroinflammation in cerebrospinal fluid/ on MRI
brain,:
(3) the presence of other autoimmune diseases, or:
(4) positive response to immunotherapy. : A two-tier antibody testing
was followed guided by clinical evaluation and preliminary investiga-
tions. First-tier included ANA, Anti-dsDNA, neuronal surface antibodies
(Anti-NMDA, -VGKC, -CASPR2, -LGI-1), anti glutamic-acid-decar-
boxylase (GAD) antibodies, anti-thyroid peroxidase and anti-basal gan-
glia antibodies; Second-tier included anti-neuronal antibodies (Anti-Hu,
-Ma, -Yo, CRMP5, -ANNA2).
Results: Of the 49, thirty patients were classifiable as AIE (19 did not
test positive for any known antibodies neither demonstrated any response
to immunotherapy). Of the thirty patients, 16 children (9 females; median
age=10 years, IQR:5-11 years) were diagnosed as Anti-NMDAR
encephalitis (associated behavioral, extrapyramidal and autonomic
abnormalities), 3(all females) had anti-GAD encephalitis, one each had
Anti-thyroperoxidase, -Ma, -Yo, and anti-basal ganglia antibody associ-
ated AIE, and seven had seronegative limbic encephalitis. Immunother-
apy was administered to all and escalated according to clinical response
(initial concomitant administration of methylprednisolone and intra-
venous gammaglobulin (IVIG) followed by tapering oral steroids, subse-
quently plasma exchange and then rituximab). Twenty-nine of thirty
patients responded to immunotherapy. Twenty-four patients responded
to concomitant administration of methylprednisolone and IVIG, four
demonstrated improvement with subsequent plasma exchange and one
improved only after adding rituximab. One Anti-GAD AIE expired dur-
ing the course of the disease.
Conclusion: Early identification and management of AIE is imperative
for treatment, immediate and long-term outcome related implications.
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KETOGENIC DIET SERVICE –SPECTRUMOF
REFFEREDCASES ACCORDING TOAGE
C. Sandu*, G. Fitzsimmons†, M. Sewell†, J.H. Cross†, D. Craiu*,
C. Eltze†
*Alexandru Obregia Clinical Hospital, Bucharest, Romania,
†Great Ormond Street Hospital, London, United Kingdom
Background: The ketogenic diet (KD) is an established treatment for
drug resistant epilepsy. Recent published data and guidelines suggest that
the KD is also safe and effective in infants under 2 years with drug resis-
tant epilepsy.
Purpose: We aimed to review referral practice for KD to a single epi-
lepsy specialist centre and compare tolerability, retention and response in
different age groups.
Method: Patients reffered over a 2 year period ( July 2012- June 2014)
to the KD service of a single specialist epilepsy centre were identified
from an electronic data base and case notes reviewed retrospectively.
Results: Eighty six patients were identified, of which 5/86(6%) were
over 12 years, 65/86 (76%) - 2 to 12 years and 16/86 (18%) < 2 years at
the time of the referral. The lag time from onset of epilepsy to referral is
quite long (average 4.5 years). Distribution of etiologies and epilepsy
syndromes are variable. All infants started on KD folowed the classical
type with variable ratios, compared to 58 % of children and adolescents.
The rate of response, at least for classical KD , at 3 mo is similar in infants
and children, with ~ 50% in both categories achievingmore than 50% sei-
zure reduction, in line with what has been reported in the literature. Also,
the range of side effects between the 2 categories are similar. Average
duration on KD for our groups of infants or children is approximately
6 months.
Conclusion: Although the KD can be effective and safe, with good
retention in infants, this age group forms a low proportion of those
referred. More data from prospective research are required to establish
this intervention also in the very young and vulnerable age group.
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ADVERSE EFFECTSOFANTIEPILEPTIC DRUGS
REPORTED BYCAREGIVERS ASA SURROGATE
MARKEROFQUALITYOFLIFE ANDMENTAL
HEALTH INCHILDRENWITHEPILEPSY
P. Girotto*, M. Gregorio*, E.M. Yacubian*, L. Guilhoto*
*UNIFESP, Neurology, Sao Paulo, Brazil
Purpose: Adverse effects caused by antiepileptic drugs (AEDs) often
lead to treatment failure in childhood epilepsy. Instruments for measuring
AED adverse effects are already used in adults but with more difficulties
in children. This study aims to evaluate:
(1) Liverpool Adverse Effects Profile (LAEP) use by proxy in children
and adolescents with epilepsy;
(2) relation of LAEP with instruments measuring caregiver burden,
child’s quality of life (QOL) and mental health;
(3) comparison of LAEP reports between adolescents and caregivers.
Method: Cross-sectional sample survey at tertiary university outpatient
childhood epilepsy center in Brazil with 84 patients aged 2-19 yrs. and
caregivers who completed four screening instruments: LAEP, QOL
(QVCE by Souza Maia Filho et al., 2007), Strengths and Difficulties
Questionnaire (SDQ) and Burden Interview (BI); 19 (11-19 yrs.) also
completed three self-reporting instruments (LAEP, QOLIE-AD-48,
SDQ).
Results: There were positive correlations of LAEP scores reported by
caregivers with seizure frequency (r = 0.257, p = 0.018), BI (r = 0.464,
p = 0.010) and negative with QOL (r = -0.669, p = 0.010). There were
differences between LAEP in SDQ subgroups (p = 0.031) with worst
results in mental health in those with higher LAEP scores. Predictors of
LAEP were polytherapy, QOL, SDQ and BI scores. There was strong
correlation between caregiver and adolescent reports on LAEP
(r = 0.751, p = 0.010).
Conclusion: High scores on caregiver reported LAEP are strongly corre-
lated with seizure frequency, caregiver burden and QOL measurements
in children with epilepsy as well are associated to mental health reported
problems. LAEP may be used in children as objective screening tool for
psychic and health assessment.
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OCCIPITAL INTERMITTENTRHYTHMICDELTA
ACTIVITY (OIRDA) IN CHILDREN
A. Winczewska-Wiktor*, M. Starczewska*, M. Cieslik-
Wilczynska*, B. Malendowicz-Major*, B. Steinborn*
*University of Medical Sciences Poznan Poland, Department of
Developmental Neurology, Poznan, Poland
Purpose: Occipital intermittent rhythmic delta activity (OIRDA) is an
electroencephalographic (EEG) pattern observed mainly in children with
epilepsy, particularly in childhood absence epilepsy (CAE), in
encephalopathy, and sometimes is not associated with epilepsy. Many
studies suggest that OIRDA occurs exclusively in the case of epilepsy.
We reviewed EEG that had been conducted on children and we found
OIRDA activity in non-epileptic patients (NEP) too.
Method: The awake 770 EEG were analyzed. In that group 39 OIRDA
were detected. Mean age on the group was 8,4 years.
Results: In the group of 39 patients with OIRDA there were 21 patients
with CAE (54%), 3 patients with focal epilepsy (8%) and 15 NEP (38%).
NEP had different diagnoses: one had mental retardation, one cerebral
palsy (CP), two had migraine, two conversion disorders, two separation
anxiety disorder, three of them had tics and four attention-deficit hyper-
activity disorder. The mean age of CAE was lower than in the rest of the
group and it was 7 years, of the focal epilepsy group was 9 years. and of
the NEP was 9 years. In the CAE group boys were 52%, in the focal epi-
lepsy group were 33% and in NEP were 40%. Analysis of neurological
and neuroimaging examinations were normal except one patient with CP.
All patients had normal intellectual development. The background of
EEGwas normal in all the cases. In the groups of CAE and focal epilepsy
epileptiform discharges different from OIRDAwere observed.
Conclusion: The importance of OIRDA in EEG is unclear. OIRDA is
significantly more often observed among children, children with epi-
lepsy, in particular in CAE. Sometimes OIRDA can be present in NEP. It
is not known how to interpret the fact that OIRDA occurs in the cases of
NEP. It appears that presence of OIRDA is not pathognomonic for
epilepsy.
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LYSINERESTRICTION IN PYRIDOXINE DEPENDENT
EPILEPSY; RESULTS AFTER 2YEARSOF FOLLOW-
UP
H. Hartmann*, R. de Rooy†, L. Bok‡, K. van Karnebeek§,
I. Lunsing¶, M. van Rijn¶, A. van Wegberg**, F. van Spronsen¶
*Medizinische Hochschule Hannover, Hannover, Germany,
†VieCuri Medical Center, Venlo, Netherlands, ‡MaximaMedical
Center, Veldhoven, Netherlands, §Academic Medical Centre,
Amsterdam, Netherlands, ¶University Medical Center
Groningen, Groningen, Netherlands, **Radboud University
Medical Center, Nijmegen, Netherlands
Purpose: To evaluate the efficacy of lysine restricted diet in pyridoxine
dependent epilepsy, a neonatal epilepsy syndrome.
Method: Data were collected from children that had a proven PDE, and
were receiving a lysine restricted diet from an international PDE network
database. Data were reviewed trough literature afterwards.
Results: 14 patients were enrolled. All of them had a genetically proven
PDE. All of them had clinical seizures in the first week of life. Age at start
of lysine restriction ranged from 4 months to 4.5 years. Duration of
lysine restriction was between 6 months and 8 years. Most of them had
lysine intake between 32 and 60 mg/kg/day. Half of the patients used
concomitant anticonvulsant medicaments at any point , while all received
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pyridoxine as a primary therapy. One of them was on arginine supple-
mentation too. All patients had lower plasma pipecolic acid and urinary
AASA levels after 2 years of lysine restriction. Clinical outcome in terms
of intelligence, motor development and behaviour was hard to interpret
because of uncomplete data, however at least two patients showed
improvement.
Conclusion: Lysine restriction might at least be partly responsible for
biochemical and clinical improvement in PDE outcome. For this study,
other factors have probably played a role in improvement as well.
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STARTINGANTIEPLIPELTICMEDICATIONS BYNON
SPECIALISTS:WHATARE THEHAZARDS?
N. El Tantawi*, B. Hassanein*, M. El Gamal*, D. Abd Elmagid*
*Paediatric Department, Neurology Unit, Medical School,
Mansoura University, Mansoura, Egypt
Aim: To study the prescription of (AEDs) in children before they were
referred to specialist (pediatric neurologist).
Methods: This was a prospective study . Six hundred children referred
for the first time to the epilepsy clinic in a tertiary university hospital
were recruited. Detailed (AEDs) history was retrieved from the parents in
their first visit regarding the number of seizure after which they start
treatment, AEDs prescribed at the beginning of diagnosis and in the fol-
lowing 12 months, if the drug has changed and the reasons. Patients were
classified as truly epileptic and non epileptic after being reviewed by 2
neurologists.
Results: Truly epileptic patients represented 65% of the newly referred
patients. Of those, forty five percent have started one or more of AEDs
before referral. Thirty nine percent started after their first seizure.
Monotherapy was initiated in 65% of epileptic patients. Soduim Val-
proate (65.1%) was the most frequently prescribed AED followed by
Levetiracetam (41.0%) and topiramate (38.0%). The combination
between Soduim valproate and Levetiracetam as a starting therapy was
the most common. Twenty five percent of patients have changed the ini-
tial (AEDs) in the first 3 months of starting treatment. Worsening of sei-
zures and non availability of the medication were the most common
causes of changing (AEDs).
The non epileptic patients included diagnosis of: febrile seizures,
breath holding attacks, pallid attacks and self stimulating. When offered
to withdraw treatment after explanation of the condition by two neurolo-
gists, twinty eight percent refused to stop AEDs.
Conclusion: Starting AEDs by non specialist pediatrician has the haz-
ards of wrong diagnosis, inappropriate starting and changing of AEDs.
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THE PREVALENCEOFAUTISTIC SPECTRUM
DISORDER IN CHILDRENWITHEPILEPSY
L. Sfaihi*, L. Cherif†, A. Belbey†, M.A. Ghamgui*, T. Kamoun*,
F. Gribi†, M. Hachicha*
*Department of Pediatric CHUHedi Chaker University
Hospital, Sfax, Tunisia, †Department of Child Psychiatry CHU
Hedi Chaker University Hospital, Sfax, Tunisia
Purpose:
Determine the prevalence of ASD in children with epilepsy:
Method: Children with epilepsy seen in a tertiary care paediatrics
department were evaluated using validated autism screening question-
naires (ASQ). In addition, questions about sleep-related disorders, behav-
ior, seizure characteristics, and antiepileptic agents. An attempt was then
made to determine if there was a correlation between the factors identi-
fied and ASD.
Results: Approximately 12% of children fit the ASQ criteria for having
ASD. The majority had onset of seizures before the age of 1 year. Most
children had not been previously diagnosed. Worst behavior and daytime
sleepiness was seen in those at greater risk (p < 0.01). Seizures also
occurred earlier (before the age of 1 year) in children at risk of having
ASD.
Conclusion: This study suggest that children with epilepsy are at greater
risk of having ASD, and illustrates the need for more clinical vigilance.
Behavioral difficulties and daytime sleepiness identified in these children
could potentially affect their ability to learn.
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PATHOGENIC VARIANTS INKCTD7 PERTURB
NEURONALK+ FLUXES ANDGLUTAMINE
TRANSPORT
M.N. Moen*, R. Fajaer†, H. El Hassan*,‡, H. El Khashab§,¶,
M.A. Salih¶, F.A. Chaudhry*,**
*Oslo University Hospital, Department of Medical
Biochemistry, Oslo, Norway, †Oslo University Hospital,
Department of Medical Genetics, Oslo, Norway, ‡Oslo
University Hospital, Department of Molecular Medecine, Oslo,
Norway, §Ain-Shams University, Pediatrics, Cairo, Egypt, ¶King
Saud University, Pediatric Neurology, Riyadh, Saudi Arabia,
**University of Oslo, Institute of Basic Medical Science,
Molecular Medicine, Oslo, Norway
Purpose: To reveal the molecular mechanisms involved in the patho-
physiology of KCTD7-related progressive myoclonus epilepsy.
Method: We present two affected brothers with progressive myoclonic
epilepsy. At 9 months of age the elder brother developed ataxia and myo-
clonic jerks. In his second year he lost the ability to walk and talk, and he
developed drug-resistant progressive myoclonus epilepsy. The cere-
brospinal fluid level of glutamate was decreased while glutamine was
increased. His younger brother manifested similar symptoms from
6 months of age. Exome sequencing of the proband done.
Results: We identified a novel homozygous frameshift variant in the
potassium channel tetramerization domain 7 (KCTD7) gene
(NM_153033.1:c.696delT: p.F232 fs), which results in a truncated pro-
tein.The identified F232 fs variant is inherited in an autosomal recessive
manner, and the healthy consanguineous parents carry the variant in a
heterozygous state. Bioinformatic analyses and structure modelling
showed that KCTD7 is a highly conserved protein, structurally similar to
KCTD5 and several voltage-gated potassium channels, and that it may
form homo- or heteromultimers. By heterologous expression in Xenopus
laevis oocytes, we demonstrate that wild-type KCTD7 hyperpolarizes
cells in a K+ dependent manner and regulates activity of the neuronal glu-
tamine transporter SAT2 (Slc38a2), while the F232 fs variant impairs
K+ fluxes and obliterates SAT2-dependent glutamine transport. Charac-
terization of four additional disease-causing variants (R94W, R184C,
N273I, Y276C) bolster these results and reveal the molecular mecha-
nisms involved in the pathophysiology of KCTD7-related progressive
myoclonus epilepsy.
Conclusion: Our data demonstrate that KCTD7 has an impact on K+
fluxes, neurotransmitter synthesis and neuronal function, and that mal-
function of the encoded protein may lead to progressive myoclonus epi-
lepsy.
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JUVENILEMYOCLONIC EPILEPSY INMOROCCO:
EXPERIENCEOFMARRAKESHTHIRD LEVEL
HOSPITAL
M. Chaqda*, N. Adali*, N. Kissani*
*University Hospital Mohammed VI, Neurology, Marrakesh,
Morocco
Introduction: Juvenile myoclonic epilepsy (JME) is an adolescent
benign epilepsy representing 5 to 11% of all forms of epilepsy. It is quite
common in our Moroccan context. The aim of this study is to describe the
epidemiological, clinical, electroencephalographic (EEG) and therapeu-
tic features and the outcomes of our patients followed for JME.
Patients and methods: This is a retrospective study of 12 years (2004-
2015) including all patients followed for JME, collected at the neurology
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department of the University Hospital Mohammed VI, Marrakech. The
diagnosis of JME was based on clinical and electric criteria from the
(ILAE) We noted epidemiological data, patient’s history, clinical signs,
type and frequency of seizures and their triggers, data from the neurologi-
cal examination, electroneuromyography (EMG), treatment received and
outcome of patients.
Results: We collected 120 cases (56 girls and 64 boys). The mean age of
onset was 21 years. The family history of epilepsy was noted in 42
patients and consanguinity in 32. The diagnostic delay was estimated at
four years (+/- 2 years). Myoclonic jerks were often associated with
tonic-clonic seizures (81%) but, rarely with absences (14%). The elec-
troencephalogram was pathological in 77%: polyspike waves were found
in 28.4%, spike waves in 33% and focal abnormalities in 12%. The
neuro-genetic study of 4 inbred families showed significant peaks on
chromosome 1 (logarithm of odds (LOD) score> 3.0) and on chromo-
some 6 (LOD score of 3.0) in one family. Monotherapy was used in
86.6% of cases (104) and the sodium valproate was the most widely used
treatment. Patient follow-up showed good control of seizures in 93.3% of
cases.
Conclusion: Juvenile myoclonic epilepsy is a common and benign epi-
lepsy syndrome with a good clinical response to monotherapy. The fre-
quency of JME in our study could be explained by the amount of
inbreeding in our context.
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TREATMENTANDOUTCOMEOFWEST SYNDROME:
ABOUT 22 CASES
L. Sfaihi*, C. Zrig*, S. Kmiha*, M.A. Ghamgui*, I. Chabchoub*,
T. Kamoun*, M. Hachicha*
*Department of Pediatric CHUHedi Chaker University
Hospital, Sfax, Tunisia
Purpose: Evaluate and correlate the outcome of West syndrome (WS)
with the underlying causes.
Method: We conducted a retrospective study of all cases of WS in pedi-
atrics department of Hedi Chaker University Hospital in Sfax, during a
period of 12 years (2005 to 2016). The studied variables were the epi-
demiological, clinical, imaging, therapeutic and evolutionary data.
Results: Our study included 22 cases. The mean age at spasm onset was
6 months, and mean age at diagnosis and treatment 7.2 months. Accord-
ing to the etiology, 3 (20%) were idiopathic, and 2 (13%) were crypto-
genic. In 10 (67%) symptomatic cases, malformation of cortical
development (33%) was the most common etiologic factor followed by
hypoxic-ischemic encephalopathy (13%). Vigabatrin was used for the
first line treatment in 13 patients (one cryptogenic and 10 symptomatic),
and was added after failure of corticosteroids in 9 patients. The mean fol-
low-up was 6.6 (0.5 to 10 years). Three patients have normal psychomo-
tor development (1children with cryptogenic and two with idiopathic
WS), two had psychomotor retardation, without epileptic fits and still
receiving AED. Ten children (67%) had severe psychomotor retardation.
Lennox-Gastaut syndrome developed in 27%.
Conclusion: The poor prognosis concerning intractable nature of the sei-
zures and serious neurologic deficit is recorded in children with malfor-
mation of cortical development and hypoxic-ischemic encephalopathy.
The outcome of these children is determined by the brain damage other
than by epilepsy itself.
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UPDATES TOTHELAFORAEPILEPSYCURE
INITIATIVE (LECI) CLINICALCENTER:
DEVELOPMENTOFADATACOLLECTIONTOOL FOR
MEASUREMENTOFLAFORAEPILEPSYDISEASE
PROGRESSION
V.-H. Nguyen*, J.M. Serratosa†, B. Gonzales†, P. Genton‡,
R. Michelucci§, S. Sinha¶, S. Chandra¶, A. Beydoun**,
M. Arabi††, M. Kecmanovic‡‡, W. Whitehouse§§, I.M. Martinez-
Juarez¶¶, L. Guilhoto***, J. Salas-Puig†††, E. Ben-
Menachem‡‡‡, D. Goldsmith§§§, R.M. Duron¶¶¶,
M.T. Medina****, J.N. Bailey††††, M. Gentry‡‡‡‡,
B. Minassian§§§§, A.V. Delgado-Escueta¶¶¶¶,*****
*Chapman University School of Pharmacy, Irvine, CA, United
States, †Fundacion Jimenez Dıaz University Hospital, Madrid,
Spain, ‡Henri Gastaut-Centre Saint Paul Hospital, Marseilles,
France, §Neurology Unit, IRCCS-Institute of Neurological
Sciences of Bologna, Bologna, Italy, ¶Dept of Neuro/NIMHANS,
Bengalaru, India, **Comprehensive Epilepsy Program,
American University of Beirut Medical Center, Beruit, Lebanon,
††Department of Clinical Neurophysiology, Ibn Sina Hospital,
Kuwait City, Kuwait, ‡‡University of Belgrade, Belgrade,
Serbia, §§University of Nottingham, Nottingham, United
Kingdom, ¶¶Instituto Nacional de Neurologıa y Neurocirugıa,
Mexico City, Mexico, ***Federal University of Sao Paulo, San
Paulo, Brazil, †††University Hospital Vall-b’Hebron, Barcelona,
Spain, ‡‡‡Institute for Clinical Neuroscience and Physiology,
University of Gothenberg, Gothenberg, Sweden, §§§Chelsea’s
Hope Lafora Research Fund, Danville, CA, United States,
¶¶¶Facultad de Ciencias de la Salud, Universidad Tecnologica
Centroamericana (UNITEC, Tegucigalpa, Honduras,
****National Autonomous University of Honduras,
Teguicigalpa, Honduras, ††††University of California Los
Angeles, Epidemiology, Los Angeles, CA, United States,
‡‡‡‡University of Kentucy, Lexington, KY, United States,
§§§§University of Texas, Southwestern, Dallas, TX, United
States, ¶¶¶¶University of California Los Angeles, Neurology, Los
Angeles, CA, United States, *****VA Greater Los Angeles
Healthcare Center, Neurology, Los Angeles, CA, United States
Purpose: Our objective is to report the advances of the Lafora Epilepsy
Cure Initiative (LECI) Clinical Center, whose goal is to cure Lafora Dis-
ease (LD). We describe the development of a data collection tool for the
measurement of LD Progression in a retrospective natural history study,
the first step towards ensuring readiness for imminent curative drug tri-
als.
Methods: The data collection tool was developed by LECI Clinical Cen-
ter principal investigators with input from various stakeholders including
LD researchers, clinicians, pharmaceutical companies, patients, families,
caretakers, and advocates from workshops held in Istanbul, Philadelphia,
and La Jolla in 2015 and 2016. Impact of disease, benefit-risk tradeoffs,
and definition of treatment benefit were also identified.
Results: Data elements to be collected on the CRF include:
(1) demographic and environmental data (including healthcare environ-
ment data, country-specific clinical care standards, healthcare sys-
tem perspectives, and treatment alternatives available) believed to
be candidate prognostic variables that may affect disease progres-
sion;
(2) pathologic data confirming the clinical diagnosis of LD on skin
biopsy;
(3) Radiographic data including brainMRI imaging;
(4) genetic data;
(5) clinical data.
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Clinical data elements were based off the diagnostic criteria of LD and
include measures of epilepsy, cognition, ataxia and quality of life/func-
tion modified from Franceschetti et al. Common data elements (CDEs)
that were likely to be recorded as part of routine care were identified and
included (e.g. demographic data, MMSE, MOCA, neurologic examina-
tion). Data elements which could be extracted from the chart and applied
to standardized instruments for scoring were also included (e.g. scoring
of performance on tandem gait with selected standardized ataxia scales).
Conclusion: A data collection tool has been developed for a retrospec-
tive longitudinal natural history study of LD. The data collection tool will
inform future prospective studies and ultimately contribute to the devel-
opment of an LD Progression Scale.
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MATHEMATICALMODELINGOFMELATONIN
DIURNAL SECRETION INCHILDRENWITHEPILEPSY
J. Paprocka*, M. Kijonka†, M. Sokoł†
*School of Medicine in Katowice, Medical University of Silesia,
Child Neurology Department, Katowice, Poland, †Maria
Skłodowska-Curie Memorial Cancer Center and Institute of
Oncology, Gliwice Branch, Department of Medical Physics,
Gliwice, Poland
Purpose: The main objective of the study was to create a mathematical
model that describes the melatonin circadian secretion and, then the func-
tionality of the model was tested by a comparison of the melatonin secre-
tions in children with and without epilepsy.
Method: The patients were divided into the epilepsy group (EG=54 )
and the comparison group (CG=32 ). The melatonin level was assessed
by a radioimmunoassay method. The diurnal melatonin secretion was
described using a nonlinear least squares method. Spearman’s rank corre-
lation coefficient was chosen to estimate the dependence of the acquired
data. The model reproduces blood concentration profiles and its parame-
ters were statistically analyzed using the Mann-Whitney-Wilcoxon test
and logistic regression
Results: The correlation analysis performed for the EG and CG groups
showed moderate correlations between age and the melatonin secretion
model parameters. Patients with epilepsy are characterized by an
increased phase shift of melatonin release.
Conclusion: Mathematical modeling of circadian melatonin cycle facili-
tates statistical analysis of the patients’ hormone levels offering a set of
parameters that enable objectification of the secretion description.
p1100
ANGELMAN SYNDROME –MATHEMATICAL
MODELINGOFMELATONIN SECRETION
J. Paprocka*, M. Kijonka†, M. Sokoł†
*School of Medicine in Katowice, Medical University of Silesia,
Child Neurology Department, Katowice, Poland, †Maria
Skłodowska-Curie Memorial Cancer Center and Institute of
Oncology, Gliwice Branch, Department of Medical Physics,
Gliwice, Polandrzesuniezcie fazowe sekrecji,
DLMOon25 DLMO na poziomie progu wzglezdnego 25% i DLMOon50
DLMO na poziomie progu wzglezdnego 50%. This clinical observation adds
to the growing data showing melatonin secretion disturbances in
Angelman syndrome and epileptic encephalopathy as compared
to the non-epileptic children.
Purpose: The aim of the study was to access melatonin secretion in chil-
dren with Angelman syndrome and to compare it to the children with and
without epilepsy.
Method: Study group consist of the Angelman syndrome group (AG,
n = 14), epilepsy group (EG, n = 74), and the comparison group (CG,
n = 35). The melatonin level was assessed by radioimmunoassay
method. The blood samples were drawn every 3 hours through an intra-
venous catheter. To describe the diurnal melatonin secretion nonlinear
least squares method was used. The Levenberg-Marquardt algorithm was
chosen to estimate the parameters of the model curve. This model repro-
duces blood concentration profiles and its parameters were statistically
analyzed using the Mann-Whitney-Wilcoxon test and Spearman´s rank
correlation coefficient.
Results: The correlation analysis performed for the EG and CG groups
showed moderate negative correlations between age and melatonin
release amplitude as well as age and maximum melatonin concentration.
Moreover, in the latter group positive correlation between age and phase
shift of melatonin release was evident. As reveals from the comparison of
the AG and CG groups AS patients are characterized by longer sleep
duration and increased phase shift of melatonin release. In AS group
DLMOon25 and DLMOon50 were phase shifted.
Conclusion: This clinical observation adds to the growing data showing
melatonin secretion disturbances in Angelman syndrome and epileptic
encephalopathy as compared to the non-epileptic children.
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DIFFUSION TENSOR IMAGE IN INTERICTAL
PSYCHOSIS AND TEMPORALLOBE EPILEPSY:
WIDESPREADWHITEMATTERALTERATIONS AND
DISRUPTIONS IN INSULAANDCINGULUM
CONNECTIVITY
L.R. Horta de Macedo*, C.E. Salmon†, A.C. dos Santos*,
A.C. Sakamoto*, J.E.C. Hallak*
*Universidade de S~ao Paulo, Faculdade de Medicina de
Ribeir~ao Preto, Department of Neuroscience and Behavior,
Ribeir~ao Preto, Brazil, †Universidade de S~ao Paulo, Faculdade
de Filosofia Cie^ncias e Letras de Ribeir~ao Pretoto, Physics
Department, Ribeir~ao Preto, Brazil
Purpose: Psychosis has greater prevalence in epilepsy than in general
population, specially in refractory epilepsy, yet few studies investigate
this condition. White matter and connectivity abnormalities are well
described in temporal lobe epilepsy (TLE) an are considered a hallmark
of schizophrenia. The objective of this study was to investigate white
matter integrity and brain connectivity in TLE subjects with IP comorbid-
ity.
Method: Diffusion weighted images scans were obtained from nine sub-
jects with TLE associated wtih hippocampal sclerosis (TLE-HS) and
interictal psychosis (IP), (mean age: 46,33, 7,78), nine subjects with
TLE-HS and no psychiatric comorbidity (mean age 46,22,  9,82) and
nine healthy matched controls (mean age 43,89,  9,62). The images
were analyzed by tract-based spatial statistic (TBSS) and by a quantita-
tive analysis of connectivity based in graph theory. The quantitative anal-
ysis was centered on limbic system’s structures.
Results: White matter abnormalities, presented as reduction in fractional
anisotropy (FA), were found in both epilepsy groups, compared to control
group. IP subjects displayed more extensive reduction in FA than the epi-
lepsy group without comorbidity, although the difference was not statisti-
cally significant. The graph analysis showed significantly bilateral
reduction of connectivity between cingulum-hippocampus and cingu-
lum-parahippocampal gyri, and increased connectivity between insula
and amygdala in psychosis, compared with the other two groups.
Conclusion: While both groups presented abnormalities in white matter,
some characteristics seem to be related only to psychosis. IP group has
more extensive reduction in FA, including brain regions not altered in
TLE. The disconnection in cingulum is a important finding, since it has
been described previously in persons schizophrenia, suggesting that IP
and schizophrenia share some physiopathological characteristics. The
aberrant insula connectivity is also noteworthy, due to its importance in
executive functions and processing of sensory information, whose dis-
ruptions are related to psychotic symptoms.
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PSYCHOGENIC NON-EPILEPTIC SEIZURES IN
ADULTSWITH INTELLECTUALDISABILITY’
J.S. van Ool *, F.M. Snoeijen-Schouwenaars*, A.I. Haenen*,
I.Y. Tan*, R.H. Lazeron†, C.J.J. van Asch†, I.M.P. Gommans†,
H.J. Schelhaas†, J.G.M. Hendriksen‡, A.P. Aldenkamp§,
N.M.G. Bodde§
*Academic Centre for Epileptology Kempenhaeghe, Department
of Residential Care, Heeze, Netherlands, †Academic Centre for
Epileptology Kempenhaeghe, Department of Neurology, Heeze,
Netherlands, ‡Academic Centre for Epileptology
Kempenhaeghe, Department of Neurological Learning
Disabilities, Heeze, Netherlands, §Academic Centre for
Epileptology Kempenhaeghe, Department of Behavioral
Sciences, Heeze, Netherlands
Purpose: Psychogenic non epileptic seizures (PNES) are episodes of
movement, behavior or sensations that resemble epileptic seizures but
are not accompanied by epileptiform brain activity on an electroen-
cephalogram. Although PNES might be common in people with epilepsy
and intellectual disability (ID), little is known about the exact presenta-
tion and (co-morbid) problems in this population. Our study aims to
describe the features of a group of adult patients with epilepsy, ID and
PNES and to analyze the differences between this group and a control
group of patients with epilepsy and ID, without PNES. We hope to con-
tribute to a better understanding of this complex group of patients in order
to optimize treatment.
Method: This observational case-control study was conducted at Kem-
penhaeghe Epilepsy Center, The Netherlands. Adult patients, living at
Kempenhaeghe, with epilepsy, ID and a registration of non-epileptic
events in their medical records were selected and evaluated on how cer-
tain the PNES diagnosis was in terms of the classification of LaFrance
(2013). Clinical characteristics of PNES were provided by the subject’s
mentor, using a standardized questionnaire. As a control group, patients
with epilepsy and ID, without PNES, (N = 100) were included. Clinical
information was retrieved from patient charts retrospectively and data on
neuropsychiatric symptoms were collected by standardized question-
naires.
Results: This study is ongoing and results will be presented at the con-
gress. Clinical characteristics of PNES in adults with ID (N = 20; mean
age=46.2) will be described qualitatively. The PNES group comprised
50% females and 60% had mild-moderate ID, versus 40% with severe
ID. Differences between the PNES group and the non-PNES group are
analyzed with respect to epilepsy characteristics, level of ID and neu-
ropsychiatric symptoms.
Conclusion: In the population of patients with epilepsy and ID there are
diagnostic questions whether the seizures manifest as PNES or represent
a reinforced behavior pattern.
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PREDICTIVE VALUESOF PSYCHOSOMATIC TOOLS
FOR SEIZURERECURRENCE THE FOLLOWING
MONTH IN PATIENTSWITHWELL-CONTROLLED
EPILEPSY
S.-P. Park*
*School of Medicine, Kyungpook National University,
Neurology, Daegu, Korea
Purpose: Stress, fatigue, sleep problems, and emotional distress such as
depression or anxiety have been reported as psychosomatic factors for
triggering seizure in patients with epilepsy. Those factors always draw
their attention, but can be ignored by patients with well-controlled epi-
lepsy (WCE). Although unexpected seizures can elicit embarrassing situ-
ation in patients with WCE, there are no studies to evaluate predictive
values of psychosomatic factors for future recurrence of seizure in those
patients.
Method: We enrolled patients who had a year of seizure freedom. Sub-
jects were asked to complete screening tools including the Perceived
Stress Scale-4 (PSS-4), the Korean version of the Neurological Disorders
Depression Inventory for Epilepsy (K-NDDI-E), the Generalized Anxi-
ety Disorder-7 (GAD-7), Fatigue Severity Scale (FSS), and the short
forms of the Patient-Reported Outcomes Measurement Information Sys-
tem Sleep-Related Impairment (PROMIS-SRI) and Sleep Disturbance
(PROMIS-SD) scales. We observed seizure recurrence the following
month. We examined predictive values of screening tools for seizure
recurrence using receiver operating characteristic (ROC) analyses.
Results: One hundred forty-three patients were initially invited. Nine
patients with irregular antiepileptic drug intake during the study period
were excluded. Seven patients (5.2%) experienced seizure recurrence the
following month. They usually had complex partial seizures with symp-
tomatic etiology. Five screening tools except the PROMIS-SRI had sig-
nificant predictive values for seizure recurrence (AUC ranging from
0.729 to 0.907). The most valuable screening tool was the PSS-4, fol-
lowed by the GAD-7, the PROMIS-SD, the K-NDDI-E, and the FSS.
Cronbach´s a coefficients for the PSS-4 was 0.746. At a cutoff score of 9,
the PSS-4 had a sensitivity of 85.7% and a specificity of 92.4%.
Conclusion: Clinicians can alert patients with WCE to occur seizure in
the following month by using the PSS-4.
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EDUCATIONAND JOB INDEPENDENCEOF PATIENTS
WITHREFRACTORYEPILEPSYWHOWERE
ASSESSEDAS POTENTIALCANDIDATES FOR
EPILEPSY SURGERY INANEPILEPSYREFERENCE
CENTER INGUATEMALA
L.E. Vega Zeissig*, W.R. Duarte Celada*, J. Leon Aldana†
*Epilepsy and Functional Neurosurgery Center / HUMANA,
Neurophysiology, Guatemala City, Guatemala, †Epilepsy and
Functional Neurosurgery Center / HUMANA, Epileptology,
Guatemala City, Guatemala
Purpose: Highlight the burden of epilepsy on education and job indepen-
dence of patients with refractory epilepsy who were assessed as potential
candidates for epilepsy surgery.
Method: It is a descriptive and retrospective study. All the clinical
records of patients with refractory epilepsy, who were assessed as poten-
tial candidates for epilepsy surgery fromMarch 2014 to December 2016,
were reviewed to document the information about education, causes of
school dropout and job status.
Results: 92 clinical records of patients with refractory epilepsy were
reviewed. 43 female, 49 male. 73 patients were older than 17 years old.
9.8% completed university, 21.7% finished high school, 3.2% completed
middle school, 32.6% completed only primary education, 11.9% did not
complete primary school, 9.7% never attended school, 10.8% are cur-
rently studying. From all the patients who are older than 17 year old:
64.3% do not work, 27.39% are currently working. From those patients
who are currently working: 45% work in informal jobs. Causes of school
dropout of all the patients who did not complete high school or never
went to school (53 patients): 25 (55.5%) due to epilepsy issues; 6 (13.3%)
learning disabilities; 6 (13.3%) lack of financial support; 3 (6.6%) psy-
chomotor impairment; 3 (6.6%) behavior issues; 2 (4.4%) because they
did not want to study; 8 patients did not answer the reason of school drop-
out.
Conclusion: Epilepsy causes a negative effect on education and job
independence of patients with refractory epilepsy. In this study more than
half of the patients (57.4%) were not able to complete high school, and
only 27.3% are currently working. Stablishing the impact of the condition
and the causes of school dropout, school non-attendance and unemploy-
ment is important to develop campaigns of education for teachers,
employers and caregivers, in order to reduce the burden of epilepsy.
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SOCIALMEDIA IN EPILEPSY: AQUANTITATIVE AND
QUALITATIVEANALYSIS
Y. Meng*, L. Elkaim†, J. Wang*, J. Liu*, N. Alotaibi*,
G. Ibrahim*, A. Fallah‡, A. Weil†, T. Valiante*, A. Lozano*,
J. Rutka*
*University of Toronto, Toronto, ON, Canada, †Sainte Justine
Hospital, Montreal, QC, Canada, ‡David Geffen School of
Medicine at University of California, Los Angeles, CA, United
States
Background: While the social burden of epilepsy has been extensively
studied, an evaluation of social media related to epilepsy may provide
novel insights into disease perceptions, patient needs and access to treat-
ments that cannot otherwise be gleaned. The objective of this study is to
assess patterns in the social media and online communications usage
related to epilepsy and associated topics.
Methods: We performed a search of two major social media platforms
(Facebook and Twitter) for public accounts dedicated to epilepsy. Results
were analyzed using qualitative and quantitative methodology. The for-
mer involved thematic and word count analysis for online posts and
tweets on these platforms, while the employed non-parametric tests for
statistical significance.
Results: Facebook had a higher number of pages (840 accounts) and
users (3 million) compared to Twitter (137 accounts and 274,663 users).
Foundation and support groups comprised most of the accounts and users
on both Facebook and Twitter. The number of accounts increased by
100% from 2012 to 2016. Among the 403 posts and tweets analyzed,
“providing information” on medications or correcting common miscon-
ceptions in epilepsy, was the most common theme (48%). Surgical inter-
ventions for epilepsy were only mentioned in 1% of all comments and
tweets.
Conclusions: The current study provides a comprehensive reference on
the usage of social media in epilepsy. The number of online users inter-
ested in epilepsy is likely the highest amongst all neurological conditions.
Surgery as method of treating refractory epilepsy is however, underrepre-
sented on social media.
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ABNORMALITIES ONDIFFUSION-WEIGHTEDMRI IN
STATUS EPILEPTICUS
J. Son*
*Bongseng Memorial Hospital, Neurology, Busan, Korea
Purpose: Transient focal abnormalities on diffusion-weighted MRI in
status epilepticus may represent increased energy metabolism, hyperper-
fusion and cell swelling as a consequence of ictal activity.
The purpose of this study is including 1) to determine the reversible
abnormality on diffusion-weighted MRI and 2) to discuss its mechanisms
and clinical significance.
Method: Retrospective review of chart of 51 patients (30 men, 21
women) presenting with status epilepticus. Patients with CNS infection
like encephalitis, acute trauma or acute stroke were excluded from this
study. All patients underwent brain MRI within 1 week from the seizure
onset. The diagnosis of status epilepticus was based on clinical criteria.
The sites and characteristics on brain diffusion-weighted MRI were
recorded
Results: 51 patients presented with status epilepticus and underwent
brain MRI within 1 week. Of them, 21 (41.2%) patients exhibited focal
abnormality on diffusion-weighted MRI. Location of abnormality was
cortical, thalamus, hippocampus and pulvinar. 5 patients showed bilateral
signal abnormality. Repetitive MRI showed that reversibility was in 14
patients and residual atrophy was in 7 patients. One patient with residual
atrophy had a neurological deficit such as permanent left hemiparesis.
Conclusion: Our findings revealed that the abnormality on diffusion-
weightedMRI and residual brain atrophy in status epilepticus is more fre-
quent than previous study. These abnormalities may reflect the epilepto-
genic hyperexcitation and propagation of ictal discharge.
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BRIVARACETAM IN ESTABLISHED STATUS
EPILEPTICUS: THE SALZBURGEXPERIENCE
G. Kalss*, A. Rohracher*, M. Leitinger*, G. Pilz*, H.F. Novak*,
C. Neuray*, R. Kreidenhuber*, J. H€ofler*, G. Kuchukhidze*,
E. Trinka*
*Christian Doppler Klinik, Paracelsus Medical University,
Department of Neurology, Salzburg, Austria
Background: Brivaracetam (BRV) is a novel affinity synaptic vesicle
glycoprotein 2A (SV2A) ligand that is structurally related to levetirac-
etam (LEV). Compared to LEV, its affinity to the ligand is >10-30 %
higher. Due to its lipophilic characteristics, it might have a stronger anti-
convulsant effect and a quicker penetration across the blood brain barrier.
Methods: We analyzed treatment response, seizure outcome and adverse
effect rates in add-on treatment with BRV in patients with established
Status epilepticus (eSE) from 01/2016 to 02/2017 by retrospective chart
view at our neurological department with intensive care unit.
Results: BRV was administered intravenously in six patients (five
women) with eSE. Median age was 71 (range 32-79) years. Two patients
had non convulsive Status epilepticus (NCSE) without coma and four
had comatose NCSE. Status arose de novo in two patients and was remote
symptomatic in four patients. The most frequent etiology was remote
vascular (in two patients). BRV was administered in median after four
antiepileptic drugs (AEDs), range 2-9. Time of treatment initiation ran-
ged from < 2 h hours to 12 days (median 4 days, in 83% of patients
>72 h). Immediate EEG or clinical improvement was observed in 2
patients (33%). Median loading dose was 100 mg intravenously over
15 minutes (range 50-200 mg), titrated up to a median dose of 100 mg/d
(range 100 mg/d - 200 mg/d). Glasgow outcome scale (GOS) was 3 in
median (range 3-5) with an improvement in 83% of patients compared to
admission. We observed no adverse effects (AEs) regarding cardio-
respiratory function.
Conclusion: BRV might have a potential as novel AED in eSE as sug-
gested by this preliminary case study. Its promising potential might be
caused by its ability to cross the blood barrier faster than LEV and good
safety profile. Prospective studies for the use of BRV in eSE are required.
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ACUTEMANIFESTATIONS ANDLONGTERM
OUTCOMEOF STATUS EPILEPTICUS IN
ALTERNATINGHEMIPLEGIAOFCHILDHOOD
J. Uchitel*, L. Prange*, M. McLean*, J. Wuchich†, E. Heinzen‡,
D. Goldstein‡, M. Mikati*
*Duke University Medical Center, Pediatric Neurology,
Durham, NC, United States, †Cure AHC Foundation, Durham,
NC, United States, ‡Columbia University College of Physicians
and Surgeons, New York City, NY, United States
Purpose: To describe the manifestation and long term outcome of status
epilepticus (SE) in Alternating Hemiplegia of Childhood (AHC). About
half of AHC patients have epilepsy and some have SE, yet the manifesta-
tions and long term outcomes of SE in these patients have yet to be char-
acterized.
Method: We analyzed a cohort of 25 patients seen in our center who ful-
filled the AHC diagnostic criteria.
Results: 14/25 had epilepsy. Seven (currently 24, 9, 11, 5, 6, 17, and 5
yo) had SE (≥30 min): mean duration 7.64  11.96 hours (30 min-36),
age of occurrence 6.18  7.15 years (0-23, median 4). Follow up was on
average 2.29  1.91 years after first SE episode. Five had 3 episodes, 1
had two, and 1 had one. All episodes were refractory (failing to stop after
a benzodiazepine and another medication); one was super-refractory
(>24 hours). Patients required 3-5 medications to stop SE. Intubation
was required in 3/15 events (2/6 patients). All episodes were secondary
generalized tonic-clonic SE. In 3/15 there was an initial complex partial
component and in one a highly lateralized component. Two episodes in
two different patients were immediately preceded by a non-epileptic
AHC spells, and 2 other SE episodes in one patient were precipitated by
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attempts to taper phenobarbital. 2/7 had regression: One had regression
after each of 3 status episodes: gross motor; swallowing, feeding, fine
motor and sign language. Another had poor coordination and lost bab-
bling after an episode. The first regained prior function after periods of
few weeks after each episode and the second after few days.
Conclusion: Long term outcome after status epilepticus in AHC patients
ranges from no regression to severe motor and linguistic regression.
Regression is not a must, but clinicians should be aware to treat early.
p1130
EPIDEMIOLOGY-BASEDMORTALITY SCOREVS.
STATUS EPILEPTICUS SEVERITY SCORE FOR
PREDICTIONOFLONGTIME SURVIVAL IN STATUS
EPILEPTICUS IN ADANISHCOHORT
H.S. Møller*, C.P. Beier*, M. Lando*, P. Aukland*
*Odense University Hospital/Institute of Clinical Research and
University of Southern Denmark, Neurology, Odense, Denmark
Purpose: Status Epilepticus (SE) is an life threatening condition. Prog-
nostic factors predicting long-term mortality after SE are lacking. The
Status Epilepticus Severity Score (STESS) was developed to predict
short-term survival and only poorly correlates with long-term survival. A
recent study suggested that Epidemiology-Based Mortality Score in Sta-
tus Epilepticus (EMSE) is more precise to predict in-house mortality and
the consideration of etiology may also improve the predictive value for
long-term survival. The aim of the study was to compare if EMSE was
superior to STESS to predict long-termmortality.
Method: We retrospectively assess EMSE and STESS in a Danish
cohort of 96 SE patients admitted to Odense University Hospital from 01/
2008 to 01/2015. We used cut-of value of 64 points in EMSE and
STESS-4 to predict mortality (EMSE >64 point bad outcome, STESS >4
point bad outcome). The primary endpoint of the study was to compare
the ability of EMSE or STESS to predict overall outcome. Further, we
compared sensitivity and specificity between EMSE and STESS to pre-
dict mortality at 3 months and at the end of follow up.
Results: The mean time of survival were 865 days (1-2863 days).
EMSE was slightly superior to STESS to predict long-term mortality in a
Kaplan Meier analysis (average survival: STESS 328 vs. 1247 days,
EMSE 420 vs. 1595 days). There was no difference in predicting short-
term mortality after 3 month (AUC: 0.656 vs. 0.660). At end of follow-
up, EMSEwas slightly better than STESS (AUC: 0.780 vs. 0.703).
Conclusion: Although EMSE predicted long-termmortality slightly bet-
ter than STESS, we did not find a clinically meaningful difference. Given
that assessment of STESS is solely based on clinical data already avail-
able in the emergency room, our data does not indicate that EMSE is
superior to STESS to predict long-termmortality in clinical practice.
p1136
RE-EVALUATIONOF THECRITICALLY ILL
PATIENTSWITHNON-CONVULSIVE STATUS
EPILEPTICUS BYUSING SALZBURGCONSENSUS
CRITERIA
O. Gungor Tuncer*, E. Altindag*, M. Nalbantoglu*, M.E. Acık*,
S. Tavukcu Ozkan†, B. Baykan‡
*Istanbul Bilim University Faculty of Medicine, Istanbul,
Turkey, †Memorial Hizmet Hospital, Istanbul, Turkey, ‡Istanbul
University Istanbul Faculty of Medicine, Istanbul, Turkey
Purpose: Systematic studies on the incidence of nonconvulsive status
epilepticus(NCSE) in critically ill patients related to etiologic groups,
electrophysiological features of “true” ictal patterns associated with
NCSE and the factors shown to be correlated with clinical and EEG
improvement are still scarce.
Method: We retrospectively reviewed all EEG data of the consecutive
patients with critical illness, followed up in the Intensive Care Unit(ICU)
with clinical suspicion of NCSE during 2 years. Two experienced, certi-
fied clinical neurophysiologists reviewed all EEG data independently
and determined NCSE according to Salzburg Consensus Criteria. The
incidence and predominant features of clearly defined ictal EEG patterns
and their relationship to clinical, laboratory, neuroradiological, and prog-
nostic findings were assessed.
Results: A total of 107 consecutive patients with the mean age of
68.2  15.3 years(57 females) were enrolled in the study. In 62 patients,
continuous EEG monitoring was applied with a mean duration of
45.3  24.5 hours. Primary neuronal injury was detected in 57 patients
(62.6%) including post-anoxic coma in 10 patients, whereas the remain-
ing patients had various metabolic, systemic problems. Twenty-four
patients(22.4%) were diagnosed as NCSE fulfilling the suggested crite-
ria. While authors decided to treat in 33 patients (30.8%), 32 patients
(29.9%) had been treated in real-life evaluation. The presence of clinical
seizures and a high mortality rate along with a long duration of stay in the
ICU were more common in the group with definite NCSE. Among the
investigated EEG features, fluctuation and triphasic waves were not pre-
dictive to diagnose NCSE. Clinical and EEG improvement was detected
in 12 patients(11.3%) in real-life treatment group showing correlation
with absence of mechanical ventilation, infection, and sepsis.
Conclusion: The diagnosis of NCSE in critically ill patients is a matter
of debate. Our findings suggest that Salzburg Criteria is compatible with
clinical practice in the decision for treatment of patients with NCSE.
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THE PRACTICEOFREVISEDCLASSIFICATIONOF
FOCALCORTICALDYSPLASIAONDRUG-RESISTANT
EPILEPSY INWESTCHINA: ANURGENT
DIAGNOSTICGAP FOR FILLING
C. Huang*, H. Zhang*, X.-S. Chi*, N. Chen*, Q. Zhou*,
I. Blumcke†, D. Zhou*, J.-M. Li*
*West China Hospital of Sichuan University, Chengdu, China,
†University Hospital Erlangen, Erlangen, Germany
Purpose: To clinically and histopathologically re-examine refractory
epilepsy cases using the revised 2011 ILAE classification of focal corti-
cal dysplasia (FCD).
Method: Consecutive patients with drug-resistant epilepsy submitted to
surgery from July 2012 to Jun 2014 were included. Pathological diagno-
sis, clinical histories and surgery outcome were reviewed. A question-
naire was developed to explore changes in histopathology practice. A
short-term training program on FCD was carried out to improve patho-
logical diagnosis accuracy.
Results: 260 cases (177 male and 83 female) were included with mean
age at surgery of 25.1 years. Pathological diagnosis was changed in 70
cases (26.9%) after re-examination. The five most common pathologies
were hippocampal sclerosis (HS) (19.2%, 50/260), brain tumors (17.7%,
46/260), vascular malformations (16.2%, 42/260), glial scars (11.2%, 29/
260) and FCD (10.0%, 26/260). The most common subtype of isolated
FCD was FCD IIb (53.8%, 14/26), followed by FCD IIa (42.3%, 11/26)
and FCD Ib (3.8%, 1/26). Forty-five cases were diagnosed with associ-
ated FCD type III (17.3%, 45/260). Half of patients with FCD achieved
Engel class I at two-year follow-up. The prognosis of HS with FCD IIIa
was poorer than HS without associated FCD IIIa. Questionnaire investi-
gation suggested most participant pathologists lack sufficient knowledge
and training courses on the new classification. The diagnostic sensitivity
for different FCD subtypes was significantly improved by two to six folds
after short-term training.
Conclusion: FCD is an important etiological factor in drug-resistant epi-
lepsy in southwest China. It is essential to provide continuing training to
improve pathological practice and diagnosis in developing countries.
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EARLY IDENTIFICATIONOF PATIENTSWITHDRUG-
RESISTANT EPILEPSY
D.M. Hughes*, L.J. Bonnett*, G. Czanner*,†, A. Komarek‡,
A. Marson§, M. Garcıa-Fi~nana*
*University of Liverpool, Department of Biostatistics, Liverpool,
United Kingdom, †University of Liverpool, Department of Eye
and Vision Science, Liverpool, United Kingdom, ‡Charles
University, Faculty of Mathematics and Physics, Prague, Czech
Republic, §University of Liverpool, Department of Molecular
and Clinical Pharmacology, Liverpool, United Kingdom
Purpose: Whilst 60 to 70% of people with epilepsy have a good progno-
sis and enter a remission from seizures, 30 to 40% do not. Currently
patients wait years before clinicians are confident that their epilepsy is
drug-resistant. Early identification of drug-resistance could alter man-
agement strategies and speed up access to epilepsy surgery. We aimed to
use data from the SANAD study to identify patients with drug resistant
epilepsy as early as possible.
Method: The SANAD study is the largest prospective study in patients
with epilepsy to date. Here we apply multivariate longitudinal discrimi-
nant analysis to the SANAD dataset in order to dynamically predict the
risk of a patient having drug resistant epilepsy. External validation was
performed with the MESS and NGPSE datasets.
Results: We have developed a model that is able to identify patients with
drug resistant epilepsy with a high degree of accuracy. 95% of patients
with drug resistant epilepsy were correctly classified (sensitivity) and the
majority of these patients were identified at least 2 years earlier than cur-
rently possible. 97% of patients who achieved remission were correctly
classified (specificity). For patients who the model predicted as being
drug resistant, 76%were truly drug resistant (Positive Predictive Value).-
Changes in patient’s seizure and treatment history were the most infor-
mative longitudinal variables. Several baseline variables informed the
evolution of the longitudinal variables over time: Number of seizures
before randomisation, history of neurological insult, type of epilepsy,
Age at randomisation, sex, and having a first degree relative with epi-
lepsy.
Conclusion: This externally validated model could be of use in the early
identification of patients with drug resistant epilepsy in order to consider
possible further interventions and offer patients more appropriate coun-
selling regarding their condition.
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DELAYEDRESPONSES EVOKEDBY SINGLE PULSE
ELECTRICAL STIMULATION LOCALISE THE
EPILEPTOGENIC ZONE FORTEMPORAL LOBE
RESECTIVE SURGERY: A LONG-TERM STUDY
T. Hope*, V. Sanchez-Sanchez†, C. Pimenta-Reis†, A. Mu~noz-
Morente†, R. Selway‡, G. Alarcon†,‡,§,¶, D. Jimenez-Jimenez‡,**,
A. Valentın‡
*King’s College London, Institute of Psychiatry, Psychology &
Neuroscience, London, United Kingdom, †King’s College
London, London, United Kingdom, ‡King’s College Hospital,
London, United Kingdom, §Universidad Complutense, Madrid,
Spain, ¶HamadMedical Corporation, Doha, Qatar, **Kings
College London, London, United Kingdom
Purpose: The epileptogenic zone is the region of cortex that needs to be
resected to achieve seizure freedom. Single pulse electrical stimulation
(SPES) is a technique used to help identify the epileptogenic zone in
patients with epilepsy. Delayed responses (DRs) elicited by SPES are a
reliable indicator of epileptogenic cortex. Short-term studies show that
surgical outcome is favourable when DRs are present within the resected
region. Here we have studied the long-term outcome of patients who
underwent temporal lobe resections for the treatment of epilepsy.
Method: A total of 308 patients who underwent invasive pre-surgical
assessment at King’s College Hospital from 1999 - 2015 were analysed.
Only 46 patients fulfilling the following criteria were included:
(a) SPES recordings and clinical notes were available,
(b) patients had unilateral DRs or no DRs,
(c) there was a post-surgical follow-up of at least 12 months,
(d) the patient underwent a temporal lobe resection.
If the area where DRs were recorded was completely removed by
resection, surgery was said to be congruent with DRs. The relationship
between surgery that was congruent with DRs and surgical outcome was
explored. Engel classification grades I-II were considered favourable,
and III-IV were considered poor.
Results: In 27 out of the 46 patients (58.7%), surgery was congruent with
DRs. Of these patients, 81.5% had a favourable outcome, whereas 18.5%
had a poor outcome. In 5 of the 46 patients (10.9%), surgery was incon-
gruent or partially congruent with DRs. Of these patients, 40% had a
favourable outcome, whereas 60% had a poor outcome. In 14 patients out
of 46 (30.4%), no DRs were found. Of these patients, 57.1% had a favour-
able surgical outcome, and 42.9% had a poor outcome. The average fol-
low up was 51.8 months.
Conclusion: Resection that is guided by DRs is associated with favour-
able long-term surgical outcome.
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